,median,median_perc,mean,std,min,max,over_threshold,names
hsa:347411,0.0,0.0,1.2973264451612903e-08,3.52529056327432e-08,0.0,1.7418515e-07,False,MPC1L; mitochondrial pyruvate carrier 1
hsa:8907,5.22433e-07,0.00036931153475213633,2.7152001620967746e-06,4.8930367645839525e-06,0.0,2.011896e-05,False,AP1M1; adaptor related protein complex 1 subunit mu
hsa:5810,9.576417e-09,6.769636029302224e-06,1.0827698082419355e-06,1.8063784237369834e-06,0.0,6.0726475e-06,False,RAD1; RAD1 checkpoint DNA
hsa:7358,0.00020408636,0.14427007259031685,0.0003471557288709677,0.00040692412290439675,0.0,0.0014379363,False,UGDH; UDP-glucose
hsa:406910,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125A; microRNA
hsa:55304,6.0082937e-07,0.00042473047598229655,1.838653185779032e-05,3.401207615927899e-05,0.0,0.000115432085,False,SPTLC3; serine palmitoyltransferase long chain base subunit
hsa:5528,2.2064078e-06,0.0015597250765305496,2.985502830632258e-05,6.342671787216091e-05,0.0,0.00033047862,False,PPP2R5D; protein phosphatase 2 regulatory subunit
hsa:2767,0.0,0.0,0.00018032619612903223,0.0002709338367669903,0.0,0.0010280483,False,GNA11; G protein subunit alpha
hsa:727,0.0,0.0,9.155006422580646e-06,2.0913775431630088e-05,0.0,0.0001067202,False,C5; complement
hsa:10999,0.0,0.0,0.00010914360212903227,0.00026672644842741375,0.0,0.0012366114,False,SLC27A4; solute carrier family 27 member
hsa:7469,0.0,0.0,2.1955376523225812e-05,4.278983022698462e-05,0.0,0.00017405832,False,NELFA; negative elongation factor complex member
hsa:5279,4.7388576e-06,0.0033499315189274514,6.741349435412903e-05,0.0001359267871693479,0.0,0.000550162,False,PIGC; phosphatidylinositol glycan anchor biosynthesis class
hsa:100133941,0.0,0.0,2.677281651612903e-06,8.878740803579565e-06,0.0,3.81666e-05,False,CD24; CD24
hsa:302,2.0766183e-07,0.00014679759729331268,2.211972817096774e-06,5.7905963343889505e-06,0.0,2.6160676e-05,False,ANXA2; annexin
hsa:5948,0.0,0.0,2.7316685483870966e-07,9.361957255948452e-07,0.0,4.2455476e-06,False,RBP2; retinol binding protein
hsa:2691,0.0,0.0,3.104928064516129e-08,1.728750782676369e-07,0.0,9.625277e-07,False,GHRH; growth hormone releasing
hsa:390154,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5T3; olfactory receptor family 5 subfamily T member
hsa:25942,0.0,0.0,1.1818406690322582e-05,3.7789534645988425e-05,0.0,0.00020327758,False,SIN3A; SIN3 transcription regulator family member
hsa:6550,2.7982198e-05,0.019780811107104945,0.00017804630176451614,0.00037248569134036585,0.0,0.0017881197,False,SLC9A3; solute carrier family 9 member
hsa:391112,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6Y1; olfactory receptor family 6 subfamily Y member
hsa:6249,0.0,0.0,1.2610233987096775e-07,2.454391603636113e-07,0.0,9.347443e-07,False,CLIP1; CAP-Gly domain containing linker protein
hsa:390748,0.0,0.0,1.099893486832258e-07,3.822828077438476e-07,0.0,1.6003103e-06,False,PABPN1L; PABPN1 like
hsa:221955,0.0,0.0,7.745768314838708e-07,1.8097830398015852e-06,0.0,6.0842954e-06,False,DAGLB; diacylglycerol lipase
hsa:51209,0.0,0.0,1.956196986451613e-06,4.344449912231666e-06,0.0,1.6598939e-05,False,RAB9B; RAB9B
hsa:134864,0.0,0.0,0.0,0.0,-0.0,-0.0,False,TAAR1; trace amine associated receptor
hsa:2660,5.5309215e-08,3.9098470191557344e-05,4.640017872580645e-07,8.37021365317528e-07,0.0,3.2325563e-06,False,MSTN;
hsa:23057,0.0,0.0,4.240120129032258e-06,1.8437189455244963e-05,0.0,9.825269e-05,False,NMNAT2; nicotinamide nucleotide adenylyltransferase
hsa:4726,2.4572214e-06,0.0017370269612750212,5.23646887451613e-06,6.0226016349621e-06,0.0,1.8500812e-05,False,NDUFS6; NADH:ubiquinone oxidoreductase subunit
hsa:808,2.7836668e-05,0.01967793493417468,0.0019499755005806454,0.003990939425324811,0.0,0.017670633,False,CALM3; calmodulin
hsa:1138,0.0,0.0,1.0843941446451612e-06,2.532622078454302e-06,0.0,1.2676628e-05,False,CHRNA5; cholinergic receptor nicotinic alpha 5
hsa:64750,7.793232e-05,0.055090901045674,0.00020029199600000002,0.0002653185556211906,0.0,0.0009057241,False,SMURF2; SMAD specific E3 ubiquitin protein ligase
hsa:219437,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5L1; olfactory receptor family 5 subfamily L member
hsa:29990,0.0,0.0,0.00033277169264516127,0.0010006148759256017,0.0,0.0045489585,False,PILRB; paired immunoglobin like type 2 receptor
hsa:6091,0.0,0.0,1.7564205856774192e-07,3.711800018336671e-07,0.0,1.3129984e-06,False,ROBO1; roundabout guidance receptor
hsa:3183,1.3521189e-07,9.558222894158109e-05,3.5291769835483875e-07,4.84774743941623e-07,0.0,1.6539609e-06,False,HNRNPC; heterogeneous nuclear ribonucleoprotein
hsa:5437,1.7115359e-05,0.012098966757696755,0.00010740514589225808,0.00014906366296018478,0.0,0.00045938583,False,POLR2H; RNA polymerase II
hsa:135250,2.305198e-07,0.00016295605585549822,2.9218762246129034e-06,6.42800080502431e-06,0.0,2.8278908e-05,False,RAET1E; retinoic acid early transcript
hsa:5833,1.0968535e-05,0.007753733961737721,0.00035140292018258064,0.0009522639522325144,0.0,0.0042231088,False,PCYT2; phosphate cytidylyltransferase 2
hsa:51103,1.8096874e-07,0.00012792806563054077,2.4726442260967743e-06,4.781358425067949e-06,0.0,1.772634e-05,False,NDUFAF1; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:89953,5.392114e-08,3.8117230284045625e-05,5.16041237451613e-07,8.147358782685812e-07,0.0,2.8757033e-06,False,KLC4; kinesin light chain
hsa:2218,0.0,0.0,1.4189729890322577e-05,3.606728776103239e-05,0.0,0.00012770237,False,FKTN;
hsa:10681,0.0,0.0,4.066532619354839e-06,6.949644490562906e-06,0.0,2.6595932e-05,False,GNB5; G protein subunit beta
hsa:23463,4.162604e-07,0.0002942573826319129,2.4229208302032257e-05,5.7643967879968504e-05,0.0,0.00025174444,False,ICMT; isoprenylcysteine carboxyl
hsa:661,0.0,0.0,7.096436003225806e-06,1.2464231861784565e-05,0.0,4.1470004e-05,False,POLR3D; RNA polymerase III subunit
hsa:6898,0.0,0.0,1.4514754838709676e-07,8.081473472618237e-07,0.0,4.499574e-06,False,TAT; tyrosine
hsa:348327,0.0,0.0,2.132795722580645e-08,4.748661236940267e-08,0.0,1.6075823e-07,False,ZNF530; zinc finger protein
hsa:10239,0.0,0.0,7.732477841290323e-07,2.42008178963495e-06,0.0,1.062733e-05,False,AP3S2; adaptor related protein complex 3 subunit sigma
hsa:4759,0.0,0.0,0.0,0.0,-0.0,-0.0,False,NEU2; neuraminidase
hsa:1789,1.5277205e-07,0.00010799562863128881,2.880626582419355e-06,5.77925939363782e-06,0.0,2.419628e-05,False,DNMT3B; DNA methyltransferase 3
hsa:1938,0.0,0.0,3.4375298622258065e-06,7.075513190390706e-06,0.0,3.2242497e-05,False,EEF2; eukaryotic translation elongation factor
hsa:84455,0.0,0.0,1.6091178277e-05,6.303368181520066e-05,0.0,0.0003443136,False,EFCAB7; EF-hand calcium binding domain
hsa:57172,0.0,0.0,5.0656714870967744e-06,1.7211718528316254e-05,0.0,9.1270595e-05,False,CAMK1G; calcium/calmodulin dependent protein kinase
hsa:7919,6.388028e-07,0.00045157415873798553,1.0240125210967742e-06,1.1442712466748283e-06,0.0,3.3412853e-06,False,DDX39B; DExD-box helicase
hsa:57493,4.9795045e-07,0.0003520046492469214,6.775999151006452e-05,0.0002268588587322705,0.0,0.0012249335,False,HEG1; heart development protein with EGF like domains
hsa:5805,0.0,0.0,1.862423179354839e-05,5.0717173020087396e-05,0.0,0.00023111969,False,PTS; 6-pyruvoyltetrahydropterin
hsa:10423,0.0,0.0,4.480497741935484e-06,2.4946355655288746e-05,0.0,0.00013889543,False,CDIPT; CDP-diacylglycerol--inositol
hsa:720,1.8452649e-05,0.013044306394183509,7.841224676451612e-05,0.00010968109661985721,0.0,0.00032362092,False,C4A; complement C4A (Rodgers blood
hsa:79158,1.6472215e-07,0.00011644323774373289,1.4966480748387097e-06,3.273948441468929e-06,0.0,1.3998038e-05,False,GNPTAB; N-acetylglucosamine-1-phosphate transferase subunits alpha and
hsa:27085,0.0,0.0,2.2182553105281294e-07,4.0540920109489134e-07,0.0,1.2342148e-06,False,MTBP; MDM2 binding
hsa:54576,0.0,0.0,6.966634161290322e-07,3.6526929544508602e-06,0.0,2.0340418e-05,False,UGT1A8; UDP glucuronosyltransferase family 1 member
hsa:26531,0.0,0.0,1.0132429032258065e-09,5.641497727471079e-09,-0.0,3.141053e-08,False,OR11A1; olfactory receptor family 11 subfamily A member
hsa:26986,5.9882285e-07,0.0004233120529869826,4.774621548709678e-06,1.3668581380843011e-05,0.0,6.0710983e-05,False,PABPC1; poly(A) binding protein cytoplasmic
hsa:9423,0.0,0.0,1.1528399299354839e-07,2.0373113681321167e-07,0.0,6.7873583e-07,False,NTN1; netrin
hsa:60436,0.0,0.0,3.2093659134116127e-06,9.878345041306957e-06,0.0,3.9574854e-05,False,TGIF2; TGFB induced factor homeobox
hsa:411,1.4265486e-07,0.00010084371639320475,5.194104263419354e-05,8.953450076814215e-05,0.0,0.00027739274,False,ARSB; arylsulfatase
hsa:1456,0.0,0.0,3.749457940322581e-05,6.468138359152763e-05,0.0,0.00022723993,False,CSNK1G3; casein kinase 1 gamma
hsa:4092,0.0,0.0,0.00017223351829032257,0.0004806444994610465,0.0,0.0018544651,False,SMAD7; SMAD family member
hsa:962,0.0,0.0,6.132957298387096e-07,1.0731645042192978e-06,0.0,3.3242356e-06,False,CD48; CD48
hsa:8526,0.0,0.0,5.33355614483871e-05,9.86282554665143e-05,0.0,0.0003286904,False,DGKE; diacylglycerol kinase
hsa:54626,0.0,0.0,1.955196493548387e-09,6.4946846378054015e-09,0.0,3.2575606e-08,False,HES2; hes family bHLH transcription factor
hsa:26497,0.0,0.0,2.097714322580645e-07,1.1679579048662632e-06,0.0,6.5029144e-06,False,OR10D3; olfactory receptor family 10 subfamily D member
hsa:8440,8.066582e-06,0.00570232312779621,1.7111411348064517e-05,2.808975127952025e-05,0.0,0.00011610585,False,NCK2; NCK adaptor protein
hsa:84920,7.311114e-08,5.168277524750218e-05,2.5176392895161293e-06,7.815946784388915e-06,0.0,3.355504e-05,False,ALG10; ALG10
hsa:9973,0.0,0.0,7.646108055903227e-08,1.3349557475468365e-07,0.0,5.4543676e-07,False,CCS; copper chaperone for superoxide
hsa:7010,9.1353365e-07,0.0006457833144713694,1.0807548916451613e-05,1.98937525759299e-05,0.0,9.9272984e-05,False,TEK; TEK receptor tyrosine
hsa:5573,5.3522325e-07,0.0003783530517645829,1.4112844969064517e-05,4.0546514968165334e-05,0.0,0.0002158861,False,PRKAR1A; protein kinase cAMP-dependent type I regulatory subunit
hsa:81537,3.452015e-07,0.00024402535016689142,1.4852862065516132e-05,3.000267592616481e-05,0.0,0.000120483135,False,SGPP1; sphingosine-1-phosphate phosphatase
hsa:55024,1.9506778e-08,1.3789477543051851e-05,2.1885650821935486e-06,4.733913625335059e-06,0.0,2.2376566e-05,False,BANK1; B cell scaffold protein with ankyrin repeats
hsa:605,1.3922051e-08,9.841595040335343e-06,6.058342684296776e-06,1.6128840134260445e-05,0.0,5.8112182e-05,False,BCL7A; BAF chromatin remodeling complex subunit
hsa:841,7.704319e-05,0.05446236884174705,0.00046002404219354836,0.0006005089629927805,0.0,0.0018599832,False,CASP8; caspase
hsa:57154,2.0195286e-05,0.014276188654656833,0.00015524000245161287,0.0002476985111978687,0.0,0.0008600657,False,SMURF1; SMAD specific E3 ubiquitin protein ligase
hsa:11285,0.0,0.0,4.818289930967742e-05,0.0001778310047495293,0.0,0.0009816997,False,B4GALT7; beta-1
hsa:6793,1.9230881e-06,0.001359444402774269,7.27871299064516e-05,0.000167231174319082,0.0,0.00069902104,False,STK10; serine/threonine kinase
hsa:10746,5.6751617e-07,0.00040118114234620375,4.734762062258064e-05,0.00010363966600983108,0.0,0.00047614588,False,MAP3K2; mitogen-activated protein kinase kinase kinase
hsa:3883,0.0,0.0,0.0,0.0,0.0,0.0,False,KRT33A; keratin
hsa:4669,0.0,0.0,5.0843930303225806e-05,0.0001392186542466249,0.0,0.00059789064,False,NAGLU;
hsa:100130933,0.0,0.0,4.706229558064517e-09,9.578524430757406e-09,0.0,3.202474e-08,False,SMIM6; small integral membrane protein
hsa:3640,2.716191e-07,0.00019200943793557066,1.7965524892903227e-06,4.381297168192624e-06,0.0,1.9813506e-05,False,INSL3; insulin like
hsa:712,0.0,0.0,4.660969395483871e-05,0.00011426271825017132,0.0,0.00060005643,False,C1QA; complement C1q A
hsa:27115,1.08470864e-07,7.667881098577281e-05,2.4859045186967748e-05,0.00011337279369523033,0.0,0.00062864984,False,PDE7B; phosphodiesterase
hsa:2940,0.0,0.0,1.338192064516129e-06,5.3582873685883e-06,0.0,2.6051948e-05,False,GSTA3; glutathione S-transferase alpha
hsa:5010,1.6767218e-06,0.0011852863454459512,4.54558437194516e-05,9.148689672608924e-05,0.0,0.00035214607,False,CLDN11; claudin
hsa:80704,0.0,0.0,8.738808889032258e-06,2.1589231289306544e-05,0.0,8.609666e-05,False,SLC19A3; solute carrier family 19 member
hsa:9140,0.0,0.0,3.126635709032258e-05,7.200084029790102e-05,0.0,0.0002597606,False,ATG12; autophagy related
hsa:6122,1.648554e-07,0.00011653743309893772,9.010198130645163e-07,1.4300945604316654e-06,0.0,4.5662396e-06,False,RPL3; ribosomal protein
hsa:30,0.0,0.0,0.00010235149396129032,0.000237429406604964,0.0,0.0010091981,False,ACAA1; acetyl-CoA acyltransferase
hsa:5467,5.2805913e-06,0.0037328868532458303,0.00014526630490212906,0.00027832020287895146,0.0,0.0012212995,False,PPARD; peroxisome proliferator activated receptor
hsa:26053,8.4375166e-08,5.96453938599328e-05,1.5494104635190324e-05,3.575921638461999e-05,0.0,0.00011003612,False,AUTS2; activator of transcription and developmental regulator
hsa:4824,2.5422442e-09,1.7971301721306215e-06,8.728021722070965e-06,3.352084470766432e-05,0.0,0.00014426843,False,NKX3-1; NK3 homeobox
hsa:10673,0.0,0.0,0.00011067441370967743,0.00032152500810906525,0.0,0.0012412939,False,TNFSF13B; TNF superfamily member
hsa:23127,1.7858978e-06,0.001262463621992607,1.5857727056290326e-05,4.99567483379835e-05,0.0,0.00027640324,False,COLGALT2; collagen beta(1-O)galactosyltransferase
hsa:1175,3.2171338e-05,0.02274214341706922,0.0003499938872,0.0005695598243514259,0.0,0.0023003998,False,AP2S1; adaptor related protein complex 2 subunit sigma
hsa:51385,1.1285837e-08,7.978036960591015e-06,8.268646463548387e-08,2.1213409145851534e-07,0.0,8.397778e-07,False,ZNF589; zinc finger protein
hsa:1967,4.0227203e-08,2.843689062275113e-05,1.6265906936774193e-07,2.5363809236244836e-07,0.0,9.95428e-07,False,EIF2B1; eukaryotic translation initiation factor 2B subunit
hsa:134111,1.2722181e-07,8.993398561163763e-05,2.0876429393548384e-07,2.513674168422335e-07,0.0,1.0271218e-06,False,UBE2QL1; ubiquitin conjugating enzyme E2 Q family like
hsa:57801,0.0,0.0,1.0866046603225804e-07,1.6591403489082318e-07,0.0,5.8630985e-07,False,HES4; hes family bHLH transcription factor
hsa:114879,4.390339e-08,3.1035612876142194e-05,2.337015963516129e-05,4.522071976716297e-05,0.0,0.00018502411,False,OSBPL5; oxysterol binding protein like
hsa:2994,0.0,0.0,2.2423265451612904e-08,1.1605577293624809e-07,0.0,6.4653597e-07,False,GYPB; glycophorin B (MNS blood
hsa:9992,7.0018996e-07,0.0004949691706795645,2.757234666280645e-06,5.573721621047e-06,0.0,2.548905e-05,False,KCNE2; potassium voltage-gated channel subfamily E regulatory subunit
hsa:92421,2.0586842e-08,1.4552982324469816e-05,5.859453893269677e-06,2.0264495768977508e-05,0.0,0.000103003455,False,CHMP4C; charged multivesicular body protein
hsa:326,7.502392e-06,0.0053034932782426636,4.9358835829874196e-05,0.00010194495782019836,0.0,0.00042462302,False,AIRE; autoimmune
hsa:3164,0.00045299187,0.3202231151936042,0.0007273466600967742,0.0008395408687656918,0.0,0.0031152137,False,NR4A1; nuclear receptor subfamily 4 group A member
hsa:285659,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2V2; olfactory receptor family 2 subfamily V member
hsa:4524,3.554173e-06,0.0025124697050236196,0.00010115940098709677,0.0001758104232608641,0.0,0.00068333413,False,MTHFR; methylenetetrahydrofolate
hsa:6494,0.0,0.0,1.8034508178064513e-05,4.676861216453951e-05,0.0,0.00018629599,False,SIPA1; signal-induced proliferation-associated
hsa:23067,1.6579106e-08,1.1719885768468592e-05,8.854034054193549e-06,2.1511053268428844e-05,0.0,9.368027e-05,False,SETD1B; SET domain containing 1B
hsa:9101,0.0,0.0,3.7695389811612907e-06,9.556007465279645e-06,0.0,3.722127e-05,False,USP8; ubiquitin specific peptidase
hsa:8813,4.5737332e-07,0.00032332039278506515,1.7385251554193546e-05,4.5418177743210407e-05,0.0,0.00017514308,False,DPM1; dolichyl-phosphate mannosyltransferase subunit 1
hsa:1730,0.0,0.0,9.70956434516129e-09,2.9431269104000936e-08,0.0,1.6007559e-07,False,DIAPH2; diaphanous related formin
hsa:58511,0.0,0.0,1.8581987100025806e-08,4.8003546419216066e-08,0.0,2.2939491e-07,False,DNASE2B; deoxyribonuclease 2
hsa:390197,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D10; olfactory receptor family 4 subfamily D member
hsa:100132074,1.5046092e-08,1.0636187470052312e-05,1.6715284757419353e-06,4.188433309097969e-06,0.0,1.7224816e-05,False,FOXO6; forkhead box
hsa:146909,3.7596886e-09,2.657750117347317e-06,1.6884353495354838e-07,3.415941174556212e-07,0.0,1.2537423e-06,False,KIF18B; kinesin family member
hsa:567,6.70459e-07,0.00047395214750672827,4.802003243548388e-06,1.0809242143019145e-05,0.0,4.5931196e-05,False,B2M;
hsa:129807,0.0,0.0,2.473465684064516e-05,0.00011225585573659262,0.0,0.0006199354,False,NEU4; neuraminidase
hsa:2048,0.0,0.0,1.3758019917096773e-05,5.46072829781164e-05,0.0,0.00029432648,False,EPHB2; EPH receptor
hsa:581,0.0,0.0,0.0003985828893548387,0.0008901345971630719,0.0,0.0035738505,False,BAX; BCL2 associated X
hsa:4326,0.0,0.0,1.0137558613548388e-06,2.988316873798712e-06,0.0,1.1069177e-05,False,MMP17; matrix metallopeptidase
hsa:29101,0.0,0.0,1.0101455967419355e-06,2.0564017176937845e-06,0.0,8.900726e-06,False,SSU72; SSU72 homolog
hsa:5019,4.3365806e-05,0.030655590993722448,0.00012921227485161287,0.00018127630729175044,0.0,0.00059492624,False,OXCT1; 3-oxoacid CoA-transferase
hsa:4157,0.0,0.0,2.300029684516129e-06,5.421294413693805e-06,0.0,2.671292e-05,False,MC1R; melanocortin 1
hsa:653,9.3851247e-07,0.000663441016703995,1.8076702003761292e-05,3.999206934726624e-05,0.0,0.00016711566,False,BMP5; bone morphogenetic protein
hsa:6139,2.3216192e-08,1.641168819469725e-05,3.6241547070967747e-07,6.338327853899522e-07,0.0,2.7115489e-06,False,RPL17; ribosomal protein
hsa:22985,0.0,0.0,5.089416658064516e-07,8.508701463664296e-07,0.0,2.7352185e-06,False,ACIN1; apoptotic chromatin condensation inducer
hsa:11041,0.0,0.0,8.067455020741935e-05,0.00019126188715070335,0.0,0.0006824567,False,B4GAT1; beta-1
hsa:54567,1.5578318e-05,0.011012421744868394,0.0003551338886354838,0.0008353552175294941,0.0,0.0040466175,False,DLL4; delta like canonical Notch ligand
hsa:7270,0.0,0.0,1.534269806654839e-05,3.8237002833955794e-05,0.0,0.00014964605,False,TTF1; transcription termination factor
hsa:79724,8.827296e-08,6.240077164863999e-05,2.1728380166032263e-07,2.9051582597358627e-07,0.0,1.1086653e-06,False,ZNF768; zinc finger protein
hsa:390078,0.0,0.0,6.031058683870968e-08,2.393265146799569e-07,0.0,1.2047328e-06,False,OR52E6; olfactory receptor family 52 subfamily E member
hsa:51073,0.0,0.0,5.39897157e-08,9.898881989608319e-08,0.0,3.3656627e-07,False,MRPL4; mitochondrial ribosomal protein
hsa:51292,1.8248316e-09,1.2899861970055423e-06,8.099319447741934e-07,2.0149403570071593e-06,0.0,7.335885e-06,False,GMPR2; guanosine monophosphate reductase
hsa:10610,4.7274596e-05,0.03341874193159162,0.00024345098314193547,0.000627830875354168,0.0,0.0034773275,False,ST6GALNAC2; ST6 N-acetylgalactosaminide alpha-2
hsa:57132,0.0,0.0,1.6965931769354847e-05,7.782860035728378e-05,0.0,0.00043460084,False,CHMP1B; charged multivesicular body protein
hsa:9545,0.0,0.0,2.804357880806452e-05,7.927402577783248e-05,0.0,0.00034009406,False,RAB3D; RAB3D
hsa:4642,0.0,0.0,9.450206934193548e-07,2.1348276873928412e-06,0.0,9.241392e-06,False,MYO1D; myosin
hsa:79324,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51G1; olfactory receptor family 51 subfamily G member
hsa:118788,3.4321797e-08,2.4262317896306832e-05,1.5965310199677418e-06,3.65969806792106e-06,0.0,1.3583778e-05,False,PIK3AP1; phosphoinositide-3-kinase adaptor protein
hsa:81300,0.0,0.0,9.136047419354838e-08,5.086735923860913e-07,0.0,2.8321747e-06,False,OR4P4; olfactory receptor family 4 subfamily P member
hsa:991,0.0,0.0,3.548521706451613e-07,8.228979952261248e-07,0.0,2.8120828e-06,False,CDC20; cell division cycle
hsa:8569,2.2211216e-06,0.001570126364466105,2.233329048954839e-05,3.654670403143473e-05,0.0,0.00013024142,False,MKNK1; MAPK interacting serine/threonine kinase
hsa:28987,0.0,0.0,1.4247333870967741e-06,2.6074391811993216e-06,0.0,8.328078e-06,False,NOB1; NIN1 (RPN12) binding protein 1
hsa:5743,0.001172847,0.8290937318267392,0.0019421325958064511,0.001968636567178588,1.704357e-05,0.0075688274,True,PTGS2; prostaglandin-endoperoxide synthase
hsa:7327,5.7591603e-08,4.071190620187801e-05,1.2058642249354837e-06,2.265112230497008e-06,0.0,9.223285e-06,False,UBE2G2; ubiquitin conjugating enzyme E2
hsa:10465,5.7200452e-08,4.043539882939229e-05,1.8200706474193547e-07,3.326459747496469e-07,0.0,1.4199517e-06,False,PPIH; peptidylprolyl isomerase
hsa:79443,0.0,0.0,9.825131245645161e-08,1.6604742150411343e-07,0.0,5.6760496e-07,False,FYCO1; FYVE and coiled-coil domain autophagy adaptor
hsa:51119,0.0,0.0,3.1163160629064516e-06,7.2150827643055116e-06,0.0,2.4452773e-05,False,SBDS; SBDS ribosome maturation
hsa:7291,0.0,0.0,4.432002255161291e-07,1.36566437438623e-06,0.0,5.3469257e-06,False,TWIST1; twist family bHLH transcription factor
hsa:9653,0.0,0.0,0.00035853506061935485,0.0008311856248476271,0.0,0.00300976,False,HS2ST1; heparan sulfate 2-O-sulfotransferase
hsa:8764,0.0,0.0,0.0004393990472258064,0.0010072333789466318,0.0,0.0052767727,False,TNFRSF14; TNF receptor superfamily member
hsa:8408,2.3583793e-06,0.0016671547907782793,1.4585511754838708e-05,2.6365464413855418e-05,0.0,9.317611e-05,False,ULK1; unc-51 like autophagy activating kinase
hsa:5214,7.2627276e-06,0.005134072840809634,0.0001846745942322581,0.000527453614225285,0.0,0.0029594747,False,PFKP; phosphofructokinase
hsa:51196,2.9216755e-05,0.02065352806872298,7.195930523548387e-05,0.00013247141813587662,0.0,0.0006858638,False,PLCE1; phospholipase C epsilon
hsa:55626,1.0159996e-07,7.182172098308426e-05,1.2334964393225805e-06,2.2335530652010466e-06,0.0,7.517411e-06,False,AMBRA1; autophagy and beclin 1 regulator
hsa:1001,7.68019e-07,0.0005429179925632588,2.412181926129032e-06,6.459634656137201e-06,0.0,3.5018023e-05,False,CDH3; cadherin
hsa:29775,0.0,0.0,2.0925658731612906e-06,4.030682195783491e-06,0.0,1.3246077e-05,False,CARD10; caspase recruitment domain family member
hsa:11035,1.8823863e-06,0.0013306720162191042,1.5010846215322576e-05,2.676402880338623e-05,0.0,0.000121182224,False,RIPK3; receptor interacting serine/threonine kinase
hsa:9486,7.1423683e-06,0.005048990011423488,7.648483115161287e-05,0.00013820454075605794,0.0,0.0005036792,False,CHST10; carbohydrate sulfotransferase
hsa:55131,7.2209514e-09,5.104540953394191e-06,1.334720271851613e-06,2.292086305229535e-06,0.0,8.584352e-06,False,RBM28; RNA binding motif protein
hsa:8883,0.0,0.0,7.360542422580645e-09,2.115505347847477e-08,0.0,9.128123e-08,False,NAE1; NEDD8 activating enzyme E1 subunit
hsa:10641,8.7799044e-08,6.206575711988015e-05,1.724400047935484e-06,4.5300074917731725e-06,0.0,2.1908485e-05,False,NPRL2; NPR2 like
hsa:3134,3.021177e-06,0.0021356911118322443,0.00011057790993548386,0.0001993806678159718,0.0,0.0008414667,False,HLA-F; major histocompatibility complex
hsa:2572,0.0,0.0,9.195269280083871e-07,3.658336111260155e-06,0.0,1.8873012e-05,False,GAD2; glutamate decarboxylase
hsa:2567,0.0,0.0,1.045929455483871e-06,2.6670206145554377e-06,0.0,1.1646006e-05,False,GABRG3; gamma-aminobutyric acid type A receptor subunit
hsa:2056,0.0,0.0,3.159821674516129e-07,1.0971383889527007e-06,0.0,5.3564977e-06,False,EPO;
hsa:171558,0.0,0.0,3.694416352258064e-05,0.00011726706530346153,0.0,0.0006323501,False,PTCRA; pre T cell antigen receptor
hsa:23620,1.6253155e-08,1.14894687311375e-05,5.512341919441935e-07,1.2941124479798146e-06,0.0,6.9130665e-06,False,NTSR2; neurotensin receptor
hsa:9479,1.3748132e-07,9.718650485124328e-05,4.4052162548387106e-07,7.232129716006377e-07,0.0,3.5382802e-06,False,MAPK8IP1; mitogen-activated protein kinase 8 interacting protein
hsa:5664,0.0,0.0,4.293055116451613e-05,0.00010080854982591504,0.0,0.0003920594,False,PSEN2; presenilin
hsa:8243,0.0,0.0,5.885434532903226e-06,1.2925752840340392e-05,0.0,4.828706e-05,False,SMC1A; structural maintenance of chromosomes
hsa:4939,4.2261678e-07,0.00029875075202716127,2.6429607590322576e-06,6.034791878007498e-06,0.0,2.6482261e-05,False,OAS2; 2'-5'-oligoadenylate synthetase
hsa:7161,9.223566e-07,0.0006520203194184944,2.8670287767741932e-06,4.518201489314843e-06,0.0,2.254941e-05,False,TP73; tumor protein
hsa:10193,5.7157843e-09,4.040527822984316e-06,3.260346640225807e-07,7.149022934721773e-07,0.0,2.74363e-06,False,RNF41; ring finger protein
hsa:8673,0.0,0.0,5.936312178709677e-05,0.00018558838439725482,0.0,0.0008223743,False,VAMP8; vesicle associated membrane protein
hsa:3305,0.0,0.0,4.0509086020645164e-05,0.00012960536773935145,0.0,0.00055978086,False,HSPA1L; heat shock protein family A (Hsp70) member 1
hsa:55331,6.3589385e-07,0.0004495178016758986,1.240522572548387e-05,2.7687425031932533e-05,0.0,0.000104695064,False,ACER3; alkaline ceramidase
hsa:81442,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR6N2; olfactory receptor family 6 subfamily N member
hsa:7772,0.0,0.0,3.2657462700193546e-08,9.200364665490551e-08,0.0,3.6493054e-07,False,ZNF229; zinc finger protein
hsa:26039,0.0,0.0,6.169894123870967e-07,1.5258420746104293e-06,0.0,5.4927864e-06,False,SS18L1; SS18L1 subunit of BAF chromatin remodeling
hsa:390326,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C76; olfactory receptor family 6 subfamily C member
hsa:8924,1.215068e-07,8.589400514672863e-05,8.067175073225806e-07,1.2402211226154367e-06,0.0,4.058976e-06,False,HERC2; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:654254,0.0,0.0,2.491765980322581e-09,5.470808472121654e-09,0.0,2.6975238e-08,False,ZNF732; zinc finger protein
hsa:4040,0.0,0.0,1.3789297077419358e-06,2.528204578055857e-06,0.0,8.186962e-06,False,LRP6; LDL receptor related protein
hsa:3373,0.0,0.0,3.992352272903226e-05,0.0001074532342869386,0.0,0.0005269166,False,HYAL1; hyaluronidase
hsa:6718,0.0,0.0,4.547009206451613e-08,1.6261334121170167e-07,0.0,8.2922327e-07,False,AKR1D1; aldo-keto reductase family 1 member
hsa:10282,0.0,0.0,5.9830513749032257e-05,0.00010831314994992386,0.0,0.0004739556,False,BET1; Bet1 golgi vesicular membrane trafficking
hsa:387748,0.0,0.0,4.025353430645161e-07,1.637247217750876e-06,0.0,8.996589e-06,False,OR56B1; olfactory receptor family 56 subfamily B member
hsa:5871,1.997775e-08,1.412241093765993e-05,3.888725725161291e-07,7.04915487551356e-07,0.0,2.8920836e-06,False,MAP4K2; mitogen-activated protein kinase kinase kinase kinase
hsa:9615,0.0,0.0,2.014928228483871e-08,6.81577573853809e-08,0.0,3.639396e-07,False,GDA; guanine
hsa:64377,1.9642525e-07,0.0001388543804498798,6.296936300967742e-06,1.1455083436207417e-05,0.0,4.065859e-05,False,CHST8; carbohydrate sulfotransferase
hsa:53637,2.5602767e-06,0.001809877472263687,1.2985428347096769e-05,2.1997913758486356e-05,0.0,7.13758e-05,False,S1PR5; sphingosine-1-phosphate receptor
hsa:3467,0.0,0.0,9.515123548387097e-09,4.2209889282782446e-08,0.0,2.2733929e-07,False,IFNW1; interferon omega
hsa:81399,0.0,0.0,4.4568329032258067e-07,2.481459540966891e-06,0.0,1.3816182e-05,False,OR4F16; olfactory receptor family 4 subfamily F member
hsa:4200,0.0,0.0,3.3450585348690318e-06,9.615586219418576e-06,0.0,4.9972066e-05,False,ME2; malic enzyme
hsa:8835,4.8218585e-06,0.003408605434558372,0.0001116832763064516,0.00017061179597593952,0.0,0.00056758255,False,SOCS2; suppressor of cytokine signaling
hsa:11027,4.609102e-06,0.0032582063794766815,1.1593752980645162e-05,1.6821406380729357e-05,0.0,7.853705e-05,False,LILRA2; leukocyte immunoglobulin like receptor
hsa:55173,2.043386e-08,1.444483828071789e-05,1.861207599548387e-07,4.1628723474021685e-07,0.0,1.5306047e-06,False,MRPS10; mitochondrial ribosomal protein
hsa:116028,0.0,0.0,7.926818843225806e-06,3.0312796793109157e-05,0.0,0.00016359708,False,RMI2; RecQ mediated genome instability
hsa:6332,9.558048e-07,0.0006756650854970087,7.328743969464515e-06,1.2028187657724577e-05,0.0,5.1315772e-05,False,SCN7A; sodium voltage-gated channel alpha subunit
hsa:1003,0.0,0.0,2.7295981832258062e-05,7.97163214855205e-05,0.0,0.0003768316,False,CDH5; cadherin
hsa:79735,0.0,0.0,1.0118558731664515e-05,2.6320877473437713e-05,0.0,0.00010320111,False,TBC1D17; TBC1 domain family member
hsa:2564,0.001104638,0.7808763135665824,0.0011487700062548388,0.0010094243579930949,0.0,0.003119493,True,GABRE; gamma-aminobutyric acid type A receptor subunit
hsa:1075,0.0,0.0,1.275830511096774e-06,3.6836968398970113e-06,0.0,1.7455835e-05,False,CTSC; cathepsin
hsa:4358,0.0,0.0,1.2536286870967745e-06,3.129203698273792e-06,0.0,1.3932716e-05,False,MPV17; mitochondrial inner membrane protein
hsa:6164,5.8596413e-07,0.0004142221340535539,1.4806390318064515e-06,2.3416838850764814e-06,0.0,1.0058291e-05,False,RPL34; ribosomal protein
hsa:4998,1.6722182e-10,1.1821027191667733e-07,3.325938061979677e-07,7.857528785172224e-07,0.0,2.935589e-06,False,ORC1; origin recognition complex subunit
hsa:55110,0.0,0.0,4.2292747193548386e-07,8.953618590832495e-07,0.0,3.1193608e-06,False,MAGOHB; mago homolog B
hsa:441669,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4Q3; olfactory receptor family 4 subfamily Q member
hsa:2879,9.861979e-06,0.006971501800581775,0.0003473394528064517,0.0008026307158413061,0.0,0.0030652448,False,GPX4; glutathione peroxidase
hsa:79143,5.3795883e-08,3.802868523633913e-05,9.76457927848387e-06,2.3768214844540985e-05,0.0,0.00011531969,False,MBOAT7; membrane bound O-acyltransferase domain containing
hsa:79798,2.2411271e-07,0.00015842683920724848,1.1728876883235483e-05,1.7815914937714968e-05,0.0,6.846215e-05,False,ARMC5; armadillo repeat containing
hsa:6585,0.0,0.0,1.0629575432258065e-07,1.841310360061778e-07,0.0,7.467584e-07,False,SLIT1; slit guidance ligand
hsa:10434,0.0,0.0,9.104788612903227e-08,2.9573133501124525e-07,0.0,1.3283292e-06,False,LYPLA1; lysophospholipase
hsa:653509,0.0,0.0,5.167462196774194e-07,2.005337388374835e-06,0.0,8.804713e-06,False,SFTPA1; surfactant protein
hsa:4646,6.5497126e-08,4.630037559823758e-05,9.844910334193548e-07,2.5671112493281935e-06,0.0,9.81622e-06,False,MYO6; myosin
hsa:11186,0.0,0.0,0.00042036194480645156,0.0008720137521065068,0.0,0.0034890748,False,RASSF1; Ras association domain family member
hsa:11283,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,CYP4F8; cytochrome P450 family 4 subfamily F member
hsa:56895,1.5575162e-06,0.0011010190746436677,7.49018661935484e-06,1.9099294218538453e-05,0.0,0.0001025704,False,AGPAT4; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:55361,2.1692013e-06,0.0015334235419457217,1.874887808645161e-05,3.638304502149482e-05,0.0,0.00016009634,False,PI4K2A; phosphatidylinositol 4-kinase type 2
hsa:10327,0.0,0.0,0.00032289696671612895,0.0007510520536594239,0.0,0.0036275007,False,AKR1A1; aldo-keto reductase family 1 member
hsa:7694,4.9846033e-08,3.5236508697834235e-05,7.843764318709679e-08,9.875969018085898e-08,0.0,3.8498055e-07,False,ZNF135; zinc finger protein
hsa:403277,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR5K3; olfactory receptor family 5 subfamily K member
hsa:759,0.0,0.0,4.768404101535484e-05,0.0002384236373490228,0.0,0.0013294723,False,CA1; carbonic anhydrase
hsa:5740,3.778044e-06,0.0026707256777445147,2.1515252777258065e-05,3.815766575745614e-05,0.0,0.00018379976,False,PTGIS; prostaglandin I2
hsa:51121,0.0,0.0,1.5585811219354835e-07,2.9499490823084786e-07,0.0,1.0511903e-06,False,RPL26L1; ribosomal protein L26 like
hsa:7639,5.3578724e-09,3.7875174023274028e-06,1.0067283379677419e-07,1.9762754919579329e-07,0.0,7.014267e-07,False,ZNF85; zinc finger protein
hsa:51052,0.0,0.0,1.24261747e-07,3.642242655175991e-07,0.0,1.6838173e-06,False,PRLH; prolactin releasing
hsa:406908,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-2; microRNA
hsa:729,5.3024124e-08,3.74831234116673e-05,1.8806112153225806e-06,3.84207450040942e-06,0.0,1.6975204e-05,False,C6; complement
hsa:391121,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10J4; olfactory receptor family 10 subfamily J member 4
hsa:23475,0.0,0.0,4.2191822070967746e-05,6.551381314587779e-05,0.0,0.00026556713,False,QPRT; quinolinate
hsa:9956,2.6303322e-05,0.018594001942640742,0.0002625577123548387,0.00046754983522620156,0.0,0.0014180706,False,HS3ST2; heparan sulfate-glucosamine 3-sulfotransferase
hsa:1675,0.0,0.0,3.6698824806451615e-06,7.581862688946701e-06,0.0,3.4900673e-05,False,CFD; complement factor
hsa:57534,0.0,0.0,3.090969174516129e-07,5.286057005017295e-07,0.0,1.8149386e-06,False,MIB1; MIB E3 ubiquitin protein ligase
hsa:5713,2.5476536e-06,0.0018009541147530977,7.423996354838709e-06,1.1717130406790484e-05,0.0,4.9139402e-05,False,PSMD7; proteasome 26S subunit
hsa:64215,2.1804219e-08,1.5413554624156e-05,3.859976844451613e-07,7.767634352762098e-07,0.0,3.1141774e-06,False,DNAJC1; DnaJ heat shock protein family (Hsp40) member
hsa:386653,0.0,0.0,8.755677993548387e-08,4.804956516059733e-07,0.0,2.6762832e-06,False,IL31; interleukin
hsa:57472,7.403592e-09,5.233650868529818e-06,2.287315540967742e-07,3.3827912268333856e-07,0.0,1.0099235e-06,False,CNOT6; CCR4-NOT transcription complex subunit
hsa:6361,0.0,0.0,0.0,0.0,0.0,0.0,False,CCL17; C-C motif chemokine ligand
hsa:817,6.020626e-05,0.0425602254878351,0.00036448318553548387,0.0005352631893790592,0.0,0.0016452521,False,CAMK2D; calcium/calmodulin dependent protein kinase II
hsa:64979,9.1181455e-08,6.445680706805054e-05,5.886431768258064e-07,1.0400615764802435e-06,0.0,4.0273053e-06,False,MRPL36; mitochondrial ribosomal protein
hsa:164,0.0,0.0,9.168114712903226e-07,1.3860355289805252e-06,0.0,4.075411e-06,False,AP1G1; adaptor related protein complex 1 subunit gamma
hsa:391013,0.0,0.0,1.2050956774193548e-07,5.897009169981454e-07,0.0,3.2651324e-06,False,PLA2G2C; phospholipase A2 group
hsa:6884,3.5357473e-07,0.0002499444449065664,1.0147982507774194e-05,2.9491067355188646e-05,0.0,0.00013986326,False,TAF13; TATA-box binding protein associated factor
hsa:6160,0.0,0.0,1.5047612845806452e-06,3.048866067641744e-06,0.0,1.2759724e-05,False,RPL31; ribosomal protein
hsa:1508,2.6984522e-05,0.01907554697802931,0.0001493294136001935,0.00026372435739930716,0.0,0.0010116292,False,CTSB; cathepsin
hsa:329,5.3738677e-05,0.0379882459155898,0.00036730039835483863,0.0006532914866353961,0.0,0.0021559813,False,BIRC2; baculoviral IAP repeat containing
hsa:7498,0.0,0.0,5.3662116722580625e-06,2.099234801026574e-05,0.0,0.000110493165,False,XDH; xanthine
hsa:390275,0.0,0.0,1.785595e-08,9.94177220744747e-08,0.0,5.5353445e-07,False,OR8A1; olfactory receptor family 8 subfamily A member
hsa:9319,6.7792494e-10,4.792298726117031e-07,4.825759892948387e-07,9.43889001444744e-07,0.0,3.31741e-06,False,TRIP13; thyroid hormone receptor interactor
hsa:64769,1.7205396e-08,1.216261454153598e-05,3.3197996134193547e-06,6.458010804748222e-06,0.0,2.236408e-05,False,MEAF6; MYST/Esa1 associated factor
hsa:116071,1.8240063e-07,0.0001289402786674206,9.705689046741937e-06,1.964828400133205e-05,0.0,8.768345e-05,False,BATF2; basic leucine zipper ATF-like transcription factor
hsa:253959,0.0,0.0,4.935338238709678e-07,9.124494901391913e-07,0.0,3.6576655e-06,False,RALGAPA1; Ral GTPase activating protein catalytic subunit alpha
hsa:2243,0.0,0.0,4.1487348387096774e-10,2.3099177985799103e-09,0.0,1.2861078e-08,False,FGA; fibrinogen alpha
hsa:10972,0.0,0.0,4.1852093264516134e-07,1.046123891565324e-06,0.0,5.143181e-06,False,TMED10; transmembrane p24 trafficking protein
hsa:65005,1.513008e-08,1.0695559173564079e-05,3.0283499563548385e-07,7.361127109135513e-07,0.0,3.3146794e-06,False,MRPL9; mitochondrial ribosomal protein
hsa:3839,5.3831303e-07,0.0003805372388160258,1.10728767e-06,1.347683252847294e-06,0.0,5.1765587e-06,False,KPNA3; karyopherin subunit alpha
hsa:64388,0.0,0.0,1.1180504964516127e-07,2.827796270819752e-07,0.0,1.3576969e-06,False,GREM2; gremlin 2
hsa:51284,2.078897e-06,0.0014695868018705016,2.5092191804709684e-05,5.435169704935101e-05,0.0,0.00021917098,False,TLR7; toll like receptor
hsa:4082,1.8957878e-07,0.00013401456301236254,1.3802189987096777e-06,2.7604250812092113e-06,0.0,1.2966542e-05,False,MARCKS; myristoylated alanine rich protein kinase C
hsa:390162,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5M9; olfactory receptor family 5 subfamily M member
hsa:9353,0.0,0.0,1.899687887e-05,6.854522706789196e-05,0.0,0.00034687092,False,SLIT2; slit guidance ligand
hsa:4690,0.0,0.0,5.742415667741936e-06,1.4689092005027167e-05,0.0,7.8165824e-05,False,NCK1; NCK adaptor protein
hsa:1360,2.9509472e-06,0.0020860451759450865,1.3781595815806453e-05,3.019137963722667e-05,0.0,0.00015887343,False,CPB1; carboxypeptidase
hsa:2550,0.0,0.0,0.0003492249654516129,0.0006524875281621828,0.0,0.0025750985,False,GABBR1; gamma-aminobutyric acid type B receptor subunit
hsa:10370,0.0,0.0,7.907887913263226e-06,2.2053712313173723e-05,0.0,8.74509e-05,False,CITED2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain
hsa:5063,0.0,0.0,2.4496389108064512e-05,5.252255512281797e-05,0.0,0.00018161096,False,PAK3; p21 (RAC1) activated kinase
hsa:284349,0.0,0.0,1.5823462841935484e-08,2.8724637253458408e-08,0.0,1.12345106e-07,False,ZNF283; zinc finger protein
hsa:3918,0.0,0.0,1.2414515426451613e-05,3.0066559416047234e-05,0.0,0.00013420002,False,LAMC2; laminin subunit gamma
hsa:125919,0.0,0.0,6.250456163870968e-09,1.3674370974544911e-08,0.0,5.1576702e-08,False,ZNF543; zinc finger protein
hsa:2197,0.0,0.0,2.2567123709677417e-07,5.232134415510267e-07,0.0,2.0240627e-06,False,FAU; FAU ubiquitin like and ribosomal protein S30
hsa:23293,0.0,0.0,5.085163248709677e-07,1.4312061449648216e-06,0.0,5.6379536e-06,False,SMG6; SMG6 nonsense mediated mRNA decay
hsa:5531,0.0,0.0,7.0711324483870965e-06,1.259480212472673e-05,0.0,4.6694022e-05,False,PPP4C; protein phosphatase 4 catalytic
hsa:53828,0.0,0.0,1.0902000345161291e-05,3.557847578326123e-05,0.0,0.0001753646,False,FXYD4; FXYD domain containing ion transport regulator
hsa:3434,0.0,0.0,3.835339189419355e-07,1.0574543561442993e-06,0.0,3.8659473e-06,False,IFIT1; interferon induced protein with tetratricopeptide repeats
hsa:56923,0.0,0.0,2.1097639352580644e-07,6.929848678231669e-07,0.0,2.778456e-06,False,NMUR2; neuromedin U receptor
hsa:26476,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10J1; olfactory receptor family 10 subfamily J member
hsa:93408,0.0,0.0,7.502897853774194e-07,3.105895676183489e-06,0.0,1.7240622e-05,False,MYL10; myosin light chain
hsa:5817,0.00013207976,0.09336810437949714,0.0002888292996774193,0.00044324234555700456,0.0,0.0016753136,False,PVR; PVR cell adhesion
hsa:10998,0.0,0.0,0.00013016523451612905,0.0003346097895522243,0.0,0.0015017855,False,SLC27A5; solute carrier family 27 member
hsa:10148,1.4390439e-06,0.0010172701787304777,9.036714092967744e-06,1.6374452008079704e-05,0.0,7.011589e-05,False,EBI3; Epstein-Barr virus induced
hsa:4312,0.0,0.0,0.00012187701691290322,0.0003143043432216364,0.0,0.0014203285,False,MMP1; matrix metallopeptidase
hsa:8390,0.0,0.0,0.0,0.0,0.0,0.0,False,OR1G1; olfactory receptor family 1 subfamily G member
hsa:283208,1.4084164e-06,0.000995619385172986,0.00012172130931633225,0.00023089098421191033,0.0,0.0008175225,False,P4HA3; prolyl 4-hydroxylase subunit alpha
hsa:4007,0.0,0.0,1.6302790829032256e-07,3.904618133531708e-07,0.0,1.5339963e-06,False,PRICKLE3; prickle planar cell polarity protein
hsa:4637,0.0,0.0,4.797757351612904e-06,8.386101492760689e-06,0.0,3.3756995e-05,False,MYL6; myosin light chain
hsa:286151,3.9170245e-09,2.7689719634033826e-06,6.572567015322582e-07,1.655290268915829e-06,0.0,6.6846947e-06,False,FBXO43; F-box protein
hsa:51639,0.0,0.0,1.3919005758064515e-07,3.3921112422875467e-07,0.0,1.3429411e-06,False,SF3B6; splicing factor 3b subunit
hsa:714,0.0,0.0,0.00020162540241935485,0.0004158552011567646,0.0,0.001468475,False,C1QC; complement C1q C
hsa:5509,0.0,0.0,7.405532014193548e-06,2.154168621439272e-05,0.0,0.0001110314,False,PPP1R3D; protein phosphatase 1 regulatory subunit
hsa:9997,1.2421851e-06,0.0008781093187590293,3.0349691450383878e-05,9.432036139377667e-05,0.0,0.0004871969,False,SCO2; synthesis of cytochrome C oxidase
hsa:5520,4.6873993e-06,0.0033135552874322435,3.4582507458064524e-05,5.351018216201375e-05,0.0,0.00019864395,False,PPP2R2A; protein phosphatase 2 regulatory subunit
hsa:5627,2.7710494e-06,0.0019588741652766697,6.539372570387097e-05,9.742901062111456e-05,0.0,0.00033090636,False,PROS1; protein
hsa:10993,0.00013327369,0.09421210183120217,0.0002021612420774193,0.00026913744595729537,0.0,0.001203258,False,SDS; serine
hsa:3932,6.4853757e-06,0.00458455735608434,6.677157360967742e-05,0.00013906345019114747,0.0,0.00064402533,False,LCK; LCK proto-oncogene
hsa:5915,0.0,0.0,1.3123655477419355e-05,4.1809764632605997e-05,0.0,0.00019068872,False,RARB; retinoic acid receptor
hsa:11031,1.5998587e-08,1.1309512834823942e-05,1.551488145483871e-07,3.475947026002134e-07,0.0,1.4178105e-06,False,RAB31; RAB31
hsa:9518,5.5354514e-07,0.00039130492370885103,4.9575826943225795e-05,0.0001333553246218592,0.0,0.0005459544,False,GDF15; growth differentiation factor
hsa:5830,0.0,0.0,8.734608699999999e-07,2.8592543553764214e-06,0.0,1.3116559e-05,False,PEX5; peroxisomal biogenesis factor
hsa:65003,0.0,0.0,7.556295112903224e-08,2.0551102419009828e-07,0.0,7.6908753e-07,False,MRPL11; mitochondrial ribosomal protein
hsa:4217,0.0,0.0,1.1869005161290321e-05,1.9373656299931602e-05,0.0,6.414114e-05,False,MAP3K5; mitogen-activated protein kinase kinase kinase
hsa:23566,0.0,0.0,1.2280403587096773e-07,3.8780907985976536e-07,0.0,2.0137272e-06,False,LPAR3; lysophosphatidic acid receptor
hsa:5198,0.0,0.0,4.328751828796774e-06,1.399530474939853e-05,0.0,6.728535e-05,False,PFAS; phosphoribosylformylglycinamidine
hsa:2010,7.867879e-06,0.0055618585899705865,0.00017636867038064514,0.00026401853715934064,0.0,0.00087938027,False,EMD;
hsa:5331,0.0,0.0,0.0003841180787096774,0.000756411859986068,0.0,0.0023197709,False,PLCB3; phospholipase C beta
hsa:23193,0.0,0.0,0.000123350081,0.00029274200545848357,0.0,0.0010873952,False,GANAB; glucosidase II alpha
hsa:7422,3.437014e-05,0.024296491900484444,0.00013153184912903228,0.00019452107470469218,0.0,0.0006554734,False,VEGFA; vascular endothelial growth factor
hsa:6124,0.0,0.0,5.324682317419355e-07,1.213422138919384e-06,0.0,4.8200322e-06,False,RPL4; ribosomal protein
hsa:2119,0.0,0.0,3.859068906225806e-05,0.00017160181942873644,0.0,0.00093164586,False,ETV5; ETS variant transcription factor
hsa:1394,0.0,0.0,3.061962158064516e-05,6.934857063331709e-05,0.0,0.00024492556,False,CRHR1; corticotropin releasing hormone receptor
hsa:83658,0.0,0.0,1.463344976451613e-06,2.9902531153834343e-06,0.0,1.0257592e-05,False,DYNLRB1; dynein light chain roadblock-type
hsa:5660,2.758399e-07,0.0001949931509205502,1.3146758829354837e-05,2.2050613946687015e-05,0.0,8.9913854e-05,False,PSAP;
hsa:84557,0.0,0.0,1.6260637725806452e-05,3.389357728467044e-05,0.0,0.00012769067,False,MAP1LC3A; microtubule associated protein 1 light chain 3
hsa:6713,0.0,0.0,2.281754507419355e-05,6.644424038755158e-05,0.0,0.00034440542,False,SQLE; squalene
hsa:3831,0.0,0.0,2.222700853548387e-06,4.509651645505419e-06,0.0,1.7388735e-05,False,KLC1; kinesin light chain
hsa:1855,1.2000962e-05,0.008483563815306589,0.00040482426384516124,0.0010909032823295814,0.0,0.004273823,False,DVL1; dishevelled segment polarity protein
hsa:1285,0.0,0.0,1.8943098977419354e-05,3.2283276873476005e-05,0.0,0.00012859276,False,COL4A3; collagen type IV alpha 3
hsa:26828,0.0,0.0,3.8105432419354843e-08,2.1033466116761022e-07,0.0,1.1713817e-06,False,RNU5F-1; RNA
hsa:10793,0.0,0.0,2.6744571387096778e-08,5.589796663096936e-08,0.0,2.7391323e-07,False,ZNF273; zinc finger protein
hsa:4324,0.0,0.0,1.3115327373451612e-06,3.311602971824209e-06,0.0,1.2320025e-05,False,MMP15; matrix metallopeptidase
hsa:4702,0.0,0.0,4.325148441935484e-06,5.15613346862918e-06,0.0,1.5564154e-05,False,NDUFA8; NADH:ubiquinone oxidoreductase subunit
hsa:8228,0.0,0.0,2.127312689354839e-05,4.164719069384028e-05,0.0,0.00017219778,False,PNPLA4; patatin like phospholipase domain containing
hsa:29883,0.0,0.0,4.003144309677419e-07,1.018929096295553e-06,0.0,4.6474806e-06,False,CNOT7; CCR4-NOT transcription complex subunit
hsa:211,1.4902181e-05,0.010534455779524122,0.00011184313037096777,0.00021855740826358288,0.0,0.0011201823,False,ALAS1; 5'-aminolevulinate synthase
hsa:10095,7.289985e-06,0.005153341287150798,0.00014192879020290318,0.00026398268186336824,0.0,0.0008936947,False,ARPC1B; actin related protein 2/3 complex subunit
hsa:391211,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2G6; olfactory receptor family 2 subfamily G member
hsa:81929,7.142964e-08,5.049411115912009e-05,2.2219167638709678e-06,4.095112391020997e-06,0.0,1.6792908e-05,False,SEH1L; SEH1 like
hsa:5734,3.833374e-05,0.0270983884099767,8.270578196774194e-05,0.00010803280107310309,0.0,0.00035626977,False,PTGER4; prostaglandin E receptor
hsa:122876,0.0,0.0,3.2036320645161287e-09,1.783706844043245e-08,0.0,9.9312594e-08,False,GPHB5; glycoprotein hormone subunit beta
hsa:79544,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4K1; olfactory receptor family 4 subfamily K member
hsa:27006,4.0960788e-07,0.0002895546698033411,3.5089598663322577e-06,6.706540765277439e-06,0.0,3.056264e-05,False,FGF22; fibroblast growth factor
hsa:23569,0.0,0.0,1.5809899595806451e-07,3.7567220850376415e-07,0.0,1.4408084e-06,False,PADI4; peptidyl arginine deiminase
hsa:126017,2.3221698e-09,1.6415580424534082e-06,9.692819570967742e-09,1.7649984642879075e-08,0.0,7.205831e-08,False,ZNF813; zinc finger protein
hsa:247,0.0,0.0,1.2776969922580646e-05,2.8911668889778403e-05,0.0,0.00012210406,False,ALOX15B; arachidonate 15-lipoxygenase type
hsa:8740,0.0,0.0,1.4394355108064515e-05,3.880604002133421e-05,0.0,0.0001904318,False,TNFSF14; TNF superfamily member
hsa:8396,0.0,0.0,1.3432855247741938e-05,4.047016179342551e-05,0.0,0.00019296884,False,PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:282890,6.4572685e-09,4.564688180190809e-06,5.262441160612903e-08,1.0502478088729075e-07,0.0,4.8724627e-07,False,ZNF311; zinc finger protein
hsa:113,0.0,0.0,0.000448198833548387,0.0007097738296727919,0.0,0.0023270769,False,ADCY7; adenylate cyclase
hsa:51460,0.0,0.0,1.3238786508064516e-06,6.7157241269922275e-06,0.0,3.746713e-05,False,SFMBT1; Scm like with four mbt domains
hsa:407014,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR25; microRNA
hsa:2560,0.0,0.0,5.7354603880645156e-05,0.00011252823334912573,0.0,0.00043128664,False,GABRB1; gamma-aminobutyric acid type A receptor subunit
hsa:26212,-0.0,0.0,8.272119787096775e-07,3.1887997273234245e-06,0.0,1.3983994e-05,False,OR2B6; olfactory receptor family 2 subfamily B member
hsa:3827,0.0,0.0,2.7548908338709675e-07,1.059380973353511e-06,0.0,5.6486483e-06,False,KNG1; kininogen
hsa:338398,0.0,0.0,2.0013285606451615e-05,8.173037475432845e-05,0.0,0.00045234262,False,TAS2R60; taste 2 receptor member
hsa:390081,0.0,0.0,5.926405161290323e-11,3.299682745672417e-10,0.0,1.8371856e-09,False,OR52E4; olfactory receptor family 52 subfamily E member
hsa:6753,0.0,0.0,2.873527611322581e-07,7.550959665436114e-07,0.0,3.066133e-06,False,SSTR3; somatostatin receptor
hsa:6133,1.604251e-08,1.134056231014598e-05,3.4576366096774195e-07,5.590836842469938e-07,0.0,2.0784416e-06,False,RPL9; ribosomal protein
hsa:4940,1.931503e-08,1.3653929543278382e-05,2.730589574516129e-06,8.77167011024103e-06,0.0,4.851689e-05,False,OAS3; 2'-5'-oligoadenylate synthetase
hsa:5741,0.0,0.0,4.163294516129032e-09,2.3180242838868867e-08,0.0,1.2906213e-07,False,PTH; parathyroid
hsa:442910,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR345; microRNA
hsa:3145,0.0,0.0,3.3554818967741934e-05,6.543119044304452e-05,0.0,0.0002558078,False,HMBS; hydroxymethylbilane
hsa:10810,1.6402194e-06,0.0011594825440663743,3.757207000548387e-05,8.339248573720678e-05,0.0,0.00036303748,False,WASF3; WASP family member
hsa:64425,1.3422322e-06,0.0009488333121677542,6.028917137170968e-05,0.00011667027843387477,0.0,0.00044605063,False,POLR1E; RNA polymerase I subunit
hsa:84321,0.0,0.0,2.764727690967742e-07,7.802563968855561e-07,0.0,3.333075e-06,False,THOC3; THO complex subunit
hsa:57657,1.4674076e-07,0.00010373206762646099,7.008847066806454e-05,0.00016949318384863003,0.0,0.0008575963,False,HCN3; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:120796,0.0,0.0,6.067680027096774e-08,3.056590396182175e-07,-0.0,1.7026375e-06,False,OR56A1; olfactory receptor family 56 subfamily A member
hsa:283869,0.0,0.0,3.8055521255806454e-07,9.736035818365213e-07,0.0,3.9332863e-06,False,NPW; neuropeptide
hsa:9451,9.421776e-07,0.0006660319226868983,1.1280908219225807e-05,2.6063719192608646e-05,0.0,0.00012869148,False,EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase
hsa:7039,1.4670155e-05,0.010370434980373993,4.3957335141935484e-05,8.439081421962248e-05,0.0,0.00038060077,False,TGFA; transforming growth factor
hsa:9791,2.2929571e-07,0.00016209073808924927,4.71733402751613e-06,7.708831881699766e-06,0.0,3.3960147e-05,False,PTDSS1; phosphatidylserine synthase
hsa:9902,0.0,0.0,5.843855343870968e-07,1.5240222431641402e-06,0.0,5.7740167e-06,False,MRC2; mannose receptor C type
hsa:2740,0.0,0.0,3.0898901127419356e-06,1.0963872604440528e-05,0.0,5.876667e-05,False,GLP1R; glucagon like peptide 1
hsa:3060,0.0,0.0,7.317769132258064e-08,1.728423997772159e-07,0.0,8.0350407e-07,False,HCRT; hypocretin neuropeptide
hsa:5481,6.85438e-07,0.00048454090717361806,4.110166186774193e-06,6.5050436823781446e-06,0.0,2.711407e-05,False,PPID; peptidylprolyl isomerase
hsa:3297,0.0,0.0,8.825826441935483e-06,2.5484242022877534e-05,0.0,0.00012469837,False,HSF1; heat shock transcription factor
hsa:284654,0.0,0.0,1.2448736459612902e-07,2.9690471513968544e-07,0.0,1.2167542e-06,False,RSPO1; R-spondin
hsa:11224,8.700998e-08,6.150796226990386e-05,1.0624894670967744e-06,2.7544676782281423e-06,0.0,1.127082e-05,False,RPL35; ribosomal protein
hsa:3480,0.0,0.0,6.673348790322581e-05,0.00015366414638477949,0.0,0.0005709849,False,IGF1R; insulin like growth factor 1
hsa:440515,2.3219775e-09,1.6414221042409813e-06,4.4106701132258054e-08,1.0873068386248244e-07,0.0,4.2384966e-07,False,ZNF506; zinc finger protein
hsa:6517,6.2626226e-05,0.04427091634677392,8.683326450322581e-05,9.208005360783311e-05,0.0,0.00039067207,False,SLC2A4; solute carrier family 2 member
hsa:100505767,0.0,0.0,1.7994788741935485e-07,9.433583538534272e-07,0.0,5.259486e-06,False,SPDYE18; speedy/RINGO cell cycle regulator family member
hsa:222546,-0.0,0.0,4.26339133548387e-06,2.3459997503071496e-05,-0.0,0.00013066122,False,RFX6; regulatory factor
hsa:3033,0.0,0.0,0.00019993262874193546,0.00041762694188868477,0.0,0.0019526355,False,HADH; hydroxyacyl-CoA
hsa:199857,0.0,0.0,2.6981048614193544e-05,7.856840087930601e-05,0.0,0.00030530724,False,ALG14; ALG14 UDP-N-acetylglucosaminyltransferase
hsa:3707,0.0,0.0,1.8519313383870967e-05,3.45560785489203e-05,0.0,0.00015161456,False,ITPKB; inositol-trisphosphate 3-kinase
hsa:8671,5.472676e-06,0.0038686728685997677,3.309728040451613e-05,6.806332070423178e-05,0.0,0.00026542836,False,SLC4A4; solute carrier family 4 member
hsa:56656,0.0,0.0,9.78898917935484e-06,4.272516793002352e-05,0.0,0.00023452645,False,OR2S2; olfactory receptor family 2 subfamily S member
hsa:390036,0.0,0.0,7.959464838709678e-07,3.2760556368778665e-06,0.0,1.6650181e-05,False,OR52K1; olfactory receptor family 52 subfamily K member
hsa:10825,5.511021e-06,0.0038957792167823493,6.416925222580645e-05,0.00013742140598131975,0.0,0.0005616091,False,NEU3; neuraminidase
hsa:6187,0.0,0.0,3.71791344516129e-07,5.861409751284126e-07,0.0,2.0755442e-06,False,RPS2; ribosomal protein
hsa:901,9.0681415e-06,0.006410332530132169,3.1681890640935484e-05,9.486301138582565e-05,0.0,0.00052299025,False,CCNG2; cyclin
hsa:25873,1.13066825e-07,7.99277279006135e-05,7.591128537096774e-07,1.7018381642091052e-06,0.0,7.6095844e-06,False,RPL36; ribosomal protein
hsa:4299,9.1557e-09,6.472228245019236e-06,4.651999044102679e-06,9.634638446673617e-06,0.0,3.713613e-05,False,AFF1; ALF transcription elongation factor
hsa:84971,1.6605982e-06,0.001173888460048724,4.1049484973974194e-05,7.206479702433696e-05,0.0,0.00027893292,False,ATG4D; autophagy related 4D cysteine
hsa:25824,0.0,0.0,4.47856021183871e-05,0.0001392252734396555,0.0,0.0005488014,False,PRDX5; peroxiredoxin
hsa:8633,1.2438715e-08,8.793014466916177e-06,5.4478548722580635e-08,8.93988445586821e-08,0.0,3.624492e-07,False,UNC5C; unc-5 netrin receptor
hsa:1510,-0.0,0.0,2.0473751027709672e-08,1.0674964712848987e-07,0.0,5.952428e-07,False,CTSE; cathepsin
hsa:23250,0.0,0.0,5.190440396258064e-06,1.627699155137714e-05,0.0,6.517243e-05,False,ATP11A; ATPase phospholipid transporting
hsa:2935,2.1075813e-08,1.4898639337827102e-05,7.797962284141934e-07,1.351447707007062e-06,0.0,4.754963e-06,False,GSPT1; G1 to S phase transition
hsa:1410,0.0,0.0,8.285460758645163e-05,0.00020223366475664428,0.0,0.00072711485,False,CRYAB; crystallin alpha
hsa:7095,0.0,0.0,0.00014709467276870968,0.00036758057415248017,0.0,0.0015708846,False,SEC62; SEC62 homolog
hsa:390433,0.0,0.0,1.9114723548387097e-08,1.0642627657805746e-07,0.0,5.9255643e-07,False,OR4K13; olfactory receptor family 4 subfamily K member
hsa:64744,0.0,0.0,5.518105437419354e-07,1.1264352642432526e-06,0.0,4.5532834e-06,False,SMAP2; small
hsa:221458,0.0,0.0,2.576400558582581e-07,7.967474446647367e-07,0.0,3.6802164e-06,False,KIF6; kinesin family member
hsa:7043,0.0007348751,0.5194883382790322,0.0007152655192580644,0.0005951343296328264,0.0,0.0023749345,True,TGFB3; transforming growth factor beta
hsa:8528,4.2295585e-05,0.029899044297717475,0.0001651685492516129,0.0002737569011848124,0.0,0.0010814529,False,DDO; D-aspartate
hsa:8394,0.0,0.0,1.8794757558064517e-05,4.4378290892316326e-05,0.0,0.00020726309,False,PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:125476,1.3499402e-07,9.542821511765255e-05,3.5964025531290317e-06,1.0620371412892046e-05,0.0,4.5847668e-05,False,INO80C; INO80 complex subunit
hsa:84445,0.0,0.0,1.7861565530419356e-05,5.672428669995243e-05,0.0,0.0002700666,False,LZTS2; leucine zipper tumor suppressor
hsa:26279,0.0,0.0,1.497947583870968e-06,4.816814041563854e-06,0.0,2.2678525e-05,False,PLA2G2D; phospholipase A2 group
hsa:1271,0.0,0.0,4.507007496774193e-07,1.3117265388333834e-06,0.0,5.7724847e-06,False,CNTFR; ciliary neurotrophic factor
hsa:25981,0.0,0.0,3.5540273719354835e-07,1.0617199131881991e-06,0.0,4.980281e-06,False,DNAH1; dynein axonemal heavy chain
hsa:54776,0.0,0.0,4.0057963632258066e-06,9.173102359601498e-06,0.0,4.1543313e-05,False,PPP1R12C; protein phosphatase 1 regulatory subunit
hsa:1907,0.0,0.0,0.0,0.0,0.0,0.0,False,EDN2; endothelin
hsa:64960,0.0,0.0,3.623806774193548e-08,4.7117690144265466e-08,0.0,1.6325029e-07,False,MRPS15; mitochondrial ribosomal protein
hsa:26275,0.0,0.0,2.172074741935484e-07,1.2093600341551602e-06,0.0,6.7334317e-06,False,HIBCH; 3-hydroxyisobutyryl-CoA
hsa:84874,0.0,0.0,1.1043976282258064e-07,2.931648621386904e-07,0.0,1.2132475e-06,False,ZNF514; zinc finger protein
hsa:115653,0.0,0.0,1.9254616645161288e-08,6.936361371811082e-08,0.0,3.553852e-07,False,KIR3DL3; killer cell immunoglobulin like receptor
hsa:11060,7.555126e-07,0.0005340771310973404,1.063176385612903e-06,1.3071562326059722e-06,0.0,5.791819e-06,False,WWP2; WW domain containing E3 ubiquitin protein ligase
hsa:3382,0.0,0.0,1.4252533951612903e-06,5.491608845868109e-06,0.0,2.8889162e-05,False,ICA1; islet cell autoantigen
hsa:23291,0.0,0.0,9.998677041935483e-05,0.00026962535341199103,0.0,0.0013246678,False,FBXW11; F-box and WD repeat domain containing
hsa:10965,0.0,0.0,0.00019311288584838713,0.00043836055520230183,0.0,0.002183172,False,ACOT2; acyl-CoA thioesterase
hsa:3681,0.0,0.0,1.8254589580645164e-09,3.509425905092683e-09,0.0,1.7566341e-08,False,ITGAD; integrin subunit alpha
hsa:25759,0.0,0.0,4.4040914032258065e-07,1.3081047934408433e-06,0.0,4.6864857e-06,False,SHC2; SHC adaptor protein
hsa:59277,0.0,0.0,7.974697940322581e-07,2.5822181479028608e-06,0.0,1.2133126e-05,False,NTN4; netrin
hsa:5698,0.0,0.0,7.727135135161288e-06,1.5711297565299772e-05,0.0,6.8912566e-05,False,PSMB9; proteasome 20S subunit beta
hsa:1140,7.726012e-07,0.0005461571817311354,3.3321468976129033e-06,4.824868540645591e-06,0.0,1.7554788e-05,False,CHRNB1; cholinergic receptor nicotinic beta 1
hsa:53358,2.9359019e-06,0.002075409548345363,3.423031499677419e-05,6.491852980361651e-05,0.0,0.00029638954,False,SHC3; SHC adaptor protein
hsa:2769,0.0,0.0,5.0874041032258064e-05,0.00014330049209286023,0.0,0.00073792564,False,GNA15; G protein subunit alpha
hsa:406889,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F2; microRNA
hsa:407047,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-2; microRNA
hsa:4741,5.6974797e-10,4.0275881734617473e-07,2.6961920375161293e-08,5.577817544191944e-08,0.0,2.1886922e-07,False,NEFM; neurofilament medium
hsa:4855,2.0316651e-05,0.014361982420393668,0.00036401489925806457,0.0008789903643530925,0.0,0.004029524,False,NOTCH4; notch receptor
hsa:93661,0.0,0.0,7.308620967741936e-11,4.0692679365625833e-10,0.0,2.2656725e-09,False,CAPZA3; capping actin protein of muscle Z-line subunit alpha
hsa:2494,0.00016567683,0.1171181077002578,0.0003947714566645161,0.0005381100544267623,0.0,0.0018799093,False,NR5A2; nuclear receptor subfamily 5 group A member
hsa:4914,0.0,0.0,4.030132840000001e-05,9.452637249971458e-05,0.0,0.00036723478,False,NTRK1; neurotrophic receptor tyrosine kinase
hsa:492,0.0,0.0,6.9468226903225816e-06,1.992028666748133e-05,0.0,0.000102653394,False,ATP2B3; ATPase plasma membrane Ca2+ transporting
hsa:27113,0.0,0.0,0.00010108420172017741,0.000209816071660876,0.0,0.00071167917,False,BBC3; BCL2 binding component
hsa:9524,5.0573703e-06,0.003575090370062519,0.00034889583289870975,0.000827198286957214,0.0,0.0034894457,False,TECR; trans-2
hsa:2170,0.0,0.0,1.0151354568580646e-06,3.1689534168332132e-06,0.0,1.527482e-05,False,FABP3; fatty acid binding protein
hsa:57819,6.167399e-07,0.00043597774070910347,1.3018873646451615e-05,4.131935132091009e-05,0.0,0.0001770424,False,LSM2; LSM2 homolog
hsa:6502,0.0,0.0,1.1482463929032256e-05,3.0241053429740657e-05,0.0,0.00014879946,False,SKP2; S-phase kinase associated protein
hsa:196403,3.226318e-07,0.00022807067168008967,0.00010574658960525806,0.0002139168790603907,0.0,0.000775887,False,DTX3; deltex E3 ubiquitin ligase
hsa:7574,0.0,0.0,1.7191685754838713e-08,2.595619327209728e-08,0.0,1.0309257e-07,False,ZNF26; zinc finger protein
hsa:10744,0.0,0.0,4.677175547270968e-07,1.129795194908873e-06,0.0,4.877776e-06,False,PTTG2; pituitary tumor-transforming
hsa:5934,0.0,0.0,2.743063408387097e-06,6.3772382440647005e-06,0.0,2.481565e-05,False,RBL2; RB transcriptional corepressor like
hsa:5519,0.0,0.0,7.390412609677418e-05,0.00011271926625487338,0.0,0.00045525696,False,PPP2R1B; protein phosphatase 2 scaffold subunit
hsa:51564,0.0,0.0,1.357360634516129e-05,2.9770518850035067e-05,0.0,0.00012971323,False,HDAC7; histone deacetylase
hsa:1107,8.2419294e-10,5.826277428938742e-07,1.0764792315659358e-05,2.1985878599020164e-05,0.0,8.208537e-05,False,CHD3; chromodomain helicase DNA binding protein
hsa:1471,1.912758e-05,0.01352141982970882,0.0009310251063870967,0.0015433631444220853,0.0,0.0057009812,False,CST3; cystatin
hsa:3123,0.0,0.0,0.00028249681124838707,0.0006029723207201802,0.0,0.0024958125,False,HLA-DRB1; major histocompatibility complex
hsa:11311,7.4163665e-08,5.242681251757316e-05,3.586376218258064e-07,6.688044979875508e-07,0.0,2.8908723e-06,False,VPS45; vacuolar protein sorting 45
hsa:4881,0.0,0.0,0.00013046640974193546,0.00027126343829298166,0.0,0.0012615273,False,NPR1; natriuretic peptide receptor
hsa:4311,7.407986e-05,0.05236757017803889,0.00019704638838387097,0.0002541302386454415,0.0,0.0010347045,False,MME; membrane
hsa:5018,0.0,0.0,9.750983656129033e-06,2.654721484898816e-05,0.0,0.00012139178,False,OXA1L; OXA1L mitochondrial inner membrane
hsa:279,0.0,0.0,3.670880580645161e-06,1.5418073424574465e-05,0.0,8.3859064e-05,False,AMY2A; amylase alpha
hsa:219959,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1S1; olfactory receptor family 1 subfamily S member
hsa:100129543,1.8839932e-09,1.3318079450467113e-06,2.2176007458064517e-08,3.805185298301623e-08,0.0,1.568107e-07,False,ZNF730; zinc finger protein
hsa:3346,0.0,0.0,9.892172077096775e-06,3.199972978372603e-05,0.0,0.00014225095,False,HTN1; histatin
hsa:126231,3.834593e-10,2.7107005606073866e-07,1.2185450417741936e-08,1.676744936551775e-08,0.0,5.126211e-08,False,ZNF573; zinc finger protein
hsa:136,1.5577078e-07,0.00011011545180212079,1.4900561116451613e-05,3.859064307579279e-05,0.0,0.0002022451,False,ADORA2B; adenosine A2b
hsa:7301,2.479676e-05,0.017529002747683212,6.945060038709676e-05,8.972538000897775e-05,0.0,0.00030558728,False,TYRO3; TYRO3 protein tyrosine
hsa:135152,6.0375933e-06,0.004268016851600522,1.2437909475483867e-05,1.731950612651978e-05,0.0,5.9086233e-05,False,B3GAT2; beta-1
hsa:4481,7.595325e-08,5.369188264698573e-05,1.7496490674193546e-07,2.417966190113579e-07,0.0,9.578276e-07,False,MSR1; macrophage scavenger receptor
hsa:10667,2.116656e-07,0.00014962789025622765,3.17646538151613e-06,1.1166777728974613e-05,0.0,6.189404e-05,False,FARS2; phenylalanyl-tRNA synthetase 2
hsa:5029,4.823888e-06,0.003410040102276107,2.0843556007741933e-05,2.9681729504528287e-05,0.0,0.0001059762,False,P2RY2; purinergic receptor
hsa:7135,2.8724205e-09,2.0305341035281056e-06,2.982259510932258e-08,8.036661911220398e-08,0.0,3.2974162e-07,False,TNNI1; troponin I1
hsa:5606,3.1985786e-05,0.022610975412949402,0.0002231853797987097,0.0004361788352471347,0.0,0.0016241029,False,MAP2K3; mitogen-activated protein kinase kinase
hsa:139760,0.0,0.0,4.356405806451612e-09,2.4255440999187076e-08,0.0,1.3504858e-07,False,GPR119; G protein-coupled receptor
hsa:5979,2.0861036e-05,0.014746811977190502,9.844002635483871e-05,0.00028843785038634403,0.0,0.0015347844,False,RET; ret
hsa:2288,0.0,0.0,2.2271318454838706e-06,4.588881273101224e-06,0.0,1.7695833e-05,False,FKBP4; FKBP prolyl isomerase
hsa:57118,0.0,0.0,4.772101364516129e-06,1.3517877750612214e-05,0.0,6.823816e-05,False,CAMK1D; calcium/calmodulin dependent protein kinase
hsa:1785,1.6487054e-05,0.011654813567062853,5.937950291096774e-05,7.874503108036976e-05,0.0,0.00027728872,False,DNM2; dynamin
hsa:64968,6.685513e-08,4.726035810592667e-05,2.504821092870968e-07,5.354261693806668e-07,0.0,2.3223824e-06,False,MRPS6; mitochondrial ribosomal protein
hsa:801,0.00034347764,0.24280674149879844,0.0008455057977419356,0.0013203744033885665,0.0,0.0047971252,False,CALM1; calmodulin
hsa:4515,0.0,0.0,1.7910887161290323e-09,5.821393079876132e-09,0.0,2.949492e-08,False,MTCP1; mature T cell proliferation
hsa:324,0.0,0.0,2.347146702258064e-06,7.069414323864952e-06,0.0,3.4944394e-05,False,APC; APC regulator of WNT signaling
hsa:2146,3.8138018e-07,0.0002696003116186114,2.6093334870967745e-06,5.294255771335018e-06,0.0,2.8042115e-05,False,EZH2; enhancer of zeste 2 polycomb repressive complex 2
hsa:5584,0.0,0.0,1.3680089132258063e-05,2.284621368902247e-05,0.0,8.8063665e-05,False,PRKCI; protein kinase C
hsa:1499,0.00017922037,0.12669213067234597,0.0003930073833064516,0.0005792850497036469,0.0,0.002191863,False,CTNNB1; catenin beta
hsa:24148,2.966791e-08,2.0972452687690578e-05,5.457382447193549e-07,1.256874554504604e-06,0.0,4.472827e-06,False,PRPF6; pre-mRNA processing factor
hsa:597,0.0,0.0,6.94543088516129e-06,1.9882923649891316e-05,0.0,0.00010119038,False,BCL2A1; BCL2 related protein
hsa:9310,9.802253e-09,6.9292810742405875e-06,5.7884358925806455e-08,1.0116191024460016e-07,0.0,3.663161e-07,False,ZNF235; zinc finger protein
hsa:22954,0.0,0.0,2.1475810869032258e-07,4.627879048325286e-07,0.0,1.8432273e-06,False,TRIM32; tripartite motif containing
hsa:346606,0.0,0.0,0.0,0.0,0.0,0.0,False,MOGAT3; monoacylglycerol O-acyltransferase
hsa:6785,0.0,0.0,8.66641378064516e-06,1.548892637232384e-05,0.0,5.8940648e-05,False,ELOVL4; ELOVL fatty acid elongase
hsa:8793,0.0,0.0,4.061732265e-05,0.00011644947100235071,0.0,0.00049488596,False,TNFRSF10D; TNF receptor superfamily member
hsa:51805,0.0,0.0,9.352253993548387e-06,2.8450266281191447e-05,0.0,0.000118389624,False,COQ3; coenzyme Q3
hsa:51176,0.00023188807,0.16392329547025322,0.00039786102945161287,0.00043215289834265205,0.0,0.0017170429,False,LEF1; lymphoid enhancer binding factor
hsa:5739,1.3638389e-06,0.00096410723923195,8.623531554516129e-06,1.429641083501848e-05,0.0,5.353774e-05,False,PTGIR; prostaglandin I2
hsa:26119,2.0087866e-05,0.014200252706768633,0.00010523288067612904,0.00019231568944001978,0.0,0.00080717047,False,LDLRAP1; low density lipoprotein receptor adaptor protein
hsa:23683,0.0,0.0,1.303559840483871e-05,4.011004526483634e-05,0.0,0.00014442911,False,PRKD3; protein kinase
hsa:5558,0.0,0.0,7.597701001548388e-06,1.7082975115426315e-05,0.0,6.0017475e-05,False,PRIM2; DNA primase subunit
hsa:65220,0.0,0.0,2.6039090548387093e-05,4.2726314986386804e-05,0.0,0.00015684353,False,NADK; NAD
hsa:362,0.0,0.0,4.930790817741935e-07,1.1921995875280396e-06,0.0,5.358988e-06,False,AQP5; aquaporin
hsa:2045,0.0,0.0,2.058518930645161e-08,5.217246719741385e-08,0.0,1.9325165e-07,False,EPHA7; EPH receptor
hsa:8678,0.0,0.0,0.00011506015787258065,0.00022713533424770184,0.0,0.0009048959,False,BECN1; beclin
hsa:6208,0.0,0.0,5.556707367741934e-07,1.185410884272221e-06,0.0,5.2273167e-06,False,RPS14; ribosomal protein
hsa:6019,2.2456422e-08,1.587460147781943e-05,1.6251387377419358e-07,3.931526916328006e-07,0.0,1.9893594e-06,False,RLN2; relaxin
hsa:5977,0.0,0.0,2.480725129816129e-06,7.075162369924076e-06,0.0,3.2922453e-05,False,DPF2; double PHD fingers
hsa:50509,4.07391e-05,0.02879875418555251,0.00018721185676774194,0.0003678585069828309,0.0,0.0014296666,False,COL5A3; collagen type V alpha 3
hsa:406956,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181B2; microRNA
hsa:9844,0.0,0.0,3.3172771699032265e-05,9.122950563680316e-05,0.0,0.00046394544,False,ELMO1; engulfment and cell motility
hsa:64211,0.0,0.0,2.7287021077419356e-10,8.688528670407345e-10,0.0,4.327625e-09,False,LHX5; LIM homeobox
hsa:1120,0.0,0.0,7.375234001935484e-07,1.389996436404348e-06,0.0,4.2871934e-06,False,CHKB; choline kinase
hsa:5802,0.0,0.0,2.9041442967741936e-06,6.687845985919094e-06,0.0,2.8960589e-05,False,PTPRS; protein tyrosine phosphatase receptor type
hsa:144165,2.5419425e-07,0.00017969168982944842,6.764230570967741e-06,2.3564946246448855e-05,0.0,0.00012275024,False,PRICKLE1; prickle planar cell polarity protein
hsa:259290,0.0,0.0,8.941469032258064e-07,3.4624299573139322e-06,0.0,1.4232089e-05,False,TAS2R31; taste 2 receptor member
hsa:130399,0.0,0.0,2.443367741935484e-09,1.3604095838836854e-08,0.0,7.57444e-08,False,ACVR1C; activin A receptor type
hsa:311,3.160617e-09,2.2342622212488354e-06,4.108915972258064e-08,6.769347251634896e-08,0.0,2.7339058e-07,False,ANXA11; annexin
hsa:7133,0.0002520624,0.17818467018221834,0.0003666441766935483,0.0004952864380746512,0.0,0.0020502366,False,TNFRSF1B; TNF receptor superfamily member
hsa:86,0.0,0.0,5.450040038709677e-06,8.204896087046317e-06,0.0,2.8792176e-05,False,ACTL6A; actin like
hsa:6752,6.153324e-07,0.0004349827691334878,8.491893614516127e-06,2.065371662503786e-05,0.0,9.8012104e-05,False,SSTR2; somatostatin receptor
hsa:100506013,0.0,0.0,1.7091679965341934e-06,5.190740002201557e-06,0.0,2.5845591e-05,False,APELA; apelin receptor early endogenous
hsa:10802,0.0,0.0,2.9779092603225807e-08,7.392332383741122e-08,0.0,2.7176014e-07,False,SEC24A; SEC24 homolog A
hsa:7805,2.1418641e-08,1.5140986844274828e-05,2.0973148413225808e-07,4.340287085854835e-07,0.0,1.9234806e-06,False,LAPTM5; lysosomal protein transmembrane
hsa:54205,0.0,0.0,0.00028461234406451614,0.0005537235637996661,0.0,0.0018282955,False,CYCS; cytochrome c
hsa:8189,7.241116e-08,5.118795449901231e-05,1.4480497287096776e-06,2.0105064096105273e-06,0.0,6.9456155e-06,False,SYMPK; symplekin scaffold
hsa:6642,0.0,0.0,6.054017484193548e-07,1.3062635173487525e-06,0.0,5.0742065e-06,False,SNX1; sorting nexin
hsa:1066,8.8144145e-07,0.0006230971142589545,4.217226958356775e-05,9.497085457836988e-05,0.0,0.00047963677,False,CES1; carboxylesterase
hsa:10568,0.0,0.0,1.4510080774193547e-07,4.0121009322263657e-07,0.0,1.6406995e-06,False,SLC34A2; solute carrier family 34 member
hsa:151056,0.0005480997,0.38745550415878305,0.000791194746896742,0.0008807947838062014,0.0,0.002743241,True,PLB1; phospholipase
hsa:788,0.0,0.0,1.590208689032258e-07,4.366182792439291e-07,0.0,1.9238064e-06,False,SLC25A20; solute carrier family 25 member
hsa:126792,0.0,0.0,5.410011200000001e-06,1.5129359217984636e-05,0.0,7.583948e-05,False,B3GALT6; beta-1
hsa:2520,0.0,0.0,1.9636159177419359e-07,5.956732648623214e-07,0.0,2.6580733e-06,False,GAST;
hsa:3604,0.0,0.0,4.147288711935484e-07,1.0946754761199e-06,0.0,5.481234e-06,False,TNFRSF9; TNF receptor superfamily member
hsa:283189,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR9G4; olfactory receptor family 9 subfamily G member
hsa:2834,1.923458e-07,0.00013597058876665038,8.119063000212903e-07,1.5618601374863906e-06,0.0,6.377668e-06,False,PRLHR; prolactin releasing hormone
hsa:8531,0.0,0.0,9.776664987096774e-07,1.832878739015597e-06,0.0,8.20592e-06,False,YBX3; Y-box binding protein
hsa:2556,0.0,0.0,1.8174250322580646e-05,6.547099743773878e-05,0.0,0.00033553306,False,GABRA3; gamma-aminobutyric acid type A receptor subunit
hsa:6389,9.1283624e-07,0.0006452903104738205,4.377402462580645e-06,5.706915733215941e-06,0.0,1.9913088e-05,False,SDHA; succinate dehydrogenase complex flavoprotein subunit
hsa:8623,3.4610963e-08,2.4466731360345548e-05,4.315079213903549e-05,9.112953706212774e-05,0.0,0.00039779185,False,ASMTL; acetylserotonin O-methyltransferase
hsa:92344,0.0,0.0,3.9738064327741945e-06,9.64519010417528e-06,0.0,3.8962466e-05,False,GORAB; golgin
hsa:29850,0.0,0.0,1.432132825806452e-06,3.407837645269067e-06,0.0,1.3544361e-05,False,TRPM5; transient receptor potential cation channel subfamily M member
hsa:64837,3.3903305e-07,0.00023966482980056341,9.534680111612903e-07,1.3157516498293907e-06,0.0,4.5367074e-06,False,KLC2; kinesin light chain
hsa:1345,9.434417e-08,6.669255238014532e-05,0.0003722069467796774,0.0007962474204381812,0.0,0.0027939097,False,COX6C; cytochrome c oxidase subunit
hsa:153527,5.338475e-08,3.773805244856107e-05,2.3227500148387092e-07,4.2432116737320523e-07,0.0,1.7969683e-06,False,ZMAT2; zinc finger matrin-type
hsa:11176,0.0,0.0,4.992682080548388e-06,1.6956499167644876e-05,0.0,7.365369e-05,False,BAZ2A; bromodomain adjacent to zinc finger domain
hsa:1977,0.0,0.0,6.292106501935483e-06,2.8354259867695342e-05,0.0,0.00015827564,False,EIF4E; eukaryotic translation initiation factor
hsa:2527,0.0,0.0,2.1146187096774192e-08,1.1773698692715541e-07,-0.0,6.555318e-07,False,FUT5; fucosyltransferase
hsa:1791,0.0,0.0,5.144568516129033e-07,2.631900283972886e-06,0.0,1.4638902e-05,False,DNTT; DNA
hsa:64127,2.2461031e-06,0.0015877859612094397,4.124244616451612e-05,0.00011806846634872195,0.0,0.0005298209,False,NOD2; nucleotide binding oligomerization domain containing
hsa:6489,0.0,0.0,1.1558058258064515e-05,3.501819360285249e-05,0.0,0.0001767559,False,ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:10946,0.0,0.0,7.509341227096775e-08,1.7688486641773225e-07,0.0,6.232587e-07,False,SF3A3; splicing factor 3a subunit
hsa:50808,0.0,0.0,1.9182441543719355e-06,5.3122599129592295e-06,0.0,2.2083017e-05,False,AK3; adenylate kinase
hsa:285126,0.0,0.0,1.0758070477741937e-07,3.140280220737508e-07,0.0,1.4383871e-06,False,DNAJC5G; DnaJ heat shock protein family (Hsp40) member C5
hsa:3784,0.00011238378,0.07944487862184518,0.0002531808752451613,0.0003366392673345824,0.0,0.0014446322,False,KCNQ1; potassium voltage-gated channel subfamily Q member
hsa:5860,0.0,0.0,1.2857289322580646e-06,3.180324408457449e-06,0.0,1.3990756e-05,False,QDPR; quinoid dihydropteridine
hsa:6591,3.2216349e-06,0.0022773962007186475,6.45184011164516e-05,0.00018106290256490713,0.0,0.0009120029,False,SNAI2; snail family transcriptional repressor
hsa:7538,3.426072e-07,0.0002421914213863445,3.5334740974193547e-06,7.0999026274899974e-06,0.0,2.612615e-05,False,ZFP36; ZFP36 ring finger
hsa:342908,3.7405112e-10,2.64419347941182e-07,1.9847092777419354e-08,3.7852818437045995e-08,0.0,1.372652e-07,False,ZNF404; zinc finger protein
hsa:100996746,0.0,0.0,2.8503716448387096e-07,7.709447787303081e-07,0.0,2.773296e-06,False,SPDYE11; speedy/RINGO cell cycle regulator family member
hsa:9588,0.0,0.0,1.5314296270322582e-05,3.0921681172656215e-05,0.0,9.768255e-05,False,PRDX6; peroxiredoxin
hsa:3071,1.2700033e-07,8.977741985350806e-05,2.8588327222580646e-07,3.3378344926153903e-07,0.0,1.234385e-06,False,NCKAP1L; NCK associated protein 1
hsa:2,5.462489e-07,0.0003861471607185346,1.7372936205483871e-06,2.2066884825692395e-06,0.0,7.9169495e-06,False,A2M;
hsa:6240,0.0,0.0,2.534362056774194e-05,8.001132877374189e-05,0.0,0.0004249466,False,RRM1; ribonucleotide reductase catalytic subunit
hsa:129401,0.0,0.0,5.1732451806451616e-08,9.88646264708929e-08,0.0,3.6051594e-07,False,NUP35; nucleoporin
hsa:5290,0.0003510921,0.24818945642857648,0.0004705807259032258,0.0005468781324598701,0.0,0.0017273906,False,PIK3CA; phosphatidylinositol-4
hsa:197257,1.4228762e-07,0.00010058411187353932,6.891452342064517e-07,1.3920927371491722e-06,0.0,6.3840666e-06,False,LDHD; lactate dehydrogenase
hsa:53832,0.0,0.0,4.552922138709679e-06,1.1531193143962844e-05,0.0,5.0524213e-05,False,IL20RA; interleukin 20 receptor subunit
hsa:6873,0.0,0.0,3.7966301347419357e-06,1.1825581023817103e-05,0.0,5.7546335e-05,False,TAF2; TATA-box binding protein associated factor
hsa:257194,0.0,0.0,1.2637475199935484e-06,2.7179335792942463e-06,0.0,1.050618e-05,False,NEGR1; neuronal growth regulator
hsa:7173,0.0,0.0,1.5589914796774196e-05,5.2943508143489056e-05,0.0,0.00021909119,False,TPO; thyroid
hsa:4175,6.045735e-07,0.0004273772276166909,8.623540642903227e-06,2.1742857800388795e-05,0.0,8.917353e-05,False,MCM6; minichromosome maintenance complex component
hsa:7424,0.0,0.0,6.102335445193548e-05,0.00015881826188095903,0.0,0.00075503846,False,VEGFC; vascular endothelial growth factor
hsa:23433,6.454891e-07,0.0004563007508843721,2.1870678574625807e-05,6.44186686468585e-05,0.0,0.00033185806,False,RHOQ; ras homolog family member
hsa:343170,0.0,0.0,1.4614994709677422e-07,5.338120982970317e-07,0.0,2.7172637e-06,False,OR14K1; olfactory receptor family 14 subfamily K member
hsa:8302,0.0,0.0,1.010624644516129e-07,4.6980072272486285e-07,0.0,2.6180628e-06,False,KLRC4; killer cell lectin like receptor
hsa:26245,0.0,0.0,1.1320249903225807e-07,4.6080128576255904e-07,0.0,2.4438123e-06,False,OR2M4; olfactory receptor family 2 subfamily M member
hsa:55062,4.3053287e-06,0.0030434669130958796,0.00021829081196103226,0.000369792324239482,0.0,0.00137107,False,WIPI1; WD repeat domain
hsa:4267,3.2680616e-06,0.0023102155590487626,5.8822523467419354e-05,0.0001376884227984215,0.0,0.0006087199,False,CD99; CD99 molecule (Xg blood
hsa:51116,2.0131424e-08,1.423104416104264e-05,4.566087014870968e-07,1.0094070422313865e-06,0.0,4.14175e-06,False,MRPS2; mitochondrial ribosomal protein
hsa:60673,1.87057e-06,0.0013223189912607044,0.00010971361201096775,0.00020743780476152688,0.0,0.0006445,False,ATG101; autophagy related
hsa:238,0.0,0.0,2.574845253870968e-06,6.5401603482687765e-06,0.0,2.427675e-05,False,ALK; ALK receptor tyrosine
hsa:6141,0.0,0.0,1.100158177248387e-06,2.282098916849361e-06,0.0,7.513082e-06,False,RPL18; ribosomal protein
hsa:51091,0.0,0.0,7.748853203225806e-06,3.2043558940409125e-05,0.0,0.00017697533,False,SEPSECS; Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA
hsa:10189,4.1827377e-08,2.9568064794004603e-05,9.441489266774193e-07,1.223457850801319e-06,0.0,3.4306465e-06,False,ALYREF; Aly/REF export
hsa:92579,0.0,0.0,0.00014112681612903227,0.0004432200087748236,0.0,0.0017098102,False,G6PC3; glucose-6-phosphatase catalytic subunit
hsa:1875,1.4840951e-07,0.00010491171865083662,6.817952007051612e-05,0.00018518632778708168,0.0,0.00077795365,False,E2F5; E2F transcription factor
hsa:55367,6.8768327e-06,0.004861281042106217,1.8910591635161296e-05,3.434120573308231e-05,0.0,0.00018202644,False,PIDD1; p53-induced death domain protein
hsa:10445,1.446674e-07,0.00010226639496854372,5.6302519366935474e-06,1.4316973311500388e-05,0.0,4.8054422e-05,False,MCRS1; microspherule protein
hsa:495,0.0,0.0,1.2506934367741933e-06,3.715780171560508e-06,0.0,1.700492e-05,False,ATP4A; ATPase H+/K+ transporting subunit
hsa:11253,0.0,0.0,3.720281902064516e-06,9.226077653077727e-06,0.0,3.761966e-05,False,MAN1B1; mannosidase alpha class 1B member
hsa:6506,0.0,0.0,1.7348797667129032e-05,5.482703238967383e-05,0.0,0.00027389204,False,SLC1A2; solute carrier family 1 member
hsa:5554,0.0,0.0,4.595642958064516e-06,1.4185343259819488e-05,0.0,7.670154e-05,False,PRH1; proline rich protein HaeIII subfamily
hsa:2918,0.0,0.0,2.4846753848387094e-05,6.679163016527024e-05,0.0,0.0002655739,False,GRM8; glutamate metabotropic receptor
hsa:53349,0.0,0.0,1.4836436548387098e-07,2.634695295310029e-07,0.0,8.268461e-07,False,ZFYVE1; zinc finger FYVE-type containing
hsa:3385,0.0,0.0,3.9363988129032264e-06,1.0315831429004048e-05,0.0,4.587366e-05,False,ICAM3; intercellular adhesion molecule
hsa:3718,0.0,0.0,3.3318258193548385e-05,6.198718506028455e-05,0.0,0.00022520812,False,JAK3; Janus kinase
hsa:887,0.0,0.0,4.527867694e-06,2.083558993926177e-05,0.0,0.00011513543,False,CCKBR; cholecystokinin B
hsa:122786,0.00015409473,0.10893064035678462,0.0004957308175516129,0.000697775106421478,0.0,0.002607049,False,FRMD6; FERM domain containing
hsa:6850,0.0,0.0,3.701770165483872e-05,7.970538157825449e-05,0.0,0.0003303479,False,SYK; spleen associated tyrosine
hsa:114786,1.5544629e-07,0.00010988606755588879,4.312521986743774e-05,8.584417883626188e-05,0.0,0.00031787486,False,XKR4; XK related
hsa:11146,2.6484475e-09,1.8722060262951585e-06,1.3614190793129031e-06,4.14930563846974e-06,0.0,1.6097105e-05,False,GLMN; glomulin
hsa:406959,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR183; microRNA
hsa:27343,9.4095565e-05,0.06651681177015885,0.00027430415040548387,0.00042768131401569584,0.0,0.0017681272,False,POLL; DNA polymerase
hsa:6810,0.0,0.0,0.0005071969853709677,0.001030885808773571,0.0,0.0034711028,False,STX4; syntaxin
hsa:341416,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C2; olfactory receptor family 6 subfamily C member
hsa:117145,2.1499442e-09,1.5198105635238468e-06,6.48742608368387e-06,1.3906534831308598e-05,0.0,5.0979055e-05,False,THEM4; thioesterase superfamily member
hsa:5048,0.0,0.0,1.2683102516129033e-05,3.649179770495076e-05,0.0,0.00017391665,False,PAFAH1B1; platelet activating factor acetylhydrolase 1b regulatory subunit
hsa:89,0.0,0.0,1.371969974e-06,3.783696677156575e-06,0.0,1.9845018e-05,False,ACTN3; actinin alpha
hsa:10870,1.2537357e-07,8.86274518532604e-05,1.4781175085774195e-05,2.9102317994778476e-05,0.0,9.855146e-05,False,HCST; hematopoietic cell signal
hsa:80824,0.0,0.0,1.0456591238709678e-07,3.6816455522983227e-07,0.0,1.8874231e-06,False,DUSP16; dual specificity phosphatase
hsa:4233,3.0846542e-05,0.02180563587640182,0.00010458874971612904,0.00014789164404038584,0.0,0.00062961807,False,MET; MET proto-oncogene
hsa:7224,0.0,0.0,1.7772657677645162e-06,6.143061011252216e-06,0.0,3.091781e-05,False,TRPC5; transient receptor potential cation channel subfamily C member
hsa:50836,-0.0,0.0,9.822269032258065e-08,3.838942777326296e-07,0.0,1.7281271e-06,False,TAS2R8; taste 2 receptor member
hsa:2352,0.0,0.0,2.6499887838709677e-06,6.93261274144843e-06,0.0,3.5558758e-05,False,FOLR3; folate receptor
hsa:26689,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D1; olfactory receptor family 4 subfamily D member
hsa:9569,1.1035348e-07,7.800964537852543e-05,5.360130889161291e-06,1.0887993358308805e-05,0.0,4.5123e-05,False,GTF2IRD1; GTF2I repeat domain containing
hsa:6259,0.0,0.0,4.722566670322581e-06,1.4420288591388733e-05,0.0,6.111943e-05,False,RYK; receptor like tyrosine
hsa:84284,1.3780748e-05,0.009741706963213336,2.9093006258064512e-05,4.530045772986607e-05,0.0,0.00022318203,False,NTPCR; nucleoside-triphosphatase
hsa:147686,1.31704265e-08,9.310266434270436e-06,1.0585565608999999e-07,2.3990551471580855e-07,0.0,8.792239e-07,False,ZNF418; zinc finger protein
hsa:64422,1.2062008e-05,0.008526717658862563,3.5193027083548396e-05,7.987154892692755e-05,0.0,0.0004285667,False,ATG3; autophagy related
hsa:1261,0.0,0.0,5.058813870967742e-07,2.1487566877400325e-06,0.0,1.1267561e-05,False,CNGA3; cyclic nucleotide gated channel subunit alpha
hsa:2107,0.0,0.0,6.155274452903225e-07,2.1111281611051168e-06,0.0,1.0057772e-05,False,ETF1; eukaryotic translation termination factor
hsa:4085,5.016163e-07,0.000354596064202851,2.6648806451612904e-06,4.903683742589904e-06,0.0,2.1066624e-05,False,MAD2L1; mitotic arrest deficient 2 like
hsa:1432,0.0,0.0,0.00014282560000000003,0.00024632903374328144,0.0,0.00078798155,False,MAPK14; mitogen-activated protein kinase
hsa:6655,2.2977762e-05,0.016243140363241447,0.00015634266232258067,0.0002302307631772584,0.0,0.00072434894,False,SOS2; SOS Ras/Rho guanine nucleotide exchange factor
hsa:127077,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T11; olfactory receptor family 2 subfamily T member
hsa:440,0.0,0.0,1.2852200819354838e-05,3.620038287762625e-05,0.0,0.00019494155,False,ASNS; asparagine synthetase
hsa:3675,0.00016476103,0.11647072228715026,0.00036044950190322584,0.0006128241413589068,0.0,0.002824219,False,ITGA3; integrin subunit alpha
hsa:7855,0.0,0.0,1.6652280751612902e-05,4.598538290801087e-05,0.0,0.0001937241,False,FZD5; frizzled class receptor
hsa:4259,0.00022114503,0.1563289654981734,0.000982827690967742,0.0019180325235513968,0.0,0.007311181,False,MGST3; microsomal glutathione S-transferase
hsa:8720,8.434555e-09,5.962445810278648e-06,1.0096408840193546e-06,2.361429767884074e-06,0.0,1.0162094e-05,False,MBTPS1; membrane bound transcription factor peptidase
hsa:4629,1.850927e-06,0.0013084332174349005,3.962629617148387e-05,0.00011047930262024684,0.0,0.00059889874,False,MYH11; myosin heavy chain
hsa:11105,-0.0,0.0,2.6780483774193544e-08,7.007331058296092e-08,-0.0,2.6957477e-07,False,PRDM7; PR/SET domain
hsa:9475,0.0,0.0,3.564203716129032e-05,9.920752026231172e-05,0.0,0.0004640531,False,ROCK2; Rho associated coiled-coil containing protein kinase
hsa:5731,0.0,0.0,6.042720628322581e-06,1.3529674295275042e-05,0.0,6.400691e-05,False,PTGER1; prostaglandin E receptor
hsa:10213,0.0,0.0,2.026154550774193e-06,3.743966910653883e-06,0.0,1.3397911e-05,False,PSMD14; proteasome 26S subunit
hsa:8821,8.46977e-07,0.0005987339539611016,1.2209467775999999e-05,2.20258414346929e-05,0.0,7.564485e-05,False,INPP4B; inositol polyphosphate-4-phosphatase type II
hsa:966,1.4855837e-05,0.010501694882401326,0.00012137747987741934,0.0002993522325503847,0.0,0.0014025506,False,CD59; CD59 molecule (CD59 blood
hsa:28514,2.3143907e-06,0.0016360589423582948,5.7318529890322575e-05,0.00010231077254878463,0.0,0.0003702922,False,DLL1; delta like canonical Notch ligand
hsa:574467,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520A; microRNA
hsa:1390,1.0067727e-07,7.116946498087833e-05,2.8268868660322575e-06,6.8281489361834465e-06,0.0,2.5550016e-05,False,CREM; cAMP responsive element
hsa:84699,0.0,0.0,0.0,0.0,0.0,0.0,False,CREB3L3; cAMP responsive element binding protein 3 like
hsa:6233,0.0,0.0,3.1809970345161284e-05,7.255484668002692e-05,0.0,0.0002921667,False,RPS27A; ribosomal protein
hsa:8884,0.0,0.0,0.0001936702347029032,0.0006037242798791644,0.0,0.0026655006,False,SLC5A6; solute carrier family 5 member
hsa:1909,8.179896e-05,0.05782425585429827,0.0004781545005903226,0.001080708898116029,0.0,0.0055102143,False,EDNRA; endothelin receptor type
hsa:23643,2.197563e-06,0.001553472625665892,4.8497818796774204e-05,0.00011412353120193627,0.0,0.00044903226,False,LY96; lymphocyte antigen
hsa:5340,0.0,0.0,1.3175723549677417e-06,4.6362335494738355e-06,0.0,2.4354184e-05,False,PLG;
hsa:10690,0.0,0.0,9.648029667741934e-07,3.8249352448052225e-06,0.0,2.1045356e-05,False,FUT9; fucosyltransferase
hsa:2735,0.0001433596,0.1013419020189237,0.00039918884677419354,0.0007008475807187629,5.423241e-06,0.0037667458,False,GLI1; GLI family zinc finger
hsa:26260,1.6202775e-06,0.0011453854757439797,4.249412803548386e-06,5.562617456640077e-06,0.0,1.8872512e-05,False,FBXO25; F-box protein
hsa:100310812,0.0,0.0,1.3913672548387098e-07,3.4192575090443757e-07,0.0,1.2279398e-06,False,SPDYE2B; speedy/RINGO cell cycle regulator family member
hsa:3601,3.0278272e-05,0.021403921846366206,8.623789040225806e-05,0.00014458775182866972,0.0,0.0006201723,False,IL15RA; interleukin 15 receptor subunit
hsa:29992,3.0899453e-05,0.02184303903166818,0.000795790184248387,0.001873001967204457,0.0,0.008299543,False,PILRA; paired immunoglobin like type 2 receptor
hsa:11221,1.02255726e-07,7.228528654632064e-05,3.434317275419355e-07,6.729742177565687e-07,0.0,3.2221817e-06,False,DUSP10; dual specificity phosphatase
hsa:3909,4.3222485e-06,0.003055427637831299,2.812902372580645e-05,4.25560353709361e-05,0.0,0.00018657609,False,LAMA3; laminin subunit alpha
hsa:10782,0.0,0.0,1.0444315242258066e-06,2.641959945171069e-06,0.0,1.2111181e-05,False,ZNF274; zinc finger protein
hsa:4647,5.3030394e-08,3.7487555718437544e-05,4.495273005354839e-07,1.358814526620723e-06,0.0,7.248421e-06,False,MYO7A; myosin
hsa:2786,1.0251613e-05,0.007246936795177472,0.00011205212432258065,0.00032928796695898667,0.0,0.0015087718,False,GNG4; G protein subunit gamma
hsa:100526767,0.0,0.0,3.1799091025806445e-08,7.888153555816186e-08,0.0,2.885123e-07,False,RNF103-CHMP3; RNF103-CHMP3
hsa:343171,1.3137562e-05,0.009287034289796672,0.00016781675372129034,0.0002692363298493792,0.0,0.0010751194,False,OR2W3; olfactory receptor family 2 subfamily W member
hsa:5027,7.1014288e-06,0.005020049593078962,1.4784757811612903e-05,1.976987203675359e-05,0.0,8.59544e-05,False,P2RX7; purinergic receptor P2X
hsa:7421,1.1667688e-05,0.008247970098154374,0.00012728214483870968,0.00019373401719835923,0.0,0.0006792574,False,VDR; vitamin D
hsa:55650,0.0,0.0,2.0345626925806454e-05,3.9944580091996075e-05,0.0,0.00013760696,False,PIGV; phosphatidylinositol glycan anchor biosynthesis class
hsa:1915,0.0,0.0,4.5776649048387095e-05,0.00011116331375689241,0.0,0.00039977764,False,EEF1A1; eukaryotic translation elongation factor 1 alpha
hsa:57521,1.2706425e-07,8.982260534772715e-05,4.890311220483871e-05,7.362663590659335e-05,0.0,0.00024090019,False,RPTOR; regulatory associated protein of MTOR complex
hsa:5146,0.0,0.0,3.6908730732258066e-09,9.895959223328834e-09,0.0,4.7626187e-08,False,PDE6C; phosphodiesterase
hsa:719,1.4565841e-05,0.010296694685568469,2.7666013478709677e-05,3.4113117463322235e-05,0.0,0.00014690137,False,C3AR1; complement C3a receptor
hsa:2122,1.2096519e-06,0.0008551113725680379,5.05160453883871e-05,0.00017283628526554718,0.0,0.0009435885,False,MECOM; MDS1 and EVI1 complex
hsa:11211,6.0973443e-06,0.0043102552506162324,3.6826838381612915e-05,9.769846501969335e-05,0.0,0.0005240368,False,FZD10; frizzled class receptor
hsa:729759,0.0,0.0,4.7573293548387095e-07,2.648768884411609e-06,0.0,1.4747721e-05,False,OR4F29; olfactory receptor family 4 subfamily F member
hsa:3284,0.0,0.0,4.947190413225806e-05,0.00018390415594919692,0.0,0.0009015716,False,HSD3B2; hydroxy-delta-5-steroid dehydrogenase
hsa:51540,0.0,0.0,4.56184324516129e-05,0.00011294165826314797,0.0,0.00043864676,False,SCLY; selenocysteine
hsa:8843,5.1999717e-08,3.675896295208525e-05,5.886311354612903e-06,3.163953408301207e-05,0.0,0.00017635361,False,HCAR3; hydroxycarboxylic acid receptor
hsa:2145,3.674493e-06,0.002597524752965417,4.236249133225806e-05,9.868594333947737e-05,0.0,0.00044170456,False,EZH1; enhancer of zeste 1 polycomb repressive complex 2
hsa:1635,2.4256638e-08,1.714718673534595e-05,0.0002471406595604839,0.0005249199761839979,0.0,0.0021803188,False,DCTD; dCMP
hsa:2002,0.0,0.0,2.0891656661290323e-05,4.063819283059123e-05,0.0,0.00013279123,False,ELK1; ETS transcription factor
hsa:10607,1.0457727e-08,7.39264022063854e-06,1.2289978895806454e-06,3.146590226905679e-06,0.0,1.3025397e-05,False,TBL3; transducin beta like
hsa:574452,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR494; microRNA
hsa:4323,1.2990024e-06,0.0009182738647648761,0.00014693833639935485,0.0003145995322468547,0.0,0.0010558978,False,MMP14; matrix metallopeptidase
hsa:54512,0.0,0.0,1.6571328286051617e-05,5.2967086552380046e-05,0.0,0.0002391219,False,EXOSC4; exosome component
hsa:5409,0.0,0.0,3.477667262580645e-06,1.1079109438202951e-05,0.0,6.0078957e-05,False,PNMT; phenylethanolamine
hsa:6173,0.0,0.0,1.6791195690322578e-07,3.505928498432766e-07,0.0,1.6220259e-06,False,RPL36A; ribosomal protein
hsa:55605,1.0827912e-08,7.654326581362727e-06,5.058097493225807e-07,1.3334533017737995e-06,0.0,5.1622114e-06,False,KIF21A; kinesin family member
hsa:1017,1.942428e-06,0.0013731159130941626,0.00020975799023419358,0.0004277528477878821,0.0,0.0019283528,False,CDK2; cyclin dependent kinase
hsa:7148,2.4822598e-06,0.0017547267810255685,0.00014017886219580645,0.00034305378309109464,0.0,0.0016471216,False,TNXB; tenascin
hsa:5783,1.8719132e-10,1.3232685087174482e-07,2.74862537488129e-06,7.019579042020725e-06,0.0,3.3306427e-05,False,PTPN13; protein tyrosine phosphatase non-receptor type
hsa:341799,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6S1; olfactory receptor family 6 subfamily S member
hsa:2643,7.122836e-07,0.0005035182492200468,4.133347122580645e-06,7.169317366429788e-06,0.0,3.0894415e-05,False,GCH1; GTP cyclohydrolase
hsa:88,0.0,0.0,4.137637998709676e-06,8.763230460869034e-06,0.0,4.2047588e-05,False,ACTN2; actinin alpha
hsa:1562,0.0,0.0,7.708410000000001e-07,4.291861049208257e-06,0.0,2.3896071e-05,False,CYP2C18; cytochrome P450 family 2 subfamily C member
hsa:10058,0.0,0.0,0.000220550419,0.0007038001181832456,0.0,0.0035877286,False,ABCB6; ATP binding cassette subfamily B member 6 (Langereis blood
hsa:6482,0.0002572871,0.18187804708532265,0.0006854213217741935,0.0009916221223410099,0.0,0.0042159823,False,ST3GAL1; ST3 beta-galactoside alpha-2
hsa:26086,3.0705064e-07,0.00021705624090558157,0.00010034474690677418,0.0001556848317639771,0.0,0.00055702426,False,GPSM1; G protein signaling modulator
hsa:26585,0.0,0.0,3.994092398709678e-07,1.8936316202190348e-06,0.0,1.051331e-05,False,GREM1; gremlin 1
hsa:3099,0.0004514051,0.3191014164035227,0.0006728765031935484,0.0007022457930760409,0.0,0.0021139113,False,HK2; hexokinase
hsa:1808,0.0,0.0,1.5126970387096775e-07,3.1357510023437893e-07,0.0,1.0469596e-06,False,DPYSL2; dihydropyrimidinase like
hsa:79133,0.0,0.0,1.9619909882258062e-06,4.891895404108479e-06,0.0,1.9992114e-05,False,NDUFAF5; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:9031,0.0,0.0,4.612442474096776e-06,1.5336841076247826e-05,0.0,6.876838e-05,False,BAZ1B; bromodomain adjacent to zinc finger domain
hsa:4314,0.0,0.0,3.095643493548387e-06,1.2191778535533705e-05,0.0,5.8008092e-05,False,MMP3; matrix metallopeptidase
hsa:25984,0.0,0.0,9.352893503225808e-08,2.3442763751490423e-07,0.0,8.517467e-07,False,KRT23; keratin
hsa:4087,0.0,0.0,0.00025624981900000004,0.0006600519241492172,0.0,0.0030174048,False,SMAD2; SMAD family member
hsa:100506658,0.0,0.0,2.1908020419354838e-07,4.1076501938705975e-07,0.0,1.5857615e-06,False,OCLN;
hsa:1027,0.0,0.0,2.363351548387097e-05,0.00010078041534293554,0.0,0.0005355514,False,CDKN1B; cyclin dependent kinase inhibitor
hsa:130589,4.789947e-06,0.003386046972437405,6.903789831548386e-05,0.00011193465631849695,0.0,0.0005108295,False,GALM; galactose
hsa:57148,2.1938174e-08,1.5508248348782357e-05,4.2454259925806444e-07,7.986194452844524e-07,0.0,4.1113212e-06,False,RALGAPB; Ral GTPase activating protein non-catalytic subunit
hsa:6881,3.2322265e-07,0.000228488347669754,2.0082406064193557e-05,5.4565484882104395e-05,0.0,0.0002386102,False,TAF10; TATA-box binding protein associated factor
hsa:1495,3.6429527e-05,0.025752286947157605,0.00010307622845161289,0.0001489751398245503,0.0,0.0005997113,False,CTNNA1; catenin alpha
hsa:100137049,0.0,0.0,5.27017036967742e-05,0.0001431173251402887,0.0,0.0005062267,False,PLA2G4B; phospholipase A2 group
hsa:162966,0.0,0.0,5.196436283870968e-09,1.0262851313013068e-08,0.0,4.0825203e-08,False,ZNF600; zinc finger protein
hsa:5244,0.0,0.0,9.968528403225806e-06,2.8040503362345142e-05,0.0,0.00013000553,False,ABCB4; ATP binding cassette subfamily B member
hsa:6539,6.1406325e-07,0.0004340855981386795,3.873354801916129e-05,0.00011572205478501265,0.0,0.0006305966,False,SLC6A12; solute carrier family 6 member
hsa:54831,0.0,0.0,3.7352669416096773e-06,1.0279787783852042e-05,0.0,4.4648747e-05,False,BEST2; bestrophin
hsa:79633,0.0,0.0,0.0,0.0,0.0,0.0,False,FAT4; FAT atypical cadherin
hsa:58510,0.0,0.0,0.0,0.0,0.0,0.0,False,PRODH2; proline dehydrogenase
hsa:51763,0.0,0.0,2.273594952580645e-07,5.666302732761382e-07,0.0,2.75759e-06,False,INPP5K; inositol polyphosphate-5-phosphatase
hsa:390437,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4N5; olfactory receptor family 4 subfamily N member
hsa:4359,1.9767274e-09,1.3973623983948183e-06,4.076545093141936e-06,1.1854607962187846e-05,0.0,6.5083674e-05,False,MPZ; myelin protein
hsa:2318,4.311178e-07,0.00030476018240992544,1.530419881612903e-06,2.485403049998124e-06,0.0,9.91432e-06,False,FLNC; filamin
hsa:8800,0.0,0.0,7.135018371290323e-08,1.459603620320148e-07,0.0,5.311785e-07,False,PEX11A; peroxisomal biogenesis factor 11
hsa:3329,0.0,0.0,3.2083146764516126e-05,8.64085492135921e-05,0.0,0.00036327317,False,HSPD1; heat shock protein family D (Hsp60) member
hsa:84679,9.192788e-08,6.498446011126827e-05,4.461560141419355e-05,0.00013775524042208167,0.0,0.00072070415,False,SLC9A7; solute carrier family 9 member
hsa:122742,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4L1; olfactory receptor family 4 subfamily L member
hsa:163051,4.1881387e-09,2.9606244840042974e-06,3.4070212164516134e-08,6.958776224250243e-08,0.0,2.746783e-07,False,ZNF709; zinc finger protein
hsa:6519,0.0,0.0,8.441216129032258e-08,2.161288814538081e-07,0.0,8.7787964e-07,False,SLC3A1; solute carrier family 3 member
hsa:6170,0.0,0.0,2.6795613206451614e-07,4.891901108409636e-07,0.0,1.90646e-06,False,RPL39; ribosomal protein
hsa:158,0.0,0.0,3.1294667999999996e-05,6.185432805553973e-05,0.0,0.00023366121,False,ADSL; adenylosuccinate
hsa:219436,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5D14; olfactory receptor family 5 subfamily D member
hsa:152002,2.2212268e-07,0.00015702007310804955,0.00011620828563935484,0.0003439057002088339,0.0,0.0018010709,False,XXYLT1; xyloside xylosyltransferase
hsa:3458,0.0,0.0,1.2993535887096775e-05,5.4275621207698974e-05,0.0,0.00029351207,False,IFNG; interferon
hsa:4758,0.0,0.0,8.613815354838708e-05,0.00021377899743258113,0.0,0.0011519726,False,NEU1; neuraminidase
hsa:90423,0.0,0.0,1.7963677167741935e-06,4.663127816164942e-06,0.0,1.6582324e-05,False,ATP6V1E2; ATPase H+ transporting V1 subunit
hsa:4718,6.4456967e-06,0.0045565079939892394,9.070779206451615e-06,1.0882543524946808e-05,0.0,4.069191e-05,False,NDUFC2; NADH:ubiquinone oxidoreductase subunit
hsa:115362,5.7647615e-08,4.0751501475692145e-05,4.701711746290323e-07,8.346471872987893e-07,0.0,4.109019e-06,False,GBP5; guanylate binding protein
hsa:314,0.0,0.0,5.659454912903226e-06,2.8972455902993623e-05,0.0,0.00016154627,False,AOC2; amine oxidase copper containing
hsa:23192,0.0,0.0,3.967982123622774e-05,0.0001001099069882664,0.0,0.00044535028,False,ATG4B; autophagy related 4B cysteine
hsa:2829,0.0,0.0,7.1132119616129025e-06,1.8940227663564966e-05,0.0,8.976895e-05,False,XCR1; X-C motif chemokine receptor
hsa:26538,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10H2; olfactory receptor family 10 subfamily H member
hsa:9636,4.507493e-06,0.003186378268054489,9.474484102903226e-05,0.0002193161204992816,0.0,0.0009513548,False,ISG15; ISG15 ubiquitin like
hsa:9069,0.0,0.0,1.537389058064516e-06,3.848375609176835e-06,0.0,1.5384412e-05,False,CLDN12; claudin
hsa:400720,0.0,0.0,3.916696985032258e-08,1.0821336285690062e-07,0.0,4.6124586e-07,False,ZNF772; zinc finger protein
hsa:1376,0.0,0.0,5.117454419354839e-06,2.1238129098422906e-05,0.0,0.00011403625,False,CPT2; carnitine palmitoyltransferase
hsa:90576,7.622233e-09,5.38820971774061e-06,3.23981836483871e-08,5.2905584482243416e-08,0.0,1.7466056e-07,False,ZNF799; zinc finger protein
hsa:6820,3.457229e-06,0.0024439393146673226,3.647276357835485e-05,7.032585784432557e-05,0.0,0.0003497977,False,SULT2B1; sulfotransferase family 2B member
hsa:5217,0.0,0.0,7.763365425806453e-07,1.7672047493309592e-06,0.0,7.739938e-06,False,PFN2; profilin
hsa:116150,8.784735e-08,6.209990496849947e-05,1.8998154731193546e-05,5.120943979150821e-05,0.0,0.00021452113,False,NUS1; NUS1 dehydrodolichyl diphosphate synthase
hsa:1622,8.7346666e-07,0.000617459679536749,0.000229065880534,0.0005832359066612349,0.0,0.0023670625,False,DBI; diazepam binding inhibitor
hsa:8766,0.00012240109,0.08652618499067702,0.0006471013636087096,0.0010001394794201424,0.0,0.0030157568,False,RAB11A; RAB11A
hsa:3111,0.00024034502,0.16990157246236912,0.0009402415887096774,0.0013018431844844364,0.0,0.004199338,False,HLA-DOA; major histocompatibility complex
hsa:4747,0.0,0.0,3.095379754516129e-08,6.24020719841664e-08,0.0,2.2184977e-07,False,NEFL; neurofilament light
hsa:126541,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10H4; olfactory receptor family 10 subfamily H member
hsa:64145,4.031273e-08,2.84973502561065e-05,4.405983204193549e-07,7.571606287995037e-07,0.0,3.3145789e-06,False,RBSN; rabenosyn
hsa:26354,1.1796116e-08,8.338756747897302e-06,2.368676548645161e-06,7.132423288274246e-06,0.0,2.8687531e-05,False,GNL3; G protein nucleolar
hsa:11232,3.507522e-06,0.0024794917874576884,1.597514950632258e-05,2.735325475480185e-05,0.0,0.00010607105,False,POLG2; DNA polymerase gamma 2
hsa:64983,5.7565487e-08,4.069344461916485e-05,2.3273954330322585e-07,3.0675374833253657e-07,0.0,9.723335e-07,False,MRPL32; mitochondrial ribosomal protein
hsa:8452,2.3963627e-05,0.01694005521396568,7.258463706129031e-05,0.00013784644356959634,0.0,0.00073226023,False,CUL3; cullin
hsa:9429,0.00029406356,0.2078755833920846,0.0005388812700967742,0.0006171634838132898,0.0,0.0020199225,False,ABCG2; ATP binding cassette subfamily G member 2 (Junior blood
hsa:391196,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2M7; olfactory receptor family 2 subfamily M member
hsa:58494,1.6903918e-05,0.011949497638748436,0.00013779802698032256,0.0003348310522326844,0.0,0.00136184,False,JAM2; junctional adhesion molecule
hsa:8683,0.0,0.0,5.013755255935485e-07,8.467760488828641e-07,0.0,2.8418724e-06,False,SRSF9; serine and arginine rich splicing factor
hsa:390037,-0.0,0.0,8.827778983870969e-08,4.84628951552133e-07,0.0,2.6992861e-06,False,OR52I1; olfactory receptor family 52 subfamily I member
hsa:26063,0.0,0.0,6.875558967741935e-08,1.4337179616989125e-07,0.0,5.6977433e-07,False,DECR2; 2
hsa:493911,0.0,0.0,5.4994443564516133e-05,0.00017460149676086463,0.0,0.00096489093,False,PHOSPHO2; phosphatase
hsa:146198,0.0,0.0,4.067128248387097e-08,7.222110222544876e-08,0.0,2.5429776e-07,False,ZFP90; ZFP90 zinc finger
hsa:55284,1.07554134e-08,7.603076814917305e-06,1.6906354743225805e-07,3.699141442655344e-07,0.0,1.4871954e-06,False,UBE2W; ubiquitin conjugating enzyme E2
hsa:5797,0.0,0.0,1.1192396067741935e-05,3.9372627883405765e-05,0.0,0.00021844223,False,PTPRM; protein tyrosine phosphatase receptor type
hsa:1727,0.0,0.0,3.95813284e-05,7.491633694460446e-05,0.0,0.00031917653,False,CYB5R3; cytochrome b5 reductase
hsa:5801,0.0,0.0,2.7790974548387095e-08,7.586059431349284e-08,0.0,3.4348855e-07,False,PTPRR; protein tyrosine phosphatase receptor type
hsa:250,0.0,0.0,5.3964641516129026e-08,1.8136132257428589e-07,0.0,8.080445e-07,False,ALPP; alkaline phosphatase
hsa:23410,0.0,0.0,4.260905569354839e-06,1.344515275833055e-05,0.0,6.862495e-05,False,SIRT3; sirtuin
hsa:165324,6.2223373e-09,4.398613674879772e-06,1.1687299977741935e-07,2.440398835177381e-07,0.0,9.505543e-07,False,UBXN2A; UBX domain protein
hsa:79814,0.0,0.0,4.128705713713871e-06,1.747900612445465e-05,0.0,9.730674e-05,False,AGMAT;
hsa:54926,0.0,0.0,9.687388419354839e-08,2.8830860707555687e-07,0.0,1.5350312e-06,False,UBE2R2; ubiquitin conjugating enzyme E2
hsa:115727,0.0,0.0,3.635422572903226e-07,9.574386392106709e-07,0.0,4.218755e-06,False,RASGRP4; RAS guanyl releasing protein
hsa:1849,0.0,0.0,2.0304519715741936e-05,5.1989623778895886e-05,0.0,0.00023822208,False,DUSP7; dual specificity phosphatase
hsa:8925,0.0,0.0,8.355184815483871e-07,2.3652950146864253e-06,0.0,1.006226e-05,False,HERC1; HECT and RLD domain containing E3 ubiquitin protein ligase family member
hsa:50834,0.0,0.0,3.919588516129032e-07,1.8946793208377594e-06,-0.0,1.0535706e-05,False,TAS2R1; taste 2 receptor member
hsa:260425,0.0,0.0,1.3207393612903226e-07,5.375922453961431e-07,0.0,2.9511612e-06,False,MAGI3; membrane associated guanylate kinase
hsa:8325,4.6408742e-05,0.03280666369455209,0.00024816386499999993,0.00037295005388104604,0.0,0.001710725,False,FZD8; frizzled class receptor
hsa:90321,7.0441617e-09,4.979567080313108e-06,2.8244171629032253e-08,4.917051662271896e-08,0.0,2.0536646e-07,False,ZNF766; zinc finger protein
hsa:6786,0.0,0.0,4.279767838709678e-06,1.4593747402593851e-05,0.0,7.099394e-05,False,STIM1; stromal interaction molecule
hsa:55256,0.0,0.0,3.081337520322581e-05,8.176961602781987e-05,0.0,0.0003569529,False,ADI1; acireductone dioxygenase
hsa:9245,5.08111e-10,3.5918721297169727e-07,4.0098683946967745e-07,9.452864006856185e-07,0.0,3.938825e-06,False,GCNT3; glucosaminyl (N-acetyl) transferase 3
hsa:81696,0.0,0.0,2.2532890645161292e-07,1.1716671701709586e-06,0.0,6.5225818e-06,False,OR5V1; olfactory receptor family 5 subfamily V member
hsa:548596,0.0,0.0,5.6890724935483864e-06,1.6720571322325528e-05,0.0,8.423489e-05,False,CKMT1A; creatine kinase
hsa:2200,0.0,0.0,0.0001071880504996129,0.0003333228957230305,0.0,0.001200113,False,FBN1; fibrillin
hsa:3695,0.0,0.0,7.959560507741935e-05,0.00019150784610726573,0.0,0.00080489053,False,ITGB7; integrin subunit beta
hsa:2585,3.3467134e-07,0.0002365815065529054,1.9285911517225803e-05,5.226127890308127e-05,0.0,0.00025271342,False,GALK2; galactokinase
hsa:80145,1.4923348e-08,1.0549418879588816e-05,1.6677797617096778e-07,2.9231555132701625e-07,0.0,1.3704606e-06,False,THOC7; THO complex subunit
hsa:1504,0.0,0.0,1.517642241419355e-06,3.646980105378814e-06,0.0,1.2986233e-05,False,CTRB1; chymotrypsinogen
hsa:1740,0.0,0.0,1.920601956129032e-06,3.027843582065277e-06,0.0,1.0400849e-05,False,DLG2; discs large MAGUK scaffold protein
hsa:8106,0.0,0.0,2.732021475806452e-07,9.74752567885847e-07,0.0,5.3058516e-06,False,PABPN1; poly(A) binding protein nuclear
hsa:55233,0.0,0.0,5.5035053516129026e-05,9.344730619061644e-05,0.0,0.00030014053,False,MOB1A; MOB kinase activator
hsa:22936,0.0,0.0,2.958307219877419e-05,6.893832948255114e-05,0.0,0.00023808489,False,ELL2; elongation factor for RNA polymerase II
hsa:26013,4.2375e-08,2.9955183315605592e-05,8.838993830225806e-07,2.5969963009101776e-06,0.0,1.2548204e-05,False,L3MBTL1; L3MBTL histone methyl-lysine binding protein
hsa:89801,0.0,0.0,1.5167289655483873e-06,2.9746899932647983e-06,0.0,1.1089235e-05,False,PPP1R3F; protein phosphatase 1 regulatory subunit
hsa:140469,0.0,0.0,2.4612400987096778e-08,8.469135663853429e-08,0.0,4.415841e-07,False,MYO3B; myosin
hsa:8942,4.720057e-06,0.003336641243542357,7.087844091129032e-05,0.00013032433537165178,0.0,0.00066600554,False,KYNU;
hsa:7089,5.9444085e-07,0.00042021438659668216,0.0005629965094270967,0.0014287444056888376,0.0,0.0063888323,False,TLE2; TLE family member 2
hsa:79981,0.0,0.0,4.015280396774193e-06,1.1428494092809272e-05,0.0,6.0455728e-05,False,FRMD1; FERM domain containing
hsa:55627,0.0,0.0,1.0704951356774193e-05,2.846829515379943e-05,0.0,0.00012916198,False,SMPD4; sphingomyelin phosphodiesterase
hsa:1108,1.4584329e-07,0.00010309763981831335,5.547533209645162e-06,1.0939154169092963e-05,0.0,3.406736e-05,False,CHD4; chromodomain helicase DNA binding protein
hsa:390058,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR51B6; olfactory receptor family 51 subfamily B member
hsa:2074,0.0,0.0,2.2515162691290323e-07,5.069645922025856e-07,0.0,2.1263545e-06,False,ERCC6; ERCC excision repair 6
hsa:23600,0.0,0.0,5.53013764516129e-07,1.9610878373871165e-06,0.0,1.0156325e-05,False,AMACR; alpha-methylacyl-CoA
hsa:55711,1.8402231e-06,0.0013008665558020532,2.6273427096129033e-05,5.489631899880948e-05,0.0,0.00025193946,False,FAR2; fatty acyl-CoA reductase
hsa:408,7.378914e-05,0.05216205818055187,0.0004660337627516129,0.0007324812641967055,0.0,0.0022077118,False,ARRB1; arrestin beta
hsa:256435,2.4596768e-06,0.0017387627006759212,4.3139772832258063e-05,7.264024639265036e-05,0.0,0.00031982298,False,ST6GALNAC3; ST6 N-acetylgalactosaminide alpha-2
hsa:23418,0.0,0.0,4.0605869626129035e-07,1.2051865395024103e-06,0.0,5.9958975e-06,False,CRB1; crumbs cell polarity complex component
hsa:2768,0.0,0.0,0.00018631797999999996,0.0004248688968302743,0.0,0.0014220318,False,GNA12; G protein subunit alpha
hsa:2246,1.3596153e-05,0.00961121546907424,7.926905652903224e-05,0.00017987893589255393,0.0,0.0007025419,False,FGF1; fibroblast growth factor
hsa:406885,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7C; microRNA
hsa:8398,0.0,0.0,2.1137398135483872e-05,6.378348379954755e-05,0.0,0.00028046512,False,PLA2G6; phospholipase A2 group
hsa:11069,0.0,0.0,7.141730016129034e-06,1.2432286789119107e-05,0.0,4.1351854e-05,False,RAPGEF4; Rap guanine nucleotide exchange factor
hsa:2069,4.1072596e-08,2.9034504836054484e-05,1.3780234034416128e-05,3.5460506892872236e-05,0.0,0.00018225514,False,EREG;
hsa:3859,0.0,0.0,1.0854037967741936e-08,4.748797522700168e-08,0.0,2.616981e-07,False,KRT12; keratin
hsa:340024,0.0,0.0,0.0,0.0,0.0,0.0,False,SLC6A19; solute carrier family 6 member
hsa:7768,0.0,0.0,2.8317050490322582e-08,5.0076246226416986e-08,0.0,1.4644841e-07,False,ZNF225; zinc finger protein
hsa:168417,-0.0,0.0,5.972702321290322e-09,2.0484892292905343e-08,0.0,1.02758584e-07,False,ZNF679; zinc finger protein
hsa:219988,2.9150334e-07,0.00020606574600144666,1.199965163032258e-05,3.861820677939554e-05,0.0,0.00017973875,False,PATL1; PAT1 homolog 1
hsa:55971,0.0,0.0,2.3517604677419356e-08,5.4078040916100585e-08,0.0,2.710098e-07,False,BAIAP2L1; BAR/IMD domain containing adaptor protein 2 like
hsa:1803,9.2491393e-07,0.0006538281138479575,2.3468022778709674e-06,3.4980406408028672e-06,0.0,1.4699373e-05,False,DPP4; dipeptidyl peptidase
hsa:7186,0.0,0.0,4.223756441935484e-05,0.00014337516189188274,0.0,0.00078254705,False,TRAF2; TNF receptor associated factor
hsa:148206,0.0,0.0,2.0943231464516133e-08,4.360861494443884e-08,0.0,1.6894936e-07,False,ZNF714; zinc finger protein
hsa:5345,5.3526934e-09,3.783856331073325e-06,2.8274799236774193e-07,5.115311939807032e-07,0.0,1.8321889e-06,False,SERPINF2; serpin family F member
hsa:6457,1.3448485e-09,9.50682792901881e-07,2.1380354296129029e-07,4.2578620254507983e-07,0.0,1.4405568e-06,False,SH3GL3; SH3 domain containing GRB2 like 3
hsa:7336,0.0,0.0,3.720263463645161e-06,1.1903618049186939e-05,0.0,5.1310228e-05,False,UBE2V2; ubiquitin conjugating enzyme E2
hsa:10907,1.3854405e-07,9.793775610705431e-05,8.472154911096774e-07,1.432833072542655e-06,0.0,5.4270586e-06,False,TXNL4A; thioredoxin like
hsa:58477,0.0,0.0,4.406443259451613e-06,9.874708688231023e-06,0.0,4.0189876e-05,False,SRPRB; SRP receptor subunit
hsa:2558,2.0682346e-05,0.014620494768773615,4.8152327248387096e-05,7.048092586462793e-05,0.0,0.00032932675,False,GABRA5; gamma-aminobutyric acid type A receptor subunit
hsa:5867,0.0,0.0,2.1135705440645163e-07,4.645694534512198e-07,0.0,2.1523294e-06,False,RAB4A; RAB4A
hsa:80010,0.0,0.0,2.3737563286129034e-05,7.771247064439515e-05,0.0,0.00036450548,False,RMI1; RecQ mediated genome instability
hsa:2960,8.2272216e-08,5.815880382445073e-05,5.476152262870968e-06,1.6729197513812948e-05,0.0,8.120659e-05,False,GTF2E1; general transcription factor IIE subunit
hsa:11258,2.5336226e-08,1.7910355029041003e-05,4.578762404516129e-07,9.677919010547444e-07,0.0,3.9815664e-06,False,DCTN3; dynactin subunit
hsa:10714,0.0,0.0,0.0001804286163548387,0.00038450860309005125,0.0,0.0014814407,False,POLD3; DNA polymerase delta 3
hsa:8897,0.0,0.0,1.5848460060941933e-05,5.2927500655943206e-05,0.0,0.00025432615,False,MTMR3; myotubularin related protein
hsa:968,4.995184e-09,3.5311304404762238e-06,1.3987984475870964e-06,2.601636367832554e-06,0.0,1.1112403e-05,False,CD68; CD68
hsa:8484,0.0,0.0,4.7401666790322585e-08,1.3799149266927394e-07,0.0,6.3801764e-07,False,GALR3; galanin receptor
hsa:83744,0.0,0.0,1.368859429032258e-10,6.554567380742368e-10,0.0,3.6452885e-09,False,ZNF484; zinc finger protein
hsa:1812,1.3182033e-06,0.0009318471150144244,2.571500716516129e-05,6.061163571134433e-05,0.0,0.00030361523,False,DRD1; dopamine receptor
hsa:3952,0.0,0.0,6.3819307351612895e-06,2.3699291533046742e-05,0.0,0.0001265344,False,LEP;
hsa:5193,1.7024638e-08,1.2034835449482593e-05,3.7494131789677425e-06,1.1105557999348236e-05,0.0,5.1683754e-05,False,PEX12; peroxisomal biogenesis factor
hsa:9306,1.1773017e-06,0.0008322427903545509,0.00015481521559032257,0.0002980398399011421,0.0,0.0009962597,False,SOCS6; suppressor of cytokine signaling
hsa:147700,3.600959e-10,2.545543055031972e-07,1.4527446567741935e-08,3.393888658384668e-08,0.0,1.7157762e-07,False,KLC3; kinesin light chain
hsa:2073,8.491469e-07,0.0006002678714189548,1.0470652135483871e-06,1.1677113355435135e-06,0.0,3.91756e-06,False,ERCC5; ERCC excision repair 5
hsa:5073,0.0,0.0,7.976997679354838e-07,1.967868475592433e-06,0.0,9.142779e-06,False,PARN; poly(A)-specific
hsa:26100,0.0,0.0,9.784931814387097e-05,0.00016631415939744347,0.0,0.00057119946,False,WIPI2; WD repeat domain
hsa:5211,0.00018916964,0.13372533909019743,0.0002559043454870967,0.0002558557269371667,0.0,0.0008330503,False,PFKL; phosphofructokinase
hsa:9829,0.0,0.0,8.174018060000002e-08,2.78185237175808e-07,0.0,1.1960036e-06,False,DNAJC6; DnaJ heat shock protein family (Hsp40) member
hsa:9132,5.899003e-08,4.1700464010456005e-05,1.2896256073354839e-06,2.473598905558447e-06,0.0,1.0103676e-05,False,KCNQ4; potassium voltage-gated channel subfamily Q member
hsa:375790,0.0,0.0,1.308522342419355e-05,3.175969956840478e-05,0.0,0.00014857115,False,AGRN;
hsa:4992,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1F1; olfactory receptor family 1 subfamily F member
hsa:9348,0.0,0.0,1.2390968132258064e-06,3.853911864463323e-06,0.0,1.7933122e-05,False,NDST3; N-deacetylase and N-sulfotransferase
hsa:6888,7.0089976e-07,0.0004954709332546069,8.886878563225808e-06,1.9267401158490568e-05,0.0,9.810309e-05,False,TALDO1; transaldolase
hsa:23417,0.0,0.0,8.911887132258067e-06,1.9329261416558564e-05,0.0,7.060997e-05,False,MLYCD; malonyl-CoA
hsa:79923,0.0,0.0,2.3339347075290323e-08,9.653740296394434e-08,0.0,5.247974e-07,False,NANOG; Nanog
hsa:338662,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8D4; olfactory receptor family 8 subfamily D member
hsa:2561,4.406941e-08,3.115297357311109e-05,2.881519412870968e-05,7.42391973491773e-05,0.0,0.000300725,False,GABRB2; gamma-aminobutyric acid type A receptor subunit
hsa:4887,1.5467274e-09,1.093392396608142e-06,1.208398599964516e-07,2.1977386406432233e-07,0.0,8.058316e-07,False,NPY2R; neuropeptide Y receptor
hsa:815,9.965911e-05,0.07044972056920595,0.00019627687383870967,0.0002967630872543482,0.0,0.0013079597,False,CAMK2A; calcium/calmodulin dependent protein kinase II
hsa:3684,0.00010561013,0.074656538150677,0.000313683767616129,0.0004507366064346408,0.0,0.0018580084,False,ITGAM; integrin subunit alpha
hsa:6404,2.6180862e-05,0.018507434113759824,0.0001564945504451613,0.00036114103324361467,0.0,0.001267995,False,SELPLG; selectin P
hsa:9064,5.5452e-08,3.9199405904825046e-05,1.592165230967742e-07,2.4987372586228035e-07,0.0,9.954706e-07,False,MAP3K6; mitogen-activated protein kinase kinase kinase
hsa:3717,0.0,0.0,7.681295966774192e-05,0.00018277584902971506,0.0,0.00065029884,False,JAK2; Janus kinase
hsa:399968,0.0,0.0,5.714892583870967e-09,2.3341049481806964e-08,0.0,1.2884205e-07,False,PATE4; prostate and testis expressed
hsa:80339,0.0,0.0,4.421795364516129e-06,1.0080242778423347e-05,0.0,3.387724e-05,False,PNPLA3; patatin like phospholipase domain containing
hsa:54657,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A4; UDP glucuronosyltransferase family 1 member
hsa:2492,0.0,0.0,1.0539896505935483e-05,2.2932655816211965e-05,0.0,8.449324e-05,False,FSHR; follicle stimulating hormone
hsa:27089,2.7440283e-06,0.0019397727610550933,9.341334834193552e-05,0.00018911164459044252,0.0,0.00064096524,False,UQCRQ; ubiquinol-cytochrome c reductase complex III subunit
hsa:27005,0.0,0.0,2.286672281732258e-05,9.192206969029754e-05,0.0,0.0004978925,False,USP21; ubiquitin specific peptidase
hsa:119679,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52J3; olfactory receptor family 52 subfamily J member
hsa:7251,0.0,0.0,3.173150754354839e-06,9.304411060231805e-06,0.0,4.386829e-05,False,TSG101; tumor susceptibility
hsa:25915,2.7277304e-07,0.00019282516617710952,1.1096851892903226e-06,1.8266456450915915e-06,0.0,7.090111e-06,False,NDUFAF3; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:2160,0.0,0.0,9.712552335096777e-08,4.157546980304999e-07,0.0,2.293102e-06,False,F11; coagulation factor
hsa:574031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR363; microRNA
hsa:5438,1.4368333e-06,0.0010157074901585021,9.391363815161291e-05,0.0001944749556143635,0.0,0.0007811767,False,POLR2I; RNA polymerase II subunit
hsa:444,0.0,0.0,0.00032202871561032255,0.000792820782504788,0.0,0.0027144712,False,ASPH; aspartate
hsa:6218,0.0,0.0,1.981662148387097e-07,3.136427690425915e-07,0.0,1.0442691e-06,False,RPS17; ribosomal protein
hsa:3931,1.8321043e-05,0.012951273194055282,0.0002762860743516129,0.0004937275539617709,0.0,0.0020266424,False,LCAT; lecithin-cholesterol
hsa:9073,0.0,0.0,2.6390325806451613e-08,1.4693511554863468e-07,0.0,8.181001e-07,False,CLDN8; claudin
hsa:392517,0.0,0.0,2.736313612903226e-09,8.834312468726563e-09,0.0,3.6359985e-08,False,NCBP2L; nuclear cap binding protein subunit 2
hsa:442184,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2B3; olfactory receptor family 2 subfamily B member
hsa:79058,0.0,0.0,1.811155015966774e-06,5.209707729500005e-06,0.0,2.2491642e-05,False,ASPSCR1; ASPSCR1 tether for SLC2A4
hsa:58484,3.2167034e-07,0.0002273910088942343,1.9910232152521288e-05,4.6238084860385625e-05,0.0,0.000195611,False,NLRC4; NLR family CARD domain containing
hsa:10284,0.0,0.0,2.565484117741935e-07,5.418077478106025e-07,0.0,2.167548e-06,False,SAP18; Sin3A associated protein
hsa:51096,0.0,0.0,2.731488295609677e-06,5.9963599389806406e-06,0.0,2.2162061e-05,False,UTP18; UTP18 small subunit processome
hsa:3588,0.0,0.0,2.705000288290323e-05,5.578597195758216e-05,0.0,0.0002516157,False,IL10RB; interleukin 10 receptor subunit
hsa:93100,0.0,0.0,0.0001317970036129032,0.00026248583898384666,0.0,0.0011350403,False,NAPRT; nicotinate
hsa:5685,0.0,0.0,7.2114862835483876e-06,1.4339676081321055e-05,0.0,6.0661165e-05,False,PSMA4; proteasome 20S subunit alpha
hsa:85366,0.0,0.0,1.051143652580645e-06,3.1380328566127636e-06,0.0,1.4129261e-05,False,MYLK2; myosin light chain kinase
hsa:390083,0.0,0.0,3.2216960583870965e-06,1.1578629195861013e-05,0.0,4.9703784e-05,False,OR56A3; olfactory receptor family 56 subfamily A member
hsa:56623,7.005803e-07,0.0004952451047504887,1.5277468103225806e-06,2.1078915499242852e-06,0.0,7.780263e-06,False,INPP5E; inositol polyphosphate-5-phosphatase
hsa:83700,3.7176394e-06,0.002628025244326088,8.842996402580645e-05,0.0001723915334669293,0.0,0.00067163224,False,JAM3; junctional adhesion molecule
hsa:6723,0.0,0.0,0.0002429893912903226,0.0004522165699132497,0.0,0.0016792096,False,SRM; spermidine
hsa:8972,0.0,0.0,2.8021115917741932e-05,7.41625086862314e-05,0.0,0.00035850643,False,MGAM;
hsa:256933,3.408887e-08,2.4097660173966912e-05,4.338494277548387e-07,6.570551210277986e-07,0.0,2.6939558e-06,False,NPB; neuropeptide
hsa:7534,1.4415671e-06,0.0010190538464246827,2.4617704583548388e-05,4.371835729044177e-05,0.0,0.00017470091,False,YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:163131,0.0,0.0,6.764761224516132e-08,1.9103102636429648e-07,0.0,7.633016e-07,False,ZNF780B; zinc finger protein
hsa:9748,1.7959016e-09,1.2695353780481272e-06,8.993237084861292e-06,2.9198513247941442e-05,0.0,0.00012229891,False,SLK; STE20 like
hsa:1806,6.579879e-05,0.04651362398572356,0.0003092806873548388,0.000747532139453263,0.0,0.003928463,False,DPYD; dihydropyrimidine
hsa:113278,0.00014401271,0.10180359003721881,0.0002808748739658065,0.00039425678498997314,0.0,0.0015709057,False,SLC52A3; solute carrier family 52 member
hsa:650,2.4677047e-05,0.01744437679227882,0.0001655444980322581,0.000266535769490767,0.0,0.00081094593,False,BMP2; bone morphogenetic protein
hsa:1384,0.0,0.0,3.0656383824193546e-06,9.162906906469632e-06,0.0,4.0637566e-05,False,CRAT; carnitine
hsa:390927,1.5044279e-08,1.0634905847695941e-05,5.759214409354839e-08,9.137918263656633e-08,0.0,2.8594124e-07,False,ZNF793; zinc finger protein
hsa:4613,9.5323195e-08,6.738463198712019e-05,1.2548450969687096e-06,3.7338320470557996e-06,0.0,2.0645226e-05,False,MYCN; MYCN proto-oncogene
hsa:3821,0.0,0.0,1.9581183856129033e-06,3.7230070709144464e-06,0.0,1.6345753e-05,False,KLRC1; killer cell lectin like receptor
hsa:11313,0.0,0.0,7.529024603225806e-07,1.810187371649426e-06,0.0,7.5322982e-06,False,LYPLA2; lysophospholipase
hsa:152586,0.0,0.0,1.195674956387097e-07,2.992559786230319e-07,0.0,1.267446e-06,False,MGAT4D; MGAT4 family member
hsa:101954277,0.0,0.0,1.5750894076774193e-07,4.6516755547611415e-07,0.0,2.2065199e-06,False,RNVU1-19; RNA
hsa:990,5.5964167e-09,3.956146033251126e-06,4.054225583451612e-07,1.0881702098146581e-06,0.0,5.453354e-06,False,CDC6; cell division cycle
hsa:3593,0.0,0.0,5.97537435483871e-07,2.3425474825832403e-06,0.0,1.0699092e-05,False,IL12B; interleukin
hsa:4501,0.0,0.0,0.00013734797096658064,0.0002932088195011957,0.0,0.001146008,False,MT1X; metallothionein
hsa:8454,0.0,0.0,0.0002974976461290323,0.0004503850790307732,0.0,0.0016052718,False,CUL1; cullin
hsa:4821,0.0,0.0,1.4491879406451613e-05,3.098573886975954e-05,0.0,0.00010256011,False,NKX2-2; NK2 homeobox
hsa:71,0.00019444586,0.13745513584095764,0.00041912385396774193,0.0006061120416486133,0.0,0.0026475615,False,ACTG1; actin gamma
hsa:29089,0.0,0.0,1.4892657293548387e-05,4.825627365583719e-05,0.0,0.0002232169,False,UBE2T; ubiquitin conjugating enzyme E2
hsa:166378,5.1682356e-09,3.6534618245720084e-06,1.749410711258064e-07,3.447810550975767e-07,0.0,1.274334e-06,False,AFG2A; AFG2 AAA ATPase homolog
hsa:5690,6.500942e-07,0.0004595561282221113,2.1385110017096776e-06,2.893844140127643e-06,0.0,9.2101645e-06,False,PSMB2; proteasome 20S subunit beta
hsa:54905,1.2349186e-07,8.729725791823248e-05,4.8723427800999995e-06,1.8853806096420405e-05,0.0,0.00010542085,False,CYP2W1; cytochrome P450 family 2 subfamily W member
hsa:7423,0.0,0.0,1.5733820380645165e-05,4.1081875442144865e-05,0.0,0.00020970152,False,VEGFB; vascular endothelial growth factor
hsa:129642,0.0,0.0,1.950869527419355e-05,4.4946658355105945e-05,0.0,0.00019602333,False,MBOAT2; membrane bound O-acyltransferase domain containing
hsa:8295,0.0,0.0,6.351939322903225e-06,1.2687817787757994e-05,0.0,4.8495174e-05,False,TRRAP; transformation/transcription domain associated
hsa:5500,0.00024852593,0.1756847148514776,0.0005792223043870967,0.0009341098540785808,0.0,0.004773299,False,PPP1CB; protein phosphatase 1 catalytic subunit
hsa:10621,0.0,0.0,3.330979193548387e-06,7.948882535053491e-06,0.0,2.5362546e-05,False,POLR3F; RNA polymerase III subunit
hsa:41,1.9631552e-06,0.0013877681154686571,4.012028118935483e-05,8.630305283910102e-05,0.0,0.00034917222,False,ASIC1; acid sensing ion channel subunit
hsa:80264,8.153172e-10,5.763534203272275e-07,1.6574093587096773e-08,3.292950914622141e-08,0.0,1.05348285e-07,False,ZNF430; zinc finger protein
hsa:55666,0.0,0.0,1.1696669410870968e-06,3.520004508504886e-06,0.0,1.4605459e-05,False,NPLOC4; NPL4 homolog
hsa:55500,6.299147e-07,0.00044529109880105485,6.082936048064516e-06,1.95394864717247e-05,0.0,0.000108349916,False,ETNK1; ethanolamine kinase
hsa:3274,0.0,0.0,9.214467147096774e-06,3.4849909211138904e-05,0.0,0.0001921122,False,HRH2; histamine receptor
hsa:4644,0.0,0.0,6.612927353548388e-07,1.8562043783746578e-06,0.0,7.274075e-06,False,MYO5A; myosin
hsa:11073,2.4659728e-06,0.0017432133870276627,4.911304265177419e-05,0.00011006099883711015,0.0,0.000525808,False,TOPBP1; DNA topoisomerase II binding protein
hsa:158326,0.0,0.0,3.832072287096775e-07,1.0770558497302683e-06,0.0,5.230287e-06,False,FREM1; FRAS1 related extracellular matrix
hsa:10556,0.0,0.0,6.805883721451613e-07,2.3263179134500796e-06,0.0,1.082451e-05,False,RPP30; ribonuclease P/MRP subunit
hsa:10499,0.0,0.0,6.759340633548387e-07,1.757219370089428e-06,0.0,7.4382315e-06,False,NCOA2; nuclear receptor coactivator
hsa:8777,0.0,0.0,1.5583474331774192e-05,4.345679777501331e-05,0.0,0.00016473765,False,MPDZ; multiple PDZ domain crumbs cell polarity complex
hsa:29881,0.0,0.0,1.854914260967742e-08,1.0033646200586064e-07,0.0,5.5903877e-07,False,NPC1L1; NPC1 like intracellular cholesterol transporter
hsa:7074,1.0849882e-06,0.0007669857327733084,3.6716499483870962e-06,6.023648863010318e-06,0.0,2.3975064e-05,False,TIAM1; TIAM Rac1 associated GEF
hsa:64919,1.8871921e-08,1.3340692697879097e-05,9.996983974015159e-08,2.0461842512078864e-07,0.0,9.780524e-07,False,BCL11B; BCL11 transcription factor
hsa:466,4.5352118e-07,0.0003205972881276639,9.717626890709677e-06,2.0769540668401902e-05,0.0,7.678283e-05,False,ATF1; activating transcription factor
hsa:81931,1.4119599e-09,9.981243100598028e-07,3.0940203529032254e-08,7.682500546990474e-08,0.0,3.864384e-07,False,ZNF93; zinc finger protein
hsa:4929,5.4947697e-07,0.0003884291059363661,9.546628032000001e-05,0.0002210186151415303,0.0,0.0009738887,False,NR4A2; nuclear receptor subfamily 4 group A member
hsa:91661,0.0,0.0,2.4040069045161293e-08,4.198645893117175e-08,0.0,1.7896542e-07,False,ZNF765; zinc finger protein
hsa:100289678,0.0,0.0,1.011736935483871e-08,1.966682275858956e-08,0.0,8.085541e-08,False,ZNF783; zinc finger protein
hsa:7637,8.036473e-09,5.681038865508314e-06,6.573642722580646e-08,1.1587606021011854e-07,0.0,3.788247e-07,False,ZNF84; zinc finger protein
hsa:55614,2.6443121e-08,1.8692826831663476e-05,1.7191307914096776e-07,4.2962790478321614e-07,0.0,1.7553011e-06,False,KIF16B; kinesin family member
hsa:6637,0.0,0.0,1.1339323312903225e-07,2.019967002790574e-07,0.0,7.2044696e-07,False,SNRPG; small nuclear ribonucleoprotein polypeptide
hsa:26056,1.2492139e-07,8.830780265463738e-05,3.3857245516129027e-07,5.072107360499635e-07,0.0,2.1570097e-06,False,RAB11FIP5; RAB11 family interacting protein
hsa:8936,4.4884578e-06,0.0031729221522916757,1.9733155786129035e-05,3.771309513748983e-05,0.0,0.00013427384,False,WASF1; WASP family member
hsa:3567,0.0,0.0,0.0,0.0,0.0,0.0,False,IL5; interleukin
hsa:94030,2.2613123e-07,0.0001598537450863332,1.2445443487096777e-06,1.6325029058027758e-06,0.0,5.7475936e-06,False,LRRC4B; leucine rich repeat containing
hsa:2787,3.6474547e-05,0.02578411189943769,0.0003218484947741935,0.0007767384927234161,0.0,0.0036954668,False,GNG5; G protein subunit gamma
hsa:4068,0.0,0.0,1.3325951029354839e-07,3.4841804874597446e-07,0.0,1.2972214e-06,False,SH2D1A; SH2 domain containing
hsa:128367,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10X1; olfactory receptor family 10 subfamily X member
hsa:4634,0.0,0.0,8.533240174193547e-05,0.0002490429124785959,0.0,0.0011374432,False,MYL3; myosin light chain
hsa:79924,0.0,0.0,4.1384967274516125e-06,1.4569228869091744e-05,0.0,7.113163e-05,False,ADM2; adrenomedullin
hsa:124,0.0,0.0,1.3704670838709678e-07,6.164167775636773e-07,0.0,3.340092e-06,False,ADH1A; alcohol dehydrogenase 1A (class I)
hsa:51175,0.0,0.0,2.3589082861451612e-08,5.837892516022335e-08,0.0,2.4026647e-07,False,TUBE1; tubulin epsilon
hsa:10393,3.164014e-06,0.00223666358426295,1.3531239498387092e-05,2.212646384576513e-05,0.0,8.5565705e-05,False,ANAPC10; anaphase promoting complex subunit
hsa:26007,0.0,0.0,6.468222519354838e-05,0.00011731025784571822,0.0,0.00048608723,False,TKFC; triokinase and FMN
hsa:8643,8.531326e-05,0.060308539057272494,0.00017508595487096776,0.00021751321007030866,0.0,0.0007607823,False,PTCH2; patched
hsa:22905,4.178143e-09,2.9535584538953227e-06,3.309292672283871e-07,6.557369173542859e-07,0.0,2.1572826e-06,False,EPN2; epsin
hsa:1299,7.1320734e-05,0.05041712474745827,0.00018345654410645165,0.00025142999476359084,0.0,0.00093119603,False,COL9A3; collagen type IX alpha 3
hsa:200316,2.9902978e-06,0.0021138623897876603,6.638024726129032e-06,1.135747497763942e-05,0.0,4.6586556e-05,False,APOBEC3F; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5874,0.0,0.0,3.550200541935484e-07,1.265505622192952e-06,0.0,6.8310223e-06,False,RAB27B; RAB27B
hsa:283459,0.0,0.0,1.4497533605741936e-06,6.130412736261674e-06,0.0,3.284397e-05,False,GATC; glutamyl-tRNA amidotransferase subunit
hsa:8650,0.0,0.0,0.00033399312792580643,0.0010322139452099434,0.0,0.0045343284,False,NUMB; NUMB endocytic adaptor
hsa:119695,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52R1; olfactory receptor family 52 subfamily R member
hsa:6944,0.0,0.0,3.442787583870968e-07,5.74436071346074e-07,0.0,2.1999178e-06,False,VPS72; vacuolar protein sorting 72
hsa:79482,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5AL1; olfactory receptor family 5 subfamily AL member 1
hsa:6885,0.0,0.0,2.1338841870967746e-05,4.4771728733098214e-05,0.0,0.00017147203,False,MAP3K7; mitogen-activated protein kinase kinase kinase
hsa:6809,1.348802e-06,0.000953477549650866,0.00011167891099945163,0.0002237874570266058,0.0,0.0010239229,False,STX3; syntaxin
hsa:9047,0.0,0.0,1.1703646904645162e-05,3.09151114555988e-05,0.0,0.00013567829,False,SH2D2A; SH2 domain containing
hsa:8065,0.0,0.0,8.766479315612902e-07,2.7696218995597063e-06,0.0,1.3639029e-05,False,CUL5; cullin
hsa:343406,-0.0,0.0,4.435627741935484e-08,2.4696530068328585e-07,-0.0,1.3750446e-06,False,OR10R2; olfactory receptor family 10 subfamily R member
hsa:114548,1.255042e-07,8.871979511217527e-05,3.465995156741935e-05,7.321355182167269e-05,0.0,0.00032285997,False,NLRP3; NLR family pyrin domain containing
hsa:5366,3.6487545e-05,0.02579330027637542,0.00038920928495325804,0.0009814610906451488,0.0,0.003445387,False,PMAIP1; phorbol-12-myristate-13-acetate-induced protein
hsa:613,0.0,0.0,7.704588499032259e-06,2.088447710086381e-05,0.0,8.108989e-05,False,BCR; BCR activator of RhoGEF and
hsa:8450,6.685343e-07,0.00047259156364059146,2.354820204451613e-06,4.866987636809133e-06,0.0,2.3308097e-05,False,CUL4B; cullin
hsa:2322,9.944981e-08,7.030176493810375e-05,8.883899540709676e-06,2.250042491368028e-05,0.0,0.00010109866,False,FLT3; fms related receptor tyrosine kinase
hsa:255231,0.0,0.0,1.3116246097258065e-06,4.402128265366214e-06,0.0,1.8970686e-05,False,MCOLN2; mucolipin TRP cation channel
hsa:91662,1.3764647e-09,9.730325053913878e-07,4.0885442625161296e-08,7.881093945048271e-08,0.0,3.265815e-07,False,NLRP12; NLR family pyrin domain containing
hsa:10913,0.0,0.0,1.9017286241612904e-07,4.085684256020275e-07,0.0,1.5230648e-06,False,EDAR; ectodysplasin A
hsa:10390,0.0,0.0,1.1119671416129034e-05,3.010207189393215e-05,0.0,0.00014361173,False,CEPT1; choline/ethanolamine phosphotransferase
hsa:51069,0.0,0.0,6.103813392580646e-08,1.2605114025768844e-07,0.0,6.1689695e-07,False,MRPL2; mitochondrial ribosomal protein
hsa:57568,0.0,0.0,1.921728194516129e-07,3.645553420404055e-07,0.0,1.4312865e-06,False,SIPA1L2; signal induced proliferation associated 1 like
hsa:2358,1.6789771e-08,1.186880632759973e-05,3.924790613290322e-06,7.714877275132144e-06,0.0,2.7807007e-05,False,FPR2; formyl peptide receptor
hsa:3133,0.0,0.0,0.0003826643425483871,0.0007456968980665687,0.0,0.003026742,False,HLA-E; major histocompatibility complex
hsa:154141,4.287229e-05,0.03030672108813698,0.00018265927524193545,0.0003576761608465444,0.0,0.0013781438,False,MBOAT1; membrane bound O-acyltransferase domain containing
hsa:10459,5.7531327e-07,0.0004066929667669733,3.374091784741936e-05,6.986106287275099e-05,0.0,0.0003138089,False,MAD2L2; mitotic arrest deficient 2 like
hsa:2697,4.669157e-06,0.0033006596782145852,6.31888496567742e-05,0.00010986625333756477,0.0,0.00040036917,False,GJA1; gap junction protein alpha
hsa:3418,0.0,0.0,1.833390584193548e-05,3.810827918601506e-05,0.0,0.00019329856,False,IDH2; isocitrate dehydrogenase (NADP(+))
hsa:54437,0.0,0.0,3.049076929677419e-08,6.92948893813894e-08,0.0,3.5363473e-07,False,SEMA5B; semaphorin
hsa:638,0.0,0.0,4.974140738735485e-07,1.8702866174854792e-06,0.0,1.0322637e-05,False,BIK; BCL2 interacting
hsa:147949,1.6095424e-08,1.137796758613328e-05,6.220666778387098e-08,8.97269297168525e-08,0.0,2.9650027e-07,False,ZNF583; zinc finger protein
hsa:55902,0.0,0.0,1.6810809312903223e-05,3.567142326040122e-05,0.0,0.00015161958,False,ACSS2; acyl-CoA synthetase short chain family member
hsa:6232,1.5551768e-07,0.00010993653364525522,7.950879401741934e-07,1.3701224928013043e-06,0.0,4.869842e-06,False,RPS27; ribosomal protein
hsa:85409,7.546817e-07,0.0005334897620869112,1.350702419193548e-05,3.0295428246668098e-05,0.0,0.00015615762,False,NKD2; NKD inhibitor of WNT signaling pathway
hsa:201595,4.887639e-06,0.003455106129215414,0.0001222413039864516,0.0002635267539056935,0.0,0.0009861335,False,STT3B; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:51010,0.0,0.0,5.69814346451613e-07,8.309828318163507e-07,0.0,2.9173398e-06,False,EXOSC3; exosome component
hsa:1768,0.0,0.0,1.0561621967741934e-08,2.7676641524879393e-08,0.0,1.2072603e-07,False,DNAH6; dynein axonemal heavy chain
hsa:9230,7.517336e-06,0.005314057296165222,0.0003742805672870968,0.0008315608743489991,0.0,0.0032787102,False,RAB11B; RAB11B
hsa:83933,6.872583e-06,0.00485827689950949,2.0006807883870968e-05,2.9223039116413814e-05,0.0,9.8620985e-05,False,HDAC10; histone deacetylase
hsa:51020,0.0,0.0,3.505021110548387e-05,0.00010358145397879177,0.0,0.0005360059,False,HDDC2; HD domain containing
hsa:9229,2.1463513e-06,0.0015172707174321738,2.2579702391290325e-05,5.7440169758237685e-05,0.0,0.0002686349,False,DLGAP1; DLG associated protein
hsa:5257,2.654175e-07,0.00018762548360282588,9.944623364516127e-06,1.7187024432079356e-05,0.0,5.8093337e-05,False,PHKB; phosphorylase kinase regulatory subunit
hsa:283927,0.0,0.0,1.3454863058064517e-08,6.097098783165128e-08,0.0,3.3224654e-07,False,NUDT7; nudix hydrolase
hsa:203228,7.315961e-08,5.171703902886636e-05,4.045579272483871e-07,6.809820824612903e-07,0.0,2.7106164e-06,False,C9orf72; C9orf72-SMCR8 complex
hsa:127608,0.0,0.0,2.3062695161290325e-08,1.2840765222984464e-07,0.0,7.1494355e-07,False,OR2AJ1; olfactory receptor family 2 subfamily AJ member
hsa:116,7.920896e-05,0.05599336677376922,0.000237642038667742,0.00037522258355467873,0.0,0.0015931157,False,ADCYAP1; adenylate cyclase activating polypeptide
hsa:79501,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4F5; olfactory receptor family 4 subfamily F member
hsa:6169,0.0,0.0,7.280845563225807e-07,1.4111866423228519e-06,0.0,4.9407313e-06,False,RPL38; ribosomal protein
hsa:390181,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AK2; olfactory receptor family 5 subfamily AK member
hsa:800,1.0809444e-07,7.64127142323948e-05,8.221220720096774e-06,2.289226704843449e-05,0.0,0.000101329635,False,CALD1; caldesmon
hsa:8089,0.0,0.0,2.9204823750967744e-07,6.186051858480721e-07,0.0,2.7976544e-06,False,YEATS4; YEATS domain containing
hsa:23474,2.8220393e-05,0.019949192815420243,0.0004062256895596774,0.0008273423693635124,0.0,0.0036363793,False,ETHE1; ETHE1 persulfide
hsa:7223,6.1987623e-07,0.00043819483428050724,3.80213225253871e-05,0.00010066051870583111,0.0,0.0005009994,False,TRPC4; transient receptor potential cation channel subfamily C member
hsa:5092,2.2827835e-06,0.001613715592031616,4.247194722435483e-06,5.784357852228766e-06,0.0,2.3897233e-05,False,PCBD1; pterin-4 alpha-carbinolamine dehydratase
hsa:776,0.0,0.0,2.808650825806452e-05,7.451439908531692e-05,0.0,0.0002990107,False,CACNA1D; calcium voltage-gated channel subunit alpha1
hsa:2523,0.0,0.0,4.0184458735483865e-05,9.562549717261987e-05,0.0,0.00047539506,False,FUT1; fucosyltransferase 1 (H blood
hsa:8702,0.0,0.0,0.00025068999595548384,0.0006359471390235324,0.0,0.002716005,False,B4GALT4; beta-1
hsa:55157,0.0,0.0,1.8454155967741934e-06,7.006786875205505e-06,0.0,3.7507325e-05,False,DARS2; aspartyl-tRNA synthetase 2
hsa:64981,1.8831015e-08,1.3311775960918433e-05,1.9987886770967743e-07,3.752873685719009e-07,0.0,1.3032006e-06,False,MRPL34; mitochondrial ribosomal protein
hsa:7728,4.3599715e-09,3.082094289871761e-06,5.367803777419354e-08,8.796050017903079e-08,0.0,3.671368e-07,False,ZNF175; zinc finger protein
hsa:64784,1.9962425e-09,1.411157758817765e-06,1.2698796347741934e-07,2.2725047112766932e-07,0.0,9.321737e-07,False,CRTC3; CREB regulated transcription coactivator
hsa:30815,2.3046294e-05,0.01629158611245643,0.00040933733487096767,0.0010171041842107044,0.0,0.003902973,False,ST6GALNAC6; ST6 N-acetylgalactosaminide alpha-2
hsa:7477,2.4673105e-05,0.017441590164960115,5.583488326451612e-05,0.00010099946624636525,9.635727e-07,0.0004829079,False,WNT7B; Wnt family member
hsa:3882,0.0,0.0,7.488650154838711e-08,2.433871205419204e-07,0.0,1.3192349e-06,False,KRT32; keratin
hsa:8030,0.0,0.0,1.491912735096774e-05,4.816373790395797e-05,0.0,0.00019301451,False,CCDC6; coiled-coil domain containing
hsa:619552,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR483; microRNA
hsa:219417,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8U1; olfactory receptor family 8 subfamily U member
hsa:6595,1.1736679e-06,0.0008296740317673592,4.055575487741935e-06,6.287912057611779e-06,0.0,2.4141915e-05,False,SMARCA2; SWI/SNF related
hsa:7462,1.6646193e-07,0.0001176731003709618,1.1361102215677418e-05,2.2902344629790094e-05,0.0,7.830607e-05,False,LAT2; linker for activation of T cells family member
hsa:25791,1.2034896e-09,8.507551996796424e-07,1.5815365561081616e-05,6.288998515452488e-05,0.0,0.00031671472,False,NGEF; neuronal guanine nucleotide exchange
hsa:27177,0.0,0.0,5.956486058064516e-09,2.1464427248034967e-08,0.0,1.08102256e-07,False,IL36B; interleukin 36
hsa:4744,1.7869241e-10,1.263189120627104e-07,2.6448995462580643e-08,5.998694208688956e-08,0.0,2.3961263e-07,False,NEFH; neurofilament heavy
hsa:55790,3.2649211e-06,0.0023079955176752483,7.784283448658064e-05,0.00020209570852580775,0.0,0.0008216874,False,CSGALNACT1; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:8644,8.529875e-05,0.060298281836979634,0.0003118153534193548,0.0004063219664073734,0.0,0.0012177387,False,AKR1C3; aldo-keto reductase family 1 member
hsa:29984,5.239855e-08,3.704090078399824e-05,2.9918687216129038e-06,9.75651855694278e-06,0.0,4.8443588e-05,False,RHOD; ras homolog family member
hsa:6857,0.0,0.0,3.801197402387097e-05,0.00013442388720459944,0.0,0.0006280734,False,SYT1; synaptotagmin
hsa:80700,0.0,0.0,1.0340844763129035e-06,2.9395382369460407e-06,0.0,1.2052092e-05,False,UBXN6; UBX domain protein
hsa:350,0.0,0.0,4.1958847099032257e-07,1.2408895810015889e-06,0.0,6.03691e-06,False,APOH; apolipoprotein
hsa:3805,0.0,0.0,1.2045418406451612e-08,3.140223628677497e-08,0.0,1.47647e-07,False,KIR2DL4; killer cell immunoglobulin like receptor
hsa:1665,0.0,0.0,1.2288569061290324e-07,2.5048205646716535e-07,0.0,9.785243e-07,False,DHX15; DEAH-box helicase
hsa:155061,2.0744917e-08,1.4664726645475464e-05,8.229965864516128e-08,1.2789322395208415e-07,0.0,5.6087515e-07,False,ZNF746; zinc finger protein
hsa:123876,0.0,0.0,1.2123437230967743e-06,3.404760818629672e-06,0.0,1.4945538e-05,False,ACSM2A; acyl-CoA synthetase medium chain family member
hsa:1956,0.000679912,0.4806345391971688,0.0011569358900000001,0.001353571654747942,0.00019715694,0.0059403824,True,EGFR; epidermal growth factor
hsa:1080,0.0,0.0,6.055437419354839e-07,3.371524866483126e-06,0.0,1.8771856e-05,False,CFTR; CF transmembrane conductance
hsa:5550,0.0,0.0,2.8793338709677414e-06,7.213800312723868e-06,0.0,2.5959547e-05,False,PREP; prolyl
hsa:4636,1.9782124e-06,0.0013984121552614536,2.5857164356451615e-05,4.873915353797349e-05,0.0,0.00022300416,False,MYL5; myosin light chain
hsa:8915,0.0,0.0,4.182431925806452e-06,8.600910777543506e-06,0.0,3.798176e-05,False,BCL10; BCL10 immune signaling
hsa:83756,0.0,0.0,3.732127398483871e-06,1.2127138252491084e-05,0.0,5.7489502e-05,False,TAS1R3; taste 1 receptor member
hsa:7054,0.0,0.0,0.0002835941375483871,0.0005889274348248663,0.0,0.0020141674,False,TH; tyrosine
hsa:8833,1.1979229e-06,0.0008468200605890705,6.572371096032256e-05,0.0001763571003415093,0.0,0.00071093714,False,GMPS; guanine monophosphate
hsa:8973,5.1202987e-06,0.003619574895319339,9.3772957184e-05,0.00019102582708299933,0.0,0.00078772084,False,CHRNA6; cholinergic receptor nicotinic alpha 6
hsa:23002,0.0,0.0,2.0659988806451612e-07,3.6337831090277076e-07,0.0,1.5121792e-06,False,DAAM1; dishevelled associated activator of morphogenesis
hsa:29922,0.0,0.0,7.805954483870968e-07,3.052163406312629e-06,0.0,1.6774487e-05,False,NME7; NME/NM23 family member
hsa:574461,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520E; microRNA
hsa:6868,3.6683432e-05,0.02593177416414283,0.00017628995193548385,0.00022978850938564692,0.0,0.00065146957,False,ADAM17; ADAM metallopeptidase domain
hsa:277,0.0,0.0,2.9844214516129034e-07,8.405305636792597e-07,0.0,3.4840607e-06,False,AMY1B; amylase alpha
hsa:6580,0.0,0.0,3.155197358064516e-07,7.84921234453808e-07,0.0,2.992963e-06,False,SLC22A1; solute carrier family 22 member
hsa:2180,0.0,0.0,5.070757841935485e-05,0.00023507849426370768,0.0,0.001311764,False,ACSL1; acyl-CoA synthetase long chain family member
hsa:170712,0.0,0.0,4.146829322580645e-07,2.189280250363088e-06,0.0,1.2200262e-05,False,COX7B2; cytochrome c oxidase subunit
hsa:5313,6.1191204e-06,0.004325648927722993,4.713232820000001e-05,8.115760113095351e-05,0.0,0.00029762572,False,PKLR; pyruvate kinase
hsa:121129,0.0,0.0,2.826971193548387e-08,1.5739909466185764e-07,0.0,8.7636107e-07,False,OR2AP1; olfactory receptor family 2 subfamily AP member
hsa:659,0.0,0.0,5.943305780741936e-05,0.00014910077259151484,0.0,0.0005143173,False,BMPR2; bone morphogenetic protein receptor type
hsa:2939,0.0,0.0,2.511140751612903e-06,1.3533833964616458e-05,0.0,7.539507e-05,False,GSTA2; glutathione S-transferase alpha
hsa:116444,7.0649953e-06,0.00499429449759037,6.006506046451612e-05,8.352004821655445e-05,0.0,0.00027617172,False,GRIN3B; glutamate ionotropic receptor NMDA type subunit
hsa:23428,5.4196124e-07,0.0003831161839328122,1.612841544967742e-05,3.382894640726196e-05,0.0,0.00015646864,False,SLC7A8; solute carrier family 7 member
hsa:26272,4.7212555e-07,0.00033374884715589646,6.886440517419356e-07,7.884994034419998e-07,0.0,3.0946387e-06,False,FBXO4; F-box protein
hsa:8099,9.484918e-09,6.704954747456925e-06,2.6413995232774195e-07,6.713968465751496e-07,0.0,2.7447975e-06,False,CDK2AP1; cyclin dependent kinase 2 associated protein
hsa:5469,0.0,0.0,1.6770802448387097e-05,3.830821230997335e-05,0.0,0.00017162331,False,MED1; mediator complex subunit
hsa:6446,0.000441443,0.3120591383691063,0.0014109350001290319,0.0019200245946766543,0.0,0.006852407,False,SGK1; serum/glucocorticoid regulated kinase
hsa:5518,0.0,0.0,5.89986264516129e-06,1.5043566725613898e-05,0.0,5.8390353e-05,False,PPP2R1A; protein phosphatase 2 scaffold subunit
hsa:9843,0.00016126723,0.11400093067728445,0.0006068890853548386,0.0008462741701464467,0.0,0.0031837597,False,HEPH;
hsa:5709,0.0,0.0,2.7341140519354844e-06,5.50300524409392e-06,0.0,2.5204814e-05,False,PSMD3; proteasome 26S subunit
hsa:54963,6.727999e-06,0.004756069460583153,0.00015139504571935484,0.0003079678259739792,0.0,0.0010748219,False,UCKL1; uridine-cytidine kinase 1 like
hsa:3276,0.0,0.0,3.4601702410322583e-06,6.29443195561504e-06,0.0,2.3892111e-05,False,PRMT1; protein arginine methyltransferase
hsa:1364,0.0,0.0,2.804619842419354e-06,8.185672059737363e-06,0.0,3.910878e-05,False,CLDN4; claudin
hsa:7334,4.5578923e-09,3.2220058850569247e-06,5.41936220813871e-06,1.6009515336849314e-05,0.0,6.99298e-05,False,UBE2N; ubiquitin conjugating enzyme E2
hsa:284161,1.0139838e-06,0.0007167922267387459,1.744359566129032e-05,4.354840432296272e-05,0.0,0.00017351782,False,GDPD1; glycerophosphodiester phosphodiesterase domain containing
hsa:92483,5.8219193e-06,0.004115555395402057,3.547792069903226e-05,0.00010591239852061538,0.0,0.00058011,False,LDHAL6B; lactate dehydrogenase A like
hsa:3357,4.5631996e-06,0.003225757652476651,9.260218856548388e-05,0.00022199350139009223,0.0,0.0008116943,False,HTR2B; 5-hydroxytryptamine receptor
hsa:219447,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5AS1; olfactory receptor family 5 subfamily AS member
hsa:2781,0.0,0.0,1.140626264516129e-06,4.681579047688326e-06,0.0,2.5781139e-05,False,GNAZ; G protein subunit alpha
hsa:56302,1.4505939e-07,0.00010254349543598642,4.457824982287098e-06,8.826700838540556e-06,0.0,3.7297235e-05,False,TRPV5; transient receptor potential cation channel subfamily V member
hsa:2739,0.0,0.0,2.041140808119355e-06,5.913950791847289e-06,0.0,3.0310652e-05,False,GLO1; glyoxalase
hsa:53918,0.0,0.0,2.969023147677419e-07,5.539595610141465e-07,0.0,2.106925e-06,False,PELO; pelota mRNA surveillance and ribosome rescue
hsa:27346,1.2159092e-07,8.595347016196186e-05,1.3592148999999999e-06,2.5271225293796514e-06,0.0,9.3117715e-06,False,TMEM97; transmembrane protein
hsa:79671,0.0,0.0,5.094914211935484e-06,1.5781124067385255e-05,0.0,7.738937e-05,False,NLRX1; NLR family member
hsa:79767,0.0,0.0,3.124188943870967e-07,8.296560791228141e-07,0.0,4.267551e-06,False,ELMO3; engulfment and cell motility
hsa:5222,-0.0,0.0,1.3443619806451615e-07,3.7043715035627663e-07,0.0,1.9564734e-06,False,PGA5; pepsinogen
hsa:23016,0.0,0.0,2.1703018105935488e-05,7.47123165445271e-05,0.0,0.0003427746,False,EXOSC7; exosome component
hsa:1553,0.0,0.0,0.0,0.0,0.0,0.0,False,CYP2A13; cytochrome P450 family 2 subfamily A member
hsa:219484,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5M8; olfactory receptor family 5 subfamily M member
hsa:285973,2.3705372e-06,0.0016757492951613542,7.074524255935482e-05,0.00015844043089512745,0.0,0.00063438417,False,ATG9B; autophagy related
hsa:5062,0.0,0.0,8.97204436451613e-06,2.4180605934290037e-05,0.0,0.00010923674,False,PAK2; p21 (RAC1) activated kinase
hsa:5970,9.8255085e-05,0.0694572054953489,0.0004929418240322581,0.0006948147751316165,0.0,0.0022694936,False,RELA; RELA proto-oncogene
hsa:114112,0.0,0.0,3.2467588577419366e-05,6.749643121864458e-05,0.0,0.00026913173,False,TXNRD3; thioredoxin reductase
hsa:3556,3.6415287e-05,0.0257422205917496,6.218622012903226e-05,7.871860701003208e-05,0.0,0.00030142028,False,IL1RAP; interleukin 1 receptor accessory
hsa:51412,4.7280727e-07,0.0003342307597829151,5.3463925420645156e-06,8.02274788041316e-06,0.0,2.7288672e-05,False,ACTL6B; actin like
hsa:377,8.1390105e-08,5.7535233400622706e-05,5.97738591548387e-07,1.1153955840254127e-06,0.0,4.8177767e-06,False,ARF3; ADP ribosylation factor
hsa:8850,7.8014145e-06,0.005514874370938608,0.0001321680608870968,0.00022232460763438344,0.0,0.00076093466,False,KAT2B; lysine acetyltransferase
hsa:4928,3.5608636e-07,0.0002517199336870024,2.764384112354839e-05,0.00011848623377845167,0.0,0.00064906274,False,NUP98; nucleoporin 98 and 96
hsa:115111,0.0,0.0,3.5865491044287098e-06,9.785047830956777e-06,0.0,4.9801012e-05,False,SLC26A7; solute carrier family 26 member
hsa:1308,4.039538e-07,0.0002855577611807782,6.093158391419355e-06,1.745632875329742e-05,0.0,7.641716e-05,False,COL17A1; collagen type XVII alpha 1
hsa:11000,0.0,0.0,0.0,0.0,0.0,0.0,False,SLC27A3; solute carrier family 27 member
hsa:9054,0.0,0.0,1.644743964516129e-05,3.735867223228657e-05,0.0,0.00016867211,False,NFS1; NFS1 cysteine
hsa:64208,2.2377964e-07,0.00015819138969912038,1.7710694302903224e-05,5.4841930204942464e-05,0.0,0.0002835713,False,POPDC3; popeye domain containing
hsa:50506,2.74661e-07,0.00019415977828076807,2.2302415865838708e-05,3.9624450252056964e-05,0.0,0.00014004188,False,DUOX2; dual oxidase
hsa:5832,2.2633621e-07,0.00015999864687927794,2.03467782853871e-05,5.3379357539753004e-05,0.0,0.00023373327,False,ALDH18A1; aldehyde dehydrogenase 18 family member
hsa:29108,2.1115848e-06,0.0014926940358807404,0.00023288322465129033,0.0004450948094926942,0.0,0.0019921514,False,PYCARD; PYD and CARD domain
hsa:58492,0.0,0.0,1.9404869332258062e-08,3.584597198894675e-08,0.0,1.5542e-07,False,ZNF77; zinc finger protein
hsa:1478,0.0,0.0,1.8159331245161287e-07,2.7119712797050245e-07,0.0,7.3136204e-07,False,CSTF2; cleavage stimulation factor subunit
hsa:2889,0.0,0.0,1.7464322371935482e-05,5.488418188277623e-05,0.0,0.00023446068,False,RAPGEF1; Rap guanine nucleotide exchange factor
hsa:5166,0.0,0.0,1.2830098270967744e-07,2.9636457682566105e-07,0.0,1.2068076e-06,False,PDK4; pyruvate dehydrogenase kinase
hsa:80237,0.0,0.0,2.372285518967743e-06,7.047459404250912e-06,0.0,3.707911e-05,False,ELL3; elongation factor for RNA polymerase II
hsa:6497,0.0,0.0,8.184298377419354e-07,1.70061579644593e-06,0.0,7.2043513e-06,False,SKI; SKI
hsa:3423,2.4578594e-06,0.0017374779679288346,8.59418360967742e-06,1.2416402232117838e-05,0.0,3.906445e-05,False,IDS; iduronate
hsa:51274,0.0,0.0,5.887880537996775e-07,1.154081645666707e-06,0.0,3.7058348e-06,False,KLF3; KLF transcription factor
hsa:406,2.6193007e-05,0.018516019499042843,0.0009467789437080645,0.0021727551794546826,0.0,0.007585273,False,BMAL1; basic helix-loop-helix ARNT like
hsa:121130,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10P1; olfactory receptor family 10 subfamily P member
hsa:10992,9.672599e-09,6.8376277565390745e-06,1.6894470267741935e-07,2.782284222016787e-07,0.0,9.023232e-07,False,SF3B2; splicing factor 3b subunit
hsa:10458,0.0,0.0,2.608340010967742e-06,7.601439339899217e-06,0.0,2.721192e-05,False,BAIAP2; BAR/IMD domain containing adaptor protein
hsa:339221,0.0,0.0,4.489092567741935e-08,1.5046428728792254e-07,0.0,7.951264e-07,False,ENPP7; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4293,2.4302187e-09,1.7179385641418927e-06,3.3757333387096776e-07,7.872041591025606e-07,0.0,3.9496745e-06,False,MAP3K9; mitogen-activated protein kinase kinase kinase
hsa:29958,0.0,0.0,3.43270098483871e-06,6.156184213496889e-06,0.0,2.537247e-05,False,DMGDH; dimethylglycine
hsa:3597,1.8841134e-05,0.013318929152658155,0.00019023566296838708,0.00036827180664981784,0.0,0.0012968166,False,IL13RA1; interleukin 13 receptor subunit alpha
hsa:349565,5.5621535e-07,0.00039319251379831796,2.1610184682258064e-05,3.367944062118529e-05,0.0,9.5504016e-05,False,NMNAT3; nicotinamide nucleotide adenylyltransferase
hsa:5723,0.0,0.0,1.900431651935484e-05,3.434984665625359e-05,0.0,0.00013784801,False,PSPH; phosphoserine
hsa:26834,0.0,0.0,2.572248142903226e-07,7.573791730886063e-07,0.0,3.7145965e-06,False,RNU4-2; RNA
hsa:158835,0.0,0.0,2.6504181419354836e-06,1.0863044548077847e-05,0.0,5.8575963e-05,False,AWAT2; acyl-CoA wax alcohol acyltransferase
hsa:2917,0.0,0.0,3.7773949877419354e-06,1.0871806327847275e-05,0.0,5.5472377e-05,False,GRM7; glutamate metabotropic receptor
hsa:285242,0.0,0.0,0.0,0.0,0.0,0.0,False,HTR3E; 5-hydroxytryptamine receptor
hsa:773,0.000551305,0.38972135310465933,0.0008682565160967742,0.0011041403144990863,8.7205895e-05,0.0058459025,True,CACNA1A; calcium voltage-gated channel subunit alpha1
hsa:122042,0.0,0.0,3.961170744387096e-07,1.1967884424244706e-06,0.0,6.3048255e-06,False,RXFP2; relaxin family peptide receptor
hsa:832,3.4172007e-07,0.00024156430299637934,1.0019049177419353e-06,1.2397957517363161e-06,0.0,4.1033004e-06,False,CAPZB; capping actin protein of muscle Z-line subunit
hsa:3456,0.0,0.0,5.077541867741934e-06,1.6937329194465355e-05,0.0,7.917818e-05,False,IFNB1; interferon beta
hsa:5557,3.6687876e-08,2.593491565876594e-05,2.4554186556451615e-06,3.820432449716142e-06,0.0,1.4323053e-05,False,PRIM1; DNA primase subunit
hsa:134860,-0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR9; trace amine associated receptor
hsa:215,0.00042339443,0.2993004782408576,0.0005078454894967742,0.0006043314437905758,0.0,0.002623964,False,ABCD1; ATP binding cassette subfamily D member
hsa:79001,0.0002434394,0.17208901128592413,0.0006336309827903225,0.0007895902423338552,0.0,0.0028479937,False,VKORC1; vitamin K epoxide reductase complex subunit
hsa:10538,0.0,0.0,7.621773756774195e-06,1.4335001622854595e-05,0.0,5.6670084e-05,False,BATF; basic leucine zipper ATF-like transcription
hsa:23275,0.0,0.0,2.4395358942258064e-05,4.477285705519234e-05,0.0,0.00016903032,False,POFUT2; protein O-fucosyltransferase
hsa:4478,0.0,0.0,2.7664078028064514e-05,6.38543643147672e-05,0.0,0.000328844,False,MSN;
hsa:4163,0.0,0.0,5.308012199838709e-06,1.8284012703766834e-05,0.0,8.799056e-05,False,MCC; MCC regulator of WNT signaling
hsa:7644,1.4719273e-08,1.0405156837461801e-05,1.9608438964516128e-07,4.4342416788090125e-07,0.0,1.7794515e-06,False,ZNF91; zinc finger protein
hsa:4091,2.1307838e-07,0.00015062659430070249,4.055298652858065e-05,8.5024330253269e-05,0.0,0.0003451075,False,SMAD6; SMAD family member
hsa:374659,0.0,0.0,6.474124776848387e-06,2.0681549686104696e-05,0.0,9.429544e-05,False,HDDC3; HD domain containing
hsa:5577,0.0,0.0,1.659199158064516e-07,3.9038827824071717e-07,0.0,1.5257649e-06,False,PRKAR2B; protein kinase cAMP-dependent type II regulatory subunit
hsa:5862,4.4195048e-07,0.00031241787952377304,6.143588423354838e-06,1.2693398080385372e-05,0.0,5.405789e-05,False,RAB2A; RAB2A
hsa:2305,0.0,0.0,2.7107023148290317e-07,4.850500856868502e-07,0.0,1.8384605e-06,False,FOXM1; forkhead box
hsa:51060,7.368808e-07,0.0005209061816106218,2.5770768036774196e-05,5.373946507379995e-05,0.0,0.0001879918,False,TXNDC12; thioredoxin domain containing
hsa:1025,0.0,0.0,2.5518756451612905e-06,5.5245626916622365e-06,0.0,1.898456e-05,False,CDK9; cyclin dependent kinase
hsa:441531,0.0,0.0,4.604281767741935e-07,1.1078022950539443e-06,0.0,4.724656e-06,False,PGAM4; phosphoglycerate mutase family member
hsa:4967,2.8695704e-06,0.0020285193479418445,2.0206362258064515e-05,3.2331643144376296e-05,0.0,0.0001409836,False,OGDH; oxoglutarate
hsa:6756,0.0,0.0,5.493696513656129e-08,2.9895988830588376e-07,-0.0,1.6655822e-06,False,SSX1; SSX family member
hsa:51699,0.0,0.0,3.4934974444193543e-07,1.1136801704816467e-06,0.0,4.86195e-06,False,VPS29; VPS29 retromer complex
hsa:1431,9.4596237e-07,0.0006687074030209964,2.974324707645161e-05,4.502016766329778e-05,0.0,0.00017915401,False,CS; citrate
hsa:7058,2.918174e-05,0.020628775720786793,0.00021643299008709674,0.00037980837230502826,0.0,0.0016142941,False,THBS2; thrombospondin
hsa:23396,0.0,0.0,2.201087653612903e-05,5.658570859333826e-05,0.0,0.00028103444,False,PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:147657,5.76099e-09,4.072484047890753e-06,4.3194093822580644e-08,7.070600342563207e-08,0.0,3.0576263e-07,False,ZNF480; zinc finger protein
hsa:913,5.1924808e-08,3.670600925705307e-05,8.04132529251613e-06,2.69926773501519e-05,0.0,0.00014556396,False,CD1E; CD1e
hsa:2847,3.3874062e-07,0.00023945810899213908,9.785494492e-06,2.5922143127713234e-05,0.0,0.00012849507,False,MCHR1; melanin concentrating hormone receptor
hsa:84992,0.0,0.0,2.0404335561290326e-05,4.26529587541912e-05,0.0,0.00019972696,False,PIGY; phosphatidylinositol glycan anchor biosynthesis class
hsa:729230,5.941641e-06,0.004200187500897182,6.0743612523290326e-05,0.00010537091299047465,0.0,0.00044730146,False,CCR2; C-C motif chemokine receptor
hsa:30061,3.263017e-06,0.002306649496092918,7.098558739548387e-05,0.0001330498014127725,0.0,0.00050262915,False,SLC40A1; solute carrier family 40 member
hsa:152831,4.93092e-10,3.485701770255715e-07,6.358896409774193e-08,2.2197131043390328e-07,0.0,1.2003384e-06,False,KLB; klotho
hsa:2885,0.0,0.0,1.986417506451613e-05,5.343012017295372e-05,0.0,0.0001943814,False,GRB2; growth factor receptor bound protein
hsa:7263,8.45849e-05,0.05979365628866471,0.00021491835543225807,0.0003374078101975305,0.0,0.0012597056,False,TST; thiosulfate
hsa:407034,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30E; microRNA
hsa:4711,0.0,0.0,2.0212002967741932e-06,3.6995854102113812e-06,0.0,1.3673448e-05,False,NDUFB5; NADH:ubiquinone oxidoreductase subunit
hsa:146664,0.0,0.0,2.5071951577419354e-05,7.40237000227271e-05,0.0,0.00038974406,False,MGAT5B; alpha-1
hsa:1540,1.033513e-05,0.0073059755455012355,0.00014453284745161293,0.00028166857016642287,0.0,0.001116011,False,CYLD; CYLD lysine 63
hsa:170958,2.0623658e-09,1.4579007811878603e-06,1.5405894051612902e-08,3.03673817049124e-08,0.0,1.13738786e-07,False,ZNF525; zinc finger protein
hsa:574455,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR193B; microRNA
hsa:7520,0.0,0.0,0.00014472165784580642,0.00047703112667218765,0.0,0.0020484207,False,XRCC5; X-ray repair cross complementing
hsa:27180,4.4850164e-08,3.17048940260761e-05,1.0363832074387097e-05,2.8693008894800327e-05,0.0,0.0001330101,False,SIGLEC9; sialic acid binding Ig like lectin
hsa:54658,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A1; UDP glucuronosyltransferase family 1 member
hsa:10257,0.0,0.0,8.400304774193547e-05,0.0001975669830696106,0.0,0.00087796577,False,ABCC4; ATP binding cassette subfamily C member
hsa:55737,1.6239595e-07,0.00011479883072476507,6.604790317560001e-07,1.0813284660017026e-06,0.0,4.2018783e-06,False,VPS35; VPS35 retromer complex
hsa:5700,6.3186735e-07,0.0004466714407173078,7.338731861935484e-06,2.1634961133935867e-05,0.0,9.8731834e-05,False,PSMC1; proteasome 26S subunit
hsa:23047,0.0,0.0,6.397011256451612e-07,1.6271174006718323e-06,0.0,6.719643e-06,False,PDS5B; PDS5 cohesin associated factor
hsa:6829,0.0,0.0,3.7137629041290336e-05,8.266127882932333e-05,0.0,0.00031807585,False,SUPT5H; SPT5 homolog
hsa:10005,0.0,0.0,2.9067960387096775e-05,6.770876584535101e-05,0.0,0.0002710009,False,ACOT8; acyl-CoA thioesterase
hsa:348980,4.3427568e-07,0.0003069925098267675,9.829718239645163e-06,3.150635453219033e-05,0.0,0.00016982183,False,HCN1; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:4249,0.0,0.0,5.605278527419354e-06,1.1510003933803173e-05,0.0,5.425735e-05,False,MGAT5; alpha-1
hsa:1824,1.443584e-06,0.0010204796071144587,5.696434368000001e-06,9.349688495154262e-06,0.0,3.741552e-05,False,DSC2; desmocollin
hsa:5837,0.0,0.0,5.9751395122580655e-05,0.0001449449789105102,0.0,0.0005412488,False,PYGM; glycogen phosphorylase
hsa:390195,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AN1; olfactory receptor family 5 subfamily AN member
hsa:4350,1.0105333e-06,0.000714353044201153,0.00012940618818354838,0.00037106099994954535,0.0,0.0014623835,False,MPG; N-methylpurine DNA
hsa:27175,0.0,0.0,1.5620416290645163e-06,4.763032100236769e-06,0.0,2.1058004e-05,False,TUBG2; tubulin gamma
hsa:346528,1.9257873e-06,0.0013613524860971123,4.309575668403226e-05,7.71574888793191e-05,0.0,0.00025797883,False,OR2A1; olfactory receptor family 2 subfamily A member
hsa:6385,2.7860959e-05,0.019695106411647706,0.00012387173051612904,0.00018946444510901787,0.0,0.000876329,False,SDC4; syndecan
hsa:84002,0.00013807701,0.09760760227069513,0.000374161718983871,0.0006559180098530692,0.0,0.002880712,False,B3GNT5; UDP-GlcNAc:betaGal beta-1
hsa:403244,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T35; olfactory receptor family 2 subfamily T member
hsa:10683,0.0,0.0,4.9851890364516115e-06,1.1981774368727037e-05,0.0,5.0185143e-05,False,DLL3; delta like canonical Notch ligand
hsa:8626,6.971615e-09,4.928283311641904e-06,1.0477221402903225e-07,2.0358742688135651e-07,0.0,7.870851e-07,False,TP63; tumor protein
hsa:393046,0.0,0.0,4.551284137741936e-06,2.1719946892187174e-05,0.0,0.000120308425,False,OR2A5; olfactory receptor family 2 subfamily A member
hsa:127385,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10J5; olfactory receptor family 10 subfamily J member
hsa:9928,0.0,0.0,2.25589379032258e-08,7.133303008656027e-08,0.0,3.795561e-07,False,KIF14; kinesin family member
hsa:8553,5.1806586e-05,0.0366224372999572,0.0020653104639469675,0.0034643530371755707,0.0,0.011338124,False,BHLHE40; basic helix-loop-helix family member
hsa:5428,2.7572085e-07,0.00019490899364447414,8.580654813225806e-06,2.669412630145867e-05,0.0,0.00012969087,False,POLG; DNA polymerase gamma
hsa:8509,0.0,0.0,5.811560353225807e-05,0.00020826463131083656,0.0,0.0011566532,False,NDST2; N-deacetylase and N-sulfotransferase
hsa:9706,4.487572e-06,0.0031722959740879955,3.119030589645161e-05,4.298058964612532e-05,0.0,0.00014983985,False,ULK2; unc-51 like autophagy activating kinase
hsa:11164,5.6784164e-09,4.014112193612771e-06,6.245878347325805e-06,1.9854884760690713e-05,0.0,9.44574e-05,False,NUDT5; nudix hydrolase
hsa:594,0.0,0.0,3.183085441935484e-07,1.000008698565874e-06,0.0,4.2039583e-06,False,BCKDHB; branched chain keto acid dehydrogenase E1 subunit
hsa:2034,1.5747873e-06,0.0011132281358014766,6.897323631161292e-05,0.0002075119578661985,0.0,0.0008002584,False,EPAS1; endothelial PAS domain protein
hsa:9630,3.9617004e-07,0.00028005536689913393,1.8284966921677416e-05,3.7576827416696364e-05,0.0,0.00013769604,False,GNA14; G protein subunit alpha
hsa:29796,0.0,0.0,8.285752258064517e-06,2.2824500576478367e-05,0.0,0.0001041836,False,UQCR10; ubiquinol-cytochrome c reductase
hsa:10814,1.6457142e-07,0.00011633668565450196,1.4801166353225806e-06,2.8135012229382544e-06,0.0,1.0020186e-05,False,CPLX2; complexin
hsa:549,0.0,0.0,2.6703134354838708e-06,4.301265113135588e-06,0.0,1.4880037e-05,False,AUH; AU RNA binding methylglutaconyl-CoA
hsa:2121,5.156565e-05,0.03645211795960726,0.00018957005438709676,0.00033994988703215523,0.0,0.0013765688,False,EVC; EvC ciliary complex subunit
hsa:8677,1.6357212e-08,1.1563027350848932e-05,1.1328752640322582e-06,2.6074944554634138e-06,0.0,1.1382228e-05,False,STX10; syntaxin
hsa:79586,5.1370087e-05,0.03631387310970166,0.000368161251934516,0.000705671161426426,0.0,0.0027029687,False,CHPF; chondroitin polymerizing
hsa:2642,4.1881698e-08,2.9606464688114032e-05,4.2360940970322585e-06,9.299536287268181e-06,0.0,4.270529e-05,False,GCGR; glucagon
hsa:5427,0.0,0.0,5.896318520451613e-06,1.280396992908457e-05,0.0,4.7769132e-05,False,POLE2; DNA polymerase epsilon 2
hsa:1139,0.0,0.0,6.927657754838709e-05,0.0001270106745628047,0.0,0.00044938747,False,CHRNA7; cholinergic receptor nicotinic alpha 7
hsa:341,0.0,0.0,4.4447514967741935e-05,0.00011352641984342656,0.0,0.0005040063,False,APOC1; apolipoprotein
hsa:527,6.2792926e-05,0.04438875774048983,0.0008953765714083871,0.0024264003693151245,0.0,0.011216625,False,ATP6V0C; ATPase H+ transporting V0 subunit
hsa:10057,0.0,0.0,0.0001420883530322581,0.0004687059953636777,0.0,0.0019039536,False,ABCC5; ATP binding cassette subfamily C member
hsa:100169851,0.0,0.0,6.8422952580645155e-09,2.2922764702598878e-08,0.0,1.06493076e-07,False,PATE3; prostate and testis expressed
hsa:23171,3.6822084e-07,0.00026029788230858464,3.882719715806451e-06,6.207344692580648e-06,0.0,2.7041444e-05,False,GPD1L; glycerol-3-phosphate dehydrogenase 1
hsa:8871,0.0,0.0,1.9829796056935485e-05,4.663551686557425e-05,0.0,0.00021039872,False,SYNJ2; synaptojanin
hsa:6210,3.6323496e-07,0.0002567733289306587,1.4043434796774196e-06,2.70253216776335e-06,0.0,1.0852882e-05,False,RPS15A; ribosomal protein
hsa:3586,0.00035007278,0.2474688920048063,0.0004844691675161291,0.00048595371679011025,0.0,0.0015887445,False,IL10; interleukin
hsa:8741,1.1152212e-06,0.0007883576515268353,4.121777319677419e-05,8.463408834865066e-05,0.0,0.00038746357,False,TNFSF13; TNF superfamily member
hsa:79587,0.0,0.0,5.942674966612903e-06,1.6223637281365845e-05,0.0,6.417902e-05,False,CARS2; cysteinyl-tRNA synthetase 2
hsa:143187,0.0,0.0,2.731088357419355e-05,8.027620061493902e-05,0.0,0.0002971897,False,VTI1A; vesicle transport through interaction with t-SNAREs
hsa:1069,7.3164546e-07,0.0005172052832172407,1.5677949132258066e-06,2.5679949534682356e-06,0.0,1.1058915e-05,False,CETN2; centrin
hsa:22987,0.0,0.0,7.516136112903225e-07,1.957143496853348e-06,0.0,8.125175e-06,False,SV2C; synaptic vesicle glycoprotein
hsa:117178,0.0,0.0,3.284943390806452e-07,1.048805310077076e-06,0.0,4.9353157e-06,False,SSX2IP; SSX family member 2 interacting
hsa:85477,0.0,0.0,3.1506395044193547e-06,9.595051948918885e-06,0.0,4.1498522e-05,False,SCIN;
hsa:84976,0.0,0.0,9.11318555483871e-06,2.2377478676981973e-05,0.0,9.4276395e-05,False,DISP1; dispatched RND transporter family member
hsa:6144,0.0,0.0,2.73591777e-07,6.765343206527297e-07,0.0,2.5971283e-06,False,RPL21; ribosomal protein
hsa:5501,0.0,0.0,7.13632483548387e-05,0.00017533592552344907,0.0,0.0009525456,False,PPP1CC; protein phosphatase 1 catalytic subunit
hsa:8876,0.0,0.0,2.3378657903225805e-06,4.498050600996446e-06,0.0,1.6672431e-05,False,VNN1; vanin
hsa:83998,0.0,0.0,4.253542717741935e-08,2.1818274333698257e-07,0.0,1.2170304e-06,False,REG4; regenerating family member
hsa:90865,5.730076e-05,0.040506307254832334,0.00016057703695806448,0.00023535914946574144,0.0,0.0007669283,False,IL33; interleukin
hsa:545,3.1020492e-05,0.021928602345729242,5.9246716548387094e-05,8.936761723460757e-05,0.0,0.0004321502,False,ATR; ATR serine/threonine
hsa:6375,0.0,0.0,4.378297096774193e-08,2.43773265453015e-07,0.0,1.3572721e-06,False,XCL1; X-C motif chemokine ligand
hsa:1564,4.000655e-07,0.0002828090947669477,0.00019999590893870968,0.000567888765699353,0.0,0.0019567427,False,CYP2D7; cytochrome P450 family 2 subfamily D member 7
hsa:6677,0.0,0.0,3.115152322580645e-09,1.4171678270635247e-08,0.0,7.712119e-08,False,SPAM1; sperm adhesion molecule
hsa:55659,1.9574767e-08,1.383753944177621e-05,6.94157212164516e-08,1.2051705489879712e-07,0.0,4.275778e-07,False,ZNF416; zinc finger protein
hsa:23335,0.0,0.0,4.1361925580096777e-07,1.1093458573000942e-06,0.0,4.477392e-06,False,WDR7; WD repeat domain
hsa:84812,0.0,0.0,8.528029903225807e-07,4.277082814416876e-06,0.0,2.3751583e-05,False,PLCD4; phospholipase C delta
hsa:3706,0.0,0.0,3.7713115774193548e-06,7.425807050690217e-06,0.0,2.739697e-05,False,ITPKA; inositol-trisphosphate 3-kinase
hsa:2178,0.0,0.0,1.3892029225806452e-05,4.643916070482811e-05,0.0,0.00022027997,False,FANCE; FA complementation group
hsa:83734,0.0,0.0,7.985478714935484e-06,1.993274127649978e-05,0.0,8.8945744e-05,False,ATG10; autophagy related
hsa:200959,0.0,0.0,1.0587919535225807e-05,2.2054352917905555e-05,0.0,8.943197e-05,False,GABRR3; gamma-aminobutyric acid type A receptor subunit
hsa:5395,0.0,0.0,1.4433299541935486e-05,3.4522370900965024e-05,0.0,0.00012803417,False,PMS2; PMS1 homolog 2
hsa:1642,0.0,0.0,4.616657243870967e-06,8.675091298671776e-06,0.0,3.2835487e-05,False,DDB1; damage specific DNA binding protein
hsa:80331,8.372322e-09,5.918452868136346e-06,2.0730378629951614e-06,5.1480117120628115e-06,0.0,2.1941007e-05,False,DNAJC5; DnaJ heat shock protein family (Hsp40) member
hsa:8817,1.2826937e-06,0.0009067451308854846,8.044006346548386e-06,1.5580651153779432e-05,0.0,6.345546e-05,False,FGF18; fibroblast growth factor
hsa:983,0.0,0.0,2.049449970596774e-05,6.697116044413631e-05,0.0,0.00029295593,False,CDK1; cyclin dependent kinase
hsa:259285,0.0,0.0,2.559957658064516e-06,1.1180515644928821e-05,0.0,6.217525e-05,False,TAS2R39; taste 2 receptor member
hsa:9519,1.071829e-06,0.0007576834024302589,7.121208418064515e-06,1.9227083954103093e-05,0.0,8.9138564e-05,False,TBPL1; TATA-box binding protein like
hsa:5000,0.0,0.0,1.20518672519871e-06,3.2464838001858935e-06,0.0,1.4666498e-05,False,ORC4; origin recognition complex subunit
hsa:382,0.0,0.0,8.945558032580646e-06,2.7160639817872963e-05,0.0,0.00012661103,False,ARF6; ADP ribosylation factor
hsa:127602,0.0,0.0,6.97075982580645e-08,1.2910662229493814e-07,0.0,4.3556648e-07,False,DNAH14; dynein axonemal heavy chain
hsa:84295,0.0,0.0,3.0714181448387096e-07,7.738356380425686e-07,0.0,2.9351313e-06,False,PHF6; PHD finger protein
hsa:25885,5.7429037e-07,0.0004059698716162115,5.864448054806451e-06,1.2164809501812701e-05,0.0,5.5907196e-05,False,POLR1A; RNA polymerase I subunit
hsa:3106,8.9555346e-05,0.06330729926424745,0.000473353670483871,0.0009307883674024136,0.0,0.00425116,False,HLA-B; major histocompatibility complex
hsa:4046,2.7393696e-07,0.00019364794935031778,1.5718575070880643e-05,3.070701757781529e-05,0.0,0.00011301446,False,LSP1; lymphocyte specific protein
hsa:79296,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52E1; olfactory receptor family 52 subfamily E member 1
hsa:50831,-0.0,0.0,8.578407419354839e-08,4.776255111932056e-07,0.0,2.6593063e-06,False,TAS2R3; taste 2 receptor member
hsa:7314,0.0,0.0,2.7925797241935486e-06,5.8358798354322664e-06,0.0,2.3762e-05,False,UBB; ubiquitin
hsa:27086,0.0,0.0,3.9651819617741934e-07,8.389372880260882e-07,0.0,3.7696313e-06,False,FOXP1; forkhead box
hsa:11181,1.2222076e-06,0.0008639870845481145,1.0245710485e-05,2.377140761351848e-05,0.0,0.00011476112,False,TREH;
hsa:3205,1.4290864e-08,1.0102311524681737e-05,1.499491456528387e-06,4.6771824645999905e-06,0.0,2.357244e-05,False,HOXA9; homeobox
hsa:116984,0.0,0.0,1.264837687580645e-07,3.0298065542272394e-07,0.0,1.0837341e-06,False,ARAP2; ArfGAP with RhoGAP domain
hsa:51561,0.0,0.0,4.081789532258064e-06,1.0072258216705492e-05,0.0,4.1375693e-05,False,IL23A; interleukin 23 subunit
hsa:22823,1.1536809e-08,8.15545081940126e-06,1.1622165797741934e-06,3.924360221331141e-06,0.0,1.8126235e-05,False,MTF2; metal response element binding transcription factor
hsa:939,4.6846114e-07,0.0003311584501460195,1.521793540903226e-06,2.558381292711291e-06,0.0,1.054024e-05,False,CD27; CD27
hsa:2902,0.0,0.0,0.00029657388967741936,0.0012608910929769765,0.0,0.007016467,False,GRIN1; glutamate ionotropic receptor NMDA type subunit
hsa:10915,2.8870656e-07,0.00020408868269540731,4.4649553748387084e-07,5.816048640057664e-07,0.0,2.294099e-06,False,TCERG1; transcription elongation regulator
hsa:64901,0.0,0.0,5.7012445706451604e-08,1.1359794757812658e-07,0.0,4.6016024e-07,False,RANBP17; RAN binding protein
hsa:9790,8.663745e-09,6.124461821230947e-06,1.3809301499999994e-07,3.436716902751617e-07,0.0,1.5338724e-06,False,BMS1; BMS1 ribosome biogenesis
hsa:55252,0.0,0.0,3.3818644548387098e-06,1.3586772609107481e-05,0.0,6.766389e-05,False,ASXL2; ASXL transcriptional regulator
hsa:2207,0.00015429781,0.10907419902646565,0.00032897365596451614,0.00048452802393206203,0.0,0.0021768382,False,FCER1G; Fc epsilon receptor
hsa:136051,0.0,0.0,8.997008275709679e-08,2.516929531297803e-07,0.0,1.0295947e-06,False,ZNF786; zinc finger protein
hsa:51761,0.0,0.0,1.7614642535806457e-07,5.663794622687988e-07,0.0,2.7169892e-06,False,ATP8A2; ATPase phospholipid transporting
hsa:7326,1.0929522e-07,7.7261553996919e-05,1.6124633121290316e-06,4.116685117811173e-06,0.0,1.8467164e-05,False,UBE2G1; ubiquitin conjugating enzyme E2
hsa:51206,0.0,0.0,1.7620720163709676e-06,6.476819662421584e-06,0.0,2.9348916e-05,False,GP6; glycoprotein VI
hsa:390067,0.0,0.0,2.8451447883870967e-07,1.090445177547625e-06,0.0,5.3599465e-06,False,OR52H1; olfactory receptor family 52 subfamily H member
hsa:79168,8.743375e-06,0.006180752824119953,1.3368290489387097e-05,1.5098197476875564e-05,0.0,4.6279012e-05,False,LILRA6; leukocyte immunoglobulin like receptor
hsa:2931,0.0,0.0,9.501138106451614e-07,1.6727943666457536e-06,0.0,6.049189e-06,False,GSK3A; glycogen synthase kinase 3
hsa:7535,0.0,0.0,0.0001037330428741936,0.0002376717070060111,0.0,0.0010344868,False,ZAP70; zeta chain of T cell receptor associated protein kinase
hsa:79017,5.830944e-07,0.0004121935018832578,2.351121065580645e-05,3.941518939959571e-05,0.0,0.00017200853,False,GGCT;
hsa:5329,0.0,0.0,1.7413221093548386e-06,4.502141329412494e-06,0.0,1.6467298e-05,False,PLAUR; plasminogen activator
hsa:3694,0.0,0.0,3.6604715548387095e-06,8.572223834965835e-06,0.0,3.56871e-05,False,ITGB6; integrin subunit beta
hsa:796,4.972898e-06,0.0035153763114999033,3.880999066870968e-05,6.648708719674142e-05,0.0,0.00024311629,False,CALCA; calcitonin related polypeptide
hsa:401992,-0.0,0.0,2.012091935483871e-08,1.120285377312478e-07,-0.0,6.237485e-07,False,OR2T2; olfactory receptor family 2 subfamily T member
hsa:84643,0.0,0.0,0.0,0.0,0.0,0.0,False,KIF2B; kinesin family member
hsa:5601,0.0,0.0,0.0001911130257096774,0.0004624620987876332,0.0,0.0017634796,False,MAPK9; mitogen-activated protein kinase
hsa:2131,4.3363038e-05,0.030653634275199324,0.0005163737825612902,0.0011531475416160133,0.0,0.0047482094,False,EXT1; exostosin glycosyltransferase
hsa:9365,4.8305217e-05,0.034147295111152984,7.209794187096776e-05,0.00010128634833185818,0.0,0.0005457364,False,KL;
hsa:162466,0.0,0.0,1.519658493548387e-06,3.846406516310544e-06,0.0,1.5824846e-05,False,PHOSPHO1; phosphoethanolamine/phosphocholine phosphatase
hsa:338376,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNE; interferon
hsa:548593,3.498385e-05,0.024730327783732124,0.0001747049989193548,0.00034043186972721216,0.0,0.0014399411,False,SLX1A; SLX1 homolog A
hsa:55870,0.0,0.0,3.4233978032258066e-06,9.514605070195527e-06,0.0,4.0565996e-05,False,ASH1L; ASH1 like histone lysine
hsa:3769,0.0,0.0,1.4331207907451613e-06,4.139234304902702e-06,0.0,2.1678601e-05,False,KCNJ13; potassium inwardly rectifying channel subfamily J member
hsa:3814,0.0,0.0,1.0421740224645162e-05,2.825256971108023e-05,0.0,0.00011949942,False,KISS1; KiSS-1 metastasis
hsa:51013,2.2765634e-07,0.0001609318559919725,1.0083561957096776e-06,2.043247001776859e-06,0.0,1.0301596e-05,False,EXOSC1; exosome component
hsa:7419,0.0,0.0,9.438287447419356e-05,0.00031388722095676075,0.0,0.0017379958,False,VDAC3; voltage dependent anion channel
hsa:648,2.7216421e-07,0.00019239477999992863,4.403382038999999e-05,0.00011155200893613752,0.0,0.00040281264,False,BMI1; BMI1 proto-oncogene
hsa:967,0.0,0.0,4.675766412903224e-06,1.2675726496222882e-05,0.0,5.700502e-05,False,CD63; CD63
hsa:246213,0.0,0.0,7.019902330322581e-06,2.3802685499096333e-05,0.0,0.00011794277,False,SLC17A8; solute carrier family 17 member
hsa:9187,0.0,0.0,0.00045595560360967734,0.0012528285423691,0.0,0.0053673303,False,SLC24A1; solute carrier family 24 member
hsa:8787,4.4770022e-05,0.03164824108681287,0.00014596335580645164,0.00026570828041871204,0.0,0.0011184302,False,RGS9; regulator of G protein signaling
hsa:4221,0.0,0.0,6.983700506451613e-06,1.2867231204210578e-05,0.0,4.3613298e-05,False,MEN1; menin
hsa:55851,0.0,0.0,1.624549441564516e-05,5.156181718823812e-05,0.0,0.00019919974,False,PSENEN; presenilin enhancer
hsa:55207,5.303328e-08,3.748959585198442e-05,3.838337561290324e-07,8.62618452141711e-07,0.0,3.653057e-06,False,ARL8B; ADP ribosylation factor like GTPase
hsa:94160,0.0,0.0,1.5731614838709677e-07,8.758992446873567e-07,0.0,4.8768006e-06,False,ABCC12; ATP binding cassette subfamily C member
hsa:6602,0.0,0.0,3.1153717806451613e-06,7.497879225256824e-06,0.0,3.287879e-05,False,SMARCD1; SWI/SNF related
hsa:6789,1.2792145e-06,0.0009042856601175397,1.982700784903226e-05,5.839426463864443e-05,0.0,0.00028612552,False,STK4; serine/threonine kinase
hsa:24146,0.0,0.0,1.5995797870967743e-06,4.0604027882293076e-06,0.0,2.1545893e-05,False,CLDN15; claudin
hsa:5579,0.0,0.0,0.0,0.0,0.0,0.0,False,PRKCB; protein kinase C
hsa:55247,0.0,0.0,4.905312095483871e-07,1.0626764663123554e-06,0.0,3.9128267e-06,False,NEIL3; nei like DNA glycosylase
hsa:64963,0.0,0.0,3.328646437741935e-07,7.638276550530779e-07,0.0,3.1656843e-06,False,MRPS11; mitochondrial ribosomal protein
hsa:6442,7.7290584e-05,0.054637253387379646,0.00020489563349483867,0.00043277538521083853,0.0,0.0022973705,False,SGCA; sarcoglycan
hsa:219858,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR8B12; olfactory receptor family 8 subfamily B member
hsa:54961,0.0,0.0,2.1513112651612902e-07,5.378554956590481e-07,0.0,2.2150114e-06,False,SSH3; slingshot protein phosphatase
hsa:6716,0.0,0.0,2.086154267741936e-08,5.0271759936335764e-08,0.0,2.2096668e-07,False,SRD5A2; steroid 5 alpha-reductase
hsa:2593,0.0,0.0,5.841234481612903e-05,0.00010040407647831044,0.0,0.0003679393,False,GAMT; guanidinoacetate
hsa:56950,1.04654866e-07,7.398125536047525e-05,1.4259828361709676e-05,3.602119578555408e-05,0.0,0.0001861735,False,SMYD2; SET and MYND domain containing
hsa:5335,0.0,0.0,0.00013787041951290324,0.0002719645383415385,0.0,0.0011496061,False,PLCG1; phospholipase C gamma
hsa:340267,6.9297653e-06,0.004898699466563365,6.797721766541937e-05,0.0001552377731837918,0.0,0.0007518668,False,COL28A1; collagen type XXVIII alpha 1
hsa:54659,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A3; UDP glucuronosyltransferase family 1 member
hsa:84134,0.0,0.0,1.1512774732903226e-08,2.8862348342485658e-08,0.0,1.2960211e-07,False,TOMM40L; translocase of outer mitochondrial membrane 40
hsa:606495,0.0,0.0,2.0537402322580644e-07,3.844448152585823e-07,0.0,1.333037e-06,False,CYB5RL; cytochrome b5 reductase
hsa:972,0.0,0.0,4.313853182903227e-06,1.599776023483853e-05,0.0,8.826815e-05,False,CD74; CD74
hsa:8674,0.0,0.0,9.63276252935484e-06,2.5187114208867306e-05,0.0,0.00010605274,False,VAMP4; vesicle associated membrane protein
hsa:6201,0.0,0.0,7.629693332258064e-07,1.3742918398811212e-06,0.0,4.8541856e-06,False,RPS7; ribosomal protein
hsa:8775,2.1963932e-07,0.0001552645685879636,0.00020205921169387094,0.0005742231508564814,0.0,0.0029058624,False,NAPA; NSF attachment protein
hsa:27289,5.306933e-09,3.7515079848645836e-06,4.764892284064517e-06,1.704571405073857e-05,0.0,8.441774e-05,False,RND1; Rho family GTPase
hsa:29925,1.5539637e-06,0.001098507787594023,5.7855730781290334e-05,0.00017870155015579616,0.0,0.00095210015,False,GMPPB; GDP-mannose pyrophosphorylase
hsa:100169751,0.0,0.0,2.7404928858064514e-06,1.2472607608832767e-05,0.0,6.907746e-05,False,RNA5S1; RNA
hsa:3581,0.0,0.0,9.374718455806452e-07,3.856173344084249e-06,0.0,2.0765117e-05,False,IL9R; interleukin 9
hsa:4843,6.024195e-06,0.00425854549979834,1.9681699512903222e-05,3.376506864993045e-05,0.0,0.00013607902,False,NOS2; nitric oxide synthase
hsa:7692,1.8015003e-09,1.2734931381620876e-06,1.213492820404839e-07,3.5295683018274306e-07,0.0,1.5405733e-06,False,ZNF133; zinc finger protein
hsa:1101,0.0,0.0,0.0,0.0,0.0,0.0,False,CHAD;
hsa:54209,1.4068806e-07,9.945337174317212e-05,7.801951776774194e-06,1.9965094232269295e-05,0.0,7.158642e-05,False,TREM2; triggering receptor expressed on myeloid cells
hsa:2876,0.00029453612,0.2082096393549783,0.00033709529173064516,0.00035296526447603163,0.0,0.0015773923,False,GPX1; glutathione peroxidase
hsa:2904,9.020383e-06,0.0063765717130848925,7.91509571935484e-05,0.00015077763646543626,0.0,0.00065821473,False,GRIN2B; glutamate ionotropic receptor NMDA type subunit
hsa:476,0.000142164,0.10049672403256053,0.0018968352200000001,0.002855321598234375,0.0,0.0117636155,False,ATP1A1; ATPase Na+/K+ transporting subunit alpha
hsa:83594,1.1052825e-05,0.00781331915115772,3.9281636677419355e-05,6.60108440127984e-05,0.0,0.00025354262,False,NUDT12; nudix hydrolase
hsa:1668,0.0,0.0,5.29881315516129e-06,2.698293202385251e-05,0.0,0.00015056654,False,DEFA3; defensin alpha
hsa:2099,3.5216885e-06,0.002489506185202598,2.6323484942645155e-05,6.436790685262608e-05,0.0,0.0003554069,False,ESR1; estrogen receptor
hsa:914,0.0,0.0,2.0059910327419357e-05,6.852400332378352e-05,0.0,0.00036799273,False,CD2; CD2
hsa:8277,3.0038538e-07,0.00021234452208207305,3.7885066496451614e-06,1.0076228866476833e-05,0.0,4.7781075e-05,False,TKTL1; transketolase like
hsa:732,0.0,0.0,1.128674287419355e-08,4.715783873917657e-08,0.0,2.4749508e-07,False,C8B; complement C8 beta
hsa:146434,1.2919482e-09,9.132872015402165e-07,1.5572396852258068e-08,2.5701417008396707e-08,0.0,8.9079634e-08,False,ZNF597; zinc finger protein
hsa:23446,0.0,0.0,3.6646855912670974e-05,0.00011829342332919071,0.0,0.00052074844,False,SLC44A1; solute carrier family 44 member
hsa:2913,0.0,0.0,2.4464459864516127e-06,5.979375207545472e-06,0.0,2.7771845e-05,False,GRM3; glutamate metabotropic receptor
hsa:1128,3.9553556e-06,0.0027960684855789296,4.514083733806452e-05,0.000154504364190005,0.0,0.00075960346,False,CHRM1; cholinergic receptor muscarinic
hsa:10769,3.7824966e-06,0.002673873251767667,1.1513655848387097e-05,1.727052245704055e-05,0.0,6.564251e-05,False,PLK2; polo like kinase
hsa:8767,3.2443631e-06,0.0022934629239619217,1.301048661451613e-05,2.0594436369080836e-05,0.0,8.971895e-05,False,RIPK2; receptor interacting serine/threonine kinase
hsa:90701,0.0,0.0,9.018724372580647e-06,2.4901471332219494e-05,0.0,0.00011665207,False,SEC11C; SEC11 homolog C
hsa:284340,0.0,0.0,2.915698935483871e-10,1.1569900703835701e-09,0.0,5.505598e-09,False,CXCL17; C-X-C motif chemokine ligand
hsa:10112,0.0,0.0,2.2039032831870968e-08,5.622567093932881e-08,0.0,2.1867884e-07,False,KIF20A; kinesin family member
hsa:8322,2.047062e-05,0.014470824181335743,0.0002002478910645161,0.000309679669638712,0.0,0.0012437623,False,FZD4; frizzled class receptor
hsa:441234,-0.0,0.0,4.485618618709677e-09,1.8782930324255142e-08,0.0,9.9347574e-08,False,ZNF716; zinc finger protein
hsa:64577,0.0,0.0,1.9413383096774192e-07,5.471432162462055e-07,0.0,1.9705972e-06,False,ALDH8A1; aldehyde dehydrogenase 8 family member
hsa:8504,0.0,0.0,6.669289495322579e-07,2.3303589500077242e-06,0.0,1.05591125e-05,False,PEX3; peroxisomal biogenesis factor
hsa:242,0.0,0.0,2.702641742580645e-06,9.967974434433118e-06,0.0,5.0237973e-05,False,ALOX12B; arachidonate 12-lipoxygenase
hsa:859,0.0,0.0,1.961983732351613e-06,9.903830989563958e-06,0.0,5.5244494e-05,False,CAV3; caveolin
hsa:25909,0.0,0.0,2.0416766516129026e-08,3.7089462228074246e-08,0.0,1.3812837e-07,False,AHCTF1; AT-hook containing transcription factor
hsa:2941,0.0,0.0,3.684100483870967e-05,0.00017156619862506605,0.0,0.00094468857,False,GSTA4; glutathione S-transferase alpha
hsa:135112,0.0,0.0,1.8873988922258065e-07,5.366512147046784e-07,0.0,2.0080486e-06,False,NCOA7; nuclear receptor coactivator
hsa:340156,0.0,0.0,1.840278101032258e-06,5.3259856738402985e-06,0.0,2.6636828e-05,False,MYLK4; myosin light chain kinase family member
hsa:9727,1.2970206e-09,9.168729165101299e-07,4.1116730645483855e-07,1.1552411712847982e-06,0.0,4.9696328e-06,False,RAB11FIP3; RAB11 family interacting protein
hsa:80230,0.0,0.0,2.9660589595483863e-07,5.974648005852695e-07,0.0,2.2210704e-06,False,RUFY1; RUN and FYVE domain containing
hsa:654364,1.1808008e-05,0.008347163285714155,0.0002463433959903226,0.000546092368209332,0.0,0.002569257,False,NME1-NME2; NME1-NME2
hsa:11315,0.0,0.0,1.5066592721935483e-08,3.538495495566537e-08,0.0,1.5200057e-07,False,PARK7; Parkinsonism associated
hsa:81050,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AC2; olfactory receptor family 5 subfamily AC member
hsa:8427,8.581116e-10,6.066050804306223e-07,3.2850354261290315e-08,5.3590569046228416e-08,0.0,1.7712368e-07,False,ZNF282; zinc finger protein
hsa:102157402,7.1723014e-07,0.0005070149928773442,7.174802242580645e-06,1.6598206506456587e-05,0.0,7.808911e-05,False,AK6; adenylate kinase
hsa:132884,6.498172e-05,0.04593603149884022,7.830607695925482e-05,7.886911918534284e-05,0.0,0.0003056992,False,EVC2; EvC ciliary complex subunit
hsa:59285,0.0,0.0,2.1330933525806453e-06,9.253585924076e-06,0.0,5.1003928e-05,False,CACNG6; calcium voltage-gated channel auxiliary subunit gamma
hsa:285613,0.0,0.0,1.0617722690322582e-06,2.157519376442553e-06,0.0,8.150039e-06,False,RELL2; RELT like
hsa:84759,0.0,0.0,1.3517442348064517e-05,3.0392659637132548e-05,0.0,0.00011195282,False,PCGF1; polycomb group ring finger
hsa:445,3.524276e-05,0.024913353070156744,0.0001741733126451613,0.0002993991380253335,0.0,0.0014500817,False,ASS1; argininosuccinate synthase
hsa:169355,0.0,0.0,1.6379013774193547e-05,6.929775690059875e-05,0.0,0.00038269718,False,IDO2; indoleamine 2
hsa:23373,9.336498e-08,6.600035613351857e-05,7.85620062516129e-07,1.489122061743321e-06,0.0,5.117129e-06,False,CRTC1; CREB regulated transcription coactivator
hsa:8313,0.0,0.0,3.3651215003225795e-05,5.857992880781277e-05,0.0,0.00024882218,False,AXIN2; axin
hsa:79813,1.5168867e-05,0.010722977974632217,3.882500577806454e-05,6.509063928458873e-05,0.0,0.00024483798,False,EHMT1; euchromatic histone lysine methyltransferase
hsa:1211,0.0,0.0,0.0001715632009870968,0.0005681601111195023,0.0,0.002649503,False,CLTA; clathrin light chain
hsa:50937,0.0,0.0,9.405763225806452e-07,2.4172902229767468e-06,0.0,9.896365e-06,False,CDON; cell adhesion associated
hsa:53354,0.0,0.0,1.4619400790322581e-05,2.4134016164531613e-05,0.0,8.404966e-05,False,PANK1; pantothenate kinase
hsa:10939,5.019347e-08,3.548211433855693e-05,8.984445667741936e-08,1.6624050501751814e-07,0.0,7.1773377e-07,False,AFG3L2; AFG3 like matrix AAA peptidase subunit
hsa:23432,0.0,0.0,3.7103769677419357e-06,1.2587442259128943e-05,0.0,6.0232698e-05,False,GPR161; G protein-coupled receptor
hsa:11151,0.0,0.0,1.1430242670967742e-07,2.9569529114441133e-07,0.0,1.1475106e-06,False,CORO1A; coronin
hsa:6135,0.0,0.0,4.869426798387097e-07,1.4443497859194178e-06,0.0,6.6251273e-06,False,RPL11; ribosomal protein
hsa:7329,6.389283e-08,4.5166287556408834e-05,4.3185961985483865e-06,9.102958432836649e-06,0.0,4.3880827e-05,False,UBE2I; ubiquitin conjugating enzyme E2
hsa:253430,0.0,0.0,7.314560056258063e-06,2.3838342284172266e-05,0.0,0.0001164475,False,IPMK; inositol polyphosphate
hsa:270,0.0,0.0,2.8963248034908705e-08,8.105939033960948e-08,0.0,3.8745438e-07,False,AMPD1; adenosine monophosphate deaminase
hsa:255189,0.0,0.0,5.716919656129032e-06,1.852200969664386e-05,0.0,9.081958e-05,False,PLA2G4F; phospholipase A2 group
hsa:9474,0.0,0.0,4.6896963290322576e-05,5.921410169165682e-05,0.0,0.00016571286,False,ATG5; autophagy related
hsa:3098,0.0,0.0,0.0005509615212580645,0.0010551636001267014,0.0,0.0032290982,False,HK1; hexokinase
hsa:2327,1.49246225e-05,0.010550319832535971,0.00017373887878387097,0.0002588220761706037,0.0,0.0010174918,False,FMO2; flavin containing dimethylaniline monoxygenase
hsa:59350,0.0,0.0,7.018008243870967e-07,2.2122213906320078e-06,0.0,1.1439638e-05,False,RXFP1; relaxin family peptide receptor
hsa:8784,9.711225e-07,0.0006864932745583289,7.100550756193547e-06,1.8306822935773952e-05,0.0,9.268237e-05,False,TNFRSF18; TNF receptor superfamily member
hsa:56261,7.131404e-07,0.0005041239271212813,2.6609899830322578e-05,7.039556429222417e-05,0.0,0.0003214444,False,GPCPD1; glycerophosphocholine phosphodiesterase
hsa:326625,6.7513433e-06,0.004772571709217359,4.933440068387097e-05,9.204886866140366e-05,0.0,0.00038371625,False,MMAB; metabolism of cobalamin associated
hsa:6615,5.8712196e-10,4.150406121632484e-07,1.0048330047805161e-05,3.3762457526664165e-05,0.0,0.0001745181,False,SNAI1; snail family transcriptional repressor
hsa:337876,2.7156815e-05,0.019197342102489388,0.00034540261160193546,0.0007537699298913755,0.0,0.0035773166,False,CHSY3; chondroitin sulfate synthase
hsa:108,0.0,0.0,5.0202441612903225e-06,2.635356441927599e-05,0.0,0.00014675807,False,ADCY2; adenylate cyclase
hsa:4651,5.38196e-07,0.0003804545094920511,1.6310224259032258e-05,4.8848905762926864e-05,0.0,0.00022384981,False,MYO10; myosin
hsa:948,0.0,0.0,0.0002549929540645161,0.0005563308547182534,0.0,0.0027540557,False,CD36; CD36
hsa:93978,0.0,0.0,1.4554729032258065e-09,5.34959591559597e-09,0.0,2.6680784e-08,False,CLEC6A; C-type lectin domain containing
hsa:6869,9.145695e-07,0.0006465155640675339,7.420691331470969e-06,1.4859378208997135e-05,0.0,5.6678768e-05,False,TACR1; tachykinin receptor
hsa:407010,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23A; microRNA
hsa:4297,1.3312011e-06,0.0009410353505707566,3.236434443e-05,6.519410652948749e-05,0.0,0.00025854356,False,KMT2A; lysine methyltransferase
hsa:203859,0.0,0.0,1.6076971397419355e-07,5.48459523396505e-07,0.0,2.4237518e-06,False,ANO5; anoctamin
hsa:8763,0.0,0.0,6.436715509096774e-07,1.5204756707296527e-06,0.0,6.2377994e-06,False,CD164; CD164
hsa:47,0.0,0.0,6.042772710967742e-06,2.155528609409747e-05,0.0,0.00011739574,False,ACLY; ATP citrate
hsa:132660,0.0,0.0,2.871336168716129e-07,5.14596646616784e-07,0.0,1.7518108e-06,False,LIN54; lin-54 DREAM MuvB core complex
hsa:116986,0.0,0.0,3.811149622225807e-07,8.859985006157927e-07,0.0,3.001174e-06,False,AGAP2; ArfGAP with GTPase domain
hsa:8630,0.0,0.0,2.0755704451612903e-07,1.0818956234647707e-06,0.0,6.0234233e-06,False,HSD17B6; hydroxysteroid 17-beta dehydrogenase
hsa:728340,0.0,0.0,8.248797477419354e-07,2.267880898779993e-06,0.0,9.430475e-06,False,GTF2H2C; GTF2H2 family member
hsa:3141,9.4276766e-07,0.0006664490402200477,9.294759020193548e-05,0.0001839226739524208,0.0,0.0009091485,False,HLCS; holocarboxylase
hsa:3290,0.00019827535,0.1401622290552415,0.0004446014055112904,0.000696346752774792,0.0,0.0030490695,False,HSD11B1; hydroxysteroid 11-beta dehydrogenase
hsa:10154,0.0,0.0,1.317584771612903e-07,2.534333971719647e-07,0.0,9.074842e-07,False,PLXNC1; plexin
hsa:1443,0.0,0.0,8.708972903225806e-09,4.848950896743295e-08,0.0,2.6997816e-07,False,CSH2; chorionic somatomammotropin hormone
hsa:8820,3.7615298e-08,2.6590516744805482e-05,5.276750159833549e-06,1.4881437661085413e-05,0.0,7.847212e-05,False,HESX1; HESX homeobox
hsa:1305,0.0,0.0,5.092189243387097e-06,1.9193846632602282e-05,0.0,0.0001045124,False,COL13A1; collagen type XIII alpha 1
hsa:440275,5.496057e-07,0.00038852010607201727,5.0720594209677435e-06,2.260572713277028e-05,0.0,0.00012670357,False,EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase
hsa:1794,0.0,0.0,1.0205656709677419e-07,1.9704624124635975e-07,0.0,8.342129e-07,False,DOCK2; dedicator of cytokinesis
hsa:5087,0.0,0.0,4.5975386096774194e-05,8.194382063477683e-05,0.0,0.0003475746,False,PBX1; PBX homeobox
hsa:2780,0.0,0.0,8.794512631129031e-07,2.4890653258114384e-06,0.0,1.1703055e-05,False,GNAT2; G protein subunit alpha transducin
hsa:2053,0.0,0.0,2.056465367096774e-06,3.8485791535292516e-06,0.0,1.7490154e-05,False,EPHX2; epoxide hydrolase
hsa:1603,5.6136873e-06,0.003968354740955445,0.00015825938201548387,0.0002960454889870146,0.0,0.0011659347,False,DAD1; defender against cell death
hsa:2193,1.4693196e-06,0.0010386722824120892,6.8450053005161275e-06,1.6193661129900675e-05,0.0,7.515308e-05,False,FARSA; phenylalanyl-tRNA synthetase subunit
hsa:51362,1.076535e-08,7.610101066823709e-06,3.279568596774194e-07,7.011614080351158e-07,0.0,2.5815611e-06,False,CDC40; cell division cycle
hsa:347688,0.0,0.0,1.299063960083871e-06,6.066136646915471e-06,0.0,3.362756e-05,False,TUBB8; tubulin beta 8 class
hsa:7547,0.0,0.0,9.875908591935485e-09,5.474565638845699e-08,0.0,3.0485208e-07,False,ZIC3; Zic family member
hsa:6511,0.0,0.0,2.0105731032258064e-08,8.77575279964317e-08,0.0,4.8055807e-07,False,SLC1A6; solute carrier family 1 member
hsa:23640,0.0,0.0,2.1899498277129036e-06,6.0031335865346606e-06,0.0,2.6814316e-05,False,HSPBP1; HSPA (Hsp70) binding protein
hsa:51534,6.4872076e-08,4.58585233898265e-05,3.1348145425806453e-07,4.428193755315685e-07,0.0,1.9186964e-06,False,VTA1; vesicle trafficking
hsa:390260,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6X1; olfactory receptor family 6 subfamily X member
hsa:11200,0.0,0.0,7.834716357719354e-06,1.845087597167269e-05,0.0,9.102903e-05,False,CHEK2; checkpoint kinase
hsa:65264,0.0,0.0,3.1987764528709675e-07,6.89219297932145e-07,0.0,2.865679e-06,False,UBE2Z; ubiquitin conjugating enzyme E2
hsa:7515,0.0,0.0,4.0031964036774195e-06,1.2425107360664305e-05,0.0,6.612806e-05,False,XRCC1; X-ray repair cross complementing
hsa:7283,0.0,0.0,4.1634469419354843e-08,1.4105445441606244e-07,0.0,7.5035405e-07,False,TUBG1; tubulin gamma
hsa:10857,6.1158266e-06,0.0043233205175093065,1.3879452427709677e-05,2.0354798970973717e-05,0.0,8.8592154e-05,False,PGRMC1; progesterone receptor membrane component
hsa:5476,7.640881e-05,0.054013921191204184,0.0006624889174167743,0.0011796847300490746,0.0,0.005298764,False,CTSA; cathepsin
hsa:1179,0.0,0.0,6.407874483870968e-09,2.2368298179272132e-08,0.0,1.04582426e-07,False,CLCA1; chloride channel accessory
hsa:6191,0.0,0.0,5.182256258064515e-07,1.3613004502511386e-06,0.0,5.782166e-06,False,RPS4X; ribosomal protein S4
hsa:102,0.0,0.0,0.00012431967607096775,0.0002380525007300496,0.0,0.000904651,False,ADAM10; ADAM metallopeptidase domain
hsa:9585,1.5715905e-09,1.1109682955649378e-06,2.6391318458451615e-07,5.93431715137413e-07,0.0,2.078564e-06,False,KIF20B; kinesin family member
hsa:1359,0.00018470158,0.13056683628512072,0.0002489473194354839,0.00024035638122392802,6.134586e-06,0.0011730276,False,CPA3; carboxypeptidase
hsa:10505,0.0,0.0,2.9070808096774194e-08,6.71469356486422e-08,0.0,2.356278e-07,False,SEMA4F; ssemaphorin
hsa:50487,0.0,0.0,1.1382055483870966e-07,6.337260289885078e-07,0.0,3.5284372e-06,False,PLA2G3; phospholipase A2 group
hsa:5081,0.0,0.0,3.1872447670364515e-08,1.1491868675619867e-07,0.0,6.3206124e-07,False,PAX7; paired box
hsa:5136,0.00053631514,0.379124916427957,0.002532723913700001,0.004749347231220606,0.0,0.017153164,True,PDE1A; phosphodiesterase
hsa:644,0.0,0.0,3.91478966451613e-05,8.448356426103763e-05,0.0,0.00037540874,False,BLVRA; biliverdin reductase
hsa:994,2.449543e-06,0.0017315990467128843,8.433497638709678e-06,2.3103089080227412e-05,0.0,0.00012456524,False,CDC25B; cell division cycle
hsa:79178,5.1738684e-06,0.0036574436902140177,2.8296217162903225e-05,5.089858593173363e-05,0.0,0.0001870811,False,THTPA; thiamine
hsa:10267,0.0,0.0,7.432175370967742e-07,1.9765844580135813e-06,0.0,8.481807e-06,False,RAMP1; receptor activity modifying protein
hsa:2937,0.0,0.0,3.4241555338709676e-05,7.048891251067547e-05,0.0,0.00030628574,False,GSS; glutathione
hsa:204,4.5943775e-06,0.00324779752763643,2.963390895258065e-05,8.847963916339455e-05,0.0,0.00048522852,False,AK2; adenylate kinase
hsa:8515,2.5591269e-06,0.0018090646706170493,0.00010749434291064516,0.00018518987997759694,0.0,0.0006916833,False,ITGA10; integrin subunit alpha
hsa:3872,0.0,0.0,1.910700322580645e-07,6.474410677087696e-07,0.0,3.38359e-06,False,KRT17; keratin
hsa:727837,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,SSX2B; SSX family member
hsa:6757,0.0,0.0,3.84305334516129e-09,2.0969298812928856e-08,0.0,1.1680653e-07,False,SSX2; SSX family member
hsa:396,0.0,0.0,5.505057320645161e-05,0.00016020421330434259,0.0,0.00062229205,False,ARHGDIA; Rho GDP dissociation inhibitor
hsa:139065,0.0,0.0,2.814206158064516e-06,1.2950566368466167e-05,0.0,7.2094015e-05,False,SLITRK4; SLIT and NTRK like family member
hsa:29986,2.3817183e-11,1.683653292805487e-08,1.0787411570967742e-09,1.7102452654112495e-09,0.0,6.8968027e-09,False,SLC39A2; solute carrier family 39 member
hsa:57677,0.0,0.0,1.4874813270967745e-08,3.4071846122952146e-08,0.0,1.5487481e-07,False,ZFP14; ZFP14 zinc finger
hsa:80834,0.0,0.0,4.3571050213612905e-06,1.71734713313746e-05,0.0,9.5340445e-05,False,TAS1R2; taste 1 receptor member
hsa:23380,0.0,0.0,1.5336905472580645e-07,3.0810841500144196e-07,0.0,1.3565764e-06,False,SRGAP2; SLIT-ROBO Rho GTPase activating protein
hsa:53829,2.8141577e-07,0.0001989347723481369,5.114706436206451e-06,1.2874792692366326e-05,0.0,6.606291e-05,False,P2RY13; purinergic receptor
hsa:25865,0.0,0.0,9.42021643032258e-06,2.8524736599031038e-05,0.0,9.984277e-05,False,PRKD2; protein kinase
hsa:26290,0.0,0.0,1.5307215280451612e-05,4.029323390625653e-05,0.0,0.00016636676,False,GALNT8; polypeptide N-acetylgalactosaminyltransferase
hsa:1147,0.0,0.0,2.4978301741935485e-05,5.9787406813167654e-05,0.0,0.00020421347,False,CHUK; component of inhibitor of nuclear factor kappa B kinase
hsa:6520,8.334799e-06,0.0058919275974920636,0.00018079554103225806,0.0004063762538456378,0.0,0.0018200106,False,SLC3A2; solute carrier family 3 member
hsa:100861540,0.0,0.0,1.9365058064516128e-08,1.0782008017574705e-07,0.0,6.003168e-07,False,CYP3A7-CYP3A51P; CYP3A7-CYP3A51P
hsa:389898,0.0,0.0,9.242633322580646e-11,4.670531158922743e-10,0.0,2.6013776e-09,False,UBE2NL; ubiquitin conjugating enzyme E2 N like
hsa:7068,1.887857e-06,0.0013345392922395098,1.132820455483871e-05,2.1904098531661077e-05,0.0,0.00010434901,False,THRB; thyroid hormone receptor
hsa:57459,1.2047789e-08,8.516666148501159e-06,3.0777757233548387e-06,7.374535235049575e-06,0.0,3.1054806e-05,False,GATAD2B; GATA zinc finger domain containing
hsa:2248,0.0,0.0,0.0,0.0,0.0,0.0,False,FGF3; fibroblast growth factor
hsa:348995,1.0545003e-08,7.454336234303503e-06,7.043376277419354e-08,1.3500109609849414e-07,0.0,5.914478e-07,False,NUP43; nucleoporin
hsa:3569,0.0015820705,1.1183766807247622,0.002473240214580645,0.002235996301984802,0.0,0.0072321882,True,IL6; interleukin
hsa:2186,9.395056e-08,6.641430672339356e-05,5.616299588935484e-06,1.3594821560318495e-05,0.0,5.584469e-05,False,BPTF; bromodomain PHD finger transcription
hsa:51074,0.0,0.0,9.403021992903227e-06,3.764631271841064e-05,0.0,0.00020873923,False,APIP; APAF1 interacting
hsa:2719,0.0,0.0,2.1359736717486122e-06,7.233400625102931e-06,0.0,3.220181e-05,False,GPC3; glypican
hsa:4205,0.0,0.0,1.840375137867742e-05,3.8788740431795055e-05,0.0,0.00015319332,False,MEF2A; myocyte enhancer factor
hsa:10850,0.0,0.0,0.0,0.0,0.0,0.0,False,CCL27; C-C motif chemokine ligand
hsa:80329,0.0,0.0,8.438356076774194e-08,2.1991483641213374e-07,0.0,9.0891956e-07,False,ULBP1; UL16 binding protein
hsa:608,0.0,0.0,3.6003780774193545e-08,1.9867091602399923e-07,0.0,1.1064333e-06,False,TNFRSF17; TNF receptor superfamily member
hsa:8692,1.2715711e-05,0.008988824872997344,4.7970105799999997e-05,8.030000677135637e-05,0.0,0.0004052582,False,HYAL2; hyaluronidase
hsa:6540,0.0,0.0,2.6711754582258068e-06,1.0088300098632729e-05,0.0,4.7612404e-05,False,SLC6A13; solute carrier family 6 member
hsa:100529215,5.8849006e-09,4.160077316038167e-06,7.461262235064517e-08,2.007379831694754e-07,0.0,8.4484634e-07,False,ZNF559-ZNF177; ZNF559-ZNF177
hsa:22872,3.7158634e-07,0.00026267697775280113,3.455000115106452e-06,8.093113025741895e-06,0.0,3.5957153e-05,False,SEC31A; SEC31 homolog A
hsa:7433,1.0737923e-07,7.590712729058584e-05,1.038883094967742e-06,2.0056067916360104e-06,0.0,8.863757e-06,False,VIPR1; vasoactive intestinal peptide receptor
hsa:405,0.0,0.0,1.6850487351612906e-05,2.627311465263167e-05,0.0,9.787239e-05,False,ARNT; aryl hydrocarbon receptor nuclear
hsa:26648,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7E24; olfactory receptor family 7 subfamily E member
hsa:81318,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4A5; olfactory receptor family 4 subfamily A member
hsa:6659,2.0887523e-08,1.4765535822393582e-05,1.0507097747741935e-06,2.348099033912101e-06,0.0,1.0586448e-05,False,SOX4; SRY-box transcription factor
hsa:23365,0.0,0.0,2.207337553870967e-05,4.532486968658728e-05,0.0,0.00017404699,False,ARHGEF12; Rho guanine nucleotide exchange factor
hsa:10947,0.0,0.0,3.7294105221290317e-07,7.275611354486199e-07,0.0,2.9128216e-06,False,AP3M2; adaptor related protein complex 3 subunit mu
hsa:342926,0.0,0.0,8.981535706774195e-08,2.286193875509117e-07,0.0,8.170292e-07,False,ZNF677; zinc finger protein
hsa:51626,0.0,0.0,3.1300220467419354e-05,9.933951618990982e-05,0.0,0.00038965614,False,DYNC2LI1; dynein cytoplasmic 2 light intermediate chain
hsa:5333,0.0,0.0,1.4895437993548386e-05,3.5155693229897366e-05,0.0,0.00017229991,False,PLCD1; phospholipase C delta
hsa:3934,0.0,0.0,3.2644838106451614e-07,1.2062722689360415e-06,0.0,5.0034623e-06,False,LCN2; lipocalin
hsa:11036,1.0846691e-08,7.667601587557033e-06,1.8721266909354836e-06,7.720610418935571e-06,0.0,4.2526637e-05,False,GTF2A1L; general transcription factor IIA subunit 1
hsa:8521,1.0062188e-09,7.113030940320633e-07,3.041263850258064e-07,9.725503572794606e-07,0.0,5.1827146e-06,False,GCM1; glial cells missing transcription factor
hsa:51619,3.2407024e-07,0.00022908751495769438,9.003034609677419e-06,1.9141456841583746e-05,0.0,6.601943e-05,False,UBE2D4; ubiquitin conjugating enzyme E2 D4
hsa:343169,0.0,0.0,9.937657967741936e-09,4.779626826850495e-08,0.0,2.6556194e-07,False,OR6F1; olfactory receptor family 6 subfamily F member
hsa:26227,1.6387692e-06,0.0011584573875626741,4.927961238870966e-05,9.623418273153044e-05,0.0,0.0004238214,False,PHGDH; phosphoglycerate
hsa:60401,0.0,0.0,3.5749403522580647e-07,9.447501266625756e-07,0.0,4.175666e-06,False,EDA2R; ectodysplasin A2
hsa:3574,0.0,0.0,7.372221890322581e-09,3.315423190270796e-08,0.0,1.8082794e-07,False,IL7; interleukin
hsa:84109,0.0,0.0,7.516551756451612e-07,2.841396440766294e-06,0.0,1.5817623e-05,False,QRFPR; pyroglutamylated RFamide peptide
hsa:4225,0.0,0.0,1.2802722903225806e-08,3.476581582091607e-08,0.0,1.4862835e-07,False,MEP1B; meprin A subunit
hsa:344807,0.0,0.0,4.247390064451613e-09,2.3605148780516703e-08,0.0,1.3143556e-07,False,CD200R1L; CD200 receptor 1
hsa:133,1.0541556e-05,0.007451899525940342,4.645703303548388e-05,7.487456141758861e-05,0.0,0.0002732748,False,ADM;
hsa:1813,0.0,0.0,1.8699810064516128e-06,4.396344426177152e-06,0.0,1.5143557e-05,False,DRD2; dopamine receptor
hsa:3758,3.9002202e-06,0.0027570928864242574,2.7811658095041944e-05,5.869287995349887e-05,0.0,0.00024309818,False,KCNJ1; potassium inwardly rectifying channel subfamily J member
hsa:2565,3.5257747e-07,0.0002492394748507948,7.140928148709678e-06,1.549757845554791e-05,0.0,5.0362345e-05,False,GABRG1; gamma-aminobutyric acid type A receptor subunit
hsa:5053,0.0,0.0,7.608711070967741e-06,1.952331958531946e-05,0.0,8.440069e-05,False,PAH; phenylalanine
hsa:30835,2.4827877e-05,0.017550999572207855,0.00013682641068387096,0.0002940362234456487,0.0,0.0015896328,False,CD209; CD209
hsa:124538,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR4D2; olfactory receptor family 4 subfamily D member
hsa:11222,3.8139422e-08,2.6961023659262315e-05,1.4654999219354837e-07,2.6423015597212194e-07,0.0,1.0669812e-06,False,MRPL3; mitochondrial ribosomal protein
hsa:2175,3.3946797e-06,0.0023997227778469613,7.448432041290324e-05,0.00015623187055457835,0.0,0.0007360997,False,FANCA; FA complementation group
hsa:6583,2.3711104e-07,0.0001676154494242806,8.347289001838709e-06,2.432103658902772e-05,0.0,9.218385e-05,False,SLC22A4; solute carrier family 22 member
hsa:10000,0.0,0.0,0.0003007236283870968,0.0006713507597685099,0.0,0.0027126754,False,AKT3; AKT serine/threonine kinase
hsa:91975,0.0,0.0,8.683590548387097e-08,1.6716189388205935e-07,0.0,6.157676e-07,False,ZNF300; zinc finger protein
hsa:4598,0.0,0.0,7.789126435483871e-07,2.598615560937486e-06,0.0,1.3023514e-05,False,MVK; mevalonate
hsa:1435,0.00041164714,0.29099623693320964,0.0007440615074516128,0.0007207718166149569,0.0,0.0022209934,False,CSF1; colony stimulating factor
hsa:7405,0.0,0.0,1.0285558145161291e-07,2.601760016909171e-07,0.0,1.3510268e-06,False,UVRAG; UV radiation resistance
hsa:6688,2.1144938e-06,0.0014947504282881764,3.3347542988709684e-05,6.937789159187993e-05,0.0,0.00025916143,False,SPI1; Spi-1
hsa:23435,1.8749746e-07,0.00013254326337487732,2.2379554448193546e-06,4.753027837208891e-06,0.0,2.0729927e-05,False,TARDBP; TAR DNA binding
hsa:2741,3.6348764e-09,2.5695195018659235e-06,2.289120702064516e-07,3.888739585062913e-07,0.0,1.55615e-06,False,GLRA1; glycine receptor alpha
hsa:664,0.0,0.0,6.802345209810644e-05,0.0002075215683896738,0.0,0.0008603891,False,BNIP3; BCL2 interacting protein
hsa:6452,0.0,0.0,1.234730875483871e-05,2.09208434053197e-05,0.0,8.348429e-05,False,SH3BP2; SH3 domain binding protein
hsa:55276,3.9221235e-05,0.027725764820989877,8.893151683774194e-05,0.0001165077220350418,0.0,0.00043495296,False,PGM2; phosphoglucomutase
hsa:286075,0.0,0.0,2.581063780645161e-08,6.152702128696857e-08,0.0,2.7644913e-07,False,ZNF707; zinc finger protein
hsa:3712,1.1319919e-08,8.002129764314024e-06,2.0587511382903227e-06,4.635235428920094e-06,0.0,1.940325e-05,False,IVD; isovaleryl-CoA
hsa:1000,0.0,0.0,4.673814823225806e-06,1.3692678202416253e-05,0.0,6.135746e-05,False,CDH2; cadherin
hsa:55052,6.290393e-09,4.4467227242997565e-06,3.8411462083225815e-07,8.3459942812422e-07,0.0,2.9764053e-06,False,MRPL20; mitochondrial ribosomal protein
hsa:5297,1.16669675e-07,8.247460771674635e-05,3.316221138725807e-05,8.54159616087498e-05,0.0,0.00041996632,False,PI4KA; phosphatidylinositol 4-kinase
hsa:10564,1.03968025e-08,7.349572266280743e-06,8.715256995161287e-08,1.36642907649571e-07,0.0,5.268329e-07,False,ARFGEF2; ADP ribosylation factor guanine nucleotide exchange factor
hsa:1201,0.0,0.0,4.249604423609677e-07,6.0566334404844e-07,0.0,1.9827705e-06,False,CLN3; CLN3 lysosomal/endosomal transmembrane protein
hsa:8140,3.324174e-06,0.0023498818063237732,0.00011686735025580646,0.0004263373395406479,0.0,0.0020904748,False,SLC7A5; solute carrier family 7 member
hsa:10813,0.0,0.0,6.438558099548387e-07,2.4001014046287887e-06,0.0,1.2917923e-05,False,UTP14A; UTP14A small subunit processome
hsa:10313,6.114627e-08,4.32247251189502e-05,1.4511546189483868e-07,2.5541491827755886e-07,6.6721145e-10,1.1992759e-06,False,RTN3; reticulon
hsa:127623,0.0,0.0,3.0799039412903226e-05,7.436080384657103e-05,0.0,0.00030188562,False,OR2B11; olfactory receptor family 2 subfamily B member
hsa:9135,3.2078464e-08,2.2676490138125183e-05,3.5633704609677426e-07,6.44751151559167e-07,0.0,2.5868426e-06,False,RABEP1; rabaptin
hsa:256471,0.0,0.0,5.153808222580644e-07,1.0048525708096227e-06,0.0,3.7832372e-06,False,MFSD8; major facilitator superfamily domain containing
hsa:140,2.3927514e-05,0.016914526682164463,8.991386564193548e-05,0.00026535405723244814,0.0,0.0014797829,False,ADORA3; adenosine A3
hsa:3553,0.0002501829,0.17685603851161819,0.0006381834453709676,0.0009655009036955726,0.0,0.0039043718,False,IL1B; interleukin 1
hsa:5321,0.00051449775,0.36370205113195553,0.0008480329407096773,0.0007957437254718247,0.0,0.0024385136,False,PLA2G4A; phospholipase A2 group
hsa:10910,8.101457e-08,5.726976508755071e-05,4.279209516129032e-07,6.485935536356243e-07,0.0,2.26242e-06,False,SUGT1; SGT1 homolog
hsa:79077,3.9925836e-09,2.822385218663847e-06,4.5923920972064515e-05,0.00010861920347712436,0.0,0.00048331806,False,DCTPP1; dCTP pyrophosphatase
hsa:2118,0.0,0.0,3.0553075245483866e-05,0.00013279818774746512,0.0,0.00073658855,False,ETV4; ETS variant transcription factor
hsa:403274,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5H15; olfactory receptor family 5 subfamily H member
hsa:6993,3.5521816e-07,0.0002511061970461857,1.0077913093548389e-06,2.056892787906658e-06,0.0,9.086629e-06,False,DYNLT1; dynein light chain Tctex-type
hsa:1763,5.8103327e-09,4.10736474697717e-06,1.796427423267742e-06,3.4050828054724707e-06,0.0,1.1840936e-05,False,DNA2; DNA replication helicase/nuclease
hsa:2696,8.067768e-07,0.0005703161519475555,2.12526447167742e-05,6.479036229551318e-05,0.0,0.000317892,False,GIPR; gastric inhibitory polypeptide
hsa:406982,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR20A; microRNA
hsa:81858,0.0,0.0,3.719239980529033e-05,0.00012502226625049132,0.0,0.000660708,False,SHARPIN; SHANK associated RH domain
hsa:2832,0.0,0.0,1.5204677480645162e-08,3.909462324391728e-08,0.0,1.5439073e-07,False,NPBWR2; neuropeptides B and W receptor
hsa:778,0.0,0.0,4.4620325806451614e-07,2.4843545988302606e-06,0.0,1.3832301e-05,False,CACNA1F; calcium voltage-gated channel subunit alpha1
hsa:7253,0.0,0.0,9.567470478387098e-06,3.5089769526797545e-05,0.0,0.00017637621,False,TSHR; thyroid stimulating hormone
hsa:5962,1.2843391e-06,0.0009079082756318561,1.2479714283225807e-05,2.1208087313784428e-05,0.0,8.8190005e-05,False,RDX;
hsa:81099,0.0,0.0,1.3534739677419354e-08,7.535824123611697e-08,0.0,4.1957693e-07,False,OR4F17; olfactory receptor family 4 subfamily F member
hsa:8900,0.0,0.0,1.4702950706451615e-05,4.485691929892946e-05,0.0,0.00021474104,False,CCNA1; cyclin
hsa:113026,1.5694453e-05,0.011094518387095128,0.00018499955693548388,0.0003899180069292468,0.0,0.0019615158,False,PLCD3; phospholipase C delta
hsa:118429,1.637057e-07,0.00011572470214299786,7.206991179354837e-07,1.333003043215976e-06,0.0,5.996432e-06,False,ANTXR2; ANTXR cell adhesion molecule
hsa:403257,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4C45; olfactory receptor family 4 subfamily C member 45
hsa:26524,0.00015783423,0.11157411901185736,0.0008847724526774193,0.0013136794903720827,0.0,0.0051652733,False,LATS2; large tumor suppressor kinase
hsa:54738,0.0,0.0,1.46148589156129e-07,3.2805420201581005e-07,0.0,1.3202391e-06,False,FEV; FEV transcription factor
hsa:51172,1.5780535e-09,1.11553703538249e-06,2.2514022862903226e-07,3.926579349710993e-07,0.0,1.4851622e-06,False,NAGPA; N-acetylglucosamine-1-phosphodiester
hsa:3419,6.1955793e-06,0.00437969825788487,2.8783847745161293e-05,7.020602535026827e-05,0.0,0.0003396811,False,IDH3A; isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit
hsa:155,0.0,0.0,1.9838038538709674e-06,6.57416126791277e-06,0.0,3.1296277e-05,False,ADRB3; adrenoceptor beta
hsa:341640,3.5299493e-07,0.000249534580239041,1.1297092205032259e-05,2.400154664991984e-05,0.0,0.000100546225,False,FREM2; FRAS1 related extracellular matrix
hsa:2194,1.9500145e-05,0.013784788629047548,6.350003490645162e-05,9.38921117699761e-05,0.0,0.00043235254,False,FASN; fatty acid
hsa:6237,1.13568185e-05,0.008028214278455714,0.0004167254781225807,0.0010997329065657302,0.0,0.0057549914,False,RRAS; RAS
hsa:730051,6.239683e-09,4.410875471298356e-06,5.4522195575806456e-08,9.429435249519124e-08,0.0,3.504121e-07,False,ZNF814; zinc finger protein
hsa:56896,0.0,0.0,8.831821602903227e-08,2.0786614413188659e-07,0.0,7.934711e-07,False,DPYSL5; dihydropyrimidinase like
hsa:9092,7.3849837e-09,5.22049653135715e-06,2.7986435947419356e-07,3.483070448514378e-07,0.0,1.1091366e-06,False,SART1; spliceosome associated factor 1
hsa:26050,0.0,0.0,5.7808261e-07,1.3392592175183573e-06,0.0,5.039892e-06,False,SLITRK5; SLIT and NTRK like family member
hsa:2998,0.0,0.0,8.551354322580645e-09,2.7156255419730568e-08,0.0,1.0953323e-07,False,GYS2; glycogen synthase
hsa:55072,9.3638505e-07,0.0006619371286546904,2.6586566226935482e-05,7.649548850847439e-05,0.0,0.00037011082,False,RNF31; ring finger protein
hsa:5023,8.5506423e-07,0.0006044508733042393,3.2425649345161295e-06,7.661161592381738e-06,0.0,4.166607e-05,False,P2RX1; purinergic receptor P2X
hsa:9378,2.4558287e-07,0.00017360424519227225,4.232527258225807e-06,8.681117648535391e-06,0.0,3.403294e-05,False,NRXN1; neurexin
hsa:3211,0.0,0.0,6.963631387096773e-10,2.86864659624664e-09,0.0,1.4595058e-08,False,HOXB1; homeobox
hsa:10424,0.0,0.0,3.390467787548387e-06,7.300697175879423e-06,0.0,3.534211e-05,False,PGRMC2; progesterone receptor membrane component
hsa:8773,0.0,0.0,5.52900041451613e-05,0.0001780738324761271,0.0,0.0008675287,False,SNAP23; synaptosome associated protein
hsa:3768,0.0,0.0,8.124827148387097e-07,2.72170675628765e-06,0.0,1.3322366e-05,False,KCNJ12; potassium inwardly rectifying channel subfamily J member
hsa:9343,0.0,0.0,3.57555501e-07,9.816834263890531e-07,0.0,3.5352123e-06,False,EFTUD2; elongation factor Tu GTP binding domain containing
hsa:8675,8.225625e-07,0.0005814751734759369,5.314730171806452e-05,8.748090792789686e-05,0.0,0.00030803023,False,STX16; syntaxin
hsa:9564,6.5544996e-06,0.004633421523541322,4.784841634838709e-05,0.00012484283667818345,0.0,0.00061073963,False,BCAR1; BCAR1 scaffold protein
hsa:6416,0.0,0.0,1.899048082580645e-05,5.509343094530811e-05,0.0,0.00022202363,False,MAP2K4; mitogen-activated protein kinase kinase
hsa:148103,4.194422e-09,2.9650661926373812e-06,1.0021183015161289e-07,2.6904532618961e-07,0.0,1.1387158e-06,False,ZNF599; zinc finger protein
hsa:7494,0.0,0.0,6.426648990322581e-06,1.044431634429327e-05,0.0,3.4338682e-05,False,XBP1; X-box binding protein
hsa:493869,0.00016311408,0.11530648183495824,0.0003708894655935484,0.00045589778099612614,0.0,0.0015681585,False,GPX8; glutathione peroxidase 8
hsa:8701,0.0,0.0,2.518809440516129e-08,7.68254361971244e-08,0.0,3.2345474e-07,False,DNAH11; dynein axonemal heavy chain
hsa:23299,0.0,0.0,1.4840035576451614e-05,2.9841999206018444e-05,0.0,9.411846e-05,False,BICD2; BICD cargo adaptor
hsa:9716,0.0,0.0,6.538014169709678e-08,1.9790040973676177e-07,0.0,9.817945e-07,False,AQR; aquarius intron-binding spliceosomal
hsa:388558,0.0,0.0,8.845696523548387e-08,2.1608140125399494e-07,0.0,8.933202e-07,False,ZNF808; zinc finger protein
hsa:90639,3.2094345e-08,2.268771652788884e-05,7.932831690483871e-07,1.5681052421996836e-06,0.0,5.70602e-06,False,COX19; cytochrome c oxidase assembly factor
hsa:7920,0.0,0.0,0.00018444958893870967,0.0005229558973399956,0.0,0.002545485,False,ABHD16A; abhydrolase domain containing 16A
hsa:4214,0.0,0.0,2.0014280614064515e-05,4.765536226216823e-05,0.0,0.00017606835,False,MAP3K1; mitogen-activated protein kinase kinase kinase
hsa:8705,7.337078e-06,0.005186631657602286,0.00011344153832258066,0.00020831019935752467,0.0,0.0008333196,False,B3GALT4; beta-1
hsa:9582,8.2986634e-07,0.000586638308959308,7.68211677451613e-06,1.6279806477565533e-05,0.0,8.541795e-05,False,APOBEC3B; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:51009,3.5452956e-08,2.506194208991384e-05,1.0777902970258065e-06,2.1528199754678977e-06,0.0,8.031104e-06,False,DERL2; derlin
hsa:2901,1.2235945e-06,0.0008649674938399237,5.5399144796774196e-05,0.00015358790475594522,0.0,0.00070056116,False,GRIK5; glutamate ionotropic receptor kainate type subunit
hsa:6445,0.0,0.0,7.323757080645161e-07,2.6118856795232057e-06,0.0,1.3159781e-05,False,SGCG; sarcoglycan
hsa:2747,5.5390097e-05,0.03915564624198644,0.00021336735153677417,0.0003626744738162694,0.0,0.0018139854,False,GLUD2; glutamate dehydrogenase
hsa:2946,0.0,0.0,0.00027994378496774196,0.0005155093495819682,0.0,0.0019902217,False,GSTM2; glutathione S-transferase mu
hsa:7168,6.626689e-05,0.0468445271434825,0.0004281124778387097,0.0006370144827865013,0.0,0.0019879146,False,TPM1; tropomyosin
hsa:79065,0.0,0.0,3.888427872635162e-05,0.00011444392496362527,0.0,0.0004282194,False,ATG9A; autophagy related
hsa:9610,0.0,0.0,4.140502970967742e-07,5.960538611289698e-07,0.0,1.9114857e-06,False,RIN1; Ras and Rab interactor
hsa:5170,0.0,0.0,6.735163106451613e-05,0.00022759136881715932,0.0,0.001078156,False,PDPK1; 3-phosphoinositide dependent protein kinase
hsa:23708,2.6342162e-08,1.862145820977887e-05,1.1778736783870966e-07,2.74673565030087e-07,0.0,1.1316017e-06,False,GSPT2; G1 to S phase transition
hsa:55593,2.2546935e-06,0.0015938585749381564,4.007099132870968e-05,0.0001108418613344966,0.0,0.0004971419,False,OTUD5; OTU deubiquitinase
hsa:6441,6.706821e-10,4.741098584541668e-07,7.160498943225806e-08,1.9686966822441664e-07,0.0,9.810581e-07,False,SFTPD; surfactant protein
hsa:10569,2.0862348e-08,1.4747739439149444e-05,1.8421991477419356e-07,2.664805285019943e-07,0.0,8.809035e-07,False,SLU7; SLU7 homolog
hsa:10411,4.242831e-05,0.02999286852675733,0.00043222617086525805,0.0009074640588727791,0.0,0.004696582,False,RAPGEF3; Rap guanine nucleotide exchange factor
hsa:168620,0.0,0.0,7.141806903225807e-08,3.0576921565341877e-07,0.0,1.6130193e-06,False,BHLHA15; basic helix-loop-helix family member
hsa:341947,0.0,0.0,3.387602249548387e-07,1.2146141096760488e-06,0.0,6.5027584e-06,False,COX8C; cytochrome c oxidase subunit
hsa:6337,0.00019847673,0.140304585983055,0.0003772777842419355,0.00044529802838829427,0.0,0.001671073,False,SCNN1A; sodium channel epithelial 1 subunit
hsa:6480,0.0,0.0,5.114516252161291e-05,0.00012313225995472376,0.0,0.0005673182,False,ST6GAL1; ST6 beta-galactoside alpha-2
hsa:57461,0.0,0.0,3.5050241112903225e-08,7.185509004661255e-08,0.0,3.0205345e-07,False,ISY1; ISY1 splicing factor
hsa:10347,0.0,0.0,0.0002669792647096774,0.000592808216244974,0.0,0.0026396976,False,ABCA7; ATP binding cassette subfamily A member
hsa:64965,0.0,0.0,6.690118125806452e-08,1.3919416536537606e-07,0.0,6.5515496e-07,False,MRPS9; mitochondrial ribosomal protein
hsa:390892,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7A10; olfactory receptor family 7 subfamily A member
hsa:26471,0.0,0.0,4.003204835188764e-05,0.0001552970700359683,0.0,0.0008596956,False,NUPR1; nuclear protein 1
hsa:4137,9.753751e-09,6.89499467185301e-06,3.597589122096774e-07,9.252298524999161e-07,0.0,4.185111e-06,False,MAPT; microtubule associated protein
hsa:5499,1.0182811e-05,0.007198300181077643,0.00013401354064516128,0.00025454573318615145,0.0,0.001296417,False,PPP1CA; protein phosphatase 1 catalytic subunit
hsa:79861,0.0,0.0,7.363071074193548e-07,2.7073331619504123e-06,0.0,1.3949558e-05,False,TUBAL3; tubulin alpha like
hsa:390063,0.0,0.0,4.621557333548387e-06,1.5620477600272003e-05,0.0,8.1449434e-05,False,OR51I1; olfactory receptor family 51 subfamily I member
hsa:27141,1.4815662e-06,0.0010473294894443699,0.00013112553781193548,0.00029144105389681754,0.0,0.0011903701,False,CIDEB; cell death inducing DFFA like effector
hsa:1454,0.0,0.0,0.0006288561717741935,0.0018961948265795823,0.0,0.007792015,False,CSNK1E; casein kinase 1
hsa:10617,1.2137133e-08,8.57982404580262e-06,3.968546940967742e-07,9.221301290137734e-07,0.0,3.965999e-06,False,STAMBP; STAM binding
hsa:4215,0.0,0.0,3.064111399032258e-06,6.6263984737274764e-06,0.0,2.5843054e-05,False,MAP3K3; mitogen-activated protein kinase kinase kinase
hsa:9252,0.0,0.0,1.2830928141935486e-05,2.996598344937331e-05,0.0,0.00012714758,False,RPS6KA5; ribosomal protein S6 kinase
hsa:6340,0.0,0.0,4.574023228064516e-06,1.7484814215006893e-05,0.0,8.761512e-05,False,SCNN1G; sodium channel epithelial 1 subunit
hsa:8405,0.0,0.0,1.7741354567741936e-05,4.0930858579288194e-05,0.0,0.00018099952,False,SPOP; speckle type BTB/POZ
hsa:1326,9.857945e-07,0.0006968650137820826,3.285854983967741e-05,9.463500949307018e-05,0.0,0.0004216203,False,MAP3K8; mitogen-activated protein kinase kinase kinase
hsa:3101,0.0,0.0,0.0002774733416870968,0.0009065869639337526,0.0,0.0038698784,False,HK3; hexokinase
hsa:3613,9.3009464e-07,0.0006574903939129721,7.925369620645161e-06,2.8833661979597843e-05,0.0,0.00015768444,False,IMPA2; inositol monophosphatase
hsa:5322,0.00010762373,0.07607996604741572,0.0002002056473935484,0.00019608668298252686,0.0,0.00060668634,False,PLA2G5; phospholipase A2 group
hsa:50944,2.2446687e-07,0.00015867719738360374,2.8701817932258065e-05,9.160266750171427e-05,0.0,0.00045194928,False,SHANK1; SH3 and multiple ankyrin repeat domains
hsa:5923,2.013764e-08,1.4235438294835913e-05,8.524586067741936e-07,1.5741792362138538e-06,0.0,6.93048e-06,False,RASGRF1; Ras protein specific guanine nucleotide releasing factor
hsa:2203,5.893681e-06,0.004166284242093254,7.677138356451613e-05,0.0001289832408387159,0.0,0.0005095185,False,FBP1; fructose-bisphosphatase
hsa:3291,0.0,0.0,1.945722180645161e-06,4.7729013419524176e-06,0.0,1.8628269e-05,False,HSD11B2; hydroxysteroid 11-beta dehydrogenase
hsa:6402,3.228303e-07,0.00022821099271579817,2.760307779451613e-06,5.261557425686639e-06,0.0,2.0284262e-05,False,SELL; selectin
hsa:84539,-0.0,0.0,3.3890638709677417e-09,1.3567238471056588e-08,0.0,6.593296e-08,False,MCHR2; melanin concentrating hormone receptor
hsa:482,0.0025533345,1.8049699826208885,0.002877135566219355,0.0019122730304539834,1.5758978e-06,0.008194197,True,ATP1B2; ATPase Na+/K+ transporting subunit beta
hsa:392392,0.0,0.0,2.2881113225806452e-07,8.62821962821038e-07,0.0,4.082724e-06,False,OR1K1; olfactory receptor family 1 subfamily K member
hsa:8714,8.3569415e-05,0.05907580285316624,0.0002432391645483871,0.00036734769804197315,0.0,0.0014185965,False,ABCC3; ATP binding cassette subfamily C member
hsa:2737,0.00020705235,0.1463667516265942,0.00033472250709677416,0.0003881465012017879,0.0,0.0017493868,False,GLI3; GLI family zinc finger
hsa:926,0.0,0.0,3.058853855387097e-05,0.00010787644940469291,0.0,0.00051755685,False,CD8B; CD8 subunit
hsa:2650,6.2716276e-06,0.004433457332040391,9.294500732567743e-05,0.0001996792637461819,0.0,0.0008917739,False,GCNT1; glucosaminyl (N-acetyl) transferase
hsa:407035,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR31; microRNA
hsa:7097,6.0332557e-05,0.04264950571880173,0.00023992296047096773,0.00036241341187118013,0.0,0.0013639674,False,TLR2; toll like receptor
hsa:55844,0.0,0.0,4.560996663870967e-05,9.815956269667476e-05,0.0,0.0004060687,False,PPP2R2D; protein phosphatase 2 regulatory subunit
hsa:6168,5.2437894e-08,3.706871333225474e-05,1.7674373084193552e-06,3.5174451542161083e-06,0.0,1.3704439e-05,False,RPL37A; ribosomal protein
hsa:533,0.0,0.0,9.916446007419356e-05,0.00021108390937603434,0.0,0.00074568787,False,ATP6V0B; ATPase H+ transporting V0 subunit
hsa:135946,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6B1; olfactory receptor family 6 subfamily B member
hsa:51447,3.988845e-07,0.0002819742376225057,1.4118265842903227e-06,2.311695896942771e-06,0.0,8.524235e-06,False,IP6K2; inositol hexakisphosphate kinase
hsa:8424,1.5739167e-07,0.00011126127025839058,2.9707423072903223e-06,9.429356275188654e-06,0.0,5.1830866e-05,False,BBOX1; gamma-butyrobetaine hydroxylase
hsa:1616,0.0,0.0,4.342566739032258e-07,9.141285662978158e-07,0.0,4.0343275e-06,False,DAXX; death domain associated
hsa:84957,4.9713174e-07,0.00035142589743258944,2.316253463064516e-05,6.528526456580504e-05,0.0,0.0002952085,False,RELT; RELT TNF
hsa:6370,0.0,0.0,0.0,0.0,0.0,0.0,False,CCL25; C-C motif chemokine ligand
hsa:51378,2.7610321e-08,1.951792865976908e-05,2.1564482181935483e-06,4.2625560443299e-06,0.0,1.4855315e-05,False,ANGPT4; angiopoietin
hsa:200909,0.0,0.0,6.139954451612903e-07,2.982892786792249e-06,0.0,1.6581127e-05,False,HTR3D; 5-hydroxytryptamine receptor
hsa:4713,0.0,0.0,3.318428481290323e-06,6.127388660656439e-06,0.0,2.0533222e-05,False,NDUFB7; NADH:ubiquinone oxidoreductase subunit
hsa:79947,0.0,0.0,3.5818450539999997e-05,9.691391718662573e-05,0.0,0.00041018182,False,DHDDS; dehydrodolichyl diphosphate synthase
hsa:3897,0.0,0.0,2.9607442480645162e-05,0.00010527254821431755,0.0,0.0005553495,False,L1CAM; L1 cell adhesion
hsa:4916,0.0,0.0,4.440780032258064e-07,1.2769707987784595e-06,0.0,4.9111845e-06,False,NTRK3; neurotrophic receptor tyrosine kinase
hsa:3912,4.7109086e-05,0.033301741757182986,0.00011105671946451612,0.0001467992985558383,0.0,0.0005593429,False,LAMB1; laminin subunit beta
hsa:23553,0.0,0.0,2.5426691057419355e-07,1.3264901444005339e-06,0.0,7.3894707e-06,False,HYAL4; hyaluronidase
hsa:604,5.4150332e-06,0.0038279247708811882,2.811037965483872e-05,8.0042676522267e-05,0.0,0.000433314,False,BCL6; BCL6 transcription
hsa:26246,0.0,0.0,1.8841495787096776e-06,6.318690674297772e-06,0.0,3.191831e-05,False,OR2L2; olfactory receptor family 2 subfamily L member
hsa:2321,1.4549968e-05,0.010285473951060655,5.4178117710000007e-05,0.00010861521247635368,0.0,0.0005504146,False,FLT1; fms related receptor tyrosine kinase
hsa:6263,4.9346505e-07,0.0003488338886747959,1.5169612013548388e-05,4.376775701791775e-05,0.0,0.00023365462,False,RYR3; ryanodine receptor
hsa:79643,0.0,0.0,9.196172327096775e-06,1.9176159743960458e-05,0.0,7.592824e-05,False,CHMP6; charged multivesicular body protein
hsa:80174,3.1857898e-08,2.252057049297616e-05,1.1807074678645164e-06,2.1974643428682297e-06,0.0,8.744351e-06,False,DBF4B; DBF4 zinc finger
hsa:1657,0.0,0.0,3.7951582387096776e-07,7.525983517476553e-07,0.0,2.8970671e-06,False,DMXL1; Dmx like
hsa:7306,0.0,0.0,6.411597921290323e-07,2.8408247483591203e-06,0.0,1.5762684e-05,False,TYRP1; tyrosinase related protein
hsa:2905,0.00026250136,0.18556404387954636,0.0006188745474999999,0.0011629138176741524,0.0,0.006319059,False,GRIN2C; glutamate ionotropic receptor NMDA type subunit
hsa:3029,6.219316e-07,0.0004396477896818381,5.655936313548389e-06,9.865075214158182e-06,0.0,3.1209394e-05,False,HAGH; hydroxyacylglutathione
hsa:51102,2.2773746e-05,0.016098920028626302,2.2128187922580643e-05,2.7229710187766742e-05,0.0,0.00011597976,False,MECR; mitochondrial trans-2-enoyl-CoA
hsa:2911,0.0,0.0,0.0,0.0,0.0,0.0,False,GRM1; glutamate metabotropic receptor
hsa:4018,0.0,0.0,2.841459746451613e-08,1.5710402602943407e-07,0.0,8.7490406e-07,False,LPA;
hsa:392391,-0.0,0.0,4.917731048387096e-07,2.4555644122889648e-06,0.0,1.3674008e-05,False,OR5C1; olfactory receptor family 5 subfamily C member
hsa:820,0.0,0.0,4.697001466129032e-06,1.77028030201989e-05,0.0,9.340782e-05,False,CAMP; cathelicidin antimicrobial
hsa:192111,0.0,0.0,2.9939717632258065e-06,5.556545851323131e-06,0.0,2.112132e-05,False,PGAM5; PGAM family member 5
hsa:3481,9.1141237e-07,0.0006442837668309274,3.596354641612903e-06,4.788240628141265e-06,0.0,1.5394295e-05,False,IGF2; insulin like growth factor
hsa:255725,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52B2; olfactory receptor family 52 subfamily B member
hsa:131890,0.0,0.0,4.988788224916129e-06,1.2275904937499342e-05,0.0,5.5398534e-05,False,GRK7; G protein-coupled receptor kinase
hsa:23429,0.0,0.0,5.198018153255162e-05,0.0001585114472519778,0.0,0.0005932248,False,RYBP; RING1 and YY1 binding
hsa:3841,0.0,0.0,5.555312026064519e-06,2.4043148778360034e-05,0.0,0.00013147597,False,KPNA5; karyopherin subunit alpha
hsa:10332,0.0,0.0,2.986813183870967e-06,7.3308440852468134e-06,0.0,3.3895918e-05,False,CLEC4M; C-type lectin domain family 4 member
hsa:54938,0.0,0.0,1.7621471145483872e-06,8.824280863215979e-06,0.0,4.9242484e-05,False,SARS2; seryl-tRNA synthetase 2
hsa:9162,0.0,0.0,4.0296682258064516e-06,1.1479646791370152e-05,0.0,4.4882603e-05,False,DGKI; diacylglycerol kinase
hsa:224,0.0,0.0,0.00013106774753419355,0.0003309848616907673,0.0,0.0016425498,False,ALDH3A2; aldehyde dehydrogenase 3 family member
hsa:988,0.0,0.0,3.788199451612903e-08,6.946676110424804e-08,0.0,2.3824644e-07,False,CDC5L; cell division cycle 5
hsa:9200,2.7137975e-07,0.0001918402397496924,2.5572835230645163e-05,5.731217728083061e-05,0.0,0.00021301524,False,HACD1; 3-hydroxyacyl-CoA dehydratase
hsa:10970,0.0,0.0,2.584872937880645e-07,7.84918309154878e-07,0.0,3.1251616e-06,False,CKAP4; cytoskeleton associated protein
hsa:3127,0.0,0.0,7.434327032258064e-06,3.227680794370396e-05,0.0,0.00017184592,False,HLA-DRB5; major histocompatibility complex
hsa:6281,1.0176235e-07,7.193651560771249e-05,2.0350918169032256e-07,2.975474270858087e-07,0.0,1.3924224e-06,False,S100A10; S100 calcium binding protein
hsa:81579,0.0,0.0,0.00015639679637096776,0.0002544479220493472,0.0,0.0008109685,False,PLA2G12A; phospholipase A2 group
hsa:2859,1.3921991e-06,0.0009841552625916487,2.5626591982580647e-06,3.85662591650101e-06,0.0,1.5398899e-05,False,GPR35; G protein-coupled receptor
hsa:100169753,0.0,0.0,3.553168077419355e-07,1.41221621629081e-06,0.0,6.8983118e-06,False,RNA5S2; RNA
hsa:729359,0.0,0.0,7.731572894e-07,2.7441904823257175e-06,0.0,1.4517579e-05,False,PLIN4; perilipin
hsa:6750,0.0,0.0,2.470762478709677e-05,5.9620495926673705e-05,0.0,0.00021726885,False,SST;
hsa:51168,0.0,0.0,1.6591235148387095e-07,3.812669202104672e-07,0.0,1.8649926e-06,False,MYO15A; myosin
hsa:9482,0.0,0.0,9.809092158387097e-05,0.0003000752409796423,0.0,0.0011403048,False,STX8; syntaxin
hsa:100169755,0.0,0.0,1.447013009548387e-06,4.791563980075684e-06,0.0,2.4505925e-05,False,RNA5S4; RNA
hsa:57599,0.0,0.0,1.8312258903225807e-07,5.869342877351065e-07,0.0,2.3135324e-06,False,WDR48; WD repeat domain
hsa:25978,1.8941765e-06,0.0013390065909053026,9.556910784548386e-05,0.00031298414790629326,0.0,0.0015592343,False,CHMP2B; charged multivesicular body protein
hsa:3921,1.423381e-09,1.006197965379351e-06,9.828566601161291e-07,2.4733891937856984e-06,0.0,1.0067337e-05,False,RPSA; ribosomal protein
hsa:3383,0.00021306596,0.15061781451599973,0.0003593794074193548,0.00040639766934051484,0.0,0.0013626441,False,ICAM1; intercellular adhesion molecule
hsa:3547,3.0321522e-07,0.000214344955732901,0.00040681201253096774,0.0010504807407703967,0.0,0.005230543,False,IGSF1; immunoglobulin superfamily member
hsa:390432,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR4Q2; olfactory receptor family 4 subfamily Q member 2
hsa:57761,0.0,0.0,1.1818558838709676e-06,3.0121654133743317e-06,0.0,1.2064686e-05,False,TRIB3; tribbles pseudokinase
hsa:55907,0.0,0.0,1.1990525538709676e-06,2.0648839850435453e-06,0.0,7.658988e-06,False,CMAS; cytidine monophosphate N-acetylneuraminic acid
hsa:3337,9.586182e-08,6.776538975970705e-05,1.3096958824967743e-05,2.7585293735018216e-05,0.0,0.00010175213,False,DNAJB1; DnaJ heat shock protein family (Hsp40) member
hsa:56001,2.9600827e-08,2.0925031246690914e-05,8.141665268893551e-06,4.2787409501932576e-05,0.0,0.00023864837,False,NXF2; nuclear RNA export factor
hsa:9469,0.0003269095,0.23109460767228238,0.001722201631722581,0.0028689745026834025,0.0,0.011026133,False,CHST3; carbohydrate sulfotransferase
hsa:780852,0.0,0.0,5.108516990246774e-07,2.124139784018959e-06,0.0,1.17616755e-05,False,SNORD3B-2; small nucleolar RNA
hsa:574473,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520B; microRNA
hsa:55226,0.0,0.0,8.446415979903225e-07,2.816025598513043e-06,0.0,1.11138315e-05,False,NAT10; N-acetyltransferase
hsa:26154,0.0,0.0,6.650877732000002e-07,2.3896986046829446e-06,0.0,1.300133e-05,False,ABCA12; ATP binding cassette subfamily A member
hsa:5694,0.0,0.0,7.4286199774193544e-06,1.723089968028286e-05,0.0,7.855012e-05,False,PSMB6; proteasome 20S subunit beta
hsa:114805,0.0,0.0,9.656552378232259e-05,0.0002908806553124552,0.0,0.0014959057,False,GALNT13; polypeptide N-acetylgalactosaminyltransferase
hsa:930,0.0,0.0,9.7657068e-06,3.1731725232273525e-05,0.0,0.00016161069,False,CD19; CD19
hsa:8480,0.0,0.0,6.410530410741935e-06,2.569050121522478e-05,0.0,0.00014105137,False,RAE1; ribonucleic acid export
hsa:10013,0.0,0.0,1.6565911251612906e-05,2.7062088656911107e-05,0.0,9.844387e-05,False,HDAC6; histone deacetylase
hsa:284433,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10H5; olfactory receptor family 10 subfamily H member
hsa:6625,1.0654609e-07,7.531817480851945e-05,4.0834684561612903e-07,5.464151580510063e-07,0.0,1.8581117e-06,False,SNRNP70; small nuclear ribonucleoprotein U1 subunit
hsa:6538,0.0,0.0,3.9027675377419357e-07,1.3467140862343181e-06,0.0,7.195401e-06,False,SLC6A11; solute carrier family 6 member
hsa:1816,0.0,0.0,2.05251048483871e-07,5.174617283915435e-07,0.0,2.6001567e-06,False,DRD5; dopamine receptor
hsa:80267,0.0,0.0,1.463574755032258e-07,3.908068874177485e-07,0.0,1.6085132e-06,False,EDEM3; ER degradation enhancing alpha-mannosidase like protein
hsa:5163,0.0,0.0,7.713960087419357e-06,1.4873135973953361e-05,0.0,5.4787757e-05,False,PDK1; pyruvate dehydrogenase kinase
hsa:2936,0.0,0.0,5.578489461290322e-05,9.616360675155558e-05,0.0,0.00034556986,False,GSR; glutathione-disulfide
hsa:4995,4.2110573e-06,0.0029768258023367346,3.616736533890323e-05,7.10792261368438e-05,0.0,0.00033491114,False,OR3A2; olfactory receptor family 3 subfamily A member
hsa:84911,0.0,0.0,3.1030947274193546e-08,7.628396507854295e-08,0.0,2.7468752e-07,False,ZNF382; zinc finger protein
hsa:10682,1.0153897e-05,0.007177860672631921,5.0343312025806454e-05,0.00010007995974276271,0.0,0.0004936734,False,EBP; EBP cholestenol
hsa:875,0.0,0.0,4.4882811193548384e-05,9.402887423502922e-05,0.0,0.00034580665,False,CBS; cystathionine
hsa:4088,8.097552e-05,0.05724216036994659,0.0005980069887096774,0.0008052991131121994,0.0,0.0025288458,False,SMAD3; SMAD family member
hsa:29895,4.8565954e-07,0.00034331611916631714,5.860851428967743e-06,1.160670974589848e-05,0.0,4.8290294e-05,False,MYL11; myosin light chain
hsa:5580,0.00026161817,0.18493971070308596,0.0003216610715483871,0.00035731444281206253,0.0,0.0012483203,False,PRKCD; protein kinase C
hsa:10787,0.0,0.0,3.30931285483871e-07,5.88057067194551e-07,0.0,2.3672212e-06,False,NCKAP1; NCK associated protein
hsa:6732,0.0,0.0,8.37077706580645e-08,1.6976412151090648e-07,0.0,6.1781185e-07,False,SRPK1; SRSF protein kinase
hsa:2938,0.0,0.0,4.242139980645161e-05,0.00014127968653388786,0.0,0.00078470923,False,GSTA1; glutathione S-transferase alpha
hsa:4173,0.0,0.0,8.763547441935483e-06,2.1353088958359593e-05,0.0,7.169639e-05,False,MCM4; minichromosome maintenance complex component
hsa:410,0.0,0.0,1.4428995431774194e-05,4.075362579669123e-05,0.0,0.00019446282,False,ARSA; arylsulfatase
hsa:23621,3.4271133e-09,2.422650316102655e-06,6.892570990322581e-08,1.4111474976179318e-07,0.0,6.250731e-07,False,BACE1; beta-secretase
hsa:260293,1.0692993e-07,7.558951398406782e-05,1.1587294287677419e-05,3.2316656369037986e-05,0.0,0.00013622847,False,CYP4X1; cytochrome P450 family 4 subfamily X member
hsa:9935,3.911057e-07,0.0002764753495994866,5.401165040193549e-05,0.00018808889776613259,0.0,0.0009758784,False,MAFB; MAF bZIP transcription factor
hsa:284371,0.0,0.0,6.851476974193549e-08,1.0759659421246541e-07,0.0,4.306763e-07,False,ZNF841; zinc finger protein
hsa:175,1.9970521e-05,0.01411730070709501,6.208990617774194e-05,9.661847494625271e-05,0.0,0.00033006695,False,AGA;
hsa:30814,0.0,0.0,7.628125161290322e-07,4.247160342823927e-06,0.0,2.3647188e-05,False,PLA2G2E; phospholipase A2 group
hsa:57379,0.0,0.0,9.98399215516129e-06,2.8747381582097406e-05,0.0,0.00015158374,False,AICDA; activation induced cytidine
hsa:9562,5.9160065e-08,4.1820662938953214e-05,9.042476056290325e-06,1.911979520143953e-05,0.0,8.323575e-05,False,MINPP1; multiple inositol-polyphosphate phosphatase
hsa:3990,3.9005918e-06,0.00275735557305836,4.49692141516129e-05,9.450822518225703e-05,0.0,0.00045788637,False,LIPC; lipase C
hsa:80179,1.42239145e-08,1.0054984455764022e-05,2.513113107903226e-07,3.7723076624604965e-07,0.0,1.1859404e-06,False,MYO19; myosin
hsa:51004,0.0,0.0,0.00016691145639419354,0.0003505222833038368,0.0,0.0016311726,False,COQ6; coenzyme Q6
hsa:1674,3.223159e-06,0.0022784735976482356,4.0014968620516125e-05,8.268693596073178e-05,0.0,0.00043888338,False,DES;
hsa:5588,0.0,0.0,7.348583703225806e-06,1.6419822853671658e-05,0.0,7.5729695e-05,False,PRKCQ; protein kinase C
hsa:2263,2.7164149e-06,0.0019202526558287302,3.2180373517096776e-05,8.949712112775061e-05,0.0,0.0004597129,False,FGFR2; fibroblast growth factor receptor
hsa:146956,0.0,0.0,8.87919513967742e-06,3.26056428980852e-05,0.0,0.00016699843,False,EME1; essential meiotic structure-specific endonuclease
hsa:5824,0.0,0.0,1.3236257356774193e-07,3.403303866991572e-07,0.0,1.4901227e-06,False,PEX19; peroxisomal biogenesis factor
hsa:6257,0.0,0.0,0.0001711518821612903,0.0004713016009715738,0.0,0.0020321342,False,RXRB; retinoid X receptor
hsa:636,6.397314e-07,0.0004522305925604485,8.331950408709678e-06,1.4552262474120777e-05,0.0,5.548036e-05,False,BICD1; BICD cargo adaptor
hsa:147658,0.0,0.0,1.4248307351612903e-09,3.1950010300380636e-09,0.0,1.2885149e-08,False,ZNF534; zinc finger protein
hsa:143502,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52I2; olfactory receptor family 52 subfamily I member
hsa:8546,0.0,0.0,8.984140624193547e-09,2.0017719917180746e-08,0.0,8.627337e-08,False,AP3B1; adaptor related protein complex 3 subunit beta
hsa:27010,2.4823498e-06,0.0017547904026538497,4.6160940441935486e-05,0.00014477337569822552,0.0,0.0006939085,False,TPK1; thiamin pyrophosphokinase
hsa:55437,0.0,0.0,1.6998688219354838e-06,4.638832713579536e-06,0.0,2.0573558e-05,False,STRADB; STE20 related adaptor
hsa:1600,0.0,0.0,4.9280162111290336e-08,1.5084208773068352e-07,0.0,5.9305324e-07,False,DAB1; DAB adaptor protein
hsa:23013,0.0,0.0,0.00017021193207903226,0.0005119379701114097,0.0,0.0020863533,False,SPEN; spen family transcriptional
hsa:6060,0.0,0.0,4.5752293765806455e-07,1.3336924229728818e-06,0.0,6.6048115e-06,False,RNU1-4; RNA
hsa:3563,5.933313e-06,0.004194300379560254,0.00015265899404838713,0.00034123163167123165,0.0,0.0012413404,False,IL3RA; interleukin 3 receptor subunit
hsa:80025,6.361547e-07,0.00044970219836186617,4.526734443119355e-05,8.973218299657158e-05,0.0,0.00031784832,False,PANK2; pantothenate kinase
hsa:1902,0.0,0.0,6.0582146678709675e-05,0.00020793033095670407,0.0,0.0009596832,False,LPAR1; lysophosphatidic acid receptor
hsa:9340,0.0,0.0,2.19796535363871e-08,5.319468526208646e-08,0.0,2.0337848e-07,False,GLP2R; glucagon like peptide 2
hsa:407032,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30C2; microRNA
hsa:55040,1.945578e-09,1.3753426700839952e-06,4.80072616316129e-08,1.0667479623477883e-07,0.0,4.7705504e-07,False,EPN3; epsin
hsa:10800,0.0,0.0,8.738614334838709e-07,1.7418340938938719e-06,0.0,7.196736e-06,False,CYSLTR1; cysteinyl leukotriene receptor
hsa:56963,0.0,0.0,0.00013221880692580642,0.0003884252335887107,0.0,0.0015102791,False,RGMA; repulsive guidance molecule BMP co-receptor
hsa:5106,8.100089e-05,0.057260094600052006,0.00023102252096774198,0.00036370281531040413,0.0,0.0012783214,False,PCK2; phosphoenolpyruvate carboxykinase 2
hsa:2566,3.443697e-06,0.002434373449401794,0.00013739200510645163,0.0002787096453182168,0.0,0.001124594,False,GABRG2; gamma-aminobutyric acid type A receptor subunit
hsa:6582,0.0,0.0,2.878316917567742e-06,1.2590132859576413e-05,0.0,6.973322e-05,False,SLC22A2; solute carrier family 22 member
hsa:57134,1.606808e-06,0.0011358637921647572,0.00011761010047861292,0.00026559914162651937,0.0,0.0011300826,False,MAN1C1; mannosidase alpha class 1C member
hsa:442900,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR326; microRNA
hsa:354,0.0,0.0,1.528413318064516e-08,5.250262742678449e-08,0.0,2.2349393e-07,False,KLK3; kallikrein related peptidase
hsa:9693,0.0,0.0,9.038916597096773e-07,1.7042415820263264e-06,0.0,5.850046e-06,False,RAPGEF2; Rap guanine nucleotide exchange factor
hsa:3991,0.0,0.0,3.537694922580645e-05,9.487438604904108e-05,0.0,0.00044568823,False,LIPE; lipase E
hsa:3326,0.0,0.0,0.00037207279532258067,0.0009085911562699137,0.0,0.004876487,False,HSP90AB1; heat shock protein 90 alpha family class B member
hsa:4862,1.8685922e-05,0.01320920870633882,0.0009531527360106452,0.0022957829615352916,0.0,0.008968038,False,NPAS2; neuronal PAS domain protein
hsa:10846,0.0,0.0,7.46076898e-05,0.0002403807863021139,0.0,0.0011174609,False,PDE10A; phosphodiesterase
hsa:1439,0.0,0.0,2.4705818138709677e-06,8.324849566251923e-06,0.0,4.6231886e-05,False,CSF2RB; colony stimulating factor 2 receptor subunit
hsa:5525,5.0708456e-07,0.00035846161537022306,2.3191546205806454e-05,3.911031537544548e-05,0.0,0.00016294012,False,PPP2R5A; protein phosphatase 2 regulatory subunit
hsa:27134,2.8090315e-09,1.985723976915883e-06,9.44966303632258e-08,2.6476918231949676e-07,0.0,1.3113652e-06,False,TJP3; tight junction protein
hsa:2208,0.0,0.0,5.4087252829032255e-06,1.996686175604205e-05,0.0,0.000102495746,False,FCER2; Fc epsilon receptor
hsa:54361,0.0,0.0,4.898689754838708e-06,1.6493605960152172e-05,0.0,8.208147e-05,False,WNT4; Wnt family member
hsa:442191,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR14J1; olfactory receptor family 14 subfamily J member
hsa:10587,2.9911082e-05,0.02114435267204981,0.00014974007203225807,0.0003170460115164583,0.0,0.0014484623,False,TXNRD2; thioredoxin reductase
hsa:170960,5.848993e-09,4.13469398293083e-06,1.3679961150967743e-07,4.1563529759361257e-07,0.0,1.8539563e-06,False,ZNF721; zinc finger protein
hsa:83657,1.9734196e-08,1.3950240914833996e-05,2.847006502096774e-07,8.719916506019326e-07,0.0,4.77422e-06,False,DYNLRB2; dynein light chain roadblock-type
hsa:11065,6.449251e-08,4.5590205534714494e-05,4.415204336225807e-07,9.822474262119198e-07,0.0,4.071495e-06,False,UBE2C; ubiquitin conjugating enzyme E2
hsa:55161,0.0,0.0,5.452769185806452e-08,9.724764304237179e-08,0.0,3.091362e-07,False,TMEM33; transmembrane protein
hsa:486,0.0,0.0,1.857472222580645e-05,5.620504695373151e-05,0.0,0.00020620237,False,FXYD2; FXYD domain containing ion transport regulator
hsa:9957,6.378454e-05,0.045089736599447254,0.0003311567936229032,0.0007169274885658834,0.0,0.0030972387,False,HS3ST1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:54941,2.666056e-07,0.00018846535978683226,2.7983581457096772e-05,8.19623796392572e-05,0.0,0.00036310928,False,RNF125; ring finger protein
hsa:2746,0.00010913055,0.07714514762437433,0.0002743921499032257,0.0003790661856758289,0.0,0.0014622823,False,GLUD1; glutamate dehydrogenase
hsa:10241,4.3290647e-06,0.0030602460571945047,2.5720893983870968e-05,4.155179129306204e-05,0.0,0.00017476853,False,CALCOCO2; calcium binding and coiled-coil domain
hsa:4985,3.7694408e-09,2.664644015606442e-06,4.2172662130645163e-07,8.89419777096318e-07,0.0,3.5289504e-06,False,OPRD1; opioid receptor delta
hsa:3320,0.0,0.0,0.0001356617991935484,0.0003301071039574783,0.0,0.0013810685,False,HSP90AA1; heat shock protein 90 alpha family class A member
hsa:4648,9.214732e-09,6.513958377915681e-06,2.068633883419355e-07,6.427139803528542e-07,0.0,3.0236363e-06,False,MYO7B; myosin
hsa:54898,1.2138811e-06,0.0008581010235716569,1.2692692915806452e-05,2.0848203238339313e-05,0.0,8.644626e-05,False,ELOVL2; ELOVL fatty acid elongase
hsa:4976,0.0,0.0,3.8388662774193545e-08,1.028694139901604e-07,0.0,4.220659e-07,False,OPA1; OPA1 mitochondrial dynamin like
hsa:8732,0.0,0.0,2.781288029032258e-08,3.9869626539688596e-08,0.0,1.18041584e-07,False,RNGTT; RNA guanylyltransferase and
hsa:7076,1.118263e-06,0.0007905079211813345,5.978919315451614e-05,0.00013510530384795057,0.0,0.00058871444,False,TIMP1; TIMP metallopeptidase inhibitor
hsa:11052,1.9327208e-06,0.0013662538256491773,1.6116387677419355e-05,2.8135040717920606e-05,0.0,0.00011029928,False,CPSF6; cleavage and polyadenylation specific factor
hsa:35,0.0,0.0,0.00016097643664516128,0.0003804585461460337,0.0,0.001825534,False,ACADS; acyl-CoA dehydrogenase short
hsa:1743,6.463083e-07,0.0004568798490831248,0.00018904331749354836,0.00030009865224951476,0.0,0.0011255431,False,DLST; dihydrolipoamide
hsa:9638,0.0,0.0,9.947364772580644e-06,3.197626822638932e-05,0.0,0.00013516775,False,FEZ1; fasciculation and elongation protein zeta
hsa:2023,1.2027369e-05,0.008502231107951196,3.4363199854838716e-05,3.978773743213577e-05,0.0,0.00013929774,False,ENO1; enolase
hsa:9757,0.0,0.0,3.5279146386774193e-06,9.674100623094711e-06,0.0,5.0907798e-05,False,KMT2B; lysine methyltransferase
hsa:10449,6.114429e-06,0.004322332544312801,8.35507756451613e-06,1.0279714483923446e-05,0.0,3.924695e-05,False,ACAA2; acetyl-CoA acyltransferase
hsa:1212,0.0,0.0,4.0153123667741934e-05,7.893350624280711e-05,0.0,0.0003221224,False,CLTB; clathrin light chain
hsa:7299,0.0,0.0,2.521810822903226e-07,7.925054780288243e-07,0.0,3.634603e-06,False,TYR;
hsa:146542,1.3626462e-08,9.632641112758316e-06,5.870105980645162e-08,1.1024612882692513e-07,0.0,4.7364625e-07,False,ZNF688; zinc finger protein
hsa:116987,3.3403296e-08,2.3613023127443895e-05,1.5493698687096772e-07,2.4844558966538844e-07,0.0,1.0774006e-06,False,AGAP1; ArfGAP with GTPase domain
hsa:3067,1.0894106e-05,0.007701119582056371,0.00014434393566451615,0.00026961055462921234,0.0,0.00112381,False,HDC; histidine
hsa:100169764,0.0,0.0,2.704284193548387e-08,1.0661383925752405e-07,0.0,4.974874e-07,False,RNA5S13; RNA
hsa:2956,0.0,0.0,0.0001835413525183871,0.0003707544228813004,0.0,0.0016331485,False,MSH6; mutS homolog
hsa:2689,0.0,0.0,2.933305893548387e-07,1.5372983756471082e-06,0.0,8.560496e-06,False,GH2; growth hormone
hsa:6548,0.0009416758,0.665677196763883,0.001352733851677419,0.001360476640841141,0.0,0.0038500482,True,SLC9A1; solute carrier family 9 member
hsa:57412,0.0,0.0,4.1379492774193554e-08,1.0904400077302821e-07,0.0,4.8292617e-07,False,AS3MT; arsenite
hsa:6309,0.0,0.0,1.6077566141935485e-05,3.339910755321997e-05,0.0,0.0001357026,False,SC5D;
hsa:860,1.868821e-06,0.0013210826109511116,8.242751908999999e-05,0.00015861116088688223,0.0,0.0005801276,False,RUNX2; RUNX family transcription factor
hsa:6137,3.891479e-07,0.0002750913671122821,1.497287036903226e-06,2.196539509616787e-06,0.0,8.2116685e-06,False,RPL13; ribosomal protein
hsa:78989,0.0,0.0,7.818188301096774e-08,1.8043619487146326e-07,0.0,9.5250516e-07,False,COLEC11; collectin subfamily member
hsa:9723,0.0,0.0,4.3231659405161294e-06,1.547781302661958e-05,0.0,7.751551e-05,False,SEMA3E; semaphorin
hsa:100529261,0.0,0.0,4.68929382932258e-06,1.9944507200478812e-05,0.0,0.00010742272,False,CHURC1-FNTB; CHURC1-FNTB
hsa:844,0.0,0.0,1.0123063020612905e-06,4.250451997320249e-06,0.0,2.3532886e-05,False,CASQ1; calsequestrin
hsa:1071,0.0,0.0,2.920655309129032e-06,6.7129136530245114e-06,0.0,2.6087238e-05,False,CETP; cholesteryl ester transfer
hsa:81620,2.2958682e-08,1.6229652578045885e-05,1.2411971873096769e-06,2.3973967299107845e-06,0.0,1.0342975e-05,False,CDT1; chromatin licensing and DNA replication factor
hsa:9542,0.0,0.0,6.439779870967742e-07,1.1865007519194236e-06,0.0,3.949702e-06,False,NRG2; neuregulin
hsa:81631,4.9783885e-06,0.0035192575842785305,0.00012120700335161291,0.00038592865382842343,0.0,0.00196696,False,MAP1LC3B; microtubule associated protein 1 light chain 3
hsa:101954271,0.0,0.0,7.799649032258065e-09,3.02092161064653e-08,0.0,1.2494321e-07,False,RNU6-9; RNA
hsa:3570,0.00010077348,0.07123747650151065,0.000269487721483871,0.0004001340575475052,0.0,0.0017153657,False,IL6R; interleukin 6
hsa:6510,0.0,0.0,2.8100800035483874e-05,4.9579703666834816e-05,0.0,0.00019247798,False,SLC1A5; solute carrier family 1 member
hsa:10454,0.0,0.0,4.430257474193549e-06,9.859353341386169e-06,0.0,4.331452e-05,False,TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:119548,0.0,0.0,3.8143563612903224e-07,1.427442828093743e-06,0.0,7.747995e-06,False,PNLIPRP3; pancreatic lipase related protein
hsa:6626,2.2080034e-08,1.5608530173092724e-05,4.528178233125805e-07,7.190026274697039e-07,0.0,2.2579652e-06,False,SNRPA; small nuclear ribonucleoprotein polypeptide
hsa:7086,0.0,0.0,9.011002238709676e-06,2.0392401590511673e-05,0.0,0.00010154042,False,TKT;
hsa:55326,0.0,0.0,2.5108563269677422e-05,5.5241511786557925e-05,0.0,0.00020707432,False,AGPAT5; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:79888,5.131124e-06,0.0036272273754596675,1.9501098793548393e-05,3.915446010902906e-05,0.0,0.00017320254,False,LPCAT1; lysophosphatidylcholine acyltransferase
hsa:7483,4.851334e-05,0.034294418712738674,7.319121271935484e-05,7.65536057123219e-05,0.0,0.0003434733,False,WNT9A; Wnt family member
hsa:24145,2.5459917e-07,0.00017997793060415415,7.822832451290323e-07,1.1852994659596328e-06,0.0,4.0840223e-06,False,PANX1; pannexin
hsa:81469,0.0,0.0,0.0,0.0,0.0,0.0,False,OR2G3; olfactory receptor family 2 subfamily G member
hsa:9971,0.0,0.0,6.406125718451614e-06,1.5659137237694957e-05,0.0,6.247324e-05,False,NR1H4; nuclear receptor subfamily 1 group H member
hsa:7551,0.0,0.0,1.1342055451612905e-08,2.664245521115847e-08,0.0,9.879648e-08,False,ZNF3; zinc finger protein
hsa:407045,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-3; microRNA
hsa:9632,2.1368656e-07,0.00015105652098834578,3.511102691612904e-06,8.586216623744098e-06,0.0,3.8371803e-05,False,SEC24C; SEC24 homolog C
hsa:390439,0.0,0.0,0.0,0.0,0.0,0.0,False,OR11G2; olfactory receptor family 11 subfamily G member
hsa:344838,0.0,0.0,2.1540919722580648e-07,5.796255317678456e-07,0.0,2.36888e-06,False,PAQR9; progestin and adipoQ receptor family member
hsa:8050,0.0,0.0,3.461006835483871e-05,7.320086470412901e-05,0.0,0.0002744042,False,PDHX; pyruvate dehydrogenase complex component
hsa:3576,0.0002964236,0.20954391214328605,0.0006485364575483871,0.0007287153667366671,0.0,0.002888861,False,CXCL8; C-X-C motif chemokine ligand
hsa:22943,3.902374e-08,2.7586154226797183e-05,8.298398691935484e-07,2.4167317885116983e-06,0.0,1.1920317e-05,False,DKK1; dickkopf WNT signaling pathway inhibitor
hsa:84219,0.0,0.0,3.177288018709678e-08,8.625866616167753e-08,0.0,3.8389513e-07,False,WDR24; WD repeat domain
hsa:55777,0.0,0.0,7.680567474838708e-06,2.9296275703161543e-05,0.0,0.00013163427,False,MBD5; methyl-CpG binding domain protein
hsa:9455,0.0,0.0,1.4079945287096774e-05,3.696050765579159e-05,0.0,0.00017067451,False,HOMER2; homer scaffold protein
hsa:7090,4.232967e-06,0.0029923139222161428,0.00010197820221870968,0.00018791813317097696,0.0,0.0007705256,False,TLE3; TLE family member 3
hsa:7517,2.12936e-06,0.0015052594488476206,4.200156784474195e-05,8.595007951303879e-05,0.0,0.0003909502,False,XRCC3; X-ray repair cross complementing
hsa:84152,1.5926573e-05,0.011258605635501464,8.86982907967742e-05,0.00014989298673831288,0.0,0.0005743381,False,PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit
hsa:83593,8.811635e-07,0.0006229006294636136,2.5995613149529035e-05,5.9816789164248047e-05,0.0,0.00022991873,False,RASSF5; Ras association domain family member
hsa:6229,1.5910294e-07,0.00011247097896759404,6.862784593870967e-07,9.69236305811516e-07,0.0,3.7248099e-06,False,RPS24; ribosomal protein
hsa:79891,3.7278034e-09,2.6352102468799477e-06,9.987592582258066e-08,2.0408909246173575e-07,0.0,7.7212445e-07,False,ZNF671; zinc finger protein
hsa:1769,0.0,0.0,4.747356018709677e-10,1.5913789456972292e-09,0.0,6.48578e-09,False,DNAH8; dynein axonemal heavy chain
hsa:26121,0.0,0.0,1.134839249032258e-07,2.1604865118294274e-07,0.0,8.182587e-07,False,PRPF31; pre-mRNA processing factor
hsa:65108,0.0,0.0,6.933161667741936e-07,1.5810367480772497e-06,0.0,6.022755e-06,False,MARCKSL1; MARCKS like
hsa:100526760,2.2490836e-07,0.00015898928974660096,1.942274463096774e-05,4.125430679261953e-05,0.0,0.0001977583,False,ABHD14A-ACY1; ABHD14A-ACY1
hsa:54474,0.0,0.0,7.763281102258064e-07,2.828010178093573e-06,0.0,1.4862432e-05,False,KRT20; keratin
hsa:645745,0.0,0.0,0.0,0.0,0.0,0.0,False,MT1HL1; metallothionein 1H like
hsa:64499,0.0,0.0,2.2753349011806455e-05,7.082328540735816e-05,0.0,0.0002796431,False,TPSB2; tryptase beta
hsa:178,0.0,0.0,1.5995809587096776e-05,4.15270736290289e-05,0.0,0.00019353973,False,AGL; amylo-alpha-1
hsa:5241,1.047636e-06,0.0007405812018413635,8.12322323935484e-06,2.0757883751618992e-05,0.0,0.00010831694,False,PGR; progesterone
hsa:729747,0.0,0.0,4.930927310967742e-09,1.1449640980018883e-08,0.0,4.3895948e-08,False,ZNF878; zinc finger protein
hsa:2774,0.0,0.0,2.174611306451613e-05,5.57904692357223e-05,0.0,0.00020927812,False,GNAL; G protein subunit alpha
hsa:84456,0.0,0.0,6.94885488069484e-06,2.5557697488952113e-05,0.0,0.0001225291,False,L3MBTL3; L3MBTL histone methyl-lysine binding protein
hsa:2903,1.758143e-06,0.0012428435601191448,5.372169016032259e-05,0.00012122021553005144,0.0,0.0005109748,False,GRIN2A; glutamate ionotropic receptor NMDA type subunit
hsa:9223,2.6563507e-09,1.8777928535466014e-06,1.3823722666635488e-05,3.9350229182985484e-05,0.0,0.00017281395,False,MAGI1; membrane associated guanylate kinase
hsa:7416,0.0,0.0,3.696959085806451e-05,0.00011103922595153602,0.0,0.00048417703,False,VDAC1; voltage dependent anion channel
hsa:10025,0.0,0.0,8.231396918387096e-07,1.7754015411756426e-06,0.0,8.661009e-06,False,MED16; mediator complex subunit
hsa:79109,0.0,0.0,1.672483630322581e-07,4.425657998904438e-07,0.0,2.2530337e-06,False,MAPKAP1; MAPK associated protein
hsa:5111,3.3028355e-05,0.02334797471711855,0.0004003119151935485,0.0008550775308497393,0.0,0.003951347,False,PCNA; proliferating cell nuclear
hsa:254531,1.8123789e-06,0.0012811832964444983,2.045369609354839e-05,3.8491363646317046e-05,0.0,0.00016428115,False,LPCAT4; lysophosphatidylcholine acyltransferase
hsa:9527,5.35256e-07,0.0003783762029682074,7.818544960248386e-05,0.00018602455874223162,0.0,0.0007405483,False,GOSR1; golgi SNAP receptor complex member
hsa:146,0.0,0.0,4.73179955483871e-05,6.919840996361797e-05,0.0,0.00022385712,False,ADRA1D; adrenoceptor alpha
hsa:4494,0.0,0.0,3.937714120967742e-05,7.029995756480807e-05,0.0,0.00024563633,False,MT1F; metallothionein
hsa:1906,8.728523e-05,0.06170253841639639,0.00022401193215161285,0.00033545777416432075,0.0,0.001390508,False,EDN1; endothelin
hsa:2188,0.0,0.0,2.285890158290322e-05,6.511401164570775e-05,0.0,0.0003373436,False,FANCF; FA complementation group
hsa:100169766,0.0,0.0,1.2821376763548387e-06,5.800188921890419e-06,0.0,3.2053755e-05,False,RNA5S15; RNA
hsa:8453,0.0,0.0,5.475182483870968e-07,1.483659544706188e-06,0.0,7.5007574e-06,False,CUL2; cullin
hsa:954,0.00018135466,0.12820087517260942,0.0011179123628683872,0.0024747535132913214,0.0,0.0108425645,False,ENTPD2; ectonucleoside triphosphate diphosphohydrolase
hsa:5902,1.08332294e-07,7.65808548854296e-05,1.0702538898064515e-06,1.707082220069883e-06,0.0,6.7922933e-06,False,RANBP1; RAN binding protein
hsa:7703,6.8470837e-07,0.00048402512663314447,6.86895171732258e-05,0.00015327166363374582,0.0,0.00056022214,False,PCGF2; polycomb group ring finger
hsa:1388,0.0,0.0,0.0002544882406451612,0.0004214992988651237,0.0,0.0016261707,False,ATF6B; activating transcription factor 6
hsa:9369,0.0,0.0,2.61379195483871e-06,4.51881743652935e-06,0.0,1.5710919e-05,False,NRXN3; neurexin
hsa:3832,0.0,0.0,4.409900642893548e-07,1.3090006046909588e-06,0.0,6.0458083e-06,False,KIF11; kinesin family member
hsa:56300,0.0,0.0,1.797718315709677e-07,8.813051557988068e-07,0.0,4.907991e-06,False,IL36G; interleukin 36
hsa:4605,0.0,0.0,2.567756080793548e-07,4.7241238389947127e-07,0.0,1.8334937e-06,False,MYBL2; MYB proto-oncogene like
hsa:406896,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A2; microRNA
hsa:2568,0.0,0.0,9.162689677419354e-07,2.1496878126600248e-06,0.0,7.578663e-06,False,GABRP; gamma-aminobutyric acid type A receptor subunit
hsa:4697,1.003363e-06,0.0007092843090760111,1.0480738804838711e-05,2.1519191854124095e-05,0.0,8.6123626e-05,False,NDUFA4; NDUFA4 mitochondrial complex
hsa:4801,0.0,0.0,2.968751282387097e-06,6.574372991355293e-06,0.0,2.6536436e-05,False,NFYB; nuclear transcription factor Y subunit
hsa:1453,2.3325492e-05,0.016488953127709538,0.0006354430254193548,0.0018724572889163263,0.0,0.008308622,False,CSNK1D; casein kinase 1
hsa:146754,2.2228523e-09,1.5713498083779473e-06,1.372805327796774e-07,6.108386179175714e-07,0.0,3.4026784e-06,False,DNAH2; dynein axonemal heavy chain
hsa:27153,0.0,0.0,3.854266053225806e-08,5.913405996528276e-08,0.0,2.1730425e-07,False,ZNF777; zinc finger protein
hsa:118813,8.818503e-08,6.233861331780952e-05,6.04324831667742e-07,1.028870263334163e-06,0.0,4.330584e-06,False,ZFYVE27; zinc finger FYVE-type containing
hsa:8991,1.5591653e-06,0.0011021848349458687,0.0001802371628090323,0.00032939955311603515,0.0,0.0013242878,False,SELENBP1; selenium binding protein
hsa:7167,0.0,0.0,5.640327903225807e-07,1.1837233309823502e-06,0.0,4.051028e-06,False,TPI1; triosephosphate isomerase
hsa:79778,0.0,0.0,3.857855419612903e-07,1.0851470880871816e-06,0.0,4.384818e-06,False,MICALL2; MICAL like
hsa:5538,0.0,0.0,3.416220174516129e-05,9.564466931539657e-05,0.0,0.000353608,False,PPT1; palmitoyl-protein thioesterase
hsa:286826,0.0,0.0,8.19665514635484e-08,1.96699417150056e-07,0.0,7.894986e-07,False,LIN9; lin-9 DREAM MuvB core complex
hsa:9815,0.0,0.0,9.72248105535484e-07,2.9110124780684118e-06,0.0,1.2012635e-05,False,GIT2; GIT ArfGAP
hsa:100533105,0.0,0.0,1.1170309325806453e-07,2.889465508845195e-07,0.0,1.3206894e-06,False,C8orf44-SGK3; C8orf44-SGK3
hsa:403239,0.0,0.0,0.0,0.0,0.0,0.0,False,OR2T27; olfactory receptor family 2 subfamily T member
hsa:5224,0.0,0.0,2.41346966e-05,7.005737038713037e-05,0.0,0.00036930348,False,PGAM2; phosphoglycerate mutase
hsa:51703,3.0896663e-05,0.02184106676119147,0.00021325536940419354,0.00038176915554606324,0.0,0.0016314804,False,ACSL5; acyl-CoA synthetase long chain family member
hsa:7576,0.0,0.0,5.270648451870967e-08,1.1077193077814892e-07,0.0,4.4501053e-07,False,ZNF28; zinc finger protein
hsa:11326,7.4534574e-07,0.0005268901067895152,4.451576381935484e-06,1.0337169903217632e-05,0.0,4.331051e-05,False,VSIG4; V-set and immunoglobulin domain containing
hsa:25800,8.328603e-09,5.887547601838412e-06,1.0904797668787096e-07,1.504345935426477e-07,0.0,4.9686736e-07,False,SLC39A6; solute carrier family 39 member
hsa:255027,0.0,0.0,5.818290089870965e-07,1.7567001903375548e-06,0.0,6.8868985e-06,False,MPV17L; MPV17 mitochondrial inner membrane protein
hsa:79660,1.6933981e-06,0.0011970749383315212,4.608951676129032e-06,6.454541760431915e-06,0.0,2.8175695e-05,False,PPP1R3B; protein phosphatase 1 regulatory subunit
hsa:151903,0.0,0.0,1.4386617570967745e-07,3.370382537331865e-07,0.0,1.2239366e-06,False,CCDC12; coiled-coil domain containing
hsa:25847,4.761663e-06,0.0033660528153896512,2.7406659370967746e-05,4.485133134552921e-05,0.0,0.00019072091,False,ANAPC13; anaphase promoting complex subunit
hsa:5617,0.0,0.0,7.774670967741936e-09,4.328753594692275e-08,0.0,2.410148e-07,False,PRL;
hsa:54910,0.0,0.0,4.3538130000000004e-09,1.2279966060942898e-08,0.0,5.468145e-08,False,SEMA4C; semaphorin
hsa:9,0.00015236154,0.10770543624655986,0.0005997034045806453,0.0015351379249525384,0.0,0.008242631,False,NAT1; N-acetyltransferase
hsa:7869,1.0449741e-07,7.386994861489077e-05,3.66395428883871e-05,0.00011338578681091603,0.0,0.00041278786,False,SEMA3B; semaphorin
hsa:1181,0.0,0.0,1.6230694783870965e-05,4.574423285528133e-05,0.0,0.00020812283,False,CLCN2; chloride voltage-gated channel
hsa:9798,3.0834645e-08,2.179722580405006e-05,7.28567396967742e-07,1.3712246029305703e-06,0.0,5.44379e-06,False,IST1; IST1 factor associated with
hsa:406888,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F1; microRNA
hsa:401427,2.3314913e-05,0.016481474758758607,0.00010724662046322581,0.0001963186515594932,0.0,0.0008083118,False,OR2A7; olfactory receptor family 2 subfamily A member
hsa:407051,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-3; microRNA
hsa:8379,2.5799784e-06,0.0018238047415292697,1.160790290322581e-05,2.0516973598702064e-05,0.0,8.180097e-05,False,MAD1L1; mitotic arrest deficient 1 like
hsa:5292,2.219686e-06,0.001569111528804326,0.00019560137139032255,0.00048199888542502527,0.0,0.001748395,False,PIM1; Pim-1 proto-oncogene
hsa:10228,0.0,0.0,3.5095045921354835e-05,8.587334065583932e-05,0.0,0.00033258053,False,STX6; syntaxin
hsa:117248,2.4981853e-05,0.017659846281498796,0.00027578418294803227,0.0008352032028241821,0.0,0.00440097,False,GALNT15; polypeptide N-acetylgalactosaminyltransferase
hsa:256148,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4S1; olfactory receptor family 4 subfamily S member
hsa:5435,8.5932874e-07,0.000607465485193354,6.504003108838711e-05,0.00017182448372306684,0.0,0.0007280296,False,POLR2F; RNA polymerase II
hsa:256051,0.0,0.0,1.9274048532258064e-08,3.878370611582273e-08,0.0,1.6722066e-07,False,ZNF549; zinc finger protein
hsa:59082,0.0,0.0,3.2673819354838713e-09,1.819201270014168e-08,0.0,1.0128884e-07,False,CARD18; caspase recruitment domain family member
hsa:6498,1.7630645e-06,0.0012463226028256405,0.00012559993477290324,0.00022128816346541914,0.0,0.00066729216,False,SKIL; SKI like
hsa:79788,6.740235e-09,4.764719174401436e-06,4.540332256774195e-08,8.602683254310464e-08,0.0,3.939623e-07,False,ZNF665; zinc finger protein
hsa:6188,0.0,0.0,9.074227422580646e-07,1.6791437208338143e-06,0.0,7.026619e-06,False,RPS3; ribosomal protein
hsa:389434,0.0,0.0,0.0,0.0,0.0,0.0,False,IYD; iodotyrosine
hsa:6672,8.4847045e-08,5.997896841917255e-05,4.0573924012903226e-07,5.958768633800919e-07,0.0,2.398605e-06,False,SP100; SP100 nuclear
hsa:4548,0.0,0.0,9.573931396774194e-05,0.00020999821458241537,0.0,0.0009626954,False,MTR; 5-methyltetrahydrofolate-homocysteine
hsa:154064,0.0,0.0,6.385646465419354e-07,2.0509823627102482e-06,0.0,9.386717e-06,False,RAET1L; retinoic acid early transcript
hsa:3269,0.0,0.0,4.775276057322581e-05,8.463413662904193e-05,0.0,0.00034515042,False,HRH1; histamine receptor
hsa:342909,0.0,0.0,2.029881743548387e-08,4.802892104492895e-08,0.0,1.8172582e-07,False,ZNF284; zinc finger protein
hsa:2678,0.0,0.0,0.00011665596774193547,0.0004060343301004352,0.0,0.0021385218,False,GGT1; gamma-glutamyltransferase
hsa:55748,0.000105901876,0.07486277543472641,0.00029677947038709684,0.0006090503211179823,0.0,0.0025532576,False,CNDP2; carnosine dipeptidase
hsa:5533,0.00016276674,0.1150609447642127,0.00035714586809677416,0.0004550999835571372,0.0,0.0020788454,False,PPP3CC; protein phosphatase 3 catalytic subunit
hsa:8482,5.4881355e-08,3.879601297070979e-05,3.549398594290323e-05,0.00012872830904696428,0.0,0.00065470394,False,SEMA7A; semaphorin 7A (John Milton Hagen blood
hsa:140886,8.504983e-09,6.0122318551294205e-06,1.539040439870968e-06,5.466624755084368e-06,0.0,2.9520466e-05,False,PABPC5; poly(A) binding protein cytoplasmic
hsa:847,0.0,0.0,0.00011246942854838708,0.00015104678415511883,0.0,0.00046086343,False,CAT;
hsa:5160,0.0,0.0,8.225528156129033e-05,0.0002877130638549759,0.0,0.0014790355,False,PDHA1; pyruvate dehydrogenase E1 subunit alpha
hsa:1442,0.0,0.0,0.0,0.0,0.0,0.0,False,CSH1; chorionic somatomammotropin hormone
hsa:114785,0.0,0.0,6.031912975732259e-05,0.0001687770844982938,0.0,0.0006569854,False,MBD6; methyl-CpG binding domain protein
hsa:5009,0.0,0.0,5.4995539582580646e-06,2.8905974033728936e-05,0.0,0.000161046,False,OTC; ornithine
hsa:275,0.0,0.0,3.1956597967741936e-05,5.846999391949672e-05,0.0,0.00021929029,False,AMT;
hsa:8542,0.0,0.0,0.00021969906223548387,0.0005668391119899504,0.0,0.0018483101,False,APOL1; apolipoprotein
hsa:5966,8.655957e-08,6.118956429663703e-05,4.580096345548388e-06,1.7438296947667164e-05,0.0,9.682911e-05,False,REL; REL proto-oncogene
hsa:1718,0.0,0.0,2.337042110483871e-05,5.858009096065932e-05,0.0,0.0002631253,False,DHCR24; 24-dehydrocholesterol
hsa:6278,0.0,0.0,3.947686329032258e-07,1.6681483371625616e-06,0.0,9.273348e-06,False,S100A7; S100 calcium binding protein
hsa:2729,0.0,0.0,4.680006038387097e-05,0.00017426678792966676,0.0,0.00072809256,False,GCLC; glutamate-cysteine ligase catalytic
hsa:9976,0.0,0.0,1.0499471324193548e-07,3.15757597227574e-07,0.0,1.6619812e-06,False,CLEC2B; C-type lectin domain family 2 member
hsa:7474,5.0248345e-05,0.03552090585913377,7.561466336999997e-05,8.948729976956188e-05,0.0,0.00041225489,False,WNT5A; Wnt family member
hsa:729597,0.0,0.0,1.6974024413032263e-06,5.252039184199002e-06,0.0,2.5460005e-05,False,SPDYE6; speedy/RINGO cell cycle regulator family member
hsa:2987,0.0,0.0,2.6536344762580644e-05,7.771374440439337e-05,0.0,0.00037394205,False,GUK1; guanylate kinase
hsa:221357,0.0,0.0,0.0,0.0,0.0,0.0,False,GSTA5; glutathione S-transferase alpha
hsa:390271,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR8B3; olfactory receptor family 8 subfamily B member
hsa:6134,0.0,0.0,8.538698567741936e-07,2.554433731191488e-06,0.0,1.1297097e-05,False,RPL10; ribosomal protein
hsa:9516,0.0,0.0,1.0595966539258066e-06,2.911955749989162e-06,0.0,1.3719517e-05,False,LITAF; lipopolysaccharide induced TNF
hsa:10478,0.0,0.0,5.416678126548387e-06,1.5985827041833954e-05,0.0,5.9909144e-05,False,SLC25A17; solute carrier family 25 member
hsa:7083,0.0,0.0,6.184305118064515e-05,0.00017532531477485925,0.0,0.0008022616,False,TK1; thymidine kinase
hsa:666,0.0,0.0,0.00015671159793534254,0.00044306459019276766,0.0,0.0020185239,False,BOK; BCL2 family apoptosis regulator
hsa:9146,3.6564714e-07,0.0002584785158118443,1.3173844221612904e-05,2.632106936663529e-05,0.0,9.946196e-05,False,HGS; hepatocyte growth factor-regulated tyrosine kinase
hsa:259287,0.0,0.0,2.2077674193548388e-08,1.2292328758901075e-07,0.0,6.844079e-07,False,TAS2R41; taste 2 receptor member
hsa:10134,0.0,0.0,6.632521858064515e-07,1.7216268597691136e-06,0.0,5.7957236e-06,False,BCAP31; B cell receptor associated protein
hsa:192666,0.0,0.0,1.8735857726451613e-06,7.984748938882067e-06,0.0,4.394537e-05,False,KRT24; keratin
hsa:134083,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2Y1; olfactory receptor family 2 subfamily Y member
hsa:7850,2.89807e-05,0.020486659141346807,0.00010106640390322579,0.00016793659385179466,0.0,0.00056485296,False,IL1R2; interleukin 1 receptor type
hsa:84720,0.0,0.0,1.349691756451613e-06,2.6148877912219087e-06,0.0,1.0003188e-05,False,PIGO; phosphatidylinositol glycan anchor biosynthesis class
hsa:27190,3.6011363e-07,0.00025456683896396846,8.08351552064516e-06,2.7631948132149185e-05,0.0,0.00014879685,False,IL17B; interleukin
hsa:137492,0.0,0.0,3.6664070359838713e-07,6.219125281825773e-07,0.0,2.0140249e-06,False,VPS37A; VPS37A subunit of
hsa:55744,6.304086e-08,4.45640240158921e-05,5.519882943548387e-07,1.3712745686612885e-06,0.0,6.3051557e-06,False,COA1; cytochrome c oxidase assembly factor
hsa:291,1.0059399e-05,0.007111059376750904,6.718349611903227e-05,0.00014186448260565117,0.0,0.000567447,False,SLC25A4; solute carrier family 25 member
hsa:283365,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C6; olfactory receptor family 6 subfamily C member
hsa:10060,0.00048002516,0.33933313661127795,0.0006692531588419355,0.0008436034501059645,0.0,0.003419752,False,ABCC9; ATP binding cassette subfamily C member
hsa:57142,0.0,0.0,5.548509723645161e-08,1.589782694325769e-07,0.0,6.732282e-07,False,RTN4; reticulon
hsa:7166,0.0,0.0,5.683082258870968e-06,8.989457220264203e-06,0.0,3.166944e-05,False,TPH1; tryptophan hydroxylase
hsa:435,5.5717945e-05,0.03938740428186029,0.00019299610577419352,0.00042824966792074005,0.0,0.0020616855,False,ASL; argininosuccinate
hsa:5426,0.0,0.0,1.0720633274193546e-05,2.209731578051795e-05,0.0,7.7070945e-05,False,POLE; DNA polymerase epsilon
hsa:5080,0.0,0.0,0.0,0.0,0.0,0.0,False,PAX6; paired box
hsa:3739,0.0,0.0,1.1550243903225806e-07,3.13601040753474e-07,0.0,1.2936306e-06,False,KCNA4; potassium voltage-gated channel subfamily A member
hsa:138883,0.0,0.0,1.7016605022580647e-06,7.221462461365758e-06,0.0,3.9383274e-05,False,OR1N1; olfactory receptor family 1 subfamily N member
hsa:11154,0.0,0.0,3.6054570986290326e-07,8.260100130946922e-07,0.0,2.883159e-06,False,AP4S1; adaptor related protein complex 4 subunit sigma
hsa:4160,7.7429725e-08,5.4735613131608944e-05,1.9421065408548384e-06,3.373594602705999e-06,0.0,1.2213062e-05,False,MC4R; melanocortin 4
hsa:6256,0.00052795355,0.37321405008553965,0.0008192732368709677,0.0009258366745819351,1.0554939e-05,0.0032869864,True,RXRA; retinoid X receptor
hsa:5521,4.806259e-06,0.003397578039109834,6.545408223702581e-05,0.00010767910738524982,0.0,0.00044812044,False,PPP2R2B; protein phosphatase 2 regulatory subunit
hsa:3361,0.0,0.0,5.6965263135483866e-06,1.9094059115748606e-05,0.0,8.515697e-05,False,HTR5A; 5-hydroxytryptamine receptor
hsa:9379,0.0,0.0,2.663556922580645e-07,6.100041053560462e-07,0.0,2.0517248e-06,False,NRXN2; neurexin
hsa:9978,0.0,0.0,5.451674787096775e-05,0.00011429798799535044,0.0,0.0004887801,False,RBX1; ring-box
hsa:10891,0.0,0.0,7.542443722580644e-07,1.5012395106503026e-06,0.0,5.3136323e-06,False,PPARGC1A; PPARG coactivator 1
hsa:434,0.0,0.0,6.0700243121999985e-06,2.8211421206051264e-05,0.0,0.00015686215,False,ASIP; agouti signaling
hsa:2495,3.1840177e-06,0.002250804339436764,0.00021478835251612902,0.000606733547024425,0.0,0.002929053,False,FTH1; ferritin heavy chain
hsa:91807,0.0,0.0,1.1973538048387095e-06,2.9125489146702786e-06,0.0,1.4089851e-05,False,MYLK3; myosin light chain kinase
hsa:340419,3.1543838e-08,2.229855928655494e-05,9.484257915246456e-06,3.883735522871211e-05,0.0,0.00021313914,False,RSPO2; R-spondin
hsa:763,0.0,0.0,1.313172730967742e-06,7.0783143548771795e-06,-0.0,3.9440434e-05,False,CA5A; carbonic anhydrase
hsa:6783,0.0,0.0,3.982971709677419e-09,1.3831515002750305e-08,0.0,6.877137e-08,False,SULT1E1; sulfotransferase family 1E member
hsa:1215,2.3771665e-06,0.0016804355936098298,5.9822386849999995e-05,0.00014182590706993364,0.0,0.00068635383,False,CMA1; chymase
hsa:57176,6.907275e-08,4.882800916490847e-05,2.1395952887096773e-06,5.2077965440480984e-06,0.0,2.0867548e-05,False,VARS2; valyl-tRNA synthetase 2
hsa:84628,0.0,0.0,1.559778843548387e-06,7.659484823427524e-06,0.0,4.277765e-05,False,NTNG2; netrin
hsa:9051,1.874991e-07,0.000132544422702326,7.794791327935484e-07,1.2616740955132292e-06,0.0,5.4466045e-06,False,PSTPIP1; proline-serine-threonine phosphatase interacting protein
hsa:55366,0.0,0.0,2.027640041935484e-07,5.531317145438811e-07,0.0,2.0085804e-06,False,LGR4; leucine rich repeat containing G protein-coupled receptor
hsa:219981,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5A2; olfactory receptor family 5 subfamily A member
hsa:368,0.0,0.0,1.1482512607741935e-05,2.9652644528699014e-05,0.0,0.00014014296,False,ABCC6; ATP binding cassette subfamily C member
hsa:219464,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5T2; olfactory receptor family 5 subfamily T member
hsa:4968,0.0,0.0,3.3098235323161274e-05,0.00010415387001535988,0.0,0.00042147824,False,OGG1; 8-oxoguanine DNA
hsa:5994,0.0,0.0,0.0001044582215483871,0.00024149388537183445,0.0,0.0008987152,False,RFXAP; regulatory factor X associated
hsa:5746,8.714343e-10,6.160229900650486e-07,5.487853202548386e-07,1.2019900087504429e-06,0.0,4.7471203e-06,False,PTH2R; parathyroid hormone 2
hsa:6455,1.13474545e-08,8.021594801486574e-06,5.993325110483871e-07,1.0989546444007052e-06,0.0,4.506401e-06,False,SH3GL1; SH3 domain containing GRB2 like 1
hsa:406902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10A; microRNA
hsa:11231,0.0,0.0,1.9324570162580645e-05,5.290583398586672e-05,0.0,0.00023704907,False,SEC63; SEC63 homolog
hsa:6045,6.0265855e-08,4.2602353609361786e-05,4.716066180258066e-06,1.770824013425633e-05,0.0,7.892415e-05,False,RNF2; ring finger protein
hsa:5641,0.0,0.0,1.912746558064516e-06,4.412474402617607e-06,0.0,2.2847047e-05,False,LGMN;
hsa:387129,-0.0,0.0,1.2864081612903225e-09,7.1624175164859575e-09,0.0,3.9878653e-08,False,NPSR1; neuropeptide S receptor
hsa:23401,2.1188346e-06,0.0014978189701108638,1.033509611935484e-05,2.159116543180562e-05,0.0,9.998471e-05,False,FRAT2; FRAT regulator of WNT signaling pathway
hsa:8550,0.0,0.0,3.0065491335483874e-07,7.711816853943213e-07,0.0,3.7080395e-06,False,MAPKAPK5; MAPK activated protein kinase
hsa:3866,0.0,0.0,7.256530170741935e-07,2.906419047888847e-06,0.0,1.6195989e-05,False,KRT15; keratin
hsa:10861,0.0,0.0,5.8797962238064515e-08,1.9212553223696904e-07,0.0,8.397866e-07,False,SLC26A1; solute carrier family 26 member
hsa:8735,0.0,0.0,0.0,0.0,0.0,0.0,False,MYH13; myosin heavy chain
hsa:119682,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51L1; olfactory receptor family 51 subfamily L member
hsa:673,0.0,0.0,0.00018501469552903226,0.0005340694058303292,0.0,0.002607564,False,BRAF; B-Raf proto-oncogene
hsa:5507,2.7631472e-06,0.0019532880449322078,7.443773235483871e-06,1.5671753868246263e-05,0.0,8.133941e-05,False,PPP1R3C; protein phosphatase 1 regulatory subunit
hsa:6464,0.0,0.0,0.0001142168702967742,0.00029163672298335814,0.0,0.0012475676,False,SHC1; SHC adaptor protein
hsa:55127,6.173648e-08,4.364194868814674e-05,9.985223848387097e-07,2.077940482012646e-06,0.0,9.031443e-06,False,HEATR1; HEAT repeat containing
hsa:26248,-0.0,0.0,7.649409135483871e-07,4.227600765185761e-06,0.0,2.3543334e-05,False,OR2K2; olfactory receptor family 2 subfamily K member
hsa:481,0.0,0.0,9.302286540645162e-05,0.00029892337390990107,0.0,0.0014703822,False,ATP1B1; ATPase Na+/K+ transporting subunit beta
hsa:6495,1.6114198e-07,0.00011391239057792684,9.386840841283871e-06,2.9821407935089006e-05,0.0,0.00012792465,False,SIX1; SIX homeobox
hsa:1908,0.0,0.0,2.5440847517419354e-06,7.808138653071452e-06,0.0,3.8367383e-05,False,EDN3; endothelin
hsa:1236,0.0,0.0,1.0573683548387097e-07,4.093320842232221e-07,0.0,1.6618068e-06,False,CCR7; C-C motif chemokine receptor
hsa:7349,0.0,0.0,6.663869583870967e-07,1.2776269743832914e-06,0.0,4.583795e-06,False,UCN;
hsa:5371,4.293018e-07,0.00030347643933261234,4.9249937739354845e-05,0.00010604777510822249,0.0,0.00046117982,False,PML; PML nuclear body
hsa:4716,8.609283e-06,0.006085962253237211,1.2013074412903223e-05,1.4689505642896607e-05,0.0,5.972702e-05,False,NDUFB10; NADH:ubiquinone oxidoreductase subunit
hsa:27338,4.118275e-09,2.9112373467628463e-06,7.008612491935484e-07,1.0297544552070095e-06,0.0,3.380257e-06,False,UBE2S; ubiquitin conjugating enzyme E2
hsa:22,1.2754616e-07,9.016327089089229e-05,0.0003277740911345162,0.0006697776366594379,0.0,0.0028044337,False,ABCB7; ATP binding cassette subfamily B member
hsa:6934,1.9878686e-05,0.01405238190450413,0.0001266680567580645,0.00020483982256944592,0.0,0.00077992136,False,TCF7L2; transcription factor 7 like
hsa:5693,5.241411e-06,0.003705190025662103,9.791471737741936e-06,1.4880878019356058e-05,0.0,6.651819e-05,False,PSMB5; proteasome 20S subunit beta
hsa:1890,0.00021876629,0.1546474175864291,0.0007009984596774193,0.0014814857066437431,0.0,0.0053725434,False,TYMP; thymidine
hsa:1329,5.5641344e-06,0.003933325450021643,1.8754723303225813e-05,6.322794089738166e-05,0.0,0.0003559417,False,COX5B; cytochrome c oxidase subunit
hsa:3655,0.0005404254,0.3820304879152679,0.0006175905545161291,0.0005216129882628228,0.0,0.0018168082,True,ITGA6; integrin subunit alpha
hsa:694,0.0,0.0,1.6909796122538713e-05,5.760314595991455e-05,0.0,0.00024833047,False,BTG1; BTG anti-proliferation factor
hsa:25834,0.0,0.0,2.6062314293677424e-06,8.931519983040744e-06,0.0,4.5556182e-05,False,MGAT4C; MGAT4 family member
hsa:6512,0.0,0.0,3.364013771903226e-05,0.00010145858581938335,0.0,0.00049946253,False,SLC1A7; solute carrier family 1 member
hsa:29086,3.2740587e-05,0.023144549509039134,7.189546290645162e-05,9.517778770435895e-05,0.0,0.0003395383,False,BABAM1; BRISC and BRCA1 A complex member
hsa:409,4.993607e-05,0.035300156481673464,0.000445255024548387,0.0007407762479224565,0.0,0.0028242762,False,ARRB2; arrestin beta
hsa:6193,1.559911e-07,0.00011027119754815253,3.3316894025806445e-07,4.1644100593535263e-07,0.0,1.7996183e-06,False,RPS5; ribosomal protein
hsa:9179,7.539982e-08,5.330065911654666e-05,3.8563428906451616e-07,8.262462037398241e-07,0.0,3.45663e-06,False,AP4M1; adaptor related protein complex 4 subunit mu
hsa:101954272,0.0,0.0,4.8504806274193546e-08,1.1721794504320479e-07,0.0,4.0726553e-07,False,RNVU1-3; RNA
hsa:3689,1.531814e-06,0.001082850010039199,0.00012493307215483872,0.000226511157342923,0.0,0.0008590814,False,ITGB2; integrin subunit beta
hsa:83547,0.0,0.0,7.616497071290322e-07,1.155051639107081e-06,0.0,3.7165555e-06,False,RILP; Rab interacting lysosomal
hsa:133121,0.0,0.0,9.936947161290323e-07,4.796335462582479e-06,0.0,2.6767484e-05,False,ENPP6; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:7390,0.0,0.0,5.945711524193548e-06,1.4939324451360181e-05,0.0,5.8941812e-05,False,UROS; uroporphyrinogen III
hsa:2167,3.063382e-06,0.002165526120961097,0.00016949989715645163,0.0004753368150133527,0.0,0.0024202922,False,FABP4; fatty acid binding protein
hsa:2688,0.0,0.0,1.4052240509677418e-06,3.8852637532097415e-06,0.0,1.981218e-05,False,GH1; growth hormone
hsa:886,0.0,0.0,5.828552829032258e-07,1.9419499001853187e-06,0.0,9.748208e-06,False,CCKAR; cholecystokinin A
hsa:140803,1.5013558e-07,0.00010613188958335738,1.0004790424387099e-05,1.8028017396904864e-05,0.0,7.24347e-05,False,TRPM6; transient receptor potential cation channel subfamily M member
hsa:26494,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8G1; olfactory receptor family 8 subfamily G member
hsa:7153,0.0,0.0,2.2170891375483875e-05,8.717084695419775e-05,0.0,0.00041711298,False,TOP2A; DNA topoisomerase II
hsa:2060,8.322838e-08,5.883472283093527e-05,3.2139679945161286e-07,6.636134855928249e-07,0.0,2.8400138e-06,False,EPS15; epidermal growth factor receptor pathway substrate
hsa:9985,1.341552e-07,9.483524740393467e-05,7.400932886774194e-06,1.621412022130214e-05,0.0,6.6999426e-05,False,REC8; REC8 meiotic recombination
hsa:346517,0.0,0.0,2.1128226451612905e-08,9.158917532171213e-08,0.0,4.8717413e-07,False,OR6V1; olfactory receptor family 6 subfamily V member
hsa:22794,8.693893e-08,6.145773652891097e-05,2.1242657516129031e-07,2.9136103089689864e-07,0.0,1.054791e-06,False,CASC3; CASC3 exon junction complex
hsa:401665,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51T1; olfactory receptor family 51 subfamily T member
hsa:54947,0.0,0.0,1.5096680012903228e-05,3.5264458840354065e-05,0.0,0.00017316845,False,LPCAT2; lysophosphatidylcholine acyltransferase
hsa:79718,0.0,0.0,2.2429935096774193e-07,6.427345914922649e-07,0.0,2.63065e-06,False,TBL1XR1; TBL1X/Y related
hsa:3683,0.0,0.0,1.2540014096774194e-06,3.826504633693945e-06,0.0,1.594379e-05,False,ITGAL; integrin subunit alpha
hsa:4706,0.0,0.0,3.718800906451612e-05,6.972123529498131e-05,0.0,0.00021205789,False,NDUFAB1; NADH:ubiquinone oxidoreductase subunit
hsa:390436,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K17; olfactory receptor family 4 subfamily K member
hsa:140465,0.0,0.0,1.512416350064516e-06,3.4505228008707426e-06,0.0,1.3838229e-05,False,MYL6B; myosin light chain
hsa:162963,0.0,0.0,1.2346173629032257e-08,2.66035641760593e-08,0.0,1.3356143e-07,False,ZNF610; zinc finger protein
hsa:7633,1.07988e-08,7.63374710533479e-06,4.6977858261290315e-08,7.283908411085498e-08,0.0,2.6114856e-07,False,ZNF79; zinc finger protein
hsa:654,0.00015891575,0.1123386530498395,0.0002939455005983871,0.00038883830069736996,0.0,0.0018979413,False,BMP6; bone morphogenetic protein
hsa:3156,0.0,0.0,2.7421673301612903e-05,5.4367506661437546e-05,0.0,0.00019454335,False,HMGCR; 3-hydroxy-3-methylglutaryl-CoA
hsa:10022,0.0,0.0,1.634321748387097e-08,6.893192188782914e-08,0.0,3.7106793e-07,False,INSL5; insulin like
hsa:4012,0.0,0.0,6.466133225806451e-06,2.0913043301994888e-05,0.0,0.00010092603,False,LNPEP; leucyl and cystinyl
hsa:80336,5.152043e-07,0.0003642015162593099,1.5007469074193547e-06,2.1226687210328797e-06,0.0,7.5073503e-06,False,PABPC1L; poly(A) binding protein cytoplasmic 1
hsa:56681,8.175406e-07,0.0005779251573085589,1.3945567905258065e-05,3.0775519017983e-05,0.0,0.00014064493,False,SAR1A; secretion associated Ras related GTPase
hsa:8600,0.0,0.0,1.0477570193548387e-08,4.2308428331923706e-08,0.0,2.0906184e-07,False,TNFSF11; TNF superfamily member
hsa:6392,9.646757e-07,0.0006819359866338678,4.3470604805161284e-05,0.00013617541292303083,0.0,0.0006411472,False,SDHD; succinate dehydrogenase complex subunit
hsa:9879,0.0,0.0,3.5096182438709677e-07,8.8706841517796e-07,0.0,3.1349205e-06,False,DDX46; DEAD-box helicase
hsa:5155,0.00033842155,0.23923255618174358,0.0006557138710000001,0.0007467348318688969,0.0,0.0022657344,False,PDGFB; platelet derived growth factor subunit
hsa:125965,0.0,0.0,6.045721314516127e-07,1.358979360694753e-06,0.0,6.2349777e-06,False,COX6B2; cytochrome c oxidase subunit
hsa:5187,3.479945e-05,0.0245999741364543,0.0016978561984161292,0.0030094419039838447,0.0,0.010424923,False,PER1; period circadian regulator
hsa:358,0.0008473734,0.5990141718883301,0.0013275511827096776,0.0015911133785102682,0.0,0.0059421635,True,AQP1; aquaporin 1 (Colton blood
hsa:5692,2.489025e-06,0.001759509148132748,4.872200215161291e-06,5.980329094802099e-06,0.0,2.0738813e-05,False,PSMB4; proteasome 20S subunit beta
hsa:51179,0.0,0.0,1.9104067879677421e-07,6.117072048435169e-07,0.0,3.2601026e-06,False,HAO2; hydroxyacid oxidase
hsa:717,0.0,0.0,1.4544724639032258e-05,3.6090128376250306e-05,0.0,0.0001484455,False,C2; complement
hsa:5707,0.0,0.0,2.3640946290322582e-06,4.5137334328638455e-06,0.0,2.0095053e-05,False,PSMD1; proteasome 26S subunit
hsa:4041,0.0,0.0,1.1369157048387097e-06,2.6288063366414625e-06,0.0,8.989818e-06,False,LRP5; LDL receptor related protein
hsa:6845,0.0,0.0,1.0164053273225806e-05,3.140273119057643e-05,0.0,0.00014404926,False,VAMP7; vesicle associated membrane protein
hsa:55813,1.3466184e-08,9.519339475673746e-06,1.0579292318709677e-06,2.718176902645616e-06,0.0,1.1080536e-05,False,UTP6; UTP6 small subunit processome
hsa:54434,0.0,0.0,3.113941837096774e-07,5.437284743660977e-07,0.0,2.421744e-06,False,SSH1; slingshot protein phosphatase
hsa:6817,2.3170871e-05,0.016379650463415916,0.0001605755342612903,0.00027460808952752566,0.0,0.0009105762,False,SULT1A1; sulfotransferase family 1A member
hsa:29079,8.112985e-07,0.0005735125732430877,2.9226374612903227e-06,5.975967194513689e-06,0.0,2.5508407e-05,False,MED4; mediator complex subunit
hsa:22829,-0.0,0.0,8.999807791612902e-07,2.5777873065304663e-06,0.0,1.13854885e-05,False,NLGN4Y; neuroligin 4
hsa:113878,0.00015710271,0.11105700241718995,0.00026398787072741934,0.00036139568172172695,0.0,0.00134352,False,DTX2; deltex E3 ubiquitin ligase
hsa:3091,0.00029644347,0.20955795838499647,0.0002923082839838709,0.00032316799005725495,0.0,0.001037983,False,HIF1A; hypoxia inducible factor 1 subunit
hsa:2001,0.0,0.0,7.306817232258064e-08,2.680181072823368e-07,0.0,1.3781408e-06,False,ELF5; E74 like ETS transcription factor
hsa:79473,0.0,0.0,5.777231519354839e-06,2.781851295873618e-05,0.0,0.00015493334,False,OR52N1; olfactory receptor family 52 subfamily N member
hsa:388566,1.074552e-08,7.5960831013924765e-06,1.0190109263870968e-07,2.5962558632687873e-07,0.0,1.1473546e-06,False,ZNF470; zinc finger protein
hsa:60490,0.0,0.0,1.642496889354839e-05,3.7661317054900886e-05,0.0,0.00016820327,False,PPCDC; phosphopantothenoylcysteine
hsa:116519,0.0,0.0,1.3043667354838709e-08,6.748277952196934e-08,0.0,3.7558542e-07,False,APOA5; apolipoprotein
hsa:148581,0.0,0.0,5.188337335483871e-09,1.8962823437520525e-08,0.0,9.917105e-08,False,UBE2U; ubiquitin conjugating enzyme E2
hsa:6203,2.0116167e-07,0.00014220258881235062,1.5917430749999998e-06,2.663522934348817e-06,0.0,1.1528704e-05,False,RPS9; ribosomal protein
hsa:9023,0.00018223804,0.1288253426613962,0.000530273940516129,0.0008480652872285376,0.0,0.003842839,False,CH25H; cholesterol
hsa:5624,4.497427e-08,3.1792625423847575e-05,7.805368058225806e-07,2.3739942685504202e-06,0.0,1.0793732e-05,False,PROC; protein C
hsa:120775,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2D3; olfactory receptor family 2 subfamily D member
hsa:4707,0.0,0.0,3.3464537812903222e-06,6.285040294864775e-06,0.0,2.3515826e-05,False,NDUFB1; NADH:ubiquinone oxidoreductase subunit
hsa:10594,9.192378e-09,6.498156179264657e-06,3.859401268709678e-07,5.433035689584304e-07,0.0,1.6557451e-06,False,PRPF8; pre-mRNA processing factor
hsa:599,5.824059e-08,4.1170679642690875e-05,5.670884461612904e-07,1.1028135457896193e-06,0.0,4.7326894e-06,False,BCL2L2; BCL2 like
hsa:7031,0.0,0.0,1.8806872580645163e-09,9.620105230054226e-09,0.0,5.3507563e-08,False,TFF1; trefoil factor
hsa:220074,0.0,0.0,1.643758582580645e-05,4.739001813725512e-05,0.0,0.00022261665,False,LRTOMT; leucine rich transmembrane and O-methyltransferase domain
hsa:407006,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR221; microRNA
hsa:219432,0.0,0.0,2.941116258064516e-08,1.6375442288591602e-07,0.0,9.1174604e-07,False,OR4C6; olfactory receptor family 4 subfamily C member
hsa:5892,0.0,0.0,1.0015569193548387e-05,2.089050046960825e-05,0.0,8.141359e-05,False,RAD51D; RAD51 paralog
hsa:91445,0.0,0.0,1.8922878524853872e-06,5.81509737199771e-06,0.0,2.6072641e-05,False,RNF185; ring finger protein
hsa:3835,0.0,0.0,2.7142507537096776e-06,8.110145726303138e-06,0.0,4.0381772e-05,False,KIF22; kinesin family member
hsa:1158,3.4945427e-07,0.0002470316629680503,4.380177537193549e-06,9.106535219054498e-06,0.0,3.6680438e-05,False,CKM; creatine kinase
hsa:6161,1.4566734e-07,0.00010297325953502412,2.0426256017258066e-06,4.262801037591879e-06,0.0,1.7498527e-05,False,RPL32; ribosomal protein
hsa:5914,0.0,0.0,4.203949532258065e-05,8.090743946330303e-05,0.0,0.0003851315,False,RARA; retinoic acid receptor
hsa:56616,0.0,0.0,0.00036416166203225806,0.0008406506576696772,0.0,0.003502344,False,DIABLO; diablo IAP-binding mitochondrial
hsa:123096,5.1675767e-07,0.0003652996043562294,1.3799728932903226e-06,2.4536859279773636e-06,0.0,1.03646635e-05,False,SLC25A29; solute carrier family 25 member
hsa:50943,0.0,0.0,2.16672483483871e-06,4.681481877485392e-06,0.0,1.9347171e-05,False,FOXP3; forkhead box
hsa:54795,1.6896929e-05,0.011944557065858933,4.09037170196129e-05,6.853630574098339e-05,0.0,0.00024480553,False,TRPM4; transient receptor potential cation channel subfamily M member
hsa:147495,0.0,0.0,3.1988939361290326e-07,1.0218104216039024e-06,0.0,4.5126744e-06,False,APCDD1; APC down-regulated
hsa:693210,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR625; microRNA
hsa:572,0.0,0.0,6.17224170967742e-05,0.00014056056535909442,0.0,0.0004832775,False,BAD; BCL2 associated agonist of cell
hsa:623,0.0,0.0,9.339224448387097e-06,2.3443947513520683e-05,0.0,0.00012025107,False,BDKRB1; bradykinin receptor
hsa:8395,2.592042e-06,0.0018323325845840456,7.95272166216129e-06,1.1732963601363695e-05,0.0,5.017661e-05,False,PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:8372,0.0,0.0,5.16574354032258e-06,1.0823440687362696e-05,0.0,4.788551e-05,False,HYAL3; hyaluronidase
hsa:268,0.0,0.0,9.742146483870967e-08,3.6001925355672485e-07,0.0,1.4864595e-06,False,AMH; anti-Mullerian
hsa:280,0.0,0.0,6.91329049032258e-05,0.00018143968329542828,0.0,0.0008954222,False,AMY2B; amylase alpha
hsa:23327,0.0,0.0,0.0001883936852096774,0.00038485048802060716,0.0,0.001525719,False,NEDD4L; NEDD4 like E3 ubiquitin protein
hsa:2147,0.0,0.0,1.3865654838709678e-08,7.720069887826943e-08,0.0,4.298353e-07,False,F2; coagulation factor II
hsa:55775,4.4123357e-07,0.00031191109084009657,8.723060129032258e-07,1.090910701133889e-06,0.0,4.7765952e-06,False,TDP1; tyrosyl-DNA phosphodiesterase
hsa:84634,0.0,0.0,2.7839815573677417e-06,1.1174774124478922e-05,0.0,6.251766e-05,False,KISS1R; KISS1
hsa:5691,0.0,0.0,2.6920930690322577e-06,7.02806814469641e-06,0.0,3.242468e-05,False,PSMB3; proteasome 20S subunit beta
hsa:283358,0.0,0.0,1.3056435934419356e-05,4.5541332066665306e-05,0.0,0.00020591833,False,B4GALNT3; beta-1
hsa:2555,0.00047029657,0.3324559284259714,0.001309471904416129,0.001937755781869726,0.0,0.008059578,False,GABRA2; gamma-aminobutyric acid type A receptor subunit
hsa:3857,0.0,0.0,8.232852796580647e-06,2.002318231306448e-05,0.0,8.649279e-05,False,KRT9; keratin
hsa:2138,0.0,0.0,5.728943307e-07,1.5984240966801829e-06,0.0,6.6993143e-06,False,EYA1; EYA transcriptional coactivator and phosphatase
hsa:1472,0.0,0.0,7.214778838709679e-08,2.021076737280379e-07,-0.0,8.852642e-07,False,CST4; cystatin
hsa:338339,0.0,0.0,2.203436599612903e-07,6.976750571975985e-07,0.0,2.8900693e-06,False,CLEC4D; C-type lectin domain family 4 member
hsa:51343,4.540562e-07,0.00032097549750058466,3.383372258451613e-05,9.586186669925797e-05,0.0,0.00043741788,False,FZR1; fizzy and cell division cycle 20 related
hsa:8694,0.0,0.0,0.00014235062354838707,0.0004263622216643603,0.0,0.001987116,False,DGAT1; diacylglycerol O-acyltransferase
hsa:7175,0.0,0.0,4.6737078926451614e-05,0.00014921799383645692,0.0,0.0006022296,False,TPR; translocated promoter region
hsa:55294,9.878552e-08,6.983217369976218e-05,5.23766296e-07,8.152924965760309e-07,0.0,3.4303819e-06,False,FBXW7; F-box and WD repeat domain containing
hsa:27044,1.2620649e-07,8.9216248815791e-05,5.911249453548387e-07,8.45021944822703e-07,0.0,3.215368e-06,False,SND1; staphylococcal nuclease and tudor domain containing
hsa:94039,8.527094e-10,6.027862275384083e-07,8.10452930935484e-08,2.3212352304384633e-07,0.0,1.1470948e-06,False,ZNF101; zinc finger protein
hsa:26091,0.0,0.0,2.204059516451613e-07,3.5795184050216836e-07,0.0,1.2717024e-06,False,HERC4; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:4502,3.4367513e-06,0.002429463485584562,0.0002326542587819355,0.000492730493359393,0.0,0.0017884922,False,MT2A; metallothionein
hsa:79720,0.0,0.0,1.2908655699999998e-07,3.375519720442257e-07,0.0,1.5174376e-06,False,VPS37B; VPS37B subunit of
hsa:79868,0.0,0.0,4.459264337154838e-05,0.00010181107169063648,0.0,0.0003721231,False,ALG13; ALG13 UDP-N-acetylglucosaminyltransferase
hsa:1850,3.4348417e-07,0.0002428113576013837,3.142599359941935e-05,7.416011700081359e-05,0.0,0.00036514676,False,DUSP8; dual specificity phosphatase
hsa:2115,4.0189713e-07,0.0002841038868003722,2.9640542932219352e-05,0.00011867942683190919,0.0,0.0006565972,False,ETV1; ETS variant transcription factor
hsa:442903,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR331; microRNA
hsa:10928,0.0,0.0,2.0202329019354836e-05,4.6758858363418363e-05,0.0,0.00014749022,False,RALBP1; ralA binding protein
hsa:1943,0.0,0.0,2.1533713882258066e-07,7.78517431439235e-07,0.0,4.2584697e-06,False,EFNA2; ephrin
hsa:4486,0.0,0.0,1.131866464516129e-07,3.508106461697079e-07,0.0,1.6199377e-06,False,MST1R; macrophage stimulating 1
hsa:5430,1.5028849e-06,0.0010623998272980668,8.911800670967742e-06,1.848449304545652e-05,0.0,7.216259e-05,False,POLR2A; RNA polymerase II subunit
hsa:8742,8.782727e-07,0.00062085710276323,2.760863480903226e-05,9.222152556461015e-05,0.0,0.0005095271,False,TNFSF12; TNF superfamily member
hsa:10758,2.4778575e-07,0.0001751614764423556,1.0737534118387098e-05,2.481395724983314e-05,0.0,0.000119199365,False,TRAF3IP2; TRAF3 interacting protein
hsa:4595,1.2278831e-06,0.0008679991351182081,2.3248846409516136e-05,5.3245324805977554e-05,0.0,0.00023409221,False,MUTYH; mutY DNA
hsa:84448,2.0253363e-09,1.4317243691386514e-06,4.76748211932258e-07,9.707732122176181e-07,0.0,3.87836e-06,False,ABLIM2; actin binding LIM protein family member
hsa:57805,0.0,0.0,6.925015861290322e-07,1.0570475787279594e-06,0.0,3.9219885e-06,False,CCAR2; cell cycle and apoptosis regulator
hsa:147945,0.0,0.0,3.246098213225806e-08,1.3125041121482079e-07,0.0,7.3016844e-07,False,NLRP4; NLR family pyrin domain containing
hsa:4920,0.0,0.0,1.347542425603226e-05,4.4900852447099935e-05,0.0,0.00021283062,False,ROR2; receptor tyrosine kinase like orphan receptor
hsa:4709,2.482438e-06,0.0017548527518495647,4.24158185967742e-06,5.3646774252452e-06,0.0,1.9833822e-05,False,NDUFB3; NADH:ubiquinone oxidoreductase subunit
hsa:574476,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520C; microRNA
hsa:64895,0.0,0.0,2.3294242325806452e-07,5.009269908921301e-07,0.0,1.8534083e-06,False,PAPOLG; poly(A) polymerase
hsa:80233,1.8539228e-06,0.0013105509693682785,6.842848649774192e-05,0.00014523488549997104,0.0,0.0005116246,False,FAAP100; FA core complex associated protein
hsa:7373,4.440103e-05,0.031387398066116894,0.0001959035724677419,0.0004456238546047857,0.0,0.0018155477,False,COL14A1; collagen type XIV alpha 1
hsa:8647,0.0,0.0,0.0,0.0,0.0,0.0,False,ABCB11; ATP binding cassette subfamily B member
hsa:5148,0.0,0.0,9.187884258064517e-06,1.7476499821293668e-05,0.0,7.550016e-05,False,PDE6G; phosphodiesterase
hsa:404281,0.0,0.0,4.7663429234838705e-06,1.1953048645518915e-05,0.0,5.0843428e-05,False,YY2; YY2 transcription
hsa:5393,1.0302631e-07,7.283001775528989e-05,6.729226406451613e-07,9.749890157694378e-07,0.0,3.6041324e-06,False,EXOSC9; exosome component
hsa:10020,0.0,0.0,3.569349648387097e-07,1.134056480488546e-06,0.0,5.4685697e-06,False,GNE; glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine
hsa:269,0.0,0.0,9.949188151612904e-08,3.050605759195547e-07,0.0,1.341868e-06,False,AMHR2; anti-Mullerian hormone receptor type
hsa:10948,0.0,0.0,3.790206485751613e-05,0.00011001028224771607,0.0,0.00041888934,False,STARD3; StAR related lipid transfer domain containing
hsa:7748,0.0,0.0,3.900105122580645e-08,9.76959233932456e-08,0.0,4.2101902e-07,False,ZNF195; zinc finger protein
hsa:6326,0.0,0.0,1.0951512774193548e-05,3.2962551856450024e-05,0.0,0.00012399245,False,SCN2A; sodium voltage-gated channel alpha subunit
hsa:63971,0.0,0.0,4.5451514319354844e-07,1.3477653960026017e-06,0.0,5.892591e-06,False,KIF13A; kinesin family member
hsa:317,0.0,0.0,6.223775835483872e-05,0.00014864709714706938,0.0,0.0006513625,False,APAF1; apoptotic peptidase activating factor
hsa:360,0.0,0.0,5.861206037419355e-05,0.00014023993146603672,0.0,0.0006139521,False,AQP3; aquaporin 3 (Gill blood
hsa:5058,7.139555e-05,0.05047001270014124,0.0003855136953225807,0.0007423812506683856,0.0,0.003052859,False,PAK1; p21 (RAC1) activated kinase
hsa:65243,0.0,0.0,6.034570035483871e-09,9.786821014310694e-09,0.0,2.8166145e-08,False,ZFP69B; ZFP69 zinc finger protein
hsa:127396,0.0,0.0,8.528949493548387e-09,1.6179483183439176e-08,0.0,6.4348086e-08,False,ZNF684; zinc finger protein
hsa:6155,0.0,0.0,1.0394571838709678e-07,1.807754446769037e-07,0.0,6.6786464e-07,False,RPL27; ribosomal protein
hsa:53342,4.362868e-06,0.003084141845941936,2.8018456923870968e-05,6.120680772001176e-05,0.0,0.0002843913,False,IL17D; interleukin
hsa:117579,0.0,0.0,5.817730967741935e-09,3.2391755154726186e-08,0.0,1.8034966e-07,False,RLN3; relaxin
hsa:2222,3.3308665e-06,0.0023546127812934417,7.513687674193549e-05,0.0001370932277210341,0.0,0.00044485336,False,FDFT1; farnesyl-diphosphate farnesyltransferase
hsa:2990,0.00011250656,0.07953167266095998,0.00022160870696774193,0.0002910729175188873,0.0,0.0010811298,False,GUSB; glucuronidase
hsa:3983,2.5830235e-07,0.0001825957343976806,3.6890140867619356e-06,1.0995057698041676e-05,0.0,5.7584424e-05,False,ABLIM1; actin binding LIM protein
hsa:92597,0.0,0.0,5.313564021612903e-05,0.00012479598145512683,0.0,0.0005368031,False,MOB1B; MOB kinase activator
hsa:1142,0.0,0.0,1.053371125483871e-06,5.040978521665201e-06,0.0,2.8131868e-05,False,CHRNB3; cholinergic receptor nicotinic beta 3
hsa:6228,5.0911433e-07,0.00035989647395284297,7.709336513225808e-07,1.0303157604308616e-06,0.0,3.896308e-06,False,RPS23; ribosomal protein
hsa:2692,0.0,0.0,1.8270949167741936e-06,7.948314495531935e-06,0.0,4.4089287e-05,False,GHRHR; growth hormone releasing hormone
hsa:57519,0.0,0.0,2.3604835577419355e-07,6.509022833623911e-07,0.0,2.9358478e-06,False,STARD9; StAR related lipid transfer domain containing
hsa:3146,4.3075397e-06,0.0030450298844306484,3.216819728064516e-05,6.083085926150569e-05,0.0,0.00021056367,False,HMGB1; high mobility group box
hsa:2968,2.9780117e-07,0.00021051772599296338,2.3102106819354835e-06,3.011522498021103e-06,0.0,1.0791206e-05,False,GTF2H4; general transcription factor IIH subunit
hsa:8707,4.464863e-05,0.03156242823458755,0.00013540411082258062,0.00029338398200961103,0.0,0.0015892088,False,B3GALT2; beta-1
hsa:7431,0.0,0.0,2.1856399576451616e-06,4.417928846163794e-06,0.0,1.6837168e-05,False,VIM;
hsa:9861,9.914972e-09,7.008962922220569e-06,7.712215372e-06,1.346985765559417e-05,0.0,5.5465338e-05,False,PSMD6; proteasome 26S subunit
hsa:728,5.5580054e-05,0.03928992817135711,7.777913492709677e-05,9.983934727881536e-05,0.0,0.00038510084,False,C5AR1; complement C5a receptor
hsa:3915,0.00023325736,0.16489125613012878,0.0003451987705612903,0.00043382754663016173,0.0,0.0018266509,False,LAMC1; laminin subunit gamma
hsa:56893,3.1079346e-09,2.197020664918309e-06,1.382581492148387e-06,4.298036093354343e-06,0.0,2.0058647e-05,False,UBQLN4; ubiquilin
hsa:488,0.00019884482,0.1405647913736542,0.00038377322451612906,0.00048769388324742,0.0,0.0020325799,False,ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:23175,0.0,0.0,4.727407711290322e-05,9.67664085165057e-05,0.0,0.0003256279,False,LPIN1; lipin
hsa:374654,0.0,0.0,8.04801380967742e-06,1.7165759046112442e-05,0.0,6.57904e-05,False,KIF7; kinesin family member
hsa:811,4.687321e-06,0.003313499936615639,0.0001330875167096774,0.00018164277299321578,0.0,0.00059995387,False,CALR;
hsa:81697,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2B2; olfactory receptor family 2 subfamily B member
hsa:56886,0.0,0.0,6.313869946e-08,1.7206321293581775e-07,0.0,6.8048945e-07,False,UGGT1; UDP-glucose glycoprotein glucosyltransferase
hsa:27350,3.7570926e-06,0.002655914986824902,2.9298757825661297e-05,6.135959286782246e-05,0.0,0.00024666684,False,APOBEC3C; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1581,8.862975e-07,0.0006265298899035504,6.803777302580645e-06,1.3243400429680128e-05,0.0,6.8337504e-05,False,CYP7A1; cytochrome P450 family 7 subfamily A member
hsa:3804,0.0,0.0,8.907444348387097e-07,1.8706940081043695e-06,0.0,8.698566e-06,False,KIR2DL3; killer cell immunoglobulin like receptor
hsa:3884,0.0,0.0,2.81817104516129e-08,1.483577600686935e-07,0.0,8.2624166e-07,False,KRT33B; keratin
hsa:25946,1.9466002e-05,0.013760652703998703,0.00020903377258451613,0.00040299353221437195,0.0,0.0017257067,False,ZNF385A; zinc finger protein
hsa:10533,8.7166645e-06,0.006161870985206644,9.9397599535e-05,0.00013480525910566606,0.0,0.00037335613,False,ATG7; autophagy related
hsa:11332,0.0,0.0,1.4480142391290321e-05,4.6326549454928276e-05,0.0,0.00020636107,False,ACOT7; acyl-CoA thioesterase
hsa:5298,0.0,0.0,1.8132811967741936e-05,4.4887548043563485e-05,0.0,0.00016556459,False,PI4KB; phosphatidylinositol 4-kinase
hsa:8659,0.0,0.0,8.150214837096774e-05,0.00013662088659766394,0.0,0.00050359254,False,ALDH4A1; aldehyde dehydrogenase 4 family member
hsa:10342,0.0,0.0,7.11899224267742e-05,0.0002129961944672915,0.0,0.0007775117,False,TFG; trafficking from ER to golgi
hsa:5730,3.753519e-05,0.026533887840379605,0.00012334617187096774,0.00022034366934087042,0.0,0.0008002877,False,PTGDS; prostaglandin D2
hsa:225,0.0,0.0,3.5457965806451614e-07,1.325315543652624e-06,0.0,6.251779e-06,False,ABCD2; ATP binding cassette subfamily D member
hsa:885,4.092583e-06,0.0028930754926095826,1.0616631056774193e-05,1.5265538557856684e-05,0.0,6.0755847e-05,False,CCK;
hsa:912,5.0528756e-06,0.003571913035255471,4.363422783248387e-05,0.00011092040806483038,0.0,0.000545751,False,CD1D; CD1d
hsa:7771,0.0,0.0,1.3641825448387096e-08,2.8886268277295433e-08,0.0,1.2744103e-07,False,ZNF112; zinc finger protein
hsa:2313,2.5598936e-07,0.00018096066561993049,1.0413285261454195e-06,1.6545598013034195e-06,0.0,6.7086635e-06,False,FLI1; Fli-1 proto-oncogene
hsa:1235,0.0,0.0,4.198544524516131e-06,2.2141316859611252e-05,0.0,0.00012346047,False,CCR6; C-C motif chemokine receptor
hsa:10126,0.0,0.0,1.2618180445161292e-07,3.02157147411374e-07,0.0,1.2686371e-06,False,DNAL4; dynein axonemal light chain
hsa:22869,7.85281e-09,5.5512062086754156e-06,4.6126386496774186e-08,7.809155069669433e-08,0.0,3.0620362e-07,False,ZNF510; zinc finger protein
hsa:3818,6.647107e-09,4.6988863410842505e-06,1.2008818159677417e-06,2.908387440800233e-06,0.0,1.3760652e-05,False,KLKB1; kallikrein
hsa:83464,0.0,0.0,6.067600508387097e-05,0.0001614268787427188,0.0,0.0006191879,False,APH1B; aph-1 homolog B
hsa:26259,1.7025469e-08,1.2035422889183721e-05,1.2230606693548387e-07,1.9812373410504645e-07,0.0,7.452991e-07,False,FBXW8; F-box and WD repeat domain containing
hsa:84449,4.2101007e-08,2.9761495751188065e-05,1.1602159561290324e-07,2.3688811634714853e-07,0.0,1.0710031e-06,False,ZNF333; zinc finger protein
hsa:551,0.0,0.0,2.3235718403225806e-06,9.349726675428937e-06,0.0,5.1522933e-05,False,AVP; arginine
hsa:249,0.0,0.0,0.00011674337339354841,0.0003958502340006457,0.0,0.002173299,False,ALPL; alkaline phosphatase
hsa:10125,0.0,0.0,5.8018031290322585e-08,1.3632803419336602e-07,0.0,5.9508744e-07,False,RASGRP1; RAS guanyl releasing protein
hsa:4725,0.0,0.0,1.1794349584838708e-05,2.5410430426279128e-05,0.0,0.00011610751,False,NDUFS5; NADH:ubiquinone oxidoreductase subunit
hsa:4123,0.0,0.0,7.094577306451614e-05,0.00019853486485450994,0.0,0.00083997066,False,MAN2C1; mannosidase alpha class 2C member
hsa:26871,5.409781e-09,3.824211954036109e-06,1.98784380032258e-07,4.863695391858227e-07,0.0,2.0770804e-06,False,RNU1-1; RNA
hsa:1536,2.2075099e-05,0.015605041587141984,0.00013880514347096773,0.0002974361476238983,0.0,0.0013466022,False,CYBB; cytochrome b-245 beta
hsa:4893,0.0,0.0,0.0001292704402580645,0.0003202638690317306,0.0,0.0013453284,False,NRAS; NRAS proto-oncogene
hsa:55651,5.4261204e-08,3.835762389959814e-05,2.9912207359903227e-06,7.165403301739338e-06,0.0,2.8298256e-05,False,NHP2; NHP2
hsa:6804,1.3029528e-05,0.009210664301022202,7.217485497741936e-05,0.00014544198142945754,0.0,0.0005723887,False,STX1A; syntaxin
hsa:10297,0.0,0.0,4.148379490322581e-06,1.675620571220899e-05,0.0,8.658725e-05,False,APC2; APC regulator of WNT signaling pathway
hsa:4686,0.0,0.0,9.221465295483871e-08,2.5183423305557177e-07,0.0,1.1411595e-06,False,NCBP1; nuclear cap binding protein subunit
hsa:4691,0.0,0.0,5.20044263032258e-07,9.135044404451135e-07,0.0,3.4879502e-06,False,NCL;
hsa:390113,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4X1; olfactory receptor family 4 subfamily X member
hsa:100129842,0.0,0.0,3.986635774193549e-08,1.1898366711762405e-07,0.0,4.869477e-07,False,ZNF737; zinc finger protein
hsa:2535,0.00015030784,0.10625366137988707,0.0002912505330806451,0.0002939173586040325,0.0,0.0009577678,False,FZD2; frizzled class receptor
hsa:318,7.493909e-09,5.297496586323695e-06,8.226129213034193e-05,0.00024169900926444683,0.0,0.00092120806,False,NUDT2; nudix hydrolase
hsa:5863,1.10776725e-07,7.830884022365614e-05,1.1055773897096775e-06,1.7638312665577404e-06,0.0,7.118046e-06,False,RGL2; ral guanine nucleotide dissociation stimulator like
hsa:2651,0.0,0.0,2.038188496451613e-05,6.60892819029525e-05,0.0,0.00032369938,False,GCNT2; glucosaminyl (N-acetyl) transferase 2 (I blood
hsa:6477,0.0,0.0,1.59776082166129e-05,3.30251088203921e-05,0.0,0.00011188585,False,SIAH1; siah E3 ubiquitin protein ligase
hsa:442319,0.0,0.0,2.241725005483871e-09,4.078079132650003e-09,0.0,1.1794526e-08,False,ZNF727; zinc finger protein
hsa:2309,0.0,0.0,5.368717062258064e-05,8.575721386468108e-05,0.0,0.00034346298,False,FOXO3; forkhead box
hsa:119772,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52M1; olfactory receptor family 52 subfamily M member
hsa:23530,0.0,0.0,1.2225858490322582e-05,3.5868468074499275e-05,0.0,0.00018056389,False,NNT; nicotinamide nucleotide
hsa:246184,0.0,0.0,4.8451008654838714e-06,1.0336291648127187e-05,0.0,3.9377832e-05,False,CDC26; cell division cycle
hsa:406906,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR122; microRNA
hsa:140801,0.0,0.0,0.0,0.0,0.0,0.0,False,RPL10L; ribosomal protein L10
hsa:60485,0.0,0.0,0.00016816138038709677,0.00035410372287768597,0.0,0.0013788145,False,SAV1; salvador family WW domain containing protein
hsa:5277,1.6555376e-06,0.0011703110865811852,3.304786797225806e-05,6.796442105149193e-05,0.0,0.0002552233,False,PIGA; phosphatidylinositol glycan anchor biosynthesis class
hsa:8912,0.0,0.0,3.724753134258064e-05,7.86979737882965e-05,0.0,0.00031776467,False,CACNA1H; calcium voltage-gated channel subunit alpha1
hsa:9350,0.0,0.0,1.4201140133548387e-08,6.657170223439352e-08,0.0,3.702299e-07,False,CER1; cerberus 1
hsa:7009,0.0,0.0,2.607479561612903e-07,3.9911264482917256e-07,0.0,1.3164973e-06,False,TMBIM6; transmembrane BAX inhibitor motif containing
hsa:4179,3.528286e-05,0.024941700040090803,0.0001568732236451613,0.0002512592046144662,0.0,0.0010586623,False,CD46; CD46
hsa:6322,0.0,0.0,3.6936793378387094e-06,1.4798139667651447e-05,0.0,8.0397054e-05,False,SCML1; Scm polycomb group protein like
hsa:1022,8.9957507e-07,0.0006359158968259288,1.5989741537096774e-05,3.954889015807261e-05,0.0,0.000183827,False,CDK7; cyclin dependent kinase
hsa:187,0.0,0.0,7.846360041935485e-06,1.8939607017062086e-05,0.0,8.4902276e-05,False,APLNR; apelin
hsa:3780,0.0,0.0,1.7894003225806452e-07,9.962959346901063e-07,0.0,5.547141e-06,False,KCNN1; potassium calcium-activated channel subfamily N member
hsa:5346,0.0,0.0,1.3344264153870968e-07,3.851641614201523e-07,0.0,1.4304761e-06,False,PLIN1; perilipin
hsa:5024,0.0,0.0,0.00033534346129032255,0.0010956683791548626,0.0,0.0048574163,False,P2RX3; purinergic receptor P2X
hsa:84061,2.4266921e-05,0.017154455859830536,0.0001606883399348387,0.00033727085212138254,0.0,0.0013225938,False,MAGT1; magnesium transporter
hsa:55353,0.0,0.0,3.5634542896087097e-07,6.656394965641644e-07,0.0,2.1019032e-06,False,LAPTM4B; lysosomal protein transmembrane 4
hsa:10461,2.708307e-07,0.00019145211247182967,6.36722069967742e-05,0.0001019792062794032,0.0,0.0003250672,False,MERTK; MER proto-oncogene
hsa:1045,0.0,0.0,7.910519522580644e-09,2.9748009487915e-08,0.0,1.5713138e-07,False,CDX2; caudal type homeobox
hsa:1159,0.0,0.0,4.826895661877419e-06,1.0926088786332939e-05,0.0,3.7286853e-05,False,CKMT1B; creatine kinase
hsa:3611,0.0,0.0,1.788128587870968e-05,4.0016919904241524e-05,0.0,0.00016249935,False,ILK; integrin linked
hsa:100131017,5.1399493e-08,3.6334660416381976e-05,1.0342822129999997e-07,2.0049954861829623e-07,0.0,8.1316637e-07,False,ZNF316; zinc finger protein
hsa:125962,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7G1; olfactory receptor family 7 subfamily G member
hsa:51744,0.0,0.0,7.315381144516129e-08,2.6142194519534764e-07,0.0,1.0908564e-06,False,CD244; CD244
hsa:5687,4.5807622e-07,0.00032381727770193925,5.063060829677419e-06,8.903458156758157e-06,0.0,3.4740464e-05,False,PSMA6; proteasome 20S subunit alpha
hsa:2912,0.0,0.0,5.106481751612904e-06,8.847093721128338e-06,0.0,3.7731363e-05,False,GRM2; glutamate metabotropic receptor
hsa:253558,0.0,0.0,5.415512858064516e-06,2.0719583234732455e-05,0.0,0.00011404992,False,LCLAT1; lysocardiolipin acyltransferase
hsa:29880,0.0,0.0,4.209756689032258e-05,9.913001606600699e-05,0.0,0.00039222103,False,ALG5; ALG5 dolichyl-phosphate
hsa:10890,5.982871e-07,0.0004229333275719659,6.6092284848387114e-06,1.3328781306505606e-05,0.0,6.596196e-05,False,RAB10; RAB10
hsa:158431,1.5702183e-09,1.109998277805748e-06,3.6214733929032256e-08,5.2413489874283573e-08,0.0,1.7640507e-07,False,ZNF782; zinc finger protein
hsa:10007,0.0,0.0,7.459983364193547e-06,2.0805828431607376e-05,0.0,0.00010623686,False,GNPDA1; glucosamine-6-phosphate deaminase
hsa:51079,0.0,0.0,4.460704612903226e-06,5.226889643957495e-06,0.0,1.49224115e-05,False,NDUFA13; NADH:ubiquinone oxidoreductase subunit
hsa:56954,4.712566e-06,0.003331345803348441,4.234128691709677e-05,0.00010448202282149863,0.0,0.0004572465,False,NIT2; nitrilase family member
hsa:11320,1.4906016e-07,0.0001053716676779587,8.490231963677418e-05,0.00014885708334996965,0.0,0.0005965923,False,MGAT4A; alpha-1
hsa:1141,0.0,0.0,4.822553451612903e-06,1.0646466895319213e-05,0.0,4.1689465e-05,False,CHRNB2; cholinergic receptor nicotinic beta 2
hsa:10735,0.0,0.0,1.815780541096774e-07,3.625541932097062e-07,0.0,1.3844971e-06,False,STAG2; STAG2 cohesin complex
hsa:1583,0.0001072129,0.07578954745245288,0.0003464376172870967,0.0005530878736718663,0.0,0.0026247452,False,CYP11A1; cytochrome P450 family 11 subfamily A member
hsa:5236,0.00012849973,0.09083735618066839,0.00023656506719354836,0.00028064977512020045,0.0,0.0013233717,False,PGM1; phosphoglucomutase
hsa:7699,0.0,0.0,2.005493722580645e-08,3.701005992121484e-08,0.0,1.570628e-07,False,ZNF140; zinc finger protein
hsa:50507,0.0,0.0,2.9612841670967737e-06,8.246347686906921e-06,0.0,4.3256612e-05,False,NOX4; NADPH oxidase
hsa:2091,9.416078e-09,6.65629127089182e-06,2.2019189405064517e-06,6.476409711242256e-06,0.0,2.8562155e-05,False,FBL;
hsa:119764,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4X2; olfactory receptor family 4 subfamily X member
hsa:148266,0.0,0.0,1.5936383387096776e-09,3.87784875548004e-09,0.0,1.4015346e-08,False,ZNF569; zinc finger protein
hsa:29968,0.0,0.0,3.098213571612903e-05,7.077559689915802e-05,0.0,0.00026755422,False,PSAT1; phosphoserine aminotransferase
hsa:3760,0.0,0.0,2.8714023588709677e-05,9.154816926820755e-05,0.0,0.00036116838,False,KCNJ3; potassium inwardly rectifying channel subfamily J member
hsa:6209,0.0,0.0,7.435434950645161e-07,1.84268754208364e-06,0.0,8.715098e-06,False,RPS15; ribosomal protein
hsa:7278,0.0,0.0,1.1732330814225806e-06,6.523111836113421e-06,0.0,3.6320787e-05,False,TUBA3C; tubulin alpha
hsa:25804,5.3429966e-07,0.0003777001595460942,1.628702315483871e-06,2.6776177483873744e-06,0.0,1.0629975e-05,False,LSM4; LSM4 homolog
hsa:3594,0.0,0.0,2.897604188064517e-05,4.785912606680694e-05,0.0,0.00013768327,False,IL12RB1; interleukin 12 receptor subunit beta
hsa:2249,0.0,0.0,1.1853299677419356e-08,3.7869857444596396e-08,0.0,1.7910259e-07,False,FGF4; fibroblast growth factor
hsa:2923,7.699461e-07,0.0005442802730061497,5.93743254483871e-06,1.0968593919168463e-05,0.0,4.5725665e-05,False,PDIA3; protein disulfide isomerase family A member
hsa:406967,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR192; microRNA
hsa:339983,1.0663132e-06,0.000753784244905015,4.146026501612903e-06,7.775483768716434e-06,0.0,2.9738932e-05,False,NAT8L; N-acetyltransferase 8
hsa:889,0.0,0.0,5.582679361612904e-07,1.1369801728191621e-06,0.0,4.4373005e-06,False,KRIT1; KRIT1 ankyrin repeat
hsa:3833,0.0,0.0,4.908481252258064e-07,1.3900155493692327e-06,0.0,6.1914225e-06,False,KIFC1; kinesin family member
hsa:23509,0.0,0.0,1.0278372191612901e-05,2.359562326463108e-05,0.0,8.631293e-05,False,POFUT1; protein O-fucosyltransferase
hsa:1164,0.0,0.0,2.175286833225806e-05,5.859287257517177e-05,0.0,0.00022518933,False,CKS2; CDC28 protein kinase regulatory subunit
hsa:81856,0.0,0.0,3.769451022258065e-08,5.666423164110157e-08,0.0,1.9273922e-07,False,ZNF611; zinc finger protein
hsa:83605,0.0,0.0,6.3397915190322585e-06,2.1939891845453436e-05,0.0,0.0001108266,False,CCM2; CCM2 scaffold
hsa:3251,0.0,0.0,9.59867029032258e-06,2.1340010242040644e-05,0.0,9.219925e-05,False,HPRT1; hypoxanthine phosphoribosyltransferase
hsa:79026,8.5419266e-08,6.03834754386897e-05,7.111239670322581e-07,1.4598140152292606e-06,0.0,6.490176e-06,False,AHNAK; AHNAK
hsa:2597,1.8993482e-07,0.00013426625017384192,4.398496538129033e-05,0.00011583428532836562,0.0,0.0005531136,False,GAPDH; glyceraldehyde-3-phosphate
hsa:56832,0.0,0.0,2.2826726838709676e-07,1.2342724182652468e-06,0.0,6.8758986e-06,False,IFNK; interferon
hsa:169841,5.90158e-09,4.171868100335378e-06,3.5063930356774195e-08,6.853396730082901e-08,0.0,2.666137e-07,False,ZNF169; zinc finger protein
hsa:6470,5.888736e-06,0.004162788587072708,0.00012398418193548387,0.00020770880518759398,0.0,0.0008552989,False,SHMT1; serine hydroxymethyltransferase
hsa:139189,0.0,0.0,9.721611129161937e-06,4.3314288987084614e-05,0.0,0.0002357475,False,DGKK; diacylglycerol kinase
hsa:284958,0.0,0.0,1.2402450870967741e-08,6.074199893628666e-08,0.0,3.377119e-07,False,NT5DC4; 5'-nucleotidase domain containing
hsa:80031,0.0,0.0,1.728607005296774e-05,6.136979790624755e-05,0.0,0.000308083,False,SEMA6D; semaphorin
hsa:10483,0.0,0.0,4.072411976129031e-07,1.0974198932131293e-06,0.0,4.9355676e-06,False,SEC23B; SEC23 homolog B
hsa:7673,1.6091306e-09,1.1375056543185937e-06,4.6158264345161294e-08,1.1367338975332463e-07,0.0,4.8696756e-07,False,ZNF222; zinc finger protein
hsa:260434,-0.0,0.0,2.851541070967742e-09,1.4606944917184062e-08,0.0,8.146973e-08,False,PYDC1; pyrin domain containing
hsa:3811,0.0,0.0,2.913473633548387e-07,7.453548036390092e-07,0.0,2.8416102e-06,False,KIR3DL1; killer cell immunoglobulin like receptor
hsa:127829,1.07252006e-07,7.581719175684792e-05,1.124091690032258e-06,2.958873349713788e-06,0.0,1.2731923e-05,False,ARL8A; ADP ribosylation factor like GTPase
hsa:10842,0.0,0.0,4.716996219516128e-06,1.2201553066660305e-05,0.0,4.8281174e-05,False,PPP1R17; protein phosphatase 1 regulatory subunit
hsa:27257,0.0,0.0,2.131225573677419e-05,7.128587541639201e-05,0.0,0.00030760557,False,LSM1; LSM1 homolog
hsa:116985,7.0492106e-08,4.9831361829689696e-05,4.957791039354839e-07,7.859729614350571e-07,0.0,2.84496e-06,False,ARAP1; ArfGAP with RhoGAP domain
hsa:58505,5.066897e-06,0.003581824860797452,0.00010316538302903226,0.0002383146110787764,0.0,0.000912386,False,OSTC; oligosaccharyltransferase complex non-catalytic
hsa:4938,0.0,0.0,3.9106448612903225e-06,1.859909819276915e-05,0.0,0.00010381468,False,OAS1; 2'-5'-oligoadenylate synthetase
hsa:22978,0.0,0.0,1.548424670967742e-05,4.776509181896108e-05,0.0,0.00023066967,False,NT5C2; 5'-nucleotidase
hsa:1297,0.0,0.0,5.017958530645161e-07,1.2473069105782476e-06,0.0,5.5472515e-06,False,COL9A1; collagen type IX alpha 1
hsa:3824,0.0,0.0,1.4369232501435486e-05,4.112128189980888e-05,0.0,0.00018547791,False,KLRD1; killer cell lectin like receptor
hsa:595,0.0,0.0,0.00011631224216129034,0.00047772296397579185,0.0,0.0025851275,False,CCND1; cyclin
hsa:10616,9.826588e-07,0.0006946483655620769,1.1249157136129033e-05,2.4608942009793906e-05,0.0,0.000101075035,False,RBCK1; RANBP2-type and C3HC4-type zinc finger containing
hsa:1537,0.0,0.0,1.0762052641290322e-05,2.4980721351006988e-05,0.0,0.00012196775,False,CYC1; cytochrome
hsa:377841,0.0,0.0,1.4749414179354837e-08,5.808381691142263e-08,0.0,3.1552443e-07,False,ENTPD8; ectonucleoside triphosphate diphosphohydrolase
hsa:9123,3.0663138e-08,2.1675986308476974e-05,4.055375311880646e-05,0.00013156936701767214,0.0,0.0005865042,False,SLC16A3; solute carrier family 16 member
hsa:23369,2.9462761e-08,2.0827431427466078e-05,2.0488880715580649e-07,3.028478931569251e-07,0.0,1.0079901e-06,False,PUM2; pumilio RNA binding family member
hsa:6443,0.0,0.0,2.3886232419354834e-05,6.203312430121324e-05,0.0,0.0002944953,False,SGCB; sarcoglycan
hsa:8438,0.0,0.0,1.2359957461290325e-06,2.985367706205563e-06,0.0,1.19173155e-05,False,RAD54L; RAD54
hsa:80349,0.0,0.0,6.756726429032258e-07,2.0744660068661432e-06,0.0,9.676156e-06,False,SKIC8; SKI8 subunit of superkiller
hsa:2977,7.9811085e-05,0.05641901313964317,0.00021400100852903223,0.0003797507142126394,0.0,0.0019634068,False,GUCY1A2; guanylate cyclase 1 soluble subunit alpha
hsa:4093,0.0,0.0,4.662042760451613e-05,0.00014543834064808535,0.0,0.0005633837,False,SMAD9; SMAD family member
hsa:11100,0.0,0.0,3.591421675193548e-06,1.0274830439187243e-05,0.0,3.9705275e-05,False,HNRNPUL1; heterogeneous nuclear ribonucleoprotein U like
hsa:7710,0.0,0.0,1.119660406451613e-08,3.5522277121093026e-08,0.0,1.8514305e-07,False,ZNF154; zinc finger protein
hsa:57121,0.0,0.0,2.1951367921290324e-06,4.725811309648281e-06,0.0,1.610647e-05,False,LPAR5; lysophosphatidic acid receptor
hsa:6611,7.84433e-06,0.005545211637477391,8.358580747419355e-05,0.0001295282594538065,0.0,0.00044088208,False,SMS; spermine
hsa:390538,0.0,0.0,4.714584193548387e-06,1.6537141887051195e-05,0.0,7.97951e-05,False,OR4M2; olfactory receptor family 4 subfamily M member
hsa:1232,0.0,0.0,5.9141229070967735e-06,1.632951024393462e-05,0.0,8.4755266e-05,False,CCR3; C-C motif chemokine receptor
hsa:441273,0.0,0.0,2.5465414967741935e-07,6.76938549202914e-07,0.0,2.7549672e-06,False,SPDYE2; speedy/RINGO cell cycle regulator family member
hsa:8013,3.444763e-07,0.00024351270122434325,1.5867602599999996e-06,5.998425056279949e-06,0.0,3.375557e-05,False,NR4A3; nuclear receptor subfamily 4 group A member
hsa:79885,4.9572636e-06,0.0035043242449977322,1.6889504775161296e-05,2.1411373163045876e-05,0.0,7.744186e-05,False,HDAC11; histone deacetylase
hsa:440279,0.0,0.0,1.8060119341935486e-10,9.746109202346473e-10,0.0,5.4311626e-09,False,UNC13C; unc-13 homolog
hsa:3135,0.0,0.0,2.4003696529032257e-05,5.2840674543127933e-05,0.0,0.00022229558,False,HLA-G; major histocompatibility complex
hsa:6880,4.454977e-07,0.0003149254341045584,3.592082759032258e-06,7.501538405344185e-06,0.0,3.187321e-05,False,TAF9; TATA-box binding protein associated factor
hsa:64328,0.0,0.0,2.3646445948387098e-08,4.6005974674202664e-08,0.0,1.6417158e-07,False,XPO4; exportin
hsa:2906,1.2714834e-06,0.0008988204915575096,0.00011209069627096774,0.0002387062176586122,0.0,0.0012143337,False,GRIN2D; glutamate ionotropic receptor NMDA type subunit
hsa:84631,1.3481126e-07,9.529902079782341e-05,5.426711263647097e-06,1.5715607330916574e-05,0.0,7.777778e-05,False,SLITRK2; SLIT and NTRK like family member
hsa:1379,0.0,0.0,4.443336653225806e-06,1.6215482278418878e-05,0.0,6.894658e-05,False,CR1L; complement C3b/C4b receptor 1
hsa:5045,1.3411814e-07,9.480904943122252e-05,1.9359096892903225e-05,4.0596468517662325e-05,0.0,0.0001566555,False,FURIN; furin
hsa:1638,0.0,0.0,6.329938585483871e-07,2.2715623243504524e-06,0.0,1.2244348e-05,False,DCT; dopachrome
hsa:9695,0.0,0.0,1.1871078035000002e-06,3.804825923199262e-06,0.0,1.5467684e-05,False,EDEM1; ER degradation enhancing alpha-mannosidase like protein
hsa:3631,1.0070967e-06,0.0007119236876705946,2.198605530096774e-05,5.464181717135961e-05,0.0,0.00025346814,False,INPP4A; inositol polyphosphate-4-phosphatase type I
hsa:3192,0.0,0.0,8.972846084193549e-08,1.380470147305202e-07,0.0,4.4871751e-07,False,HNRNPU; heterogeneous nuclear ribonucleoprotein
hsa:26291,0.0,0.0,2.7127922580645163e-08,1.5104188058212794e-07,0.0,8.409656e-07,False,FGF21; fibroblast growth factor
hsa:6675,8.856743e-06,0.00626089345473054,4.117968844741935e-05,8.823629556058863e-05,0.0,0.0004601042,False,UAP1; UDP-N-acetylglucosamine pyrophosphorylase
hsa:7100,9.805708e-06,0.006931723437859593,5.439611013225807e-05,8.732476628595763e-05,0.0,0.00032140978,False,TLR5; toll like receptor
hsa:2157,3.087538e-07,0.00021826021659916993,6.414483093548386e-07,8.817915465785992e-07,0.0,3.4635693e-06,False,F8; coagulation factor
hsa:6599,1.0605079e-07,7.496804378088005e-05,5.2458372512903235e-06,1.4162581441476054e-05,0.0,6.427578e-05,False,SMARCC1; SWI/SNF related
hsa:50614,0.0,0.0,6.05681936583871e-05,0.0001770077028110076,0.0,0.0008028286,False,GALNT9; polypeptide N-acetylgalactosaminyltransferase
hsa:6184,2.9769724e-06,0.0021044425715043857,0.0001581925096241935,0.0003570919910047907,0.0,0.0017000623,False,RPN1; ribophorin
hsa:1607,0.0,0.0,1.425482374032258e-05,3.6705475444233044e-05,0.0,0.00012765531,False,DGKB; diacylglycerol kinase
hsa:100532731,0.0,0.0,4.0523022161290325e-05,0.00011002884638497789,0.0,0.00038618155,False,COMMD3-BMI1; COMMD3-BMI1
hsa:2134,0.00010158469,0.07181092651348593,0.0003146581075806452,0.0004942315470422732,0.0,0.0018744408,False,EXTL1; exostosin like glycosyltransferase
hsa:6484,0.00021930881,0.1550309287617066,0.0002924462626451613,0.0003560735010154755,0.0,0.001785958,False,ST3GAL4; ST3 beta-galactoside alpha-2
hsa:4210,0.0,0.0,2.90860703e-06,6.348033050455729e-06,0.0,2.433085e-05,False,MEFV; MEFV innate immunity regulator
hsa:28964,0.0,0.0,2.9476963774193547e-07,1.1273024266938404e-06,0.0,5.3722756e-06,False,GIT1; GIT ArfGAP
hsa:10902,3.1050945e-08,2.1950129784018566e-05,7.806035652632257e-06,1.9831276502857882e-05,0.0,7.8324156e-05,False,BRD8; bromodomain containing
hsa:91734,0.0,0.0,1.1506943632596453e-06,6.139823492600376e-06,0.0,3.4212357e-05,False,IDI2; isopentenyl-diphosphate delta isomerase
hsa:9652,9.55454e-08,6.75417102528109e-05,7.087457751612903e-07,1.0831577099863757e-06,0.0,3.3462688e-06,False,SKIC3; SKI3 subunit of superkiller
hsa:23466,1.3438674e-07,9.499892464629207e-05,5.323507377712901e-05,0.0001442985706067261,0.0,0.00052597513,False,CBX6; chromobox
hsa:5462,0.0,0.0,1.6872274193548387e-08,6.108068989408736e-08,0.0,3.157995e-07,False,POU5F1B; POU class 5 homeobox
hsa:148268,4.9790407e-09,3.5197186290114736e-06,2.992916826258065e-08,6.136537469033725e-08,0.0,2.1636313e-07,False,ZNF570; zinc finger protein
hsa:6261,5.25114e-06,0.003712067523679272,0.0001259694564387097,0.0002630443885962318,0.0,0.0012780557,False,RYR1; ryanodine receptor
hsa:1962,0.0,0.0,5.611670858709677e-05,0.00021856141081572195,0.0,0.0011967379,False,EHHADH; enoyl-CoA hydratase and 3-hydroxyacyl CoA
hsa:84775,0.0,0.0,2.8224121783870968e-08,6.595585291193619e-08,0.0,2.922227e-07,False,ZNF607; zinc finger protein
hsa:29929,2.1587084e-07,0.0001526006037685844,1.4880997706774195e-06,2.9238984526054786e-06,0.0,1.4137427e-05,False,ALG6; ALG6
hsa:89845,0.0,0.0,4.803742419354839e-06,1.5809781698188554e-05,0.0,6.512894e-05,False,ABCC10; ATP binding cassette subfamily C member
hsa:9922,0.0,0.0,5.145489625416128e-07,1.2030257870985398e-06,0.0,4.6755076e-06,False,IQSEC1; IQ motif and Sec7 domain ArfGEF
hsa:8831,0.0,0.0,7.471015725806451e-08,1.508322959298602e-07,0.0,5.9105105e-07,False,SYNGAP1; synaptic Ras GTPase activating protein
hsa:6927,-0.0,0.0,1.6487832258064517e-08,9.180036486677088e-08,0.0,5.111228e-07,False,HNF1A; HNF1 homeobox
hsa:51602,1.1181147e-08,7.904030868760672e-06,2.03117913312129e-06,5.7738739502242414e-06,0.0,2.394815e-05,False,NOP58; NOP58
hsa:574484,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520G; microRNA
hsa:1770,6.7659496e-09,4.782897004652468e-06,2.0654941780645158e-07,5.457250750098357e-07,0.0,2.334762e-06,False,DNAH9; dynein axonemal heavy chain
hsa:3672,0.00014724417,0.10408793166971546,0.00028487738227096776,0.0003456868721779861,0.0,0.0013967485,False,ITGA1; integrin subunit alpha
hsa:145226,0.0,0.0,9.508280151290324e-06,3.053973869500803e-05,0.0,0.00013198965,False,RDH12; retinol dehydrogenase
hsa:1310,0.0,0.0,1.0956093216129031e-07,1.6376805549317996e-07,0.0,4.8793567e-07,False,COL19A1; collagen type XIX alpha 1
hsa:286362,-0.0,0.0,1.3738130322580645e-08,7.649067242197901e-08,0.0,4.2588204e-07,False,OR13C9; olfactory receptor family 13 subfamily C member
hsa:57541,0.0,0.0,3.272870603225807e-08,7.127252531267348e-08,0.0,2.5704065e-07,False,ZNF398; zinc finger protein
hsa:340980,0.0,0.0,1.1995617989354838e-06,4.2500754451337956e-06,0.0,2.2166701e-05,False,OR52B6; olfactory receptor family 52 subfamily B member
hsa:6328,0.0,0.0,6.366460258064516e-05,0.000132184486300151,0.0,0.0005486663,False,SCN3A; sodium voltage-gated channel alpha subunit
hsa:3171,0.0,0.0,2.8024373225806453e-08,1.1888431917326729e-07,0.0,6.227692e-07,False,FOXA3; forkhead box
hsa:23179,6.138494e-08,4.339344260808142e-05,6.920160058387097e-07,1.167049620413612e-06,0.0,4.5961997e-06,False,RGL1; ral guanine nucleotide dissociation stimulator like
hsa:6932,0.0,0.0,0.00011401349519354839,0.00023970913971068001,0.0,0.0009479999,False,TCF7; transcription factor
hsa:1051,9.430049e-05,0.06666167468321964,0.00020373644006451617,0.0003157450734461248,0.0,0.0014515946,False,CEBPB; CCAAT enhancer binding protein
hsa:6158,0.0,0.0,6.908124735483872e-07,1.0981940582249742e-06,0.0,3.2061212e-06,False,RPL28; ribosomal protein
hsa:259286,-0.0,0.0,1.549774387096774e-08,8.628778602904155e-08,0.0,4.8043006e-07,False,TAS2R40; taste 2 receptor member
hsa:26870,0.0,0.0,3.886418031967741e-07,7.395335551982244e-07,0.0,2.5740405e-06,False,RNU1-2; RNA
hsa:6877,0.0,0.0,1.3828687548387097e-08,5.066924196326967e-08,0.0,2.6159333e-07,False,TAF5; TATA-box binding protein associated factor
hsa:5034,0.0,0.0,8.301393198358066e-07,2.000780736298801e-06,0.0,8.749324e-06,False,P4HB; prolyl 4-hydroxylase subunit
hsa:1874,2.5097522e-06,0.001774161350507243,0.00010239131316580645,0.0002115096203607438,0.0,0.0007996653,False,E2F4; E2F transcription factor
hsa:343,0.0,0.0,1.9930628812903226e-06,5.424085868563272e-06,0.0,2.0211355e-05,False,AQP8; aquaporin
hsa:1846,2.1023396e-09,1.4861585394609305e-06,5.412156841869678e-05,9.120004566075771e-05,0.0,0.0003847433,False,DUSP4; dual specificity phosphatase
hsa:4191,0.0,0.0,6.340033153548386e-05,0.00017611122224432321,0.0,0.00080018386,False,MDH2; malate dehydrogenase
hsa:566,1.3043515e-07,9.220551808964042e-05,7.330620531741937e-07,1.4406219066134804e-06,0.0,5.6291187e-06,False,AZU1; azurocidin
hsa:973,0.0,0.0,2.1839062892903225e-05,6.282506549440029e-05,0.0,0.00029342354,False,CD79A; CD79a
hsa:10371,0.0,0.0,2.5798343870967743e-08,7.242044813337806e-08,0.0,3.0787186e-07,False,SEMA3A; semaphorin
hsa:3633,0.0,0.0,7.874656581935483e-06,2.7422383231407237e-05,0.0,0.00013676177,False,INPP5B; inositol polyphosphate-5-phosphatase
hsa:2893,0.0,0.0,6.1430662645161295e-06,1.7288546979584294e-05,0.0,8.2572835e-05,False,GRIA4; glutamate ionotropic receptor AMPA type subunit
hsa:120066,0.0,0.0,2.4249961290322583e-07,1.350180702722656e-06,0.0,7.517488e-06,False,OR5P3; olfactory receptor family 5 subfamily P member
hsa:6405,3.5477484e-07,0.00025079281104341337,1.783636143812904e-05,7.442994343942886e-05,0.0,0.00040987408,False,SEMA3F; semaphorin
hsa:8534,0.0,0.0,6.574980912580646e-05,0.00020820842117695384,0.0,0.0009825884,False,CHST1; carbohydrate sulfotransferase
hsa:54566,2.5657693e-08,1.8137602295469743e-05,1.0014406599258066e-05,3.05800444265646e-05,0.0,0.00013098863,False,EPB41L4B; erythrocyte membrane protein band 4.1 like
hsa:64781,0.0,0.0,2.1262348741935484e-05,6.736159807000904e-05,0.0,0.00031138476,False,CERK; ceramide
hsa:140838,0.0,0.0,2.459934283870968e-07,6.857235574172166e-07,0.0,2.9564283e-06,False,NANP; N-acetylneuraminic acid
hsa:80763,0.0,0.0,1.6165919645354836e-06,3.4617967682225386e-06,0.0,1.0899595e-05,False,SPX; spexin
hsa:3444,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA7; interferon alpha
hsa:782,0.0,0.0,0.00016461450645161293,0.0002981392068073898,0.0,0.0011134724,False,CACNB1; calcium voltage-gated channel auxiliary subunit beta
hsa:5328,0.0,0.0,8.114523493548386e-05,0.0002913752405502905,0.0,0.0012935377,False,PLAU; plasminogen activator
hsa:283694,0.0,0.0,7.03524e-08,3.917055855595627e-07,0.0,2.1809244e-06,False,OR4N4; olfactory receptor family 4 subfamily N member
hsa:6423,0.0,0.0,1.8744533503225808e-06,4.999756525415233e-06,0.0,2.0064534e-05,False,SFRP2; secreted frizzled related protein
hsa:9001,0.0,0.0,1.8688621987419358e-05,5.017393252652002e-05,0.0,0.0002469648,False,HAP1; huntingtin associated protein
hsa:57556,4.5000776e-09,3.1811362700283286e-06,1.0885387495019356e-05,3.956416154057993e-05,0.0,0.00020746235,False,SEMA6A; semaphorin
hsa:55083,1.5521632e-08,1.0972350015749141e-05,3.3657930951612904e-07,8.955351005508896e-07,0.0,4.0342024e-06,False,KIF26B; kinesin family member
hsa:115509,5.3665e-09,3.7936163129958086e-06,1.621235319032258e-08,2.3922167516248173e-08,0.0,9.160532e-08,False,ZNF689; zinc finger protein
hsa:9975,7.5501777e-07,0.000533727332315982,2.1191342129774195e-05,4.5528244736156615e-05,0.0,0.0002331742,False,NR1D2; nuclear receptor subfamily 1 group D member
hsa:5199,1.5217228e-08,1.0757164703135486e-05,1.353654830032258e-07,3.32208131353867e-07,0.0,1.7129964e-06,False,CFP; complement factor
hsa:59,0.0,0.0,7.745233835483872e-06,1.2825658836689621e-05,0.0,5.1082163e-05,False,ACTA2; actin alpha 2
hsa:5165,1.2937381e-08,9.14552494345328e-06,1.9758201092258065e-07,3.773259520424354e-07,0.0,1.7016819e-06,False,PDK3; pyruvate dehydrogenase kinase
hsa:2339,0.0,0.0,1.8027276755645164e-05,7.376798154815824e-05,0.0,0.00040825421,False,FNTA; farnesyltransferase
hsa:2542,0.0,0.0,0.0001417246959589355,0.0004612666514361283,0.0,0.0023747787,False,SLC37A4; solute carrier family 37 member
hsa:51181,0.0,0.0,7.76985070967742e-08,2.1618818044494926e-07,0.0,8.512202e-07,False,DCXR; dicarbonyl and L-xylulose
hsa:2662,4.662935e-08,3.29626130297943e-05,4.298108429774194e-06,1.0142495333094678e-05,0.0,4.9272723e-05,False,GDF10; growth differentiation factor
hsa:653857,3.8278606e-07,0.000270594138004918,1.3984229476419355e-05,2.4460933013095138e-05,0.0,8.8678935e-05,False,ACTR3C; actin related protein
hsa:6175,0.0,0.0,1.6301455283225807e-06,4.424908438383727e-06,0.0,1.9009782e-05,False,RPLP0; ribosomal protein lateral stalk subunit
hsa:219875,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D5; olfactory receptor family 4 subfamily D member
hsa:10898,6.08284e-07,0.00043000020596931755,1.265499980827419e-05,5.2191933910000395e-05,0.0,0.00028640655,False,CPSF4; cleavage and polyadenylation specific factor
hsa:54413,4.6971536e-07,0.0003320450670196029,3.2561489219354847e-06,6.740968104072807e-06,0.0,3.131662e-05,False,NLGN3; neuroligin
hsa:230,3.30232e-06,0.002334433061163201,4.4712765777419356e-05,9.447732061231533e-05,0.0,0.0004753452,False,ALDOC; aldolase
hsa:1814,0.0,0.0,1.1304343741935483e-08,5.562921027018676e-08,0.0,3.095636e-07,False,DRD3; dopamine receptor
hsa:5897,0.0,0.0,7.394210419354838e-10,3.953999787985166e-09,0.0,2.2026589e-08,False,RAG2; recombination activating
hsa:996,0.0,0.0,3.2495102361290315e-05,0.00010495083551225689,0.0,0.00046786654,False,CDC27; cell division cycle
hsa:7436,4.5439666e-08,3.2121617105130166e-05,1.7413090727741932e-06,3.1723788623356907e-06,0.0,1.5137332e-05,False,VLDLR; very low density lipoprotein
hsa:163087,7.778429e-09,5.498625760529149e-06,4.538127276451613e-08,8.32641013189655e-08,0.0,3.316291e-07,False,ZNF383; zinc finger protein
hsa:7994,0.0,0.0,1.3573433439645161e-06,5.121825629960495e-06,0.0,2.104492e-05,False,KAT6A; lysine acetyltransferase
hsa:4804,0.0006256748,0.4422938838927401,0.0036017391576129033,0.00613020432719072,0.0,0.021677809,True,NGFR; nerve growth factor
hsa:90649,4.1394688e-09,2.9262193919346286e-06,1.8358207867419354e-08,3.310841507563685e-08,0.0,1.1986344e-07,False,ZNF486; zinc finger protein
hsa:8823,4.9956466e-06,0.003531457455645588,3.276937216451612e-05,5.459073111577119e-05,0.0,0.00018337303,False,FGF16; fibroblast growth factor
hsa:54433,1.6621746e-07,0.00011750028282134136,1.0790606065383869e-06,2.091178078531546e-06,0.0,1.0122709e-05,False,GAR1; GAR1
hsa:5495,8.487299e-08,5.999730912079198e-05,4.21276869516129e-07,7.74833342315783e-07,0.0,3.8243197e-06,False,PPM1B; protein phosphatase
hsa:6368,3.6907793e-05,0.02609037652128436,0.0001011218224319355,0.00019724750115080746,0.0,0.00081547425,False,CCL23; C-C motif chemokine ligand
hsa:26061,1.3054002e-07,9.227965142472733e-05,9.491620170470966e-06,2.8453489827182067e-05,0.0,0.00011540539,False,HACL1; 2-hydroxyacyl-CoA lyase
hsa:283093,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4C12; olfactory receptor family 4 subfamily C member
hsa:10498,3.7478515e-07,0.0002649382388723714,4.718011021941937e-06,7.464936288614068e-06,0.0,2.913083e-05,False,CARM1; coactivator associated arginine methyltransferase
hsa:975,3.849852e-05,0.027214872542289277,5.004329655806453e-05,5.7871447257287184e-05,0.0,0.00019137704,False,CD81; CD81
hsa:390980,7.645587e-09,5.404718823372531e-06,5.501635993870968e-08,7.463583746151834e-08,0.0,2.3797537e-07,False,ZNF805; zinc finger protein
hsa:84313,1.3720857e-07,9.699369597220299e-05,7.629169878483871e-07,1.3448905647276978e-06,0.0,5.682106e-06,False,VPS25; vacuolar protein sorting 25
hsa:23001,2.8953492e-08,2.04674256162105e-05,2.9535738977419354e-07,5.452283830910109e-07,0.0,1.966806e-06,False,WDFY3; WD repeat and FYVE domain containing
hsa:55217,4.349344e-06,0.0030745816359322546,3.0669378498064515e-05,7.340697259314144e-05,0.0,0.0003736457,False,TMLHE; trimethyllysine hydroxylase
hsa:1213,9.92949e-06,0.007019225797769264,0.00030793858405483873,0.0007416858969184125,0.0,0.0034083368,False,CLTC; clathrin heavy
hsa:7367,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2B17; UDP glucuronosyltransferase family 2 member
hsa:80818,0.0,0.0,4.320293677870968e-08,7.981572975423911e-08,0.0,2.75406e-07,False,ZNF436; zinc finger protein
hsa:50964,0.0,0.0,1.2270911083580644e-07,4.876422752705203e-07,0.0,2.6293683e-06,False,SOST;
hsa:2224,6.407951e-07,0.00045298252951603106,7.663202291548386e-05,0.000186485242960443,0.0,0.0008262333,False,FDPS; farnesyl diphosphate
hsa:11269,2.8699373e-10,2.0287787121131363e-07,3.0890383810741936e-07,5.651198274605917e-07,0.0,1.8976793e-06,False,DDX19B; DEAD-box helicase
hsa:4437,0.0,0.0,1.2129293593548387e-05,3.451882323422549e-05,0.0,0.00017528354,False,MSH3; mutS homolog
hsa:5905,0.0,0.0,1.312054438387097e-07,2.665810570592851e-07,0.0,1.1747522e-06,False,RANGAP1; Ran GTPase activating protein
hsa:2742,0.0,0.0,9.721326943838711e-08,2.152599564706748e-07,0.0,9.3254613e-07,False,GLRA2; glycine receptor alpha
hsa:83692,0.0,0.0,1.761718470567742e-05,4.854858045205548e-05,0.0,0.0001800037,False,CD99L2; CD99 molecule like
hsa:3122,0.0,0.0,0.0001622084293225806,0.00040864192915307187,0.0,0.0017786908,False,HLA-DRA; major histocompatibility complex
hsa:157570,1.7410756e-08,1.230778495913345e-05,3.928130199032259e-07,1.0142572899775772e-06,0.0,4.5189017e-06,False,ESCO2; establishment of sister chromatid cohesion N-acetyltransferase
hsa:7417,1.598099e-05,0.011297073392681057,0.00015536105874193546,0.00043269007077736797,0.0,0.002371176,False,VDAC2; voltage dependent anion channel
hsa:9860,0.0,0.0,1.0029936e-07,2.199737640321547e-07,0.0,9.613551e-07,False,LRIG2; leucine rich repeats and immunoglobulin like domains
hsa:9454,6.512254e-06,0.004603557813989045,0.00010947652982580646,0.0003360682897663503,0.0,0.0017769535,False,HOMER3; homer scaffold protein
hsa:6546,0.0,0.0,7.924515377419356e-06,3.927021530793056e-05,0.0,0.00021796532,False,SLC8A1; solute carrier family 8 member
hsa:9459,1.3149063e-05,0.009295164426983995,7.936000045290324e-05,0.00012028338481533635,0.0,0.0004748993,False,ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor
hsa:6400,2.306391e-08,1.630403898583195e-05,5.783876931354837e-07,1.1568731601563484e-06,0.0,5.029033e-06,False,SEL1L; SEL1L adaptor subunit of SYVN1 ubiquitin
hsa:2921,0.00025246086,0.1784663443378275,0.0005190299575870968,0.0006959706017709118,0.0,0.0028291799,False,CXCL3; C-X-C motif chemokine ligand
hsa:4842,0.0,0.0,1.2007240218387097e-05,3.097098590828535e-05,0.0,0.00012313078,False,NOS1; nitric oxide synthase
hsa:94026,0.0,0.0,1.7540793064516128e-10,5.003298146930378e-10,0.0,2.424151e-09,False,POM121L2; POM121 transmembrane nucleoporin like
hsa:123745,0.0,0.0,1.0813740806451613e-07,5.206066290248425e-07,0.0,2.8750085e-06,False,PLA2G4E; phospholipase A2 group
hsa:103625684,0.0,0.0,0.0,0.0,0.0,0.0,False,RNU6-2; RNA
hsa:407019,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27B; microRNA
hsa:154664,0.0,0.0,2.9377195806451614e-06,1.4724582620541728e-05,0.0,8.176397e-05,False,ABCA13; ATP binding cassette subfamily A member
hsa:3454,1.14713275e-05,0.008109161489931507,0.00023994364500322577,0.0005041350745023876,0.0,0.001847785,False,IFNAR1; interferon alpha and beta receptor subunit
hsa:55802,0.0,0.0,3.042074661290323e-07,4.493144287532522e-07,0.0,1.5150847e-06,False,DCP1A; decapping mRNA
hsa:6588,7.2598234e-09,5.132019841555707e-06,2.463236031109677e-06,1.1777543932752803e-05,0.0,6.5716944e-05,False,SLN;
hsa:1582,0.0,0.0,4.8122110661290315e-06,1.6745305706971544e-05,0.0,9.1809066e-05,False,CYP8B1; cytochrome P450 family 8 subfamily B member
hsa:834,1.6838496e-06,0.0011903250370244047,5.710340092903226e-05,0.00014557949949990808,0.0,0.00061460503,False,CASP1; caspase
hsa:401494,3.9115287e-07,0.0002765086944017756,9.015286213225808e-06,1.4265295559251083e-05,0.0,4.9789574e-05,False,HACD4; 3-hydroxyacyl-CoA dehydratase
hsa:11201,2.611436e-05,0.018460423385716056,3.621343706774193e-05,3.809153810790325e-05,0.0,0.0001414468,False,POLI; DNA polymerase
hsa:84503,0.0,0.0,1.1015888122580644e-08,1.6912531738488458e-08,0.0,5.895173e-08,False,ZNF527; zinc finger protein
hsa:11194,0.0,0.0,0.00017502081350096772,0.0003646402063794965,0.0,0.001176707,False,ABCB8; ATP binding cassette subfamily B member
hsa:204962,0.0,0.0,5.2643940918709675e-08,1.6528837681889415e-07,0.0,8.259196e-07,False,SLC44A5; solute carrier family 44 member
hsa:6722,4.007299e-06,0.002832787637650572,9.507139158874194e-05,0.0003036682123350531,0.0,0.0016113843,False,SRF; serum response
hsa:390072,6.187979e-06,0.004374325552757941,7.827264115806452e-05,0.00015993205068235943,0.0,0.0006405934,False,OR52N4; olfactory receptor family 52 subfamily N member
hsa:10960,2.5261494e-08,1.785752645654444e-05,1.1732588736387095e-06,2.1677771336058117e-06,0.0,8.564103e-06,False,LMAN2; lectin
hsa:5829,5.285763e-07,0.0003736542764078947,8.243966677096773e-05,0.00017646351261820786,0.0,0.0006477277,False,PXN;
hsa:6935,0.0,0.0,5.641223239032258e-06,2.7493695859122164e-05,0.0,0.0001535222,False,ZEB1; zinc finger E-box binding homeobox
hsa:56992,0.0,0.0,2.8640768532258067e-08,1.0313305983991332e-07,0.0,5.5404786e-07,False,KIF15; kinesin family member
hsa:10901,1.9634597e-05,0.013879833686443412,0.0002246926795806452,0.0005747563209635576,0.0,0.003057198,False,DHRS4; dehydrogenase/reductase
hsa:3716,9.2385024e-05,0.06530761839614448,0.00017863213041935486,0.00021841384057466248,0.0,0.00082111073,False,JAK1; Janus kinase
hsa:5151,6.794554e-05,0.04803117654696902,0.00017365098135483872,0.00022559426112341997,0.0,0.00080512,False,PDE8A; phosphodiesterase
hsa:7277,1.8482758e-06,0.0013065590656471406,0.00015909076883580638,0.0005004446377498249,0.0,0.0020132028,False,TUBA4A; tubulin alpha
hsa:642843,0.0,0.0,1.456907935483871e-08,5.504793294025059e-08,0.0,3.0323946e-07,False,CPSF4L; cleavage and polyadenylation specific factor 4
hsa:406891,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7I; microRNA
hsa:10858,1.9519987e-06,0.001379881507736255,7.663051416225806e-05,0.0001565337366069285,0.0,0.00072249694,False,CYP46A1; cytochrome P450 family 46 subfamily A member
hsa:6657,3.0043745e-07,0.00021238133072856849,5.7036779672903226e-05,0.00012277041945891968,0.0,0.0004915646,False,SOX2; SRY-box transcription factor
hsa:284323,1.8706762e-08,1.322394064782076e-05,9.990559787741936e-08,2.6153464096750055e-07,0.0,1.2941938e-06,False,ZNF780A; zinc finger protein
hsa:6584,1.6494822e-08,1.1660304820490477e-05,3.1994332509612896e-07,6.989115573166443e-07,0.0,3.412154e-06,False,SLC22A5; solute carrier family 22 member
hsa:3394,2.6039044e-07,0.00018407181979542654,2.7794947270967742e-06,6.069050644796316e-06,0.0,2.5912232e-05,False,IRF8; interferon regulatory factor
hsa:23239,0.0,0.0,1.0089267783870968e-07,2.625410487718937e-07,0.0,1.3401408e-06,False,PHLPP1; PH domain and leucine rich repeat protein phosphatase
hsa:1029,0.0,0.0,8.13630045483871e-05,0.00019537309032965658,0.0,0.0009617514,False,CDKN2A; cyclin dependent kinase inhibitor
hsa:125893,0.0,0.0,1.6913745937612907e-08,3.957988575107502e-08,0.0,1.5766273e-07,False,ZNF816; zinc finger protein
hsa:55825,0.0,0.0,9.944862983548386e-07,2.99094472706013e-06,0.0,1.2068976e-05,False,PECR; peroxisomal trans-2-enoyl-CoA
hsa:245711,8.7194655e-07,0.0006163851031660143,1.9114905119354838e-06,2.3393036045437733e-06,0.0,8.570599e-06,False,SPDYA; speedy/RINGO cell cycle regulator family member
hsa:123720,0.0,0.0,1.7307139610322581e-06,3.9385577232988255e-06,0.0,1.661244e-05,False,WHAMM; WASP homolog associated with actin
hsa:2629,0.0,0.0,3.5920133935483874e-05,6.745906330182104e-05,0.0,0.00021086431,False,GBA1; glucosylceramidase beta
hsa:51167,1.0101481e-06,0.0007140807436321106,5.010820520967742e-06,9.054943958939792e-06,0.0,3.7350066e-05,False,CYB5R4; cytochrome b5 reductase
hsa:10572,1.6312206e-09,1.1531212295266582e-06,5.06596510639871e-05,0.00011653768445361583,0.0,0.00047940973,False,SIVA1; SIVA1 apoptosis inducing
hsa:3620,0.0,0.0,7.964278787096773e-05,0.00028250188513831307,0.0,0.0015212306,False,IDO1; indoleamine 2
hsa:9422,0.0,0.0,6.149362817741934e-08,1.63743306483677e-07,0.0,7.220503e-07,False,ZNF264; zinc finger protein
hsa:133396,0.0,0.0,2.688953255870968e-06,1.2002386723885084e-05,0.0,6.6251494e-05,False,IL31RA; interleukin 31 receptor
hsa:84364,3.7170356e-08,2.6275984138910212e-05,4.6680117250000004e-07,8.289575569375721e-07,0.0,3.06884e-06,False,ARFGAP2; ADP ribosylation factor GTPase activating protein
hsa:135941,-0.0,0.0,1.794723664516129e-07,7.076269011267961e-07,-0.0,3.7969514e-06,False,OR2A14; olfactory receptor family 2 subfamily A member
hsa:1870,0.0,0.0,1.1476851645161292e-06,4.517633537463154e-06,0.0,2.2942531e-05,False,E2F2; E2F transcription factor
hsa:9709,0.0,0.0,3.3067611295548385e-06,6.509603407007384e-06,0.0,2.9031e-05,False,HERPUD1; homocysteine inducible ER protein with ubiquitin like domain
hsa:55781,6.8795697e-07,0.0004863215846512938,3.0539171013374196e-06,5.0248638384513545e-06,0.0,1.7581593e-05,False,RIOK2; RIO kinase
hsa:5078,0.0,0.0,1.5562883212903226e-06,4.869430506139688e-06,-0.0,2.4475681e-05,False,PAX4; paired box
hsa:797,2.728943e-06,0.0019291088571761336,8.624763190870968e-06,1.2844621746961911e-05,0.0,4.818844e-05,False,CALCB; calcitonin related polypeptide
hsa:9394,3.282008e-06,0.0023200743665671756,6.379666759622579e-05,0.00011925058040529827,0.0,0.00043627282,False,HS6ST1; heparan sulfate 6-O-sulfotransferase
hsa:81624,7.434188e-11,5.255279394517411e-08,4.7714220961258064e-08,2.0285076798600087e-07,0.0,1.1277157e-06,False,DIAPH3; diaphanous related formin
hsa:29785,0.00013452941,0.09509977906525696,0.00019969967506451607,0.0002124226450532653,0.0,0.0007525253,False,CYP2S1; cytochrome P450 family 2 subfamily S member
hsa:6863,3.6179574e-07,0.0002557559342656089,6.025913052741935e-06,1.7872996071756995e-05,0.0,8.077432e-05,False,TAC1; tachykinin precursor
hsa:1434,0.0,0.0,8.040057349354839e-07,1.8309176450723524e-06,0.0,7.694806e-06,False,CSE1L; chromosome segregation 1
hsa:390093,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10A6; olfactory receptor family 10 subfamily A member 6
hsa:6156,4.5937114e-07,0.00032473266568964533,1.831291437096774e-06,2.9522185214231917e-06,0.0,1.2203517e-05,False,RPL30; ribosomal protein
hsa:336,0.0,0.0,5.265572990967742e-07,2.39101645616877e-06,0.0,1.32719115e-05,False,APOA2; apolipoprotein
hsa:4287,0.0,0.0,5.297723640322582e-07,1.1841484358313174e-06,0.0,5.3403255e-06,False,ATXN3; ataxin
hsa:10520,1.4035381e-08,9.921708808480653e-06,1.010682351303226e-07,1.9033222237976436e-07,0.0,6.8593744e-07,False,ZNF211; zinc finger protein
hsa:348180,0.0,0.0,1.2080511123225807e-05,3.076712749923196e-05,0.0,0.0001454074,False,CTU2; cytosolic thiouridylase subunit
hsa:23512,0.0,0.0,3.91355943667742e-06,1.640935280442012e-05,0.0,8.7705725e-05,False,SUZ12; SUZ12 polycomb repressive complex 2
hsa:374900,0.0,0.0,1.038223208064516e-07,1.875233164666652e-07,0.0,6.5654444e-07,False,ZNF568; zinc finger protein
hsa:91937,0.0,0.0,4.6078223717419356e-08,1.3970137353950116e-07,0.0,4.914508e-07,False,TIMD4; T cell immunoglobulin and mucin domain containing
hsa:7384,7.952247e-06,0.005621498918135094,0.0001725952309645161,0.0003563990360655435,0.0,0.0012610044,False,UQCRC1; ubiquinol-cytochrome c reductase core protein
hsa:2078,2.3188771e-07,0.00016392304098374012,4.569457907419354e-06,9.290249361195503e-06,0.0,3.3672513e-05,False,ERG; ETS transcription factor
hsa:378884,0.0,0.0,2.1605499977419353e-08,5.297241834415872e-08,0.0,1.9444224e-07,False,NHLRC1; NHL repeat containing E3 ubiquitin protein ligase
hsa:10580,1.9841948e-05,0.01402641155583985,0.00017518842327096779,0.00036372389512585304,0.0,0.0016149783,False,SORBS1; sorbin and SH3 domain containing
hsa:8120,0.0,0.0,3.967627837741936e-07,9.385303994255496e-07,0.0,3.436335e-06,False,AP3B2; adaptor related protein complex 3 subunit beta
hsa:5138,0.0,0.0,5.810641096774193e-05,0.00013879614318490304,0.0,0.0005448784,False,PDE2A; phosphodiesterase
hsa:5433,2.1138328e-06,0.0014942831627738017,1.889262867967742e-05,4.596514536290401e-05,0.0,0.00019686764,False,POLR2D; RNA polymerase II subunit
hsa:4522,0.0,0.0,1.9158415027741935e-05,5.0572197786067976e-05,0.0,0.0002605315,False,MTHFD1; methylenetetrahydrofolate dehydrogenase
hsa:5095,0.0,0.0,5.430313525870968e-05,0.00023424659222089176,0.0,0.0012563666,False,PCCA; propionyl-CoA carboxylase subunit
hsa:166012,2.3246412e-07,0.00016433050923660026,5.967137995903226e-05,0.00013958129572400236,0.0,0.0006385554,False,CHST13; carbohydrate sulfotransferase
hsa:8309,3.278246e-05,0.023174149825050325,0.0001249003556548387,0.0001751343805360044,0.0,0.00062595255,False,ACOX2; acyl-CoA oxidase
hsa:10131,0.0,0.0,1.77289051965e-07,4.08924148178642e-07,0.0,1.9414017e-06,False,TRAP1; TNF receptor associated protein
hsa:57713,6.3399035e-08,4.4817220423775696e-05,2.5346489712419356e-05,7.714991619615371e-05,0.0,0.0003282598,False,SFMBT2; Scm like with four mbt domains
hsa:665,0.0,0.0,8.070052577419355e-07,1.7750197671339205e-06,0.0,6.633219e-06,False,BNIP3L; BCL2 interacting protein 3
hsa:57171,0.0,0.0,1.4126016746967741e-05,3.651707805517408e-05,0.0,0.00013186086,False,DOLPP1; dolichyldiphosphatase
hsa:115201,1.4667336e-07,0.00010368442209594837,3.3735233064677415e-05,5.9577601664969056e-05,0.0,0.00024635775,False,ATG4A; autophagy related 4A cysteine
hsa:84870,3.13817e-07,0.000221839428024859,1.9446026977064523e-05,6.633694853831957e-05,0.0,0.00031661152,False,RSPO3; R-spondin
hsa:163059,2.7773572e-08,1.963333193130786e-05,1.1203255696129033e-07,2.2198258149077414e-07,0.0,9.868418e-07,False,ZNF433; zinc finger protein
hsa:399694,0.00018544559,0.1310927821479796,0.0003680683433677419,0.00048038490224774064,1.1155824e-06,0.0020801956,False,SHC4; SHC adaptor protein
hsa:29964,0.0,0.0,5.445153707741936e-07,1.514745221367658e-06,0.0,6.559513e-06,False,PRICKLE4; prickle planar cell polarity protein
hsa:8435,0.0,0.0,1.273645340967742e-06,4.083719111906156e-06,0.0,2.2324626e-05,False,SOAT2; sterol O-acyltransferase
hsa:5973,3.918349e-06,0.0027699082616995836,2.2534795303225807e-05,3.0243139981941916e-05,0.0,9.216697e-05,False,RENBP; renin binding
hsa:388561,3.023115e-09,2.1370610975612267e-06,1.085257789548387e-07,1.8313558214030574e-07,0.0,7.5941745e-07,False,ZNF761; zinc finger protein
hsa:4695,5.5634027e-06,0.003932808206183719,1.3505220725806451e-05,2.7257664418610042e-05,0.0,0.00012837203,False,NDUFA2; NADH:ubiquinone oxidoreductase subunit
hsa:6343,2.8839765e-06,0.002038703120599377,4.3262894719483865e-05,0.00010016409306866882,0.0,0.00047760725,False,SCT;
hsa:55119,2.5628661e-09,1.8117079372000275e-06,5.747409884193548e-08,7.971190100352991e-08,0.0,2.9188084e-07,False,PRPF38B; pre-mRNA processing factor
hsa:3977,7.592639e-07,0.0005367289512547877,2.82027708967742e-06,4.831569842845362e-06,0.0,1.9173147e-05,False,LIFR; LIF receptor subunit
hsa:157855,0.0,0.0,0.0,0.0,0.0,0.0,False,KCNU1; potassium calcium-activated channel subfamily U member
hsa:5194,0.0,0.0,3.9577179420645154e-06,1.106444450841451e-05,0.0,5.199265e-05,False,PEX13; peroxisomal biogenesis factor
hsa:523,0.0,0.0,7.85122140967742e-05,0.00021645365725143686,0.0,0.0011598768,False,ATP6V1A; ATPase H+ transporting V1 subunit
hsa:9514,0.0,0.0,2.414623112354839e-05,4.932699626168187e-05,0.0,0.00015711343,False,GAL3ST1; galactose-3-O-sulfotransferase
hsa:4942,0.0,0.0,0.00015940524823870967,0.0003112636306223118,0.0,0.0010998589,False,OAT; ornithine
hsa:140885,7.788505e-07,0.0005505748555268689,5.9746227861290315e-05,0.00010842986482677938,0.0,0.00039650267,False,SIRPA; signal regulatory protein
hsa:219477,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8J1; olfactory receptor family 8 subfamily J member
hsa:29107,1.3502893e-07,9.545289324035575e-05,5.273216777419355e-06,1.2871817135441606e-05,0.0,6.721863e-05,False,NXT1; nuclear transport factor 2 like export factor
hsa:2900,4.6386026e-06,0.0032790605595573977,1.4704978027741937e-05,2.4368236168523073e-05,0.0,0.00011593706,False,GRIK4; glutamate ionotropic receptor kainate type subunit
hsa:85301,2.6062346e-05,0.018423654326011566,0.00010190571781677418,0.00018055926329836906,0.0,0.0007045196,False,COL27A1; collagen type XXVII alpha 1
hsa:79549,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6J1; olfactory receptor family 6 subfamily J member
hsa:54753,0.0,0.0,3.077846677419355e-08,8.033290844607594e-08,0.0,3.9847734e-07,False,ZNF853; zinc finger protein
hsa:51645,4.6768054e-08,3.306066385567295e-05,3.0786605322580643e-07,4.677033720140306e-07,0.0,1.5301572e-06,False,PPIL1; peptidylprolyl isomerase like
hsa:1468,0.0,0.0,0.00014518317987096777,0.000349981300192557,0.0,0.0016164437,False,SLC25A10; solute carrier family 25 member
hsa:6532,0.0,0.0,1.2949495907709677e-07,2.875931485563055e-07,0.0,1.067564e-06,False,SLC6A4; solute carrier family 6 member
hsa:9677,1.3399756e-07,9.47238105874657e-05,9.600444716774194e-06,3.310216034116713e-05,0.0,0.0001677865,False,PPIP5K1; diphosphoinositol pentakisphosphate kinase
hsa:407007,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR222; microRNA
hsa:80095,0.0,0.0,1.0034730009677418e-08,2.443169217974152e-08,0.0,1.1168981e-07,False,ZNF606; zinc finger protein
hsa:442186,0.0,0.0,7.538712258064516e-11,4.197377345208147e-10,0.0,2.3370008e-09,False,OR2J3; olfactory receptor family 2 subfamily J member
hsa:10798,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5I1; olfactory receptor family 5 subfamily I member
hsa:406988,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR205; microRNA
hsa:64116,3.0792794e-08,2.1767641039992447e-05,4.9502870226119356e-05,0.00016867942566585868,0.0,0.00072989205,False,SLC39A8; solute carrier family 39 member
hsa:1146,0.0,0.0,1.296510675483871e-07,3.430656075303717e-07,0.0,1.6356114e-06,False,CHRNG; cholinergic receptor nicotinic gamma
hsa:27123,4.038657e-08,2.85495482675761e-05,9.316548203580643e-06,3.406824300492548e-05,0.0,0.00017126632,False,DKK2; dickkopf WNT signaling pathway inhibitor
hsa:25825,2.2842626e-08,1.6147611781470643e-05,6.872414379354838e-08,1.0515605148693717e-07,0.0,4.3942742e-07,False,BACE2; beta-secretase
hsa:51510,0.0,0.0,6.597323008064517e-05,0.00024771364107638533,0.0,0.0013298269,False,CHMP5; charged multivesicular body protein
hsa:4242,0.00014783771,0.10450750923915843,0.00038954572606129034,0.000586422242219431,0.0,0.002486779,False,MFNG; MFNG O-fucosylpeptide
hsa:50617,0.0,0.0,1.924724064516129e-07,4.501920939169517e-07,0.0,1.9753993e-06,False,ATP6V0A4; ATPase H+ transporting V0 subunit
hsa:26149,1.6314846e-09,1.1533078529696157e-06,4.62869053516129e-08,9.37726738248501e-08,0.0,3.8236826e-07,False,ZNF658; zinc finger protein
hsa:23761,1.0372048e-06,0.0007332073137422073,9.516264045161288e-06,2.262046001906549e-05,0.0,0.00010254912,False,PISD; phosphatidylserine
hsa:5578,0.0,0.0,0.0003649778688548387,0.0005619605536386651,0.0,0.001790357,False,PRKCA; protein kinase C
hsa:7350,0.0,0.0,1.1478468290322581e-08,3.291463558236632e-08,0.0,1.3493627e-07,False,UCP1; uncoupling protein
hsa:6373,0.0,0.0,1.924435139516129e-05,5.645839718986014e-05,0.0,0.00029541014,False,CXCL11; C-X-C motif chemokine ligand
hsa:10893,2.2485375e-08,1.5895068555637403e-05,8.461583611290322e-07,1.4541919997550596e-06,0.0,5.9692184e-06,False,MMP24; matrix metallopeptidase
hsa:1945,0.0,0.0,3.879574023225807e-06,1.2988265152737432e-05,0.0,6.915476e-05,False,EFNA4; ephrin
hsa:27097,2.1918095e-07,0.00015494054363512883,8.848478784677419e-06,2.370979264761803e-05,0.0,0.00010924925,False,TAF5L; TATA-box binding protein associated factor 5
hsa:5077,0.0,0.0,4.829881808580645e-08,1.590025840230785e-07,0.0,7.139576e-07,False,PAX3; paired box
hsa:843,0.0,0.0,7.916440787914839e-05,0.0002990646698002054,0.0,0.0013289838,False,CASP10; caspase
hsa:23205,2.14881e-05,0.015190087896261108,0.00028259556890000004,0.0006512627857763579,0.0,0.0027732563,False,ACSBG1; acyl-CoA synthetase bubblegum family member
hsa:5599,0.0,0.0,0.00013806965196774194,0.0003316414006033047,0.0,0.0012036992,False,MAPK8; mitogen-activated protein kinase
hsa:9672,0.0,0.0,1.160323266451613e-06,2.8216560050592694e-06,0.0,1.0745442e-05,False,SDC3; syndecan
hsa:6300,0.0,0.0,6.447708297741936e-05,0.0002590006625514538,0.0,0.0014146552,False,MAPK12; mitogen-activated protein kinase
hsa:8739,0.0,0.0,2.232405122467742e-07,5.545161166685171e-07,0.0,2.28293e-06,False,HRK; harakiri
hsa:390442,0.0,0.0,2.150228398387097e-07,8.529042166108837e-07,0.0,4.092115e-06,False,OR11H4; olfactory receptor family 11 subfamily H member
hsa:155054,7.8404666e-10,5.542480573047384e-07,1.9388253395483868e-08,3.961098625907155e-08,0.0,1.7359626e-07,False,ZNF425; zinc finger protein
hsa:10840,0.0,0.0,2.3555505920645167e-06,6.167115584329624e-06,0.0,2.4347526e-05,False,ALDH1L1; aldehyde dehydrogenase 1 family member
hsa:60496,0.0,0.0,4.072538628290323e-05,0.00011259604748613616,0.0,0.0004733498,False,AASDHPPT; aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl
hsa:9376,0.0,0.0,1.2627614193548387e-06,5.9544666736598895e-06,0.0,3.2743083e-05,False,SLC22A8; solute carrier family 22 member
hsa:118471,7.133327e-09,5.042598653337083e-06,4.388595089354839e-08,8.003770133089422e-08,0.0,3.6043977e-07,False,PRAP1; proline rich acidic protein
hsa:489,0.0,0.0,0.00016641531493548383,0.0004637073101097816,0.0,0.0024654064,False,ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84867,0.0,0.0,7.04971380516129e-09,2.7756414682173075e-08,0.0,1.5390563e-07,False,PTPN5; protein tyrosine phosphatase non-receptor type
hsa:4908,0.0,0.0,1.3568485161290322e-06,4.3407764949283825e-06,0.0,2.1963226e-05,False,NTF3; neurotrophin
hsa:57502,2.2873263e-09,1.6169269290644451e-06,2.7423812727838706e-06,5.1023587432626255e-06,0.0,2.4281902e-05,False,NLGN4X; neuroligin 4
hsa:84869,1.7772073e-06,0.0012563202468751022,2.26229572e-05,3.477329745953133e-05,0.0,0.00013011554,False,CBR4; carbonyl reductase
hsa:254879,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T6; olfactory receptor family 2 subfamily T member
hsa:6143,1.1767275e-07,8.318368843661187e-05,1.0556484467741935e-06,2.2240035877673244e-06,0.0,9.620077e-06,False,RPL19; ribosomal protein
hsa:746,0.0,0.0,7.580496462580645e-05,0.0002896058909906623,0.0,0.0015808853,False,TMEM258; transmembrane protein
hsa:9616,0.0,0.0,3.9809744997741933e-07,9.159056190402255e-07,0.0,3.712185e-06,False,RNF7; ring finger protein
hsa:2621,0.0,0.0,4.777457923290322e-05,0.00010316454297456555,0.0,0.00037639245,False,GAS6; growth arrest specific
hsa:55509,0.0,0.0,9.866907141935484e-06,2.034177855071224e-05,0.0,7.094531e-05,False,BATF3; basic leucine zipper ATF-like transcription factor
hsa:84883,4.2226076e-09,2.9849907900382152e-06,5.958963493748548e-05,0.00010853095964120518,0.0,0.00042935397,False,AIFM2; apoptosis inducing factor mitochondria associated
hsa:29985,7.3190067e-09,5.173856929478361e-06,1.7904848232709679e-07,4.1562147161563324e-07,0.0,1.799708e-06,False,SLC39A3; solute carrier family 39 member
hsa:9334,0.0,0.0,7.68713348451613e-05,0.00015083651723346616,0.0,0.0005848087,False,B4GALT5; beta-1
hsa:162967,0.0,0.0,3.968797013548387e-08,1.109924342874025e-07,0.0,3.8246165e-07,False,ZNF320; zinc finger protein
hsa:11024,3.1100976e-07,0.0002198549704717994,3.997260321935484e-06,5.922374937779044e-06,0.0,1.9312505e-05,False,LILRA1; leukocyte immunoglobulin like receptor
hsa:57343,0.0,0.0,5.072584021612905e-08,1.039518980348817e-07,0.0,3.8002773e-07,False,ZNF304; zinc finger protein
hsa:11337,3.4392756e-06,0.0024312479308764463,0.0001055896973051613,0.00024130585901281537,0.0,0.0011207998,False,GABARAP; GABA type A receptor-associated
hsa:64005,0.0,0.0,5.310485064516129e-08,1.5949094490269576e-07,0.0,8.091812e-07,False,MYO1G; myosin
hsa:3359,0.0,0.0,3.022052258064516e-06,1.1851146378885962e-05,0.0,6.359109e-05,False,HTR3A; 5-hydroxytryptamine receptor
hsa:3053,3.1293932e-09,2.2121898990586334e-06,9.645828527096774e-08,2.608849503850411e-07,0.0,1.1260522e-06,False,SERPIND1; serpin family D member
hsa:64065,0.0,0.0,1.975212011923871e-06,7.1547288454265825e-06,0.0,3.3384284e-05,False,PERP; p53 apoptosis effector related to
hsa:2150,2.5712243e-06,0.0018176164071277798,5.632841179274193e-05,0.00011791570923019238,0.0,0.00046912458,False,F2RL1; F2R like trypsin receptor
hsa:79184,0.0,0.0,2.095489609225806e-05,5.071384201194511e-05,0.0,0.000213235,False,BRCC3; BRCA1/BRCA2-containing complex subunit
hsa:8324,9.0715235e-05,0.0641272328954157,0.0002259911618512903,0.0002888481446761135,0.0,0.0012953224,False,FZD7; frizzled class receptor
hsa:10063,5.1315106e-07,0.0003627500665698484,3.724732728064517e-06,6.88620802760317e-06,0.0,2.5462245e-05,False,COX17; cytochrome c oxidase copper chaperone
hsa:27030,1.190598e-05,0.008416420376446817,6.637862812903225e-05,0.0001202394661956986,0.0,0.00046455822,False,MLH3; mutL homolog
hsa:254973,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1L4; olfactory receptor family 1 subfamily L member
hsa:388,2.960738e-08,2.0929663608136747e-05,6.27373244048387e-07,1.720797071746336e-06,0.0,8.172212e-06,False,RHOB; ras homolog family member
hsa:51710,0.0,0.0,8.511395258064516e-08,2.0368877377686777e-07,0.0,8.968291e-07,False,ZNF44; zinc finger protein
hsa:259230,0.0,0.0,1.4008132042903225e-05,3.023109096590896e-05,0.0,0.00012526347,False,SGMS1; sphingomyelin synthase
hsa:26003,0.0,0.0,8.886116035483871e-08,2.0547777690315665e-07,0.0,9.5338373e-07,False,GORASP2; golgi reassembly stacking protein
hsa:701,2.3907639e-08,1.690047690591909e-05,5.79490844729032e-07,1.0186262717187411e-06,0.0,3.472046e-06,False,BUB1B; BUB1 mitotic checkpoint serine/threonine kinase
hsa:57679,0.0,0.0,2.2517173359258064e-08,4.817653192486048e-08,0.0,1.932223e-07,False,ALS2; alsin Rho guanine nucleotide exchange factor
hsa:403278,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR5K4; olfactory receptor family 5 subfamily K member
hsa:8086,1.0959733e-08,7.747511766491847e-06,2.1284560437419355e-07,3.118138528411643e-07,0.0,1.0505614e-06,False,AAAS; aladin WD repeat
hsa:5708,9.284905e-07,0.0006563564161486323,4.033456603225806e-06,6.567366502490129e-06,0.0,2.9076176e-05,False,PSMD2; proteasome 26S subunit ubiquitin receptor
hsa:6811,3.107073e-07,0.00021964115938635662,0.00012106933114580644,0.0002665966858518719,0.0,0.00090972387,False,STX5; syntaxin
hsa:79023,0.0,0.0,1.844059955483871e-07,5.044079819093948e-07,0.0,2.0488794e-06,False,NUP37; nucleoporin
hsa:283160,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR8D2; olfactory receptor family 8 subfamily D member
hsa:8861,0.0,0.0,2.766363812129032e-06,5.657709999376544e-06,0.0,2.1446938e-05,False,LDB1; LIM domain binding
hsa:3720,0.0,0.0,1.4523999822580647e-05,3.8521915003386853e-05,0.0,0.00018113735,False,JARID2; jumonji and AT-rich interaction domain containing
hsa:51728,0.0,0.0,2.4392462307741934e-05,4.343522166362212e-05,0.0,0.00018003717,False,POLR3K; RNA polymerase III subunit
hsa:412,3.622559e-05,0.025608122458193956,0.00016763976727258065,0.0002596004640971506,0.0,0.00094002206,False,STS; steroid
hsa:1571,0.0,0.0,0.00020285393225806452,0.0005949379498150558,0.0,0.002696969,False,CYP2E1; cytochrome P450 family 2 subfamily E member
hsa:1447,0.0,0.0,9.303018367741936e-08,4.872399169529234e-07,0.0,2.7163978e-06,False,CSN2; casein
hsa:53371,0.0,0.0,1.7420716274193548e-07,4.5426156269573973e-07,0.0,1.9942272e-06,False,NUP54; nucleoporin
hsa:28956,1.5275164e-07,0.00010798120065980866,3.424656888709677e-06,7.678820453301818e-06,0.0,3.19777e-05,False,LAMTOR2; late endosomal/lysosomal adaptor
hsa:390429,-0.0,0.0,1.0327965483870968e-09,5.750367816163535e-09,-0.0,3.2016693e-08,False,OR4N2; olfactory receptor family 4 subfamily N member
hsa:66004,1.3860838e-08,9.798323143313557e-06,9.358757992903225e-07,1.6070271222806438e-06,0.0,6.1750848e-06,False,LYNX1; Ly6/neurotoxin
hsa:58508,0.0,0.0,7.49875467451613e-06,1.994217118097637e-05,0.0,9.918317e-05,False,KMT2C; lysine methyltransferase
hsa:7132,0.00032803597,0.23189091717905594,0.0014980618799677423,0.002509197102996562,0.0,0.009836424,False,TNFRSF1A; TNF receptor superfamily member
hsa:7936,7.36573e-07,0.0005206885956419011,3.060894055506451e-05,7.29228730990578e-05,0.0,0.00028348155,False,NELFE; negative elongation factor complex member
hsa:5360,1.3084466e-05,0.009249500356738846,0.00044851449441935486,0.0009328914144324392,0.0,0.0037632356,False,PLTP; phospholipid transfer
hsa:5188,0.0,0.0,5.677309006451612e-06,1.4570319890992416e-05,0.0,6.962552e-05,False,GATB; glutamyl-tRNA amidotransferase subunit
hsa:57486,0.0,0.0,1.1903944161290323e-05,3.555014161725597e-05,0.0,0.00016444831,False,NLN;
hsa:6571,0.0,0.0,2.5229530187096776e-05,5.918057282368527e-05,0.0,0.00029740002,False,SLC18A2; solute carrier family 18 member
hsa:57449,0.0,0.0,1.0980899253548385e-07,2.604622619920899e-07,0.0,1.2624188e-06,False,PLEKHG5; pleckstrin homology and RhoGEF domain containing
hsa:4991,-0.0,0.0,1.1975452580645163e-07,6.66764981072769e-07,-0.0,3.7123903e-06,False,OR1D2; olfactory receptor family 1 subfamily D member
hsa:29894,9.334079e-08,6.598325605365062e-05,9.184170177801934e-07,1.6570297445717234e-06,0.0,6.448183e-06,False,CPSF1; cleavage and polyadenylation specific factor
hsa:81027,0.0,0.0,2.6065913846677417e-06,8.657607471915502e-06,0.0,4.0060597e-05,False,TUBB1; tubulin beta 1 class
hsa:8994,5.0935043e-05,0.036006337469103325,0.00015180980832258065,0.0002402976371493225,0.0,0.0010856868,False,LIMD1; LIM domain containing
hsa:23586,2.2597182e-05,0.015974105704450806,5.192237251290324e-05,7.580076262994361e-05,0.0,0.0002339975,False,RIGI; RNA sensor
hsa:1053,1.2537893e-07,8.863124087467803e-05,6.770432257828806e-06,2.300440372727332e-05,0.0,0.00012516177,False,CEBPE; CCAAT enhancer binding protein
hsa:340485,7.4451116e-09,5.263001363613962e-06,3.884450424825807e-06,9.344046514279643e-06,0.0,4.0461116e-05,False,ACER2; alkaline ceramidase
hsa:3908,0.0005689328,0.40218256798255514,0.0008698746834516129,0.0009783590131494445,1.0198042e-05,0.0046768948,True,LAMA2; laminin subunit alpha
hsa:92552,0.0,0.0,2.0896990774193544e-09,1.0906723194967419e-08,0.0,6.072585e-08,False,ATXN3L; ataxin 3
hsa:845,5.1752405e-08,3.6584136372825095e-05,0.0001452975553698387,0.00030006884851937473,0.0,0.0011897179,False,CASQ2; calsequestrin
hsa:2773,0.0,0.0,9.315211858064517e-05,0.00021176887790087053,0.0,0.00074324844,False,GNAI3; G protein subunit alpha
hsa:30837,0.0,0.0,1.2668075258064516e-07,2.711465868578107e-07,0.0,1.1407938e-06,False,SOCS7; suppressor of cytokine signaling
hsa:2958,4.5204692e-07,0.0003195551234420035,1.0317542960064516e-05,2.8068404215799046e-05,0.0,0.00012675478,False,GTF2A2; general transcription factor IIA subunit
hsa:4124,0.0,0.0,0.00011049316171851614,0.00032079377843722754,0.0,0.0012313797,False,MAN2A1; mannosidase alpha class 2A member
hsa:3339,1.3299909e-06,0.0009401798517424723,0.00014842341680193548,0.0003141573187023615,0.0,0.001082229,False,HSPG2; heparan sulfate proteoglycan
hsa:164091,0.0,0.0,8.914508414096774e-07,2.102360907583388e-06,0.0,8.483369e-06,False,PAQR7; progestin and adipoQ receptor family member
hsa:7276,0.0,0.0,3.847092596022581e-06,1.830014916843431e-05,0.0,0.00010186314,False,TTR;
hsa:5575,0.0,0.0,6.307219792432259e-06,2.1794731827295932e-05,0.0,0.000118605225,False,PRKAR1B; protein kinase cAMP-dependent type I regulatory subunit
hsa:387787,1.134675e-06,0.000802109678551853,5.553007447096774e-06,7.455107438068018e-06,0.0,2.9239629e-05,False,LIPT2; lipoyl(octanoyl) transferase
hsa:285676,0.0,0.0,5.242305843870968e-09,1.066256909966819e-08,0.0,3.9981554e-08,False,ZNF454; zinc finger protein
hsa:153129,0.0,0.0,9.44049066451613e-07,2.8287588722758886e-06,0.0,1.2832443e-05,False,SLC38A9; solute carrier family 38 member
hsa:5928,0.0,0.0,2.5171448487838715e-05,7.558684926405301e-05,0.0,0.00032131423,False,RBBP4; RB binding protein 4
hsa:3249,0.0,0.0,5.374576725806453e-08,9.645652116412865e-08,0.0,3.3422123e-07,False,HPN;
hsa:2255,0.0,0.0,2.8543195987096777e-06,6.458580512561751e-06,0.0,2.9225344e-05,False,FGF10; fibroblast growth factor
hsa:51276,0.0,0.0,6.757993219032258e-08,1.418850484001866e-07,0.0,5.1977537e-07,False,ZNF571; zinc finger protein
hsa:9611,3.2285373e-06,0.0022822755554636064,7.97370507483871e-05,0.00015516913759765002,0.0,0.00057496206,False,NCOR1; nuclear receptor corepressor
hsa:462,2.7369444e-08,1.934765102693101e-05,3.0126433412903227e-07,8.536414142534523e-07,0.0,3.7288114e-06,False,SERPINC1; serpin family C member
hsa:1477,0.0,0.0,1.4191180516129033e-08,2.7928743762998887e-08,0.0,1.1119624e-07,False,CSTF1; cleavage stimulation factor subunit
hsa:121536,0.0,0.0,4.8950253064125804e-05,0.00014120496876146043,0.0,0.0005325572,False,AEBP2; AE binding protein
hsa:4987,7.147209e-07,0.0005052411936045927,1.4775342378064516e-06,2.404897338338231e-06,0.0,9.065883e-06,False,OPRL1; opioid related nociceptin receptor
hsa:92285,0.0,0.0,3.3042837063225806e-08,6.360877919444662e-08,0.0,2.5698506e-07,False,ZNF585B; zinc finger protein
hsa:4363,0.00016132402,0.11404107592472973,0.0004519089304516129,0.0006336597431788988,0.0,0.0022075044,False,ABCC1; ATP binding cassette subfamily C member
hsa:65258,0.0,0.0,2.307202736774193e-05,6.048584867659155e-05,0.0,0.00028592985,False,MPPE1; metallophosphoesterase
hsa:2668,0.0,0.0,1.361100621603226e-06,4.037448575328252e-06,0.0,1.9149289e-05,False,GDNF; glial cell derived neurotrophic
hsa:23516,1.1888292e-06,0.0008403916605768672,1.4223734755645164e-05,2.3051452108883456e-05,0.0,9.33408e-05,False,SLC39A14; solute carrier family 39 member
hsa:4126,0.0,0.0,8.590890267741935e-06,1.6715121787741206e-05,0.0,6.4246145e-05,False,MANBA; mannosidase
hsa:29924,1.5962506e-08,1.1284006924046115e-05,4.473699523580645e-07,9.777026700889079e-07,0.0,3.914842e-06,False,EPN1; epsin
hsa:8578,0.0,0.0,1.2587119497741937e-05,2.8211548696951168e-05,0.0,0.00011003304,False,SCARF1; scavenger receptor class F member
hsa:148203,8.602196e-09,6.080952403463578e-06,3.666860040322581e-08,9.639603758805671e-08,0.0,5.277733e-07,False,ZNF738; zinc finger protein
hsa:51363,0.0,0.0,3.6182666601e-05,9.890211671815377e-05,0.0,0.00042510408,False,CHST15; carbohydrate sulfotransferase
hsa:874,4.0702682e-05,0.028773010047122127,0.00017803565091290322,0.00031780049130163195,0.0,0.0014774717,False,CBR3; carbonyl reductase
hsa:57030,0.00032112602,0.2270062252863912,0.000946837206696774,0.002561212189108241,0.0,0.014293917,False,SLC17A7; solute carrier family 17 member
hsa:3399,6.929782e-07,0.0004898711271909945,0.0006533834105699999,0.0012015339990238466,0.0,0.004106431,False,ID3; inhibitor of DNA binding
hsa:50814,0.0,0.0,4.466456098709677e-05,9.358327537227849e-05,0.0,0.0003646485,False,NSDHL; NAD(P) dependent steroid
hsa:6182,4.5806163e-09,3.238069639290879e-06,1.6378478810645164e-07,4.2199550125609044e-07,0.0,1.8372288e-06,False,MRPL12; mitochondrial ribosomal protein
hsa:7171,0.0,0.0,0.0004012922910645161,0.0009934216179329541,0.0,0.004984123,False,TPM4; tropomyosin
hsa:23436,0.0,0.0,3.2228e-07,1.7943790988528592e-06,0.0,9.99068e-06,False,CELA3B; chymotrypsin like elastase
hsa:374378,4.3632597e-05,0.03084418741406354,0.00013546226558064516,0.00018361718286756578,0.0,0.00072515325,False,GALNT18; polypeptide N-acetylgalactosaminyltransferase
hsa:22999,0.0,0.0,1.812570677419355e-08,8.954819562907272e-08,0.0,4.964561e-07,False,RIMS1; regulating synaptic membrane exocytosis
hsa:7114,0.0,0.0,2.1825804880645158e-07,6.362252807449326e-07,0.0,3.4982725e-06,False,TMSB4X; thymosin beta 4
hsa:1871,0.0,0.0,3.989189467741936e-05,7.02255525548973e-05,0.0,0.00026246358,False,E2F3; E2F transcription factor
hsa:5319,0.0,0.0,1.3570339374193549e-06,4.574990277585785e-06,0.0,2.2663045e-05,False,PLA2G1B; phospholipase A2 group
hsa:1738,0.0,0.0,1.287743107419355e-05,3.2194560056328256e-05,0.0,0.0001402695,False,DLD; dihydrolipoamide
hsa:1026,0.00081942487,0.579257160925458,0.001090204368064516,0.0010521974245208845,0.0,0.003967383,True,CDKN1A; cyclin dependent kinase inhibitor
hsa:390191,0.0,0.0,1.0921197774193548e-07,4.314771875443843e-07,0.0,2.274639e-06,False,OR5B12; olfactory receptor family 5 subfamily B member
hsa:4617,0.0,0.0,1.3045540967741936e-09,5.419581754000233e-09,-0.0,2.7841917e-08,False,MYF5; myogenic factor
hsa:339318,1.6291972e-08,1.1516908739415067e-05,1.2773704756774195e-07,2.662328448268002e-07,0.0,1.0671945e-06,False,ZNF181; zinc finger protein
hsa:54,3.5189256e-05,0.02487553071905071,0.00022421000612806455,0.0005562644836628694,0.0,0.0028303813,False,ACP5; acid phosphatase 5
hsa:83401,0.0,0.0,1.48888014476129e-05,4.470183439902355e-05,0.0,0.00023054107,False,ELOVL3; ELOVL fatty acid elongase
hsa:210,1.3698997e-05,0.009683916610617842,6.850839587548387e-05,0.00011715337766120615,0.0,0.0004761979,False,ALAD; aminolevulinate
hsa:4066,0.0,0.0,1.0278158930543551e-05,4.167304516897157e-05,0.0,0.00023131484,False,LYL1; LYL1 basic helix-loop-helix family
hsa:8879,1.6561173e-06,0.0011707208805580125,2.0351543984838707e-05,2.7743892438596284e-05,0.0,9.997322e-05,False,SGPL1; sphingosine-1-phosphate lyase
hsa:4430,0.0,0.0,1.2399322416129033e-07,2.116082794142419e-07,0.0,6.7099575e-07,False,MYO1B; myosin
hsa:5348,6.8086564e-08,4.813086739704335e-05,0.0003231369477273548,0.0011583310603548963,0.0,0.0058619613,False,FXYD1; FXYD domain containing ion transport regulator
hsa:317749,2.2120714e-05,0.015637287149075706,7.010837748774193e-05,9.258870991221418e-05,0.0,0.00034645476,False,DHRS4L2; dehydrogenase/reductase 4 like
hsa:5547,0.00022779444,0.16102947984603466,0.0006147120831290323,0.0007739766685212074,0.0,0.0029320964,False,PRCP;
hsa:89941,4.795254e-09,3.389798527785038e-06,1.947826728145161e-06,4.2406738464802415e-06,0.0,1.9004527e-05,False,RHOT2; ras homolog family member
hsa:50700,0.0,0.0,7.14405948612903e-05,0.00018246398868229552,0.0,0.0008309107,False,RDH8; retinol dehydrogenase
hsa:201562,3.927166e-07,0.0002776141060550172,1.735604598645161e-05,2.743928539641483e-05,0.0,0.000117927426,False,HACD2; 3-hydroxyacyl-CoA dehydratase
hsa:3703,1.000875e-06,0.0007075255245075337,8.339423714419357e-05,0.0002209095430556553,0.0,0.0008885722,False,STT3A; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:7345,0.0,0.0,2.4182582560967747e-07,7.332855602715655e-07,0.0,3.3181454e-06,False,UCHL1; ubiquitin C-terminal hydrolase
hsa:594857,0.0,0.0,0.0,0.0,0.0,0.0,False,NPS; neuropeptide
hsa:3449,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA16; interferon alpha
hsa:126969,0.0,0.0,4.915908266348387e-06,1.306223203831992e-05,0.0,4.510378e-05,False,SLC44A3; solute carrier family 44 member
hsa:6166,0.0,0.0,8.234684129032259e-08,1.2694252457455353e-07,0.0,4.2095832e-07,False,RPL36AL; ribosomal protein L36a
hsa:3860,0.0,0.0,8.117289032258064e-09,2.8431724454842866e-08,0.0,1.3811857e-07,False,KRT13; keratin
hsa:10955,0.0,0.0,1.4375923548387098e-05,2.347494454426802e-05,0.0,9.790533e-05,False,SERINC3; serine incorporator
hsa:9246,2.7930182e-07,0.00019744040633586492,7.992452391612903e-07,1.1434880043017473e-06,0.0,3.982466e-06,False,UBE2L6; ubiquitin conjugating enzyme E2
hsa:2051,2.4177105e-10,1.7090964302434088e-07,3.186742003435484e-07,6.165987504662614e-07,0.0,2.0276093e-06,False,EPHB6; EPH receptor
hsa:2891,0.0,0.0,1.0818932258064514e-06,6.023726547032375e-06,0.0,3.353869e-05,False,GRIA2; glutamate ionotropic receptor AMPA type subunit
hsa:2346,2.2250419e-05,0.015728976519033242,0.00012103926329451614,0.00023567283464087446,0.0,0.0012397098,False,FOLH1; folate hydrolase
hsa:253782,0.0,0.0,9.587123878709677e-06,2.041376761965267e-05,0.0,7.651081e-05,False,CERS6; ceramide synthase
hsa:779,0.0,0.0,2.10922657e-05,8.126252945770841e-05,0.0,0.00045318936,False,CACNA1S; calcium voltage-gated channel subunit alpha1
hsa:3066,0.0,0.0,5.039993225806452e-05,0.00016015878866523995,0.0,0.0006620971,False,HDAC2; histone deacetylase
hsa:2710,1.1274815e-05,0.007970245431847543,0.00015625133286451616,0.00040085060256556777,0.0,0.0018563087,False,GK; glycerol
hsa:9134,0.0,0.0,8.993788593548387e-07,3.036576404982143e-06,0.0,1.348999e-05,False,CCNE2; cyclin
hsa:22877,0.0,0.0,3.077463000967742e-06,4.796015079556398e-06,0.0,2.008703e-05,False,MLXIP; MLX interacting
hsa:55215,1.5433834e-06,0.001091028499664015,5.7872720588451604e-05,0.0001439215824952145,0.0,0.0005572111,False,FANCI; FA complementation group
hsa:6195,0.0,0.0,2.5140633793548388e-05,6.021365910077321e-05,0.0,0.00024484485,False,RPS6KA1; ribosomal protein S6 kinase
hsa:92935,1.3866552e-05,0.009802362409802416,5.439103148387098e-05,9.429458415167265e-05,0.0,0.00037298637,False,MARS2; methionyl-tRNA synthetase 2
hsa:6892,1.1127413e-06,0.0007866045929049033,2.670617817458065e-06,5.383920189903756e-06,0.0,2.354054e-05,False,TAPBP; TAP binding
hsa:26832,0.0,0.0,3.519428815580645e-08,1.0388068815227884e-07,0.0,4.7917e-07,False,RNU5B-1; RNA
hsa:102723555,0.0,0.0,3.204174735483871e-07,8.196044514294048e-07,0.0,3.6746028e-06,False,SPDYE16; speedy/RINGO cell cycle regulator family member
hsa:3110,0.0,0.0,2.1225020967741935e-08,1.1817591534451356e-07,0.0,6.5797565e-07,False,MNX1; motor neuron and pancreas homeobox
hsa:643246,1.3153716e-06,0.0009298453665166119,4.750129477419355e-06,6.479208939022932e-06,0.0,2.0623564e-05,False,MAP1LC3B2; microtubule associated protein 1 light chain 3 beta
hsa:27019,2.0755467e-08,1.4672184514123952e-05,1.1249649851129031e-07,3.79068142287097e-07,0.0,2.0954851e-06,False,DNAI1; dynein axonemal intermediate chain
hsa:6731,4.0701375e-06,0.002877208611969809,4.090664017387096e-05,0.00010800879065523227,0.0,0.00044483613,False,SRP72; signal recognition particle
hsa:2949,0.0007608389,0.5378423297497041,0.0008164399055161293,0.0007842907348605636,0.0,0.0036362146,True,GSTM5; glutathione S-transferase mu
hsa:23633,0.0,0.0,1.3852008787806454e-05,6.06673465719621e-05,0.0,0.0003283526,False,KPNA6; karyopherin subunit alpha
hsa:58528,0.0,0.0,9.40879654266129e-07,2.759533340031421e-06,0.0,1.3281136e-05,False,RRAGD; Ras related GTP binding
hsa:55821,0.0,0.0,1.4826880201948805e-05,6.0801418249512006e-05,0.0,0.00033091815,False,ALLC;
hsa:5869,0.0,0.0,0.00013579156559032258,0.0002963579475140328,0.0,0.0013293463,False,RAB5B; RAB5B
hsa:51266,7.741143e-09,5.47226802683934e-06,1.5482800977741935e-07,3.538690278352547e-07,0.0,1.69364e-06,False,CLEC1B; C-type lectin domain family 1 member
hsa:1145,5.4948094e-07,0.0003884319123570803,4.328801218032259e-06,1.0214662618283551e-05,0.0,5.3083004e-05,False,CHRNE; cholinergic receptor nicotinic epsilon
hsa:4649,0.0,0.0,5.217404496774194e-08,1.1042279193937666e-07,0.0,5.093672e-07,False,MYO9A; myosin
hsa:151,1.7376132e-06,0.0012283309011826794,2.6260495679377416e-05,6.495181704294961e-05,0.0,0.00033176676,False,ADRA2B; adrenoceptor alpha
hsa:6230,2.1555467e-08,1.5237710098843348e-05,1.3972078593870968e-06,4.252098583701707e-06,0.0,1.843742e-05,False,RPS25; ribosomal protein
hsa:254122,0.0,0.0,2.480680866935484e-07,4.6475938659168225e-07,0.0,1.8438654e-06,False,SNX32; sorting nexin
hsa:6609,3.7200941e-06,0.0026297604888921014,0.00013279676291235484,0.0004287007697158851,0.0,0.0021769784,False,SMPD1; sphingomyelin phosphodiesterase
hsa:790,0.0,0.0,8.163863842064516e-05,0.00013511290589617443,0.0,0.00048121592,False,CAD; carbamoyl-phosphate synthetase 2
hsa:283748,0.0,0.0,0.0,0.0,0.0,0.0,False,PLA2G4D; phospholipase A2 group
hsa:3776,4.7403346e-06,0.0033509756205382397,3.657329738387097e-05,6.727349919601412e-05,0.0,0.00025959875,False,KCNK2; potassium two pore domain channel subfamily K member
hsa:57038,4.3018488e-07,0.00030410069474930487,1.8481474956129033e-06,2.956720321573556e-06,0.0,1.1239458e-05,False,RARS2; arginyl-tRNA synthetase 2
hsa:5881,0.0,0.0,4.376556751612903e-05,0.00016935401366981255,0.0,0.0009088792,False,RAC3; Rac family small GTPase
hsa:23352,0.0,0.0,4.7031200096774195e-07,9.72347416846041e-07,0.0,4.619673e-06,False,UBR4; ubiquitin protein ligase E3 component n-recognin
hsa:100,3.1351465e-05,0.02216256946991841,0.00028626084132935486,0.0006457814007136218,0.0,0.0030874687,False,ADA; adenosine
hsa:406949,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15B; microRNA
hsa:113457,0.0,0.0,7.306073219354839e-07,2.240663380752476e-06,0.0,1.1038073e-05,False,TUBA3D; tubulin alpha
hsa:7292,8.6536573e-07,0.0006117330755679729,1.1762838910838707e-05,3.572483801309942e-05,0.0,0.0001831835,False,TNFSF4; TNF superfamily member
hsa:4143,0.0,0.0,1.8788197293548388e-07,4.6138447583554644e-07,0.0,1.7135064e-06,False,MAT1A; methionine adenosyltransferase
hsa:3678,0.0011122458,0.7862543204958676,0.002477932122903226,0.004425806363162788,0.0,0.023473673,True,ITGA5; integrin subunit alpha
hsa:112744,0.0,0.0,1.5138920387096774e-07,7.738417704672401e-07,0.0,4.303952e-06,False,IL17F; interleukin
hsa:4099,4.8255497e-09,3.411214769606267e-06,2.6736044605709677e-06,7.705372751571532e-06,0.0,4.015527e-05,False,MAG; myelin associated
hsa:3785,2.6428243e-06,0.0018682309469601657,4.843660583870967e-06,6.566839330497067e-06,0.0,2.3398707e-05,False,KCNQ2; potassium voltage-gated channel subfamily Q member
hsa:54106,0.0,0.0,1.5989745705161288e-05,4.468245293335932e-05,0.0,0.00021761967,False,TLR9; toll like receptor
hsa:84649,0.0,0.0,4.302745525806452e-06,1.4557616325122692e-05,0.0,7.027043e-05,False,DGAT2; diacylglycerol O-acyltransferase
hsa:1829,0.0,0.0,4.700067798516129e-07,1.2316672350500476e-06,0.0,4.4594135e-06,False,DSG2; desmoglein
hsa:10795,3.7635277e-09,2.660464003937687e-06,3.9160160690322574e-08,7.580529607398388e-08,0.0,2.8545344e-07,False,ZNF268; zinc finger protein
hsa:4780,1.5465941e-06,0.001093298165907588,5.332669241935482e-06,8.4736214784424e-06,0.0,3.234381e-05,False,NFE2L2; NFE2 like bZIP transcription factor
hsa:283464,0.0,0.0,5.460679525806453e-07,1.313109812917157e-06,0.0,4.9064606e-06,False,GXYLT1; glucoside xylosyltransferase
hsa:2205,1.5093027e-05,0.010669366149200818,0.00015840591017000002,0.0002630855792078354,0.0,0.0009831206,False,FCER1A; Fc epsilon receptor
hsa:1109,0.0,0.0,2.9601695326451613e-06,1.0766595057429561e-05,0.0,5.6991696e-05,False,AKR1C4; aldo-keto reductase family 1 member
hsa:731,0.0,0.0,0.0,0.0,0.0,0.0,False,C8A; complement C8 alpha
hsa:51170,0.0,0.0,8.646308055161291e-05,0.0002283272076181489,0.0,0.00083187345,False,HSD17B11; hydroxysteroid 17-beta dehydrogenase
hsa:387712,0.0,0.0,3.0350409938709673e-07,5.50377641599367e-07,0.0,1.5188471e-06,False,ENO4; enolase
hsa:119504,2.13984e-07,0.00015126678340074447,3.579452087258064e-05,9.107310811749228e-05,0.0,0.00039520315,False,ANAPC16; anaphase promoting complex subunit
hsa:65010,3.0402919e-06,0.0021492035680814353,2.9412305760322577e-05,4.3481268365022464e-05,0.0,0.00016190192,False,SLC26A6; solute carrier family 26 member
hsa:79726,1.07909884e-07,7.628225030762796e-05,4.4421323594838705e-06,7.420126567417581e-06,0.0,2.9290797e-05,False,WDR59; WD repeat domain
hsa:117581,7.713361e-08,5.452628737095996e-05,8.804331127741935e-07,2.3770294672747903e-06,0.0,1.06224215e-05,False,TWIST2; twist family bHLH transcription factor
hsa:162972,8.079668e-09,5.711573712548257e-06,6.062353416774194e-08,1.0839925156036496e-07,0.0,3.6892584e-07,False,ZNF550; zinc finger protein
hsa:4298,0.0,0.0,1.2792340367741936e-05,3.412297237092304e-05,0.0,0.00015179864,False,MLLT1; MLLT1 super elongation complex
hsa:50604,0.0,0.0,0.0,0.0,0.0,0.0,False,IL20; interleukin
hsa:5094,2.6146006e-08,1.8482794164033597e-05,2.088212086469355e-05,3.935232159102041e-05,0.0,0.00011579934,False,PCBP2; poly(rC) binding protein
hsa:6776,0.00027393448,0.19364619622100515,0.0004882203889193549,0.0005029245315393373,0.0,0.0016028333,False,STAT5A; signal transducer and activator of transcription
hsa:4708,1.1007055e-06,0.000778096401864196,4.470605690322581e-06,6.498131099608624e-06,0.0,2.3276314e-05,False,NDUFB2; NADH:ubiquinone oxidoreductase subunit
hsa:4800,0.0,0.0,1.1300081364516133e-06,3.7382978949245835e-06,0.0,1.652242e-05,False,NFYA; nuclear transcription factor Y subunit
hsa:6727,1.0794511e-06,0.0007630715181293712,2.1050977449999998e-05,4.632439170989297e-05,0.0,0.00016058605,False,SRP14; signal recognition particle
hsa:540,0.0,0.0,1.048242357096774e-05,1.8635691771024707e-05,0.0,6.543338e-05,False,ATP7B; ATPase copper transporting
hsa:3001,1.2783925e-06,0.0009037045825792407,5.716464584580645e-06,9.7473990122278e-06,0.0,3.6038575e-05,False,GZMA; granzyme
hsa:92335,0.0,0.0,2.4956050258064522e-06,6.2736357215749e-06,0.0,2.6469046e-05,False,STRADA; STE20 related adaptor
hsa:9869,0.0,0.0,2.6928088370967744e-06,7.482277064778554e-06,0.0,2.5372927e-05,False,SETDB1; SET domain bifurcated histone lysine methyltransferase
hsa:81605,3.0136298e-06,0.0021303559434660015,6.608372603870969e-05,0.0001270381745337583,0.0,0.0005705994,False,URM1; ubiquitin related modifier
hsa:8202,9.561981e-06,0.006759431120125963,2.707568563354839e-05,4.0192335518583325e-05,0.0,0.0001491309,False,NCOA3; nuclear receptor coactivator
hsa:6648,0.0,0.0,7.230411192580644e-05,0.0001400363438747127,0.0,0.00057721033,False,SOD2; superoxide dismutase
hsa:4700,0.0,0.0,2.9302246680645164e-06,4.889887100659202e-06,0.0,1.3490579e-05,False,NDUFA6; NADH:ubiquinone oxidoreductase subunit
hsa:774,0.0,0.0,4.4838043e-05,0.00011956294957946475,0.0,0.00050406245,False,CACNA1B; calcium voltage-gated channel subunit alpha1
hsa:55048,2.1764068e-09,1.5385171601965914e-06,2.712149522980645e-07,3.921099053780575e-07,0.0,1.3469287e-06,False,VPS37C; VPS37C subunit of
hsa:9409,0.0,0.0,1.0872474365483873e-05,2.8444866721596014e-05,0.0,0.000110566325,False,PEX16; peroxisomal biogenesis factor
hsa:3078,0.0,0.0,5.613332918193548e-07,1.6847149763901153e-06,0.0,9.154241e-06,False,CFHR1; complement factor H related
hsa:183,0.00032253767,0.22800413052597762,0.0006669919588870967,0.0007742585208198819,0.0,0.002657429,False,AGT;
hsa:442890,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133B; microRNA
hsa:5825,0.0,0.0,7.743486781935483e-05,0.0002717421534239882,0.0,0.0011409313,False,ABCD3; ATP binding cassette subfamily D member
hsa:54872,0.0,0.0,5.383495841935483e-06,9.179112504275932e-06,0.0,3.5800942e-05,False,PIGG; phosphatidylinositol glycan anchor biosynthesis class
hsa:339745,0.0,0.0,1.393918900967742e-05,3.341676904777471e-05,0.0,0.00011905504,False,SPOPL; speckle type BTB/POZ protein
hsa:100169754,0.0,0.0,4.976651993548388e-07,1.7825232514435889e-06,0.0,9.359554e-06,False,RNA5S3; RNA
hsa:8131,0.0,0.0,1.913088706129032e-06,6.2217420181102835e-06,0.0,3.101981e-05,False,NPRL3; NPR3 like
hsa:6383,0.0,0.0,2.410813923709677e-05,4.0833952382443024e-05,0.0,0.00019560246,False,SDC2; syndecan
hsa:3590,0.0,0.0,3.8713561622580643e-07,1.2713038504806452e-06,0.0,5.580549e-06,False,IL11RA; interleukin 11 receptor subunit
hsa:201266,0.0,0.0,1.4508054299419355e-08,4.559919793881088e-08,0.0,1.8589742e-07,False,SLC39A11; solute carrier family 39 member
hsa:1398,1.2046237e-05,0.008515569028866802,0.0001006790480967742,0.00015792872787797713,0.0,0.0006548697,False,CRK; CRK proto-oncogene
hsa:7169,0.00020916131,0.14785759017303146,0.0007848754111290321,0.0012646175112059116,0.0,0.005447774,False,TPM2; tropomyosin
hsa:406992,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR210; microRNA
hsa:5733,0.0,0.0,1.75027432973871e-05,3.615258021872828e-05,0.0,0.00014152909,False,PTGER3; prostaglandin E receptor
hsa:170506,2.6379956e-07,0.00018648175052214975,7.568727801580645e-06,1.969824530898555e-05,0.0,8.806652e-05,False,DHX36; DEAH-box helicase
hsa:8560,0.0,0.0,3.6252998669032254e-05,6.088477291143947e-05,0.0,0.00019088468,False,DEGS1; delta 4-desaturase
hsa:255022,0.0,0.0,2.721953149032258e-06,8.071789658268141e-06,0.0,3.6979396e-05,False,CALHM1; calcium homeostasis modulator
hsa:26740,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR1J2; olfactory receptor family 1 subfamily J member
hsa:51807,6.9399675e-08,4.905911472963895e-05,2.4010698398387097e-06,5.7441376966975775e-06,0.0,2.8447634e-05,False,TUBA8; tubulin alpha
hsa:3442,0.0,0.0,8.11394193548387e-08,4.517651675045918e-07,0.0,2.515322e-06,False,IFNA5; interferon alpha
hsa:4621,0.0,0.0,4.5721161119354835e-08,9.461403507956154e-08,0.0,4.1880207e-07,False,MYH3; myosin heavy chain
hsa:3692,2.1542286e-08,1.5228392357928115e-05,1.5237045910354836e-06,4.646817954704315e-06,0.0,2.1174044e-05,False,EIF6; eukaryotic translation initiation factor
hsa:221823,0.0,0.0,1.1321621290322581e-08,4.41829322280127e-08,0.0,1.9725019e-07,False,PRPS1L1; phosphoribosyl pyrophosphate synthetase 1 like
hsa:158067,0.0,0.0,3.988326177645161e-06,9.951420579224217e-06,0.0,4.0116476e-05,False,AK8; adenylate kinase
hsa:81035,5.417519e-10,3.829682000254307e-07,1.4774533627741934e-07,2.6382259967192524e-07,0.0,1.0611976e-06,False,COLEC12; collectin subfamily member
hsa:2563,4.336311e-05,0.030653685172501943,0.00025153480669,0.00037924233262360527,0.0,0.0013845795,False,GABRD; gamma-aminobutyric acid type A receptor subunit
hsa:9129,0.0,0.0,2.656006400203226e-07,4.0510539684023353e-07,0.0,1.3592326e-06,False,PRPF3; pre-mRNA processing factor
hsa:27429,4.8875907e-05,0.03455071985608238,0.00031402813751935484,0.00040271830261339836,0.0,0.0014904821,False,HTRA2; HtrA serine peptidase
hsa:126129,0.0,0.0,1.3923374838709679e-06,6.093886653449471e-06,0.0,3.259625e-05,False,CPT1C; carnitine palmitoyltransferase
hsa:9373,0.0,0.0,1.6689395390322575e-07,3.3131171297480155e-07,0.0,1.1378634e-06,False,PLAA; phospholipase A2 activating
hsa:25920,8.4333266e-07,0.0005961577445743312,3.267882995580644e-05,7.351469518302965e-05,0.0,0.00031330402,False,NELFB; negative elongation factor complex member
hsa:7088,7.414786e-05,0.052415639852740045,0.0008295535947741935,0.001612774667576998,0.0,0.007000988,False,TLE1; TLE family member 1
hsa:921,0.0,0.0,1.247064192483871e-06,3.535443221387793e-06,0.0,1.5202639e-05,False,CD5; CD5
hsa:7706,2.0093347e-09,1.4204127263930942e-06,7.611047594022581e-06,1.6765610061435132e-05,0.0,6.643523e-05,False,TRIM25; tripartite motif containing
hsa:199746,8.033571e-08,5.6789874214497445e-05,4.80580645451613e-07,9.774539013235356e-07,0.0,5.117563e-06,False,U2AF1L4; U2 small nuclear RNA auxiliary factor 1 like
hsa:9407,0.0,0.0,1.873121966267742e-07,1.041788445099245e-06,0.0,5.800633e-06,False,TMPRSS11D; transmembrane serine protease
hsa:10197,0.0,0.0,6.482201696129032e-06,1.7218295546783885e-05,0.0,7.635525e-05,False,PSME3; proteasome activator subunit
hsa:9789,1.1059439e-06,0.0007817994633929387,0.0002009119568129032,0.0005651538890236006,0.0,0.0026245592,False,SPCS2; signal peptidase complex subunit
hsa:343563,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T29; olfactory receptor family 2 subfamily T member
hsa:8697,0.0,0.0,1.2832809333225807e-05,3.6392233216291066e-05,0.0,0.00016081965,False,CDC23; cell division cycle
hsa:10749,0.0,0.0,4.265078001290322e-08,1.5210332785235868e-07,0.0,7.641899e-07,False,KIF1C; kinesin family member
hsa:55811,0.0,0.0,5.71983920967742e-07,1.4200035666693519e-06,0.0,6.1623914e-06,False,ADCY10; adenylate cyclase
hsa:127,0.0,0.0,2.6894954016129033e-06,1.486278598429167e-05,0.0,8.277042e-05,False,ADH4; alcohol dehydrogenase 4 (class II)
hsa:9440,0.0,0.0,9.930938099999999e-06,3.2725785049866486e-05,0.0,0.00015289453,False,MED17; mediator complex subunit
hsa:27430,0.0,0.0,1.90104697e-05,5.78660645149655e-05,0.0,0.0003092409,False,MAT2B; methionine adenosyltransferase 2 non-catalytic beta
hsa:1386,0.0,0.0,8.61644131935484e-05,0.0002328676317306665,0.0,0.0009469802,False,ATF2; activating transcription factor
hsa:287,0.0,0.0,7.05128082548387e-07,1.9639487621105327e-06,0.0,8.229221e-06,False,ANK2; ankyrin
hsa:4626,0.0,0.0,2.8648101754838703e-10,1.4334278596012682e-09,0.0,7.9648155e-09,False,MYH8; myosin heavy chain
hsa:3400,0.0,0.0,0.00022773219859032262,0.0006255311620133074,0.0,0.0023539094,False,ID4; inhibitor of DNA binding
hsa:7280,7.4290506e-07,0.0005251647730593738,3.699611618903226e-05,0.00010646674482504015,0.0,0.00046093087,False,TUBB2A; tubulin beta 2A class
hsa:112574,3.6861156e-08,2.6057408500416163e-05,5.168390153999999e-07,1.0747808106815972e-06,0.0,4.574623e-06,False,SNX18; sorting nexin
hsa:10263,0.0,0.0,2.419631612903226e-09,1.34719386654995e-08,0.0,7.500858e-08,False,CDK2AP2; cyclin dependent kinase 2 associated protein
hsa:93973,7.338924e-08,5.1879366078890254e-05,6.790920187741935e-06,1.7464174838166423e-05,0.0,6.066874e-05,False,ACTR8; actin related protein
hsa:1497,0.0,0.0,9.153554151290323e-08,2.4920965443916695e-07,0.0,1.1940472e-06,False,CTNS; cystinosin
hsa:8854,0.0,0.0,1.9795378952903226e-05,3.603127731729759e-05,0.0,0.00012918237,False,ALDH1A2; aldehyde dehydrogenase 1 family member
hsa:2172,0.0,0.0,1.548106152870968e-06,3.7312169913329986e-06,0.0,1.4846701e-05,False,FABP6; fatty acid binding protein
hsa:9658,7.8977806e-08,5.582996239750643e-05,1.1678982647419356e-06,2.1606334485865795e-06,0.0,7.7563245e-06,False,ZNF516; zinc finger protein
hsa:3796,0.0,0.0,6.916578104032258e-08,1.2213811362103835e-07,0.0,4.4009366e-07,False,KIF2A; kinesin family member
hsa:2512,6.753494e-06,0.004774092054061179,0.0005668443724129031,0.0010319612950587876,0.0,0.004579117,False,FTL; ferritin light
hsa:11282,0.0,0.0,0.00010490971702945161,0.0002616925826591548,0.0,0.0012213583,False,MGAT4B; alpha-1
hsa:50840,0.0,0.0,4.561220741935484e-06,1.4753964783360235e-05,0.0,6.235408e-05,False,TAS2R14; taste 2 receptor member
hsa:91319,0.0,0.0,1.3933951861741936e-07,3.8638681064314193e-07,0.0,1.4879271e-06,False,DERL3; derlin
hsa:100288814,1.8175714e-09,1.2848539109428176e-06,1.0606743101096775e-06,2.9647987826879576e-06,0.0,1.3639208e-05,False,CLDN34; claudin
hsa:1339,0.0,0.0,3.545610688935484e-05,8.842473698924661e-05,0.0,0.00043165873,False,COX6A2; cytochrome c oxidase subunit
hsa:8731,2.3655613e-08,1.6722317967150978e-05,3.7589915316129034e-07,7.99731334932114e-07,0.0,2.7687809e-06,False,RNMT; RNA guanine-7
hsa:26696,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T1; olfactory receptor family 2 subfamily T member
hsa:51554,8.837007e-08,6.246941938555512e-05,3.090637811135484e-05,0.00010528851960742585,0.0,0.00056636904,False,ACKR4; atypical chemokine receptor
hsa:10523,0.0,0.0,2.379320074154839e-07,5.018088285181346e-07,0.0,1.8707441e-06,False,CHERP; calcium homeostasis endoplasmic reticulum
hsa:377677,0.0,0.0,9.120631240967741e-05,0.00017290412785915226,0.0,0.00053932396,False,CA13; carbonic anhydrase
hsa:2548,0.0,0.0,0.00013553002950967744,0.00023481190666631285,0.0,0.00090133125,False,GAA; alpha
hsa:3000,0.0,0.0,1.326308648387097e-06,4.774191256400689e-06,0.0,2.571022e-05,False,GUCY2D; guanylate cyclase 2D
hsa:79008,0.0,0.0,3.1066703548387097e-07,1.0909610010964947e-06,0.0,5.441044e-06,False,SLX1B; SLX1 homolog B
hsa:3929,0.0,0.0,2.076964425483871e-07,5.138501133006649e-07,0.0,2.4433139e-06,False,LBP; lipopolysaccharide binding
hsa:1891,0.0,0.0,3.185052612580645e-05,9.122943784958239e-05,0.0,0.00036278486,False,ECH1; enoyl-CoA hydratase
hsa:79679,0.0,0.0,6.454237223870967e-08,2.4500277096223935e-07,-0.0,1.3339978e-06,False,VTCN1; V-set domain containing T cell activation inhibitor
hsa:23411,0.0,0.0,8.950708548387096e-06,2.5145623891680418e-05,0.0,0.000115552146,False,SIRT1; sirtuin
hsa:5425,0.0,0.0,0.0003271375641796775,0.000844483120223464,0.0,0.0031379694,False,POLD2; DNA polymerase delta 2
hsa:6157,0.0,0.0,2.1059093977419354e-07,4.461443322260642e-07,0.0,1.9278104e-06,False,RPL27A; ribosomal protein
hsa:219865,0.0,0.0,1.9196654193548387e-08,6.63507984436945e-08,0.0,3.2838463e-07,False,OR8G5; olfactory receptor family 8 subfamily G member
hsa:390199,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D9; olfactory receptor family 4 subfamily D member
hsa:4089,0.0,0.0,4.285612967741935e-05,7.620644690482294e-05,0.0,0.00024464147,False,SMAD4; SMAD family member
hsa:5527,3.6281872e-06,0.0025647908596892924,2.444760611290323e-05,4.065452365423625e-05,0.0,0.00019720147,False,PPP2R5C; protein phosphatase 2 regulatory subunit
hsa:1513,1.3993295e-05,0.009891957921282528,8.883556056129031e-05,0.000180923049786342,0.0,0.00070376054,False,CTSK; cathepsin
hsa:780854,0.0,0.0,0.0,0.0,-0.0,-0.0,False,SNORD3D; small nucleolar RNA
hsa:1358,0.0,0.0,1.5054733429032258e-06,5.940225243224598e-06,0.0,3.1504533e-05,False,CPA2; carboxypeptidase
hsa:26188,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1C1; olfactory receptor family 1 subfamily C member
hsa:2619,6.0000973e-05,0.042415106674447235,0.00016390739438709677,0.0002555349314328217,0.0,0.0012948638,False,GAS1; growth arrest specific
hsa:212,3.6474523e-07,0.00025784094933670144,1.2279289206322584e-05,3.097333396736134e-05,0.0,0.0001476385,False,ALAS2; 5'-aminolevulinate synthase
hsa:4261,0.00010940222,0.07733719304387521,0.0003710996521612903,0.0005439344485239208,0.0,0.0018877542,False,CIITA; class II major histocompatibility complex
hsa:388761,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR14A2; olfactory receptor family 14 subfamily A member
hsa:7325,0.0,0.0,1.238398655483871e-07,2.3305109268504428e-07,0.0,9.329159e-07,False,UBE2E2; ubiquitin conjugating enzyme E2
hsa:596,0.0,0.0,9.585493354838711e-05,0.0002429632919432578,0.0,0.001139357,False,BCL2; BCL2 apoptosis
hsa:653166,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1D4; olfactory receptor family 1 subfamily D member
hsa:143503,0.0,0.0,2.608506590151613e-05,7.469664023410873e-05,0.0,0.00031068907,False,OR51E1; olfactory receptor family 51 subfamily E member
hsa:10073,9.387434e-09,6.636042627330941e-06,1.0173039647096773e-07,1.8868680179378916e-07,0.0,7.6221903e-07,False,SNUPN; snurportin
hsa:80223,0.0,0.0,6.066587995806452e-08,1.3289012204550564e-07,0.0,5.7196576e-07,False,RAB11FIP1; RAB11 family interacting protein
hsa:3612,6.948326e-07,0.0004911820154963741,5.400927287741935e-06,1.0006476216698644e-05,0.0,3.4599467e-05,False,IMPA1; inositol monophosphatase
hsa:11345,0.0,0.0,6.321459851612903e-05,0.00016390157630990484,0.0,0.0007943098,False,GABARAPL2; GABA type A receptor associated protein like
hsa:284370,0.0,0.0,2.624662734e-08,4.2014021966459793e-08,0.0,1.4101174e-07,False,ZNF615; zinc finger protein
hsa:81539,0.0,0.0,2.295445945483871e-05,6.076576535637093e-05,0.0,0.00024238942,False,SLC38A1; solute carrier family 38 member
hsa:6870,0.0,0.0,1.538140170967742e-08,6.90119482535e-08,0.0,3.8169182e-07,False,TACR3; tachykinin receptor
hsa:9846,0.0,0.0,1.124570871612903e-05,2.798945795687445e-05,0.0,0.0001125531,False,GAB2; GRB2 associated binding protein
hsa:2814,0.0,0.0,1.0092351780645163e-06,2.198512394226934e-06,0.0,1.0346619e-05,False,GP5; glycoprotein V
hsa:6775,0.0,0.0,6.506765419354839e-06,1.4118746724737705e-05,0.0,5.5027187e-05,False,STAT4; signal transducer and activator of transcription
hsa:284273,0.0,0.0,5.5397654387096765e-06,1.3226527810087303e-05,0.0,6.638668e-05,False,PTGR3; prostaglandin reductase
hsa:821,3.107616e-06,0.002196795444354194,9.146377328064517e-05,0.00011737847424887663,0.0,0.00039999245,False,CANX;
hsa:890,0.0,0.0,1.989581483870968e-07,6.231812936599962e-07,0.0,2.3180226e-06,False,CCNA2; cyclin
hsa:8729,0.0,0.0,4.315282554516129e-07,9.979698051335378e-07,0.0,4.2622255e-06,False,GBF1; golgi brefeldin A resistant guanine nucleotide exchange factor
hsa:29761,1.4052567e-06,0.000993385771185439,5.544317730483869e-06,8.977360877981599e-06,0.0,4.4772107e-05,False,USP25; ubiquitin specific peptidase
hsa:1399,0.0,0.0,2.8580834451612904e-05,4.711888311811874e-05,0.0,0.0002057325,False,CRKL; CRK like proto-oncogene
hsa:55526,4.5327856e-06,0.003204257783559582,4.2608159803225803e-05,9.796402224076031e-05,0.0,0.00044209568,False,DHTKD1; dehydrogenase E1 and transketolase domain containing
hsa:79796,4.58395e-07,0.00032404262550931034,8.688115975483871e-06,1.8237695323597292e-05,0.0,9.248916e-05,False,ALG9; ALG9
hsa:8473,0.0,0.0,0.00034841770376129035,0.000757251653754979,0.0,0.003203859,False,OGT; O-linked N-acetylglucosamine (GlcNAc)
hsa:6940,0.0,0.0,2.9452302276129033e-08,5.144636111455122e-08,0.0,1.9131637e-07,False,ZNF354A; zinc finger protein
hsa:7113,0.0,0.0,2.717116039677419e-07,1.1525888970176323e-06,0.0,6.2476274e-06,False,TMPRSS2; transmembrane serine protease
hsa:6176,0.0,0.0,1.5883027809677418e-07,3.2532955914413277e-07,0.0,1.1902994e-06,False,RPLP1; ribosomal protein lateral stalk subunit
hsa:1072,0.0,0.0,7.320416638064515e-05,0.00018618226090743014,0.0,0.00094255595,False,CFL1; cofilin
hsa:6622,9.548675e-09,6.750025015838118e-06,4.486126231193548e-07,1.211027210015589e-06,0.0,5.2890814e-06,False,SNCA; synuclein
hsa:9173,2.3319854e-08,1.6484967586151226e-05,8.359337979645161e-07,1.5698647021427056e-06,0.0,6.304151e-06,False,IL1RL1; interleukin 1 receptor like
hsa:635,0.0,0.0,3.43739765516129e-06,9.913082392102967e-06,0.0,4.46065e-05,False,BHMT; betaine--homocysteine
hsa:4851,0.00010162318,0.07183813536318073,0.00028568661675483866,0.0004208718931888207,0.0,0.0017999571,False,NOTCH1; notch receptor
hsa:29896,3.7461405e-08,2.6481728708793956e-05,2.422695186645161e-05,8.963383558767521e-05,0.0,0.000481552,False,TRA2A; transformer 2 alpha
hsa:80201,0.00015002061,0.10605061648776339,0.0004532961179032258,0.0006220152593810178,0.0,0.0020870082,False,HKDC1; hexokinase domain containing
hsa:59284,0.0,0.0,2.967446870967742e-06,1.2188040108417156e-05,0.0,6.6263274e-05,False,CACNG7; calcium voltage-gated channel auxiliary subunit gamma
hsa:383,0.0,0.0,3.853246177419355e-06,1.2178036509398882e-05,0.0,5.9172777e-05,False,ARG1; arginase
hsa:148022,0.0,0.0,0.00013254891596774194,0.0002576063272793973,0.0,0.0011400176,False,TICAM1; TIR domain containing adaptor molecule
hsa:374875,0.0,0.0,8.510452387096775e-06,2.4696488181588103e-05,0.0,0.00010862256,False,HSD11B1L; hydroxysteroid 11-beta dehydrogenase 1
hsa:678,1.6931077e-08,1.196869652544268e-05,1.145367262312903e-06,2.222556468688025e-06,0.0,7.780822e-06,False,ZFP36L2; ZFP36 ring finger protein like
hsa:4854,4.3482833e-06,0.003073831819697615,0.00026615962757741936,0.0004505659065616463,0.0,0.0016024347,False,NOTCH3; notch receptor
hsa:55163,0.0,0.0,2.9648468087096774e-05,5.675409452267127e-05,0.0,0.00021426346,False,PNPO; pyridoxamine 5'-phosphate
hsa:1284,0.00036288425,0.25652540958338754,0.0004055617698967742,0.00039801165440852605,0.0,0.0010316963,False,COL4A2; collagen type IV alpha 2
hsa:116512,0.0,0.0,4.727735419354839e-08,2.0455093863793172e-07,-0.0,1.0867294e-06,False,MRGPRD; MAS related GPR family member
hsa:8649,0.0,0.0,7.568185512903225e-07,1.5803513050938699e-06,0.0,7.2958824e-06,False,LAMTOR3; late endosomal/lysosomal adaptor
hsa:7030,1.4209856e-07,0.0001004504640397305,1.9643951267263875e-05,7.925319769632492e-05,0.0,0.0004383141,False,TFE3; transcription factor binding to IGHM enhancer
hsa:6356,0.00048558874,0.3432660701520694,0.0007191100318709677,0.0007547190048200385,0.0,0.0027964443,False,CCL11; C-C motif chemokine ligand
hsa:11260,4.897061e-09,3.4617666067894472e-06,6.886194429999999e-08,1.341043998599935e-07,0.0,5.207963e-07,False,XPOT; exportin for
hsa:6154,0.0,0.0,3.542483581451613e-07,7.867330283101876e-07,0.0,3.6287884e-06,False,RPL26; ribosomal protein
hsa:26830,0.0,0.0,1.527393129032258e-08,8.504165031857244e-08,0.0,4.7349187e-07,False,RNU5D-1; RNA
hsa:5334,0.0,0.0,1.5868866369677416e-05,4.820115335532706e-05,0.0,0.00018084871,False,PLCL1; phospholipase C like 1
hsa:407024,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B1; microRNA
hsa:107,0.0,0.0,0.0,0.0,0.0,0.0,False,ADCY1; adenylate cyclase
hsa:85480,4.564392e-06,0.0032266005683606754,4.898080202990968e-05,0.00012788608429217606,0.0,0.00053595094,False,TSLP; thymic stromal
hsa:30009,0.0,0.0,7.533363378064518e-07,1.5326081176112408e-06,0.0,4.9848927e-06,False,TBX21; T-box transcription factor
hsa:57724,0.0,0.0,1.867399475483871e-07,3.124984654788356e-07,0.0,9.06411e-07,False,EPG5; ectopic P-granules 5 autophagy tethering
hsa:5728,0.0,0.0,0.00035539094709677424,0.0005574788766562452,0.0,0.0019968948,False,PTEN; phosphatase and tensin
hsa:3868,0.0,0.0,2.5999167379202257e-05,9.121944673997457e-05,0.0,0.000496114,False,KRT16; keratin
hsa:63970,0.0,0.0,3.667140964516129e-07,9.486694021818223e-07,0.0,3.8011622e-06,False,TP53AIP1; tumor protein p53 regulated apoptosis inducing protein
hsa:114026,0.0,0.0,0.0,0.0,0.0,0.0,False,ZIM3; zinc finger imprinted
hsa:80012,4.521649e-08,3.1963852432760994e-05,4.221018989600451e-05,0.00012944151809217024,0.0,0.0005519293,False,PHC3; polyhomeotic homolog
hsa:3565,0.0,0.0,0.0,0.0,0.0,0.0,False,IL4; interleukin
hsa:6768,0.0,0.0,1.0769828438709676e-07,2.9403779632253406e-07,0.0,1.3896383e-06,False,ST14; ST14 transmembrane serine protease
hsa:337,0.0,0.0,3.5644351612903226e-07,1.4073174172648444e-06,0.0,6.598747e-06,False,APOA4; apolipoprotein
hsa:1834,0.0,0.0,2.0049764516129033e-08,1.1163236435603717e-07,0.0,6.215427e-07,False,DSPP; dentin
hsa:3579,2.8378187e-07,0.0002006073849556426,1.588784515903226e-05,5.948783585895549e-05,0.0,0.00033101588,False,CXCR2; C-X-C motif chemokine receptor
hsa:2790,0.0,0.0,3.1232021322580646e-05,8.280216628037997e-05,0.0,0.00042604038,False,GNG10; G protein subunit gamma
hsa:55505,1.2244826e-08,8.655952979296603e-06,1.4383805718387098e-06,3.234032632445825e-06,0.0,1.4031849e-05,False,NOP10; NOP10
hsa:55300,0.0,0.0,1.7451468943548387e-05,4.761969689272732e-05,0.0,0.00022870109,False,PI4K2B; phosphatidylinositol 4-kinase type 2
hsa:6907,0.0,0.0,1.2162238097419356e-05,4.221135733900452e-05,0.0,0.00021064866,False,TBL1X; transducin beta like 1
hsa:1154,0.0,0.0,1.9340613241935484e-06,5.58239167723e-06,0.0,2.0341742e-05,False,CISH; cytokine inducible SH2 containing
hsa:2215,0.0,0.0,7.5121500887096764e-06,1.4283397846532037e-05,0.0,5.6320478e-05,False,FCGR3B; Fc gamma receptor
hsa:3984,6.2125e-07,0.0004391659618836572,4.536800130645162e-06,8.435430157984175e-06,0.0,3.5106717e-05,False,LIMK1; LIM domain kinase
hsa:221037,1.9959408e-08,1.4109444849816278e-05,1.1059177203796776e-06,2.4094654881389144e-06,0.0,9.995605e-06,False,JMJD1C; jumonji domain containing
hsa:339403,7.354829e-08,5.1991799634202275e-05,2.6631525080096776e-06,7.4271178279276755e-06,0.0,3.802201e-05,False,RXFP4; relaxin family peptide/INSL5 receptor
hsa:10715,0.0,0.0,2.567755265903226e-05,7.627485551339843e-05,0.0,0.00038809323,False,CERS1; ceramide synthase
hsa:163050,0.0,0.0,1.3319677609677417e-08,2.8962402707560632e-08,0.0,1.1605684e-07,False,ZNF564; zinc finger protein
hsa:5771,0.0,0.0,2.5474577032258064e-06,7.1538519189671775e-06,0.0,3.622479e-05,False,PTPN2; protein tyrosine phosphatase non-receptor type
hsa:3592,0.00015025506,0.1062163508294352,0.00021796849841935483,0.00024083740700959943,0.0,0.000869477,False,IL12A; interleukin
hsa:534,0.0,0.0,7.846676106451613e-06,1.861856267907803e-05,0.0,8.8788285e-05,False,ATP6V1G2; ATPase H+ transporting V1 subunit
hsa:6693,2.9230955e-08,2.066356614785175e-05,1.065268964032258e-06,1.9343111627243503e-06,0.0,8.380618e-06,False,SPN;
hsa:90226,6.645712e-07,0.00046979002058458963,6.894501148377419e-06,1.4573920774185843e-05,0.0,5.629268e-05,False,UCN2; urocortin
hsa:6833,0.0,0.0,1.684058541935484e-05,4.8245278163783175e-05,0.0,0.00018099444,False,ABCC8; ATP binding cassette subfamily C member
hsa:4224,0.0,0.0,4.6446034241935475e-08,1.3435377937923053e-07,0.0,5.718368e-07,False,MEP1A; meprin A subunit
hsa:22861,4.96835e-07,0.0003512161298550773,1.495608684935484e-06,2.259192073989701e-06,0.0,8.501614e-06,False,NLRP1; NLR family pyrin domain containing
hsa:8498,1.4586301e-08,1.0311158002397668e-05,1.5259048505806454e-06,4.327710470187949e-06,0.0,1.678531e-05,False,RANBP3; RAN binding protein
hsa:3751,0.0,0.0,3.375911657258065e-07,8.602910701810594e-07,0.0,4.4138446e-06,False,KCND2; potassium voltage-gated channel subfamily D member
hsa:1520,0.0,0.0,1.684333319e-07,5.232898504020385e-07,0.0,1.8183326e-06,False,CTSS; cathepsin
hsa:1601,0.0,0.0,8.571747086451613e-08,1.716197803677766e-07,0.0,7.047124e-07,False,DAB2; DAB adaptor protein
hsa:406887,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7E; microRNA
hsa:6189,0.0,0.0,1.348563880870968e-06,3.414134886181792e-06,0.0,1.4291866e-05,False,RPS3A; ribosomal protein
hsa:9103,4.3340933e-05,0.030638008096386542,0.0005002383542999999,0.0011952234271336401,0.0,0.004362056,False,FCGR2C; Fc gamma receptor IIc
hsa:1719,6.259352e-06,0.004424779624705663,0.00017865631690322582,0.0005365526698923668,0.0,0.0021981862,False,DHFR; dihydrofolate
hsa:100526794,0.0,0.0,0.0,0.0,0.0,0.0,False,NT5C1B-RDH14; NT5C1B-RDH14
hsa:30011,0.0,0.0,3.279530535161291e-07,6.407768399482084e-07,0.0,2.5084796e-06,False,SH3KBP1; SH3 domain containing kinase binding protein
hsa:6317,0.0,0.0,8.762013259677419e-08,4.790187515462991e-07,0.0,2.6685523e-06,False,SERPINB3; serpin family B member
hsa:79132,4.4136056e-07,0.00031200086095760094,6.304131976129032e-05,0.00018889389703875888,0.0,0.0007926763,False,DHX58; DExH-box helicase
hsa:4988,0.0,0.0,3.2209251064516143e-07,8.836662271153407e-07,0.0,3.904768e-06,False,OPRM1; opioid receptor mu
hsa:2043,2.2721382e-08,1.6061903551478494e-05,1.1204531028451615e-05,4.411080506372054e-05,0.0,0.00023628563,False,EPHA4; EPH receptor
hsa:1836,0.0,0.0,2.9870963956354835e-07,6.705317193832771e-07,0.0,2.7186284e-06,False,SLC26A2; solute carrier family 26 member
hsa:960,0.0,0.0,6.410044832258064e-05,0.00012622873733256294,0.0,0.0004270743,False,CD44; CD44 molecule (Indian blood
hsa:5747,0.0,0.0,0.00023309921070967742,0.0007159634736303224,0.0,0.003884205,False,PTK2; protein tyrosine kinase
hsa:6908,4.5903508e-07,0.00032449510252964434,9.5339603e-07,1.5688723787280378e-06,0.0,7.273693e-06,False,TBP; TATA-box binding
hsa:10873,0.0,0.0,1.3224998206451615e-06,2.620329366676742e-06,0.0,9.409026e-06,False,ME3; malic enzyme
hsa:11112,1.4739225e-06,0.0010419261045544704,4.0794199845161284e-06,6.413291111963261e-06,0.0,3.093535e-05,False,HIBADH; 3-hydroxyisobutyrate
hsa:23492,0.0,0.0,8.604260197019357e-05,0.00027103689446522335,0.0,0.0010554956,False,CBX7; chromobox
hsa:8505,1.1141424e-07,7.875950402758412e-05,2.8472330113354827e-06,1.24426434511438e-05,0.0,6.970095e-05,False,PARG; poly(ADP-ribose)
hsa:645,4.2417443e-05,0.029985186568595903,0.0002658387642258065,0.0005034097076393847,0.0,0.0021177784,False,BLVRB; biliverdin reductase
hsa:221937,4.0324448e-08,2.850563379210868e-05,6.88886247716129e-07,3.051143284154557e-06,0.0,1.7102899e-05,False,FOXK1; forkhead box
hsa:10450,3.88093e-08,2.7434565093813145e-05,4.0957846833548386e-07,1.0553766251674814e-06,0.0,3.97224e-06,False,PPIE; peptidylprolyl isomerase
hsa:1573,4.1463198e-05,0.029310624116607696,0.0003620197941870968,0.0005932620193431039,0.0,0.002265339,False,CYP2J2; cytochrome P450 family 2 subfamily J member
hsa:10507,0.0,0.0,1.419842380483871e-05,5.389473924192972e-05,0.0,0.00028633754,False,SEMA4D; semaphorin
hsa:27,1.4444318e-05,0.01021078922852865,9.462922242170966e-05,0.00021916430392237887,0.0,0.0012092673,False,ABL2; ABL proto-oncogene 2
hsa:43,0.0,0.0,3.864140115161291e-05,0.00012081149159560979,0.0,0.0005812865,False,ACHE; acetylcholinesterase (Cartwright blood
hsa:57105,1.8444427e-06,0.0013038494204986556,3.3485277989354836e-06,4.314979993429688e-06,0.0,1.8967216e-05,False,CYSLTR2; cysteinyl leukotriene receptor
hsa:10952,3.00209e-05,0.021221983782878203,0.00015230057098903222,0.0003137064258541913,0.0,0.0014460557,False,SEC61B; SEC61 translocon subunit
hsa:4360,0.0,0.0,5.593998196774194e-08,1.382620671405046e-07,0.0,6.338065e-07,False,MRC1; mannose receptor C-type
hsa:388569,1.404384e-10,9.92768853463208e-08,4.918104004000001e-08,1.400009721860597e-07,0.0,5.891665e-07,False,ZNF324B; zinc finger protein
hsa:7098,3.684274e-08,2.6044390101455923e-05,7.540669295387096e-05,0.0001871248979120868,0.0,0.0007385051,False,TLR3; toll like receptor
hsa:2762,3.941721e-06,0.0027864300916571605,2.100797912580645e-05,3.814750047025784e-05,0.0,0.00019127871,False,GMDS; GDP-mannose
hsa:6382,9.5165586e-07,0.0006727321708476765,4.9285367601935484e-05,0.00011495648927991539,0.0,0.00055422,False,SDC1; syndecan
hsa:5162,0.0,0.0,2.2553299825806454e-05,5.2199144521976315e-05,0.0,0.00019986178,False,PDHB; pyruvate dehydrogenase E1 subunit
hsa:81030,0.0,0.0,1.539799930916129e-05,3.640036799954618e-05,0.0,0.00016329362,False,ZBP1; Z-DNA binding protein
hsa:3595,0.0,0.0,1.1731887408709675e-05,3.2253895344859855e-05,0.0,0.00015131592,False,IL12RB2; interleukin 12 receptor subunit beta
hsa:3375,0.0,0.0,0.0,0.0,0.0,0.0,False,IAPP; islet amyloid
hsa:5568,0.0,0.0,1.0107710967741935e-06,5.62773529159797e-06,0.0,3.1333904e-05,False,PRKACG; protein kinase cAMP-activated catalytic subunit
hsa:100169767,0.0,0.0,2.148410812903226e-07,7.607240921945558e-07,0.0,3.8561047e-06,False,RNA5S16; RNA
hsa:55916,0.0,0.0,1.3691964919118064e-05,4.0299173633006934e-05,0.0,0.00020704638,False,NXT2; nuclear transport factor 2 like export factor
hsa:51005,0.0,0.0,4.2312063806451605e-06,9.514672470286325e-06,0.0,3.6373982e-05,False,AMDHD2; amidohydrolase domain containing
hsa:55860,1.9717575e-07,0.0001393849141390447,8.195064696774194e-07,1.7961265819999887e-06,0.0,8.035069e-06,False,ACTR10; actin related protein
hsa:64689,3.3040173e-09,2.3356328943818817e-06,2.566877736225807e-07,4.206167884254061e-07,0.0,1.2543094e-06,False,GORASP1; golgi reassembly stacking protein
hsa:56983,7.491176e-08,5.2955646095448976e-05,0.00010942455169,0.0002984467327683202,0.0,0.001478555,False,POGLUT1; protein O-glucosyltransferase
hsa:1292,0.0,0.0,0.00017126681877419352,0.0003230230017746119,0.0,0.00093375053,False,COL6A2; collagen type VI alpha 2
hsa:2683,0.00040819956,0.28855911856400107,0.000899289348,0.0014464378947307685,0.0,0.005687169,False,B4GALT1; beta-1
hsa:1741,0.0,0.0,2.7418289632258066e-06,7.209699686218273e-06,0.0,3.3371572e-05,False,DLG3; discs large MAGUK scaffold protein
hsa:4303,9.835284e-07,0.000695263091872667,1.8182509806451611e-06,2.909768025398707e-06,0.0,1.1564049e-05,False,FOXO4; forkhead box
hsa:7643,5.3296617e-10,3.7675750615613485e-07,9.806005267419354e-09,2.3664400239663685e-08,0.0,1.2959447e-07,False,ZNF90; zinc finger protein
hsa:171392,0.0,0.0,3.325167570967742e-08,5.61222059951798e-08,0.0,2.6979524e-07,False,ZNF675; zinc finger protein
hsa:23529,2.8253933e-05,0.019972902475559603,0.00029543837021494206,0.0006411573774131776,0.0,0.0025697881,False,CLCF1; cardiotrophin like cytokine factor
hsa:170572,-0.0,0.0,3.442238129032258e-07,9.937050127724583e-07,0.0,3.8082615e-06,False,HTR3C; 5-hydroxytryptamine receptor
hsa:151449,0.0,0.0,2.2744204462258063e-06,5.714242412456074e-06,0.0,3.059771e-05,False,GDF7; growth differentiation factor
hsa:7044,0.0,0.0,3.45170225483871e-08,1.0092032783358946e-07,0.0,5.0249713e-07,False,LEFTY2; left-right determination factor
hsa:1839,0.0005125681,0.3623379680762633,0.0007535333179677419,0.000718997518219678,4.3186683e-05,0.0024338337,False,HBEGF; heparin binding EGF like growth
hsa:1500,0.0,0.0,3.43023166967742e-06,7.072503704708914e-06,0.0,2.2972572e-05,False,CTNND1; catenin delta
hsa:7294,0.0,0.0,2.0699631925806454e-08,6.631548144169537e-08,0.0,3.0068992e-07,False,TXK; TXK tyrosine
hsa:79709,7.9790846e-07,0.0005640470604925676,0.00020323865974387098,0.0004968464292250576,0.0,0.0019411239,False,COLGALT1; collagen beta(1-O)galactosyltransferase
hsa:1291,0.0,0.0,0.00013235934229032258,0.00033408094399085386,0.0,0.0013636199,False,COL6A1; collagen type VI alpha 1
hsa:26285,0.0,0.0,0.0,0.0,0.0,0.0,False,CLDN17; claudin
hsa:80712,0.0,0.0,0.0,0.0,-0.0,-0.0,False,ESX1; ESX homeobox
hsa:4917,0.0,0.0,9.681104409677419e-09,2.4356706649369087e-08,0.0,9.728743e-08,False,NTN3; netrin
hsa:3708,0.002750195,1.9441320443342045,0.002793807537419355,0.001842572386833541,0.00039259426,0.006923017,True,ITPR1; inositol 1
hsa:406911,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B1; microRNA
hsa:286530,5.537919e-07,0.00039147936007545776,5.185850092145161e-06,8.408451027824041e-06,0.0,3.4024477e-05,False,P2RY8; P2Y receptor family member
hsa:57181,0.0,0.0,2.539920767464516e-07,6.585870580511775e-07,0.0,2.6451557e-06,False,SLC39A10; solute carrier family 39 member
hsa:22824,1.13361374e-07,8.013594664493039e-05,6.401293230332259e-07,1.1263344570757128e-06,0.0,4.2284446e-06,False,HSPA4L; heat shock protein family A (Hsp70) member 4
hsa:9970,2.9512095e-09,2.086230597646176e-06,6.526265999796773e-08,1.1834002388182245e-07,0.0,4.217424e-07,False,NR1I3; nuclear receptor subfamily 1 group I member
hsa:131450,4.6087262e-10,3.2579407238332593e-07,1.7683493948725806e-07,4.2175489791729243e-07,0.0,2.0324894e-06,False,CD200R1; CD200 receptor
hsa:1854,2.4338842e-06,0.0017205297316803792,0.00010445332066774194,0.00023533951073045884,0.0,0.0011369764,False,DUT; deoxyuridine
hsa:23381,1.2339272e-07,8.722717516014612e-05,5.092340526129033e-07,7.679725370494435e-07,0.0,3.0728565e-06,False,SMG5; SMG5 nonsense mediated mRNA decay
hsa:402135,0.0,0.0,1.4878395288709677e-05,3.367737301797152e-05,0.0,0.00014717245,False,OR5K2; olfactory receptor family 5 subfamily K member
hsa:28960,0.0,0.0,2.4914950258451613e-05,8.476745035806187e-05,0.0,0.00036342815,False,DCPS; decapping enzyme
hsa:9770,0.00011015622,0.07787020090747325,0.0002801990466129032,0.00047273582137325414,0.0,0.0018504685,False,RASSF2; Ras association domain family member
hsa:9219,1.3042215e-07,9.219632829888872e-05,3.8047748944580646e-06,1.006352650399e-05,0.0,3.7707872e-05,False,MTA2; metastasis associated 1 family member
hsa:3705,3.010185e-07,0.00021279207902982,8.528594010967742e-06,2.5170972949550592e-05,0.0,0.00013160527,False,ITPK1; inositol-tetrakisphosphate
hsa:1288,0.0,0.0,2.5024677193548387e-06,1.027550386737755e-05,0.0,5.634673e-05,False,COL4A6; collagen type IV alpha 6
hsa:8458,0.0,0.0,5.222549953995484e-05,0.00012489902980984078,0.0,0.0005307655,False,TTF2; transcription termination factor
hsa:5799,0.0,0.0,2.337838152483871e-05,6.088424414615846e-05,0.0,0.0002855837,False,PTPRN2; protein tyrosine phosphatase receptor type
hsa:6330,0.0,0.0,2.734699720000001e-07,7.874821228143523e-07,0.0,3.1492793e-06,False,SCN4B; sodium voltage-gated channel beta subunit
hsa:56922,6.8573524e-07,0.0004847510282046205,3.5676035229032258e-06,7.57364709904059e-06,0.0,3.9474628e-05,False,MCCC1; methylcrotonyl-CoA carboxylase subunit
hsa:117608,0.0,0.0,1.4265640835483873e-08,4.056420458877315e-08,0.0,2.0062346e-07,False,ZNF354B; zinc finger protein
hsa:29780,4.8964456e-08,3.461331576233402e-05,6.538753496290322e-07,1.117630612328007e-06,0.0,4.0145774e-06,False,PARVB; parvin
hsa:1378,0.0,0.0,1.3184954241161292e-05,3.605793573812339e-05,0.0,0.00014808367,False,CR1; complement C3b/C4b receptor 1 (Knops blood
hsa:51655,1.6328354e-06,0.0011542627429194142,0.00019575582472258069,0.0005966522903198179,0.0,0.002528378,False,RASD1; ras related dexamethasone induced
hsa:2618,4.306854e-05,0.030445451583138456,0.00010120797283870969,0.00016945939391338637,0.0,0.000630895,False,GART; phosphoribosylglycinamide formyltransferase
hsa:3998,0.0,0.0,5.775898816967742e-07,1.4172525496565368e-06,0.0,5.3579492e-06,False,LMAN1; lectin
hsa:8792,2.3010227e-06,0.0016266090098376337,9.780180093548387e-06,1.7745853748977388e-05,0.0,5.966659e-05,False,TNFRSF11A; TNF receptor superfamily member
hsa:50515,0.0,0.0,0.0006955049831709677,0.0014499005087142934,0.0,0.00462087,False,CHST11; carbohydrate sulfotransferase
hsa:6444,7.60837e-05,0.05378409866264404,0.00018975901455580644,0.0003552359429946239,0.0,0.0018652643,False,SGCD; sarcoglycan
hsa:9091,2.0292922e-05,0.01434520822464391,6.751745602387099e-05,0.0001266814820903166,0.0,0.0005669944,False,PIGQ; phosphatidylinositol glycan anchor biosynthesis class
hsa:9197,0.0,0.0,0.0002524059864302903,0.0006702690673175653,0.0,0.0025097341,False,SLC33A1; solute carrier family 33 member
hsa:55703,8.777408e-07,0.0006204810989400897,1.0931361359354836e-05,1.876982232771858e-05,0.0,6.9097514e-05,False,POLR3B; RNA polymerase III subunit
hsa:10243,0.0,0.0,2.1955629790322583e-06,8.46643515137773e-06,0.0,4.215733e-05,False,GPHN;
hsa:203068,4.0887693e-07,0.00028903795614565274,5.134941426709677e-05,0.00014644811777643593,0.0,0.0005679917,False,TUBB; tubulin beta class
hsa:3032,3.7865004e-06,0.002676703565937791,4.85299007548387e-05,9.648818141875014e-05,0.0,0.00030285958,False,HADHB; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:9807,2.4099808e-07,0.0001703632251353152,1.2904125896774193e-06,3.0057186954954618e-06,0.0,1.6135216e-05,False,IP6K1; inositol hexakisphosphate kinase
hsa:10062,5.113271e-05,0.036146069651296735,0.0001297708752516129,0.00020445620653474636,0.0,0.0007510468,False,NR1H3; nuclear receptor subfamily 1 group H member
hsa:414062,4.65545e-05,0.032909701042273996,0.00029724275548387096,0.00046701332312402543,0.0,0.0015805907,False,CCL3L3; C-C motif chemokine ligand 3 like
hsa:59067,0.0,0.0,0.0,0.0,0.0,0.0,False,IL21; interleukin
hsa:5289,0.0,0.0,3.2110905419354836e-05,9.089933913671148e-05,0.0,0.000373153,False,PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type
hsa:9871,0.0,0.0,2.2065404767741936e-07,4.4742253763167e-07,0.0,1.8110584e-06,False,SEC24D; SEC24 homolog D
hsa:79071,4.1868043e-06,0.0029596811873289853,7.131944116516127e-05,0.0001623683171070552,0.0,0.00064603833,False,ELOVL6; ELOVL fatty acid elongase
hsa:5732,4.51673e-05,0.03192907967837055,0.00010163281821290321,0.00015868053031442596,0.0,0.00064185134,False,PTGER2; prostaglandin E receptor
hsa:5885,0.0,0.0,5.673644935341936e-07,1.570722951676234e-06,0.0,6.2278864e-06,False,RAD21; RAD21 cohesin complex
hsa:196385,0.0,0.0,4.6261816325806454e-08,1.4511331267127613e-07,0.0,7.2760434e-07,False,DNAH10; dynein axonemal heavy chain
hsa:5535,0.0,0.0,7.009786441935484e-07,1.8969638784202482e-06,0.0,9.705445e-06,False,PPP3R2; protein phosphatase 3 regulatory subunit B
hsa:1543,0.0,0.0,0.00012086203994193548,0.0005676408415276491,0.0,0.0031546983,False,CYP1A1; cytochrome P450 family 1 subfamily A member
hsa:10600,0.0,0.0,1.9325883645243222e-05,5.3692017457635516e-05,0.0,0.00019985788,False,USP16; ubiquitin specific peptidase
hsa:79154,3.4500328e-08,2.4388522706513758e-05,6.232918893612903e-06,1.3287635561196304e-05,0.0,5.991732e-05,False,DHRS11; dehydrogenase/reductase
hsa:129685,0.0,0.0,7.290226782580644e-07,1.5548421729412633e-06,0.0,6.582661e-06,False,TAF8; TATA-box binding protein associated factor
hsa:2961,0.0,0.0,2.1438980096774194e-07,4.835072198900245e-07,0.0,1.9425675e-06,False,GTF2E2; general transcription factor IIE subunit
hsa:26533,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10G3; olfactory receptor family 10 subfamily G member
hsa:3643,0.0002445913,0.17290329743722196,0.000534076779032258,0.0007060702362244785,0.0,0.0027391703,False,INSR; insulin
hsa:2235,0.0,0.0,4.30165491051613e-05,0.00012477770896809405,0.0,0.0006161874,False,FECH;
hsa:1260,0.0,0.0,8.794292031290322e-07,4.862120625969907e-06,0.0,2.707676e-05,False,CNGA2; cyclic nucleotide gated channel subunit alpha
hsa:100101267,0.0,0.0,6.883943661290323e-08,1.068849032487579e-07,0.0,3.2771518e-07,False,POM121C; POM121 transmembrane nucleoporin
hsa:84952,0.0,0.0,1.502224143e-05,4.43211271616988e-05,0.0,0.00015757426,False,CGNL1; cingulin like
hsa:55584,1.03841415e-08,7.340622116995577e-06,7.087941491451613e-07,2.769005105460073e-06,0.0,1.5392217e-05,False,CHRNA9; cholinergic receptor nicotinic alpha 9
hsa:290,0.00034227912,0.24195949934405106,0.0006798438361290323,0.0007099507218574073,0.0,0.00201234,False,ANPEP; alanyl aminopeptidase
hsa:11059,0.0,0.0,2.638164018064516e-07,5.279195868741246e-07,0.0,1.9059883e-06,False,WWP1; WW domain containing E3 ubiquitin protein ligase
hsa:392376,-0.0,0.0,3.3095880645161293e-07,1.8427006481260484e-06,-0.0,1.0259723e-05,False,OR13C2; olfactory receptor family 13 subfamily C member
hsa:1677,0.0,0.0,4.8158726290322594e-08,1.0671250168338393e-07,0.0,4.350586e-07,False,DFFB; DNA fragmentation factor subunit
hsa:79541,0.0,0.0,0.0,0.0,0.0,0.0,False,OR2A4; olfactory receptor family 2 subfamily A member
hsa:58,0.0,0.0,1.0107973645161291e-07,2.5925213416503337e-07,0.0,1.0872053e-06,False,ACTA1; actin alpha 1
hsa:909,0.0,0.0,0.0,0.0,0.0,0.0,False,CD1A; CD1a
hsa:282616,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNL2; interferon lambda
hsa:93183,0.0,0.0,9.405285529032259e-06,2.8123398763825686e-05,0.0,0.00012844393,False,PIGM; phosphatidylinositol glycan anchor biosynthesis class
hsa:2831,-0.0,0.0,0.0,0.0,0.0,0.0,False,NPBWR1; neuropeptides B and W receptor
hsa:672,1.6726362e-05,0.01182398206284789,6.600112370967742e-05,8.144279880859127e-05,0.0,0.00027598717,False,BRCA1; BRCA1 DNA repair
hsa:5213,0.0,0.0,3.5706673e-05,0.00012798432472672773,0.0,0.00069400435,False,PFKM; phosphofructokinase
hsa:8681,0.0,0.0,0.00014523743021935484,0.00032209208871247335,0.0,0.0012033705,False,JMJD7-PLA2G4B; JMJD7-PLA2G4B
hsa:693200,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR615; microRNA
hsa:9152,0.0,0.0,2.040752428387097e-08,7.4945042009698e-08,0.0,4.0654913e-07,False,SLC6A5; solute carrier family 6 member
hsa:6778,0.00017294627,0.12225692558348603,0.00039308707685354845,0.0005348090213791939,0.0,0.0016625847,False,STAT6; signal transducer and activator of transcription
hsa:6130,0.0,0.0,8.489175098387096e-07,1.5401265381806505e-06,0.0,5.148749e-06,False,RPL7A; ribosomal protein
hsa:27173,3.6225867e-08,2.560831827142766e-05,2.531211345038709e-07,4.3596980528961707e-07,0.0,2.0622704e-06,False,SLC39A1; solute carrier family 39 member
hsa:6843,3.6043014e-07,0.00025479058209249293,7.746624946258066e-05,0.00019466506519582718,0.0,0.00093510246,False,VAMP1; vesicle associated membrane protein
hsa:4086,0.0,0.0,6.0613905806451615e-06,1.8551687119198872e-05,0.0,7.557335e-05,False,SMAD1; SMAD family member
hsa:2782,0.0,0.0,0.00029816678620387093,0.0007803932529216469,0.0,0.0031844077,False,GNB1; G protein subunit beta
hsa:8555,0.0,0.0,9.188731799999999e-07,1.840924052804694e-06,0.0,8.626393e-06,False,CDC14B; cell division cycle
hsa:51109,0.0,0.0,3.5559081677419354e-05,0.00010616396147071398,0.0,0.0005493018,False,RDH11; retinol dehydrogenase
hsa:6654,0.0,0.0,7.092985029032258e-05,0.00012750087350414733,0.0,0.00039307313,False,SOS1; SOS Ras/Rac guanine nucleotide exchange factor
hsa:404672,1.416208e-07,0.00010011273216053608,9.346234013225805e-07,1.3582036393042455e-06,0.0,5.1082e-06,False,GTF2H5; general transcription factor IIH subunit
hsa:3693,1.215737e-05,0.008594129722375077,0.0003217592381709677,0.0005046601334821053,0.0,0.001934876,False,ITGB5; integrin subunit beta
hsa:9958,0.0,0.0,1.653696216129032e-07,3.406749534461008e-07,0.0,1.475126e-06,False,USP15; ubiquitin specific peptidase
hsa:8754,0.0,0.0,4.928021611287097e-05,0.00011287184524381287,0.0,0.00046673426,False,ADAM9; ADAM metallopeptidase domain
hsa:952,0.0,0.0,3.4347685741935487e-05,8.384662453442809e-05,0.0,0.00038676916,False,CD38; CD38
hsa:1040,4.6399265e-08,3.27999643370941e-05,7.016195720967743e-07,1.9108268673525513e-06,0.0,1.0443782e-05,False,CDS1; CDP-diacylglycerol synthase
hsa:8288,0.0,0.0,5.6985935483870967e-08,3.1728426076962773e-07,0.0,1.766564e-06,False,EPX; eosinophil
hsa:2153,0.0,0.0,6.223119980645162e-08,3.323914285017564e-07,0.0,1.8526026e-06,False,F5; coagulation factor
hsa:89849,2.0198915e-08,1.4278754020090514e-05,1.4333782461290317e-07,2.2054052304249845e-07,0.0,7.5208186e-07,False,ATG16L2; autophagy related 16 like
hsa:9488,3.6698973e-06,0.002594276020553298,1.6847786306451614e-05,2.383526784624845e-05,0.0,8.27234e-05,False,PIGB; phosphatidylinositol glycan anchor biosynthesis class
hsa:768,1.2825404e-07,9.066367620453125e-05,1.4908555546451615e-05,4.2646424998360694e-05,0.0,0.00023277967,False,CA9; carbonic anhydrase
hsa:4495,0.0,0.0,5.468332227122581e-05,0.00017659985807780114,0.0,0.0009379416,False,MT1G; metallothionein
hsa:55801,0.0,0.0,1.6269503029032256e-08,5.603133564427097e-08,0.0,2.3321178e-07,False,IL26; interleukin
hsa:55904,5.9075137e-07,0.000417606267428794,3.0839049324732254e-05,5.6594130675388425e-05,0.0,0.00020276119,False,KMT2E; lysine methyltransferase 2E
hsa:1633,0.0,0.0,3.2356821802774193e-06,9.36376730663145e-06,0.0,4.2278843e-05,False,DCK; deoxycytidine
hsa:10978,1.1837959e-08,8.368335856699069e-06,5.049371996451614e-07,1.0389692547800758e-06,0.0,4.53753e-06,False,CLP1; cleavage factor polyribonucleotide kinase subunit
hsa:8853,0.0,0.0,1.8792602838709676e-07,5.288332119206702e-07,0.0,2.489935e-06,False,ASAP2; ArfGAP with SH3 domain
hsa:669,1.3458879e-06,0.0009514175520178277,6.820762893870967e-05,0.0001514069716609553,0.0,0.0006536445,False,BPGM; bisphosphoglycerate
hsa:8930,3.4772556e-06,0.0024580962580109996,3.342157506888709e-05,0.00010193552557308571,0.0,0.0004834275,False,MBD4; methyl-CpG binding domain 4
hsa:84667,0.0,0.0,1.152660590129032e-08,2.36931279251462e-08,0.0,9.851856e-08,False,HES7; hes family bHLH transcription factor
hsa:767,0.0,0.0,5.648669189161291e-05,0.00017070153905394172,0.0,0.00070173776,False,CA8; carbonic anhydrase
hsa:9456,0.0,0.0,3.315640907161289e-05,0.000138811426523793,0.0,0.00077230507,False,HOMER1; homer scaffold protein
hsa:112483,1.8293844e-06,0.0012932046031081804,9.197020596774193e-05,0.00024975361222009425,0.0,0.00096900656,False,SAT2; spermidine/spermine N1-acetyltransferase family member
hsa:10026,1.5114194e-05,0.010684329249265514,5.970088607096774e-05,8.393484604865294e-05,0.0,0.00033516623,False,PIGK; phosphatidylinositol glycan anchor biosynthesis class
hsa:5451,0.0,0.0,4.4426063432419355e-07,8.325220919334508e-07,0.0,3.11042e-06,False,POU2F1; POU class 2 homeobox
hsa:51455,1.5658765e-05,0.011069290290760798,7.548763986451613e-05,0.00014282857561639153,0.0,0.0006457112,False,REV1; REV1 DNA directed
hsa:5498,0.0,0.0,2.0914785606451613e-05,4.7619967520883004e-05,0.0,0.00017662464,False,PPOX; protoporphyrinogen
hsa:5883,1.61032e-08,1.1383464494816753e-05,4.285560898258064e-07,5.663030630590785e-07,0.0,1.9391111e-06,False,RAD9A; RAD9 checkpoint clamp component
hsa:80168,0.0,0.0,8.915093548387097e-09,4.96371401500055e-08,0.0,2.763679e-07,False,MOGAT2; monoacylglycerol O-acyltransferase
hsa:8864,2.2920933e-05,0.016202967546423922,0.0004602945116935484,0.0007144157868208052,0.0,0.0025117826,False,PER2; period circadian regulator
hsa:998,0.00017833157,0.1260638317477227,0.0002588261364516129,0.0003320697645285312,0.0,0.0016745527,False,CDC42; cell division cycle
hsa:388567,0.0,0.0,5.06199280967742e-08,8.978110413038206e-08,0.0,3.6167913e-07,False,ZNF749; zinc finger protein
hsa:441639,0.0,0.0,1.3930794838709677e-07,7.756338304886417e-07,-0.0,4.3185464e-06,False,OR9K2; olfactory receptor family 9 subfamily K member
hsa:7036,0.0,0.0,2.7503930866193543e-07,5.813302098491886e-07,0.0,2.3300797e-06,False,TFR2; transferrin receptor
hsa:8818,1.0926366e-06,0.0007723924401260181,9.737688436774193e-05,0.00015917325656077832,0.0,0.0005083467,False,DPM2; dolichyl-phosphate mannosyltransferase subunit 2
hsa:2744,1.4805499e-05,0.01046611059879682,0.0002531927722258065,0.0003476247093370009,0.0,0.0010933548,False,GLS;
hsa:26493,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8B8; olfactory receptor family 8 subfamily B member
hsa:7082,2.900733e-06,0.0020505484074248154,8.926830752903223e-05,0.00017114396466372196,0.0,0.00081040914,False,TJP1; tight junction protein
hsa:9113,0.0,0.0,2.6765203225806452e-05,4.779489441619253e-05,0.0,0.00014427607,False,LATS1; large tumor suppressor kinase
hsa:84938,0.0,0.0,3.980264029067742e-05,9.639479255094943e-05,0.0,0.000382053,False,ATG4C; autophagy related 4C cysteine
hsa:441670,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4M1; olfactory receptor family 4 subfamily M member
hsa:64926,2.486992e-07,0.000175807200624058,1.1116091273225805e-06,1.602118818344471e-06,0.0,5.416247e-06,False,RASAL3; RAS protein activator like
hsa:7201,0.0,0.0,5.443905080645162e-09,2.8055596984368004e-08,0.0,1.5611639e-07,False,TRHR; thyrotropin releasing hormone
hsa:2335,7.012276e-05,0.049570268563922486,0.0003935236526774193,0.0006863378593249746,0.0,0.0030227308,False,FN1; fibronectin
hsa:79346,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C5; olfactory receptor family 4 subfamily C member
hsa:3207,2.4206082e-09,1.7111448346019603e-06,1.3245017905709672e-06,4.6322382374002536e-06,0.0,2.2958171e-05,False,HOXA11; homeobox
hsa:57492,2.2091328e-06,0.0015616513980535,1.0835692745387096e-05,1.7716255761840337e-05,0.0,5.947791e-05,False,ARID1B; AT-rich interaction domain
hsa:414189,2.3938304e-08,1.6922154208488367e-05,5.284657540000001e-07,1.0014921363918092e-06,0.0,4.6077544e-06,False,AGAP6; ArfGAP with GTPase domain
hsa:6142,3.7333442e-07,0.0002639127077079714,1.292369587496774e-06,2.355239533328255e-06,0.0,1.0195148e-05,False,RPL18A; ribosomal protein
hsa:55471,2.326073e-07,0.0001644317241781254,1.1567418912903223e-06,2.228339477875358e-06,0.0,8.874522e-06,False,NDUFAF7; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:10666,0.0,0.0,6.183622329032256e-07,2.9289918818365585e-06,0.0,1.6318016e-05,False,CD226; CD226
hsa:26281,0.0,0.0,4.056887684516129e-07,1.0902785492978021e-06,0.0,5.4232996e-06,False,FGF20; fibroblast growth factor
hsa:185,5.8704223e-05,0.04149842504696614,0.00016835607922580643,0.0002320156004055066,0.0,0.00081647234,False,AGTR1; angiotensin II receptor type
hsa:3283,0.0,0.0,3.6724974838709675e-07,1.8636209540901e-06,0.0,1.035967e-05,False,HSD3B1; hydroxy-delta-5-steroid dehydrogenase
hsa:128360,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10T2; olfactory receptor family 10 subfamily T member
hsa:55850,0.0,0.0,9.868757814161291e-06,2.8494952911419455e-05,0.0,0.00012987881,False,USE1; unconventional SNARE in the ER
hsa:54840,6.4252635e-07,0.00045420636222671284,0.00011457619747069032,0.00031333219168212356,0.0,0.001229207,False,APTX;
hsa:8794,0.0,0.0,5.392545258064516e-07,2.5343804003856205e-06,0.0,1.392531e-05,False,TNFRSF10C; TNF receptor superfamily member
hsa:3578,0.0,0.0,0.0,0.0,0.0,0.0,False,IL9; interleukin
hsa:1591,0.0,0.0,7.732475421935484e-06,2.8690663168825682e-05,0.0,0.00015474392,False,CYP24A1; cytochrome P450 family 24 subfamily A member
hsa:81876,0.0,0.0,7.1089552235483885e-06,2.1870847689525825e-05,0.0,0.000102204,False,RAB1B; RAB1B
hsa:401666,0.0,0.0,0.0,0.0,0.0,0.0,False,OR51A4; olfactory receptor family 51 subfamily A member
hsa:254783,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C74; olfactory receptor family 6 subfamily C member
hsa:5338,0.0,0.0,8.862949658064517e-05,0.0001450550200159281,0.0,0.00047556998,False,PLD2; phospholipase
hsa:7752,1.3308391e-08,9.40779450243671e-06,1.2822340759677422e-07,2.5897733681982194e-07,0.0,1.1813785e-06,False,ZNF200; zinc finger protein
hsa:574537,0.0,0.0,1.142385935483871e-07,6.360535700185335e-07,0.0,3.5413964e-06,False,UGT2A2; UDP glucuronosyltransferase family 2 member
hsa:37,0.0,0.0,3.4893393139032253e-05,6.414801805400314e-05,0.0,0.00025959304,False,ACADVL; acyl-CoA dehydrogenase very long
hsa:7006,4.4154586e-07,0.00031213185082116157,2.239750269354839e-06,4.099211482189342e-06,0.0,1.4780244e-05,False,TEC; tec protein tyrosine
hsa:3562,0.0,0.0,0.0,0.0,0.0,0.0,False,IL3; interleukin
hsa:5139,0.0,0.0,4.072294897419355e-05,9.126729658691555e-05,0.0,0.00043344608,False,PDE3A; phosphodiesterase
hsa:84335,0.0,0.0,1.147185782867742e-05,2.4475828076290496e-05,0.0,9.545258e-05,False,AKT1S1; AKT1 substrate
hsa:142,0.0,0.0,5.6580551774193554e-06,1.5907563956806302e-05,0.0,8.222711e-05,False,PARP1; poly(ADP-ribose) polymerase
hsa:138474,-0.0,0.0,1.392639787096774e-09,4.202934268094128e-09,0.0,1.8023924e-08,False,TAF1L; TATA-box binding protein associated factor 1
hsa:2587,2.3762384e-07,0.00016797795132408573,6.5902187543554846e-06,2.197894542329267e-05,0.0,0.00012135733,False,GALR1; galanin receptor
hsa:4199,1.1990203e-07,8.475958203099093e-05,9.323471968870968e-06,2.5242315308146525e-05,0.0,0.00011588091,False,ME1; malic enzyme
hsa:200916,0.0,0.0,3.7556458377419347e-07,1.011877781160166e-06,0.0,4.58551e-06,False,RPL22L1; ribosomal protein L22 like
hsa:112755,0.0,0.0,9.009945808741937e-06,3.124662164583006e-05,0.0,0.00014512293,False,STX1B; syntaxin
hsa:2066,0.0,0.0,6.723609754967743e-06,3.0257348610241492e-05,0.0,0.00016876216,False,ERBB4; erb-b2 receptor tyrosine kinase
hsa:139341,1.070164e-08,7.565064023070617e-06,4.073090768996775e-06,9.26372354454399e-06,0.0,3.8770264e-05,False,FUNDC1; FUN14 domain containing
hsa:1200,0.0,0.0,3.47324180483871e-07,8.522509590622088e-07,0.0,4.2134825e-06,False,TPP1; tripeptidyl peptidase
hsa:5502,0.0,0.0,1.6231601053548388e-06,2.638341550914802e-06,0.0,9.88815e-06,False,PPP1R1A; protein phosphatase 1 regulatory inhibitor subunit
hsa:390648,0.0,0.0,1.094688e-07,6.094964834817675e-07,-0.0,3.3935328e-06,False,OR4F6; olfactory receptor family 4 subfamily F member
hsa:160,0.0,0.0,0.00010261719258387097,0.0002633248624217339,0.0,0.001334995,False,AP2A1; adaptor related protein complex 2 subunit alpha
hsa:6351,0.0,0.0,0.00013230398820870964,0.00029196474160140537,0.0,0.001110707,False,CCL4; C-C motif chemokine ligand
hsa:574493,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520H; microRNA
hsa:23493,3.911409e-06,0.002765002327252143,0.00020630053880161292,0.00047135425547818933,0.0,0.0017376937,False,HEY2; hes related family bHLH transcription factor with YRPW motif
hsa:5494,5.3059836e-08,3.750836847376918e-05,1.9249959811290325e-07,3.204891166393087e-07,0.0,1.3276801e-06,False,PPM1A; protein phosphatase
hsa:286204,0.0,0.0,6.591706608709678e-08,2.1017641275091398e-07,0.0,1.1393927e-06,False,CRB2; crumbs cell polarity complex component
hsa:23160,0.0,0.0,3.214622457752903e-07,6.628515381152358e-07,0.0,2.9405896e-06,False,WDR43; WD repeat domain
hsa:119774,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52K2; olfactory receptor family 52 subfamily K member
hsa:911,9.781095e-06,0.006914324336338721,4.572920844154839e-05,7.206723199002426e-05,0.0,0.00028160593,False,CD1C; CD1c
hsa:3119,0.00036793173,0.26009350843133694,0.000898345288548387,0.0013902031752974387,0.0,0.0052530267,False,HLA-DQB1; major histocompatibility complex
hsa:124540,2.634476e-07,0.0001862329475411525,1.067567982787097e-06,1.5489935661566739e-06,0.0,5.7750945e-06,False,MSI2; musashi RNA binding protein
hsa:1436,0.0,0.0,0.00018371932164516132,0.0003509061467443758,0.0,0.0012004718,False,CSF1R; colony stimulating factor 1
hsa:10815,0.0,0.0,4.950677082529032e-05,0.00016861303907683445,0.0,0.00084714964,False,CPLX1; complexin
hsa:53407,4.7245138e-08,3.339791786574829e-05,9.523589290729032e-05,0.00021311930199126547,0.0,0.0008987257,False,STX18; syntaxin
hsa:10133,1.2857059e-07,9.088744760933492e-05,2.9443242516129036e-06,6.876336028990455e-06,0.0,2.7164479e-05,False,OPTN;
hsa:38,5.241382e-05,0.03705169525359657,0.0002348920102419355,0.000324914296659347,0.0,0.0013334221,False,ACAT1; acetyl-CoA acetyltransferase
hsa:90550,9.3157126e-07,0.0006585342268991075,5.578278505483872e-06,1.0075619081897145e-05,0.0,4.7154987e-05,False,MCU; mitochondrial calcium
hsa:64840,8.581968e-08,6.066653089053949e-05,5.981495585967743e-06,1.8143641804679127e-05,0.0,8.59357e-05,False,PORCN; porcupine
hsa:7027,0.0,0.0,0.00023330910246774196,0.0007283991110259248,0.0,0.003246367,False,TFDP1; transcription factor
hsa:84433,2.0971846e-08,1.482514433974395e-05,1.1701239505161288e-06,2.2086952679164854e-06,0.0,7.956856e-06,False,CARD11; caspase recruitment domain family member
hsa:154796,0.0,0.0,6.763525580645161e-08,2.1330185958697872e-07,0.0,1.0754097e-06,False,AMOT;
hsa:2953,0.0,0.0,3.5887425483870966e-05,0.00011170180852415409,0.0,0.00048092013,False,GSTT2; glutathione S-transferase theta 2
hsa:23195,6.1492584e-09,4.346953690313334e-06,1.2103987848161289e-06,2.7185705006916242e-06,0.0,9.772384e-06,False,MDN1; midasin AAA ATPase
hsa:144715,1.9501687e-08,1.3785878679612092e-05,1.6506862534632257e-07,3.1411148834736635e-07,0.0,1.3241187e-06,False,RAD9B; RAD9 checkpoint clamp component
hsa:9550,0.0,0.0,7.33621548032258e-05,0.00023695490001497847,0.0,0.0010235861,False,ATP6V1G1; ATPase H+ transporting V1 subunit
hsa:4828,1.3441737e-06,0.0009502057720711702,2.2266684931935485e-05,4.095640428535784e-05,0.0,0.0001480315,False,NMB; neuromedin
hsa:7184,0.0,0.0,6.655574996774192e-05,0.00018801131812350372,0.0,0.0008783289,False,HSP90B1; heat shock protein 90 beta family member
hsa:5424,2.2899421e-05,0.016187760563450813,0.00018128682819354842,0.0003869023998480866,0.0,0.0018553529,False,POLD1; DNA polymerase delta 1
hsa:23007,1.4008077e-09,9.90240742027418e-07,6.396720499354838e-07,2.1204180077173254e-06,0.0,9.866362e-06,False,PLCH1; phospholipase C eta
hsa:54577,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A7; UDP glucuronosyltransferase family 1 member
hsa:389692,0.0,0.0,5.303598806451614e-06,1.350790625273113e-05,0.0,7.132303e-05,False,MAFA; MAF bZIP transcription factor
hsa:10163,0.0,0.0,6.451736947580644e-05,0.0001636867118840652,0.0,0.0007799929,False,WASF2; WASP family member
hsa:1278,7.5618445e-05,0.053455206655245766,0.00027404260054838706,0.00043758758110438675,0.0,0.0018142991,False,COL1A2; collagen type I alpha 2
hsa:8703,4.4214987e-05,0.03125588297066945,0.0001181794159032258,0.0001860623006872233,0.0,0.0008740955,False,B4GALT3; beta-1
hsa:3626,0.0,0.0,2.158651322580645e-08,9.742733183635153e-08,0.0,5.286343e-07,False,INHBC; inhibin subunit beta
hsa:23604,4.132144e-06,0.002921041439680938,1.9648117803677423e-05,3.7339030681239426e-05,0.0,0.00018653636,False,DAPK2; death associated protein kinase
hsa:51780,8.690565e-09,6.143421066458664e-06,2.9334165952709674e-06,6.655515466742747e-06,0.0,2.5320674e-05,False,KDM3B; lysine demethylase
hsa:5367,0.0,0.0,6.296364510032257e-07,1.5169064274851694e-06,-0.0,6.829819e-06,False,PMCH; pro-melanin concentrating
hsa:9112,0.0,0.0,9.560696021032257e-06,3.1338778030363656e-05,0.0,0.0001412927,False,MTA1; metastasis associated
hsa:26301,2.7349981e-06,0.0019333892496361767,0.000274677558553871,0.0007198163748972694,0.0,0.0032016698,False,GBGT1; globoside alpha-1
hsa:9462,0.0,0.0,2.962544369354838e-07,7.102598123695511e-07,0.0,2.7559158e-06,False,RASAL2; RAS protein activator like
hsa:5295,0.0,0.0,7.21181454548387e-05,0.0002037315932634858,0.0,0.00087870494,False,PIK3R1; phosphoinositide-3-kinase regulatory subunit
hsa:406918,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-2; microRNA
hsa:26189,0.0,0.0,9.730973548387096e-09,5.4179767738351316e-08,0.0,3.0166018e-07,False,OR1A2; olfactory receptor family 1 subfamily A member
hsa:51144,0.0,0.0,0.00022376883431290324,0.0003901361889373583,0.0,0.0014305095,False,HSD17B12; hydroxysteroid 17-beta dehydrogenase
hsa:162993,0.0,0.0,3.2055356880645166e-08,6.471550357901757e-08,0.0,2.1154308e-07,False,ZNF846; zinc finger protein
hsa:9744,0.0,0.0,3.505200325483871e-07,6.795761511245419e-07,0.0,2.9290832e-06,False,ACAP1; ArfGAP with coiled-coil
hsa:23163,0.0,0.0,3.3823838103548395e-07,6.737755633370648e-07,0.0,2.5370068e-06,False,GGA3; golgi associated
hsa:406986,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR203A; microRNA
hsa:4791,1.7307655e-05,0.012234902142495757,4.0613047193548385e-05,5.1970116286275496e-05,0.0,0.00020409134,False,NFKB2; nuclear factor kappa B subunit
hsa:130367,0.0,0.0,7.102734805290322e-06,2.0854269216890555e-05,0.0,8.890876e-05,False,SGPP2; sphingosine-1-phosphate phosphatase
hsa:84254,2.1449191e-09,1.5162582852541302e-06,6.993299107874194e-06,1.6136516910523848e-05,0.0,6.177363e-05,False,CAMKK1; calcium/calmodulin dependent protein kinase kinase
hsa:4051,-0.0,0.0,4.1217583258064516e-07,1.2648349513271802e-06,-0.0,6.3447155e-06,False,CYP4F3; cytochrome P450 family 4 subfamily F member
hsa:10308,6.6115557e-09,4.673754878934208e-06,7.953525882903225e-08,1.2612949006325892e-07,0.0,5.4022905e-07,False,ZNF267; zinc finger protein
hsa:55738,1.786133e-08,1.2626298865145145e-05,8.79558362448387e-07,1.3773990927938594e-06,0.0,4.7772783e-06,False,ARFGAP1; ADP ribosylation factor GTPase activating protein
hsa:163227,0.0,0.0,1.3026743241935484e-08,2.6028556995417703e-08,0.0,1.02603046e-07,False,ZNF100; zinc finger protein
hsa:80343,-0.0,0.0,3.287337586096774e-08,1.3953449825959272e-07,0.0,7.607101e-07,False,SEL1L2; SEL1L2 adaptor subunit of SYVN1 ubiquitin
hsa:3420,0.0,0.0,3.760871902903226e-06,7.439568362570991e-06,0.0,2.8858478e-05,False,IDH3B; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:4325,0.0,0.0,5.664531780645162e-07,1.3176729777942255e-06,0.0,5.362681e-06,False,MMP16; matrix metallopeptidase
hsa:9341,0.0,0.0,7.759363188966776e-05,0.0002505869357690237,0.0,0.0011631859,False,VAMP3; vesicle associated membrane protein
hsa:26,0.0,0.0,3.6509698634193553e-06,1.3387004446557186e-05,0.0,7.148291e-05,False,AOC1; amine oxidase copper containing
hsa:6755,0.0,0.0,2.6921489677419355e-08,1.4705970555795798e-07,0.0,8.191625e-07,False,SSTR5; somatostatin receptor
hsa:4886,2.9949267e-06,0.0021171345915115447,2.4509709501612903e-05,6.02472603965783e-05,0.0,0.0002461049,False,NPY1R; neuropeptide Y receptor
hsa:26872,2.4025218e-07,0.00016983594321826246,1.9649144582580643e-05,4.14831356707028e-05,0.0,0.00018608016,False,STEAP1; STEAP family member
hsa:9048,0.0,0.0,1.2628709729032256e-07,3.3245385172607287e-07,0.0,1.7824657e-06,False,ARTN;
hsa:477,0.003133189,2.214873176576731,0.0035976698470774194,0.0027696077842611073,0.0,0.010366389,True,ATP1A2; ATPase Na+/K+ transporting subunit alpha
hsa:10629,8.617048e-09,6.091451385943896e-06,1.0579629209032258e-06,2.0476654270019214e-06,0.0,9.572632e-06,False,TAF6L; TATA-box binding protein associated factor 6
hsa:223,0.0003443467,0.24342108607961874,0.00040112018258064514,0.00041439762397246977,0.0,0.0014406795,False,ALDH9A1; aldehyde dehydrogenase 9 family member
hsa:83937,0.00012629216,0.08927680953684465,0.00021007684032258063,0.0002782380973335573,0.0,0.0012134911,False,RASSF4; Ras association domain family member
hsa:347168,0.0,0.0,3.4108943032258063e-07,1.1796685671308229e-06,0.0,6.2999666e-06,False,OR1J1; olfactory receptor family 1 subfamily J member
hsa:4683,2.8111065e-06,0.001987190808901249,2.4556149630967745e-05,4.140104612050964e-05,0.0,0.00017344135,False,NBN;
hsa:795,-0.0,0.0,5.732851935483871e-07,3.191916870376823e-06,0.0,1.7771841e-05,False,S100G; S100 calcium binding protein
hsa:57016,1.707085e-05,0.01206750303488391,4.983087931290322e-05,6.933754352159659e-05,0.0,0.00024454706,False,AKR1B10; aldo-keto reductase family 1 member
hsa:5284,0.0,0.0,1.8224568864516131e-07,7.744162481013655e-07,0.0,4.155684e-06,False,PIGR; polymeric immunoglobulin
hsa:205,0.0,0.0,1.8432311725806452e-05,6.013053240109075e-05,0.0,0.00033049914,False,AK4; adenylate kinase
hsa:64106,-0.0,0.0,1.4041893846935485e-07,2.531988608663839e-07,0.0,9.256488e-07,False,NPFFR1; neuropeptide FF receptor
hsa:23534,0.0,0.0,1.56491291e-05,2.5447232592324916e-05,0.0,9.461673e-05,False,TNPO3; transportin
hsa:9371,1.6195452e-08,1.1448678077618671e-05,8.227057483548387e-07,2.2488472591139903e-06,0.0,9.086158e-06,False,KIF3B; kinesin family member
hsa:4499,1.2044508e-05,0.008514346786696828,0.00023798752593203227,0.00037727089814125155,0.0,0.0012770122,False,MT1M; metallothionein
hsa:730087,0.0,0.0,4.8997531554838716e-09,1.1060226423762702e-08,0.0,4.845095e-08,False,ZNF726; zinc finger protein
hsa:6363,0.0,0.0,5.3847473580645167e-05,0.00012197571517406798,0.0,0.00054561684,False,CCL19; C-C motif chemokine ligand
hsa:5008,7.939594e-06,0.005612554424105775,0.00016461167054132255,0.0003823530644892209,0.0,0.0018260271,False,OSM; oncostatin
hsa:4838,0.0,0.0,3.1054629032258065e-09,1.022838298868894e-08,0.0,4.450546e-08,False,NODAL; nodal growth differentiation
hsa:57711,2.1161075e-08,1.4958911640832534e-05,1.587320492580645e-07,3.8275063348167643e-07,0.0,1.5658673e-06,False,ZNF529; zinc finger protein
hsa:245972,0.0,0.0,2.2426794225806453e-07,7.701449850236055e-07,0.0,4.0937025e-06,False,ATP6V0D2; ATPase H+ transporting V0 subunit
hsa:55515,0.0,0.0,2.8360236689354835e-05,0.0001298589374636117,0.0,0.0007226505,False,ASIC4; acid sensing ion channel subunit family member
hsa:1371,0.0,0.0,3.853886934774193e-05,0.00011314036902295036,0.0,0.00053641055,False,CPOX; coproporphyrinogen
hsa:83444,1.0521207e-08,7.437514675786023e-06,6.877029265709677e-06,1.7853720647867132e-05,0.0,5.956925e-05,False,INO80B; INO80 complex subunit
hsa:9559,0.0,0.0,2.019287010096774e-07,6.000631605158751e-07,0.0,2.7641331e-06,False,VPS26A; VPS26 retromer complex component
hsa:693187,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR602; microRNA
hsa:1469,0.0,0.0,1.2075886754516128e-06,3.61791410786485e-06,0.0,1.9373801e-05,False,CST1; cystatin
hsa:136227,0.0,0.0,5.192104019354839e-07,9.605383904751678e-07,0.0,3.3562376e-06,False,COL26A1; collagen type XXVI alpha 1
hsa:4773,0.00036718196,0.25956349078426805,0.0004375797322903226,0.0004843832641688416,0.0,0.0021689956,False,NFATC2; nuclear factor of activated T cells
hsa:65083,0.0,0.0,9.789060280161291e-07,2.844358017735228e-06,0.0,1.2756543e-05,False,NOL6; nucleolar protein
hsa:10231,2.5863167e-07,0.00018282853300463035,2.404200917741935e-06,4.464129037698297e-06,0.0,1.8369663e-05,False,RCAN2; regulator of calcineurin
hsa:27068,0.0,0.0,3.5559063032258067e-07,8.910054406009928e-07,0.0,3.6876622e-06,False,PPA2; inorganic pyrophosphatase
hsa:51601,4.5483857e-06,0.0032152856031523076,8.424808689258063e-06,1.1229809040645796e-05,0.0,4.2202297e-05,False,LIPT1; lipoyltransferase
hsa:51366,0.0,0.0,1.244136562580645e-06,2.4917107199932446e-06,0.0,1.0601203e-05,False,UBR5; ubiquitin protein ligase E3 component n-recognin
hsa:140612,1.01052e-09,7.14343642338307e-07,8.816792701516128e-08,1.6662811059669993e-07,0.0,5.860094e-07,False,ZFP28; ZFP28 zinc finger
hsa:5596,0.0,0.0,9.659651317096774e-07,1.9548761057313e-06,0.0,6.792952e-06,False,MAPK4; mitogen-activated protein kinase
hsa:1132,9.026161e-07,0.0006380656221620528,3.4450647591935484e-05,0.00010714288881884498,0.0,0.00057877874,False,CHRM4; cholinergic receptor muscarinic
hsa:1375,0.0,0.0,1.6030099032258062e-08,8.925181412444247e-08,0.0,4.9693307e-07,False,CPT1B; carnitine palmitoyltransferase
hsa:79723,9.821727e-09,6.943047380786617e-06,2.160069293967742e-06,4.46565787828998e-06,0.0,1.8249828e-05,False,SUV39H2; SUV39H2 histone lysine
hsa:5609,0.0,0.0,1.552703811935484e-05,4.078726487345494e-05,0.0,0.00016866521,False,MAP2K7; mitogen-activated protein kinase kinase
hsa:4591,7.0126163e-09,4.957267416837848e-06,1.8730345833225808e-07,3.1523477772395336e-07,0.0,1.1367201e-06,False,TRIM37; tripartite motif containing
hsa:10479,2.142466e-06,0.0015145241717392862,0.00012203828151138709,0.00024358587080045965,0.0,0.0008232085,False,SLC9A6; solute carrier family 9 member
hsa:1407,6.0052002e-06,0.004245117943077555,7.461675510451612e-05,0.00021672356993780042,0.0,0.0010339597,False,CRY1; cryptochrome circadian regulator
hsa:7108,0.0,0.0,3.956776927419355e-05,9.924743493367804e-05,0.0,0.0005031198,False,TM7SF2; transmembrane 7 superfamily member
hsa:5209,1.805995e-05,0.012766704729691354,0.00013063613074000002,0.00017136101602664217,0.0,0.00050287804,False,PFKFB3; 6-phosphofructo-2-kinase/fructose-2
hsa:83729,0.0,0.0,1.761288361935484e-06,3.5254957489259178e-06,0.0,1.5082542e-05,False,INHBE; inhibin subunit beta
hsa:3690,0.0007602955,0.5374581964962835,0.0010871135360645166,0.0011190815822919584,0.0,0.0034459475,True,ITGB3; integrin subunit beta
hsa:8906,8.1308804e-07,0.0005747776115616862,5.4539288837096775e-06,1.0514614385851657e-05,0.0,4.3232896e-05,False,AP1G2; adaptor related protein complex 1 subunit gamma
hsa:9655,0.0,0.0,3.2078764661290314e-05,6.786768506778208e-05,0.0,0.00022891564,False,SOCS5; suppressor of cytokine signaling
hsa:50484,0.0,0.0,8.416489932903225e-05,0.0001416053216083504,0.0,0.0004888794,False,RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit
hsa:378,0.0,0.0,4.83106419516129e-07,7.628524519046875e-07,0.0,2.7132103e-06,False,ARF4; ADP ribosylation factor
hsa:953,6.8024e-07,0.00048086640468690377,0.00012808426701322578,0.00023216105205412294,0.0,0.0010189273,False,ENTPD1; ectonucleoside triphosphate diphosphohydrolase
hsa:191,0.0,0.0,2.8104501953548385e-06,8.651049003989989e-06,0.0,3.4234778e-05,False,AHCY;
hsa:55168,6.0145744e-08,4.2517446304979e-05,2.4223307388709675e-07,4.7333600700842125e-07,0.0,2.0950804e-06,False,MRPS18A; mitochondrial ribosomal protein
hsa:3636,0.0,0.0,2.9667399600000004e-05,5.020724287533154e-05,0.0,0.00019013308,False,INPPL1; inositol polyphosphate phosphatase like
hsa:4216,5.118747e-07,0.0003618477987757078,1.6158889183870963e-06,2.0576882822908028e-06,0.0,6.9837797e-06,False,MAP3K4; mitogen-activated protein kinase kinase kinase
hsa:1015,0.0,0.0,1.9065523968387098e-07,5.899748694647033e-07,0.0,2.4312835e-06,False,CDH17; cadherin
hsa:5315,0.00022669914,0.1602552046298557,0.0003342846975806452,0.0003943661469092917,0.0,0.0014441705,False,PKM; pyruvate kinase
hsa:4357,0.00014233567,0.10061807875397152,0.0002226059018064516,0.00030253489409086496,0.0,0.001505326,False,MPST; mercaptopyruvate
hsa:57504,8.563258e-09,6.053426859441324e-06,1.8843257154838709e-07,2.7704530801885494e-07,0.0,1.1232463e-06,False,MTA3; metastasis associated 1 family member
hsa:2021,0.0,0.0,5.411924066129032e-07,9.746208913558377e-07,0.0,3.4745356e-06,False,ENDOG; endonuclease
hsa:50940,0.0,0.0,4.021242578709678e-06,1.0496847074680558e-05,0.0,4.5682493e-05,False,PDE11A; phosphodiesterase
hsa:57467,0.0,0.0,3.857237582903225e-06,2.124801717998801e-05,0.0,0.00011834242,False,HHATL; hedgehog acyltransferase
hsa:56904,1.3946463e-07,9.858852053553054e-05,4.663046068258064e-07,7.335683997372353e-07,0.0,2.9807e-06,False,SH3GLB2; SH3 domain containing GRB2 like
hsa:80896,0.0,0.0,2.250232206e-06,3.765649619858503e-06,0.0,1.4443221e-05,False,NPL; N-acetylneuraminate pyruvate
hsa:7991,0.0,0.0,6.740778101612904e-05,0.00015393706717335926,0.0,0.00063871604,False,TUSC3; tumor suppressor candidate
hsa:406937,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR145; microRNA
hsa:1013,6.873957e-07,0.0004859248189701245,7.155649919738065e-06,1.8491645492202058e-05,0.0,8.663561e-05,False,CDH15; cadherin
hsa:680,0.0,0.0,7.81791313548387e-09,3.120404573904305e-08,0.0,1.6739777e-07,False,BRS3; bombesin receptor subtype
hsa:84168,8.719884e-07,0.000616414687223165,1.8791093662258067e-06,2.9687520179198856e-06,0.0,1.231856e-05,False,ANTXR1; ANTXR cell adhesion molecule
hsa:761,0.0,0.0,4.960414128741936e-05,0.00015509741423790627,0.0,0.0006843102,False,CA3; carbonic anhydrase
hsa:8554,6.7405597e-07,0.0004764948707098133,3.016021544193548e-06,5.594780456439667e-06,0.0,2.1014559e-05,False,PIAS1; protein inhibitor of activated STAT
hsa:4291,4.775499e-07,0.00033758335803773734,6.773068379437097e-06,1.6931825430179463e-05,0.0,8.365373e-05,False,MLF1; myeloid leukemia factor
hsa:10314,0.0,0.0,6.544497906451613e-06,1.4300110421560591e-05,0.0,5.2914966e-05,False,LANCL1; LanC like glutathione S-transferase
hsa:90990,0.0,0.0,5.978597419354838e-08,1.326555442282018e-07,0.0,4.776061e-07,False,KIFC2; kinesin family member
hsa:332,0.0,0.0,1.332449976483871e-05,4.589861782805825e-05,0.0,0.00020185395,False,BIRC5; baculoviral IAP repeat containing
hsa:10250,0.0,0.0,5.475560572580646e-07,1.0102172317987447e-06,0.0,3.6846939e-06,False,SRRM1; serine and arginine repetitive matrix
hsa:10157,0.0,0.0,3.0029831631193556e-05,5.473568760215133e-05,0.0,0.00019350287,False,AASS; aminoadipate-semialdehyde
hsa:90075,4.5609565e-09,3.224171989427796e-06,4.7390876496774193e-08,8.775691932452738e-08,0.0,3.1093808e-07,False,ZNF30; zinc finger protein
hsa:8824,0.0,0.0,4.040722960535484e-05,0.00010392110438727638,0.0,0.0004566349,False,CES2; carboxylesterase
hsa:2166,0.0,0.0,8.433396779048387e-07,1.7368985480152416e-06,0.0,6.8992113e-06,False,FAAH; fatty acid amide
hsa:4756,0.0,0.0,8.207397158032257e-06,1.8322461107111436e-05,0.0,7.0377806e-05,False,NEO1; neogenin
hsa:2658,-0.0,0.0,0.0,0.0,0.0,0.0,False,GDF2; growth differentiation factor
hsa:5566,0.0008886009,0.6281581794433537,0.0014480141948387097,0.0016035399732891795,0.0,0.0050965627,True,PRKACA; protein kinase cAMP-activated catalytic subunit
hsa:150094,0.0,0.0,3.5454883885483878e-06,8.563868939274256e-06,0.0,4.446481e-05,False,SIK1; salt inducible kinase
hsa:7565,0.0,0.0,4.0047559612903224e-08,7.536737504554738e-08,0.0,3.342885e-07,False,ZNF17; zinc finger protein
hsa:7324,1.5233304e-07,0.00010768528939760424,1.695156788016129e-06,3.66519996777596e-06,0.0,1.5942884e-05,False,UBE2E1; ubiquitin conjugating enzyme E2
hsa:171023,0.0,0.0,4.841558020254838e-05,0.0001498925923216832,0.0,0.00061127957,False,ASXL1; ASXL transcriptional regulator
hsa:10055,2.7261873e-07,0.000192716083360887,1.0392404117516129e-06,1.575101930445559e-06,0.0,6.1601363e-06,False,SAE1; SUMO1 activating enzyme subunit
hsa:54490,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2B28; UDP glucuronosyltransferase family 2 member
hsa:51023,1.06517604e-07,7.529803785626155e-05,3.345223221451613e-07,4.421706862809107e-07,0.0,1.7394108e-06,False,MRPS18C; mitochondrial ribosomal protein
hsa:84436,7.2235924e-09,5.1064078947307455e-06,1.554192127483871e-07,3.8545882798399774e-07,0.0,1.6179467e-06,False,ZNF528; zinc finger protein
hsa:10623,0.0,0.0,1.8008611425806457e-05,5.0616222006094956e-05,0.0,0.00018629082,False,POLR3C; RNA polymerase III subunit
hsa:163,0.0,0.0,3.368197132903225e-05,8.336770509418245e-05,0.0,0.00039989382,False,AP2B1; adaptor related protein complex 2 subunit beta
hsa:140735,0.0,0.0,3.419792536774194e-05,5.960593468199175e-05,0.0,0.00019044711,False,DYNLL2; dynein light chain LC8-type
hsa:339559,5.23579e-09,3.701216501522468e-06,7.467954156451614e-08,1.0892222217276873e-07,0.0,3.5830735e-07,False,ZFP69; ZFP69 zinc finger
hsa:223117,0.0,0.0,4.109554628387097e-08,1.3561378185868705e-07,0.0,6.3348523e-07,False,SEMA3D; semaphorin
hsa:49861,0.0,0.0,3.9313854612903216e-09,9.152594397652743e-09,0.0,3.7552432e-08,False,CLDN20; claudin
hsa:4833,1.213291e-05,0.008576838777622282,0.0001507216286174516,0.00031277088049443065,0.0,0.0016445381,False,NME4; NME/NM23 nucleoside diphosphate kinase
hsa:6424,0.0,0.0,3.197318901935484e-05,0.00011015978995628162,0.0,0.0005460836,False,SFRP4; secreted frizzled related protein
hsa:51371,0.0,0.0,3.9627183e-06,8.524616627381727e-06,0.0,3.927578e-05,False,POMP; proteasome maturation
hsa:943,3.7926606e-07,0.0002681058254321527,1.0757838063225803e-05,2.814309154958709e-05,0.0,0.000118456766,False,TNFRSF8; TNF receptor superfamily member
hsa:55034,1.0107122e-09,7.144795098600359e-07,2.91014181337742e-06,8.038295084681694e-06,0.0,4.1181833e-05,False,MOCOS; molybdenum cofactor
hsa:442361,0.0,0.0,1.1002255206451614e-06,6.027753225781286e-06,0.0,3.3574637e-05,False,OR2A2; olfactory receptor family 2 subfamily A member
hsa:3696,0.00011007884,0.07781550044529126,0.00041704341644838703,0.0006870471726708453,0.0,0.0025881534,False,ITGB8; integrin subunit beta
hsa:23026,0.0,0.0,5.744283052064516e-09,2.3232752946150417e-08,0.0,1.2898607e-07,False,MYO16; myosin
hsa:8632,0.0,0.0,5.622880490322582e-08,8.262776486058053e-08,0.0,2.618176e-07,False,DNAH17; dynein axonemal heavy chain
hsa:6662,3.0364735e-08,2.1465043144655697e-05,0.00024621556438924843,0.0011523312867972387,0.0,0.006384224,False,SOX9; SRY-box transcription factor
hsa:6358,3.001265e-05,0.021216151800285785,0.00032581974647096775,0.0004904557298174633,0.0,0.0017261348,False,CCL14; C-C motif chemokine ligand
hsa:7412,7.798477e-05,0.05512797831682217,0.00018212252719354837,0.0002389992976992923,0.0,0.0009800026,False,VCAM1; vascular cell adhesion molecule
hsa:154,5.0298163e-06,0.0035556122551108206,7.726753944645161e-05,0.00013147366998132056,0.0,0.00043550238,False,ADRB2; adrenoceptor beta
hsa:1847,8.972012e-07,0.0006342377915511814,0.00012707523368999998,0.00020718431026113312,0.0,0.00078743644,False,DUSP5; dual specificity phosphatase
hsa:55613,0.0,0.0,6.684904014838708e-07,1.6289317709274107e-06,0.0,7.131257e-06,False,MTMR8; myotubularin related protein
hsa:3483,2.1383696e-10,1.5116283979827303e-07,9.821105623096774e-08,1.5964712805457448e-07,0.0,5.2990265e-07,False,IGFALS; insulin like growth factor binding protein acid labile
hsa:51032,0.0,0.0,1.6246045161290323e-10,9.045415128595943e-10,0.0,5.036274e-09,False,CELA2B; chymotrypsin like elastase
hsa:8878,1.0812569e-05,0.00764348050755479,9.990377041612904e-05,0.00029665432571227896,0.0,0.0015215533,False,SQSTM1; sequestosome
hsa:2176,0.0,0.0,7.702308462258064e-06,1.5304079815943762e-05,0.0,6.27274e-05,False,FANCC; FA complementation group
hsa:101954267,0.0,0.0,1.523891309064516e-07,2.8424734335974873e-07,0.0,1.1802425e-06,False,RNVU1-15; RNA
hsa:1649,2.7256528e-06,0.001926782991827579,9.699492812903226e-06,1.6175111267819702e-05,0.0,7.5700314e-05,False,DDIT3; DNA damage inducible transcript
hsa:10940,0.0,0.0,3.3243017143548384e-07,8.220520571218766e-07,0.0,2.8004788e-06,False,POP1; POP1 homolog
hsa:100169768,0.0,0.0,2.8298815161290323e-07,9.97763853406541e-07,0.0,4.8177862e-06,False,RNA5S17; RNA
hsa:1632,0.0,0.0,1.5062408461290321e-06,4.604293801382941e-06,0.0,2.0701122e-05,False,ECI1; enoyl-CoA delta isomerase
hsa:406984,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200B; microRNA
hsa:375775,0.0,0.0,1.7310998419354837e-06,2.760653804699186e-06,0.0,9.041525e-06,False,PNPLA7; patatin like phospholipase domain containing
hsa:100131827,1.5615305e-08,1.1038568113370915e-05,1.1099653982903226e-07,1.834567012558019e-07,0.0,7.9306596e-07,False,ZNF717; zinc finger protein
hsa:93343,0.0,0.0,1.621388341451613e-07,4.2279305797571034e-07,0.0,2.0062791e-06,False,MVB12A; multivesicular body subunit
hsa:3043,8.040342e-06,0.005683773888617414,4.699648306451613e-05,0.00011660946723999666,0.0,0.0005518315,False,HBB; hemoglobin subunit
hsa:81616,0.0,0.0,0.0,0.0,0.0,0.0,False,ACSBG2; acyl-CoA synthetase bubblegum family member
hsa:9070,0.0,0.0,6.287344752903226e-07,1.4753364167302564e-06,0.0,6.9614043e-06,False,ASH2L; ASH2 like
hsa:64324,0.0,0.0,1.5328030838709678e-06,3.643145682016331e-06,0.0,1.5080861e-05,False,NSD1; nuclear receptor binding SET domain protein
hsa:339302,0.0,0.0,4.931202645161291e-09,1.6359551617235077e-08,0.0,7.423492e-08,False,CPLX4; complexin
hsa:6746,6.2548264e-09,4.421580446472905e-06,1.0930434722935483e-06,2.925912763176392e-06,0.0,1.2973607e-05,False,SSR2; signal sequence receptor subunit
hsa:2806,0.00020113107,0.1421809574587351,0.0004688770633225807,0.0006749191163232887,0.0,0.0033461172,False,GOT2; glutamic-oxaloacetic transaminase
hsa:2266,0.0,0.0,1.9917870032258064e-08,9.411558980431966e-08,0.0,5.2395336e-07,False,FGG; fibrinogen gamma
hsa:3662,5.986704e-08,4.2320428501774456e-05,4.877762125096774e-07,8.714471940815104e-07,0.0,3.8092996e-06,False,IRF4; interferon regulatory factor
hsa:343172,0.0,0.0,3.0727376000000003e-06,8.05269995508099e-06,0.0,3.2781238e-05,False,OR2T8; olfactory receptor family 2 subfamily T member
hsa:171546,0.0,0.0,1.748266040129032e-06,3.125688043615529e-06,0.0,1.2465973e-05,False,SPTSSA; serine palmitoyltransferase small subunit
hsa:406909,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-3; microRNA
hsa:3155,0.00010033216,0.07092550431270019,0.0002664811167645161,0.0004008457288231085,0.0,0.0016628491,False,HMGCL; 3-hydroxy-3-methylglutaryl-CoA
hsa:283455,0.0,0.0,2.3107304654838704e-08,5.245311720486181e-08,0.0,2.0809658e-07,False,KSR2; kinase suppressor of ras
hsa:2169,0.0,0.0,2.544539506129032e-06,8.235706297063893e-06,0.0,3.9917417e-05,False,FABP2; fatty acid binding protein
hsa:5770,8.4816145e-07,0.0005995712499346276,4.048944085916129e-05,0.0001030896536021021,0.0,0.00053619157,False,PTPN1; protein tyrosine phosphatase non-receptor type
hsa:391114,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6K3; olfactory receptor family 6 subfamily K member
hsa:10156,9.496728e-08,6.713303318901344e-05,6.665736448387097e-07,1.2589469153315742e-06,0.0,5.263466e-06,False,RASA4; RAS p21 protein activator
hsa:273,0.0,0.0,5.3023764964322576e-06,1.7222780353603793e-05,0.0,7.938358e-05,False,AMPH;
hsa:5305,9.602061e-07,0.0006787763951920404,7.172170158064517e-06,1.4459259918478643e-05,0.0,5.0030332e-05,False,PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:168374,0.0,0.0,1.9220574387096773e-09,6.527274868984816e-09,0.0,3.3645353e-08,False,ZNF92; zinc finger protein
hsa:414328,0.0,0.0,6.629834998064516e-07,1.5760344264280248e-06,0.0,6.7789165e-06,False,IDNK; IDNK
hsa:83667,1.7206297e-06,0.001216325146472577,6.0540970866774195e-05,0.0001207287170753054,0.0,0.00042190938,False,SESN2; sestrin
hsa:9231,1.167048e-07,8.249943782445044e-05,9.546895306451611e-07,1.51793789202141e-06,0.0,6.505895e-06,False,DLG5; discs large MAGUK scaffold protein
hsa:6303,3.4879078e-05,0.02465626372552935,0.0004053899407935483,0.0008042626590951078,0.0,0.0027969282,False,SAT1; spermidine/spermine N1-acetyltransferase
hsa:747,0.0,0.0,5.835203738387097e-06,1.2275919588364516e-05,0.0,4.852376e-05,False,DAGLA; diacylglycerol lipase
hsa:26873,3.672019e-06,0.002595775865094672,5.254015565903226e-05,0.0001625793917001777,0.0,0.00090096355,False,OPLAH; 5-oxoprolinase
hsa:7323,0.0,0.0,1.1541844036032259e-05,3.0447895107126476e-05,0.0,0.00012258178,False,UBE2D3; ubiquitin conjugating enzyme E2
hsa:1019,0.0,0.0,5.2374459516129036e-05,0.00016549535342652512,0.0,0.0008880255,False,CDK4; cyclin dependent kinase
hsa:51727,4.9455703e-06,0.0034960581695979835,0.00023848481983387095,0.00063290815651205,0.0,0.0023556103,False,CMPK1; cytidine/uridine monophosphate kinase
hsa:81490,0.0,0.0,5.265950699354839e-06,1.7948962977389908e-05,0.0,9.890479e-05,False,PTDSS2; phosphatidylserine synthase
hsa:283617,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K3; olfactory receptor family 4 subfamily K member 3
hsa:100271927,0.0,0.0,1.359436977741935e-06,2.942966449625919e-06,0.0,1.2780832e-05,False,RASA4B; RAS p21 protein activator
hsa:2894,1.9664837e-08,1.3901210553545805e-05,9.641055012258064e-07,1.4481843851634926e-06,0.0,5.05077e-06,False,GRID1; glutamate ionotropic receptor delta type subunit
hsa:92912,7.414942e-08,5.241674262763025e-05,6.408328774193548e-07,8.334934087488011e-07,0.0,2.4339486e-06,False,UBE2Q2; ubiquitin conjugating enzyme E2
hsa:1462,1.4618136e-06,0.0010333662386134595,1.7470044227612902e-05,3.7389105087934716e-05,0.0,0.0001920976,False,VCAN;
hsa:98,5.260373e-07,0.00037185943958339143,2.9506680945161294e-06,4.138987266987321e-06,0.0,1.594338e-05,False,ACYP2; acylphosphatase
hsa:3842,0.0,0.0,2.909219864516129e-08,5.0279218798624246e-08,0.0,1.5639677e-07,False,TNPO1; transportin
hsa:7102,9.5340965e-08,6.739719372417077e-05,1.3040254665672258e-06,2.3934594966134645e-06,0.0,8.734536e-06,False,TSPAN7; tetraspanin
hsa:8896,4.617726e-08,3.264302745279956e-05,3.204069433870968e-07,5.036899996886503e-07,0.0,1.732286e-06,False,BUD31; BUD31
hsa:3628,1.3536516e-06,0.0009569057657454351,9.983979937741936e-06,2.392084309493805e-05,0.0,0.00011592103,False,INPP1; inositol
hsa:10438,2.9977903e-07,0.00021191588903420478,8.657220027419355e-06,2.4460023762172944e-05,0.0,0.0001178612,False,C1D; C1D nuclear receptor
hsa:7867,2.3080534e-06,0.0016315790607482421,5.749827119806452e-05,8.379482140574514e-05,0.0,0.00031690797,False,MAPKAPK3; MAPK activated protein kinase
hsa:6342,0.0,0.0,0.0002558525459354838,0.0004208673888103477,0.0,0.0015768355,False,SCP2; sterol carrier protein
hsa:439996,0.0,0.0,6.640281477419355e-09,1.6670278463842312e-08,0.0,7.361778e-08,False,IFIT1B; interferon induced protein with tetratricopeptide repeats
hsa:10847,0.0,0.0,4.88537615883871e-06,1.3399976808907027e-05,0.0,5.4218435e-05,False,SRCAP; Snf2 related CREBBP activator
hsa:6374,3.4364857e-07,0.0002429275731090435,2.3078067708709677e-05,5.293818549383205e-05,0.0,0.00018518468,False,CXCL5; C-X-C motif chemokine ligand
hsa:28234,0.0,0.0,9.753300238709675e-08,3.2655180695342887e-07,0.0,1.524308e-06,False,SLCO1B3; solute carrier organic anion transporter family member
hsa:90381,0.0,0.0,2.5004153090258065e-07,5.448931851070007e-07,0.0,2.244787e-06,False,TICRR; TOPBP1 interacting checkpoint and replication
hsa:23545,0.0,0.0,3.966145197741936e-05,0.00011151305644620974,0.0,0.00044101354,False,ATP6V0A2; ATPase H+ transporting V0 subunit
hsa:3439,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA1; interferon alpha
hsa:128366,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR6P1; olfactory receptor family 6 subfamily P member
hsa:226,3.852921e-05,0.027236567517533075,0.00010813018583870965,0.00016099399013745766,0.0,0.0006857773,False,ALDOA; aldolase
hsa:1584,0.0,0.0,1.3329866774193547e-07,7.421755718662683e-07,0.0,4.1322587e-06,False,CYP11B1; cytochrome P450 family 11 subfamily B member
hsa:9899,0.0,0.0,1.8871592735483874e-06,7.971784754434499e-06,0.0,4.4474626e-05,False,SV2B; synaptic vesicle glycoprotein
hsa:8434,3.1714354e-08,2.2419098237309956e-05,4.1427183840645163e-07,7.102556793447655e-07,0.0,2.4007322e-06,False,RECK; reversion inducing cysteine rich protein with kazal
hsa:775,0.00063830515,0.45122236647894093,0.000872975292645161,0.0011359292728579133,0.0,0.004954167,True,CACNA1C; calcium voltage-gated channel subunit alpha1
hsa:90317,1.0613069e-10,7.50245256486539e-08,5.7807916747767744e-08,1.2335848048937792e-07,0.0,4.546141e-07,False,ZNF616; zinc finger protein
hsa:80308,0.0,0.0,0.00010674142678709677,0.0002952100644597136,0.0,0.0012038321,False,FLAD1; flavin adenine dinucleotide synthetase
hsa:7318,2.1759736e-07,0.00015382109280924657,1.0983099164516129e-06,1.8433434133794977e-06,0.0,8.162644e-06,False,UBA7; ubiquitin like modifier activating enzyme
hsa:10452,1.3966381e-08,9.872932226798605e-06,5.849934211935484e-08,7.919376784721877e-08,0.0,3.3024457e-07,False,TOMM40; translocase of outer mitochondrial membrane
hsa:21,0.0,0.0,6.788038666129033e-05,0.00015433033805896032,0.0,0.0005705396,False,ABCA3; ATP binding cassette subfamily A member
hsa:2869,0.0,0.0,2.4407968329032256e-05,7.344097397495046e-05,0.0,0.00036953494,False,GRK5; G protein-coupled receptor kinase
hsa:6391,0.0,0.0,1.6531505838709679e-06,3.131678045950643e-06,0.0,1.2834009e-05,False,SDHC; succinate dehydrogenase complex subunit
hsa:5288,0.0,0.0,6.582872806451613e-09,2.771876140942375e-08,0.0,1.5295186e-07,False,PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:406943,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR152; microRNA
hsa:7295,1.2029458e-06,0.0008503707836634295,2.4309031851612902e-06,3.3256322041225723e-06,0.0,1.1340719e-05,False,TXN;
hsa:7988,2.739239e-08,1.9363871714514724e-05,9.12172965967742e-08,1.2826457722437746e-07,0.0,4.7414642e-07,False,ZNF212; zinc finger protein
hsa:54575,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A10; UDP glucuronosyltransferase family 1 member
hsa:91543,1.5275326e-07,0.00010798234584911772,3.6369487155806454e-06,1.1185127133329406e-05,0.0,5.190892e-05,False,RSAD2; radical S-adenosyl methionine domain containing
hsa:6569,0.0,0.0,9.11954502580645e-09,5.034608411852346e-08,0.0,2.8038295e-07,False,SLC34A1; solute carrier family 34 member
hsa:129521,0.0,0.0,7.617725716129033e-08,3.409174437956258e-07,0.0,1.8491094e-06,False,NMS; neuromedin
hsa:84465,0.0,0.0,7.967050580645162e-08,2.7853092526031383e-07,0.0,1.2532173e-06,False,MEGF11; multiple EGF like domains
hsa:1815,6.724615e-07,0.00047536772873597904,7.0712259964516126e-06,1.828231442611497e-05,0.0,9.688124e-05,False,DRD4; dopamine receptor
hsa:56915,0.0,0.0,1.3766481354838712e-07,3.6896890465670284e-07,0.0,1.7203439e-06,False,EXOSC5; exosome component
hsa:406971,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR195; microRNA
hsa:9883,0.0,0.0,1.5752631083870967e-07,3.729855126004873e-07,0.0,1.5847553e-06,False,POM121; POM121 transmembrane
hsa:84245,0.0,0.0,3.197407430096774e-05,0.0001499104073572578,0.0,0.0008353677,False,MRI1; methylthioribose-1-phosphate isomerase
hsa:5581,0.0,0.0,6.657999873548387e-05,0.00010312892463134928,0.0,0.0003522978,False,PRKCE; protein kinase C
hsa:9175,5.5555565e-09,3.927261672630188e-06,2.932632894354838e-07,7.227593628895593e-07,0.0,2.9909263e-06,False,MAP3K13; mitogen-activated protein kinase kinase kinase
hsa:4853,0.0004774979,0.33754659887473054,0.00045687857243225814,0.00040282574659200707,0.0,0.0013340102,False,NOTCH2; notch receptor
hsa:128372,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6N1; olfactory receptor family 6 subfamily N member
hsa:3443,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA6; interferon alpha
hsa:54600,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A9; UDP glucuronosyltransferase family 1 member
hsa:9107,2.4187836e-08,1.7098550121246118e-05,4.387794048580645e-06,1.0691112286270124e-05,0.0,5.4229855e-05,False,MTMR6; myotubularin related protein
hsa:353091,5.676115e-10,4.0124853178869296e-07,5.4432487311303225e-06,1.2241357237160906e-05,0.0,4.8355563e-05,False,RAET1G; retinoic acid early transcript
hsa:64600,0.0,0.0,6.293910803225806e-07,1.8823811190618812e-06,0.0,8.190424e-06,False,PLA2G2F; phospholipase A2 group
hsa:3992,0.0,0.0,3.739454780645161e-05,6.402178350930337e-05,0.0,0.000265118,False,FADS1; fatty acid desaturase
hsa:283446,0.0,0.0,2.062474822709678e-08,7.654497042542418e-08,0.0,4.266082e-07,False,MYO1H; myosin
hsa:3178,7.6306044e-08,5.39412751884051e-05,5.752456268709677e-07,9.70308683642846e-07,0.0,3.3130366e-06,False,HNRNPA1; heterogeneous nuclear ribonucleoprotein
hsa:8733,0.0,0.0,7.973408169354839e-05,0.00020259987493681202,0.0,0.00097070815,False,GPAA1; glycosylphosphatidylinositol anchor attachment
hsa:92283,0.0,0.0,9.183481070967741e-08,2.308628126265562e-07,0.0,1.004156e-06,False,ZNF461; zinc finger protein
hsa:9274,0.0,0.0,3.206176890645161e-07,9.677284737191626e-07,0.0,4.013788e-06,False,BCL7C; BAF chromatin remodeling complex subunit
hsa:23295,0.0,0.0,9.013567080645161e-05,0.0002525765077123576,0.0,0.001297105,False,MGRN1; mahogunin ring finger
hsa:6774,0.00027802386,0.19653700749055494,0.000426038428967742,0.0005863704984932874,0.0,0.0024393015,False,STAT3; signal transducer and activator of transcription
hsa:10663,0.0,0.0,1.2934553092322583e-05,4.010795956706199e-05,0.0,0.00015524523,False,CXCR6; C-X-C motif chemokine receptor
hsa:2064,0.000217385,0.1536709740427828,0.0004372580147419355,0.0006718083508505609,0.0,0.0028944528,False,ERBB2; erb-b2 receptor tyrosine kinase
hsa:658,0.0,0.0,1.3154188064516127e-07,4.4517912322178416e-07,0.0,1.9775966e-06,False,BMPR1B; bone morphogenetic protein receptor type
hsa:6262,0.0,0.0,4.338308122580645e-05,9.267519580458349e-05,0.0,0.0003892632,False,RYR2; ryanodine receptor
hsa:406981,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B2; microRNA
hsa:10528,0.0,0.0,3.102063767741936e-07,5.480306429341748e-07,0.0,1.945287e-06,False,NOP56; NOP56
hsa:9453,1.5379584e-08,1.0871935292926364e-05,3.640475209606451e-05,0.00011964758983124941,0.0,0.00056331506,False,GGPS1; geranylgeranyl diphosphate synthase
hsa:653247,0.0,0.0,1.8218304755064514e-06,7.80503685239174e-06,0.0,4.1480696e-05,False,PRB2; proline rich protein BstNI subfamily
hsa:57455,0.0,0.0,1.5868692794612904e-06,3.123331311397713e-06,0.0,1.1183667e-05,False,REXO1; RNA exonuclease 1
hsa:4440,1.5437196e-08,1.0912661617909933e-05,2.700335611419355e-07,5.327504013616188e-07,0.0,1.924616e-06,False,MSI1; musashi RNA binding protein
hsa:10349,0.0,0.0,0.00017967464904193549,0.00035828663852098774,0.0,0.0015474674,False,ABCA10; ATP binding cassette subfamily A member
hsa:65008,1.0581536e-07,7.480161667036694e-05,2.6427783847419353e-07,3.7943729269838664e-07,0.0,1.4585758e-06,False,MRPL1; mitochondrial ribosomal protein
hsa:392133,0.0,0.0,1.276779344651613e-05,4.7797193656255674e-05,0.0,0.0002635062,False,OR10AC1; olfactory receptor family 10 subfamily AC member 1
hsa:5720,0.0,0.0,1.7094652803225806e-06,3.83672552051082e-06,0.0,2.0449315e-05,False,PSME1; proteasome activator subunit
hsa:25906,0.0,0.0,5.622055525806452e-06,1.1787140024615427e-05,0.0,4.119423e-05,False,ANAPC15; anaphase promoting complex subunit
hsa:6572,0.0,0.0,0.00010816463585709674,0.00036909298066112523,0.0,0.001803831,False,SLC18A3; solute carrier family 18 member
hsa:57369,6.284456e-10,4.442525817554158e-07,2.511229329337097e-06,1.2512861131520583e-05,0.0,6.977187e-05,False,GJD2; gap junction protein delta
hsa:9002,1.201427e-06,0.0008492971333408396,5.128932934516129e-06,7.865984543251645e-06,0.0,2.843121e-05,False,F2RL3; F2R like thrombin or trypsin receptor
hsa:535,0.0,0.0,0.000165664246,0.0005202772167643933,0.0,0.002125352,False,ATP6V0A1; ATPase H+ transporting V0 subunit
hsa:1896,0.0,0.0,2.1806884952258064e-05,7.782933009403415e-05,0.0,0.00042892023,False,EDA; ectodysplasin
hsa:10389,3.0253382e-08,2.1386326931611626e-05,1.1796859734193547e-06,4.555095036360798e-06,0.0,2.4034915e-05,False,SCML2; Scm polycomb group protein like
hsa:55706,3.34861e-08,2.367155785309027e-05,5.62024106032258e-08,6.335193114593827e-08,0.0,1.7353445e-07,False,NDC1; NDC1 transmembrane
hsa:3981,1.3412892e-06,0.0009481666988847662,6.401935820051612e-05,0.00014412646638771058,0.0,0.00069567974,False,LIG4; DNA ligase
hsa:6821,0.0,0.0,4.613998352903225e-06,1.0667442402254651e-05,0.0,4.5537585e-05,False,SUOX; sulfite
hsa:7317,2.0094885e-07,0.00014205214486867564,1.9111622937741935e-06,3.557689200519649e-06,0.0,1.4568575e-05,False,UBA1; ubiquitin like modifier activating enzyme
hsa:138804,0.0,0.0,1.0239512903225805e-08,5.70111950353188e-08,0.0,3.174249e-07,False,OR13C4; olfactory receptor family 13 subfamily C member
hsa:2264,0.0,0.0,2.5767917780129034e-06,1.1306440572874918e-05,0.0,6.173417e-05,False,FGFR4; fibroblast growth factor receptor
hsa:83544,5.634895e-08,3.9833466121342624e-05,2.944307671935484e-07,4.014907895182061e-07,0.0,1.3443307e-06,False,DNAL1; dynein axonemal light chain
hsa:276,0.0,0.0,0.0,0.0,0.0,0.0,False,AMY1A; amylase alpha
hsa:65985,0.0,0.0,1.9206040035483872e-05,5.900329013218366e-05,0.0,0.00022987094,False,AACS; acetoacetyl-CoA
hsa:79944,0.0,0.0,2.1849433032258064e-06,7.0855480628833014e-06,0.0,2.9014409e-05,False,L2HGDH; L-2-hydroxyglutarate
hsa:3248,2.2171555e-06,0.0015673227006891605,3.1039636930967744e-05,9.29379836096186e-05,0.0,0.0005147315,False,HPGD; 15-hydroxyprostaglandin
hsa:57615,6.0141414e-10,4.251438539775171e-07,3.746937369096775e-09,5.972828091528053e-09,0.0,2.3159034e-08,False,ZNF492; zinc finger protein
hsa:391191,-0.0,0.0,1.407438227419355e-07,4.3067191790812175e-07,0.0,1.5016348e-06,False,OR2AK2; olfactory receptor family 2 subfamily AK member
hsa:11238,2.3683557e-05,0.016742071775825228,0.0001860551041967742,0.0002811265945845349,0.0,0.0009134313,False,CA5B; carbonic anhydrase
hsa:80142,0.0,0.0,1.622749691516129e-05,4.214195702124331e-05,0.0,0.00022075204,False,PTGES2; prostaglandin E synthase
hsa:259296,0.0,0.0,1.0892087247096775e-05,3.6072583279778165e-05,0.0,0.00018674205,False,TAS2R50; taste 2 receptor member
hsa:8676,0.0,0.0,6.468078148064517e-07,2.4808093633983408e-06,0.0,1.3757102e-05,False,STX11; syntaxin
hsa:3315,8.198718e-06,0.0057957309886243116,0.00023364739668903226,0.0005749085311116398,0.0,0.003072192,False,HSPB1; heat shock protein family B (small) member
hsa:5207,0.0,0.0,1.72754880083871e-06,6.7746527409130725e-06,0.0,3.7644822e-05,False,PFKFB1; 6-phosphofructo-2-kinase/fructose-2
hsa:1844,1.5124468e-09,1.0691592011587274e-06,1.8227452381509677e-05,3.902210441098264e-05,0.0,0.00013966806,False,DUSP2; dual specificity phosphatase
hsa:101954264,0.0,0.0,4.5899724548387095e-08,1.6408649244642804e-07,0.0,9.04311e-07,False,RNVU1-4; RNA
hsa:4599,1.0240708e-05,0.0072392279745507665,1.6346334393548386e-05,2.0472177069498065e-05,0.0,6.6513276e-05,False,MX1; MX dynamin like GTPase
hsa:27329,0.0,0.0,1.7442459967741934e-07,3.8047315625340783e-07,0.0,1.5845864e-06,False,ANGPTL3; angiopoietin like
hsa:8799,0.0,0.0,6.60025961483871e-06,1.8425087265738093e-05,0.0,6.855476e-05,False,PEX11B; peroxisomal biogenesis factor 11
hsa:59345,2.1492018e-05,0.015192857557812273,0.00036986175151612914,0.0006242728859611534,0.0,0.002035437,False,GNB4; G protein subunit beta
hsa:6741,3.1876294e-08,2.253357475379678e-05,1.943134942387097e-06,3.5650992116055597e-06,0.0,1.4495454e-05,False,SSB; small RNA binding exonuclease protection factor
hsa:248,0.0,0.0,1.6879532774193548e-09,9.025579234169988e-09,0.0,5.0278864e-08,False,ALPI; alkaline phosphatase
hsa:6120,1.1839097e-06,0.0008369140316843333,3.8219117206451604e-05,6.783379509200989e-05,0.0,0.00022688288,False,RPE;
hsa:284486,0.0,0.0,1.7905250023032256e-06,5.957950470370773e-06,0.0,2.668035e-05,False,THEM5; thioesterase superfamily member
hsa:427,7.061204e-07,0.0004991614401153687,3.6453369975806446e-05,8.344333348940175e-05,0.0,0.0003501823,False,ASAH1; N-acylsphingosine amidohydrolase
hsa:27258,6.0385126e-08,4.268666711188062e-05,1.065766186151613e-05,3.419352188024903e-05,0.0,0.00015294431,False,LSM3; LSM3 homolog
hsa:84962,0.00016163196,0.11425876086042785,0.00038525764861290326,0.0006462113163590573,0.0,0.0027050055,False,AJUBA; ajuba LIM
hsa:353088,1.3677948e-08,9.669036925576893e-06,1.2918817448387099e-07,3.2526717962423357e-07,0.0,1.3395313e-06,False,ZNF429; zinc finger protein
hsa:3980,3.9653742e-07,0.0002803150703857767,3.856037428870967e-06,7.4593877715659644e-06,0.0,2.7354889e-05,False,LIG3; DNA ligase
hsa:2639,7.1129252e-06,0.005028176478494173,9.250665010645162e-05,0.00015002658853977406,0.0,0.00053115265,False,GCDH; glutaryl-CoA
hsa:3589,4.030275e-05,0.028490295324437125,0.0002933498268619355,0.0005928785602282455,0.0,0.002237755,False,IL11; interleukin
hsa:2986,0.0,0.0,7.441555483870968e-08,4.1432827427119096e-07,0.0,2.3068822e-06,False,GUCY2F; guanylate cyclase 2F
hsa:9282,0.0,0.0,1.0993029848709677e-05,3.7347187061435684e-05,0.0,0.00017813274,False,MED14; mediator complex subunit
hsa:51135,0.0,0.0,6.745255613870966e-05,0.00014743741911287826,0.0,0.00056749734,False,IRAK4; interleukin 1 receptor associated kinase
hsa:57494,3.745244e-06,0.0026475391287710194,2.0129875099419357e-05,4.8326241465824675e-05,0.0,0.00021545133,False,RIMKLB; ribosomal modification protein rimK like family member
hsa:5686,1.753989e-06,0.0012399070685204894,7.64302878332258e-06,1.2337328099769412e-05,0.0,4.3845142e-05,False,PSMA5; proteasome 20S subunit alpha
hsa:7057,0.0013627724,0.963353322936821,0.0015285074100322583,0.0013457063586993204,0.0,0.005233048,True,THBS1; thrombospondin
hsa:92359,0.0,0.0,2.430598396774193e-09,6.968177571304389e-09,0.0,3.2958656e-08,False,CRB3; crumbs cell polarity complex component
hsa:257202,0.0,0.0,0.0,0.0,0.0,0.0,False,GPX6; glutathione peroxidase
hsa:3231,8.008665e-09,5.661381196183468e-06,1.026395661229032e-05,2.3824129152253502e-05,0.0,9.1674796e-05,False,HOXD1; homeobox
hsa:255631,1.7186203e-06,0.0012149046875851582,2.0358567196774195e-05,4.661580254440156e-05,0.0,0.00017445211,False,COL24A1; collagen type XXIV alpha 1
hsa:4607,6.080353e-06,0.004298243982031679,1.3420932221290324e-05,1.8324167119220903e-05,0.0,7.644273e-05,False,MYBPC3; myosin binding protein
hsa:197342,3.3785096e-07,0.00023882920212751224,0.0001285824032032258,0.00033960820798739286,0.0,0.0013765789,False,EME2; essential meiotic structure-specific endonuclease subunit
hsa:6745,3.7303902e-10,2.6370388738581385e-07,2.144131624103226e-07,4.20983183985448e-07,0.0,1.6150526e-06,False,SSR1; signal sequence receptor subunit
hsa:283297,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10A4; olfactory receptor family 10 subfamily A member
hsa:84639,0.0,0.0,0.0,0.0,0.0,0.0,False,IL1F10; interleukin 1 family member
hsa:5351,1.528598e-05,0.010805765971886273,2.6024106600109677e-05,3.7061628742245276e-05,0.0,0.00016291355,False,PLOD1; procollagen-lysine
hsa:53632,0.0,0.0,4.245130365483871e-06,1.6862725224220604e-05,0.0,9.2091046e-05,False,PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma
hsa:2962,1.1649523e-06,0.0008235129132846338,1.601446539258065e-05,4.1322629037629624e-05,0.0,0.00018308232,False,GTF2F1; general transcription factor IIF subunit
hsa:274,4.284364e-07,0.0003028646820313421,9.511102233935485e-06,2.6886745515376175e-05,0.0,0.00011673919,False,BIN1; bridging integrator
hsa:4728,0.0,0.0,1.0329772640645164e-05,2.750658920247166e-05,0.0,0.00011827864,False,NDUFS8; NADH:ubiquinone oxidoreductase core subunit
hsa:124995,1.214591e-08,8.586028568373973e-06,2.1477848790322584e-07,3.145101742564009e-07,0.0,1.1184758e-06,False,MRPL10; mitochondrial ribosomal protein
hsa:5449,0.0,0.0,8.300434559032258e-08,4.459767735334998e-07,0.0,2.4852395e-06,False,POU1F1; POU class 1 homeobox
hsa:26595,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8B2; olfactory receptor family 8 subfamily B member
hsa:7479,0.0,0.0,0.0,0.0,0.0,0.0,False,WNT8B; Wnt family member
hsa:51719,0.0,0.0,2.1352630225806448e-07,4.611964107718508e-07,0.0,2.1117812e-06,False,CAB39; calcium binding protein
hsa:406989,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR206; microRNA
hsa:5590,0.0,0.0,4.005013567741936e-05,7.108017070159201e-05,0.0,0.00028903945,False,PRKCZ; protein kinase C
hsa:5196,0.0,0.0,1.2093082580645161e-08,6.733143422927657e-08,0.0,3.7488556e-07,False,PF4; platelet factor
hsa:1191,3.52322e-07,0.0002490588813243845,9.117630795483875e-06,3.126091136174953e-05,0.0,0.00014082294,False,CLU;
hsa:3759,3.0993326e-06,0.0021909398510686134,6.74003534e-05,0.00015821342377648025,0.0,0.0007281008,False,KCNJ2; potassium inwardly rectifying channel subfamily J member
hsa:6598,1.5581494e-06,0.0011014666881439732,2.2959641058064517e-05,3.936139295118828e-05,0.0,0.00015134599,False,SMARCB1; SWI/SNF related
hsa:3937,3.0092917e-06,0.0021272893102921627,1.2227254080645161e-05,2.6441740319403674e-05,0.0,0.00011813194,False,LCP2; lymphocyte cytosolic protein
hsa:84466,0.0,0.0,8.934844813378065e-06,2.688787255106835e-05,0.0,0.00013368957,False,MEGF10; multiple EGF like domains
hsa:7156,1.2108281e-05,0.008559428365589716,4.678651566451613e-05,0.00011829294321591844,0.0,0.0006546613,False,TOP3A; DNA topoisomerase III
hsa:6023,0.0,0.0,6.516898946193549e-07,1.8676524234132517e-06,0.0,9.900791e-06,False,RMRP; RNA component of mitochondrial RNA processing
hsa:64087,2.7318777e-07,0.00019311834170929784,1.3819889093548386e-06,2.1880745958954495e-06,0.0,7.769399e-06,False,MCCC2; methylcrotonyl-CoA carboxylase subunit
hsa:111,0.0,0.0,5.938952834193548e-05,0.00017485755799628058,0.0,0.00076414977,False,ADCY5; adenylate cyclase
hsa:164668,0.0,0.0,2.6276538223870973e-06,5.516756632862389e-06,0.0,2.680422e-05,False,APOBEC3H; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1347,7.1319837e-06,0.0050416490651896415,0.0003855361384741935,0.000846735819639909,0.0,0.003272853,False,COX7A2; cytochrome c oxidase subunit
hsa:4902,5.0025006e-09,3.5363025960926714e-06,5.6690934941935485e-08,1.8975485899229604e-07,0.0,1.0344477e-06,False,NRTN;
hsa:56848,0.0,0.0,6.309947142580645e-05,0.00010922883843479226,0.0,0.0003804893,False,SPHK2; sphingosine kinase
hsa:9349,1.7725941e-07,0.00012530591435908178,5.249685587096773e-07,7.292873017795803e-07,0.0,2.5641953e-06,False,RPL23; ribosomal protein
hsa:166336,0.0,0.0,5.17118351496774e-06,1.9025991149530652e-05,0.0,0.000100202415,False,PRICKLE2; prickle planar cell polarity protein
hsa:79087,2.1721855e-06,0.0015355330937581214,9.105670771304838e-05,0.00013175473459671035,0.0,0.00055578595,False,ALG12; ALG12
hsa:6092,0.0,0.0,3.2483440980645164e-08,6.845688506177296e-08,0.0,2.6998805e-07,False,ROBO2; roundabout guidance receptor
hsa:64170,0.0,0.0,1.430904540967742e-05,2.5849609420176747e-05,0.0,0.00010482948,False,CARD9; caspase recruitment domain family member
hsa:7125,6.3051466e-09,4.4571521471331515e-06,7.702916119987097e-06,3.2420097225424005e-05,0.0,0.0001801174,False,TNNC2; troponin C2
hsa:127124,0.0,0.0,2.3565393129032257e-07,8.929865553201397e-07,0.0,4.7279204e-06,False,ATP6V1G3; ATPase H+ transporting V1 subunit
hsa:2633,9.5018905e-08,6.716952726190236e-05,4.1504573800000005e-07,5.089482773052494e-07,0.0,1.4751624e-06,False,GBP1; guanylate binding protein
hsa:1521,0.0,0.0,8.156545847822581e-07,2.336561052937313e-06,0.0,1.1165487e-05,False,CTSW; cathepsin
hsa:51720,0.0,0.0,3.55218721183871e-05,9.942857741611786e-05,0.0,0.00042952746,False,UIMC1; ubiquitin interaction motif containing
hsa:5362,0.0,0.0,2.2300430238709674e-07,4.083756780948008e-07,0.0,1.1541084e-06,False,PLXNA2; plexin
hsa:432,0.0,0.0,2.1422828813096772e-06,7.022288377731746e-06,0.0,3.0329782e-05,False,ASGR1; asialoglycoprotein receptor
hsa:83746,8.2421906e-08,5.8264620730421534e-05,2.0918904571983878e-05,5.6423967754424426e-05,0.0,0.00026138272,False,L3MBTL2; L3MBTL histone methyl-lysine binding protein
hsa:55879,4.288542e-05,0.030316002776796188,0.00025160634586129027,0.0003937905514435682,0.0,0.0012315618,False,GABRQ; gamma-aminobutyric acid type A receptor subunit
hsa:138805,0.0,0.0,0.0,0.0,0.0,0.0,False,OR13F1; olfactory receptor family 13 subfamily F member
hsa:3158,0.0,0.0,5.047732603225806e-07,2.4009959998177103e-06,0.0,1.3278489e-05,False,HMGCS2; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:5697,5.7544856e-08,4.067886042124192e-05,9.240986108387097e-07,2.1557376818584604e-06,0.0,1.0521414e-05,False,PYY; peptide
hsa:4067,6.632685e-05,0.046886913286057215,0.00014385428287096776,0.00016199653782264135,0.0,0.000525353,False,LYN; LYN proto-oncogene
hsa:229,0.0,0.0,4.3681115012903224e-05,0.00022566445700652695,0.0,0.0012584277,False,ALDOB; aldolase
hsa:9448,0.0,0.0,2.716054603354839e-07,5.995628213926583e-07,0.0,2.2606491e-06,False,MAP4K4; mitogen-activated protein kinase kinase kinase kinase
hsa:84552,6.3900177e-07,0.000451714812019975,7.881589920967744e-06,2.266463703478694e-05,0.0,0.00012385863,False,PARD6G; par-6 family cell polarity regulator
hsa:56246,0.0,0.0,2.6773718435483878e-06,7.854937501285106e-06,0.0,3.354207e-05,False,MRAP; melanocortin 2 receptor accessory
hsa:9368,0.0,0.0,1.2789648129032255e-06,2.738613409869885e-06,0.0,1.2919753e-05,False,NHERF1; NHERF family PDZ scaffold protein
hsa:84516,0.0,0.0,5.052061484193548e-05,0.00012045174279352489,0.0,0.00048063614,False,DCTN5; dynactin subunit
hsa:5264,0.0,0.0,5.393959527419355e-08,1.0976855097830237e-07,0.0,4.5612555e-07,False,PHYH; phytanoyl-CoA
hsa:5787,0.0,0.0,2.110842449677419e-06,9.079638894650113e-06,0.0,5.0499697e-05,False,PTPRB; protein tyrosine phosphatase receptor type
hsa:2820,1.4778221e-06,0.0010446827590171852,7.379325472419355e-06,1.7182962102235068e-05,0.0,9.25661e-05,False,GPD2; glycerol-3-phosphate dehydrogenase
hsa:1512,6.752763e-07,0.0004773575305058142,2.6114223121290316e-06,4.732889258927542e-06,0.0,1.7849652e-05,False,CTSH; cathepsin
hsa:25939,1.5769128e-06,0.001114730666589378,0.00013872304464193554,0.0002182083451563862,0.0,0.0006096679,False,SAMHD1; SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase
hsa:10645,0.0,0.0,9.190622261290321e-06,1.6067758935505692e-05,0.0,7.445842e-05,False,CAMKK2; calcium/calmodulin dependent protein kinase kinase
hsa:917,0.0,0.0,1.7725564051064516e-06,3.4283459126614107e-06,0.0,1.2090822e-05,False,CD3G; CD3 gamma subunit of T-cell receptor
hsa:390168,-0.0,0.0,1.1581044516129032e-08,6.448052694125137e-08,0.0,3.5901238e-07,False,OR5M1; olfactory receptor family 5 subfamily M member
hsa:9966,0.0,0.0,8.984362009032259e-07,3.704585385314818e-06,0.0,2.0756852e-05,False,TNFSF15; TNF superfamily member
hsa:768211,2.3133039e-06,0.0016352906758514535,1.273779531354839e-05,2.4400929098732686e-05,0.0,0.00011411999,False,RELL1; RELT like
hsa:11004,0.0,0.0,2.483850944709678e-08,1.0522008331136524e-07,0.0,5.584504e-07,False,KIF2C; kinesin family member
hsa:5443,2.7501597e-05,0.019441070905177788,7.076673495806451e-05,0.00010644754464243207,0.0,0.00045438047,False,POMC;
hsa:10558,0.0,0.0,3.417197769032258e-06,8.777472418076249e-06,0.0,3.2721702e-05,False,SPTLC1; serine palmitoyltransferase long chain base subunit
hsa:10603,0.0,0.0,8.799119825806451e-07,2.4786608005743982e-06,0.0,9.257768e-06,False,SH2B2; SH2B adaptor protein
hsa:347169,-0.0,0.0,3.1675754838709674e-07,1.7636313895670852e-06,-0.0,9.819484e-06,False,OR1B1; olfactory receptor family 1 subfamily B member
hsa:781,0.0,0.0,3.2118673290322576e-05,7.804319965686497e-05,0.0,0.00026704423,False,CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:150763,1.2496738e-05,0.008834031330668894,0.00018027351818950327,0.0005515895837303939,0.0,0.0027862333,False,GPAT2; glycerol-3-phosphate acyltransferase 2
hsa:5803,0.0,0.0,9.114835533177418e-05,0.0003016694982294171,0.0,0.0013131294,False,PTPRZ1; protein tyrosine phosphatase receptor type
hsa:1230,8.524505e-06,0.006026032093210535,0.0002688264466309678,0.0005260661726681243,0.0,0.0022883138,False,CCR1; C-C motif chemokine receptor
hsa:2590,1.6427563e-05,0.011612758963862177,8.496222680483872e-05,0.0001302092255327214,0.0,0.00050860975,False,GALNT2; polypeptide N-acetylgalactosaminyltransferase
hsa:5260,0.0,0.0,3.855823331193548e-06,1.3856924845777616e-05,0.0,7.235671e-05,False,PHKG1; phosphorylase kinase catalytic subunit gamma
hsa:23165,0.0,0.0,7.037860822129031e-08,2.110257786731331e-07,0.0,9.676951e-07,False,NUP205; nucleoporin
hsa:1558,0.0,0.0,2.482640967741936e-07,1.3822759905895388e-06,0.0,7.696187e-06,False,CYP2C8; cytochrome P450 family 2 subfamily C member
hsa:10110,0.0,0.0,2.783864469354838e-07,6.579779538874784e-07,0.0,2.6658483e-06,False,SGK2; serum/glucocorticoid regulated kinase
hsa:1777,0.0,0.0,9.390048450958066e-05,0.00016755910645538158,0.0,0.00050775404,False,DNASE2; deoxyribonuclease 2
hsa:53343,9.734299e-08,6.88124391726056e-05,5.570268774725355e-06,1.6868011348879002e-05,0.0,8.065731e-05,False,NUDT9; nudix hydrolase
hsa:9926,5.612174e-07,0.00039672849786212506,4.948739689354839e-06,1.0068188011609413e-05,0.0,4.5900746e-05,False,LPGAT1; lysophosphatidylglycerol acyltransferase
hsa:103,0.0,0.0,4.1658556113548386e-05,0.0001351818285481323,0.0,0.0007317293,False,ADAR; adenosine deaminase RNA
hsa:1237,0.0,0.0,1.5086457648387098e-06,5.823627482140359e-06,0.0,2.359034e-05,False,CCR8; C-C motif chemokine receptor
hsa:1783,6.512938e-05,0.0460404133836398,0.0002937565452006452,0.0003971638672738585,0.0,0.00120158,False,DYNC1LI2; dynein cytoplasmic 1 light intermediate chain
hsa:122706,0.0,0.0,1.928241702580645e-08,4.66244372310969e-08,0.0,1.8496665e-07,False,PSMB11; proteasome subunit beta
hsa:5742,2.2787259e-05,0.016108472462659194,0.0002088970348709677,0.00048070563255029806,0.0,0.0020696083,False,PTGS1; prostaglandin-endoperoxide synthase
hsa:947,4.795076e-06,0.0033896726983424375,3.0597146990322575e-05,4.8642126295605883e-05,0.0,0.00015642833,False,CD34; CD34
hsa:2966,0.0,0.0,2.544455780645162e-07,4.4266765154333604e-07,0.0,1.3862085e-06,False,GTF2H2; general transcription factor IIH subunit
hsa:22928,0.0,0.0,0.00013866169080645164,0.00025442826866911344,0.0,0.0012380951,False,SEPHS2; selenophosphate synthetase
hsa:6319,0.0,0.0,9.800163548387097e-05,0.00026873947704464824,0.0,0.0011870473,False,SCD; stearoyl-CoA
hsa:8995,0.0,0.0,3.0418413741935483e-07,6.615144333368844e-07,0.0,2.5818747e-06,False,TNFSF18; TNF superfamily member
hsa:100169765,0.0,0.0,2.4407312225806455e-06,9.990657024316232e-06,0.0,5.5286982e-05,False,RNA5S14; RNA
hsa:55754,3.5674032e-07,0.00025218222257623126,2.9986483154709672e-05,6.372205401340666e-05,0.0,0.00026024593,False,TMEM30A; transmembrane protein
hsa:55501,0.0,0.0,8.703181178248387e-05,0.000263424370948204,0.0,0.0010116413,False,CHST12; carbohydrate sulfotransferase
hsa:8074,0.0,0.0,1.1577350125806452e-06,6.412538808954696e-06,0.0,3.5709072e-05,False,FGF23; fibroblast growth factor
hsa:10799,0.0,0.0,2.1612722158064518e-08,5.3370796730424075e-08,0.0,1.9455639e-07,False,RPP40; ribonuclease P/MRP subunit
hsa:10382,4.8940574e-06,0.003459643340981618,0.00010199219157687098,0.00025861274751886405,0.0,0.0013310461,False,TUBB4A; tubulin beta 4A class
hsa:1293,1.548308e-05,0.010945097337821513,0.00020432018349354837,0.0003849313599750255,0.0,0.0014671129,False,COL6A3; collagen type VI alpha 3
hsa:3157,0.0,0.0,0.00012965725794516122,0.00034482574371534863,0.0,0.0016500329,False,HMGCS1; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:3630,0.0,0.0,0.0,0.0,0.0,0.0,False,INS;
hsa:10280,2.9103473e-09,2.057344823211275e-06,6.743752148838708e-08,1.0314971707090587e-07,0.0,3.8027878e-07,False,SIGMAR1; sigma non-opioid intracellular receptor
hsa:84441,1.8560508e-05,0.013120552674236324,0.00018853366464935482,0.00028994882389957643,0.0,0.000939533,False,MAML2; mastermind like transcriptional coactivator
hsa:1262,0.0,0.0,1.136755482516129e-06,3.3257110708377972e-06,0.0,1.5956597e-05,False,CNGA4; cyclic nucleotide gated channel subunit alpha
hsa:373156,2.6724007e-05,0.018891387105900343,0.0004559712377741936,0.0007080746379327643,0.0,0.002382451,False,GSTK1; glutathione S-transferase kappa
hsa:2130,1.2599008e-07,8.90632670760546e-05,2.231530307746258e-05,7.94389697553988e-05,0.0,0.00043942576,False,EWSR1; EWS RNA binding protein
hsa:283106,5.0850986e-07,0.00035946916989009874,2.730068343870968e-06,3.9832002348613995e-06,0.0,1.3797191e-05,False,CSNK2A3; casein kinase 2 alpha
hsa:6354,6.0897528e-05,0.043048887662707355,0.00022136674786354843,0.00045078813798743033,0.0,0.0019278404,False,CCL7; C-C motif chemokine ligand
hsa:50835,-0.0,0.0,1.967577806451613e-07,7.757138314234434e-07,-0.0,4.108469e-06,False,TAS2R9; taste 2 receptor member
hsa:286046,0.0,0.0,2.5865339620645164e-08,1.342173233907139e-07,0.0,7.4746623e-07,False,XKR6; XK related
hsa:55967,3.1486754e-06,0.002225820620845729,9.475739061612904e-06,1.137537036002701e-05,0.0,3.9363716e-05,False,NDUFA12; NADH:ubiquinone oxidoreductase subunit
hsa:148156,0.0,0.0,4.0271335870967744e-08,1.1005286334571043e-07,0.0,4.0261048e-07,False,ZNF558; zinc finger protein
hsa:6522,0.0,0.0,0.00035546604399999996,0.0006535088659391082,0.0,0.002186017,False,SLC4A2; solute carrier family 4 member
hsa:63916,0.0,0.0,1.1241460357903228e-05,3.423838490299525e-05,0.0,0.00015697489,False,ELMO2; engulfment and cell motility
hsa:5929,6.0119726e-10,4.249905399914997e-07,2.7052217872019355e-06,5.209286210185786e-06,0.0,1.82351e-05,False,RBBP5; RB binding protein 5
hsa:805,0.0004502521,0.31828635265454586,0.0008980061897741936,0.0012847081398826331,0.0,0.004895445,False,CALM2; calmodulin
hsa:7942,0.0,0.0,1.7866527806451613e-06,4.205261668776204e-06,0.0,2.248177e-05,False,TFEB; transcription factor
hsa:5721,1.9973795e-06,0.0014119615120550474,1.0314572422580647e-05,2.287012760457197e-05,0.0,0.000108703454,False,PSME2; proteasome activator subunit
hsa:271,1.11201075e-08,7.860881620100072e-06,2.043671174301613e-05,6.328417529438595e-05,0.0,0.00029697624,False,AMPD2; adenosine monophosphate deaminase
hsa:8464,0.0,0.0,1.6214258978134518e-06,3.245264820627007e-06,0.0,1.1123304e-05,False,SUPT3H; SPT3 homolog
hsa:113146,0.0,0.0,1.669571258064516e-07,2.7532003284223495e-07,0.0,8.410203e-07,False,AHNAK2; AHNAK nucleoprotein
hsa:4121,3.0130582e-07,0.00021299518754357196,0.0001554168591966129,0.0002656763592345845,0.0,0.00088772597,False,MAN1A1; mannosidase alpha class 1A member
hsa:4158,0.0,0.0,3.972146322580645e-06,1.8423217153700142e-05,0.0,0.000100876416,False,MC2R; melanocortin 2
hsa:1506,0.0,0.0,2.5845135483870967e-08,1.4389962429961048e-07,0.0,8.011992e-07,False,CTRL; chymotrypsin
hsa:10552,0.0,0.0,1.3748646122580644e-06,2.9828934658006416e-06,0.0,1.14472505e-05,False,ARPC1A; actin related protein 2/3 complex subunit
hsa:25828,2.4713436e-06,0.0017470100430406765,3.2955149761290317e-06,3.6530120942115626e-06,0.0,1.3610627e-05,False,TXN2; thioredoxin
hsa:5983,6.3071093e-06,0.004458539593464563,3.523415469967743e-05,7.58834448506392e-05,0.0,0.00035537977,False,RFC3; replication factor C subunit
hsa:7386,2.3618568e-06,0.0016696130598043567,9.699028331612903e-05,0.00014238816648303408,0.0,0.00052555674,False,UQCRFS1; ubiquinol-cytochrome c reductase
hsa:5587,0.0,0.0,6.294009479354839e-06,1.9024329416937073e-05,0.0,7.867715e-05,False,PRKD1; protein kinase
hsa:285643,0.0,0.0,9.636180419354837e-10,4.88951097754759e-09,0.0,2.724791e-08,False,KIF4B; kinesin family member
hsa:2731,2.566761e-06,0.0018144612691999324,7.135266812903226e-06,1.1131235833734129e-05,0.0,4.4292137e-05,False,GLDC; glycine
hsa:7993,0.0,0.0,4.523185154193548e-07,7.536440069158969e-07,0.0,2.8292538e-06,False,UBXN8; UBX domain protein
hsa:26122,0.0,0.0,3.8103582135483872e-06,1.2534899808134631e-05,0.0,5.712963e-05,False,EPC2; enhancer of polycomb homolog
hsa:644150,0.0,0.0,2.949867961290322e-07,4.499400951247993e-07,0.0,1.8515224e-06,False,WIPF3; WAS/WASL interacting protein family member
hsa:1032,0.0,0.0,7.40514345483871e-06,1.1438780023937016e-05,0.0,3.7109938e-05,False,CDKN2D; cyclin dependent kinase inhibitor
hsa:785,0.0,0.0,3.1660114916129033e-05,7.091593411939244e-05,0.0,0.0002563569,False,CACNB4; calcium voltage-gated channel auxiliary subunit beta
hsa:94235,0.0,0.0,4.447011000645161e-05,0.00016930512536877384,0.0,0.0008584858,False,GNG8; G protein subunit gamma
hsa:10938,2.4439434e-08,1.7276406503826408e-05,5.663764916129032e-07,9.58345580618012e-07,0.0,3.3024905e-06,False,EHD1; EH domain containing
hsa:26716,0.0,0.0,1.233767022580645e-07,6.284572049088631e-07,-0.0,3.494513e-06,False,OR2H1; olfactory receptor family 2 subfamily H member
hsa:4952,0.0,0.0,2.4827139129032256e-06,6.050829437927583e-06,0.0,2.3921622e-05,False,OCRL; OCRL inositol
hsa:1286,1.4950058e-07,0.00010568300365048635,1.8425363625161293e-05,3.706865033627998e-05,0.0,0.00015988835,False,COL4A4; collagen type IV alpha 4
hsa:3914,4.9004625e-06,0.003464171150884976,5.720447173387096e-05,9.981553846942062e-05,0.0,0.0003207772,False,LAMB3; laminin subunit beta
hsa:10010,0.0,0.0,1.910558090645162e-06,3.6553558145832345e-06,0.0,1.3424465e-05,False,TANK; TRAF family member associated NFKB
hsa:1346,1.1400439e-05,0.00805904991441603,0.00038460812046645163,0.0007831021084286155,0.0,0.0027547893,False,COX7A1; cytochrome c oxidase subunit
hsa:6348,0.0,0.0,0.00016346534125806449,0.00027326858528596294,0.0,0.00090021396,False,CCL3; C-C motif chemokine ligand
hsa:7248,0.0,0.0,6.2991130792258055e-06,1.2908058165036422e-05,0.0,5.847733e-05,False,TSC1; TSC complex subunit
hsa:23370,0.0,0.0,1.2197864908290323e-06,2.654546922773344e-06,0.0,9.993956e-06,False,ARHGEF18; Rho/Rac guanine nucleotide exchange factor
hsa:2628,6.925171e-05,0.0489545172382102,0.00017295220592258064,0.000333048293321874,0.0,0.0014154759,False,GATM; glycine
hsa:84950,9.131693e-08,6.455257529128786e-05,5.258573506751613e-07,9.23123791594079e-07,0.0,3.2830087e-06,False,PRPF38A; pre-mRNA processing factor
hsa:1609,1.081395e-06,0.0007644456746095412,2.5629273048387094e-05,4.2290247862604624e-05,0.0,0.00019141234,False,DGKQ; diacylglycerol kinase
hsa:131870,1.3184405e-06,0.0009320147933502936,2.7301268773548392e-05,7.027357607596931e-05,0.0,0.00031757445,False,NUDT16; nudix hydrolase
hsa:127062,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR2M3; olfactory receptor family 2 subfamily M member
hsa:11001,0.0,0.0,8.756866374193547e-08,3.306014293167436e-07,0.0,1.7646855e-06,False,SLC27A2; solute carrier family 27 member
hsa:6396,0.0,0.0,9.051428967741935e-07,1.7653222483806707e-06,0.0,6.9360594e-06,False,SEC13; SEC13 homolog
hsa:6528,-0.0,0.0,1.740162484387097e-07,4.064930427440165e-07,0.0,1.4350935e-06,False,SLC5A5; solute carrier family 5 member
hsa:441308,-0.0,0.0,2.120015893548387e-06,9.034929685774562e-06,0.0,4.9412694e-05,False,OR4F21; olfactory receptor family 4 subfamily F member
hsa:3885,0.0,0.0,6.2125361632258065e-06,2.5297589089393617e-05,0.0,0.00013491134,False,KRT34; keratin
hsa:7003,0.0,0.0,8.242181e-05,0.00016272517403124383,0.0,0.0005312476,False,TEAD1; TEA domain transcription factor
hsa:54988,0.0001181375,0.0835122234559848,0.0002273768670645161,0.0003311861027493212,0.0,0.0015044359,False,ACSM5; acyl-CoA synthetase medium chain family member
hsa:7490,0.0,0.0,8.012811286935484e-08,1.9358974283400512e-07,0.0,9.195761e-07,False,WT1; WT1 transcription
hsa:1729,0.0,0.0,6.585619064516129e-07,2.217140971602388e-06,0.0,1.1766892e-05,False,DIAPH1; diaphanous related formin
hsa:896,6.3768166e-05,0.045078161704542014,0.00040666131724193536,0.000564908986214517,0.0,0.0017179273,False,CCND3; cyclin
hsa:55288,0.0,0.0,1.883714041935484e-07,2.666668154128617e-07,0.0,8.129504e-07,False,RHOT1; ras homolog family member
hsa:120787,0.0,0.0,3.732959664516129e-07,2.034137812856711e-06,-0.0,1.1331073e-05,False,OR52W1; olfactory receptor family 52 subfamily W member
hsa:3092,0.0,0.0,4.267628490564515e-08,9.040688300748643e-08,0.0,3.9036777e-07,False,HIP1; huntingtin interacting protein
hsa:5218,1.0310922e-08,7.2888627413076255e-06,4.826030402214613e-06,1.958500828331571e-05,0.0,0.000108225846,False,CDK14; cyclin dependent kinase
hsa:7189,0.0,0.0,4.6236167516129036e-05,0.00011199980114980834,0.0,0.0004978306,False,TRAF6; TNF receptor associated factor
hsa:8620,0.0,0.0,1.1006039e-06,2.8284336505141293e-06,0.0,1.4529978e-05,False,NPFF; neuropeptide FF-amide peptide
hsa:100507436,1.4747218e-06,0.001042491135304303,2.6903384746774194e-05,4.4458052096280794e-05,0.0,0.00017922706,False,MICA; MHC class I polypeptide-related sequence
hsa:55696,5.4807003e-10,3.8743453022865976e-07,1.2029819105387097e-07,2.271387600908927e-07,0.0,8.107683e-07,False,RBM22; RNA binding motif protein
hsa:8685,0.0,0.0,5.91683089463871e-07,2.054620910051326e-06,0.0,1.0180823e-05,False,MARCO; macrophage receptor with collagenous
hsa:26528,7.785932e-08,5.5039296836068366e-05,2.2217069866451617e-07,3.446333770518607e-07,0.0,1.4621761e-06,False,DAZAP1; DAZ associated protein
hsa:55277,2.4378209e-05,0.017233126123920854,0.0001377103319391935,0.0002229838385783734,0.0,0.00075212517,False,FGGY; FGGY carbohydrate kinase domain
hsa:2342,7.2191257e-09,5.103250353319163e-06,7.407425403883871e-06,1.5726907268011585e-05,0.0,5.435519e-05,False,FNTB; farnesyltransferase
hsa:7587,3.7748904e-08,2.6684963758895508e-05,1.1065620627580645e-07,2.2661825065141215e-07,0.0,8.7466526e-07,False,ZNF37A; zinc finger protein
hsa:1911,0.0,0.0,2.9173864984322584e-06,1.0669403874506322e-05,0.0,5.8016918e-05,False,PHC1; polyhomeotic homolog
hsa:23114,0.0,0.0,2.929508894741935e-06,5.594827635886069e-06,0.0,1.813574e-05,False,NFASC;
hsa:93643,0.0,0.0,5.458059244741935e-07,1.3548967835275988e-06,0.0,5.4705633e-06,False,TJAP1; tight junction associated protein
hsa:440077,0.0,0.0,1.226891270967742e-09,4.944839713276991e-09,0.0,2.6632854e-08,False,ZNF705A; zinc finger protein
hsa:9447,0.0,0.0,3.246285064064517e-06,8.495759389502909e-06,0.0,3.748448e-05,False,AIM2; absent in melanoma
hsa:4487,4.6149453e-09,3.2623370490381695e-06,1.0278101609741935e-06,2.731565668843679e-06,0.0,1.1839596e-05,False,MSX1; msh homeobox
hsa:5526,1.7529175e-06,0.0012391496176904558,2.129575317741936e-05,3.734311742193463e-05,0.0,0.00014391,False,PPP2R5B; protein phosphatase 2 regulatory subunit
hsa:1350,1.571987e-05,0.011112485841828647,0.000545701383832258,0.0011321492947498615,0.0,0.003847401,False,COX7C; cytochrome c oxidase subunit
hsa:406997,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR215; microRNA
hsa:51340,5.064408e-09,3.580065369321994e-06,1.7705521985483872e-07,3.421899445779131e-07,0.0,1.4095043e-06,False,CRNKL1; crooked neck pre-mRNA splicing factor
hsa:6566,0.0,0.0,9.263086161290321e-08,2.01379471099091e-07,0.0,7.8507725e-07,False,SLC16A1; solute carrier family 16 member
hsa:5925,0.0,0.0,8.60460126451613e-05,0.00022289661244905966,0.0,0.0011378509,False,RB1; RB transcriptional corepressor
hsa:2657,0.0,0.0,6.153011427741933e-06,1.581108379552844e-05,0.0,6.2406354e-05,False,GDF1; growth differentiation factor
hsa:339761,1.0527042e-06,0.0007441639478019571,6.841595139580644e-05,0.0002276919825350701,0.0,0.0012431619,False,CYP27C1; cytochrome P450 family 27 subfamily C member
hsa:151531,0.0,0.0,2.176629712580645e-06,6.757160452425932e-06,0.0,2.8602213e-05,False,UPP2; uridine phosphorylase
hsa:9651,1.8486779e-07,0.000130684331294416,3.427413468064516e-07,4.7072238545279183e-07,0.0,2.2079064e-06,False,PLCH2; phospholipase C eta
hsa:1440,0.000100895406,0.07132366684206377,0.0005778980066419357,0.0011206135033105797,0.0,0.0042221877,False,CSF3; colony stimulating factor
hsa:22938,0.0,0.0,8.358506949677419e-07,1.7568889906248833e-06,0.0,6.239895e-06,False,SNW1; SNW domain containing
hsa:1644,0.0,0.0,4.629989722580645e-05,0.0001978901896862857,0.0,0.0010883709,False,DDC; dopa
hsa:3425,0.0,0.0,9.596884000483869e-05,0.00024348933492601818,0.0,0.0011781183,False,IDUA;
hsa:2625,0.0,0.0,6.341077387096775e-07,2.114831507391094e-06,0.0,9.878311e-06,False,GATA3; GATA binding protein
hsa:978,7.1578716e-06,0.005059949402420463,0.00016099893758064518,0.0003698903164565034,0.0,0.00171214,False,CDA; cytidine
hsa:5190,1.1176079e-08,7.900448264181476e-06,3.4676258585687094e-06,7.147315363233873e-06,0.0,2.7293414e-05,False,PEX6; peroxisomal biogenesis factor
hsa:842,0.00013984278,0.09885583741035758,0.00038395725693548394,0.0004988474342669349,0.0,0.0016496344,False,CASP9; caspase
hsa:26999,0.0,0.0,1.6903043687096776e-07,3.0815922359915327e-07,0.0,1.2745792e-06,False,CYFIP2; cytoplasmic FMR1 interacting protein
hsa:4849,0.0,0.0,4.680718843548387e-07,9.462576225674739e-07,0.0,3.5568055e-06,False,CNOT3; CCR4-NOT transcription complex subunit
hsa:2920,0.00027688616,0.19573275941838583,0.0005955025202870967,0.0008038041786273103,0.0,0.0033939895,False,CXCL2; C-X-C motif chemokine ligand
hsa:374,9.91166e-06,0.00700662164629983,0.00010631041700419355,0.0002964435151981556,0.0,0.0014742813,False,AREG;
hsa:55558,2.52913e-07,0.00017878596526017123,5.041785756483872e-06,1.6578033629869078e-05,0.0,8.5932035e-05,False,PLXNA3; plexin
hsa:10588,0.0,0.0,3.849841045483871e-06,7.816706861579312e-06,0.0,2.5703484e-05,False,MTHFS; methenyltetrahydrofolate
hsa:112609,1.4533289e-07,0.00010273683449526235,3.5877463445161293e-06,9.071994852481935e-06,0.0,3.7364367e-05,False,MRAP2; melanocortin 2 receptor accessory protein
hsa:259307,4.1919524e-05,0.02963320415157353,0.00013483964332258066,0.0002849015526225907,0.0,0.0015372123,False,IL4I1; interleukin 4 induced
hsa:10344,9.8266275e-05,0.06946511578446515,0.00021575498093525804,0.0003380046857954066,0.0,0.0013681585,False,CCL26; C-C motif chemokine ligand
hsa:57216,0.0,0.0,1.5697027196774193e-07,2.4233069363286723e-07,0.0,7.6315143e-07,False,VANGL2; VANGL planar cell polarity protein
hsa:1646,0.0,0.0,9.793645924193549e-05,0.00017277073108747733,0.0,0.0005998953,False,AKR1C2; aldo-keto reductase family 1 member
hsa:348158,0.0,0.0,1.830384369032258e-06,3.982784216732672e-06,-0.0,1.3727196e-05,False,ACSM2B; acyl-CoA synthetase medium chain family member
hsa:10084,1.3227685e-07,9.350742867636255e-05,5.677589028064516e-07,9.241224167203457e-07,0.0,2.8601694e-06,False,PQBP1; polyglutamine binding protein
hsa:9181,0.0,0.0,1.8805276903225805e-06,3.6148560157747752e-06,0.0,1.4378953e-05,False,ARHGEF2; Rho/Rac guanine nucleotide exchange factor
hsa:1233,0.0,0.0,7.650266408580646e-06,2.880525221842347e-05,0.0,0.00015579787,False,CCR4; C-C motif chemokine receptor
hsa:4923,2.932264e-08,2.0728378914395495e-05,1.1604242006451616e-07,2.0665721005604377e-07,0.0,1.0223093e-06,False,NTSR1; neurotensin receptor
hsa:55113,1.08346796e-07,7.65911064504666e-05,3.0288021121525802e-05,5.874245243676799e-05,0.0,0.00019961037,False,XKR8; XK related
hsa:10039,0.0,0.0,2.5606418974193545e-06,9.53162111163209e-06,0.0,5.2389907e-05,False,PARP3; poly(ADP-ribose) polymerase family member
hsa:3587,7.6010733e-06,0.005373251778096876,0.00043344300223548376,0.0010359132913209826,0.0,0.0041516824,False,IL10RA; interleukin 10 receptor subunit
hsa:23383,0.0,0.0,6.475629774225806e-08,2.2511993608368463e-07,0.0,1.2116094e-06,False,MAU2; MAU2 sister chromatid cohesion
hsa:51762,2.3194657e-09,1.6396464952863585e-06,3.0503072942580653e-06,8.290382578615384e-06,0.0,3.6254987e-05,False,RAB8B; RAB8B
hsa:115209,2.8504376e-08,2.0149942380576955e-05,2.2444264445161293e-07,4.4040783298959344e-07,0.0,1.6263235e-06,False,OMA1; OMA1 zinc
hsa:10622,7.4747404e-06,0.005283946169169629,4.4753638490322574e-05,6.578108803025123e-05,0.0,0.00024550638,False,POLR3G; RNA polymerase III subunit
hsa:2778,0.0,0.0,0.00042016958580645165,0.0011567420620830168,0.0,0.005497046,False,GNAS; GNAS complex
hsa:6601,0.0,0.0,5.431493998064516e-06,1.0430378279517875e-05,0.0,3.7215937e-05,False,SMARCC2; SWI/SNF related
hsa:29945,0.0,0.0,1.672773579032258e-06,3.0753925724869694e-06,0.0,1.1667185e-05,False,ANAPC4; anaphase promoting complex subunit
hsa:27339,1.0695399e-07,7.560652216602825e-05,6.05457178967742e-07,1.0458828662053097e-06,0.0,3.9378083e-06,False,PRPF19; pre-mRNA processing factor
hsa:2047,0.0,0.0,7.670648387096775e-08,1.6366380891869121e-07,0.0,5.6482816e-07,False,EPHB1; EPH receptor
hsa:1559,0.0,0.0,1.2331053870967743e-07,4.934457849066289e-07,0.0,2.3959756e-06,False,CYP2C9; cytochrome P450 family 2 subfamily C member
hsa:406950,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-1; microRNA
hsa:5407,0.0,0.0,0.0,0.0,0.0,0.0,False,PNLIPRP1; pancreatic lipase related protein
hsa:134526,0.0,0.0,1.9900157161290323e-08,3.193517738105082e-08,0.0,9.2915535e-08,False,ACOT12; acyl-CoA thioesterase
hsa:1030,7.02334e-05,0.04964848075228917,0.0003049665182580645,0.0005374632922980173,0.0,0.002794017,False,CDKN2B; cyclin dependent kinase inhibitor
hsa:6643,0.0,0.0,2.6005807813225803e-07,5.242038025083371e-07,0.0,2.0063178e-06,False,SNX2; sorting nexin
hsa:8808,2.9860962e-07,0.0002110892249416714,4.050958794709677e-06,6.612297831166124e-06,0.0,2.3892015e-05,False,IL1RL2; interleukin 1 receptor like
hsa:2992,9.3652525e-05,0.06620362370134125,0.0002862812168583871,0.00036110987721734995,0.0,0.0013263784,False,GYG1; glycogenin
hsa:23216,1.2156246e-08,8.593335158928548e-06,1.2121464433548386e-06,2.190560620059002e-06,0.0,7.8953135e-06,False,TBC1D1; TBC1 domain family member
hsa:54554,0.0,0.0,1.7377392801290324e-06,6.614759201006245e-06,0.0,3.5580786e-05,False,WDR5B; WD repeat domain
hsa:23644,3.4640723e-07,0.000244877689120971,1.944393376774193e-05,6.041021779432294e-05,0.0,0.00026846366,False,EDC4; enhancer of mRNA decapping
hsa:9826,0.0,0.0,1.2727716669032256e-06,3.1300125870601217e-06,0.0,1.3534409e-05,False,ARHGEF11; Rho guanine nucleotide exchange factor
hsa:3837,0.0,0.0,3.77580179032258e-07,9.257221437417986e-07,0.0,4.306782e-06,False,KPNB1; karyopherin subunit beta
hsa:374928,4.1614268e-09,2.941741655421215e-06,7.369795830483871e-08,1.9083085982160344e-07,0.0,7.975604e-07,False,ZNF773; zinc finger protein
hsa:40,9.165075e-07,0.0006478855497965166,0.0002445604152096774,0.00051275625517791,0.0,0.0019064567,False,ASIC2; acid sensing ion channel subunit
hsa:119016,0.0,0.0,4.898242869193548e-07,7.438667862085311e-07,0.0,2.699432e-06,False,AGAP4; ArfGAP with GTPase domain
hsa:64431,0.0,0.0,1.2556505770967742e-07,2.899849260822209e-07,0.0,9.917458e-07,False,ACTR6; actin related protein
hsa:25937,0.0004523945,0.31980083017042443,0.0012146747417741935,0.0023836397736504366,0.0,0.010141994,False,WWTR1; WW domain containing transcription regulator
hsa:10525,0.0,0.0,7.513144134451614e-07,1.9660920949781698e-06,0.0,7.784792e-06,False,HYOU1; hypoxia up-regulated
hsa:11177,0.0,0.0,5.125888186096775e-07,1.0048376748901098e-06,0.0,4.0630775e-06,False,BAZ1A; bromodomain adjacent to zinc finger domain
hsa:1269,0.0,0.0,3.936546111935483e-08,9.386133211019694e-08,0.0,4.8825774e-07,False,CNR2; cannabinoid receptor
hsa:1503,1.3039859e-09,9.217967357041875e-07,2.217401303611291e-06,4.866192457848478e-06,0.0,1.7796718e-05,False,CTPS1; CTP synthase
hsa:23085,0.0,0.0,3.7205192095806454e-07,9.121868580410274e-07,0.0,3.2164328e-06,False,ERC1; ELKS/RAB6-interacting/CAST family member
hsa:8563,0.0,0.0,2.7612316967741936e-08,5.480898668697364e-08,0.0,2.4456125e-07,False,THOC5; THO complex subunit
hsa:79365,1.9987629e-05,0.014129394471724236,0.0007018380853691291,0.001638965265475807,0.0,0.0076344362,False,BHLHE41; basic helix-loop-helix family member
hsa:9553,7.510805e-08,5.309440486672969e-05,2.578442064193549e-07,5.687254281714127e-07,0.0,2.517501e-06,False,MRPL33; mitochondrial ribosomal protein
hsa:9093,1.46444386e-08,1.0352255877690394e-05,3.025605037290322e-07,4.540490650797104e-07,0.0,1.6046477e-06,False,DNAJA3; DnaJ heat shock protein family (Hsp40) member
hsa:140609,3.7344797e-08,2.6399297699565258e-05,8.135545303548388e-07,2.1144932436697566e-06,0.0,1.0140985e-05,False,NEK7; NIMA related kinase
hsa:23431,3.076868e-08,2.1750594685055042e-05,1.4355589458064514e-07,2.5066481087034814e-07,0.0,8.886544e-07,False,AP4E1; adaptor related protein complex 4 subunit epsilon
hsa:4986,0.0,0.0,7.343221009677419e-08,2.435504636119346e-07,0.0,1.1603861e-06,False,OPRK1; opioid receptor kappa
hsa:6197,2.1109241e-05,0.0149222698243846,0.00010856822597290321,0.0001954457933617097,0.0,0.00071264105,False,RPS6KA3; ribosomal protein S6 kinase
hsa:147183,0.0,0.0,3.992518483870968e-08,2.1718499662277264e-07,0.0,1.2098427e-06,False,KRT25; keratin
hsa:6117,0.00024194548,0.17103294880901915,0.0004070470393677421,0.000491756340818698,0.0,0.0016982693,False,RPA1; replication protein
hsa:8893,5.9107856e-09,4.178375603238744e-06,2.0626783151612907e-07,5.710849677849489e-07,0.0,2.575077e-06,False,EIF2B5; eukaryotic translation initiation factor 2B subunit
hsa:310,0.0,0.0,3.5982826277419354e-08,8.814762054940908e-08,0.0,3.9213245e-07,False,ANXA7; annexin
hsa:7372,0.0,0.0,1.6377690050322583e-05,3.216761328118104e-05,0.0,0.0001243417,False,UMPS; uridine monophosphate
hsa:1188,3.0539368e-07,0.00021588492431451076,1.8958453360000003e-06,6.026806365861929e-06,0.0,3.1450996e-05,False,CLCNKB; chloride voltage-gated channel
hsa:655,0.0,0.0,8.110600797774194e-05,0.0002109617269274263,0.0,0.0006951305,False,BMP7; bone morphogenetic protein
hsa:5901,0.0,0.0,1.6241888214193546e-05,3.974302815866544e-05,0.0,0.00014514572,False,RAN; RAN
hsa:5408,0.0,0.0,3.190569693548387e-05,6.880272713743282e-05,0.0,0.00034488825,False,PNLIPRP2; pancreatic lipase related protein 2
hsa:1294,0.0,0.0,7.671388277419355e-06,1.8151035357543305e-05,0.0,9.276421e-05,False,COL7A1; collagen type VII alpha 1
hsa:346525,0.0,0.0,3.1953790322580647e-07,1.7791117501540726e-06,0.0,9.905675e-06,False,OR2A12; olfactory receptor family 2 subfamily A member
hsa:554213,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR449A; microRNA
hsa:401152,1.6787762e-06,0.0011867386151475105,9.694525736129035e-06,1.7644898787711834e-05,0.0,7.926529e-05,False,C4orf3; chromosome 4 open reading frame
hsa:4306,6.3418984e-06,0.004483132251113765,0.00011811277463301935,0.00027473323363148714,0.0,0.0012884219,False,NR3C2; nuclear receptor subfamily 3 group C member
hsa:529,2.8898572e-05,0.020428602284819516,0.00018307595964516131,0.0003330649694771527,0.0,0.0011694958,False,ATP6V1E1; ATPase H+ transporting V1 subunit
hsa:407033,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30D; microRNA
hsa:768239,0.0,0.0,1.2590741651612904e-08,4.6816858956036846e-08,0.0,2.2687247e-07,False,PSAPL1; prosaposin like
hsa:407009,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR224; microRNA
hsa:58513,0.0,0.0,1.7449409141935483e-07,4.597328956762716e-07,0.0,1.9015414e-06,False,EPS15L1; epidermal growth factor receptor pathway substrate 15 like
hsa:130576,6.535337e-08,4.619875347829142e-05,7.526513796774193e-07,2.8458189612558916e-06,0.0,1.585014e-05,False,LYPD6B; LY6/PLAUR domain containing
hsa:6224,2.460825e-07,0.00017395743712713896,9.772506387096773e-07,1.5847458209844901e-06,0.0,5.8104224e-06,False,RPS20; ribosomal protein
hsa:1605,0.00019351838,0.13679949375431322,0.00031159031,0.0004431077437067246,0.0,0.0019286288,False,DAG1; dystroglycan
hsa:4633,0.0,0.0,7.056908825806453e-06,2.4732555199634052e-05,0.0,0.00012959544,False,MYL2; myosin light chain
hsa:2736,4.3753487e-05,0.03092964539898445,9.967026494516128e-05,0.00014059058304533216,0.0,0.000480458,False,GLI2; GLI family zinc finger
hsa:1298,0.0,0.0,5.354302096774194e-07,1.2618201060695054e-06,0.0,4.190946e-06,False,COL9A2; collagen type IX alpha 2
hsa:84818,3.7204012e-05,0.026299775800259353,9.193082141935484e-05,0.0001137142356088677,0.0,0.00045623534,False,IL17RC; interleukin 17 receptor
hsa:5719,0.0,0.0,4.966838906451614e-06,1.2758385005926492e-05,0.0,5.674892e-05,False,PSMD13; proteasome 26S subunit
hsa:4342,0.0,0.0,0.0,0.0,0.0,0.0,False,MOS; MOS proto-oncogene
hsa:246778,2.8996806e-07,0.0002049804458518117,4.661069836451612e-06,1.3114617374770063e-05,0.0,6.831558e-05,False,IL27; interleukin
hsa:10352,0.0,0.0,7.910247990322579e-07,1.2022794708028909e-06,0.0,4.3617815e-06,False,WARS2; tryptophanyl tRNA synthetase 2
hsa:4283,0.0,0.0,0.0,0.0,0.0,0.0,False,CXCL9; C-X-C motif chemokine ligand
hsa:53944,0.0,0.0,7.099215560322582e-06,2.1102873027860533e-05,0.0,0.00010075722,False,CSNK1G1; casein kinase 1 gamma
hsa:9675,2.828738e-07,0.0001999654639334974,2.3016653495806456e-06,5.283013102621377e-06,0.0,2.1146463e-05,False,TTI1; TELO2 interacting protein
hsa:2957,0.0,0.0,2.452586509258065e-07,4.2181171885973805e-07,0.0,1.6581276e-06,False,GTF2A1; general transcription factor IIA subunit
hsa:9075,6.043102e-08,4.271910990086201e-05,6.217040965483872e-07,2.151383354225548e-06,0.0,1.1692468e-05,False,CLDN2; claudin
hsa:80854,0.0,0.0,5.776731210548387e-05,0.0001248550680519679,0.0,0.00058346195,False,SETD7; SET domain containing 7
hsa:26153,0.0,0.0,9.691685606451616e-09,2.7327966687226153e-08,0.0,9.7879344e-08,False,KIF26A; kinesin family member
hsa:57733,0.0,0.0,6.095228341935484e-07,2.040397938135239e-06,0.0,1.0361987e-05,False,GBA3; glucosylceramidase beta 3
hsa:330,0.0,0.0,0.00038971725287096775,0.0011524515053270895,0.0,0.004797739,False,BIRC3; baculoviral IAP repeat containing
hsa:2013,0.0,0.0,4.4306604081290323e-07,1.4006099824831522e-06,0.0,5.572172e-06,False,EMP2; epithelial membrane protein
hsa:1488,0.0,0.0,0.0002834647690322581,0.0007132514990166953,0.0,0.0030415445,False,CTBP2; C-terminal binding protein
hsa:353376,6.6843163e-06,0.004725189855008625,3.9199617951612896e-05,8.83518058924769e-05,0.0,0.0004516436,False,TICAM2; TIR domain containing adaptor molecule
hsa:5350,1.6101041e-05,0.011381938282644992,9.374682275806451e-05,0.0001512934647652558,0.0,0.00056985696,False,PLN;
hsa:956,0.0,0.0,1.5107851639032256e-05,4.702715160878165e-05,0.0,0.0002329689,False,ENTPD3; ectonucleoside triphosphate diphosphohydrolase
hsa:54431,2.5813858e-08,1.8247996424141873e-05,2.737257368446452e-06,5.452258377019813e-06,0.0,2.4736988e-05,False,DNAJC10; DnaJ heat shock protein family (Hsp40) member
hsa:80314,1.10820736e-07,7.83399519067925e-05,3.65962715962258e-06,1.2047203380034683e-05,0.0,5.645988e-05,False,EPC1; enhancer of polycomb homolog
hsa:6773,0.0,0.0,2.113163106774194e-05,5.840405024239496e-05,0.0,0.00024095958,False,STAT2; signal transducer and activator of transcription
hsa:132158,0.0,0.0,4.796046559677418e-05,8.331348859969515e-05,0.0,0.00034779776,False,GLYCTK; glycerate
hsa:1655,3.0644887e-06,0.002166308454916858,1.8763636770322573e-05,5.7680808890128785e-05,0.0,0.0003207528,False,DDX5; DEAD-box helicase
hsa:1119,0.0,0.0,3.0806520580645163e-06,6.331328460198198e-06,0.0,2.500577e-05,False,CHKA; choline kinase
hsa:406883,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A3; microRNA
hsa:6751,2.2068884e-08,1.56006481602557e-05,3.857058522193547e-06,1.2253247532715573e-05,0.0,6.724787e-05,False,SSTR1; somatostatin receptor
hsa:3976,6.136906e-06,0.004338221692522474,0.0004254118828193547,0.0010155260258300786,0.0,0.0036831982,False,LIF; LIF interleukin 6 family
hsa:351,2.6002039e-07,0.00018381022886714476,0.00013530177404203224,0.0003529660546972454,0.0,0.0014868022,False,APP; amyloid beta precursor
hsa:222236,0.0,0.0,2.408666375451613e-07,4.453459385960394e-07,0.0,1.6039713e-06,False,NAPEPLD; N-acyl phosphatidylethanolamine phospholipase
hsa:7059,0.0,0.0,4.060116548387097e-06,1.001107333366271e-05,0.0,4.3603857e-05,False,THBS3; thrombospondin
hsa:124454,9.715975e-07,0.0006868290553742561,7.023593600967742e-05,0.0002508478437687103,0.0,0.0013857352,False,EARS2; glutamyl-tRNA synthetase 2
hsa:196527,0.0,0.0,5.943934650645162e-08,1.636589827681309e-07,0.0,6.463274e-07,False,ANO6; anoctamin
hsa:1062,2.8951097e-09,2.0465732573991244e-06,2.830537934716129e-07,7.679493470523824e-07,0.0,3.7977939e-06,False,CENPE; centromere protein
hsa:1798,0.0,0.0,2.0499103933870965e-05,5.979389691766804e-05,0.0,0.00030231272,False,DPAGT1; dolichyl-phosphate N-acetylglucosaminephosphotransferase
hsa:640,0.0,0.0,2.267236208387097e-07,4.888954911193971e-07,0.0,2.0880386e-06,False,BLK; BLK proto-oncogene
hsa:22801,2.2613203e-06,0.0015985431061191794,0.00013239144331419355,0.0002681789364783565,0.0,0.001042326,False,ITGA11; integrin subunit alpha
hsa:5420,4.165831e-08,2.9448550151464908e-05,2.421362076129033e-07,4.268319624172885e-07,0.0,1.7177078e-06,False,PODXL; podocalyxin
hsa:1050,6.5497363e-07,0.00046300543135192044,3.87685205821613e-05,0.0001507855134625603,0.0,0.00084216485,False,CEBPA; CCAAT enhancer binding protein
hsa:285220,0.0,0.0,2.608960711935484e-08,5.133956361211816e-08,0.0,2.1819204e-07,False,EPHA6; EPH receptor
hsa:125981,0.0,0.0,5.364085058064517e-07,1.8986960164347571e-06,0.0,1.0514218e-05,False,ACER1; alkaline ceramidase
hsa:4616,0.00090860965,0.6423025044974215,0.0015159777001612904,0.001471583397255498,0.0,0.004990072,True,GADD45B; growth arrest and DNA damage inducible
hsa:8844,0.0,0.0,3.446799028e-06,1.0377691080809877e-05,0.0,5.6488614e-05,False,KSR1; kinase suppressor of ras
hsa:152,6.685259e-08,4.725856256219519e-05,3.4240454541935484e-06,1.0875440288081337e-05,0.0,5.8793994e-05,False,ADRA2C; adrenoceptor alpha
hsa:390431,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K2; olfactory receptor family 4 subfamily K member
hsa:5026,0.0,0.0,7.410691712903226e-07,1.5907137695984958e-06,0.0,7.4884197e-06,False,P2RX5; purinergic receptor P2X
hsa:23590,0.0,0.0,3.501978595483871e-07,1.6689746571342961e-06,0.0,9.249263e-06,False,PDSS1; decaprenyl diphosphate synthase subunit
hsa:9927,1.0505719e-06,0.0007426566100465857,5.731551348064516e-06,1.287568432562789e-05,0.0,5.272841e-05,False,MFN2; mitofusin
hsa:1473,0.0,0.0,1.1414721297741935e-05,3.2152665736193366e-05,0.0,0.00013828183,False,CST5; cystatin
hsa:51360,2.7376517e-08,1.935265098000691e-05,1.252450723965484e-06,3.27344095416597e-06,0.0,1.40323145e-05,False,MBTPS2; membrane bound transcription factor peptidase
hsa:64386,4.1717602e-08,2.9490464080176388e-05,2.631839745312903e-06,7.86888103319975e-06,0.0,2.991105e-05,False,MMP25; matrix metallopeptidase
hsa:57448,0.0,0.0,0.0001550821108254839,0.0005493908993238488,0.0,0.0027928215,False,BIRC6; baculoviral IAP repeat containing
hsa:10436,0.0,0.0,1.6186798635483873e-06,4.629356341313978e-06,0.0,1.843817e-05,False,EMG1; EMG1 N1-specific pseudouridine
hsa:4602,5.76787e-09,4.077347567919339e-06,2.68916156e-08,7.656232281542524e-08,0.0,4.1290951e-07,False,MYB; MYB proto-oncogene
hsa:95,1.9863206e-05,0.014041438984439809,8.60963301483871e-05,0.00013966069936872794,0.0,0.00059512147,False,ACY1; aminoacylase
hsa:1287,7.231083e-05,0.05111703052161869,9.840092423225807e-05,9.989609277477813e-05,0.0,0.00033250597,False,COL4A5; collagen type IV alpha 5
hsa:51287,8.983794e-08,6.350706693560769e-05,2.0741661641935488e-06,5.331494265471421e-06,0.0,2.1476066e-05,False,COA4; cytochrome c oxidase assembly factor 4
hsa:115361,9.196873e-09,6.501333726143801e-06,7.689401238903226e-07,1.5544628684529677e-06,0.0,6.0204447e-06,False,GBP4; guanylate binding protein
hsa:90293,6.40174e-09,4.525434695901945e-06,1.5611451812903228e-07,2.0003424447302421e-07,0.0,5.461254e-07,False,KLHL13; kelch like family member
hsa:152404,2.0791963e-07,0.00014697983791298852,1.835612177903226e-06,3.468769061198813e-06,0.0,1.3576509e-05,False,IGSF11; immunoglobulin superfamily member
hsa:10114,0.0,0.0,4.1144966629032256e-07,8.392638533959392e-07,0.0,3.2786122e-06,False,HIPK3; homeodomain interacting protein kinase
hsa:7442,0.0,0.0,1.2966137098709676e-05,4.256443173141127e-05,0.0,0.00020227718,False,TRPV1; transient receptor potential cation channel subfamily V member
hsa:9261,0.00030948772,0.2187790297705915,0.00040076717228709676,0.0005318567625074572,0.0,0.0028312858,False,MAPKAPK2; MAPK activated protein kinase
hsa:7376,7.666151e-06,0.005419255658527744,6.555091215806452e-05,0.00013976864229346393,0.0,0.00063864974,False,NR1H2; nuclear receptor subfamily 1 group H member
hsa:2549,0.0,0.0,7.870339797741934e-05,0.00022899517407093086,0.0,0.0009654507,False,GAB1; GRB2 associated binding protein
hsa:7712,0.0,0.0,6.003376439870967e-09,1.4536666485228481e-08,0.0,5.759576e-08,False,ZNF157; zinc finger protein
hsa:2237,0.0,0.0,4.807834683225807e-05,0.00010900526564108171,0.0,0.00044018705,False,FEN1; flap structure-specific endonuclease
hsa:8672,0.0,0.0,7.66463798387097e-06,2.2061791265333926e-05,0.0,0.00011982097,False,EIF4G3; eukaryotic translation initiation factor 4 gamma
hsa:5093,0.0,0.0,6.174539071935483e-06,1.3631621526928559e-05,0.0,5.1503048e-05,False,PCBP1; poly(rC) binding protein
hsa:7450,3.6465113e-05,0.025777442938979885,0.0001853888202567742,0.00032020553691501267,0.0,0.0014285163,False,VWF; von Willebrand
hsa:6754,0.0,0.0,1.5795095212258064e-07,5.057065000476178e-07,0.0,2.7174053e-06,False,SSTR4; somatostatin receptor
hsa:6258,0.0001284169,0.0907788030754405,0.00018119077696774193,0.00018462899936534766,0.0,0.0006883604,False,RXRG; retinoid X receptor
hsa:8516,0.0,0.0,2.6818984870967746e-06,7.074269858723745e-06,0.0,3.1000858e-05,False,ITGA8; integrin subunit alpha
hsa:55070,5.8721533e-08,4.15106616068055e-05,3.357735650967742e-07,4.620946900667229e-07,0.0,1.5268262e-06,False,DET1; DET1 partner of COP1 E3 ubiquitin
hsa:2562,0.0,0.0,0.0003014071222032258,0.001508892811191421,0.0,0.008387937,False,GABRB3; gamma-aminobutyric acid type A receptor subunit
hsa:7695,0.0,0.0,7.672142032258063e-08,1.768365091170023e-07,0.0,6.7132794e-07,False,ZNF136; zinc finger protein
hsa:9110,0.0,0.0,6.555760452258063e-07,3.040254262576466e-06,0.0,1.6880686e-05,False,MTMR4; myotubularin related protein
hsa:65082,0.0,0.0,3.743935917741935e-07,1.101237591360677e-06,0.0,4.216171e-06,False,VPS33A; VPS33A core subunit of CORVET and HOPS
hsa:3603,1.0971764e-06,0.0007756016564379046,3.096826838483871e-05,7.143362915795327e-05,0.0,0.00031684144,False,IL16; interleukin
hsa:90161,0.0,0.0,1.5840522000000002e-05,5.991203036311352e-05,0.0,0.00032700933,False,HS6ST2; heparan sulfate 6-O-sulfotransferase
hsa:924,1.738282e-07,0.00012288036805715047,4.923187182919354e-05,0.00014673412243933434,0.0,0.00072464824,False,CD7; CD7
hsa:170959,3.29884e-08,2.331973024869672e-05,6.703660277419355e-08,9.359651435860267e-08,0.0,3.693396e-07,False,ZNF431; zinc finger protein
hsa:119692,0.0,0.0,4.221894193548387e-09,2.3506512034477715e-08,0.0,1.3087872e-07,False,OR51S1; olfactory receptor family 51 subfamily S member
hsa:8687,0.0,0.0,6.979588709677419e-09,2.8706244934298736e-08,0.0,1.4576165e-07,False,KRT38; keratin
hsa:84618,0.0,0.0,8.67952429032258e-08,2.7169147617028885e-07,0.0,1.0311848e-06,False,NT5C1A; 5'-nucleotidase
hsa:27436,8.049667e-06,0.005690365796214299,3.43819843032258e-05,9.862336526022855e-05,0.0,0.00051672634,False,EML4; EMAP like
hsa:84700,3.060854e-09,2.1637390601133834e-06,6.231701801935485e-08,1.6857683386207632e-07,0.0,7.8280044e-07,False,MYO18B; myosin
hsa:10524,5.411635e-07,0.00038255225595786957,6.4076281032258065e-06,1.4294647335580958e-05,0.0,5.0541334e-05,False,KAT5; lysine acetyltransferase
hsa:2785,0.0,0.0,0.00014044475209677422,0.00038999802891568003,0.0,0.0019147955,False,GNG3; G protein subunit gamma
hsa:5347,0.0,0.0,1.4208438354838709e-05,5.186656831429613e-05,0.0,0.0002838358,False,PLK1; polo like kinase
hsa:51272,1.874608e-06,0.0013251734816495757,8.851217313970968e-05,0.00017698559746830866,0.0,0.00064608746,False,BET1L; Bet1 golgi vesicular membrane trafficking protein
hsa:9741,0.0,0.0,7.149805692580646e-07,2.1565933807605576e-06,0.0,1.08770355e-05,False,LAPTM4A; lysosomal protein transmembrane 4
hsa:57180,0.0,0.0,1.7738720257129033e-06,3.1149464041251197e-06,0.0,1.1453913e-05,False,ACTR3B; actin related protein
hsa:2760,3.6001593e-06,0.0025449777415193467,3.3075922073451614e-05,6.37855709782462e-05,0.0,0.000268367,False,GM2A; ganglioside GM2
hsa:10203,1.4575146e-06,0.0010303272455025737,1.3806300761290323e-05,3.537782645349127e-05,0.0,0.0001561148,False,CALCRL; calcitonin receptor like
hsa:57332,3.6420307e-08,2.5745769264793713e-05,8.566357283354839e-06,3.146819924684665e-05,0.0,0.00014421907,False,CBX8; chromobox
hsa:2184,4.249474e-05,0.03003982835749847,0.00024286321893548387,0.0004964161807406344,0.0,0.0018657546,False,FAH; fumarylacetoacetate
hsa:5422,0.0,0.0,3.135632353112903e-06,9.700749340662856e-06,0.0,3.434191e-05,False,POLA1; DNA polymerase alpha 1
hsa:10211,0.0,0.0,1.5862720896774193e-06,4.088224385691068e-06,0.0,1.5900283e-05,False,FLOT1; flotillin
hsa:3861,4.9577843e-06,0.0035046923314626865,6.224865366225806e-05,0.00015828068294955423,0.0,0.00066966115,False,KRT14; keratin
hsa:84444,0.0,0.0,1.5138294132258066e-05,3.6258133126839384e-05,0.0,0.00012594913,False,DOT1L; DOT1 like histone lysine
hsa:219431,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4S2; olfactory receptor family 4 subfamily S member
hsa:1917,0.0,0.0,4.730266538709677e-05,0.0001083713415322427,0.0,0.000469418,False,EEF1A2; eukaryotic translation elongation factor 1 alpha
hsa:23324,1.0107833e-05,0.0071452977094637795,7.960846085483872e-05,0.00015539427797492075,0.0,0.000775155,False,MAN2B2; mannosidase alpha class 2B member
hsa:102723849,0.0,0.0,5.1268125806451615e-09,2.8544884381424748e-08,0.0,1.5893119e-07,False,SPDYE17; speedy/RINGO cell cycle regulator family member
hsa:390054,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52A5; olfactory receptor family 52 subfamily A member
hsa:1081,2.6583235e-05,0.018791874396385192,0.00015966373556580644,0.00027957382214699103,0.0,0.0010515373,False,CGA; glycoprotein hormones
hsa:11235,0.0,0.0,2.8070990930967745e-05,7.885160351301636e-05,0.0,0.00034380055,False,PDCD10; programmed cell death
hsa:26339,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5K1; olfactory receptor family 5 subfamily K member
hsa:11128,0.0,0.0,7.945947433870968e-06,2.1441438445075788e-05,0.0,8.38583e-05,False,POLR3A; RNA polymerase III subunit
hsa:394,7.362117e-07,0.0005204331901497022,3.026265714635484e-05,7.465817946361929e-05,0.0,0.0003028097,False,ARHGAP5; Rho GTPase activating protein
hsa:22798,0.0,0.0,2.145361935483871e-06,7.225550628468973e-06,0.0,3.2967648e-05,False,LAMB4; laminin subunit beta
hsa:6581,0.0,0.0,2.362934160850645e-05,7.521549372947797e-05,0.0,0.00032664536,False,SLC22A3; solute carrier family 22 member
hsa:9942,0.0,0.0,1.0070083778516129e-05,3.588632688072884e-05,0.0,0.00019602882,False,XYLB;
hsa:22953,0.0,0.0,1.051720783870968e-06,4.561268969388866e-06,0.0,2.5098676e-05,False,P2RX2; purinergic receptor P2X
hsa:90673,0.0,0.0,2.5278135941935484e-06,7.29266925678358e-06,0.0,3.3404824e-05,False,PPP1R3E; protein phosphatase 1 regulatory subunit
hsa:55503,0.0,0.0,2.933502673548387e-06,6.516819786615498e-06,0.0,2.381032e-05,False,TRPV6; transient receptor potential cation channel subfamily V member
hsa:9554,6.602593e-08,4.6674190837365015e-05,3.1616863295806454e-05,7.311476903295681e-05,0.0,0.00031563555,False,SEC22B; SEC22 homolog B
hsa:390084,0.0,0.0,8.741114193548387e-09,4.866846409826638e-08,-0.0,2.7097454e-07,False,OR56A5; olfactory receptor family 56 subfamily A member
hsa:728927,1.2916139e-08,9.130508825365018e-06,1.1188938390967742e-07,2.0020414638394194e-07,0.0,6.1228377e-07,False,ZNF736; zinc finger protein
hsa:89790,0.0,0.0,3.358088525593548e-06,1.0838870614293711e-05,0.0,4.586811e-05,False,SIGLEC10; sialic acid binding Ig like lectin
hsa:144983,1.3839723e-07,9.783396802411869e-05,2.924112342774193e-07,4.019640336543891e-07,0.0,1.5820711e-06,False,HNRNPA1L2; heterogeneous nuclear ribonucleoprotein A1 like
hsa:391189,0.0,0.0,4.665571161290322e-07,1.7811345220294181e-06,0.0,8.036448e-06,False,OR11L1; olfactory receptor family 11 subfamily L member
hsa:335,0.0001851628,0.1308928759228511,0.0003156533855354839,0.0004008636941403306,0.0,0.0014344008,False,APOA1; apolipoprotein
hsa:51552,0.0,0.0,1.5497480838709677e-05,3.909960742850204e-05,0.0,0.00017490097,False,RAB14; RAB14
hsa:53947,0.0005752078,0.40661840928769794,0.0013376610367741935,0.002748604034153501,0.0,0.011480345,True,A4GALT; alpha 1
hsa:7249,0.0,0.0,4.925504503225807e-05,0.00013566026972548157,0.0,0.00054274825,False,TSC2; TSC complex subunit
hsa:7733,0.0,0.0,2.0665670096774198e-08,3.2709697449225656e-08,0.0,1.1789414e-07,False,ZNF180; zinc finger protein
hsa:10670,0.0,0.0,1.1240029758870968e-05,2.774503700311184e-05,0.0,0.00012107755,False,RRAGA; Ras related GTP binding
hsa:8905,0.0,0.0,7.408798719354838e-07,1.2182404957568761e-06,0.0,5.0233402e-06,False,AP1S2; adaptor related protein complex 1 subunit sigma
hsa:283159,0.0,0.0,1.8244948387096774e-07,1.0158357343135037e-06,-0.0,5.655934e-06,False,OR8D1; olfactory receptor family 8 subfamily D member
hsa:11184,4.0326423e-08,2.8507029933395955e-05,2.0300151846451616e-07,2.8769107770221254e-07,0.0,1.0212937e-06,False,MAP4K1; mitogen-activated protein kinase kinase kinase kinase
hsa:406882,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A2; microRNA
hsa:1144,0.0,0.0,3.25404978323742e-08,6.466817490151771e-08,0.0,2.8437742e-07,False,CHRND; cholinergic receptor nicotinic delta
hsa:602,7.532863e-06,0.0053250334408576445,5.4055716828709675e-05,8.396083541588219e-05,0.0,0.00031873933,False,BCL3; BCL3 transcription
hsa:1301,5.727914e-07,0.00040491023925905297,1.7359730187096776e-05,4.420480092483519e-05,0.0,0.00018319661,False,COL11A1; collagen type XI alpha 1
hsa:284306,0.0,0.0,5.856546836129032e-09,1.483033294789231e-08,0.0,6.073769e-08,False,ZNF547; zinc finger protein
hsa:221178,0.0,0.0,4.646679125754838e-09,8.465423309342541e-09,0.0,3.435362e-08,False,SPATA13; spermatogenesis associated
hsa:79973,0.0,0.0,1.4865891072580646e-08,3.6697441575352945e-08,0.0,1.7581537e-07,False,ZNF442; zinc finger protein
hsa:3973,0.0,0.0,8.65342059032258e-06,2.3726196552625175e-05,0.0,9.991871e-05,False,LHCGR; luteinizing hormone/choriogonadotropin
hsa:219699,0.0,0.0,1.1126058912258066e-05,4.806252827010645e-05,0.0,0.00026441953,False,UNC5B; unc-5 netrin receptor
hsa:56052,6.758186e-07,0.00047774088616155585,1.11929506883871e-05,4.293983833955747e-05,0.0,0.00023647783,False,ALG1; ALG1 chitobiosyldiphosphodolichol
hsa:219428,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C16; olfactory receptor family 4 subfamily C member
hsa:5336,0.00014761192,0.10434789671194117,0.00023923943493548387,0.0002926357572397902,0.0,0.0011174835,False,PLCG2; phospholipase C gamma
hsa:51160,0.0,0.0,3.5237676877419363e-07,1.028394133625257e-06,0.0,4.4709695e-06,False,VPS28; VPS28 subunit of
hsa:10018,4.037153e-06,0.0028538916386583375,0.00014620593999677419,0.0003037080419025741,0.0,0.0010230417,False,BCL2L11; BCL2 like
hsa:166929,1.1424153e-06,0.0008075813506561075,4.10474887567742e-05,6.731253719245424e-05,0.0,0.00026144294,False,SGMS2; sphingomyelin synthase
hsa:1857,0.0,0.0,4.028748470645161e-05,0.00010588732986765173,0.0,0.0005225754,False,DVL3; dishevelled segment polarity protein
hsa:25949,0.0,0.0,1.0169763281935483e-07,2.4974375625125044e-07,0.0,1.0195675e-06,False,SYF2; SYF2 pre-mRNA splicing
hsa:261729,4.130779e-06,0.002920076511652011,2.9463162374896768e-05,5.7448161316468094e-05,0.0,0.00024006116,False,STEAP2; STEAP2
hsa:150681,0.0,0.0,1.2001291908709677e-05,5.643836932024222e-05,0.0,0.0003147572,False,OR6B3; olfactory receptor family 6 subfamily B member
hsa:10762,0.0,0.0,4.245399846129032e-08,1.0127526210096767e-07,0.0,3.9897841e-07,False,NUP50; nucleoporin
hsa:23350,0.0,0.0,6.77874517516129e-08,1.1129703369880195e-07,0.0,3.4630688e-07,False,U2SURP; U2 snRNP associated SURP domain
hsa:10500,0.0,0.0,4.584377170967741e-07,1.064377765043207e-06,0.0,4.0858527e-06,False,SEMA6C; semaphorin
hsa:3360,0.0,0.0,2.604664518064516e-06,8.633303772773236e-06,0.0,4.2079566e-05,False,HTR4; 5-hydroxytryptamine receptor
hsa:216,0.00012077513,0.08537678251601406,0.0002465215624548387,0.0003514179157938959,0.0,0.0015024276,False,ALDH1A1; aldehyde dehydrogenase 1 family member
hsa:85358,4.4396117e-08,3.138392503211973e-05,6.532223967054839e-05,0.00022192901294950892,0.0,0.0011924808,False,SHANK3; SH3 and multiple ankyrin repeat domains
hsa:140739,0.0,0.0,2.988324283870967e-08,5.7665918988669875e-08,0.0,2.1733871e-07,False,UBE2F; ubiquitin conjugating enzyme E2 F
hsa:9388,2.4014169e-05,0.016975783706594288,6.474496736451612e-05,9.67882359720515e-05,0.0,0.00044896567,False,LIPG; lipase G
hsa:150084,0.0,0.0,1.1295738533870969e-07,3.784772759767542e-07,0.0,1.964509e-06,False,IGSF5; immunoglobulin superfamily member
hsa:390882,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7G2; olfactory receptor family 7 subfamily G member
hsa:135924,-0.0,0.0,8.047239403225807e-07,4.45663128282108e-06,0.0,2.4817438e-05,False,OR9A2; olfactory receptor family 9 subfamily A member
hsa:23710,0.0,0.0,8.334040187096775e-05,0.0001483095999516912,0.0,0.0005524431,False,GABARAPL1; GABA type A receptor associated protein like
hsa:338751,0.0,0.0,7.231338709677418e-08,4.026238996329517e-07,0.0,2.241715e-06,False,OR52L1; olfactory receptor family 52 subfamily L member
hsa:4625,5.826414e-07,0.00041187327302091056,3.440391471593548e-05,8.738534563950052e-05,0.0,0.00045900568,False,MYH7; myosin heavy chain
hsa:79840,5.6565036e-06,0.003998621882321723,5.9689752019354826e-05,0.00012267605050321606,0.0,0.0005679814,False,NHEJ1; non-homologous end joining factor
hsa:57103,1.8838595e-06,0.001331713431583365,0.00012856671759354837,0.00042759360530217214,0.0,0.0019374089,False,TIGAR; TP53 induced glycolysis regulatory
hsa:5597,0.0,0.0,1.1909071022774195e-05,3.098948378101446e-05,0.0,0.00014322692,False,MAPK6; mitogen-activated protein kinase
hsa:80235,6.317462e-07,0.0004465857989365719,1.3922951725806452e-05,2.671228464620357e-05,0.0,0.00011762453,False,PIGZ; phosphatidylinositol glycan anchor biosynthesis class
hsa:2113,2.8904633e-06,0.0020432886848030744,3.509251082251614e-05,9.938031506764617e-05,0.0,0.0003828867,False,ETS1; ETS proto-oncogene 1
hsa:9690,1.4712465e-08,1.040034421473584e-05,3.989901361612903e-07,6.889840798910301e-07,0.0,2.7633785e-06,False,UBE3C; ubiquitin protein ligase
hsa:5959,0.0,0.0,9.729901930806451e-05,0.00036775310307653663,0.0,0.002003671,False,RDH5; retinol dehydrogenase
hsa:8737,0.0,0.0,1.4093224225806453e-05,2.7891116196894576e-05,0.0,0.000107978914,False,RIPK1; receptor interacting serine/threonine kinase
hsa:6605,4.937952e-07,0.00034906727401453984,1.7036503683870966e-06,2.810160792287084e-06,0.0,1.178069e-05,False,SMARCE1; SWI/SNF related
hsa:7410,0.0,0.0,8.58207916419355e-06,2.1817360663227485e-05,0.0,8.4800246e-05,False,VAV2; vav guanine nucleotide exchange factor
hsa:407049,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR92A2; microRNA
hsa:84617,0.0,0.0,0.00015614549811129034,0.0004838542340134262,0.0,0.0022352547,False,TUBB6; tubulin beta 6 class
hsa:23743,1.0098453e-07,7.138666921982944e-05,5.992475949774193e-05,0.00011878667156635127,0.0,0.0003884643,False,BHMT2; betaine--homocysteine S-methyltransferase
hsa:23500,1.11951024e-07,7.913896038441914e-05,5.118194394658064e-05,0.00017865039618907239,0.0,0.0009235916,False,DAAM2; dishevelled associated activator of morphogenesis
hsa:9342,0.0,0.0,3.679180278903226e-05,0.00010789520104413881,0.0,0.00044877102,False,SNAP29; synaptosome associated protein
hsa:51585,3.1878598e-09,2.2535203467480775e-06,1.885635060903226e-07,3.5117717264207624e-07,0.0,1.4262231e-06,False,PCF11; PCF11 cleavage and polyadenylation factor
hsa:50833,0.0,0.0,0.0,0.0,0.0,0.0,False,TAS2R16; taste 2 receptor member
hsa:9771,0.0,0.0,3.226498135483871e-07,6.140846354462894e-07,0.0,2.7630388e-06,False,RAPGEF5; Rap guanine nucleotide exchange factor
hsa:1876,5.3666177e-08,3.7936995159474605e-05,7.757903208225807e-06,2.8626096814030727e-05,0.0,0.00011696104,False,E2F6; E2F transcription factor
hsa:684,2.1795645e-06,0.0015407493603701765,2.0656079824193547e-05,3.432747334747217e-05,0.0,0.00014096418,False,BST2; bone marrow stromal cell antigen
hsa:3549,0.0,0.0,1.557824541935484e-08,5.23794143676062e-08,0.0,2.749424e-07,False,IHH; Indian hedgehog signaling
hsa:116255,0.0,0.0,3.154108387419355e-07,1.4025058867345358e-06,0.0,7.712487e-06,False,MOGAT1; monoacylglycerol O-acyltransferase
hsa:63035,0.0,0.0,2.3721958365161286e-06,8.952177894566887e-06,0.0,4.32596e-05,False,BCORL1; BCL6 corepressor like
hsa:9493,1.8726105e-08,1.3237614349552291e-05,7.1597536365e-07,1.5538444509915104e-06,0.0,6.6389334e-06,False,KIF23; kinesin family member
hsa:137362,0.0,0.0,0.0,0.0,0.0,0.0,False,GOT1L1; glutamic-oxaloacetic transaminase 1 like
hsa:284307,4.8622115e-09,3.4371312519585995e-06,1.7941051803225804e-08,2.4428428628449428e-08,0.0,7.435871e-08,False,ZIK1; zinc finger protein interacting with K protein
hsa:22916,0.0,0.0,2.5473648548387093e-07,3.762313890774544e-07,0.0,1.4000819e-06,False,NCBP2; nuclear cap binding protein subunit
hsa:219469,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR8H1; olfactory receptor family 8 subfamily H member
hsa:3791,7.0564233e-06,0.004988234890950101,8.468215422903226e-05,0.00021403949072086793,0.0,0.001113686,False,KDR; kinase insert domain
hsa:342371,2.1792633e-07,0.000154053643998753,7.779755778258065e-05,0.00012274252083331217,0.0,0.00035905573,False,ATXN1L; ataxin 1
hsa:84678,1.6924713e-07,0.00011964197769416237,3.9496356560645155e-05,0.00011158174612016338,0.0,0.00039496366,False,KDM2B; lysine demethylase
hsa:50649,5.0214397e-09,3.549690778094621e-06,4.6702941919354846e-08,8.614650275074869e-08,0.0,4.104753e-07,False,ARHGEF4; Rho guanine nucleotide exchange factor
hsa:9612,3.3532206e-07,0.00023704150506351617,9.206174236322578e-05,0.00015966564676535774,0.0,0.00056281884,False,NCOR2; nuclear receptor corepressor
hsa:7064,0.0,0.0,0.00010002615903225806,0.0003251463713182402,0.0,0.0014790792,False,THOP1; thimet oligopeptidase
hsa:3685,0.0004330728,0.30614218555758343,0.0006206589298709677,0.0006240232184853327,0.0,0.0023559274,False,ITGAV; integrin subunit alpha
hsa:6315,0.0,0.0,8.665319377419355e-10,2.635585716972065e-09,0.0,1.3648993e-08,False,ATXN8OS; ATXN8 opposite strand
hsa:1827,2.0912119e-06,0.001478292290649578,2.0967312562903224e-05,4.807882286893657e-05,0.0,0.000204448,False,RCAN1; regulator of calcineurin
hsa:8724,0.0,0.0,2.5562233977419354e-07,6.742402877540109e-07,0.0,3.2348742e-06,False,SNX3; sorting nexin
hsa:10253,0.0,0.0,4.3122890322580646e-08,1.2744111320278405e-07,0.0,5.9231274e-07,False,SPRY2; sprouty RTK signaling antagonist
hsa:6121,1.3451373e-05,0.009508869476379647,4.57844281451613e-05,8.020321282956741e-05,-0.0,0.00034350695,False,RPE65; retinoid isomerohydrolase
hsa:83660,0.0,0.0,2.5248183333870973e-06,7.810376978094389e-06,0.0,3.3970427e-05,False,TLN2; talin
hsa:2583,1.8397825e-05,0.01300555092586269,0.0002747247259935483,0.0005290975074393147,0.0,0.0017162206,False,B4GALNT1; beta-1
hsa:5598,0.0,0.0,2.149886093548387e-06,4.961227294650054e-06,0.0,2.3415076e-05,False,MAPK7; mitogen-activated protein kinase
hsa:81671,0.0,0.0,1.9103994558064514e-07,3.9030993771654725e-07,0.0,1.665901e-06,False,VMP1; vacuole membrane protein
hsa:5745,0.0,0.0,4.849630425180644e-05,0.00013128089225769604,0.0,0.00066843396,False,PTH1R; parathyroid hormone 1
hsa:23607,0.0,0.0,3.2239887418870964e-06,6.813488135953084e-06,0.0,2.5655285e-05,False,CD2AP; CD2 associated
hsa:64343,1.2197012e-06,0.0008622152928911888,1.096670782463871e-05,1.839482665532768e-05,0.0,5.815779e-05,False,AZI2; 5-azacytidine induced
hsa:3996,0.0,0.0,3.536695810645161e-07,7.452895021457866e-07,0.0,2.7062374e-06,False,LLGL1; LLGL scribble cell polarity complex component
hsa:407043,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-1; microRNA
hsa:6692,2.8113763e-07,0.0001987381532404696,3.993665476125806e-05,0.0001738534947872408,0.0,0.00095219153,False,SPINT1; serine peptidase inhibitor
hsa:3886,0.0,0.0,1.8012141922580642e-07,5.936830015467964e-07,0.0,2.943166e-06,False,KRT35; keratin
hsa:22925,0.0,0.0,1.332069316451613e-07,2.4770240920116056e-07,0.0,9.627416e-07,False,PLA2R1; phospholipase A2 receptor
hsa:7532,3.190258e-06,0.0022552156510696696,8.005730399999999e-06,1.1796789055713328e-05,0.0,3.887448e-05,False,YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7738,1.0328668e-08,7.301407512590663e-06,4.7924982870967744e-08,1.0477459098898269e-07,0.0,4.9563386e-07,False,ZNF184; zinc finger protein
hsa:27092,0.0,0.0,2.3188316483870968e-06,1.277880856522593e-05,0.0,7.116962e-05,False,CACNG4; calcium voltage-gated channel auxiliary subunit gamma
hsa:162,0.0,0.0,1.1958461816129033e-06,2.935941593942638e-06,0.0,1.3306079e-05,False,AP1B1; adaptor related protein complex 1 subunit beta
hsa:9235,2.697326e-06,0.0019067585791610422,5.711552572258065e-06,1.3134346703419681e-05,0.0,7.10018e-05,False,IL32; interleukin
hsa:79913,0.0,0.0,1.9689742935483874e-07,4.18893501540138e-07,0.0,1.4487292e-06,False,ACTR5; actin related protein
hsa:154197,0.0,0.0,8.004199179032257e-08,1.7393229894663271e-07,0.0,6.5731075e-07,False,PNLDC1; PARN like ribonuclease domain containing exonuclease
hsa:29760,5.8589998e-05,0.04141767859707292,0.000249113631967742,0.0004998770434313871,0.0,0.002197464,False,BLNK; B cell
hsa:50674,0.0,0.0,4.167092225806452e-08,1.873199678760287e-07,0.0,1.0147636e-06,False,NEUROG3; neurogenin
hsa:63976,1.2597541e-06,0.000890528967506448,3.4119251430322576e-05,8.011065349963531e-05,0.0,0.0003405444,False,PRDM16; PR/SET domain
hsa:51056,0.0,0.0,0.0001398832655367742,0.0005565540832109324,0.0,0.0030547779,False,LAP3; leucine aminopeptidase
hsa:5778,4.4405564e-08,3.1390603182368286e-05,3.668073353548388e-07,5.89545085075648e-07,0.0,2.4983206e-06,False,PTPN7; protein tyrosine phosphatase non-receptor type
hsa:23678,0.0,0.0,1.6179340032258065e-06,3.994028203388254e-06,0.0,1.5143628e-05,False,SGK3; serum/glucocorticoid regulated kinase family member
hsa:80736,1.921839e-09,1.358561405264428e-06,3.7124874450399996e-06,1.3368645983084444e-05,0.0,6.844635e-05,False,SLC44A4; solute carrier family 44 member
hsa:390064,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51I2; olfactory receptor family 51 subfamily I member
hsa:2239,6.4871494e-07,0.0004585811196996362,3.824888497419354e-06,7.528431164969601e-06,0.0,2.9797195e-05,False,GPC4; glypican
hsa:10229,0.0,0.0,0.00018920412444193546,0.0003556011823607235,0.0,0.0012461671,False,COQ7; coenzyme Q7
hsa:6579,0.0,0.0,2.542936831387097e-07,1.1356555725360348e-06,0.0,6.2403506e-06,False,SLCO1A2; solute carrier organic anion transporter family member
hsa:1395,0.0,0.0,5.303904332258065e-08,1.272688022357011e-07,0.0,5.7428105e-07,False,CRHR2; corticotropin releasing hormone receptor
hsa:55670,0.0,0.0,1.1717786248387097e-07,3.3681868585197773e-07,0.0,1.727543e-06,False,PEX26; peroxisomal biogenesis factor
hsa:4909,0.0,0.0,1.0902706003225808e-08,2.716090536206099e-08,0.0,1.124063e-07,False,NTF4; neurotrophin
hsa:675,0.0,0.0,1.2618729677419355e-06,7.025811340212107e-06,0.0,3.9118062e-05,False,BRCA2; BRCA2 DNA repair
hsa:26851,0.0,0.0,2.903697802732258e-06,7.4503648038651215e-06,0.0,3.1244475e-05,False,SNORD3B-1; small nucleolar RNA
hsa:51804,1.474955e-07,0.00010426559860122487,3.033329940379129e-06,1.0342870121911263e-05,0.0,4.85645e-05,False,SIX4; SIX homeobox
hsa:79230,4.1706053e-10,2.948230001145398e-07,3.036036748548387e-08,4.8205608464742595e-08,0.0,1.3393826e-07,False,ZNF557; zinc finger protein
hsa:27183,0.0,0.0,3.720663143870968e-05,0.00013435445070676943,0.0,0.00073580653,False,VPS4A; vacuolar protein sorting 4 homolog
hsa:4734,1.5479469e-07,0.00010942544696713486,1.046729020135484e-05,3.0392914965522225e-05,0.0,0.00013479961,False,NEDD4; NEDD4 E3 ubiquitin protein
hsa:55576,0.0,0.0,1.200150571608903e-06,3.827191588378028e-06,0.0,1.6467135e-05,False,STAB2; stabilin
hsa:79310,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5H2; olfactory receptor family 5 subfamily H member
hsa:92856,0.0,0.0,8.032375380645161e-08,1.7510577397871873e-07,0.0,7.248002e-07,False,IMP4; IMP U3 small nucleolar ribonucleoprotein
hsa:5140,0.0,0.0,0.0,0.0,0.0,0.0,False,PDE3B; phosphodiesterase
hsa:9583,0.0,0.0,2.494788487096774e-07,5.756558083088519e-07,0.0,1.9933057e-06,False,ENTPD4; ectonucleoside triphosphate diphosphohydrolase
hsa:406925,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135A1; microRNA
hsa:9421,0.0,0.0,1.6046358442580648e-07,8.172364197918597e-07,0.0,4.5604943e-06,False,HAND1; heart and neural crest derivatives expressed
hsa:4055,0.00019547514,0.13818274105825765,0.0005745891310290322,0.0008497943749986307,0.0,0.0034976662,False,LTBR; lymphotoxin beta
hsa:4496,0.0,0.0,4.350946832709678e-06,2.348693984873617e-05,0.0,0.00013084519,False,MT1H; metallothionein
hsa:2165,0.0,0.0,3.6659477419354836e-08,1.5039966640247062e-07,0.0,7.612387e-07,False,F13B; coagulation factor XIII B
hsa:387332,0.0,0.0,4.583179032258064e-09,2.5518060884276248e-08,0.0,1.4207855e-07,False,TBPL2; TATA-box binding protein like
hsa:92610,0.0,0.0,2.198410757696774e-06,7.461048597399173e-06,0.0,3.656016e-05,False,TIFA; TRAF interacting protein with forkhead associated
hsa:3702,0.0,0.0,1.2580440502903224e-06,3.6803779706991824e-06,0.0,1.8742077e-05,False,ITK; IL2 inducible T cell
hsa:9900,8.545838e-07,0.000604111253983406,8.736071516129032e-06,2.61518959860621e-05,0.0,0.000113107715,False,SV2A; synaptic vesicle glycoprotein
hsa:8718,7.7309653e-07,0.0005465073339659841,7.951104320967741e-06,1.7663733011157835e-05,0.0,8.366729e-05,False,TNFRSF25; TNF receptor superfamily member
hsa:6586,0.0,0.0,3.154857213666775e-05,0.00012617949172209287,0.0,0.0006818727,False,SLIT3; slit guidance ligand
hsa:219968,0.0,0.0,2.51641e-09,1.4010777920269097e-08,-0.0,7.800871e-08,False,OR5B21; olfactory receptor family 5 subfamily B member
hsa:9061,0.0,0.0,0.0001996367408064516,0.00045959094220032797,0.0,0.0017542724,False,PAPSS1; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:1548,0.0,0.0,2.1732752903225806e-06,7.355565357420671e-06,0.0,3.112194e-05,False,CYP2A6; cytochrome P450 family 2 subfamily A member
hsa:255403,3.2222025e-09,2.277797441121006e-06,3.8025280077419355e-08,8.375161553925668e-08,0.0,3.5031601e-07,False,ZNF718; zinc finger protein
hsa:7549,0.0,0.0,3.595109939032259e-08,8.598772684777372e-08,0.0,4.5079884e-07,False,ZNF2; zinc finger protein
hsa:5283,0.0,0.0,2.7854860970967742e-05,4.289127536100875e-05,0.0,0.00014175943,False,PIGH; phosphatidylinositol glycan anchor biosynthesis class
hsa:2177,0.0,0.0,3.893180531935484e-05,9.613978069180147e-05,0.0,0.0004033048,False,FANCD2; FA complementation group
hsa:6010,0.0,0.0,2.0551723212580644e-07,1.132356330042537e-06,0.0,6.306681e-06,False,RHO;
hsa:79659,5.217893e-06,0.0036885649872853148,0.0001115376354767742,0.00021239164638985398,0.0,0.0008532424,False,DYNC2H1; dynein cytoplasmic 2 heavy chain
hsa:84376,0.0,0.0,4.845740530967741e-07,1.4878653020728994e-06,0.0,5.286611e-06,False,HOOK3; hook microtubule tethering protein
hsa:4129,2.353239e-05,0.016635210768243633,0.00020341024848387096,0.00033892692435163693,0.0,0.0012624516,False,MAOB; monoamine oxidase
hsa:4296,0.0,0.0,5.164233969354838e-07,1.9631975608232438e-06,0.0,1.0138667e-05,False,MAP3K11; mitogen-activated protein kinase kinase kinase
hsa:79695,3.3619253e-05,0.023765684638317953,0.00021419239432580648,0.00043363757835266986,0.0,0.0018913252,False,GALNT12; polypeptide N-acetylgalactosaminyltransferase
hsa:10172,0.0,0.0,2.5642009322580648e-08,4.767550922357963e-08,0.0,1.9079631e-07,False,ZNF256; zinc finger protein
hsa:5145,0.0,0.0,1.2547062317741935e-06,6.266828194368492e-06,0.0,3.498655e-05,False,PDE6A; phosphodiesterase
hsa:89910,0.0,0.0,6.262096964000001e-07,1.4232860505806623e-06,0.0,6.351942e-06,False,UBE3B; ubiquitin protein ligase
hsa:3054,3.6493514e-08,2.5797519804144403e-05,5.084405261116128e-05,0.00014055205654377637,0.0,0.0005339504,False,HCFC1; host cell factor
hsa:2817,0.0,0.0,8.287354466451613e-07,1.7050210358655609e-06,0.0,7.277118e-06,False,GPC1; glypican
hsa:11025,1.1117269e-05,0.007858875064634792,1.754560832580645e-05,2.1618640016312597e-05,0.0,8.867464e-05,False,LILRB3; leukocyte immunoglobulin like receptor
hsa:9643,2.0388358e-08,1.4412672599273008e-05,2.137861748032258e-05,4.2043930750706986e-05,0.0,0.0001448764,False,MORF4L2; mortality factor 4 like
hsa:387778,0.0,0.0,2.5413663414161293e-08,1.2148068955879863e-07,0.0,6.763142e-07,False,SPDYC; speedy/RINGO cell cycle regulator family member
hsa:407048,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR92A1; microRNA
hsa:54675,0.0,0.0,5.803095122580646e-06,1.905011900985809e-05,0.0,0.000103065344,False,CRLS1; cardiolipin synthase
hsa:5189,0.0,0.0,7.617624363548387e-07,1.6947392121124845e-06,0.0,6.845559e-06,False,PEX1; peroxisomal biogenesis factor
hsa:3635,1.0120551e-05,0.007154288152446855,3.784819942903226e-05,5.336634781682981e-05,0.0,0.00018462042,False,INPP5D; inositol polyphosphate-5-phosphatase
hsa:148254,0.0,0.0,1.4668578612903224e-08,2.257299351452686e-08,0.0,8.7821e-08,False,ZNF555; zinc finger protein
hsa:7366,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2B15; UDP glucuronosyltransferase family 2 member
hsa:23513,0.0,0.0,1.1175948967741936e-06,4.02766608033304e-06,0.0,1.7356895e-05,False,SCRIB; scribble planar cell polarity
hsa:79901,9.867331e-06,0.006975285166743547,0.00020104718698774187,0.0003131619975851247,0.0,0.0009775681,False,CYBRD1; cytochrome b reductase
hsa:6564,0.0,0.0,0.0,0.0,-0.0,-0.0,False,SLC15A1; solute carrier family 15 member
hsa:26658,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7C2; olfactory receptor family 7 subfamily C member
hsa:64077,1.5336018e-07,0.00010841138183396507,7.306481251612903e-07,1.5503733981141066e-06,0.0,7.5794183e-06,False,LHPP; phospholysine phosphohistidine inorganic pyrophosphate
hsa:5001,0.0,0.0,1.3315630910645162e-07,4.844234000959561e-07,0.0,2.3312252e-06,False,ORC5; origin recognition complex subunit
hsa:55713,0.0,0.0,6.110766980645161e-08,1.2978539775034785e-07,0.0,4.878073e-07,False,ZNF334; zinc finger protein
hsa:10718,0.0,0.0,5.8880267095580655e-06,1.7322130226848732e-05,0.0,8.422502e-05,False,NRG3; neuregulin
hsa:6866,0.0,0.0,7.838284200322581e-07,1.2788656394313563e-06,0.0,5.173758e-06,False,TAC3; tachykinin precursor
hsa:5104,0.0,0.0,1.028371994935484e-06,1.769974784698667e-06,0.0,5.8230426e-06,False,SERPINA5; serpin family A member
hsa:56474,0.0,0.0,4.8909384477419356e-08,1.8010265859026882e-07,0.0,8.053532e-07,False,CTPS2; CTP synthase
hsa:51082,2.8655734e-06,0.00202569384073919,3.177387076451613e-05,5.857159137410388e-05,0.0,0.00023472888,False,POLR1D; RNA polymerase I and III subunit
hsa:100528032,0.0,0.0,6.239378354838709e-08,1.8607419384924967e-07,0.0,9.112393e-07,False,KLRC4-KLRK1; KLRC4-KLRK1
hsa:5777,4.055388e-05,0.028667820874550352,6.050925599032259e-05,7.549947593567725e-05,0.0,0.0002887424,False,PTPN6; protein tyrosine phosphatase non-receptor type
hsa:9540,5.3431745e-07,0.00037771273542128435,0.00021405363365822584,0.0004841164160336144,0.0,0.002040555,False,TP53I3; tumor protein p53 inducible protein
hsa:22920,0.0,0.0,5.500093017574194e-07,1.725488592603206e-06,0.0,6.668315e-06,False,KIFAP3; kinesin associated protein
hsa:162655,0.0,0.0,1.5835933677419356e-08,4.4606939649339065e-08,0.0,1.938593e-07,False,ZNF519; zinc finger protein
hsa:1759,1.8012311e-06,0.0012733028388028297,0.00012666150752258063,0.0004013333603683831,0.0,0.0019372486,False,DNM1; dynamin
hsa:10678,0.0,0.0,0.0002351119322677419,0.0005319502800927573,0.0,0.0024191516,False,B3GNT2; UDP-GlcNAc:betaGal beta-1
hsa:83852,0.0,0.0,1.1835615930967743e-06,3.403761768981378e-06,0.0,1.785348e-05,False,SETDB2; SET domain bifurcated histone lysine methyltransferase
hsa:1912,0.0,0.0,5.999506708258064e-06,3.2028688074563044e-05,0.0,0.00017855717,False,PHC2; polyhomeotic homolog
hsa:23339,0.0,0.0,2.1411347382387096e-05,3.800216752289776e-05,0.0,0.0001431433,False,VPS39; VPS39 subunit of HOPS
hsa:9541,6.2984886e-06,0.0044524455604543255,5.847540704870968e-05,9.318137439109364e-05,0.0,0.0002813515,False,CIR1; corepressor interacting with RBPJ
hsa:60495,0.0,0.0,3.100542377322581e-07,7.091898979828463e-07,0.0,2.5708227e-06,False,HPSE2; heparanase 2
hsa:6310,0.0,0.0,0.00020817870690532258,0.0006464814708519809,0.0,0.0023550808,False,ATXN1; ataxin
hsa:147741,0.0,0.0,1.0662439210645162e-09,2.9815613077687453e-09,0.0,1.3973521e-08,False,ZNF560; zinc finger protein
hsa:6307,3.6048577e-06,0.0025482990732784033,2.2516718178064523e-05,4.19554444931667e-05,0.0,0.00016386011,False,MSMO1; methylsterol monooxygenase
hsa:3242,4.1717278e-05,0.02949023504231458,0.00015977718385645157,0.0002301741209435317,0.0,0.0007992712,False,HPD; 4-hydroxyphenylpyruvate
hsa:1735,0.0,0.0,2.270026186290323e-06,5.532964837443034e-06,0.0,2.7832011e-05,False,DIO3; iodothyronine deiodinase
hsa:55308,0.0,0.0,4.19299350467742e-07,8.312508040214495e-07,0.0,2.9397847e-06,False,DDX19A; DEAD-box helicase
hsa:27302,-0.0,0.0,0.0,0.0,0.0,0.0,False,BMP10; bone morphogenetic protein
hsa:285704,1.1328053e-06,0.0008007879745696657,0.00024380079310741936,0.0006140309671634496,0.0,0.0026698487,False,RGMB; repulsive guidance molecule BMP co-receptor
hsa:643834,0.0,0.0,1.2433555e-07,3.115108779945443e-07,0.0,1.1433507e-06,False,PGA3; pepsinogen
hsa:7170,0.0,0.0,0.000574958054516129,0.0010225780916282682,0.0,0.003202661,False,TPM3; tropomyosin
hsa:26529,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR12D2; olfactory receptor family 12 subfamily D member
hsa:3607,0.0,0.0,3.3649437110161292e-06,1.1578897552683357e-05,0.0,4.9400696e-05,False,FOXK2; forkhead box
hsa:26060,1.4379129e-06,0.0010164706669350807,6.177388342580644e-06,9.84978984153799e-06,0.0,3.6443984e-05,False,APPL1; adaptor protein
hsa:10224,0.0,0.0,5.7859278741935486e-08,1.30635693839895e-07,0.0,4.750114e-07,False,ZNF443; zinc finger protein
hsa:64850,0.0,0.0,1.0831890825806452e-07,2.689323529808003e-07,0.0,1.1407412e-06,False,ETNPPL; ethanolamine-phosphate
hsa:26534,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10G2; olfactory receptor family 10 subfamily G member
hsa:57678,0.0,0.0,1.3641278319354837e-05,3.1920452709902666e-05,0.0,0.00012804384,False,GPAM; glycerol-3-phosphate acyltransferase
hsa:85479,1.1788751e-09,8.333550377982979e-07,6.564009509451613e-08,1.724185735999611e-07,0.0,9.1199087e-07,False,DNAJC5B; DnaJ heat shock protein family (Hsp40) member C5
hsa:406995,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A1; microRNA
hsa:26338,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5L2; olfactory receptor family 5 subfamily L member
hsa:7556,3.514605e-09,2.484498809603398e-06,2.3180752932258062e-08,4.044314877973938e-08,0.0,1.3919207e-07,False,ZNF10; zinc finger protein
hsa:392309,0.0,0.0,8.393117712903225e-07,3.147560606463797e-06,0.0,1.3987874e-05,False,OR13J1; olfactory receptor family 13 subfamily J member
hsa:894,0.00067103875,0.47436197682890463,0.0007378135649677419,0.0004973164637540994,2.5249597e-05,0.001791123,True,CCND2; cyclin
hsa:162962,6.231244e-09,4.404909883286547e-06,5.808910912903226e-08,1.1971443258398174e-07,0.0,5.3176643e-07,False,ZNF836; zinc finger protein
hsa:7531,1.3603311e-05,0.009616275509243518,3.139883671096774e-05,3.925970012489744e-05,0.0,0.00014952166,False,YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10780,0.0,0.0,1.279326055483871e-08,2.1051328182261796e-08,0.0,7.860798e-08,False,ZNF234; zinc finger protein
hsa:4850,3.3458502e-07,0.00023652048634231418,8.325820290322581e-07,1.3938217971871643e-06,0.0,5.8797264e-06,False,CNOT4; CCR4-NOT transcription complex subunit
hsa:51028,0.0,0.0,2.2323476022580647e-07,4.4111716652355314e-07,0.0,1.592609e-06,False,VPS36; vacuolar protein sorting 36
hsa:10808,0.0,0.0,2.743071410483871e-07,6.781435005313243e-07,0.0,2.9885805e-06,False,HSPH1; heat shock protein family H (Hsp110) member
hsa:3765,0.0,0.0,4.4138315237419356e-05,0.000146248047093232,0.0,0.0007418063,False,KCNJ9; potassium inwardly rectifying channel subfamily J member
hsa:390174,0.0,0.0,1.8547377419354837e-08,1.0326742701944213e-07,-0.0,5.749687e-07,False,OR9G1; olfactory receptor family 9 subfamily G member
hsa:9688,0.0,0.0,2.1105716772580644e-07,4.7019982787422823e-07,0.0,1.7668496e-06,False,NUP93; nucleoporin
hsa:5985,0.0,0.0,9.282883654838708e-05,0.0002781701988215973,0.0,0.0013737956,False,RFC5; replication factor C subunit
hsa:339896,0.0,0.0,4.877226007096773e-06,1.4816480042714215e-05,0.0,8.1905455e-05,False,GADL1; glutamate decarboxylase like
hsa:388536,4.8664455e-09,3.4401242961157267e-06,8.361482461451611e-08,2.2669936791684142e-07,0.0,1.0031755e-06,False,ZNF790; zinc finger protein
hsa:80222,0.0,0.0,2.249534691709677e-06,7.399773917495654e-06,0.0,4.118527e-05,False,TARS2; threonyl-tRNA synthetase 2
hsa:9166,0.0,0.0,4.122905490741936e-07,1.0603069268744312e-06,0.0,4.4156955e-06,False,EBAG9; estrogen receptor binding site associated antigen
hsa:5795,0.0,0.0,6.115956678709677e-06,1.249204091388996e-05,0.0,4.309259e-05,False,PTPRJ; protein tyrosine phosphatase receptor type
hsa:4050,0.0,0.0,5.94582414516129e-08,2.3098905090178608e-07,0.0,1.2306122e-06,False,LTB; lymphotoxin
hsa:407029,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30A; microRNA
hsa:10908,0.0,0.0,9.485798875032258e-06,2.745659552107659e-05,0.0,0.00012894598,False,PNPLA6; patatin like phospholipase domain containing
hsa:5150,6.223692e-07,0.0004399571321766797,7.926890775258065e-06,1.4619490581775995e-05,0.0,5.2181305e-05,False,PDE7A; phosphodiesterase
hsa:5834,0.0,0.0,0.00011177970706451612,0.00023268552463670758,0.0,0.0012137669,False,PYGB; glycogen phosphorylase
hsa:130574,0.0,0.0,9.91335511129032e-07,1.7615163783425512e-06,0.0,6.2009835e-06,False,LYPD6; LY6/PLAUR domain containing
hsa:5149,0.0,0.0,5.847656319245162e-09,2.14360937736282e-08,0.0,1.1259671e-07,False,PDE6H; phosphodiesterase
hsa:3632,1.1545533e-05,0.008161617875902626,2.718944352064516e-05,5.522285601442723e-05,0.0,0.0002759511,False,INPP5A; inositol polyphosphate-5-phosphatase
hsa:165829,1.9637788e-07,0.00013882089426619463,3.1904330473645165e-06,8.290294336398757e-06,0.0,3.894003e-05,False,GPR156; G protein-coupled receptor
hsa:30833,0.0,0.0,0.00011106102525806453,0.00015402232255842422,0.0,0.00055041356,False,NT5C; 5'
hsa:406901,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR107; microRNA
hsa:8388,0.0,0.0,2.0346151774193548e-07,6.195983889620055e-07,0.0,3.0875094e-06,False,OR1E2; olfactory receptor family 1 subfamily E member
hsa:64283,0.0,0.0,9.66981755870968e-08,2.2429099707784484e-07,0.0,1.0041757e-06,False,ARHGEF28; Rho guanine nucleotide exchange factor
hsa:79816,0.0,0.0,6.297140848387096e-07,1.6782306125208712e-06,0.0,8.081117e-06,False,TLE6; TLE family member 6
hsa:79147,0.0,0.0,4.544602532258064e-05,8.265678074558253e-05,0.0,0.00033597302,False,FKRP; fukutin related
hsa:537,2.7611916e-06,0.001951905617640361,0.00013170448756451614,0.0002769214246975941,0.0,0.0010992686,False,ATP6AP1; ATPase H+ transporting accessory protein
hsa:29940,0.00010158558,0.07181155566069893,0.0005444433839306452,0.0009747327834013435,0.0,0.0038023146,False,DSE; dermatan sulfate
hsa:9491,0.0,0.0,1.0575465407741933e-06,3.0898564476517973e-06,0.0,1.6611422e-05,False,PSMF1; proteasome inhibitor subunit
hsa:5432,0.0,0.0,3.1363535637096774e-05,7.217290121684623e-05,0.0,0.0002710554,False,POLR2C; RNA polymerase II subunit
hsa:140032,0.0,0.0,2.948752129032258e-10,1.2343850267503812e-09,0.0,6.390805e-09,False,RPS4Y2; ribosomal protein S4 Y-linked
hsa:3559,1.1402631e-06,0.0008060599454518161,8.763633017741938e-05,0.0002403121821695022,0.0,0.0011138018,False,IL2RA; interleukin 2 receptor subunit
hsa:5827,0.0,0.0,7.716972328709676e-07,1.579907519522042e-06,0.0,6.206822e-06,False,PXMP2; peroxisomal membrane protein
hsa:4798,7.9752045e-09,5.637727735149088e-06,3.839914741490323e-06,8.671910057864075e-06,0.0,3.0043018e-05,False,NFRKB; nuclear factor related to kappaB binding
hsa:5909,0.0,0.0,5.007076281935484e-08,1.2030294007247043e-07,0.0,4.9230266e-07,False,RAP1GAP; RAP1 GTPase activating
hsa:64147,0.0,0.0,4.593797689774193e-07,1.2800598690926612e-06,0.0,5.769614e-06,False,KIF9; kinesin family member
hsa:51382,2.7943013e-05,0.01975311095705841,4.964692066451612e-05,6.881499396869168e-05,0.0,0.00024367815,False,ATP6V1D; ATPase H+ transporting V1 subunit
hsa:27124,0.0,0.0,3.661092329677419e-07,1.1926299968986727e-06,0.0,6.384757e-06,False,INPP5J; inositol polyphosphate-5-phosphatase
hsa:6926,0.0,0.0,4.89934027896129e-05,0.00011906418637250664,0.0,0.0005956269,False,TBX3; T-box transcription factor
hsa:54884,1.0840686e-05,0.007663356611136734,0.00016575027350000004,0.0004068650157689363,0.0,0.0020353366,False,RETSAT; retinol
hsa:143686,0.0,0.0,3.35449673032258e-05,8.94971344554443e-05,0.0,0.00034858022,False,SESN3; sestrin
hsa:5275,0.0,0.0,1.3593104335483871e-08,7.086253599874638e-08,0.0,3.9472002e-07,False,SERPINB13; serpin family B member
hsa:9253,0.0,0.0,0.00028614396000000005,0.0008032858753284286,0.0,0.0027023917,False,NUMBL; NUMB like endocytic adaptor
hsa:28996,4.7656483e-09,3.368870051780629e-06,7.618821617206452e-07,1.7453698708430166e-06,0.0,7.2151506e-06,False,HIPK2; homeodomain interacting protein kinase
hsa:399687,6.0354535e-09,4.266504212042793e-06,2.0197559011290322e-07,4.506317651218141e-07,0.0,1.8780613e-06,False,MYO18A; myosin
hsa:9468,0.0,0.0,2.8413149354838714e-07,1.2540149498815566e-06,0.0,6.7372926e-06,False,PCYT1B; phosphate cytidylyltransferase 1B
hsa:10803,0.0,0.0,2.320836048387097e-06,6.420372362903252e-06,0.0,2.4425613e-05,False,CCR9; C-C motif chemokine receptor
hsa:225689,2.7963345e-06,0.001976748378979405,2.264060052290322e-05,5.344427550654101e-05,0.0,0.00022984229,False,MAPK15; mitogen-activated protein kinase
hsa:10768,0.0,0.0,0.0,0.0,0.0,0.0,False,AHCYL1; adenosylhomocysteinase like
hsa:4878,0.0,0.0,4.619392003225806e-06,8.07706516690844e-06,0.0,2.825905e-05,False,NPPA; natriuretic peptide
hsa:1353,2.9765172e-07,0.00021041207874466803,2.175493650322581e-06,2.9839439566277244e-06,0.0,1.02282875e-05,False,COX11; cytochrome c oxidase copper chaperone
hsa:131669,0.0,0.0,2.1377644821612898e-07,6.417196776539866e-07,-0.0,2.8596023e-06,False,UROC1; urocanate hydratase
hsa:100533467,0.0,0.0,2.81794867e-07,6.727451837787624e-07,0.0,3.1290685e-06,False,BIVM-ERCC5; BIVM-ERCC5
hsa:6631,0.0,0.0,7.016046912903226e-07,1.3739029232450663e-06,0.0,4.8728198e-06,False,SNRPC; small nuclear ribonucleoprotein polypeptide
hsa:4353,0.0,0.0,6.336255516129032e-07,2.184461262113663e-06,0.0,1.1563731e-05,False,MPO;
hsa:5286,0.0,0.0,3.4810642472258063e-06,9.247088234824796e-06,0.0,5.0230297e-05,False,PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:2868,0.0,0.0,9.501638918709678e-06,2.178156627705264e-05,0.0,8.6426684e-05,False,GRK4; G protein-coupled receptor kinase
hsa:22909,0.0,0.0,2.5775028699999994e-05,6.284399573487835e-05,0.0,0.0002630701,False,FAN1; FANCD2 and FANCI associated nuclease
hsa:51806,0.0,0.0,0.0,0.0,0.0,0.0,False,CALML5; calmodulin like
hsa:3752,6.8389516e-10,4.834502628072075e-07,5.5567565466451616e-08,1.284296319261038e-07,0.0,5.6638754e-07,False,KCND3; potassium voltage-gated channel subfamily D member
hsa:4880,1.8436523e-07,0.00013032906812209528,2.6581815559419357e-05,8.392715458885456e-05,0.0,0.0004359399,False,NPPC; natriuretic peptide
hsa:22854,0.0,0.0,8.578192067741936e-07,1.4794431192197127e-06,0.0,5.5474025e-06,False,NTNG1; netrin
hsa:9963,0.0,0.0,1.8524936187903226e-06,5.073357221005277e-06,0.0,2.49565e-05,False,SLC23A1; solute carrier family 23 member
hsa:81392,0.0,0.0,1.0985222841935482e-05,2.05107570667924e-05,0.0,8.7893815e-05,False,OR2AE1; olfactory receptor family 2 subfamily AE member
hsa:132,7.958756e-09,5.626100175673767e-06,8.570068444096772e-06,2.7587090982353513e-05,0.0,0.00012821051,False,ADK; adenosine
hsa:6499,0.0,0.0,1.3521419688612903e-05,4.5018273595017106e-05,0.0,0.00018656008,False,SKIC2; SKI2 subunit of superkiller
hsa:3352,0.0,0.0,9.78791492903226e-06,1.780193942195522e-05,0.0,6.851421e-05,False,HTR1D; 5-hydroxytryptamine receptor
hsa:6425,0.0,0.0,2.6401534939770964e-05,0.0001317474239975522,0.0,0.00073428574,False,SFRP5; secreted frizzled related protein
hsa:2882,0.0,0.0,1.1357643031935484e-05,3.4467564624673934e-05,0.0,0.00018318922,False,GPX7; glutathione peroxidase
hsa:388559,0.0,0.0,6.843281806451613e-10,2.0718221855027845e-09,0.0,1.023569e-08,False,ZNF888; zinc finger protein
hsa:2615,1.5262069e-05,0.010788863119065989,0.00017347455417806454,0.0003165116603265409,0.0,0.0012302133,False,LRRC32; leucine rich repeat containing
hsa:4659,1.5095514e-05,0.010671124226862314,5.476644196774193e-05,0.0001507530795132294,0.0,0.00080047257,False,PPP1R12A; protein phosphatase 1 regulatory subunit
hsa:10268,5.2703665e-08,3.725658870747531e-05,2.0428492681580644e-05,7.83460395503753e-05,0.0,0.00043569427,False,RAMP3; receptor activity modifying protein
hsa:9618,0.0,0.0,2.648295583548387e-05,5.017302429329249e-05,0.0,0.00021943112,False,TRAF4; TNF receptor associated factor
hsa:578,0.0,0.0,9.584741345161289e-05,0.00018819505736953422,0.0,0.0007069355,False,BAK1; BCL2 antagonist/killer
hsa:5352,7.324836e-07,0.0005177977702342117,5.980318866525805e-05,0.0001249905274365949,0.0,0.00053744286,False,PLOD2; procollagen-lysine
hsa:5715,7.4461646e-08,5.2637457366648485e-05,1.738258087783871e-06,3.636648369761473e-06,0.0,1.2172775e-05,False,PSMD9; proteasome 26S subunit
hsa:5717,0.0,0.0,3.901927630645161e-06,1.0237040208453228e-05,0.0,4.3197942e-05,False,PSMD11; proteasome 26S subunit
hsa:1241,2.3171654e-06,0.001638020397158196,7.1278556706451624e-06,1.2270013060764505e-05,0.0,5.655837e-05,False,LTB4R; leukotriene B4
hsa:441933,0.0,0.0,5.0825193548387095e-08,2.829827013726479e-07,0.0,1.575581e-06,False,OR13G1; olfactory receptor family 13 subfamily G member
hsa:93,0.0,0.0,1.0728525806451612e-09,5.9733903650863536e-09,0.0,3.325843e-08,False,ACVR2B; activin A receptor type
hsa:406895,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A1; microRNA
hsa:79139,1.0008999e-07,7.075431264913581e-05,8.484572370967744e-07,1.5098058358041189e-06,0.0,6.312694e-06,False,DERL1; derlin
hsa:5255,0.0,0.0,5.466784471290322e-07,9.531927423113378e-07,0.0,3.7642635e-06,False,PHKA1; phosphorylase kinase regulatory subunit alpha
hsa:3441,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA4; interferon alpha
hsa:6360,1.3775872e-06,0.0009738260084774473,4.0117312134838717e-05,7.747349644707233e-05,0.0,0.00028359907,False,CCL16; C-C motif chemokine ligand
hsa:23729,0.0,0.0,2.107723416774194e-06,4.379018302488298e-06,0.0,1.9704366e-05,False,SHPK;
hsa:4329,9.557588e-06,0.006756325677758872,0.00010994365932258066,0.0002365235387623743,0.0,0.0012368732,False,ALDH6A1; aldehyde dehydrogenase 6 family member
hsa:7042,0.0002519318,0.1780923481305129,0.00027734554187096777,0.00023624669122559167,0.0,0.0009692162,False,TGFB2; transforming growth factor beta
hsa:407031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30C1; microRNA
hsa:2915,0.0,0.0,1.056613045483871e-07,5.352699665844552e-07,0.0,2.9760397e-06,False,GRM5; glutamate metabotropic receptor
hsa:8590,0.0,0.0,2.610733225806451e-10,1.4535947415501416e-09,0.0,8.093273e-09,False,OR6A2; olfactory receptor family 6 subfamily A member
hsa:79339,0.0,0.0,6.1289384248387095e-06,1.5063252399016504e-05,0.0,5.7992263e-05,False,OR51B4; olfactory receptor family 51 subfamily B member
hsa:148213,0.0,0.0,5.342801822580645e-09,1.408481208140525e-08,0.0,7.230504e-08,False,ZNF681; zinc finger protein
hsa:23409,0.0,0.0,1.0435356111935485e-05,3.286129649333566e-05,0.0,0.00015834508,False,SIRT4; sirtuin
hsa:8916,0.0,0.0,3.747752379774194e-07,6.755498605740518e-07,0.0,2.2357947e-06,False,HERC3; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:92745,0.0,0.0,1.2832521457741934e-06,2.7675777043571887e-06,0.0,1.1469216e-05,False,SLC38A5; solute carrier family 38 member
hsa:54913,1.0034273e-08,7.09329763194883e-06,6.899156986870968e-07,1.1231889257697366e-06,0.0,3.8121923e-06,False,RPP25; ribonuclease P and MRP subunit
hsa:53904,0.0,0.0,4.0535323776129044e-09,1.4076934147148694e-08,0.0,7.6364486e-08,False,MYO3A; myosin
hsa:6119,0.0,0.0,1.700369941935484e-05,4.0408724077712024e-05,0.0,0.00016047165,False,RPA3; replication protein
hsa:219749,3.9522305e-08,2.793859330572922e-05,1.9793898620645161e-07,3.5979438671368566e-07,0.0,1.4619553e-06,False,ZNF25; zinc finger protein
hsa:3354,0.0,0.0,4.174570709677419e-06,1.0956061583616048e-05,0.0,5.032774e-05,False,HTR1E; 5-hydroxytryptamine receptor
hsa:51174,0.0,0.0,2.84796409483871e-08,5.534950979544921e-08,0.0,2.0661933e-07,False,TUBD1; tubulin delta
hsa:5465,3.6997706e-05,0.026153936648657956,0.0002739664252419355,0.0006295805892399211,0.0,0.0031335736,False,PPARA; peroxisome proliferator activated receptor
hsa:7766,0.0,0.0,1.6049434583870967e-08,2.61023894578199e-08,0.0,7.798481e-08,False,ZNF223; zinc finger protein
hsa:5924,0.0,0.0,2.2224638536774196e-07,6.222312075275006e-07,0.0,2.5111392e-06,False,RASGRF2; Ras protein specific guanine nucleotide releasing factor
hsa:10113,0.0,0.0,2.3032554696774196e-07,7.303879721098682e-07,0.0,3.1116006e-06,False,PREB; prolactin regulatory element
hsa:90390,0.0,0.0,6.264913677419355e-08,1.8052779624514803e-07,0.0,7.927641e-07,False,MED30; mediator complex subunit
hsa:1161,0.0,0.0,1.0020885689354839e-06,2.2776420634963658e-06,0.0,7.940039e-06,False,ERCC8; ERCC excision repair 8
hsa:5879,0.00013848476,0.09789584359215679,0.00040371403537419365,0.0006088358469048661,0.0,0.0022058613,False,RAC1; Rac family small GTPase
hsa:29979,1.5458912e-07,0.0001092801280990714,1.9792866459032255e-06,4.708272283068588e-06,0.0,2.1706841e-05,False,UBQLN1; ubiquilin
hsa:9063,0.0,0.0,6.108663287096773e-06,1.4227427283920662e-05,0.0,5.024741e-05,False,PIAS2; protein inhibitor of activated STAT
hsa:64218,5.6363127e-09,3.9843487941610835e-06,2.810097927967742e-07,5.727865338191828e-07,0.0,2.554495e-06,False,SEMA4A; semaphorin
hsa:6570,0.0,0.0,3.805488094193548e-05,0.0001733556111768111,0.0,0.00096697157,False,SLC18A1; solute carrier family 18 member
hsa:79902,1.4708354e-08,1.0397438120137363e-05,3.2096183003225804e-07,8.560355104751155e-07,0.0,3.45679e-06,False,NUP85; nucleoporin
hsa:56475,0.0,0.0,3.917520620967741e-05,0.00011989848755536707,0.0,0.00058422866,False,RPRM; reprimo
hsa:54498,0.00030721683,0.21717372177673722,0.0007490304093225805,0.001673538183895126,2.4500603e-05,0.009437672,False,SMOX; spermine
hsa:91133,8.202446e-08,5.7983663378491045e-05,5.067608203451613e-06,1.3584481204940616e-05,0.0,4.772247e-05,False,L3MBTL4; L3MBTL histone methyl-lysine binding protein
hsa:54891,3.2049774e-09,2.265620897684318e-06,3.6332302044954834e-06,7.873801997546198e-06,0.0,3.1312153e-05,False,INO80D; INO80 complex subunit
hsa:4149,4.9474033e-06,0.0034973539300939714,0.00015553514143870967,0.00027673778270784005,0.0,0.0009872766,False,MAX; MYC associated factor
hsa:56413,9.8753226e-08,6.980934484572101e-05,2.7137712221290325e-06,4.279059310414174e-06,0.0,1.4811886e-05,False,LTB4R2; leukotriene B4 receptor
hsa:387082,0.0,0.0,3.289719281612903e-08,8.080021259868758e-08,0.0,3.8235967e-07,False,SUMO4; small ubiquitin like modifier
hsa:2244,0.0,0.0,0.0,0.0,0.0,0.0,False,FGB; fibrinogen beta
hsa:51513,9.54298e-08,6.745999180581897e-05,1.7401400317196613e-05,8.291802005970376e-05,0.0,0.00046004867,False,ETV7; ETS variant transcription factor
hsa:2743,0.0,0.0,2.1712745564516133e-06,3.231454510445372e-06,0.0,1.0736165e-05,False,GLRB; glycine receptor
hsa:683,0.0001459748,0.1031906051553714,0.0004964121853870968,0.0006174417975462576,0.0,0.0017901701,False,BST1; bone marrow stromal cell antigen
hsa:2712,0.0,0.0,0.0,0.0,0.0,0.0,False,GK2; glycerol kinase
hsa:51588,1.3352666e-06,0.0009439092809016024,3.9735872496129054e-05,9.453007847831521e-05,0.0,0.0003625852,False,PIAS4; protein inhibitor of activated STAT
hsa:81570,2.3140316e-07,0.00016358050920614538,1.679764400735807e-05,5.109805059347846e-05,0.0,0.0001968246,False,CLPB; ClpB family mitochondrial
hsa:27243,0.0,0.0,3.3637427333225807e-07,8.617132849788899e-07,0.0,4.2612724e-06,False,CHMP2A; charged multivesicular body protein
hsa:1663,0.0,0.0,7.643311529419354e-07,2.2495001632980566e-06,0.0,1.03052525e-05,False,DDX11; DEAD/H-box helicase
hsa:2635,0.0,0.0,8.276091932258065e-08,1.5078897390265326e-07,0.0,4.5773274e-07,False,GBP3; guanylate binding protein
hsa:824,0.0,0.0,2.1872433319354837e-06,3.7852574856516917e-06,0.0,1.2744424e-05,False,CAPN2; calpain
hsa:9862,2.400107e-07,0.00016966523932051487,1.208888828883871e-05,3.476327640388908e-05,0.0,0.00017255377,False,MED24; mediator complex subunit
hsa:81930,0.0,0.0,2.278770427419355e-08,7.989685996057403e-08,0.0,4.3050366e-07,False,KIF18A; kinesin family member
hsa:26827,0.0,0.0,1.9979279290322584e-08,6.28603701642737e-08,0.0,2.6331278e-07,False,RNU6-1; RNA
hsa:122011,0.0,0.0,1.4987711612903225e-09,8.344804659869622e-09,0.0,4.6461906e-08,False,CSNK1A1L; casein kinase 1 alpha 1
hsa:5798,0.0,0.0,1.0025998767741937e-05,2.7892052769757337e-05,0.0,0.00012570972,False,PTPRN; protein tyrosine phosphatase receptor type
hsa:23521,2.64038e-08,1.8665030542267535e-05,1.438781136870968e-06,4.093889048744168e-06,0.0,1.769491e-05,False,RPL13A; ribosomal protein
hsa:7226,1.4548193e-07,0.00010284219191169558,1.7317282790645162e-06,2.301080300566966e-06,0.0,8.094545e-06,False,TRPM2; transient receptor potential cation channel subfamily M member
hsa:60682,6.606545e-09,4.670212780125015e-06,1.0413576761290322e-07,1.4161885969838916e-07,0.0,4.7021797e-07,False,SMAP1; small ArfGAP
hsa:7529,0.0,0.0,1.0224519251612906e-05,2.163171921229932e-05,0.0,8.134824e-05,False,YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10794,6.5564487e-09,4.634799355937792e-06,3.3456744167741936e-08,5.520653582816713e-08,0.0,2.150121e-07,False,ZNF460; zinc finger protein
hsa:6629,2.1520502e-07,0.00015212993096256207,5.523522154645159e-07,6.177703765487348e-07,0.0,1.6677399e-06,False,SNRPB2; small nuclear ribonucleoprotein polypeptide
hsa:160851,0.0,0.0,1.0854271683870965e-05,1.9726525156011424e-05,0.0,6.439499e-05,False,DGKH; diacylglycerol kinase
hsa:84765,0.0,0.0,1.599877433064516e-07,3.9631673538764543e-07,0.0,1.7070237e-06,False,ZNF577; zinc finger protein
hsa:81309,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4C15; olfactory receptor family 4 subfamily C member
hsa:8811,3.7731857e-07,0.0002667291311559212,2.9478895151548384e-06,6.82516008793333e-06,0.0,3.0968084e-05,False,GALR2; galanin receptor
hsa:1629,0.0,0.0,2.1378616983870967e-05,5.773164416969529e-05,0.0,0.00029455763,False,DBT; dihydrolipoamide branched chain transacylase
hsa:130340,8.624029e-10,6.096386303577553e-07,2.3619215989032257e-07,4.7590999687426867e-07,0.0,2.0768694e-06,False,AP1S3; adaptor related protein complex 1 subunit sigma
hsa:28,4.5561414e-05,0.032207681616240685,0.00022358022967741936,0.000498431936224508,0.0,0.002122099,False,ABO; ABO
hsa:9039,1.3682099e-07,9.671971296454606e-05,8.493826948870968e-07,1.5339224460824577e-06,0.0,6.466656e-06,False,UBA3; ubiquitin like modifier activating enzyme
hsa:10497,0.0,0.0,1.6895199767741935e-06,4.837772825684247e-06,0.0,1.975412e-05,False,UNC13B; unc-13 homolog
hsa:928,0.0,0.0,6.921139804516128e-05,0.00014176572072784136,0.0,0.00056809006,False,CD9; CD9
hsa:4193,0.0,0.0,0.00011558513703225806,0.0003299385097663883,0.0,0.0013087854,False,MDM2; MDM2
hsa:7273,0.0,0.0,1.0906337720564517e-06,3.5659785635422668e-06,0.0,1.8766998e-05,False,TTN;
hsa:3566,0.00015652593,0.11064927260874688,0.0004635531667096773,0.0007656267807051352,2.0367263e-05,0.0029864481,False,IL4R; interleukin 4
hsa:93010,1.9187338e-07,0.00013563663177073397,5.640312649096774e-06,9.593107738110113e-06,0.0,4.2457672e-05,False,B3GNT7; UDP-GlcNAc:betaGal beta-1
hsa:5529,0.0,0.0,2.6057378780645163e-05,5.788755449621669e-05,0.0,0.0002975222,False,PPP2R5E; protein phosphatase 2 regulatory subunit
hsa:5130,1.9069594e-05,0.013480429121514396,0.0011328793616129035,0.0026784742415340967,0.0,0.013922976,False,PCYT1A; phosphate cytidylyltransferase 1A
hsa:54363,0.0,0.0,1.9540800277419355e-07,9.608777286457475e-07,0.0,5.3483577e-06,False,HAO1; hydroxyacid oxidase
hsa:55315,2.1543397e-06,0.0015229177731583892,2.386972036612903e-05,7.183616025672312e-05,0.0,0.0003843679,False,SLC29A3; solute carrier family 29 member
hsa:406912,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B2; microRNA
hsa:7409,0.0,0.0,1.534872745548387e-05,3.3660958503123497e-05,0.0,0.00014526109,False,VAV1; vav guanine nucleotide exchange factor
hsa:526,0.0,0.0,5.520631638709677e-05,0.00018603639242050903,0.0,0.0010155541,False,ATP6V1B2; ATPase H+ transporting V1 subunit
hsa:5822,0.0,0.0,1.6898995122612902e-06,5.720230122007931e-06,0.0,2.889383e-05,False,PWP2; PWP2 small subunit processome
hsa:199692,8.872797e-09,6.2722421394018955e-06,9.322419069032259e-08,1.7075668621775528e-07,0.0,6.340782e-07,False,ZNF627; zinc finger protein
hsa:83732,0.0,0.0,2.303810441193548e-07,6.948974607776848e-07,0.0,3.0542221e-06,False,RIOK1; RIO kinase
hsa:10200,0.0,0.0,9.9588755e-07,1.8404709602062721e-06,0.0,8.623143e-06,False,MPHOSPH6; M-phase phosphoprotein
hsa:10038,3.884387e-07,0.0002745900286814283,1.7120367186129032e-05,3.4306115908751665e-05,0.0,0.0001398184,False,PARP2; poly(ADP-ribose) polymerase
hsa:55762,0.0,0.0,4.769182556774193e-08,1.2236203124471084e-07,0.0,4.845119e-07,False,ZNF701; zinc finger protein
hsa:83443,0.0,0.0,1.0650205535483874e-07,2.0590222903822977e-07,0.0,6.7108465e-07,False,SF3B5; splicing factor 3b subunit
hsa:26286,0.0,0.0,2.90261141667742e-07,7.432416618782623e-07,0.0,3.2546204e-06,False,ARFGAP3; ADP ribosylation factor GTPase activating protein
hsa:131405,0.0,0.0,1.124371198064516e-08,3.389693157063998e-08,0.0,1.8697133e-07,False,TRIM71; tripartite motif containing
hsa:4600,1.561076e-07,0.00011035355221142728,2.9932447381612903e-05,5.103821120875841e-05,0.0,0.00015619257,False,MX2; MX dynamin like GTPase
hsa:22871,0.0,0.0,0.0,0.0,0.0,0.0,False,NLGN1; neuroligin
hsa:9392,0.0,0.0,9.023240987690323e-06,2.8234296835368772e-05,0.0,0.000109630484,False,TGFBRAP1; transforming growth factor beta receptor associated protein
hsa:5565,0.0,0.0,3.593432709677419e-05,0.00014420436787981997,0.0,0.0007279507,False,PRKAB2; protein kinase AMP-activated non-catalytic subunit beta
hsa:23235,9.1415905e-07,0.0006462254140972237,3.1441424596774197e-06,6.008753963316662e-06,0.0,2.558304e-05,False,SIK2; salt inducible kinase
hsa:23560,0.0,0.0,5.575150537419355e-07,1.640413276433419e-06,0.0,6.858676e-06,False,GTPBP4; GTP binding protein
hsa:9739,2.3373248e-06,0.001652271217748936,7.692393453516128e-06,1.4297869240523126e-05,0.0,6.33133e-05,False,SETD1A; SET domain containing 1A
hsa:10325,0.0,0.0,2.46228994967742e-07,5.832926041038479e-07,0.0,2.3437688e-06,False,RRAGB; Ras related GTP binding
hsa:8875,0.0,0.0,6.294923792903226e-06,1.288103171945821e-05,0.0,5.2924715e-05,False,VNN2; vanin
hsa:402317,0.0,0.0,1.7691048387096775e-08,9.849958875077889e-08,0.0,5.484225e-07,False,OR2A42; olfactory receptor family 2 subfamily A member
hsa:353164,0.0,0.0,3.417202816129033e-05,0.00013631884986893737,0.0,0.00070751796,False,TAS2R42; taste 2 receptor member
hsa:9782,4.615111e-09,3.262454183524905e-06,5.075631896451613e-08,8.201007744108589e-08,0.0,2.6112886e-07,False,MATR3; matrin
hsa:2539,0.0,0.0,1.1909830867741935e-05,3.704504398777645e-05,0.0,0.00020229648,False,G6PD; glucose-6-phosphate
hsa:10402,6.921995e-05,0.048932065872496835,0.00022008203891935485,0.0003450138008651554,0.0,0.001353333,False,ST3GAL6; ST3 beta-galactoside alpha-2
hsa:4295,-0.0,0.0,9.741746451612903e-11,5.423974872501613e-10,0.0,3.0199414e-09,False,MLN;
hsa:6238,0.0,0.0,2.5783705856129036e-07,5.877897235144022e-07,0.0,2.4882052e-06,False,RRBP1; ribosome binding protein
hsa:4008,1.431426e-07,0.00010118850320406855,5.779393099290323e-06,1.7125834112687635e-05,0.0,8.030989e-05,False,LMO7; LIM domain
hsa:23464,0.0,0.0,3.891894254193549e-05,8.31978241009919e-05,0.0,0.00029976616,False,GCAT; glycine
hsa:7094,1.2748342e-06,0.0009011891954691068,3.2973921263387103e-06,5.892357433129945e-06,0.0,2.3471239e-05,False,TLN1; talin
hsa:5356,0.0,0.0,9.211160400322578e-08,1.8758943110068795e-07,0.0,8.212442e-07,False,PLRG1; pleiotropic regulator
hsa:8667,6.4597145e-09,4.566417274666089e-06,4.256417315080646e-06,9.799181820850428e-06,0.0,3.56962e-05,False,EIF3H; eukaryotic translation initiation factor 3 subunit
hsa:255043,1.3319232e-06,0.0009415458081016639,1.2735283741935481e-05,2.3762434256968916e-05,0.0,9.901154e-05,False,TMEM86B; transmembrane protein
hsa:25766,2.1023183e-08,1.4861434823422374e-05,2.8059212796774196e-07,5.18551229556868e-07,0.0,1.9675485e-06,False,PRPF40B; pre-mRNA processing factor 40 homolog
hsa:7518,1.2752946e-05,0.009015146554431128,7.461609830032259e-05,0.00012683490597786124,0.0,0.00045271663,False,XRCC4; X-ray repair cross complementing
hsa:389090,0.0,0.0,7.425176609677419e-07,2.7384691584180784e-06,0.0,1.4335937e-05,False,OR6B2; olfactory receptor family 6 subfamily B member
hsa:7035,8.912484e-08,6.300297156752845e-05,1.1330068158064516e-06,1.7560162457355164e-06,0.0,7.0305805e-06,False,TFPI; tissue factor pathway
hsa:3820,8.244566e-07,0.0005828141259884581,6.265157443870968e-06,1.3919121835481862e-05,0.0,7.158481e-05,False,KLRB1; killer cell lectin like receptor
hsa:392138,0.0,0.0,3.8917809032258064e-07,1.828233727384388e-06,-0.0,1.0044247e-05,False,OR2A25; olfactory receptor family 2 subfamily A member
hsa:84701,1.4899183e-06,0.0010532336472395384,0.00014600477731580648,0.00033048417270530717,0.0,0.0012973648,False,COX4I2; cytochrome c oxidase subunit
hsa:51652,0.0,0.0,0.00015297695376129033,0.0005714004416336811,0.0,0.0030428667,False,CHMP3; charged multivesicular body protein
hsa:26503,0.0,0.0,1.964981193151613e-07,5.844634169496074e-07,0.0,2.598686e-06,False,SLC17A5; solute carrier family 17 member
hsa:9156,0.0,0.0,7.190441051935484e-06,2.79289974388486e-05,0.0,0.00013796294,False,EXO1; exonuclease
hsa:51194,0.0,0.0,2.5344425148387095e-07,6.723937356809922e-07,0.0,3.091151e-06,False,IPO11; importin
hsa:23062,0.0,0.0,6.507616942580645e-08,2.595658084192753e-07,0.0,1.2965494e-06,False,GGA2; golgi associated
hsa:109,0.00065846957,0.46547673574272536,0.002082706933548387,0.0023923551669450846,0.0,0.0075917575,True,ADCY3; adenylate cyclase
hsa:119687,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51A7; olfactory receptor family 51 subfamily A member
hsa:219954,0.0,0.0,0.0,0.0,0.0,0.0,False,OR9I1; olfactory receptor family 9 subfamily I member
hsa:55900,1.5467675e-08,1.0934207435780759e-05,1.1186922627741934e-07,1.8137374123386353e-07,0.0,6.0503254e-07,False,ZNF302; zinc finger protein
hsa:10398,0.00035272873,0.24934640160072566,0.0011467917078064516,0.0026837067629488127,0.0,0.014449082,False,MYL9; myosin light chain
hsa:10728,0.0,0.0,3.1414779612903233e-07,1.5795773991128406e-06,0.0,8.807282e-06,False,PTGES3; prostaglandin E synthase
hsa:80816,1.4846851e-08,1.0495342616270965e-05,2.4038768920967735e-06,1.0539895712241093e-05,0.0,5.7675155e-05,False,ASXL3; ASXL transcriptional regulator
hsa:1327,0.0,0.0,0.00015938738813225803,0.000568262473901633,0.0,0.0026132076,False,COX4I1; cytochrome c oxidase subunit
hsa:2531,0.0,0.0,2.259644858825807e-06,7.339164617337855e-06,0.0,3.714922e-05,False,KDSR; 3-ketodihydrosphingosine
hsa:3162,0.0,0.0,0.0002478811565645161,0.000548111289944489,0.0,0.0025930214,False,HMOX1; heme oxygenase
hsa:10838,0.0,0.0,1.9390603032258066e-08,5.290125729404285e-08,0.0,2.2000586e-07,False,ZNF275; zinc finger protein
hsa:256892,0.0,0.0,1.0153407096774193e-08,5.653177819472477e-08,0.0,3.1475562e-07,False,OR51F1; olfactory receptor family 51 subfamily F member
hsa:1959,3.5566998e-07,0.0002514255917582955,2.3078889328838702e-05,4.361204993463429e-05,0.0,0.00015500998,False,EGR2; early growth response
hsa:4245,1.0588798e-06,0.0007485295225531985,0.00016680227471709677,0.00027784476189507965,0.0,0.0009725542,False,MGAT1; alpha-1
hsa:9626,-0.0,0.0,7.787489032258064e-08,3.335688028795702e-07,0.0,1.7602571e-06,False,GUCA1C; guanylate cyclase activator
hsa:23556,1.014229e-05,0.007169655603304624,2.4263403701290328e-05,3.0250458067839912e-05,0.0,9.438089e-05,False,PIGN; phosphatidylinositol glycan anchor biosynthesis class
hsa:79054,0.0,0.0,1.3056600708064519e-06,3.180415730060721e-06,0.0,1.4445146e-05,False,TRPM8; transient receptor potential cation channel subfamily M member
hsa:201625,0.0,0.0,7.333056706774193e-09,1.859141178015366e-08,0.0,7.841488e-08,False,DNAH12; dynein axonemal heavy chain
hsa:3761,0.0,0.0,4.83785839432258e-06,2.3391969475528265e-05,0.0,0.00012989623,False,KCNJ4; potassium inwardly rectifying channel subfamily J member
hsa:1659,0.0,0.0,1.4563666181935486e-07,2.449478055886656e-07,0.0,7.660327e-07,False,DHX8; DEAH-box helicase
hsa:115024,0.0,0.0,4.0971767107096777e-07,1.6635207984182959e-06,0.0,9.06066e-06,False,NT5C3B; 5'-nucleotidase
hsa:10235,7.5683073e-07,0.0005350089263960731,1.197087046129032e-06,1.6828144661275566e-06,0.0,7.3923143e-06,False,RASGRP2; RAS guanyl releasing protein
hsa:64319,8.728344e-08,6.170127305290056e-05,3.0671568783170965e-05,9.230851453051617e-05,0.0,0.00039836744,False,FBRS;
hsa:11019,6.0042235e-06,0.004244427507029309,1.2629263457741934e-05,2.041000763308597e-05,0.0,8.7081666e-05,False,LIAS; lipoic acid
hsa:58478,0.0,0.0,2.643328061290323e-06,9.57242072431222e-06,0.0,4.9374517e-05,False,ENOPH1; enolase-phosphatase
hsa:29078,1.2023831e-07,8.499730071052774e-05,3.772289080967742e-07,7.747992140529133e-07,0.0,3.1693523e-06,False,NDUFAF4; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:81029,0.0,0.0,1.424441292903226e-05,3.3608985579332374e-05,0.0,0.00013815738,False,WNT5B; Wnt family member
hsa:23130,3.0879103e-06,0.0021828653474606882,4.8497110498870965e-05,8.243691238811513e-05,0.0,0.00028900095,False,ATG2A; autophagy related
hsa:4069,9.385691e-07,0.0006634810488463234,0.00027581567265709675,0.00053007937002616,0.0,0.0019815054,False,LYZ;
hsa:3624,9.113339e-06,0.006442282958401362,0.00020118100832580642,0.00037371844679067015,0.0,0.0014885376,False,INHBA; inhibin subunit beta
hsa:2187,7.538775e-08,5.329212674928722e-05,1.5050898017548388e-05,5.519609335908292e-05,0.0,0.00027649655,False,FANCB; FA complementation group
hsa:387,1.1330415e-05,0.008009549459985542,0.00028350574,0.0007115645457484135,0.0,0.003833102,False,RHOA; ras homolog family member
hsa:5021,1.0473013e-07,7.403446000748565e-05,7.028315762045162e-05,0.00031688187553314894,0.0,0.0017449973,False,OXTR; oxytocin
hsa:57758,0.0,0.0,6.161520407419355e-05,0.00015449678157450708,0.0,0.0006822142,False,SCUBE2; signal peptide
hsa:8321,0.0002865751,0.20258193874189978,0.00036299121141935474,0.00039680189852249345,1.7598517e-05,0.0016583996,False,FZD1; frizzled class receptor
hsa:6878,0.0,0.0,1.8516898306451616e-06,3.8320835076831995e-06,0.0,1.7640488e-05,False,TAF6; TATA-box binding protein associated factor
hsa:10266,0.0,0.0,6.26818969e-06,2.19137442617126e-05,0.0,0.00011960617,False,RAMP2; receptor activity modifying protein
hsa:784,0.0,0.0,1.6720315161290324e-05,6.12518932571942e-05,0.0,0.00031335274,False,CACNB3; calcium voltage-gated channel auxiliary subunit beta
hsa:1195,0.0,0.0,0.0001131602803654839,0.0002168640201591403,0.0,0.00082272704,False,CLK1; CDC like kinase
hsa:3836,0.0,0.0,1.680957898064516e-06,4.708805114418562e-06,0.0,1.7721099e-05,False,KPNA1; karyopherin subunit alpha
hsa:80328,0.0,0.0,7.043298314741936e-06,2.0852263937953978e-05,0.0,9.1281865e-05,False,ULBP2; UL16 binding protein
hsa:3250,0.0,0.0,4.289243610195161e-05,0.00012355115516801479,0.0,0.00044904646,False,HPR; haptoglobin-related
hsa:3554,0.00020081035,0.1419542382518211,0.00022266456699999998,0.0002460555548662087,0.0,0.0011701992,False,IL1R1; interleukin 1 receptor type
hsa:3766,0.0,0.0,6.031250304916128e-06,2.0552381654932046e-05,0.0,9.804893e-05,False,KCNJ10; potassium inwardly rectifying channel subfamily J member
hsa:196883,0.0020637775,1.4588987217727956,0.002359125814838709,0.0017066288682275306,0.0,0.007837778,True,ADCY4; adenylate cyclase
hsa:6132,0.0,0.0,5.748169598064515e-07,9.93357485368111e-07,0.0,3.2943797e-06,False,RPL8; ribosomal protein
hsa:11152,0.0,0.0,3.041888654245161e-07,5.33618396304216e-07,0.0,1.9022287e-06,False,WDR45; WD repeat domain
hsa:91860,0.0,0.0,0.00022547562961290323,0.0007489261369423378,0.0,0.0038508715,False,CALML4; calmodulin like
hsa:995,2.436282e-07,0.00017222247532391793,2.0602935993548384e-06,3.6809702738095573e-06,0.0,1.6966482e-05,False,CDC25C; cell division cycle
hsa:6990,7.08921e-09,5.011412038060751e-06,4.5886815332258064e-07,8.751624142475067e-07,0.0,3.106348e-06,False,DYNLT3; dynein light chain Tctex-type
hsa:10316,3.55317e-07,0.00025117606773217776,1.7106498812258069e-06,2.928325005071369e-06,0.0,1.3882931e-05,False,NMUR1; neuromedin U receptor
hsa:118424,5.3257335e-08,3.76479818955898e-05,3.1056991953225805e-06,8.21180739708354e-06,0.0,3.609701e-05,False,UBE2J2; ubiquitin conjugating enzyme E2
hsa:7205,0.0,0.0,2.1748925096774192e-07,4.3011708608325016e-07,0.0,1.8509998e-06,False,TRIP6; thyroid hormone receptor interactor
hsa:10090,6.344622e-05,0.04485057582966943,0.000194903691223871,0.0003838904666330995,0.0,0.0017444182,False,UST; uronyl
hsa:406917,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-1; microRNA
hsa:90427,0.0,0.0,1.0675776561870967e-06,4.266270652919475e-06,0.0,2.3658416e-05,False,BMF; Bcl2 modifying
hsa:5896,0.0,0.0,3.970706656451613e-06,1.4954187218381066e-05,0.0,8.364661e-05,False,RAG1; recombination activating
hsa:403253,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR4A47; olfactory receptor family 4 subfamily A member
hsa:26525,0.0,0.0,0.0,0.0,-0.0,-0.0,False,IL36RN; interleukin 36 receptor
hsa:4793,2.982162e-05,0.0210811113597246,0.00012025490007419357,0.0002563526826292267,0.0,0.0010485423,False,NFKBIB; NFKB inhibitor
hsa:26289,5.696642e-07,0.00040269959974838476,7.925715147741936e-05,0.00021099069943634262,0.0,0.00087554014,False,AK5; adenylate kinase
hsa:729238,0.0,0.0,5.22932480503226e-07,2.002552347194107e-06,0.0,9.223026e-06,False,SFTPA2; surfactant protein
hsa:2965,0.0,0.0,1.417882799032258e-06,3.4875487730298357e-06,0.0,1.754455e-05,False,GTF2H1; general transcription factor IIH subunit
hsa:55823,8.949398e-08,6.32639192104576e-05,2.551844155229032e-05,5.873466909079855e-05,0.0,0.00023213263,False,VPS11; VPS11 core subunit of CORVET and HOPS
hsa:2534,0.0,0.0,1.4762142080645164e-05,2.90236864230912e-05,0.0,0.00010454251,False,FYN; FYN proto-oncogene
hsa:2872,1.5828821e-06,0.0011189504064304599,2.4983213459677422e-05,6.393585185289382e-05,0.0,0.00030279582,False,MKNK2; MAPK interacting serine/threonine kinase
hsa:87178,1.5232749e-07,0.00010768136606386023,7.034301529354839e-06,2.3460510552170137e-05,0.0,0.00011328941,False,PNPT1; polyribonucleotide nucleotidyltransferase
hsa:10672,0.0,0.0,5.111369618709677e-05,9.676841093658383e-05,0.0,0.00032760054,False,GNA13; G protein subunit alpha
hsa:645974,6.927916e-09,4.897392183483587e-06,5.672666569838711e-07,2.5627251545983572e-06,0.0,1.434343e-05,False,PABPC1L2B; poly(A) binding protein cytoplasmic 1 like
hsa:4331,4.371747e-07,0.00030904184730253404,8.590073240322584e-06,2.165427897694619e-05,0.0,0.00010483138,False,MNAT1; MNAT1 component of CDK activating
hsa:6790,0.0,0.0,2.405801496774194e-06,4.7202848937652025e-06,0.0,1.6877058e-05,False,AURKA; aurora kinase
hsa:338,0.0,0.0,1.364119404516129e-07,2.9915242688703624e-07,0.0,1.124728e-06,False,APOB; apolipoprotein
hsa:126370,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1I1; olfactory receptor family 1 subfamily I member
hsa:2775,1.8272061e-05,0.012916647476316875,0.000176877817116129,0.0003975907645896974,0.0,0.0019188629,False,GNAO1; G protein subunit alpha
hsa:7320,1.0726152e-07,7.58239172698642e-05,2.2750234812903224e-06,3.7405165359003727e-06,0.0,1.2298357e-05,False,UBE2B; ubiquitin conjugating enzyme E2
hsa:1630,0.0,0.0,3.478503975322581e-08,1.9364496484619273e-07,0.0,1.0781749e-06,False,DCC; DCC netrin 1
hsa:7832,0.0,0.0,3.430660761967742e-05,0.00011835307015220228,0.0,0.00047609935,False,BTG2; BTG anti-proliferation factor
hsa:6999,8.929991e-07,0.0006312672977267448,2.233602193848387e-05,4.504730318706477e-05,0.0,0.00015182621,False,TDO2; tryptophan
hsa:5473,0.0,0.0,4.881430710967742e-06,1.7979270140837293e-05,0.0,9.594595e-05,False,PPBP; pro-platelet basic
hsa:119749,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C46; olfactory receptor family 4 subfamily C member
hsa:3823,0.0,0.0,1.8069862939999998e-07,5.12574750815679e-07,0.0,2.2669728e-06,False,KLRC3; killer cell lectin like receptor
hsa:7874,4.4717194e-06,0.0031610896604825924,7.313019343838711e-05,0.00020414286765612957,0.0,0.0007533825,False,USP7; ubiquitin specific peptidase
hsa:64768,1.1780844e-06,0.0008327960864485008,7.793471027096772e-06,2.124373250945004e-05,0.0,9.587702e-05,False,IPPK; inositol-pentakisphosphate
hsa:5594,0.0,0.0,0.0005138189893548387,0.0007997407005543376,0.0,0.0026277823,False,MAPK1; mitogen-activated protein kinase
hsa:4776,0.0,0.0,6.112345822580645e-05,0.00012143481575915387,0.0,0.0005084537,False,NFATC4; nuclear factor of activated T cells
hsa:100169759,0.0,0.0,1.1085225638709678e-06,3.7185739740134997e-06,0.0,1.9434621e-05,False,RNA5S8; RNA
hsa:391,1.6645407e-07,0.00011766754408209193,3.958442819587097e-05,8.089470205173645e-05,0.0,0.00029164949,False,RHOG; ras homolog family member
hsa:1021,0.0,0.0,3.604110410645162e-05,0.00011666312626538595,0.0,0.0006113397,False,CDK6; cyclin dependent kinase
hsa:11338,8.3447034e-08,5.898929086993681e-05,4.642403139741936e-07,7.913579363467834e-07,0.0,2.9923929e-06,False,U2AF2; U2 small nuclear RNA auxiliary factor
hsa:100532726,0.0,0.0,1.4365305806451616e-07,5.469322015660017e-07,0.0,3.0172744e-06,False,NDUFC2-KCTD14; NDUFC2-KCTD14
hsa:718,0.000108958106,0.07702324575696012,0.00019472822185483872,0.00021440483998533543,0.0,0.00063963764,False,C3; complement
hsa:113235,0.0,0.0,0.00015930935925806452,0.000524229520081826,0.0,0.002705959,False,SLC46A1; solute carrier family 46 member
hsa:407036,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR32; microRNA
hsa:50636,6.38367e-10,4.512660886757096e-07,5.355912025693549e-06,1.2041022312421002e-05,0.0,4.922859e-05,False,ANO7; anoctamin
hsa:4489,1.3044596e-06,0.0009221315975410393,2.1312721201096773e-05,3.677910079149119e-05,0.0,0.00010704117,False,MT1A; metallothionein
hsa:2245,4.1332058e-08,2.9217920335132568e-05,7.433677769064516e-07,2.117431274721406e-06,0.0,9.353721e-06,False,FGD1; FYVE
hsa:390144,0.0,0.0,1.5848576774193547e-09,8.824114096493047e-09,-0.0,4.9130588e-08,False,OR5D16; olfactory receptor family 5 subfamily D member
hsa:79862,1.5606673e-08,1.1032466092311794e-05,5.118040418387097e-08,6.57685509088809e-08,0.0,2.1951881e-07,False,ZNF669; zinc finger protein
hsa:5372,0.0,0.0,1.4917524661290321e-05,3.425962137441586e-05,0.0,0.00013744656,False,PMM1; phosphomannomutase
hsa:7200,3.4841503e-09,2.4629701695722056e-06,4.930184809193548e-07,9.839562647198863e-07,0.0,3.4119707e-06,False,TRH; thyrotropin releasing
hsa:4802,0.0,0.0,4.0580151e-07,1.1756394997436147e-06,0.0,6.3194375e-06,False,NFYC; nuclear transcription factor Y subunit
hsa:442194,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10C1; olfactory receptor family 10 subfamily C member
hsa:1300,6.3351737e-09,4.478378513739312e-06,8.295425576670001e-05,0.0002810638959157053,0.0,0.0013607193,False,COL10A1; collagen type X alpha 1
hsa:57571,5.0018716e-05,0.035358579516016855,9.467364411612901e-05,0.00011651235744602322,0.0,0.00048669285,False,CARNS1; carnosine synthase
hsa:51256,0.0,0.0,3.469542409677419e-07,6.558325628410845e-07,0.0,2.4942658e-06,False,TBC1D7; TBC1 domain family member
hsa:64223,9.342379e-06,0.006604192933306526,4.8220787617806454e-05,0.00011176021096218858,0.0,0.0005797198,False,MLST8; MTOR associated protein
hsa:117157,0.0,0.0,9.541805893612903e-08,2.084751814135284e-07,0.0,7.6809624e-07,False,SH2D1B; SH2 domain containing
hsa:25788,0.0,0.0,1.808599257096774e-05,3.37964435662238e-05,0.0,0.00013370786,False,RAD54B; RAD54 homolog
hsa:7554,0.0,0.0,3.1654439854838704e-08,7.809076076133149e-08,0.0,3.3421009e-07,False,ZNF8; zinc finger protein
hsa:27034,0.0,0.0,2.0462832096774194e-06,3.56482367822031e-06,0.0,1.5516493e-05,False,ACAD8; acyl-CoA dehydrogenase family member
hsa:10654,0.0,0.0,1.994617981270968e-05,4.705043057950527e-05,0.0,0.00022837431,False,PMVK; phosphomevalonate
hsa:8506,0.0,0.0,8.648822491774192e-07,1.4084653265272578e-06,0.0,4.7888057e-06,False,CNTNAP1; contactin associated protein
hsa:8829,0.0,0.0,3.2693759741935485e-07,7.2395980492232e-07,0.0,3.1801765e-06,False,NRP1; neuropilin
hsa:1258,0.0,0.0,9.779308516129035e-06,2.7559065188019528e-05,0.0,0.00012605738,False,CNGB1; cyclic nucleotide gated channel subunit beta
hsa:7802,0.0,0.0,1.3653072135483869e-07,2.5919308539768626e-07,0.0,1.0324749e-06,False,DNALI1; dynein axonemal light intermediate chain
hsa:2797,0.0,0.0,8.597341762258065e-06,3.406038068975636e-05,0.0,0.0001828788,False,GNRH2; gonadotropin releasing hormone
hsa:6217,0.0,0.0,1.831951623548387e-07,3.6422853148165474e-07,0.0,1.2256772e-06,False,RPS16; ribosomal protein
hsa:9573,4.798076e-08,3.391793419285135e-05,6.528237737096773e-07,1.524011502826402e-06,0.0,7.5834087e-06,False,GDF3; growth differentiation factor
hsa:11340,0.0,0.0,8.337374261290323e-07,2.180560006452423e-06,0.0,1.0123517e-05,False,EXOSC8; exosome component
hsa:6514,0.0,0.0,3.9827293548387094e-07,1.599084231045318e-06,0.0,7.818196e-06,False,SLC2A2; solute carrier family 2 member
hsa:90665,0.0,0.0,1.3933248698709679e-08,4.4056543194211855e-08,0.0,1.8806794e-07,False,TBL1Y; transducin beta like 1
hsa:284716,0.0,0.0,2.962338332935484e-06,8.439868158644364e-06,0.0,3.1446125e-05,False,RIMKLA; ribosomal modification protein rimK like family member
hsa:941,0.0,0.0,1.1132992741935484e-05,4.204326325643574e-05,0.0,0.0001745501,False,CD80; CD80
hsa:84620,5.763341e-07,0.0004074145986202847,6.757786872819354e-05,0.00023630168416678801,0.0,0.0013010751,False,ST6GAL2; ST6 beta-galactoside alpha-2
hsa:9532,6.3616085e-08,4.4970654583979866e-05,6.980982336677418e-07,9.622674683064407e-07,0.0,3.4666048e-06,False,BAG2; BAG cochaperone
hsa:4043,3.5884373e-06,0.0025366913778892457,5.802488956451613e-05,9.869711779359106e-05,0.0,0.00032121417,False,LRPAP1; LDL receptor related protein associated protein
hsa:7625,1.2598773e-08,8.906160584464948e-06,3.1047004536677416e-08,6.646495811121765e-08,0.0,3.6491826e-07,False,ZNF74; zinc finger protein
hsa:403282,0.0,0.0,1.9924700967741935e-07,1.1093603998823847e-06,0.0,6.1766573e-06,False,OR6C65; olfactory receptor family 6 subfamily C member
hsa:8772,2.7499578e-05,0.019439643659983352,0.0003203311029409678,0.00048679100530495714,0.0,0.001464284,False,FADD; Fas associated via death
hsa:5031,6.4955316e-06,0.004591736632691656,1.312687206754839e-05,1.850853418550179e-05,3.789538e-09,8.2571205e-05,False,P2RY6; pyrimidinergic receptor
hsa:6603,2.0366138e-06,0.001439696512615743,6.1703812600000005e-06,9.419653186475274e-06,0.0,2.7359258e-05,False,SMARCD2; SWI/SNF related
hsa:79345,0.0,0.0,1.7687310000000002e-07,8.353130086877473e-07,0.0,4.59494e-06,False,OR51B2; olfactory receptor family 51 subfamily B member
hsa:115,0.0005523725,0.39047597630676933,0.0006469184976109677,0.0005980412128225035,0.0,0.0019895402,True,ADCY9; adenylate cyclase
hsa:100169762,0.0,0.0,3.4529743903225806e-07,1.8676603759097857e-06,0.0,1.0406107e-05,False,RNA5S11; RNA
hsa:7581,0.0,0.0,4.5116547295483874e-08,1.2077530936807147e-07,0.0,4.975644e-07,False,ZNF33A; zinc finger protein
hsa:2733,0.0,0.0,1.3365966625806455e-07,2.792781800348015e-07,0.0,1.2771895e-06,False,GLE1; GLE1 RNA export
hsa:5169,2.10647e-05,0.014890783480548368,3.706167832258064e-05,4.629854209361337e-05,0.0,0.0001951238,False,ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4122,1.0988724e-07,7.768005706775097e-05,0.0001071556799529032,0.0002934918560853465,0.0,0.0012697586,False,MAN2A2; mannosidase alpha class 2A member
hsa:6865,1.2139535e-06,0.000858152203637074,5.995350451612903e-06,9.566759513806158e-06,0.0,3.1141888e-05,False,TACR2; tachykinin receptor
hsa:3059,3.3108407e-07,0.00023404564034753495,5.890904782709676e-05,0.00013907706433967954,0.0,0.0005232292,False,HCLS1; hematopoietic cell-specific Lyn substrate
hsa:90952,0.0,0.0,9.893031077419355e-06,2.562127568545091e-05,0.0,0.0001377796,False,ESAM; endothelial cell adhesion
hsa:22908,0.0,0.0,1.1650629316129033e-05,3.2777150429925225e-05,0.0,0.00015197622,False,SACM1L; SAC1 like phosphatidylinositide
hsa:22803,0.0,0.0,9.086894159354837e-06,2.7229756791871954e-05,0.0,0.00013179767,False,XRN2; 5'-3' exoribonuclease
hsa:25799,0.0,0.0,6.20092875483871e-08,1.697866829400276e-07,0.0,7.3872087e-07,False,ZNF324; zinc finger protein
hsa:472,3.202135e-07,0.00022636115852818102,8.099886851290322e-05,0.00018582071293733664,0.0,0.00079609477,False,ATM; ATM serine/threonine
hsa:4615,9.332732e-06,0.006597373401661792,0.00013279479816129033,0.00024626844279318456,0.0,0.0010453992,False,MYD88; MYD88 innate immune signal transduction
hsa:3727,0.0,0.0,7.856520438709677e-05,0.00020068870866171625,0.0,0.0008061572,False,JUND; JunD proto-oncogene
hsa:147746,9.188077e-09,6.495115772339811e-06,1.2418047523096776e-08,1.35618386544309e-08,0.0,4.6838416e-08,False,HIPK4; homeodomain interacting protein kinase
hsa:407040,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR34A; microRNA
hsa:50615,0.0,0.0,1.7503529174193548e-06,3.6673288806107207e-06,0.0,1.8735178e-05,False,IL21R; interleukin 21
hsa:10544,1.5225581e-07,0.00010763069497146938,8.535742219032261e-07,1.456476562247876e-06,0.0,4.5899114e-06,False,PROCR; protein C
hsa:23657,4.9809784e-10,3.5210884026683615e-07,1.3648134671838712e-07,3.1107035798568887e-07,0.0,1.2973704e-06,False,SLC7A11; solute carrier family 7 member
hsa:710,0.0,0.0,6.45792919583871e-05,0.0002474126129632699,0.0,0.0011685014,False,SERPING1; serpin family G member
hsa:64241,0.0,0.0,0.0,0.0,0.0,0.0,False,ABCG8; ATP binding cassette subfamily G member
hsa:200931,1.2750086e-05,0.009013124800465757,9.487980610316128e-05,0.00013998152251480328,0.0,0.0005807442,False,SLC51A; solute carrier family 51 member
hsa:7700,0.0,0.0,1.054996400387097e-07,2.138294847505859e-07,0.0,7.648381e-07,False,ZNF141; zinc finger protein
hsa:219453,0.0,0.0,1.4824237741935484e-10,8.253786260566811e-10,0.0,4.5955137e-09,False,OR8K5; olfactory receptor family 8 subfamily K member
hsa:2661,0.0,0.0,2.0804000532258063e-07,4.0043982650495383e-07,0.0,1.5663127e-06,False,GDF9; growth differentiation factor
hsa:10467,0.0,0.0,8.885638512903227e-07,1.8579567970077695e-06,0.0,7.5918024e-06,False,ZNHIT1; zinc finger HIT-type containing
hsa:9266,0.0,0.0,1.6186318956774193e-06,5.829166160774714e-06,0.0,3.0584528e-05,False,CYTH2; cytohesin
hsa:5646,0.0,0.0,4.966734456129032e-05,0.00015103929343027634,0.0,0.00069339015,False,PRSS3; serine protease
hsa:5555,0.0,0.0,3.0275073774193554e-07,1.043798576060957e-06,0.0,5.809518e-06,False,PRH2; proline rich protein HaeIII subfamily
hsa:57654,0.0,0.0,5.72874805483871e-07,1.2401609969556109e-06,0.0,4.4083786e-06,False,UVSSA; UV stimulated scaffold protein
hsa:316,0.00029841234,0.21094976633247964,0.0005083387390870968,0.0005361510987137677,0.0,0.0018415077,False,AOX1; aldehyde oxidase
hsa:923,0.0,0.0,1.2856480101612902e-06,4.496131378231873e-06,0.0,2.3281802e-05,False,CD6; CD6
hsa:9953,0.0,0.0,1.1478088379999998e-05,3.551370343999372e-05,0.0,0.00016285283,False,HS3ST3B1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:2114,2.879811e-07,0.00020357584995704412,1.4370518060322578e-06,2.5502866807032867e-06,0.0,8.726308e-06,False,ETS2; ETS proto-oncogene 2
hsa:1670,0.0,0.0,5.970028064516129e-08,3.3239709502708e-07,0.0,1.8507087e-06,False,DEFA5; defensin alpha
hsa:10171,1.7936534e-08,1.2679461097736695e-05,2.52186960983871e-06,7.374927488586989e-06,0.0,3.6170466e-05,False,RCL1; RNA terminal phosphate cyclase like
hsa:340529,0.0,0.0,1.4067331351612902e-07,2.718583851699641e-07,0.0,1.1239292e-06,False,PABPC1L2A; poly(A) binding protein cytoplasmic 1 like
hsa:9138,0.0,0.0,4.775908122580645e-06,1.0722829676784071e-05,0.0,4.4407578e-05,False,ARHGEF1; Rho guanine nucleotide exchange factor
hsa:25904,0.0,0.0,1.5435904003838713e-05,5.347298285076734e-05,0.0,0.000231696,False,CNOT10; CCR4-NOT transcription complex subunit
hsa:84186,0.0,0.0,3.235705826451613e-07,6.236748440576718e-07,0.0,2.416166e-06,False,ZCCHC7; zinc finger CCHC-type containing
hsa:7052,5.0624016e-10,3.578647031155517e-07,2.427908200838709e-08,4.9638368650354507e-08,0.0,2.265872e-07,False,TGM2; transglutaminase
hsa:56477,0.0,0.0,1.5109813677419355e-06,4.043470955432613e-06,0.0,1.7839528e-05,False,CCL28; C-C motif chemokine ligand
hsa:81466,-0.0,0.0,2.2807984193548385e-07,7.519300932619971e-07,-0.0,3.477191e-06,False,OR2L5; olfactory receptor family 2 subfamily L member
hsa:6430,7.6419276e-08,5.402131967966628e-05,4.5966362748387096e-07,8.838092880515829e-07,0.0,3.971563e-06,False,SRSF5; serine and arginine rich splicing factor
hsa:6009,0.0,0.0,4.841723235483871e-05,9.326407037363728e-05,0.0,0.0004153156,False,RHEB; Ras homolog
hsa:944,0.0,0.0,4.4244603845161285e-06,9.714617571710432e-06,0.0,3.799585e-05,False,TNFSF8; TNF superfamily member
hsa:9074,0.0,0.0,5.0549842677419366e-08,1.0532716077555677e-07,0.0,4.1192362e-07,False,CLDN6; claudin
hsa:7773,3.7423376e-09,2.6454845743217337e-06,4.944870922580645e-08,9.682904664664805e-08,0.0,3.5993364e-07,False,ZNF230; zinc finger protein
hsa:2185,1.603605e-06,0.001133599569104937,1.5866358537419355e-05,3.168875689755708e-05,0.0,0.000156836,False,PTK2B; protein tyrosine kinase 2
hsa:6708,0.0,0.0,2.637198406751613e-08,6.572008030186884e-08,0.0,3.154907e-07,False,SPTA1; spectrin alpha
hsa:8660,0.0,0.0,9.426619638709678e-05,0.0001393630608811547,0.0,0.000434221,False,IRS2; insulin receptor substrate
hsa:55577,0.0,0.0,3.100020414645161e-05,0.00010383293563192284,0.0,0.00053931196,False,NAGK; N-acetylglucosamine
hsa:6772,0.0,0.0,6.630761622580645e-05,0.00010572761906761014,0.0,0.00036328562,False,STAT1; signal transducer and activator of transcription
hsa:3800,0.0,0.0,3.0855549041935483e-06,7.446816964740677e-06,0.0,2.5016305e-05,False,KIF5C; kinesin family member
hsa:829,4.9493065e-07,0.0003498699315460019,1.7815410971935486e-06,3.6764201600839104e-06,0.0,1.6531156e-05,False,CAPZA1; capping actin protein of muscle Z-line subunit alpha
hsa:407021,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29A; microRNA
hsa:10926,1.0342436e-10,7.311140207903684e-08,1.5870840506309677e-06,2.5839128010659204e-06,0.0,7.208468e-06,False,DBF4; DBF4 zinc
hsa:161,0.0,0.0,9.953174019032257e-05,0.00027773198440824624,0.0,0.0014135084,False,AP2A2; adaptor related protein complex 2 subunit alpha
hsa:79603,6.89797e-06,0.004876223147033579,3.101208164580645e-05,4.04089371869659e-05,0.0,0.00015651797,False,CERS4; ceramide synthase
hsa:134430,0.0,0.0,9.064361416935484e-07,1.5936927152217232e-06,0.0,4.735864e-06,False,WDR36; WD repeat domain
hsa:8417,7.3140865e-07,0.000517037880575094,6.955067344625808e-05,0.0001705658039662175,0.0,0.000778568,False,STX7; syntaxin
hsa:971,0.0,0.0,3.020345671612904e-06,8.47736031873299e-06,0.0,3.3921086e-05,False,CD72; CD72
hsa:9785,2.4210902e-07,0.0001711485563766754,4.1808607096774196e-07,4.896945455126959e-07,0.0,1.9033473e-06,False,DHX38; DEAH-box helicase
hsa:7138,0.0,0.0,1.8324490093548383e-08,4.3654946546110754e-08,0.0,1.853609e-07,False,TNNT1; troponin T1
hsa:575,9.795635e-08,6.924602763840995e-05,1.2406657895858066e-05,2.483035880935191e-05,0.0,0.00012943464,False,ADGRB1; adhesion G protein-coupled receptor
hsa:120065,0.0,0.0,1.9235963296774194e-07,1.0662439047219485e-06,0.0,5.9373974e-06,False,OR5P2; olfactory receptor family 5 subfamily P member
hsa:144193,0.0,0.0,7.533416896129031e-06,2.4123811358581303e-05,0.0,0.00013134432,False,AMDHD1; amidohydrolase domain containing
hsa:2870,5.4383383e-07,0.0003844399308761743,9.925733104193547e-06,3.144466146081682e-05,0.0,0.0001704164,False,GRK6; G protein-coupled receptor kinase
hsa:23035,0.0,0.0,5.879526385161289e-08,1.2661811828292286e-07,0.0,5.99786e-07,False,PHLPP2; PH domain and leucine rich repeat protein phosphatase
hsa:873,0.0002481671,0.17543105541952153,0.0006556732912903225,0.0008776231077331154,0.0,0.0033207287,False,CBR1; carbonyl reductase
hsa:7592,0.0,0.0,1.4310644629032259e-08,4.404279131528798e-08,0.0,2.2748519e-07,False,ZNF41; zinc finger protein
hsa:2547,0.0,0.0,9.439548631935486e-05,0.0002212554212138278,0.0,0.0011445709,False,XRCC6; X-ray repair cross complementing
hsa:5013,0.0,0.0,1.4376275316774193e-08,6.833717492963284e-08,0.0,3.7856606e-07,False,OTX1; orthodenticle homeobox
hsa:23498,5.1565326e-05,0.036451888921745446,0.00022573840401600006,0.0003597191951374624,0.0,0.0014645605,False,HAAO; 3-hydroxyanthranilate
hsa:390151,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR8H2; olfactory receptor family 8 subfamily H member
hsa:22992,0.0,0.0,2.3184512071806457e-05,6.137838035028369e-05,0.0,0.00021781687,False,KDM2A; lysine demethylase
hsa:3551,0.00013220032,0.09345332908511435,0.0002363947670967742,0.00030264235669392206,0.0,0.0011735393,False,IKBKB; inhibitor of nuclear factor kappa B kinase subunit
hsa:5270,5.576029e-07,0.0003941733825796647,1.7840105325161288e-06,2.3212287975841432e-06,0.0,7.724695e-06,False,SERPINE2; serpin family E member
hsa:338674,0.0,0.0,6.89509e-07,3.839023638050562e-06,0.0,2.1374779e-05,False,OR5F1; olfactory receptor family 5 subfamily F member
hsa:8520,2.656049e-06,0.0018775795797104642,4.634034674193547e-05,0.00013057597597876733,0.0,0.000709226,False,HAT1; histone acetyltransferase
hsa:9842,0.0,0.0,1.182292314516129e-06,2.7783252433250916e-06,0.0,1.2016388e-05,False,PLEKHM1; pleckstrin homology and RUN domain containing
hsa:9104,2.0365228e-06,0.001439632184080481,2.9938048277419355e-05,5.6873731271439496e-05,0.0,0.00024026261,False,RGN;
hsa:128,0.0,0.0,0.00026409547751612907,0.0006531815555150353,0.0,0.0024133672,False,ADH5; alcohol dehydrogenase 5 (class III)
hsa:84464,0.0,0.0,4.9827411e-05,0.00011731146610006916,0.0,0.00045799653,False,SLX4; SLX4 structure-specific endonuclease
hsa:4128,0.0,0.0,0.0,0.0,0.0,0.0,False,MAOA; monoamine oxidase
hsa:147929,0.0,0.0,6.855323739290323e-08,1.716881384539455e-07,0.0,7.1078097e-07,False,ZNF565; zinc finger protein
hsa:1840,0.0,0.0,3.295170648935484e-05,0.00010044823926279149,0.0,0.00038634802,False,DTX1; deltex E3 ubiquitin ligase
hsa:7060,5.867351e-06,0.004147671381286178,9.032838078064517e-05,0.0002214457503827902,0.0,0.0011291577,False,THBS4; thrombospondin
hsa:84133,0.0,0.0,7.067541293670967e-06,2.5151633330075277e-05,0.0,0.00012882674,False,ZNRF3; zinc and ring finger
hsa:7941,0.0,0.0,5.539489365806451e-06,1.4158343884332796e-05,0.0,6.815398e-05,False,PLA2G7; phospholipase A2 group
hsa:6138,1.6352884e-07,0.00011559967857435601,1.4740318903225807e-06,3.189260869458892e-06,0.0,1.4348837e-05,False,RPL15; ribosomal protein
hsa:4712,1.1236534e-06,0.0007943184325711739,2.9261211864516128e-06,3.833540403594313e-06,0.0,1.1868552e-05,False,NDUFB6; NADH:ubiquinone oxidoreductase subunit
hsa:9986,0.0,0.0,1.3779198003225806e-06,6.314250643260666e-06,0.0,3.52398e-05,False,RCE1; Ras converting CAAX endopeptidase
hsa:11335,0.0,0.0,1.165940326451613e-06,5.991074829694544e-06,0.0,3.3436107e-05,False,CBX3; chromobox
hsa:8698,0.0,0.0,3.0742277777419356e-06,6.243551343208967e-06,0.0,3.025704e-05,False,S1PR4; sphingosine-1-phosphate receptor
hsa:4794,0.0,0.0,2.5130168032258062e-05,4.3159431716639256e-05,0.0,0.0002025665,False,NFKBIE; NFKB inhibitor
hsa:116931,0.0,0.0,4.584307722258065e-07,1.0960776963587144e-06,0.0,5.5226637e-06,False,MED12L; mediator complex subunit
hsa:64419,0.0,0.0,2.5834931183870967e-06,1.0074944993003834e-05,0.0,5.4124732e-05,False,MTMR14; myotubularin related protein
hsa:57644,0.0,0.0,1.301243037950323e-07,4.1925898883287177e-07,0.0,1.8798569e-06,False,MYH7B; myosin heavy chain
hsa:5054,2.1699761e-05,0.015339712534745226,0.00032182851459354835,0.0005875386591274655,0.0,0.0022899937,False,SERPINE1; serpin family E member
hsa:9322,2.942803e-07,0.00020802879841112467,2.653909873716129e-05,8.574995262532157e-05,0.0,0.00042785125,False,TRIP10; thyroid hormone receptor interactor
hsa:1979,3.8721876e-07,0.0002737276445791501,5.9350420431535485e-05,0.00015431157273851817,0.0,0.00057939766,False,EIF4EBP2; eukaryotic translation initiation factor 4E binding protein
hsa:51302,3.4686313e-05,0.024519996801356306,0.00011983267620419354,0.0002428543239816115,0.0,0.0012582939,False,CYP39A1; cytochrome P450 family 39 subfamily A member
hsa:84532,9.787585e-06,0.006918912162644756,0.0002690434652255484,0.0009542775313119493,0.0,0.0040306924,False,ACSS1; acyl-CoA synthetase short chain family member
hsa:27130,1.9620298e-07,0.00013869725623523533,7.313766748387097e-07,1.5188468052689576e-06,0.0,6.736804e-06,False,INVS;
hsa:101954275,-0.0,0.0,5.121252322580645e-08,2.4239393492678885e-07,0.0,1.3340398e-06,False,RNU6-7; RNA
hsa:259289,-0.0,0.0,5.617164838709678e-07,3.127505020910962e-06,0.0,1.7413211e-05,False,TAS2R43; taste 2 receptor member
hsa:9354,7.054528e-08,4.986895090149203e-05,4.930217022258064e-07,8.590875866909791e-07,0.0,3.3876902e-06,False,UBE4A; ubiquitination factor
hsa:5522,6.6408847e-06,0.0046944877537770015,2.721000976806452e-05,4.420005057745314e-05,0.0,0.00018930016,False,PPP2R2C; protein phosphatase 2 regulatory subunit
hsa:3398,0.0,0.0,6.630758067516129e-05,0.00026421284265325343,0.0,0.0014562511,False,ID2; inhibitor of DNA binding
hsa:257313,1.0527578e-08,7.442018380161332e-06,3.725111465451613e-07,8.644875133229718e-07,0.0,3.9217425e-06,False,UTS2B; urotensin
hsa:10437,1.6492918e-07,0.00011658958869598847,2.3312469259999996e-06,9.652835617870283e-06,0.0,5.419199e-05,False,IFI30; IFI30 lysosomal thiol
hsa:2984,0.0,0.0,3.6406459709677416e-09,1.011007805655351e-08,0.0,4.7350394e-08,False,GUCY2C; guanylate cyclase
hsa:54543,1.312558e-06,0.0009278564130351537,1.7262657713941932e-05,4.869175712191362e-05,0.0,0.00017870922,False,TOMM7; translocase of outer mitochondrial membrane
hsa:2329,0.00014362152,0.10152705509536082,0.00024993032074193544,0.0002925633275499677,0.0,0.0013865884,False,FMO4; flavin containing dimethylaniline monoxygenase
hsa:1259,2.2969512e-06,0.0016237308380649027,8.879659770000002e-05,0.0001862354961215101,0.0,0.0007862869,False,CNGA1; cyclic nucleotide gated channel subunit alpha
hsa:6401,2.2002436e-05,0.015553675605188905,0.00014357270973225806,0.00022155035707767634,0.0,0.00097525655,False,SELE; selectin
hsa:7155,0.0,0.0,6.8400834516129034e-09,3.250896047618805e-08,0.0,1.7983567e-07,False,TOP2B; DNA topoisomerase II
hsa:81873,3.0808715e-06,0.002177889570603534,1.004120946064516e-05,1.5310330047866953e-05,0.0,5.7832975e-05,False,ARPC5L; actin related protein 2/3 complex subunit 5
hsa:2103,2.3705606e-09,1.6757658367847073e-06,7.500489400537418e-06,1.7640459576676537e-05,0.0,7.183059e-05,False,ESRRB; estrogen related receptor
hsa:3347,-0.0,0.0,9.922412903225807e-07,5.524565695586542e-06,0.0,3.075948e-05,False,HTN3; histatin
hsa:2584,4.439906e-06,0.0031386005459364524,3.415735872838709e-05,5.986651807110662e-05,0.0,0.00029527806,False,GALK1; galactokinase
hsa:9331,1.9674978e-06,0.0013908379297239105,1.0073542946774197e-05,2.20215238470059e-05,0.0,0.00010429101,False,B4GALT6; beta-1
hsa:9126,0.0,0.0,2.4699112757495485e-06,5.065120458223636e-06,0.0,2.1112315e-05,False,SMC3; structural maintenance of chromosomes
hsa:7322,4.31109e-08,3.0475396162849347e-05,2.1611455128312903e-05,4.240914417033919e-05,0.0,0.00015891732,False,UBE2D2; ubiquitin conjugating enzyme E2
hsa:1793,3.9036426e-05,0.027595122048756873,0.00010246511518064516,0.00014754311003845145,0.0,0.00050981244,False,DOCK1; dedicator of cytokinesis
hsa:837,1.3823015e-06,0.0009771585800575004,3.57797203267742e-05,8.48695246991648e-05,0.0,0.00041631452,False,CASP4; caspase
hsa:11273,0.0,0.0,2.3105888000000002e-07,4.243593666844222e-07,0.0,1.9471177e-06,False,ATXN2L; ataxin 2
hsa:100169761,0.0,0.0,2.405319019354839e-07,1.277610185842771e-06,0.0,7.116647e-06,False,RNA5S10; RNA
hsa:10392,0.0,0.0,5.012227596774193e-08,1.195286475643354e-07,0.0,4.076902e-07,False,NOD1; nucleotide binding oligomerization domain containing
hsa:6696,0.0,0.0,6.629998929032258e-05,0.00011023374123573714,0.0,0.00038820246,False,SPP1; secreted phosphoprotein
hsa:10365,1.1621704e-05,0.008215463687544703,2.0978413370967743e-05,2.5910358285407416e-05,0.0,0.00010091093,False,KLF2; KLF transcription factor
hsa:2919,0.00018640044,0.13176777227869124,0.0004471469666580645,0.0005560063413126041,0.0,0.0020679438,False,CXCL1; C-X-C motif chemokine ligand
hsa:29851,0.0,0.0,1.716841741935484e-06,4.726918988548321e-06,0.0,1.8275146e-05,False,ICOS; inducible T cell
hsa:259294,0.0,0.0,7.293250645161291e-07,3.0433911901676032e-06,0.0,1.570744e-05,False,TAS2R19; taste 2 receptor member
hsa:3163,0.0,0.0,0.00014868073058064515,0.00035797448840749527,0.0,0.0015452531,False,HMOX2; heme oxygenase
hsa:89869,0.0,0.0,6.945764483870967e-09,3.4097871117813694e-08,0.0,1.8888258e-07,False,PLCZ1; phospholipase C zeta
hsa:598,0.0,0.0,0.0005798191482258064,0.0013191361469207562,0.0,0.004662362,False,BCL2L1; BCL2 like
hsa:23462,0.00018497118,0.13075741840717114,0.00042339922651870974,0.000672942623548086,0.0,0.002794325,False,HEY1; hes related family bHLH transcription factor with YRPW motif
hsa:933,0.0,0.0,2.7005663741935485e-06,6.625119233029514e-06,0.0,2.6517931e-05,False,CD22; CD22
hsa:10336,0.0,0.0,3.0443514450322582e-05,8.340041537791652e-05,0.0,0.00029125885,False,PCGF3; polycomb group ring finger
hsa:51384,0.0,0.0,1.4724754944193547e-06,3.832608503654305e-06,0.0,1.8926348e-05,False,WNT16; Wnt family member
hsa:1604,6.810382e-06,0.004814306578390576,0.00010798463019354839,0.00023101894524668652,0.0,0.001153254,False,CD55; CD55 molecule (Cromer blood
hsa:115752,2.1042322e-07,0.00014874964316129806,5.472147651612903e-07,9.794802533183014e-07,0.0,4.166263e-06,False,DIS3L; DIS3 like exosome 3'-5'
hsa:390038,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51D1; olfactory receptor family 51 subfamily D member
hsa:1848,1.5055605e-06,0.0010642912276161607,5.078371189764517e-05,0.0001778218511406962,0.0,0.00097104855,False,DUSP6; dual specificity phosphatase
hsa:733,1.4971894e-08,1.0583736385883549e-05,1.077476766967742e-06,2.833067579337688e-06,0.0,1.1079405e-05,False,C8G; complement C8 gamma
hsa:11108,2.1384263e-08,1.5116684796085474e-05,2.0815703760580643e-06,4.6546870169449e-06,0.0,2.0511672e-05,False,PRDM4; PR/SET domain
hsa:4318,0.0,0.0,5.429032528387098e-05,0.00012764786395867068,0.0,0.000507749,False,MMP9; matrix metallopeptidase
hsa:79092,0.0,0.0,2.4563847974193544e-07,5.691107594767554e-07,0.0,2.3979692e-06,False,CARD14; caspase recruitment domain family member
hsa:1781,0.0,0.0,1.6731187693548386e-05,5.5121162885855855e-05,0.0,0.00027115364,False,DYNC1I2; dynein cytoplasmic 1 intermediate chain
hsa:6760,1.5759579e-06,0.0011140556411133172,1.8652257053870967e-05,4.10455147341745e-05,0.0,0.00021485382,False,SS18; SS18 subunit of BAF chromatin remodeling
hsa:91181,0.0,0.0,1.3495723143548386e-09,2.929056210149259e-09,0.0,1.0943777e-08,False,NUP210L; nucleoporin 210
hsa:137682,0.0,0.0,5.037293469354837e-07,1.7928427679614256e-06,0.0,8.153443e-06,False,NDUFAF6; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:7559,1.661169e-08,1.1742919625534212e-05,8.361641883870969e-08,1.7978065909274735e-07,0.0,7.5710403e-07,False,ZNF12; zinc finger protein
hsa:9536,2.6764405e-06,0.001891994473411471,0.00012301141292996774,0.00027076091390666534,0.0,0.0010126564,False,PTGES; prostaglandin E
hsa:407053,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR96; microRNA
hsa:24137,0.0,0.0,4.473653206451613e-08,1.5069109651220634e-07,0.0,7.865329e-07,False,KIF4A; kinesin family member
hsa:6720,1.9791121e-05,0.013990481594721684,8.857104074193549e-05,0.00013630063652931177,0.0,0.0004891375,False,SREBF1; sterol regulatory element binding transcription factor
hsa:79661,8.3057057e-07,0.0005871361340624667,1.7061368319419365e-05,3.540647582002637e-05,0.0,0.0001689455,False,NEIL1; nei like DNA glycosylase
hsa:390148,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5W2; olfactory receptor family 5 subfamily W member
hsa:501,4.0691673e-05,0.028765227708169406,0.00023352050490322584,0.0003888474778251605,0.0,0.0016951145,False,ALDH7A1; aldehyde dehydrogenase 7 family member
hsa:6523,0.0,0.0,4.985766774193548e-08,2.775957456673683e-07,0.0,1.5455877e-06,False,SLC5A1; solute carrier family 5 member
hsa:100500809,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23C; microRNA
hsa:81839,0.0,0.0,7.476209641451614e-06,2.4523019819327337e-05,0.0,0.00012626627,False,VANGL1; VANGL planar cell polarity protein
hsa:4254,6.35034e-05,0.044890996770837244,0.00012644826644,0.000203766519796924,0.0,0.0009918984,False,KITLG; KIT
hsa:27179,-0.0,0.0,0.0,0.0,0.0,0.0,False,IL36A; interleukin 36
hsa:57084,0.0,0.0,2.0506283935483868e-07,6.86878580622541e-07,0.0,3.1911472e-06,False,SLC17A6; solute carrier family 17 member
hsa:442117,0.0,0.0,3.091066923870968e-05,9.767207781901517e-05,0.0,0.00048090093,False,GALNTL6; polypeptide N-acetylgalactosaminyltransferase like
hsa:23649,0.0,0.0,8.038093865870968e-06,2.1001888996350822e-05,0.0,8.672329e-05,False,POLA2; DNA polymerase alpha 2
hsa:197320,6.2960117e-09,4.450694622553335e-06,5.385967794516129e-08,1.0117960983103405e-07,0.0,3.7596473e-07,False,ZNF778; zinc finger protein
hsa:6915,6.35383e-06,0.004491566782447063,2.0504420616129036e-05,3.618033237043728e-05,0.0,0.00017632273,False,TBXA2R; thromboxane A2
hsa:390441,0.0,0.0,1.1962498943225809e-06,5.329246571717636e-06,0.0,2.8840548e-05,False,OR11H7; olfactory receptor family 11 subfamily H member 7
hsa:3161,0.0,0.0,1.0495501806451613e-07,3.3496752473226835e-07,0.0,1.4295239e-06,False,HMMR; hyaluronan mediated motility
hsa:54541,0.0,0.0,5.567296870967741e-06,1.1255175592432513e-05,0.0,4.76869e-05,False,DDIT4; DNA damage inducible transcript
hsa:85315,0.0,0.0,2.321390824516129e-07,6.057521100417984e-07,0.0,2.6759e-06,False,PAQR8; progestin and adipoQ receptor family member
hsa:3447,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA13; interferon alpha
hsa:9965,0.0,0.0,3.199129565483871e-07,1.2807497659534564e-06,0.0,6.9994503e-06,False,FGF19; fibroblast growth factor
hsa:2793,4.531215e-06,0.003203147515455382,3.296998381612904e-05,7.549659495280413e-05,0.0,0.0003607883,False,GNGT2; G protein subunit gamma transducin
hsa:2359,3.7207144e-06,0.002630198983292353,1.3259709841935483e-05,2.1967283215464683e-05,0.0,9.2896415e-05,False,FPR3; formyl peptide receptor
hsa:3304,0.0,0.0,3.591740034193549e-05,6.349213304128739e-05,0.0,0.0002086259,False,HSPA1B; heat shock protein family A (Hsp70) member
hsa:84189,0.0,0.0,2.127813137e-07,4.5430760910866544e-07,0.0,1.7196132e-06,False,SLITRK6; SLIT and NTRK like family member
hsa:388112,0.0,0.0,7.365361870967742e-09,2.873462781973396e-08,0.0,1.5321866e-07,False,NANOGP8; Nanog homeobox retrogene
hsa:63940,8.653129e-07,0.0006116957296721721,9.685724143225807e-07,9.388802944151135e-07,0.0,3.5412195e-06,False,GPSM3; G protein signaling modulator
hsa:135948,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2F2; olfactory receptor family 2 subfamily F member
hsa:1244,0.0,0.0,7.577554580645161e-07,2.880280729548002e-06,0.0,1.4930049e-05,False,ABCC2; ATP binding cassette subfamily C member
hsa:8819,5.0046417e-08,3.537816154629475e-05,2.4232283222580646e-07,4.658904642653227e-07,0.0,1.9819292e-06,False,SAP30; Sin3A associated protein
hsa:84440,1.2167576e-08,8.601344415022136e-06,1.679954627741936e-07,3.205580081890838e-07,0.0,1.0962922e-06,False,RAB11FIP4; RAB11 family interacting protein
hsa:55740,0.0,0.0,2.2719183852903222e-05,8.40505608735526e-05,0.0,0.00045833807,False,ENAH; ENAH actin
hsa:2779,2.136671e-06,0.001510427645784975,2.7708903094838708e-05,9.693908898529694e-05,0.0,0.00053347327,False,GNAT1; G protein subunit alpha transducin
hsa:5228,0.0,0.0,8.056316935483871e-07,1.4952606269504536e-06,0.0,6.4769233e-06,False,PGF; placental growth
hsa:112,0.00050601346,0.3577044473029819,0.0018581507772258065,0.002371123853831789,0.0,0.006683472,False,ADCY6; adenylate cyclase
hsa:496,0.0,0.0,3.265778499351613e-06,1.1830106358079574e-05,0.0,5.6991987e-05,False,ATP4B; ATPase H+/K+ transporting subunit
hsa:204219,0.0,0.0,3.011952886903225e-07,7.370858275688375e-07,0.0,2.9580203e-06,False,CERS3; ceramide synthase
hsa:23550,2.6197029e-08,1.8518862678920017e-05,1.8174821779354836e-07,4.796705090430551e-07,0.0,2.302694e-06,False,PSD4; pleckstrin and Sec7 domain containing
hsa:11140,0.0,0.0,6.961858964935483e-08,3.722256642117208e-07,0.0,2.073586e-06,False,CDC37; cell division cycle 37
hsa:3351,0.0,0.0,2.5836387980645158e-05,0.00010307727732551265,0.0,0.0005609943,False,HTR1B; 5-hydroxytryptamine receptor
hsa:3176,8.218628e-05,0.05809805506614016,0.00042692817454838717,0.0006936337914946666,0.0,0.0034354508,False,HNMT; histamine
hsa:9663,3.0499382e-06,0.002156022604891284,1.4185506512903227e-05,2.078174534983721e-05,0.0,8.699713e-05,False,LPIN2; lipin
hsa:8836,1.8242866e-06,0.0012896009327009522,8.085739529354838e-05,0.00015753479213244178,0.0,0.0006748321,False,GGH; gamma-glutamyl
hsa:10905,0.0,0.0,4.924609003225807e-06,1.022292545202233e-05,0.0,4.1877433e-05,False,MAN1A2; mannosidase alpha class 1A member
hsa:23305,0.0,0.0,6.343049677419355e-07,3.531660594559595e-06,0.0,1.9663454e-05,False,ACSL6; acyl-CoA synthetase long chain family member
hsa:3074,0.00054406526,0.3846035303587638,0.0008904737181935484,0.001218256724463077,0.0,0.0061091427,True,HEXB; hexosaminidase subunit
hsa:8881,4.144365e-06,0.0029296805498945076,5.5197001792903215e-05,0.00012370571711569955,0.0,0.0005266984,False,CDC16; cell division cycle
hsa:6555,-0.0,0.0,0.0,0.0,0.0,0.0,False,SLC10A2; solute carrier family 10 member
hsa:203,1.575678e-06,0.0011138577778493637,3.624966409999999e-05,8.324745049884542e-05,0.0,0.0003127513,False,AK1; adenylate kinase
hsa:23483,0.0,0.0,5.414257064516128e-06,1.1534031812007501e-05,0.0,4.725712e-05,False,TGDS; TDP-glucose
hsa:2588,1.0994382e-06,0.0007772005386473026,9.197634326709676e-05,0.00026391606503225253,0.0,0.001376225,False,GALNS; galactosamine
hsa:10294,1.7110914e-08,1.2095824556166657e-05,6.57558822432258e-07,1.8262367779825293e-06,0.0,8.64027e-06,False,DNAJA2; DnaJ heat shock protein family (Hsp40) member
hsa:3972,1.7963213e-05,0.012698320669080106,0.00010041822725483871,0.0002495595843047331,0.0,0.0013243613,False,LHB; luteinizing hormone subunit
hsa:145173,1.0916797e-06,0.0007717160008359956,5.947975987516129e-05,0.00016675719691229375,0.0,0.0007821291,False,B3GLCT; beta
hsa:2214,8.92979e-06,0.006312530888964287,0.00022728400925806452,0.0004903979545849257,0.0,0.0019418441,False,FCGR3A; Fc gamma receptor
hsa:8085,0.0,0.0,4.134489112903225e-06,7.154405722348067e-06,0.0,3.0753312e-05,False,KMT2D; lysine methyltransferase
hsa:58191,4.3587406e-06,0.003081224158068973,3.0384378326129033e-05,6.247019233449458e-05,0.0,0.0003260531,False,CXCL16; C-X-C motif chemokine ligand
hsa:7293,0.0,0.0,8.755556861290322e-07,2.0104337996948505e-06,0.0,9.354051e-06,False,TNFRSF4; TNF receptor superfamily member
hsa:4705,0.0,0.0,3.4760745812903227e-06,7.110445481641848e-06,0.0,2.6593942e-05,False,NDUFA10; NADH:ubiquinone oxidoreductase subunit
hsa:115196,1.00793525e-08,7.1251646451942775e-06,4.929783081290323e-08,8.828010320661565e-08,0.0,3.755957e-07,False,ZNF554; zinc finger protein
hsa:9470,0.0,0.0,2.5306433029032257e-05,5.342668944315102e-05,0.0,0.00024163847,False,EIF4E2; eukaryotic translation initiation factor 4E family member
hsa:80110,0.0,0.0,2.1247494761290323e-08,4.2270414875403575e-08,0.0,1.7592053e-07,False,ZNF614; zinc finger protein
hsa:6737,4.9408357e-07,0.0003492711247806217,2.2141729102774188e-05,4.910717310379114e-05,0.0,0.00019157193,False,TRIM21; tripartite motif containing
hsa:6500,5.352253e-06,0.003783545009238938,0.00014052801235483868,0.00016960962895054806,0.0,0.000472794,False,SKP1; S-phase kinase associated protein
hsa:138799,0.0,0.0,1.608954419354839e-08,6.521799510014811e-08,0.0,3.2434792e-07,False,OR13C5; olfactory receptor family 13 subfamily C member
hsa:222,0.0,0.0,2.696495806451613e-07,1.5013453255681883e-06,0.0,8.359137e-06,False,ALDH3B2; aldehyde dehydrogenase 3 family member
hsa:7272,0.0,0.0,3.451219877548387e-08,6.753525370871913e-08,0.0,3.250697e-07,False,TTK; TTK protein
hsa:27232,0.0,0.0,5.124092749999999e-06,1.0726912586298395e-05,0.0,4.839267e-05,False,GNMT; glycine
hsa:552,2.979334e-06,0.002106112003030477,2.9937756880903226e-05,0.00010019405492593264,0.0,0.0005592754,False,AVPR1A; arginine vasopressin receptor
hsa:8760,2.7536487e-06,0.001946573488974136,2.3212089245161287e-05,6.348283361934635e-05,0.0,0.000269727,False,CDS2; CDP-diacylglycerol synthase
hsa:55733,2.0605634e-05,0.014566266520454875,7.184206528358063e-05,0.00013205141636009546,0.0,0.0006493625,False,HHAT; hedgehog
hsa:5296,0.0,0.0,0.0002917255070967742,0.0005361779834153953,0.0,0.001908256,False,PIK3R2; phosphoinositide-3-kinase regulatory subunit
hsa:5042,9.76493e-09,6.902897184992484e-06,8.764762753225806e-08,1.811710188196358e-07,0.0,8.773936e-07,False,PABPC3; poly(A) binding protein cytoplasmic
hsa:4583,0.0,0.0,1.0396822580645162e-08,5.788705825118261e-08,0.0,3.223015e-07,False,MUC2; mucin 2
hsa:293,3.9454926e-06,0.0027890962620263204,3.482160852580646e-05,6.186409987557725e-05,0.0,0.00020675748,False,SLC25A6; solute carrier family 25 member
hsa:5471,0.0,0.0,2.9786917387096775e-06,7.4231756139235385e-06,0.0,2.7083986e-05,False,PPAT; phosphoribosyl pyrophosphate
hsa:390066,0.0,0.0,7.933222461290323e-07,3.327143698263889e-06,0.0,1.7600038e-05,False,OR52D1; olfactory receptor family 52 subfamily D member
hsa:338382,2.6874332e-06,0.0018997652897804022,5.0731908092580637e-05,7.193880101164676e-05,0.0,0.00023704478,False,RAB7B; RAB7B
hsa:253639,0.0,0.0,2.1401115212903228e-08,3.2410092217332005e-08,0.0,1.05522396e-07,False,ZNF620; zinc finger protein
hsa:114799,0.0,0.0,4.722641183419354e-07,1.4799347813747986e-06,0.0,6.7150772e-06,False,ESCO1; establishment of sister chromatid cohesion N-acetyltransferase
hsa:391192,0.0,0.0,8.600962251612903e-07,3.2302441817364884e-06,0.0,1.4329756e-05,False,OR2L3; olfactory receptor family 2 subfamily L member
hsa:9344,1.6402923e-07,0.00011595340775852819,5.002946796451614e-07,8.400380812808093e-07,0.0,3.7147809e-06,False,TAOK2; TAO kinase
hsa:390077,0.0,0.0,2.0166712887225807e-05,6.731237033868517e-05,0.0,0.00031629257,False,OR52N2; olfactory receptor family 52 subfamily N member
hsa:6476,0.0,0.0,0.0,0.0,0.0,0.0,False,SI;
hsa:3665,3.5699225e-06,0.002523603136519292,2.4131234964516126e-05,5.354690050978355e-05,0.0,0.000213886,False,IRF7; interferon regulatory factor
hsa:3645,3.6229018e-08,2.5610545735324475e-05,3.333367220645161e-07,6.970537728100532e-07,0.0,2.6556402e-06,False,INSRR; insulin receptor related
hsa:153562,0.0,0.0,1.594213884980645e-06,4.885883781453473e-06,0.0,2.056589e-05,False,MARVELD2; MARVEL domain containing
hsa:2162,2.094327e-06,0.0014804943765857775,4.947848936225808e-06,7.766791041399927e-06,0.0,3.101332e-05,False,F13A1; coagulation factor XIII A
hsa:23220,3.316584e-07,0.00023445163823387482,0.00012154502306903224,0.00022289578681090698,0.0,0.0009193776,False,DTX4; deltex E3 ubiquitin ligase
hsa:147179,0.0,0.0,8.868728700000002e-07,2.1084713641378607e-06,0.0,7.923507e-06,False,WIPF2; WAS/WASL interacting protein family member
hsa:4829,0.0,0.0,2.5015040654612904e-07,7.372262600157924e-07,0.0,3.425321e-06,False,NMBR; neuromedin B
hsa:3988,0.00012259305,0.08666188285473042,0.00019153738561935484,0.0002404563004421856,0.0,0.00074900565,False,LIPA; lipase A
hsa:201633,0.0,0.0,9.871359499193548e-07,3.3288722908505567e-06,0.0,1.7431217e-05,False,TIGIT; T cell immunoreceptor with Ig and ITIM
hsa:81488,0.0,0.0,1.5644129642903222e-05,3.8952273807248924e-05,0.0,0.00016311325,False,POLR2M; RNA polymerase II subunit
hsa:1317,1.04126265e-07,7.360758362346492e-05,6.223211543725807e-05,0.00013098045986508186,0.0,0.0006437249,False,SLC31A1; solute carrier family 31 member
hsa:282775,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5J2; olfactory receptor family 5 subfamily J member
hsa:10501,9.904559e-08,7.001601899828464e-05,4.0282082733548395e-06,1.4148481102418177e-05,0.0,7.596865e-05,False,SEMA6B; semaphorin
hsa:56894,1.26203695e-05,0.00892142730107794,0.0003592606152709676,0.001009809778303886,0.0,0.004873547,False,AGPAT3; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:3600,0.0,0.0,5.466448167741935e-05,9.110147827501757e-05,0.0,0.00028882176,False,IL15; interleukin
hsa:3560,5.04718e-06,0.0035678867758550618,6.555876478709677e-05,9.625596314854042e-05,0.0,0.0003859896,False,IL2RB; interleukin 2 receptor subunit
hsa:5032,0.0,0.0,2.2951801045161293e-06,4.516493451522944e-06,0.0,1.7046792e-05,False,P2RY11; purinergic receptor
hsa:123099,1.8759897e-08,1.3261502150250842e-05,1.9084502299999997e-06,3.270823902296696e-06,0.0,1.057334e-05,False,DEGS2; delta 4-desaturase
hsa:438,3.3181007e-07,0.0002345588548156678,2.372500056451613e-06,3.730033096898008e-06,0.0,1.539625e-05,False,ASMT; acetylserotonin
hsa:8178,0.0,0.0,1.1926667783225805e-05,3.172494162746208e-05,0.0,0.00015112277,False,ELL; elongation factor for RNA polymerase
hsa:51208,0.0,0.0,1.471115063387097e-07,5.629285193719386e-07,0.0,3.010979e-06,False,CLDN18; claudin
hsa:6364,0.0,0.0,5.724501441180645e-05,0.0002553854796989438,0.0,0.0014114997,False,CCL20; C-C motif chemokine ligand
hsa:81472,0.0,0.0,1.5011020322580644e-07,7.320517089301522e-07,0.0,4.0512914e-06,False,OR2C3; olfactory receptor family 2 subfamily C member
hsa:54108,1.2286416e-09,8.685353240632202e-07,3.4225078845000005e-07,6.606924785718482e-07,0.0,2.3280033e-06,False,CHRAC1; chromatin accessibility complex subunit
hsa:54981,1.8038021e-06,0.0012751202966507216,5.996803437419355e-05,9.978868446959885e-05,0.0,0.00035284416,False,NMRK1; nicotinamide riboside kinase
hsa:219,0.0,0.0,7.934746561290324e-05,0.00016453053585926546,0.0,0.0007883867,False,ALDH1B1; aldehyde dehydrogenase 1 family member
hsa:5176,0.0,0.0,9.957548054838709e-07,2.1413163331768033e-06,0.0,7.876458e-06,False,SERPINF1; serpin family F member
hsa:5718,0.0,0.0,2.599697702580645e-06,4.175004047463266e-06,0.0,1.48469735e-05,False,PSMD12; proteasome 26S subunit
hsa:4258,0.0,0.0,0.00023168526238709678,0.0004161330764990534,0.0,0.0020374605,False,MGST2; microsomal glutathione S-transferase
hsa:4218,9.193363e-07,0.0006498852482640844,4.510379374838709e-05,0.00013239710837081175,0.0,0.00057156483,False,RAB8A; RAB8A
hsa:10138,0.0,0.0,2.5296595174193547e-06,9.965963563391272e-06,0.0,5.4459375e-05,False,YAF2; YY1 associated factor
hsa:11014,3.8598646e-08,2.7285652310658794e-05,8.130600933741936e-06,1.7940196106858933e-05,0.0,7.809134e-05,False,KDELR2; KDEL endoplasmic reticulum protein retention receptor
hsa:5563,0.0,0.0,5.187746254838711e-06,1.704742994794149e-05,0.0,8.549678e-05,False,PRKAA2; protein kinase AMP-activated catalytic subunit alpha
hsa:9019,0.0,0.0,2.476192703483871e-06,6.526662887630647e-06,0.0,2.5490526e-05,False,MPZL1; myelin protein zero like
hsa:7767,0.0,0.0,2.29249895e-08,6.532555301143678e-08,0.0,2.7311398e-07,False,ZNF224; zinc finger protein
hsa:27125,0.0,0.0,1.374411702483871e-05,2.209716254146609e-05,0.0,7.077348e-05,False,AFF4; ALF transcription elongation factor
hsa:55432,2.72855e-08,1.92883104273264e-05,3.206090441029031e-07,6.72136716280211e-07,0.0,3.0099663e-06,False,YOD1; YOD1
hsa:64805,1.1905063e-07,8.415772142745333e-05,4.981213002532258e-05,0.00012264653053791402,0.0,0.00058438146,False,P2RY12; purinergic receptor
hsa:57468,0.0,0.0,1.2555206358745485e-05,4.009658979680266e-05,0.0,0.00021939722,False,SLC12A5; solute carrier family 12 member
hsa:100169758,0.0,0.0,3.2372860629032255e-06,1.121245580269838e-05,0.0,5.967335e-05,False,RNA5S7; RNA
hsa:2271,1.1716622e-05,0.008282561884357697,6.345369039677419e-05,0.0001449131266377009,0.0,0.00059146155,False,FH; fumarate
hsa:79590,0.0,0.0,3.075767882903225e-07,9.68472985514098e-07,0.0,4.2367005e-06,False,MRPL24; mitochondrial ribosomal protein
hsa:10856,0.0,0.0,1.0789910182903226e-06,2.282454127891008e-06,0.0,9.374191e-06,False,RUVBL2; RuvB like AAA ATPase
hsa:374899,2.3120719e-09,1.6344197664509858e-06,3.685622195612903e-08,5.658215718305781e-08,0.0,1.70621e-07,False,ZNF829; zinc finger protein
hsa:80380,0.0,0.0,7.716238516129032e-07,1.8819414175371478e-06,0.0,8.599008e-06,False,PDCD1LG2; programmed cell death 1 ligand
hsa:23451,2.5028097e-08,1.76925364879235e-05,2.7491718300096776e-07,6.815334927100647e-07,0.0,2.5996574e-06,False,SF3B1; splicing factor 3b subunit
hsa:174,0.0,0.0,2.2291029225806452e-07,1.1108897227406378e-06,0.0,6.1650057e-06,False,AFP; alpha
hsa:8383,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1A1; olfactory receptor family 1 subfamily A member
hsa:51427,6.0922116e-09,4.306626909155371e-06,6.609537793548386e-08,1.291649335463923e-07,0.0,5.175184e-07,False,ZNF107; zinc finger protein
hsa:54429,0.0,0.0,2.347971783870967e-05,9.360256894335252e-05,0.0,0.00049837446,False,TAS2R5; taste 2 receptor member
hsa:440073,0.0,0.0,4.6002636883870977e-07,1.141354082447195e-06,0.0,4.5408074e-06,False,IQSEC3; IQ motif and Sec7 domain ArfGEF
hsa:51077,0.0,0.0,2.671102473612903e-06,7.685453216068853e-06,0.0,3.6356098e-05,False,FCF1; FCF1 rRNA-processing
hsa:3627,0.0,0.0,6.009696368709678e-05,0.00010911136592797227,0.0,0.00039012858,False,CXCL10; C-X-C motif chemokine ligand
hsa:4493,1.9254274e-05,0.013610980702746868,0.000263057461806129,0.0004548856676523193,0.0,0.0014478524,False,MT1E; metallothionein
hsa:4240,1.4067216e-07,9.944213192217582e-05,8.226105499612902e-05,0.0001481786252436697,0.0,0.0005722657,False,MFGE8; milk fat globule EGF and factor V/VIII domain
hsa:2488,0.0,0.0,0.0,0.0,0.0,0.0,False,FSHB; follicle stimulating hormone subunit
hsa:392255,0.0,0.0,2.076641085629032e-05,6.766949170122099e-05,0.0,0.00026968075,False,GDF6; growth differentiation factor
hsa:29933,0.0,0.0,1.9403645645161294e-05,3.743783300944134e-05,0.0,0.0001257883,False,GPR132; G protein-coupled receptor
hsa:1667,0.0,0.0,7.70948199783871e-06,3.6858587553788065e-05,0.0,0.00020414733,False,DEFA1; defensin alpha
hsa:285955,0.0,0.0,1.3165424380645163e-07,4.959993341435989e-07,0.0,2.7608785e-06,False,SPDYE1; speedy/RINGO cell cycle regulator family member
hsa:2979,0.0,0.0,1.2572977464516131e-05,3.139257217914486e-05,0.0,0.00013934515,False,GUCA1B; guanylate cyclase activator
hsa:56034,2.78326e-05,0.019675059236576378,0.00012866422667741936,0.0002514877361051739,0.0,0.0010865688,False,PDGFC; platelet derived growth factor
hsa:91653,0.00013818478,0.09768378563602664,0.0002145073572967742,0.0002353407489665013,0.0,0.0009499871,False,BOC; BOC cell adhesion associated
hsa:9267,0.0,0.0,1.2359966449677419e-05,2.498669232793478e-05,0.0,8.765854e-05,False,CYTH1; cytohesin
hsa:2528,0.0,0.0,4.910027741935484e-09,2.7337877482055166e-08,0.0,1.5221086e-07,False,FUT6; fucosyltransferase
hsa:53630,0.0,0.0,1.4288960587096773e-06,5.7043474088891286e-06,0.0,2.8203398e-05,False,BCO1; beta-carotene oxygenase
hsa:125963,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1M1; olfactory receptor family 1 subfamily M member
hsa:5984,0.0,0.0,2.0458729916129034e-05,6.975644576395009e-05,0.0,0.00031211332,False,RFC4; replication factor C subunit
hsa:9517,0.0,0.0,2.334120432741935e-05,6.58170968318164e-05,0.0,0.0002931508,False,SPTLC2; serine palmitoyltransferase long chain base subunit
hsa:5147,8.0780005e-09,5.710394945157608e-06,8.330588725383871e-06,2.6448375984788e-05,0.0,0.0001263877,False,PDE6D; phosphodiesterase
hsa:4153,0.0,0.0,8.914979366000001e-07,3.8768615951377545e-06,0.0,2.091658e-05,False,MBL2; mannose binding lectin
hsa:246181,0.0,0.0,0.00023812142865903223,0.0007557503979971942,0.0,0.0034735363,False,AKR7L; aldo-keto reductase family 7 like
hsa:2673,0.0,0.0,6.461739203225807e-06,1.3117181978666028e-05,0.0,5.2047868e-05,False,GFPT1; glutamine--fructose-6-phosphate transaminase
hsa:1594,0.0,0.0,1.0511999572580645e-05,2.877190487648365e-05,0.0,0.00011605999,False,CYP27B1; cytochrome P450 family 27 subfamily B member
hsa:390075,0.0,0.0,1.5288086954838711e-06,4.996714582306447e-06,0.0,2.4807443e-05,False,OR52N5; olfactory receptor family 52 subfamily N member
hsa:5648,0.0,0.0,2.8052230009677415e-07,7.845551522289766e-07,0.0,3.6868958e-06,False,MASP1; MBL associated serine protease
hsa:10345,0.0,0.0,7.065093154212903e-06,2.1594095140085995e-05,0.0,0.00010287558,False,TRDN;
hsa:84172,0.0,0.0,2.7686844377741932e-06,5.724314966569004e-06,0.0,2.2209715e-05,False,POLR1B; RNA polymerase I subunit
hsa:57576,0.0,0.0,2.9298887639354837e-07,9.509427994948207e-07,0.0,4.674457e-06,False,KIF17; kinesin family member
hsa:1944,0.0,0.0,5.573131925806453e-07,1.5499930843385926e-06,0.0,8.073435e-06,False,EFNA3; ephrin
hsa:5886,0.0,0.0,6.691732287096776e-06,1.4076779287098363e-05,0.0,5.872635e-05,False,RAD23A; RAD23 homolog A
hsa:4915,0.0,0.0,7.343145019677418e-06,1.1756817334130005e-05,0.0,4.16685e-05,False,NTRK2; neurotrophic receptor tyrosine kinase
hsa:4799,2.774409e-08,1.961249089969699e-05,1.713810454535484e-07,2.9517800285046807e-07,0.0,1.1672571e-06,False,NFX1; nuclear transcription factor
hsa:121275,0.0,0.0,1.6158890951612901e-06,6.5796622577581975e-06,0.0,3.5301946e-05,False,OR10AD1; olfactory receptor family 10 subfamily AD member
hsa:51764,0.0,0.0,3.0648856174193544e-07,8.716410577340369e-07,0.0,3.1544769e-06,False,GNG13; G protein subunit gamma
hsa:10096,2.6225077e-06,0.0018538690005920281,3.571080783903224e-05,6.926010617112087e-05,0.0,0.00022626836,False,ACTR3; actin related protein
hsa:83990,0.0,0.0,4.729354944064515e-06,1.3072332362642268e-05,0.0,5.62394e-05,False,BRIP1; BRCA1 interacting helicase
hsa:64579,0.0,0.0,5.199605206451613e-07,2.1716951294897256e-06,0.0,1.1655198e-05,False,NDST4; N-deacetylase and N-sulfotransferase
hsa:25780,7.5174074e-07,0.0005314107769323658,5.784214747419355e-06,1.1226171643340143e-05,0.0,5.6561337e-05,False,RASGRP3; RAS guanyl releasing protein
hsa:142680,0.0,0.0,2.2568708364516132e-07,9.511752250935778e-07,0.0,5.2645387e-06,False,SLC34A3; solute carrier family 34 member
hsa:52,0.0,0.0,0.0001080566735483871,0.00020881521889617823,0.0,0.0008675464,False,ACP1; acid phosphatase
hsa:3925,2.6480166e-07,0.00018719014200770887,6.095534007741935e-07,7.672716371289787e-07,0.0,2.9051146e-06,False,STMN1; stathmin
hsa:201514,9.951566e-09,7.034831476279595e-06,8.052300638709678e-08,1.704408119267556e-07,0.0,7.082862e-07,False,ZNF584; zinc finger protein
hsa:23583,0.0,0.0,5.8989671258064514e-06,1.5466125826588017e-05,0.0,5.6631277e-05,False,SMUG1; single-strand-selective monofunctional uracil-DNA glycosylase
hsa:677,5.1351073e-08,3.6300431980366837e-05,2.5806409128709676e-06,4.479482018658068e-06,0.0,1.7172804e-05,False,ZFP36L1; ZFP36 ring finger protein like
hsa:4025,1.5194232e-08,1.0740908670202728e-05,1.8602419928387096e-06,4.37477750117076e-06,0.0,1.7390268e-05,False,LPO;
hsa:259197,0.0,0.0,5.0760303945161284e-08,1.782980418272265e-07,0.0,9.2538465e-07,False,NCR3; natural cytotoxicity triggering receptor
hsa:64091,0.0,0.0,9.386927006451614e-08,2.282348931640215e-07,0.0,1.1491145e-06,False,POPDC2; popeye domain containing
hsa:54788,0.0,0.0,5.314192737e-08,1.3993465002746943e-07,0.0,6.094536e-07,False,DNAJB12; DnaJ heat shock protein family (Hsp40) member
hsa:479,0.0,0.0,7.3829852322580645e-09,1.5161232421571422e-08,0.0,5.7549336e-08,False,ATP12A; ATPase H+/K+ transporting non-gastric alpha2
hsa:10474,4.773403e-08,3.374351903345408e-05,4.3605477214516137e-07,8.322392717297678e-07,0.0,3.6014071e-06,False,TADA3; transcriptional adaptor
hsa:283162,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8B4; olfactory receptor family 8 subfamily B member
hsa:57187,2.6613503e-08,1.8813271056883052e-05,3.0717133933774195e-07,4.922941746091669e-07,0.0,1.565308e-06,False,THOC2; THO complex subunit
hsa:2784,0.0,0.0,6.876790212903227e-05,0.00024158604621649495,0.0,0.0013384192,False,GNB3; G protein subunit beta
hsa:6097,0.0,0.0,7.617031977419356e-07,1.8725316073310184e-06,0.0,6.567733e-06,False,RORC; RAR related orphan receptor
hsa:64332,0.0,0.0,2.830143471922516e-06,6.468767934584678e-06,0.0,2.8798568e-05,False,NFKBIZ; NFKB inhibitor
hsa:85007,7.953334e-06,0.005622267326023332,4.14717589693742e-05,7.633512565649695e-05,0.0,0.00032409237,False,PHYKPL; 5-phosphohydroxy-L-lysine
hsa:145957,0.0,0.0,4.864504850967741e-07,7.592469807686164e-07,0.0,2.6914072e-06,False,NRG4; neuregulin
hsa:5273,0.0,0.0,1.3335278434516127e-07,4.180233249991399e-07,0.0,2.1756887e-06,False,SERPINB10; serpin family B member
hsa:5033,6.8224317e-06,0.0048228245954383174,0.00022698672334516134,0.000389228021025759,0.0,0.001212341,False,P4HA1; prolyl 4-hydroxylase subunit alpha
hsa:63826,1.2932341e-05,0.009141962132269548,3.521615429032257e-05,4.663937058608544e-05,0.0,0.0001533993,False,SRR; serine
hsa:57573,0.0,0.0,5.2831202422580644e-08,1.3888260480114508e-07,0.0,4.918537e-07,False,ZNF471; zinc finger protein
hsa:27040,0.0,0.0,1.917889287419355e-06,8.879662332753287e-06,0.0,4.9442504e-05,False,LAT; linker for activation of T
hsa:4927,0.0,0.0,2.3311685677419356e-07,5.415896645562395e-07,0.0,2.1934504e-06,False,NUP88; nucleoporin
hsa:116442,0.0,0.0,1.3519960483870967e-07,3.0369535636490803e-07,0.0,1.1440198e-06,False,RAB39B; RAB39B
hsa:2878,9.421003e-05,0.06659772787772748,0.00028926556890322583,0.0004412436670217015,0.0,0.0015602602,False,GPX3; glutathione peroxidase
hsa:84749,1.862914e-07,0.00013169069114149398,5.730726630387095e-06,1.6233263271860637e-05,0.0,5.9890855e-05,False,USP30; ubiquitin specific peptidase
hsa:51700,4.953235e-06,0.0035014763995344818,4.3119886631612914e-05,6.330871586701864e-05,0.0,0.00028904597,False,CYB5R2; cytochrome b5 reductase
hsa:3978,0.0,0.0,4.570631538709678e-06,9.706610610819153e-06,0.0,3.3465607e-05,False,LIG1; DNA ligase
hsa:406979,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19A; microRNA
hsa:90233,5.7096905e-09,4.036220073224112e-06,5.889255303290323e-08,1.1214825784729508e-07,0.0,4.811733e-07,False,ZNF551; zinc finger protein
hsa:6037,1.2085056e-06,0.000854301045095833,5.073651559325807e-05,0.00014219291160099952,0.0,0.0007434583,False,RNASE3; ribonuclease A family member
hsa:3596,3.7049813e-07,0.00026190771450711675,1.2117849513225804e-05,3.129211965110927e-05,0.0,0.0001647331,False,IL13; interleukin
hsa:3625,2.4426106e-05,0.017266984847584984,0.0002664992009903226,0.00044930028303905684,0.0,0.001945778,False,INHBB; inhibin subunit beta
hsa:7596,2.2434278e-08,1.5858947729634398e-05,1.4072637115161292e-07,2.9984174865902107e-07,0.0,1.1704303e-06,False,ZNF45; zinc finger protein
hsa:390445,0.0,0.0,3.1626152874193555e-06,1.1500961718383861e-05,0.0,5.7142e-05,False,OR5AU1; olfactory receptor family 5 subfamily AU member
hsa:2331,0.0,0.0,1.220331082411613e-05,2.962248515181798e-05,0.0,0.00014426191,False,FMOD;
hsa:4650,0.0,0.0,2.0161884967741937e-08,5.6433945671098136e-08,0.0,2.1679598e-07,False,MYO9B; myosin
hsa:23395,0.0,0.0,8.127595935483871e-07,3.575423601246058e-06,0.0,1.9845365e-05,False,LARS2; leucyl-tRNA synthetase 2
hsa:9210,0.0,0.0,7.215621612903226e-09,4.017488087198868e-08,0.0,2.2368427e-07,False,BMP15; bone morphogenetic protein
hsa:2067,0.0,0.0,0.0004445032653548388,0.000984434285009386,0.0,0.003511473,False,ERCC1; ERCC excision repair 1
hsa:6150,0.0,0.0,8.80096232064516e-08,1.4899553549597233e-07,0.0,5.308648e-07,False,MRPL23; mitochondrial ribosomal protein
hsa:11015,1.7816036e-07,0.00012594280220352296,2.2104142665483875e-05,5.947883083451491e-05,0.0,0.00030314873,False,KDELR3; KDEL endoplasmic reticulum protein retention receptor
hsa:4803,4.484076e-05,0.03169824627282772,0.00013270823146129034,0.0002537430342738071,0.0,0.0011988004,False,NGF; nerve growth
hsa:3949,0.00023047735,0.16292604765415905,0.0008257865732580644,0.0012922634121562502,0.0,0.0054001044,False,LDLR; low density lipoprotein
hsa:1002,0.0,0.0,2.1939543810322585e-06,6.156662430910849e-06,0.0,2.8570705e-05,False,CDH4; cadherin
hsa:344,0.0,0.0,5.6269948475999996e-05,0.00010766818862894794,0.0,0.00050478696,False,APOC2; apolipoprotein
hsa:7177,1.8975744e-08,1.3414085901357e-05,2.391339661685484e-05,7.735086440276743e-05,0.0,0.00034631565,False,TPSAB1; tryptase alpha/beta
hsa:1728,0.00017174937,0.12141082861804771,0.0002529202163870967,0.00028824346704306946,0.0,0.0011945623,False,NQO1; NAD(P)H quinone dehydrogenase
hsa:610,6.5667355e-06,0.004642071166668906,2.9515145858064512e-05,5.678825436094037e-05,0.0,0.00025359023,False,HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel
hsa:3109,0.00022746735,0.16079825764165231,0.00044937352980645157,0.0006533352203987205,0.0,0.0029349867,False,HLA-DMB; major histocompatibility complex
hsa:252969,1.4549645e-08,1.0285245620105825e-05,6.574753624854837e-05,0.0001944972655290187,0.0,0.00077986013,False,NEIL2; nei like DNA glycosylase
hsa:6426,0.0,0.0,1.0600087713225806e-05,2.5110016982951224e-05,0.0,0.00010474399,False,SRSF1; serine and arginine rich splicing factor
hsa:4000,0.0001403813,0.09923652095771146,0.00035941892554387095,0.0005668373658394582,0.0,0.0019787988,False,LMNA; lamin
hsa:632,0.0,0.0,8.020634838709677e-07,1.524583766150696e-06,0.0,6.2059034e-06,False,BGLAP; bone gamma-carboxyglutamate
hsa:398,2.2446337e-05,0.01586747232091706,0.00021965983169870966,0.0005055352207254375,0.0,0.002312255,False,ARHGDIG; Rho GDP dissociation inhibitor
hsa:728819,0.0,0.0,1.4225887630967741e-05,3.843419306522763e-05,0.0,0.00016329694,False,C1GALT1C1L; C1GALT1 specific chaperone 1
hsa:950,0.0,0.0,2.941540654096774e-07,6.680943615256083e-07,0.0,2.6299867e-06,False,SCARB2; scavenger receptor class B member
hsa:57817,5.8478395e-06,0.004133878565728362,0.0002173628834163548,0.0004640702999486805,0.0,0.0015528591,False,HAMP; hepcidin antimicrobial
hsa:54578,0.0,0.0,8.620017741935483e-07,4.79942275905109e-06,0.0,2.6722055e-05,False,UGT1A6; UDP glucuronosyltransferase family 1 member
hsa:3452,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA21; interferon alpha
hsa:341208,0.0,0.0,2.2843963677419357e-07,6.614591455212996e-07,0.0,2.5457527e-06,False,HEPHL1; hephaestin like
hsa:6839,0.0,0.0,2.340952251903226e-05,4.519514026663131e-05,0.0,0.00016253788,False,SUV39H1; SUV39H1 histone lysine
hsa:8200,8.341019e-06,0.0058963245589132565,7.943534877096773e-05,0.0001709255919417473,0.0,0.0007731338,False,GDF5; growth differentiation factor
hsa:1054,0.0,0.0,7.865707290322581e-08,2.227675109779989e-07,0.0,1.022835e-06,False,CEBPG; CCAAT enhancer binding protein
hsa:56288,4.5065292e-07,0.00031856969511062986,1.4013138940645164e-05,3.786129370460749e-05,0.0,0.00016725091,False,PARD3; par-3 family cell polarity
hsa:256144,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C3; olfactory receptor family 4 subfamily C member
hsa:9275,0.0,0.0,5.544399277322582e-06,1.878475193983757e-05,0.0,8.959336e-05,False,BCL7B; BAF chromatin remodeling complex subunit
hsa:10482,0.0,0.0,2.537400279032258e-05,8.754581318076759e-05,0.0,0.00047194687,False,NXF1; nuclear RNA export factor
hsa:7841,0.0,0.0,1.161133884419355e-05,2.4071371534779075e-05,0.0,0.00011230169,False,MOGS; mannosyl-oligosaccharide
hsa:9572,0.0,0.0,0.0004667496859354839,0.000993218467796053,0.0,0.0034646823,False,NR1D1; nuclear receptor subfamily 1 group D member
hsa:7638,1.0464661e-09,7.397541913644095e-07,3.4177260260000005e-08,6.129329715758737e-08,0.0,1.751465e-07,False,ZNF221; zinc finger protein
hsa:90594,9.128413e-09,6.452938874231438e-06,4.836415287096775e-08,8.18090064288148e-08,0.0,2.9500296e-07,False,ZNF439; zinc finger protein
hsa:6422,4.2002338e-07,0.0002969174594628972,1.7040764826709675e-05,4.825897342343071e-05,0.0,0.0002482036,False,SFRP1; secreted frizzled related protein
hsa:10855,0.0,0.0,3.003341435483871e-07,9.753412321054584e-07,0.0,4.811791e-06,False,HPSE;
hsa:5645,0.0,0.0,1.957923924193549e-06,4.971726904546567e-06,0.0,2.3176164e-05,False,PRSS2; serine protease
hsa:3605,0.0,0.0,1.8859936870967744e-07,6.187338266852127e-07,0.0,3.0089238e-06,False,IL17A; interleukin
hsa:475,0.0,0.0,1.145909662632258e-05,2.2174472489710814e-05,0.0,8.697173e-05,False,ATOX1; antioxidant 1 copper
hsa:780851,0.0,0.0,5.451247823635485e-06,1.738264119559416e-05,0.0,8.466003e-05,False,SNORD3A; small nucleolar RNA
hsa:4640,0.0,0.0,4.10691982e-08,1.6683912554005842e-07,0.0,9.087562e-07,False,MYO1A; myosin
hsa:1592,0.0,0.0,1.4269881969999998e-05,3.5172310316761824e-05,0.0,0.00017019562,False,CYP26A1; cytochrome P450 family 26 subfamily A member
hsa:5591,0.0,0.0,0.00016268725945161287,0.00029766391166355843,0.0,0.0009718721,False,PRKDC; protein kinase
hsa:10859,2.865543e-07,0.0002025672350766971,6.988481205645162e-06,1.1795760208527342e-05,0.0,4.4110366e-05,False,LILRB1; leukocyte immunoglobulin like receptor
hsa:8519,1.5216993e-06,0.0010756998579994975,2.605272666854838e-05,3.869548314817994e-05,0.0,0.00012578581,False,IFITM1; interferon induced transmembrane protein
hsa:55586,0.0,0.0,6.369891788387096e-07,1.9696015942431724e-06,0.0,9.192726e-06,False,MIOX; myo-inositol
hsa:1514,0.0,0.0,1.5813964099999998e-05,4.918571200327267e-05,0.0,0.00025927345,False,CTSL; cathepsin
hsa:23595,0.0,0.0,7.768397964019354e-07,1.6142040309955406e-06,0.0,6.8177687e-06,False,ORC3; origin recognition complex subunit
hsa:9681,0.0,0.0,5.713615231290321e-07,1.5510750152014604e-06,0.0,7.3269475e-06,False,DEPDC5; DEP domain containing 5
hsa:10797,0.0,0.0,2.0180463791935483e-05,4.224692152725693e-05,0.0,0.00019323433,False,MTHFD2; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:60482,2.0556476e-07,0.0001453151638708783,2.7048522802741937e-05,6.507870093696064e-05,0.0,0.00023731063,False,SLC5A7; solute carrier family 5 member
hsa:786,0.0,0.0,1.909368530967742e-05,4.25632486526863e-05,0.0,0.00015548812,False,CACNG1; calcium voltage-gated channel auxiliary subunit gamma
hsa:2899,6.1278647e-06,0.00433183033443607,2.2916860741935482e-05,3.302883813967153e-05,0.0,0.00013724012,False,GRIK3; glutamate ionotropic receptor kainate type subunit
hsa:3615,0.0,0.0,6.741032981903227e-05,0.00014068369191478288,0.0,0.00043422036,False,IMPDH2; inosine monophosphate dehydrogenase
hsa:9570,0.0,0.0,8.944357856774195e-06,2.4229917475940247e-05,0.0,0.000104572835,False,GOSR2; golgi SNAP receptor complex member
hsa:9968,4.859863e-08,3.435471080913957e-05,9.70317125464516e-06,2.1082339253700767e-05,0.0,9.259618e-05,False,MED12; mediator complex subunit
hsa:6536,1.1503009e-07,8.131557363446866e-05,4.830831066225806e-05,0.00012861519265634119,0.0,0.00062285876,False,SLC6A9; solute carrier family 6 member
hsa:8556,0.0,0.0,6.908380279512904e-07,1.1879357103594056e-06,0.0,5.613589e-06,False,CDC14A; cell division cycle
hsa:9915,0.0,0.0,2.4515771032258063e-06,6.0886450967099234e-06,0.0,2.7383356e-05,False,ARNT2; aryl hydrocarbon receptor nuclear translocator
hsa:23362,1.7586418e-08,1.2431961653212174e-05,2.5467910348709676e-07,6.358898501861089e-07,0.0,2.5720256e-06,False,PSD3; pleckstrin and Sec7 domain containing
hsa:8317,4.6280174e-08,3.271577807783183e-05,1.084717365246774e-06,2.1524443092680284e-06,0.0,7.4304767e-06,False,CDC7; cell division cycle
hsa:6547,0.0,0.0,0.0,0.0,0.0,0.0,False,SLC8A3; solute carrier family 8 member
hsa:219983,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D6; olfactory receptor family 4 subfamily D member
hsa:8387,4.0931677e-06,0.0028934888211213147,8.025614660967741e-05,0.00018420131589745988,0.0,0.00072323845,False,OR1E1; olfactory receptor family 1 subfamily E member
hsa:163081,0.0,0.0,3.37757229e-08,7.541403972838238e-08,0.0,3.1894132e-07,False,ZNF567; zinc finger protein
hsa:3080,0.0,0.0,9.865065483870968e-09,5.492636003808129e-08,0.0,3.0581703e-07,False,CFHR2; complement factor H related
hsa:8443,0.0,0.0,3.392481409677419e-06,9.48925385942649e-06,0.0,4.633874e-05,False,GNPAT; glyceronephosphate
hsa:84197,1.7547667e-06,0.0012404568300795346,7.504818016129034e-06,1.722587839310251e-05,0.0,7.5456075e-05,False,POMK; protein O-mannose
hsa:56479,1.030427e-07,7.284160396070683e-05,2.428996494645161e-06,6.506188345818429e-06,0.0,3.0003914e-05,False,KCNQ5; potassium voltage-gated channel subfamily Q member
hsa:157506,0.0002913146,0.2059323243778718,0.0007953222933032257,0.0012027402691539616,0.0,0.0055620144,False,RDH10; retinol dehydrogenase
hsa:5330,4.719984e-06,0.0033365896393327517,0.0006662871397290322,0.000983325594839183,0.0,0.0028692372,False,PLCB2; phospholipase C beta
hsa:7582,0.0,0.0,4.348305045161291e-08,6.992984607126253e-08,0.0,2.0928088e-07,False,ZNF33B; zinc finger protein
hsa:1365,0.0,0.0,4.2304309258064516e-07,1.1871377668725932e-06,0.0,5.260666e-06,False,CLDN3; claudin
hsa:10164,0.0,0.0,1.1686252300322581e-06,3.4599125844920012e-06,0.0,1.5557876e-05,False,CHST4; carbohydrate sulfotransferase
hsa:6827,7.883743e-07,0.0005573072962315572,2.247335521064516e-05,4.034150017213238e-05,0.0,0.00013679152,False,SUPT4H1; SPT4 homolog
hsa:3782,4.4982344e-06,0.0031798332990811353,3.851040909387097e-05,8.008389841175725e-05,0.0,0.00030321,False,KCNN3; potassium calcium-activated channel subfamily N member
hsa:219487,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5M11; olfactory receptor family 5 subfamily M member
hsa:8110,0.0,0.0,4.489185312258065e-07,1.0531525167038086e-06,0.0,4.2767056e-06,False,DPF3; double PHD fingers
hsa:3295,0.0,0.0,0.00042754712716129036,0.0011738340591798916,0.0,0.0047282926,False,HSD17B4; hydroxysteroid 17-beta dehydrogenase
hsa:3575,3.8824233e-05,0.027445121335758913,0.0002781353272870968,0.0004119801651770322,0.0,0.001525081,False,IL7R; interleukin 7
hsa:8310,5.5209985e-05,0.03902832381184271,0.00024142072230645166,0.00042643808778338783,0.0,0.0017314845,False,ACOX3; acyl-CoA oxidase 3
hsa:55236,0.0,0.0,4.4512251592419354e-07,9.828735477319578e-07,0.0,3.909797e-06,False,UBA6; ubiquitin like modifier activating enzyme
hsa:3623,9.4520885e-08,6.681747344727491e-05,2.7762097577322588e-05,5.0759426184149156e-05,0.0,0.00018495659,False,INHA; inhibin subunit
hsa:867,0.0,0.0,3.7429114838709676e-06,1.2070366009441421e-05,0.0,5.260319e-05,False,CBL; Cbl
hsa:11343,0.00031334697,0.22150716053662692,0.0007261043889225804,0.0009492462475760724,0.0,0.003865276,False,MGLL; monoglyceride
hsa:51068,0.0,0.0,2.5682766326774192e-06,6.050619661101678e-06,0.0,2.2831697e-05,False,NMD3; NMD3 ribosome export
hsa:196528,0.0,0.0,1.651301952580645e-06,4.621436207149096e-06,0.0,1.9436337e-05,False,ARID2; AT-rich interaction domain
hsa:319100,0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR6; trace amine associated receptor
hsa:4161,2.3518782e-08,1.6625591178047553e-05,2.4816180074193557e-06,5.980074093053179e-06,0.0,2.5233061e-05,False,MC5R; melanocortin 5
hsa:5025,1.748809e-06,0.0012362452903594311,1.8993275678709674e-05,3.438538922379331e-05,0.0,0.00013155007,False,P2RX4; purinergic receptor P2X
hsa:51422,2.8022469e-05,0.01980927895813274,0.0004138091516451613,0.0009285252536594133,0.0,0.004117995,False,PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma
hsa:10121,1.10674236e-07,7.823639003409075e-05,1.4595843023225806e-06,2.6227397386209804e-06,0.0,1.0320549e-05,False,ACTR1A; actin related protein
hsa:8174,0.0,0.0,6.82293811935484e-07,2.3106313887000324e-06,0.0,1.1495408e-05,False,MADCAM1; mucosal vascular addressin cell adhesion molecule
hsa:27341,0.0,0.0,5.8831369096774184e-08,2.1461107305474447e-07,0.0,9.529903e-07,False,RRP7A; ribosomal RNA processing 7 homolog
hsa:5903,0.0,0.0,1.7320234803193549e-06,4.359331601155862e-06,0.0,1.7898892e-05,False,RANBP2; RAN binding protein
hsa:259293,0.0,0.0,2.6655623324838706e-05,7.775157405212366e-05,0.0,0.00031256326,False,TAS2R30; taste 2 receptor member
hsa:9955,0.0,0.0,1.3689331674193548e-05,4.962904615081898e-05,0.0,0.00027593193,False,HS3ST3A1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:7157,0.00016025366,0.11328443096865443,0.0005651501125483871,0.0007831608689799019,0.0,0.0028538462,False,TP53; tumor protein
hsa:3802,0.0,0.0,3.998560761290323e-07,1.2995640780768839e-06,0.0,6.4694573e-06,False,KIR2DL1; killer cell immunoglobulin like receptor
hsa:5634,3.59416e-06,0.0025407367944688375,1.4232587716129034e-05,2.2789537824549e-05,0.0,9.056812e-05,False,PRPS2; phosphoribosyl pyrophosphate synthetase
hsa:84153,2.1302765e-06,0.0015059073290956146,1.916673144635484e-05,6.081261282486489e-05,0.0,0.00026615916,False,RNASEH2C; ribonuclease H2 subunit
hsa:6728,5.1134575e-06,0.003614738803281611,0.0001912594199087097,0.000512186016095781,0.0,0.0023823439,False,SRP19; signal recognition particle
hsa:5621,1.5845467e-06,0.001120127123790865,0.00013362135426129033,0.000500471597812059,0.0,0.0025693593,False,PRNP; prion
hsa:29082,0.0,0.0,1.268618498987097e-05,3.367869942238038e-05,0.0,0.0001365026,False,CHMP4A; charged multivesicular body protein
hsa:171389,5.7992866e-10,4.0995561817754593e-07,2.7810707987419353e-08,1.105805084091094e-07,0.0,6.1789154e-07,False,NLRP6; NLR family pyrin domain containing
hsa:3682,2.981052e-08,2.107326469223662e-05,1.5878968240645162e-06,4.370760641583079e-06,0.0,1.541164e-05,False,ITGAE; integrin subunit alpha
hsa:121274,0.0,0.0,9.439663867741934e-08,2.2677689462335556e-07,0.0,8.3015135e-07,False,ZNF641; zinc finger protein
hsa:90333,9.880449e-09,6.984558372518985e-06,2.018585478064516e-08,2.793296838269987e-08,0.0,9.331995e-08,False,ZNF468; zinc finger protein
hsa:2908,3.1451111e-06,0.00222330099229371,2.7938081535032255e-05,4.9854389622795596e-05,0.0,0.00016747248,False,NR3C1; nuclear receptor subfamily 3 group C member
hsa:11346,1.8970395e-08,1.341030465591617e-05,4.70886732660742e-05,0.00013564851238975496,0.0,0.00052293297,False,SYNPO;
hsa:7137,0.0,0.0,0.0,0.0,0.0,0.0,False,TNNI3; troponin I3
hsa:5553,0.0,0.0,1.0245638311612902e-05,2.6372375352801904e-05,0.0,0.0001395645,False,PRG2; proteoglycan 2
hsa:3763,0.0,0.0,6.946985248064517e-06,2.470577676192354e-05,0.0,0.00012373853,False,KCNJ6; potassium inwardly rectifying channel subfamily J member
hsa:57506,1.7780561e-06,0.0012569202695204896,5.458628777419355e-05,0.00012143928168019276,0.0,0.0004786724,False,MAVS; mitochondrial antiviral signaling
hsa:2081,4.4539394e-07,0.00031485208543622034,2.533415223032258e-06,5.178369401826591e-06,0.0,2.3485683e-05,False,ERN1; endoplasmic reticulum to nucleus signaling
hsa:490,0.0,0.0,0.00035434456612903225,0.0005026960603263416,0.0,0.0015411483,False,ATP2B1; ATPase plasma membrane Ca2+ transporting
hsa:8638,3.032644e-08,2.143797214182216e-05,1.8239063416451612e-07,3.2446689830736784e-07,0.0,1.2690954e-06,False,OASL; 2'-5'-oligoadenylate synthetase
hsa:10652,3.6898147e-08,2.608355769654661e-05,4.3582438250548384e-05,8.553636540471258e-05,0.0,0.00027495195,False,YKT6; YKT6 v-SNARE
hsa:8938,1.2927186e-10,9.138318026783013e-08,9.101159215993548e-07,2.5865416060299584e-06,0.0,1.2078764e-05,False,BAIAP3; BAI1 associated protein
hsa:9825,0.0,0.0,7.456198935483872e-07,1.520111576455047e-06,0.0,5.2282467e-06,False,SPATA2; spermatogenesis associated
hsa:5452,7.207911e-07,0.0005095322603600471,1.1780695540967745e-06,1.8466845192074838e-06,0.0,7.2833504e-06,False,POU2F2; POU class 2 homeobox
hsa:831,0.0,0.0,1.1450732320129033e-05,3.5703318247056726e-05,0.0,0.00015348221,False,CAST;
hsa:84572,0.0,0.0,5.164149406451612e-07,8.030749341572785e-07,0.0,2.9403604e-06,False,GNPTG; N-acetylglucosamine-1-phosphate transferase subunit
hsa:3371,0.0,0.0,2.780948648709677e-06,4.732835545056103e-06,0.0,1.8447241e-05,False,TNC; tenascin
hsa:60,0.0002637647,0.18645710774479562,0.0004515350242580645,0.0006807441511436887,0.0,0.0027803178,False,ACTB; actin
hsa:3195,0.0,0.0,1.2784546981290323e-09,4.835779200520335e-09,0.0,2.4776009e-08,False,TLX1; T cell leukemia homeobox
hsa:10401,6.19699e-08,4.380695491562825e-05,0.00010313618560064517,0.00027928661532750353,0.0,0.0011032232,False,PIAS3; protein inhibitor of activated STAT
hsa:6448,0.0,0.0,1.2400862361290323e-05,3.6165981741713915e-05,0.0,0.00017867777,False,SGSH; N-sulfoglucosamine
hsa:2251,0.0,0.0,2.6838103225806453e-07,1.4942823470659875e-06,0.0,8.319812e-06,False,FGF6; fibroblast growth factor
hsa:51512,0.0,0.0,3.165133949054839e-06,9.63702806543663e-06,0.0,5.0131475e-05,False,GTSE1; G2 and S-phase expressed
hsa:29978,7.008002e-09,4.954005535955884e-06,1.6390411964696775e-07,2.73075062334603e-07,0.0,9.297047e-07,False,UBQLN2; ubiquilin
hsa:3422,0.0,0.0,0.00017385191890377418,0.000532745666599053,0.0,0.002398345,False,IDI1; isopentenyl-diphosphate delta isomerase
hsa:121601,4.4512345e-11,3.146608741669569e-08,5.1002465203014515e-06,1.4998020874164521e-05,0.0,7.779673e-05,False,ANO4; anoctamin
hsa:1960,2.1878894e-07,0.00015466342902954651,4.5613183318387094e-05,9.072391833045568e-05,0.0,0.0003436367,False,EGR3; early growth response
hsa:400713,0.0,0.0,3.2181182374193554e-08,4.946810842801678e-08,0.0,1.761626e-07,False,ZNF880; zinc finger protein
hsa:390079,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52E8; olfactory receptor family 52 subfamily E member
hsa:245973,0.0,0.0,2.1473673811935483e-05,5.61136166829825e-05,0.0,0.00022435837,False,ATP6V1C2; ATPase H+ transporting V1 subunit
hsa:406969,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR194-1; microRNA
hsa:272,0.0,0.0,1.320786399289032e-07,3.900678093024905e-07,0.0,1.866583e-06,False,AMPD3; adenosine monophosphate deaminase
hsa:4131,6.3803856e-07,0.0004510339121469031,3.9270136438258066e-05,6.999386711855665e-05,0.0,0.00026704324,False,MAP1B; microtubule associated protein
hsa:3002,3.746354e-05,0.026483237955198174,0.00014021105728538713,0.0002549189331938884,0.0,0.0012246139,False,GZMB; granzyme
hsa:148789,0.0,0.0,3.288632025870968e-05,7.809667484560823e-05,0.0,0.0002786102,False,B3GALNT2; beta-1
hsa:23636,1.760774e-08,1.2447034323858906e-05,1.569492022258065e-07,3.856567073697253e-07,0.0,1.5087568e-06,False,NUP62; nucleoporin
hsa:8693,1.9593715e-05,0.013850933915250288,7.678870915806453e-05,0.00010953777479879928,0.0,0.00039456575,False,GALNT4; polypeptide N-acetylgalactosaminyltransferase
hsa:162514,1.4377132e-06,0.0010163294976109954,3.551059089570968e-05,7.849259981503956e-05,0.0,0.00036325393,False,TRPV3; transient receptor potential cation channel subfamily V member
hsa:22865,0.0,0.0,1.674836349096774e-08,6.489611794143369e-08,0.0,3.5188518e-07,False,SLITRK3; SLIT and NTRK like family member
hsa:50632,0.0,0.0,1.3545891838709677e-06,2.6409685737338613e-06,0.0,9.5916175e-06,False,CALY; calcyon neuron specific vesicular
hsa:6949,0.0,0.0,3.8958830124193544e-07,1.1813323603905778e-06,0.0,5.013726e-06,False,TCOF1; treacle ribosome biogenesis factor
hsa:138050,0.0,0.0,5.414414390322581e-06,1.6892866909667895e-05,0.0,8.728087e-05,False,HGSNAT; heparan-alpha-glucosaminide
hsa:6335,0.0,0.0,6.321006880322581e-05,0.00014307610268074253,0.0,0.00058189215,False,SCN9A; sodium voltage-gated channel alpha subunit
hsa:2273,0.0,0.0,8.602646711096775e-05,0.00024086700883134285,0.0,0.0010295527,False,FHL1; four and a half LIM domains
hsa:5683,0.0,0.0,5.3362166032258055e-06,1.4242004684946763e-05,0.0,6.915153e-05,False,PSMA2; proteasome 20S subunit alpha
hsa:706,6.1200066e-05,0.043262753886894656,0.0002259858993451613,0.0003550387705106783,0.0,0.0014212173,False,TSPO; translocator
hsa:56624,0.0,0.0,3.998099243967742e-06,1.3713134375347474e-05,0.0,7.3334246e-05,False,ASAH2; N-acylsphingosine amidohydrolase
hsa:266722,0.0,0.0,1.9016527322580645e-06,5.1564435202753185e-06,0.0,2.534859e-05,False,HS6ST3; heparan sulfate 6-O-sulfotransferase
hsa:79621,4.0605082e-07,0.0002870401592578636,3.6595714093548386e-06,6.68584125760751e-06,0.0,2.463924e-05,False,RNASEH2B; ribonuclease H2 subunit
hsa:390167,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5M10; olfactory receptor family 5 subfamily M member
hsa:9817,7.817638e-07,0.0005526342876343227,2.4373100467741934e-06,4.973827514519376e-06,0.0,2.598123e-05,False,KEAP1; kelch like ECH associated protein
hsa:23456,0.0,0.0,0.00023533928191935485,0.0005252865396600038,0.0,0.0019889188,False,ABCB10; ATP binding cassette subfamily B member
hsa:55240,1.3363479e-06,0.0009446736594200488,4.832592692191936e-05,0.00012197914250030231,0.0,0.000601271,False,STEAP3; STEAP3
hsa:7525,2.2067386e-08,1.559958921359831e-05,1.288551798733549e-05,4.4609304987704314e-05,0.0,0.00022562235,False,YES1; YES proto-oncogene 1
hsa:8887,0.0,0.0,2.599635890967742e-06,6.281826137277602e-06,0.0,2.6120122e-05,False,TAX1BP1; Tax1 binding protein
hsa:2181,0.00011879469,0.08397679565476196,0.00025151636459677424,0.00042404292696738937,0.0,0.0017485772,False,ACSL3; acyl-CoA synthetase long chain family member
hsa:10914,6.016092e-08,4.252817432532113e-05,7.869679333870967e-07,1.725303996677942e-06,0.0,6.1885457e-06,False,PAPOLA; poly(A) polymerase
hsa:28972,8.097884e-06,0.0057244507301123185,0.0002329988144887097,0.000624212833217076,0.0,0.002916702,False,SPCS1; signal peptidase complex subunit
hsa:1716,0.0,0.0,1.6419515137329034e-05,5.372330581950821e-05,0.0,0.0002597087,False,DGUOK; deoxyguanosine
hsa:177,0.0,0.0,1.1219774253225805e-05,3.3226819913028134e-05,0.0,0.00015487747,False,AGER; advanced glycosylation end-product specific
hsa:440567,1.188877e-06,0.0008404254507305539,3.071887535935484e-05,7.039189225720597e-05,0.0,0.00024625513,False,UQCRHL; ubiquinol-cytochrome c reductase hinge protein
hsa:127074,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR2T4; olfactory receptor family 2 subfamily T member
hsa:642517,0.0,0.0,7.887480625806452e-08,1.4540046445375137e-07,0.0,5.102636e-07,False,AGAP9; ArfGAP with GTPase domain
hsa:93166,1.4790947e-09,1.0455823688410774e-06,4.303308884674194e-06,9.809485207735803e-06,0.0,3.9001887e-05,False,PRDM6; PR/SET domain
hsa:3945,0.0,0.0,2.3083650725806453e-05,6.900680372528969e-05,0.0,0.00026447733,False,LDHB; lactate dehydrogenase
hsa:5710,0.0,0.0,5.044700753548387e-06,8.656640855461795e-06,0.0,3.0753992e-05,False,PSMD4; proteasome 26S subunit ubiquitin receptor
hsa:2995,3.5207015e-06,0.0024888084680124503,0.00010138651347838711,0.00022454349160002843,0.0,0.0010153226,False,GYPC; glycophorin C (Gerbich blood
hsa:6872,2.3152946e-07,0.00016366979155783297,4.60095490335484e-06,1.1272171351695353e-05,0.0,5.5498665e-05,False,TAF1; TATA-box binding protein associated factor
hsa:149461,0.0,0.0,7.829571801096774e-06,1.8164830324966292e-05,0.0,8.1754835e-05,False,CLDN19; claudin
hsa:89780,0.0,0.0,1.5600467322580644e-07,8.041468672101797e-07,0.0,4.474754e-06,False,WNT3A; Wnt family member
hsa:6483,0.0,0.0,5.869941916129032e-05,0.00014128299029673872,0.0,0.0005805686,False,ST3GAL2; ST3 beta-galactoside alpha-2
hsa:22876,0.0,0.0,2.884436228387097e-06,6.7758642957204426e-06,0.0,3.116228e-05,False,INPP5F; inositol polyphosphate-5-phosphatase
hsa:11284,4.478796e-08,3.1660921584236237e-05,2.6975053785322582e-05,7.335622573848282e-05,0.0,0.00034531002,False,PNKP; polynucleotide kinase
hsa:652,0.000114010036,0.08059449034097446,0.00035248340192064516,0.0006011306307895825,0.0,0.0028667662,False,BMP4; bone morphogenetic protein
hsa:29071,1.3256924e-05,0.00937141212085077,0.00022756035240816127,0.0006823200189498549,0.0,0.0034532982,False,C1GALT1C1; C1GALT1 specific chaperone
hsa:64393,5.0174745e-06,0.003546887750533959,6.572736556261547e-05,0.0001431821622599113,0.0,0.0005268291,False,ZMAT3; zinc finger matrin-type
hsa:29882,0.0,0.0,5.9312480158064524e-05,0.00014832894265138358,0.0,0.0006419933,False,ANAPC2; anaphase promoting complex subunit
hsa:257364,5.2710615e-08,3.726150171099256e-05,1.396104433548387e-07,1.7825465250983221e-07,0.0,5.6217806e-07,False,SNX33; sorting nexin
hsa:858,0.0,0.0,9.623743979032258e-06,2.8200839200364813e-05,0.0,0.00012636914,False,CAV2; caveolin
hsa:23408,0.0,0.0,4.6596216806451616e-05,0.00017642021339592915,0.0,0.00096568215,False,SIRT5; sirtuin
hsa:388646,0.0,0.0,2.564052775249677e-08,6.233216310568994e-08,0.0,2.996234e-07,False,GBP7; guanylate binding protein
hsa:3340,5.128964e-05,0.03625700456380925,0.0005075880952064517,0.001082490396011525,0.0,0.0047201337,False,NDST1; N-deacetylase and N-sulfotransferase
hsa:84991,0.0,0.0,3.333211747419356e-07,5.665909281688753e-07,0.0,1.821644e-06,False,RBM17; RNA binding motif protein
hsa:4790,0.00040740773,0.28799936840931556,0.0006461780224516131,0.0006788785741803112,0.0,0.003023923,False,NFKB1; nuclear factor kappa B subunit
hsa:7428,0.0,0.0,1.1764085683870966e-05,3.6390303932591106e-05,0.0,0.0001390346,False,VHL; von Hippel-Lindau tumor
hsa:10277,0.0,0.0,1.0607936935483869e-06,1.69801763244113e-06,0.0,6.141053e-06,False,UBE4B; ubiquitination factor
hsa:221264,0.0,0.0,9.009484982587096e-06,2.773710213180109e-05,0.0,0.00010140664,False,AK9; adenylate kinase
hsa:970,0.0,0.0,4.174408371977419e-06,1.7689270665680145e-05,0.0,9.506545e-05,False,CD70; CD70
hsa:997,0.0,0.0,4.772250144516129e-07,1.0580777627461362e-06,0.0,4.1464414e-06,False,CDC34; cell division cycle 34
hsa:10535,2.0359623e-08,1.439235962717687e-05,1.3505667188064518e-05,3.532790049150689e-05,0.0,0.00012674788,False,RNASEH2A; ribonuclease H2 subunit
hsa:84868,1.4127713e-08,9.986978943841043e-06,2.675661942687097e-05,4.764285050484537e-05,0.0,0.00016327704,False,HAVCR2; hepatitis A virus cellular receptor
hsa:1892,6.8349136e-06,0.004831648137683203,0.00011226379366451613,0.0001617429390359005,0.0,0.0005739382,False,ECHS1; enoyl-CoA hydratase
hsa:221074,0.0,0.0,7.152068180516128e-10,1.78084139271553e-09,0.0,7.823088e-09,False,SLC39A12; solute carrier family 39 member
hsa:433,4.752171e-07,0.00033593428543269557,3.591606541267742e-05,7.022028930424377e-05,0.0,0.00030177247,False,ASGR2; asialoglycoprotein receptor
hsa:7849,7.119566e-05,0.050328709063729285,0.00016993957236290322,0.00020404738806822,0.0,0.00068306905,False,PAX8; paired box
hsa:6822,0.0,0.0,5.5113325806451605e-06,2.7542692113977283e-05,0.0,0.00015289613,False,SULT2A1; sulfotransferase family 2A member
hsa:29117,0.0,0.0,3.9667768419354845e-07,1.0875378253323396e-06,0.0,4.4016433e-06,False,BRD7; bromodomain containing
hsa:64928,0.0,0.0,7.09288852580645e-08,1.4834916396702907e-07,0.0,5.9390237e-07,False,MRPL14; mitochondrial ribosomal protein
hsa:92595,4.869102e-08,3.442002194510486e-05,1.76674088583871e-07,3.0307317103469144e-07,0.0,1.202265e-06,False,ZNF764; zinc finger protein
hsa:3786,0.0,0.0,9.548846477741935e-07,1.6006053108557355e-06,0.0,5.7609427e-06,False,KCNQ3; potassium voltage-gated channel subfamily Q member
hsa:2993,0.0,0.0,0.0,0.0,0.0,0.0,False,GYPA; glycophorin A (MNS blood
hsa:10628,6.6851334e-07,0.0004725767468702719,1.1937845700967742e-06,1.2604273917664945e-06,0.0,3.9623346e-06,False,TXNIP; thioredoxin interacting
hsa:81849,0.0,0.0,2.0515901867096777e-05,4.5620026374455016e-05,0.0,0.00019003017,False,ST6GALNAC5; ST6 N-acetylgalactosaminide alpha-2
hsa:54798,0.0,0.0,0.0,0.0,0.0,0.0,False,DCHS2; dachsous cadherin-related
hsa:1355,0.0,0.0,1.968703881935484e-05,4.1271164775292225e-05,0.0,0.00019466235,False,COX15; cytochrome c oxidase assembly homolog
hsa:5836,0.00060812035,0.4298845206418934,0.0008536157509258066,0.0007834906187941598,0.0,0.0024643,True,PYGL; glycogen phosphorylase
hsa:23198,0.0,0.0,5.803817803225807e-07,1.3702939429064731e-06,0.0,5.273512e-06,False,PSME4; proteasome activator subunit
hsa:4543,0.0,0.0,1.3521785161290321e-08,4.4734545806330705e-08,0.0,2.0827079e-07,False,MTNR1A; melatonin receptor
hsa:23312,4.6457708e-07,0.0003284127810177879,1.9028481209677416e-06,5.033027670386161e-06,0.0,2.2246379e-05,False,DMXL2; Dmx like
hsa:262,0.0,0.0,4.6149596325935485e-05,0.00010718093289771787,0.0,0.00042456522,False,AMD1; adenosylmethionine decarboxylase
hsa:8986,5.8243956e-09,4.117305909158858e-06,1.7593101643741934e-06,2.254457257110771e-06,0.0,7.428166e-06,False,RPS6KA4; ribosomal protein S6 kinase
hsa:85569,0.0,0.0,8.208249838709677e-09,3.267902219360642e-08,0.0,1.5682794e-07,False,GALP; galanin like
hsa:51263,0.0,0.0,2.8448055854838712e-08,6.42596638850447e-08,0.0,3.017985e-07,False,MRPL30; mitochondrial ribosomal protein
hsa:345,0.0,0.0,1.8281905483870969e-07,1.0178934183772355e-06,0.0,5.6673907e-06,False,APOC3; apolipoprotein
hsa:23308,1.7196297e-06,0.001215618239491678,0.0002460627605725807,0.0007407839378937436,0.0,0.0029224793,False,ICOSLG; inducible T cell costimulator
hsa:10254,0.0,0.0,1.4931202580645161e-06,5.522188978536797e-06,0.0,2.9188483e-05,False,STAM2; signal transducing adaptor molecule
hsa:79088,0.0,0.0,1.1898535503225806e-08,2.2433103126027984e-08,0.0,8.947973e-08,False,ZNF426; zinc finger protein
hsa:1991,1.987366e-07,0.00014048828990018128,1.1046972305161288e-05,4.038969308056983e-05,0.0,0.0002128237,False,ELANE; elastase
hsa:905,0.0,0.0,2.5923858441935486e-05,7.589197345769444e-05,0.0,0.0003158023,False,CCNT2; cyclin
hsa:64764,0.001662497,1.1752307350240554,0.0019803785819354834,0.0017496085876918268,0.0,0.0074485377,True,CREB3L2; cAMP responsive element binding protein 3 like
hsa:27121,0.0,0.0,2.4787311972580646e-08,6.288021002163114e-08,0.0,3.153698e-07,False,DKK4; dickkopf WNT signaling pathway inhibitor
hsa:64506,0.0,0.0,2.3803920034193543e-05,7.776340168371469e-05,0.0,0.00039298402,False,CPEB1; cytoplasmic polyadenylation element binding protein
hsa:126014,0.0,0.0,7.095692402580646e-07,1.767937447343689e-06,0.0,8.032222e-06,False,OSCAR; osteoclast associated Ig-like
hsa:128869,1.9145546e-06,0.0013534120120527653,2.7080395063225804e-05,6.27575104835029e-05,0.0,0.0002856915,False,PIGU; phosphatidylinositol glycan anchor biosynthesis class
hsa:10560,3.0554788e-06,0.0021599392937096543,0.00014730452051612907,0.00031318406412386,0.0,0.0013035322,False,SLC19A2; solute carrier family 19 member
hsa:29126,5.941082e-07,0.000419979233989486,4.103473958064516e-06,1.033954590667803e-05,0.0,5.3281005e-05,False,CD274; CD274
hsa:144245,0.0,0.0,1.2369914654677418e-05,3.380921980595606e-05,0.0,0.00014215843,False,ALG10B; ALG10 alpha-1
hsa:2324,0.0,0.0,1.3181979815806452e-05,4.903394085290126e-05,0.0,0.00027087255,False,FLT4; fms related receptor tyrosine kinase
hsa:125958,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7D4; olfactory receptor family 7 subfamily D member
hsa:64902,0.0,0.0,2.620540806451613e-08,1.0546412716447878e-07,0.0,5.179834e-07,False,AGXT2; alanine--glyoxylate aminotransferase
hsa:780853,-0.0,0.0,1.426384371612903e-07,7.249807697307886e-07,0.0,4.037728e-06,False,SNORD3C; small nucleolar RNA
hsa:7769,0.0,0.0,3.558144770967742e-08,7.121242596084726e-08,0.0,2.5760255e-07,False,ZNF226; zinc finger protein
hsa:79317,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4K5; olfactory receptor family 4 subfamily K member
hsa:84693,4.569252e-06,0.0032300361362878464,0.0001086086103787097,0.0003462673002171324,0.0,0.001800222,False,MCEE; methylmalonyl-CoA
hsa:4001,0.0,0.0,1.1714633711935482e-06,2.662214360725897e-06,0.0,1.1827183e-05,False,LMNB1; lamin
hsa:51529,1.7052934e-06,0.001205483808941412,1.5483311725806454e-05,3.515329113250569e-05,0.0,0.00016107433,False,ANAPC11; anaphase promoting complex subunit
hsa:399967,0.0,0.0,4.554283553709678e-08,1.0352030048293577e-07,0.0,3.4393983e-07,False,PATE2; prostate and testis expressed
hsa:5898,0.0,0.0,3.481489060645162e-05,9.630092779874851e-05,0.0,0.00045713983,False,RALA; RAS like proto-oncogene
hsa:7553,1.70132e-09,1.202674984743507e-06,1.0527491273548388e-07,2.069373358445624e-07,0.0,8.8108806e-07,False,ZNF7; zinc finger protein
hsa:7004,0.00025944502,0.18340349579754475,0.0009902555292580647,0.0014611651987141965,0.0,0.005695384,False,TEAD4; TEA domain transcription factor
hsa:3294,0.0,0.0,6.507431930129032e-06,2.2091084911131138e-05,0.0,0.000102229475,False,HSD17B2; hydroxysteroid 17-beta dehydrogenase
hsa:10285,0.0,0.0,6.190062522580646e-08,1.0541971706785259e-07,0.0,4.0721883e-07,False,SMNDC1; survival motor neuron domain containing
hsa:23028,9.0885514e-08,6.424760430921624e-05,1.724533223354839e-06,3.176024580078482e-06,0.0,1.0143518e-05,False,KDM1A; lysine demethylase
hsa:9416,4.200841e-08,2.9696038285477736e-05,1.247114540419355e-07,2.0850815070493128e-07,0.0,9.089964e-07,False,DDX23; DEAD-box helicase
hsa:10733,1.8691584e-07,0.0001321321121366467,1.0413808162580644e-06,2.055934245002624e-06,0.0,8.4361745e-06,False,PLK4; polo like kinase
hsa:346562,-0.0,0.0,0.0,0.0,0.0,0.0,False,GNAT3; G protein subunit alpha transducin
hsa:384,0.0,0.0,0.00010648834989032257,0.0003196706573947251,0.0,0.0017179025,False,ARG2; arginase
hsa:51738,0.0,0.0,1.2580670129032256e-06,2.0801558039726207e-06,0.0,8.949869e-06,False,GHRL; ghrelin and obestatin
hsa:283092,0.0,0.0,2.4266605677419354e-07,1.247457644595655e-06,0.0,6.940545e-06,False,OR4C13; olfactory receptor family 4 subfamily C member
hsa:6207,6.3150816e-07,0.00044641752679883855,1.6191971449677425e-06,2.422849556029094e-06,0.0,8.322987e-06,False,RPS13; ribosomal protein
hsa:5423,2.93339e-07,0.00020736338687000417,5.177483568870967e-06,1.1319813488786053e-05,0.0,4.6402085e-05,False,POLB; DNA polymerase
hsa:2791,4.2118503e-05,0.02977386379572588,0.00045936458628741936,0.0009320367026079044,0.0,0.0033495363,False,GNG11; G protein subunit gamma
hsa:390992,0.0,0.0,5.794755140967742e-09,1.93299349957389e-08,0.0,8.8697796e-08,False,HES3; hes family bHLH transcription factor
hsa:91862,4.976842e-10,3.51816435263257e-07,1.0026904510603226e-07,2.609938429082984e-07,0.0,1.2364275e-06,False,MARVELD3; MARVEL domain containing
hsa:7533,0.0,0.0,1.5891837229032258e-05,3.6543473242231466e-05,0.0,0.00015640727,False,YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:4282,0.0,0.0,8.990584812903227e-05,0.00015375555694218093,0.0,0.0005197763,False,MIF; macrophage migration inhibitory
hsa:8437,0.0,0.0,9.15309497096774e-08,4.0128646959410586e-07,0.0,2.219522e-06,False,RASAL1; RAS protein activator like
hsa:7220,0.0,0.0,6.235220299032258e-05,0.0001652266690801373,0.0,0.0007312155,False,TRPC1; transient receptor potential cation channel subfamily C member
hsa:9372,0.0,0.0,2.8016015735645166e-06,9.475469915857592e-06,0.0,4.79531e-05,False,ZFYVE9; zinc finger FYVE-type containing
hsa:728343,0.0,0.0,3.733630052716129e-06,1.8089842465673546e-05,0.0,0.00010110339,False,NXF2B; nuclear RNA export factor
hsa:1134,1.1434956e-05,0.00808345022267573,0.00016442424445548383,0.00035186536780833536,0.0,0.001682701,False,CHRNA1; cholinergic receptor nicotinic alpha 1
hsa:131873,0.0,0.0,6.696165919354839e-07,2.170179814193882e-06,0.0,1.1712938e-05,False,COL6A6; collagen type VI alpha 6
hsa:5268,0.0,0.0,7.596928016129033e-09,3.067134704907184e-08,0.0,1.6710904e-07,False,SERPINB5; serpin family B member
hsa:3845,0.0,0.0,4.4157149677419355e-05,0.00012172858180333841,0.0,0.00042246084,False,KRAS; KRAS proto-oncogene
hsa:341392,-0.0,0.0,0.0,0.0,0.0,0.0,False,ACSM4; acyl-CoA synthetase medium chain family member
hsa:3606,0.0,0.0,0.00016997365777419356,0.00032025051479322525,0.0,0.0012815121,False,IL18; interleukin
hsa:9648,1.05227194e-07,7.438583801903935e-05,8.397552776129032e-07,2.125189913917435e-06,0.0,9.308795e-06,False,GCC2; GRIP and coiled-coil domain containing
hsa:2887,0.0,0.0,8.149412745806451e-07,2.2090314995573587e-06,0.0,1.0167316e-05,False,GRB10; growth factor receptor bound protein
hsa:3052,5.83556e-06,0.00412519810145641,0.00010611444760580646,0.0002489366552194639,0.0,0.0011191887,False,HCCS; holocytochrome c
hsa:2554,0.0,0.0,0.0,0.0,0.0,0.0,False,GABRA1; gamma-aminobutyric acid type A receptor subunit
hsa:114,0.0,0.0,2.2545633051612902e-05,8.549268802684512e-05,0.0,0.0003696448,False,ADCY8; adenylate cyclase
hsa:2641,0.0,0.0,3.818388934806452e-06,9.908407275503755e-06,0.0,4.8656508e-05,False,GCG;
hsa:945,0.0,0.0,2.9203426571935484e-05,5.053109622705656e-05,0.0,0.00015926837,False,CD33; CD33
hsa:3704,1.12950566e-07,7.984554360192115e-05,4.394208283374194e-05,0.0001387039550775985,0.0,0.00055700564,False,ITPA; inosine
hsa:407016,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A2; microRNA
hsa:285,2.6273926e-07,0.0001857322170503023,1.4319594696774191e-05,3.8393774133384684e-05,0.0,0.00014555626,False,ANGPT2; angiopoietin
hsa:5589,0.0,0.0,3.607199427419355e-08,1.3393926804759874e-07,0.0,7.231885e-07,False,PRKCSH; protein kinase C substrate
hsa:6093,0.0,0.0,0.00010987728798387097,0.0002791003311704249,0.0,0.0012302435,False,ROCK1; Rho associated coiled-coil containing protein kinase
hsa:929,0.00012501134,0.08837138893756927,0.00017698142919354834,0.0001848849982530679,0.0,0.00073090306,False,CD14; CD14
hsa:392390,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1L6; olfactory receptor family 1 subfamily L member
hsa:79295,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5H6; olfactory receptor family 5 subfamily H member
hsa:861,0.00010991899,0.07770250136439452,0.0003193913160387096,0.0005499014806027974,1.2829229e-06,0.0027648006,False,RUNX1; RUNX family transcription factor
hsa:8517,3.851661e-05,0.027227660489573747,0.00021034104600000002,0.00033848116298191395,0.0,0.0012591013,False,IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit
hsa:7084,1.4388106e-05,0.01017105257331834,0.00013605374260967744,0.0002319783688478013,0.0,0.00086940185,False,TK2; thymidine kinase
hsa:55862,0.0,0.0,4.105107034258065e-05,0.00019738873989526138,0.0,0.0011023311,False,ECHDC1; ethylmalonyl-CoA decarboxylase
hsa:1723,0.0,0.0,2.116871898183871e-06,6.441228895511727e-06,0.0,2.87977e-05,False,DHODH; dihydroorotate dehydrogenase
hsa:11047,1.1349788e-07,8.023244368926503e-05,6.662110659999999e-06,1.443476149250784e-05,0.0,6.241195e-05,False,ADRM1; ADRM1 26S proteasome ubiquitin
hsa:4668,7.177284e-07,0.0005073672163496472,0.00037698533343225797,0.0013045570493460832,0.0,0.0068879225,False,NAGA;
hsa:57547,9.56714e-09,6.763078053240423e-06,1.2682384316129036e-07,2.0694650293907726e-07,0.0,8.494497e-07,False,ZNF624; zinc finger protein
hsa:1272,0.0,0.0,1.4029980349354835e-06,5.701010823396511e-06,0.0,3.1634154e-05,False,CNTN1; contactin
hsa:84527,0.0,0.0,2.5953610383870968e-08,7.230498078211234e-08,0.0,2.887338e-07,False,ZNF559; zinc finger protein
hsa:8803,0.0,0.0,9.993986024838708e-05,0.00040620708689626867,0.0,0.0021917832,False,SUCLA2; succinate-CoA ligase ADP-forming subunit
hsa:27198,1.5771292e-08,1.1148836412600448e-05,8.88073618737968e-06,4.287717752743143e-05,0.0,0.00023782298,False,HCAR1; hydroxycarboxylic acid receptor
hsa:5173,0.0,0.0,1.5902117683870967e-07,6.041194450741641e-07,0.0,3.2133764e-06,False,PDYN;
hsa:149233,0.0,0.0,4.259177925806451e-06,1.6849284388804092e-05,0.0,9.072644e-05,False,IL23R; interleukin 23
hsa:2158,-0.0,0.0,2.4367154516129034e-09,1.0523338012091794e-08,0.0,5.584222e-08,False,F9; coagulation factor
hsa:6612,0.0,0.0,5.776145573387097e-07,1.2247454296489209e-06,0.0,5.0661706e-06,False,SUMO3; small ubiquitin like modifier
hsa:3561,0.0,0.0,1.4770886629032257e-05,3.986111060188174e-05,0.0,0.0001678464,False,IL2RG; interleukin 2 receptor subunit
hsa:83551,0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR8; trace amine associated receptor
hsa:55312,0.0,0.0,0.00010352356348387099,0.0001829738399105848,0.0,0.0007294312,False,RFK; riboflavin
hsa:7091,0.0,0.0,7.372418119354839e-06,1.7196553433349146e-05,0.0,8.260995e-05,False,TLE4; TLE family member 4
hsa:643847,0.0,0.0,7.250399636451612e-07,2.5566774398499226e-06,0.0,1.383558e-05,False,PGA4; pepsinogen
hsa:25974,0.0,0.0,9.43660310983871e-05,0.00023465035339922052,0.0,0.0010192961,False,MMACHC; metabolism of cobalamin associated
hsa:5688,3.680735e-07,0.00026019372663401894,2.8815787158709676e-06,4.921253977072565e-06,0.0,2.1715741e-05,False,PSMA7; proteasome 20S subunit alpha
hsa:54874,0.0,0.0,9.22954853548387e-08,2.0005000230109938e-07,0.0,7.2826487e-07,False,FNBP1L; formin binding protein 1
hsa:6194,0.0,0.0,5.142003460645161e-05,0.00012216188321743742,0.0,0.00043733485,False,RPS6; ribosomal protein
hsa:56903,0.0,0.0,4.647470103354838e-09,1.4659138414071004e-08,0.0,6.674499e-08,False,PAPOLB; poly(A) polymerase
hsa:8708,0.0,0.0,1.435176573870968e-05,3.297642108140439e-05,0.0,0.0001373737,False,B3GALT1; beta-1
hsa:2487,0.0,0.0,1.4921800433019355e-05,4.590712435504445e-05,0.0,0.00022620312,False,FRZB; frizzled related
hsa:440387,2.7251747e-06,0.0019264450196000112,1.2652225888064518e-05,2.5471751470133306e-05,0.0,0.000103462764,False,CTRB2; chymotrypsinogen
hsa:8218,0.0,0.0,2.4755797921935477e-05,8.194165935385581e-05,0.0,0.00038640283,False,CLTCL1; clathrin heavy chain like
hsa:1152,1.1101873e-07,7.847991524756866e-05,2.1670834729032257e-06,3.5610223153811695e-06,0.0,1.2695514e-05,False,CKB; creatine kinase
hsa:910,0.0,0.0,0.0,0.0,0.0,0.0,False,CD1B; CD1b
hsa:8826,0.0,0.0,2.4585295919354836e-05,7.980227064358618e-05,0.0,0.0004198649,False,IQGAP1; IQ motif containing GTPase activating protein
hsa:283871,0.0,0.0,4.404186150645161e-06,8.536484467461198e-06,0.0,3.7797527e-05,False,PGP; phosphoglycolate
hsa:4597,1.4885851e-06,0.0010522911988526036,0.0002913576490787096,0.0006852675670815267,0.0,0.0029519405,False,MVD; mevalonate diphosphate
hsa:246175,1.7905809e-07,0.00012657741380748565,3.857905458258064e-06,1.1702957465071e-05,0.0,5.8963185e-05,False,CNOT6L; CCR4-NOT transcription complex subunit 6
hsa:9924,3.951645e-07,0.0002793445436535605,1.1285041441935484e-06,2.461647912370816e-06,0.0,1.160862e-05,False,PAN2; poly(A) specific ribonuclease subunit
hsa:23225,9.803164e-09,6.929925066500186e-06,6.389470813225807e-08,1.112061828718917e-07,0.0,3.8085548e-07,False,NUP210; nucleoporin
hsa:64446,0.0,0.0,1.4180786977419355e-08,3.82840555578431e-08,0.0,1.674057e-07,False,DNAI2; dynein axonemal intermediate chain
hsa:6390,0.0,0.0,1.672864579677419e-05,5.246739695507563e-05,0.0,0.0002486011,False,SDHB; succinate dehydrogenase complex iron sulfur subunit
hsa:81127,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K15; olfactory receptor family 4 subfamily K member
hsa:1717,0.0,0.0,7.300304789032259e-06,1.4895816547736784e-05,0.0,6.417486e-05,False,DHCR7; 7-dehydrocholesterol
hsa:64101,1.6110006e-08,1.1388275703728753e-05,1.5807135929870966e-05,4.629429179861089e-05,0.0,0.00024755954,False,LRRC4; leucine rich repeat containing
hsa:55257,4.1827402e-08,2.9568082466679124e-05,1.9980403382341936e-07,3.6542837584700075e-07,0.0,1.6002517e-06,False,MRGBP; MRG domain binding
hsa:9670,0.0,0.0,5.358306228387097e-08,1.3063954117195525e-07,0.0,5.097623e-07,False,IPO13; importin
hsa:4907,0.00019022333,0.13447019990690115,0.0003620640237096774,0.0005105618684538831,0.0,0.0020793965,False,NT5E; 5'-nucleotidase
hsa:4736,3.5289838e-07,0.0002494663283700352,1.315989928516129e-06,2.0923901844144914e-06,0.0,6.78376e-06,False,RPL10A; ribosomal protein
hsa:55534,0.0,0.0,1.212156235483871e-06,3.311014653481196e-06,0.0,1.262774e-05,False,MAML3; mastermind like transcriptional coactivator
hsa:10877,-0.0,0.0,1.3929803970967742e-08,6.31308282325812e-08,-0.0,3.4864297e-07,False,CFHR4; complement factor H related
hsa:112849,1.7515816e-08,1.2382052606546724e-05,4.20683802542387e-05,0.0001104080501750638,0.0,0.0005202209,False,L3HYPDH; trans-L-3-hydroxyproline
hsa:169270,0.0,0.0,2.6626871225806446e-08,5.969463708131754e-08,0.0,2.3905102e-07,False,ZNF596; zinc finger protein
hsa:3440,0.0,0.0,1.4729085483870968e-09,8.200807725417381e-09,0.0,4.5660165e-08,False,IFNA2; interferon alpha
hsa:1136,0.0,0.0,1.2385535787096773e-05,2.2148403696907133e-05,0.0,9.8706485e-05,False,CHRNA3; cholinergic receptor nicotinic alpha 3
hsa:7932,0.0,0.0,1.0676328119354838e-06,3.4208181051947293e-06,0.0,1.45563e-05,False,OR2H2; olfactory receptor family 2 subfamily H member
hsa:5888,0.0,0.0,4.481563649041936e-05,0.00010791960758261017,0.0,0.00036790784,False,RAD51; RAD51
hsa:8935,0.0,0.0,3.0100813127419354e-06,8.308677844392535e-06,0.0,3.1072028e-05,False,SKAP2; src kinase associated phosphoprotein
hsa:2042,2.1064396e-08,1.4890568580826176e-05,3.397826635322581e-07,6.543497297804008e-07,0.0,2.4675414e-06,False,EPHA3; EPH receptor
hsa:403284,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C68; olfactory receptor family 6 subfamily C member
hsa:51421,7.4850774e-09,5.291253466631185e-06,4.342891519806452e-06,9.648549741707172e-06,0.0,4.5116896e-05,False,AMOTL2; angiomotin like
hsa:282618,0.0,0.0,3.0372995903225806e-08,9.395534845263428e-08,0.0,3.5352195e-07,False,IFNL1; interferon lambda
hsa:25776,0.0,0.0,1.3725605e-07,2.1666073789963603e-07,0.0,7.360532e-07,False,CBY1; chibby 1
hsa:8822,0.0,0.0,8.177297935483871e-07,2.8923398385245393e-06,0.0,1.3949905e-05,False,FGF17; fibroblast growth factor
hsa:5631,0.0,0.0,2.161384032903226e-06,4.4709080599167755e-06,0.0,1.3677155e-05,False,PRPS1; phosphoribosyl pyrophosphate synthetase
hsa:57186,0.0,0.0,1.8485575686451612e-07,4.1139749030378815e-07,0.0,1.5792374e-06,False,RALGAPA2; Ral GTPase activating protein catalytic subunit alpha
hsa:7225,0.0,0.0,2.5686291744741932e-05,7.89322869822885e-05,0.0,0.00042759543,False,TRPC6; transient receptor potential cation channel subfamily C member
hsa:1307,4.367841e-06,0.0030876572943579483,7.663092490322582e-05,0.00021824504610056623,0.0,0.0012110809,False,COL16A1; collagen type XVI alpha 1
hsa:59343,0.0,0.0,6.56186235483871e-08,1.6767334802559777e-07,0.0,6.01006e-07,False,SENP2; SUMO specific peptidase
hsa:441478,3.171878e-05,0.022422227007607414,0.00021165438795580645,0.000502533746281688,0.0,0.0023260035,False,NRARP; NOTCH regulated ankyrin repeat
hsa:51099,1.6783654e-06,0.001186448217759757,5.7479718393064515e-05,0.0001631191797340305,0.0,0.0007649416,False,ABHD5; abhydrolase domain containing 5
hsa:5320,7.347524e-05,0.05194016007924759,0.00022754276387096774,0.00038124910299813314,0.0,0.0018814002,False,PLA2G2A; phospholipase A2 group
hsa:27071,0.0,0.0,1.9593667399225802e-06,4.6653219466543895e-06,0.0,1.6328635e-05,False,DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides
hsa:651,0.0,0.0,4.995921497645161e-07,1.6641158153225194e-06,0.0,7.979093e-06,False,BMP3; bone morphogenetic protein
hsa:1975,0.0,0.0,1.9015932725806454e-06,5.643823517229083e-06,0.0,2.2613998e-05,False,EIF4B; eukaryotic translation initiation factor
hsa:23414,1.0648682e-08,7.527627643176154e-06,1.021975001483871e-07,2.33391724564673e-07,0.0,8.576057e-07,False,ZFPM2; zinc finger protein
hsa:81285,0.0,0.0,7.5175438006451605e-06,1.6838433410302795e-05,0.0,7.5788346e-05,False,OR51E2; olfactory receptor family 51 subfamily E member
hsa:8314,7.633606e-09,5.396249370834377e-06,4.496858137922581e-05,0.0001379566072520576,0.0,0.00053423183,False,BAP1; BRCA1 associated protein
hsa:26152,0.0,0.0,7.897817298709676e-08,1.9240861329415544e-07,0.0,8.468251e-07,False,ZNF337; zinc finger protein
hsa:155382,0.0,0.0,1.6093624120967743e-07,2.9609133918090065e-07,0.0,8.0662096e-07,False,VPS37D; VPS37D subunit of
hsa:2571,8.5261025e-05,0.06027161377112522,0.0002043009696612903,0.0003044203727262857,0.0,0.0013870173,False,GAD1; glutamate decarboxylase
hsa:3875,4.0176105e-06,0.0028400769089841136,6.60701086967742e-05,0.00018479866301624882,0.0,0.0009372649,False,KRT18; keratin
hsa:406954,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A2; microRNA
hsa:6346,0.0,0.0,2.6508787096774195e-09,1.4759468009926775e-08,0.0,8.217724e-08,False,CCL1; C-C motif chemokine ligand
hsa:955,0.0,0.0,1.9675384929806453e-06,8.414052339626336e-06,0.0,4.619668e-05,False,ENTPD6; ectonucleoside triphosphate diphosphohydrolase
hsa:2589,0.0,0.0,0.00010523278726129031,0.00026093805050038854,0.0,0.0011732678,False,GALNT1; polypeptide N-acetylgalactosaminyltransferase
hsa:79644,2.873073e-06,0.002030995360333142,0.00014447851149032256,0.00025931001404741184,0.0,0.0010247672,False,SRD5A3; steroid 5 alpha-reductase
hsa:942,0.00030969843,0.21892798214053674,0.0011798151822580646,0.0017401275620756995,0.0,0.006152265,False,CD86; CD86
hsa:369,0.0003122514,0.22073269445556315,0.0005368436286451613,0.000577668801873715,0.0,0.0016390514,False,ARAF; A-Raf proto-oncogene
hsa:5436,0.0,0.0,5.440337161354838e-06,1.0252881722334886e-05,0.0,3.6517114e-05,False,POLR2G; RNA polymerase II subunit
hsa:118460,0.0,0.0,4.925097709516127e-07,1.0146879831402637e-06,0.0,5.329565e-06,False,EXOSC6; exosome component
hsa:407041,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34B; microRNA
hsa:961,0.0,0.0,1.5172697774193548e-06,3.0652747815401093e-06,0.0,1.108733e-05,False,CD47; CD47
hsa:11136,0.0,0.0,1.5726328148387097e-07,4.3994539243785815e-07,0.0,2.045449e-06,False,SLC7A9; solute carrier family 7 member
hsa:20,0.0,0.0,0.00029895945303483876,0.0007101086645374038,0.0,0.0029022496,False,ABCA2; ATP binding cassette subfamily A member
hsa:1755,0.0,0.0,1.9023142325354838e-06,5.597185533490253e-06,0.0,2.5154324e-05,False,DMBT1; deleted in malignant brain tumors
hsa:90249,0.0,0.0,5.6079113096774204e-08,1.1686149536563526e-07,0.0,3.5486082e-07,False,UNC5A; unc-5 netrin receptor
hsa:4313,0.00013840711,0.09784095226508997,0.00027216351377419356,0.000287774752038999,0.0,0.000946361,False,MMP2; matrix metallopeptidase
hsa:5997,5.2529875e-05,0.03713373534326483,0.0003906403635451613,0.0007022718220931474,0.0,0.00235728,False,RGS2; regulator of G protein signaling
hsa:11317,0.0,0.0,5.700573096774193e-08,2.0477180767763228e-07,0.0,8.517809e-07,False,RBPJL; recombination signal binding protein for immunoglobulin kappa J region
hsa:7385,0.0,0.0,5.484451587022581e-05,0.00011752934286358154,0.0,0.0004589276,False,UQCRC2; ubiquinol-cytochrome c reductase core protein
hsa:11267,6.113867e-08,4.321935262589536e-05,7.237997953548387e-07,1.3447641529316983e-06,0.0,5.2864357e-06,False,SNF8; SNF8 subunit of
hsa:79658,3.3997586e-07,0.0002403313087712251,8.672454525419355e-06,1.4005828057571316e-05,0.0,4.610012e-05,False,ARHGAP10; Rho GTPase activating protein
hsa:407030,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30B; microRNA
hsa:113091,0.0,0.0,3.6285393548387094e-09,2.0202852108997207e-08,0.0,1.1248472e-07,False,PTH2; parathyroid hormone
hsa:7475,2.0746947e-05,0.014666161666646691,7.906092638583872e-05,0.00011714647491324354,0.0,0.0004264793,False,WNT6; Wnt family member
hsa:120227,0.0,0.0,1.3328980372258064e-05,3.0402172867504265e-05,0.0,0.000116936666,False,CYP2R1; cytochrome P450 family 2 subfamily R member
hsa:3316,0.0,0.0,3.1682912226774193e-07,8.939752469356676e-07,0.0,3.6943798e-06,False,HSPB2; heat shock protein family B (small) member
hsa:25970,3.7821866e-07,0.0002673654110603588,1.4660775001935484e-05,3.369242261987714e-05,0.0,0.00014359811,False,SH2B1; SH2B adaptor protein
hsa:1758,0.0,0.0,7.562689421619354e-06,3.567293453003772e-05,0.0,0.00019783927,False,DMP1; dentin matrix acidic phosphoprotein
hsa:9038,0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR5; trace amine associated receptor
hsa:54407,0.0,0.0,0.0001458981987719355,0.0003642987663111269,0.0,0.0012918655,False,SLC38A2; solute carrier family 38 member
hsa:2289,0.0,0.0,2.215680094612903e-06,4.047474494515923e-06,0.0,1.6611792e-05,False,FKBP5; FKBP prolyl isomerase
hsa:554,9.662917e-07,0.0006830783483150008,4.3027857144516124e-05,0.00010253675795524289,0.0,0.00045925815,False,AVPR2; arginine vasopressin receptor
hsa:407026,0.0,0.0,1.4601141935483873e-07,8.129571772501e-07,0.0,4.526354e-06,False,MIR29C; microRNA
hsa:10,0.0,0.0,1.2044346741935484e-05,2.9488177502726455e-05,0.0,0.00010922405,False,NAT2; N-acetyltransferase
hsa:64240,0.0,0.0,6.474744193548387e-09,3.6049849979279285e-08,0.0,2.0071707e-07,False,ABCG5; ATP binding cassette subfamily G member
hsa:573,4.612291e-08,3.260460705838769e-05,1.4638484847758068e-06,3.782669793778459e-06,0.0,1.7159204e-05,False,BAG1; BAG cochaperone
hsa:23538,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52A1; olfactory receptor family 52 subfamily A member
hsa:9563,6.00167e-07,0.00042426224200535836,1.2608022691058065e-05,3.1473655893786245e-05,0.0,0.00012580829,False,H6PD; hexose-6-phosphate dehydrogenase/glucose
hsa:64786,0.0,0.0,8.830424421548386e-07,1.95239447437867e-06,0.0,7.2237153e-06,False,TBC1D15; TBC1 domain family member
hsa:1277,0.0,0.0,0.0003327101106451613,0.0006162390240093744,0.0,0.002331389,False,COL1A1; collagen type I alpha 1
hsa:580,7.1948364e-08,5.086080077588007e-05,2.8296115427129028e-05,7.857725347450433e-05,0.0,0.0003891245,False,BARD1; BRCA1 associated RING domain
hsa:682,0.0,0.0,5.223902376187096e-05,0.00011933838668113667,0.0,0.00047942108,False,BSG; basigin (Ok blood
hsa:84844,2.3612218e-08,1.6691641738714855e-05,2.527721426e-07,4.4595323903856217e-07,0.0,1.8120882e-06,False,PHF5A; PHD finger protein
hsa:84188,7.564633e-07,0.0005347491875640814,5.693447561419355e-05,9.30199588959851e-05,0.0,0.0003626651,False,FAR1; fatty acyl-CoA reductase
hsa:34,0.0,0.0,4.745613951612903e-06,1.1280528621753562e-05,0.0,4.1914634e-05,False,ACADM; acyl-CoA dehydrogenase medium
hsa:345630,5.936647e-08,4.1966572074345724e-05,2.752780702903226e-06,5.806550812231048e-06,0.0,2.4945439e-05,False,FBLL1; fibrillarin like
hsa:9027,-0.0,0.0,3.496464098709678e-08,7.068305183465216e-08,0.0,2.907348e-07,False,NAT8; N-acetyltransferase 8
hsa:7371,0.0,0.0,7.842395392903227e-06,2.0296952561266045e-05,0.0,7.593701e-05,False,UCK2; uridine-cytidine kinase
hsa:10878,6.0795e-09,4.297640990376972e-06,7.418240582903226e-07,2.245030210780267e-06,0.0,1.209876e-05,False,CFHR3; complement factor H related
hsa:3300,1.4516735e-07,0.00010261981311364429,1.8754486036419357e-06,5.0123345221508235e-06,0.0,2.393354e-05,False,DNAJB2; DnaJ heat shock protein family (Hsp40) member
hsa:57715,0.0,0.0,3.7076522080645165e-07,8.260232493956137e-07,0.0,2.9850787e-06,False,SEMA4G; semaphorin
hsa:80335,5.2920587e-08,3.740993238358594e-05,7.68644126483871e-07,1.4419891829475045e-06,0.0,5.6122726e-06,False,WDR82; WD repeat domain
hsa:799,0.0,0.0,1.0591646278387096e-06,2.875076523103106e-06,0.0,1.4398657e-05,False,CALCR; calcitonin
hsa:27035,0.0,0.0,1.3758166225806452e-08,4.303843328326393e-08,0.0,2.175885e-07,False,NOX1; NADPH oxidase
hsa:406903,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10B; microRNA
hsa:322,0.0,0.0,5.608223422580645e-08,1.46444634451665e-07,0.0,6.171153e-07,False,APBB1; amyloid beta precursor protein binding family B member
hsa:6818,0.0,0.0,3.341252371935484e-05,8.23021929080019e-05,0.0,0.00036773703,False,SULT1A3; sulfotransferase family 1A member
hsa:196743,0.0,0.0,7.606640133225807e-06,2.378937121754444e-05,0.0,0.000100311256,False,PAOX; polyamine
hsa:9724,4.389331e-08,3.1028487253774724e-05,1.143711988323871e-06,3.1142112157297086e-06,0.0,1.3064777e-05,False,UTP14C; UTP14C small subunit processome
hsa:4645,1.6366583e-09,1.156965177616694e-06,1.6012414736451617e-07,2.7953242329681174e-07,0.0,9.4663136e-07,False,MYO5B; myosin
hsa:120586,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8I2; olfactory receptor family 8 subfamily I member
hsa:6428,3.0389705e-07,0.0002148269461196875,4.983418261290322e-07,5.964545944434887e-07,0.0,2.1015896e-06,False,SRSF3; serine and arginine rich splicing factor
hsa:6521,0.0,0.0,2.1353363508387096e-06,6.8724213422108716e-06,0.0,2.9120145e-05,False,SLC4A1; solute carrier family 4 member 1 (Diego blood
hsa:22841,0.0,0.0,1.3603478529999999e-07,3.561775776238032e-07,0.0,1.3096145e-06,False,RAB11FIP2; RAB11 family interacting protein
hsa:341568,1.1340111e-06,0.000801640363007234,1.9076528620483868e-05,4.6013622967400974e-05,0.0,0.00019495009,False,OR8S1; olfactory receptor family 8 subfamily S member
hsa:114907,8.3081835e-09,5.873112914741939e-06,4.250670254435486e-06,7.210055498394904e-06,0.0,2.9362329e-05,False,FBXO32; F-box protein
hsa:7730,3.5789736e-09,2.530001422294109e-06,3.150423696677419e-08,6.942893088919615e-08,0.0,3.006085e-07,False,ZNF177; zinc finger protein
hsa:5727,0.0,0.0,4.7972411870967745e-05,0.00016399645153722376,0.0,0.00087560614,False,PTCH1; patched
hsa:9080,0.0,0.0,2.7087906935483874e-07,1.302693297609138e-06,0.0,7.2473267e-06,False,CLDN9; claudin
hsa:8471,0.0,0.0,0.0,0.0,0.0,0.0,False,IRS4; insulin receptor substrate
hsa:123264,8.628079e-06,0.006099249276850194,2.9196901738290323e-05,5.134817427040505e-05,0.0,0.00025009093,False,SLC51B; SLC51 subunit
hsa:2783,0.00010510492,0.07429940167485688,0.000350843176867742,0.0005853037855301001,0.0,0.0024061082,False,GNB2; G protein subunit beta
hsa:58533,0.0,0.0,6.890118125503226e-07,1.3800051570933518e-06,0.0,5.901308e-06,False,SNX6; sorting nexin
hsa:8869,0.0,0.0,7.877306908709676e-05,0.00024905314288417173,0.0,0.0012340839,False,ST3GAL5; ST3 beta-galactoside alpha-2
hsa:2734,5.5163607e-08,3.8995538879882566e-05,3.0025949347419355e-06,5.783724212920815e-06,0.0,2.6294058e-05,False,GLG1; golgi glycoprotein
hsa:3198,0.0,0.0,9.167956444670968e-06,1.9312138387298143e-05,0.0,6.459356e-05,False,HOXA1; homeobox
hsa:7594,0.0,0.0,3.8181413051290325e-08,8.823057729256324e-08,0.0,4.2504058e-07,False,ZNF43; zinc finger protein
hsa:3688,0.00027883274,0.1971088104092647,0.0005778078991451612,0.0007319297719900511,0.0,0.002583049,False,ITGB1; integrin subunit beta
hsa:84108,1.5336948e-06,0.0010841795606888745,4.0662393396774186e-05,7.572058823884747e-05,0.0,0.00023886107,False,PCGF6; polycomb group ring finger
hsa:347468,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR13H1; olfactory receptor family 13 subfamily H member
hsa:29119,0.0,0.0,4.500356680322581e-06,7.0426597956199225e-06,0.0,2.37867e-05,False,CTNNA3; catenin alpha
hsa:26869,1.41581085e-08,1.0008465734978967e-05,1.7147280617741936e-07,3.3598832720485915e-07,0.0,1.7131812e-06,False,RNU1-3; RNA
hsa:4281,0.0,0.0,5.7866901870967745e-08,1.4699131256143754e-07,0.0,6.605e-07,False,MID1; midline
hsa:9370,0.0,0.0,4.612375520322581e-06,1.881859988607104e-05,0.0,9.9086734e-05,False,ADIPOQ; adiponectin
hsa:3075,4.446781e-06,0.0031434605314301345,0.0003908396100935484,0.001073151428240881,0.0,0.0036821025,False,CFH; complement factor
hsa:51692,6.655472e-08,4.7047996179794734e-05,1.476701811225807e-06,2.4385556349618877e-06,0.0,8.993606e-06,False,CPSF3; cleavage and polyadenylation specific factor
hsa:85414,8.9579196e-08,6.33241589957419e-05,1.3454940365483873e-05,6.580651589167938e-05,0.0,0.000365588,False,SLC45A3; solute carrier family 45 member
hsa:1131,0.0,0.0,1.0689753870967742e-06,4.267461232105276e-06,0.0,2.0611973e-05,False,CHRM3; cholinergic receptor muscarinic
hsa:10152,3.8211027e-08,2.701164173362961e-05,1.0662012497741935e-07,2.5654204247417057e-07,0.0,1.3345331e-06,False,ABI2; abl interactor
hsa:101954276,0.0,0.0,9.049704445161292e-08,1.6901048785355332e-07,0.0,7.134793e-07,False,RNVU1-6; RNA
hsa:347240,0.0,0.0,7.757731506451613e-09,1.441203191931497e-08,0.0,5.418525e-08,False,KIF24; kinesin family member
hsa:10015,7.117563e-06,0.005031454971690187,1.3888632070967741e-05,2.0802888034823633e-05,0.0,8.991953e-05,False,PDCD6IP; programmed cell death 6 interacting
hsa:7923,7.5621706e-06,0.0053457511878910475,5.984289091290323e-05,0.00011697085052837947,0.0,0.0004598111,False,HSD17B8; hydroxysteroid 17-beta dehydrogenase
hsa:56913,2.4005055e-06,0.0016969340956370376,4.72657074032258e-05,9.103210158869941e-05,0.0,0.00038178253,False,C1GALT1; core 1 synthase
hsa:1756,0.00017747995,0.1254618156246493,0.0002785579705483871,0.0003237071590821726,0.0,0.0013805206,False,DMD;
hsa:6504,0.0,0.0,3.405014626580646e-07,8.70992228177773e-07,0.0,3.521628e-06,False,SLAMF1; signaling lymphocytic activation molecule family member
hsa:10019,0.0,0.0,3.3195056552258067e-06,7.2022993234925105e-06,0.0,3.3564465e-05,False,SH2B3; SH2B adaptor protein
hsa:54811,1.0552123e-09,7.459369412007505e-07,5.5155058248387097e-08,9.143582342342512e-08,0.0,2.9772218e-07,False,ZNF562; zinc finger protein
hsa:64746,2.6101874e-08,1.8451596945152553e-05,3.4131781862580643e-07,7.407970392411797e-07,0.0,3.3220717e-06,False,ACBD3; acyl-CoA binding domain containing
hsa:7037,0.0,0.0,4.3861601290322585e-06,1.9309438636921467e-05,0.0,0.00010646635,False,TFRC; transferrin
hsa:8036,3.9923602e-08,2.8222272956443135e-05,6.753354419677421e-07,1.0845851422958439e-06,0.0,4.231773e-06,False,SHOC2; SHOC2 leucine rich repeat scaffold
hsa:1608,0.0,0.0,3.680593854612903e-05,8.855925025718973e-05,0.0,0.00039635907,False,DGKG; diacylglycerol kinase
hsa:7378,2.9907792e-06,0.002114202694808265,0.0003756336456290323,0.0007260804206775136,0.0,0.0025984484,False,UPP1; uridine phosphorylase
hsa:2517,8.154246e-06,0.0057642934213697605,5.320265473548388e-05,0.00010340134518625543,0.0,0.0004012667,False,FUCA1; alpha-L-fucosidase
hsa:6125,1.6223176e-08,1.1468276366757122e-05,2.090264530967742e-07,3.960670660028239e-07,0.0,1.4816852e-06,False,RPL5; ribosomal protein
hsa:285267,9.35614e-10,6.613920680270682e-07,7.158861645161291e-09,1.0943789454845546e-08,0.0,4.767475e-08,False,ZNF619; zinc finger protein
hsa:345456,0.0,0.0,6.972910451612904e-10,2.447551799450498e-09,0.0,1.1614287e-08,False,PFN3; profilin
hsa:494324,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR375; microRNA
hsa:4723,1.2863678e-06,0.0009093423778240063,4.141729006451614e-06,6.930352365831216e-06,0.0,2.9295492e-05,False,NDUFV1; NADH:ubiquinone oxidoreductase core subunit
hsa:6928,0.0,0.0,9.85638617419355e-07,3.44563482344162e-06,-0.0,1.8389817e-05,False,HNF1B; HNF1 homeobox
hsa:7465,1.0408198e-06,0.0007357627824781582,1.725527901419355e-06,2.214577378349624e-06,0.0,7.3976307e-06,False,WEE1; WEE1 G2 checkpoint
hsa:9180,4.0192434e-05,0.028412312173932246,0.0002748900320929034,0.0005043309584457748,0.0,0.0017802862,False,OSMR; oncostatin M
hsa:5272,0.0,0.0,2.2050031322580643e-07,6.043963449114776e-07,0.0,2.8138368e-06,False,SERPINB9; serpin family B member
hsa:3482,0.0,0.0,0.00033827974917741946,0.0009567648299518774,0.0,0.003775918,False,IGF2R; insulin like growth factor 2
hsa:2132,6.165592e-06,0.00435850002617655,6.339318775483872e-05,0.0001996360407270458,0.0,0.0011004321,False,EXT2; exostosin glycosyltransferase
hsa:138803,0.0,0.0,0.0,0.0,0.0,0.0,False,OR13C3; olfactory receptor family 13 subfamily C member
hsa:390142,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5D13; olfactory receptor family 5 subfamily D member
hsa:23191,0.0,0.0,4.619746473225806e-06,1.2737961675030806e-05,0.0,4.4201897e-05,False,CYFIP1; cytoplasmic FMR1 interacting protein
hsa:11127,0.0,0.0,3.502365916129032e-06,8.697803916198717e-06,0.0,3.542384e-05,False,KIF3A; kinesin family member
hsa:221,0.0010381134,0.7338496094250523,0.0013810790304516127,0.0017822835379524879,0.0,0.009230444,True,ALDH3B1; aldehyde dehydrogenase 3 family member
hsa:9863,0.0,0.0,3.913278574193548e-07,8.409945474227302e-07,0.0,3.550807e-06,False,MAGI2; membrane associated guanylate kinase
hsa:5175,1.5329327e-06,0.0010836408268787311,9.901753415161289e-05,0.00019685595922760044,0.0,0.0008678785,False,PECAM1; platelet and endothelial cell adhesion molecule
hsa:10008,0.0,0.0,1.2175442922580644e-06,3.7082095443730344e-06,0.0,1.8465682e-05,False,KCNE3; potassium voltage-gated channel subfamily E regulatory subunit
hsa:222537,0.0,0.0,1.972106081935484e-06,5.523312875518831e-06,0.0,1.997528e-05,False,HS3ST5; heparan sulfate-glucosamine 3-sulfotransferase
hsa:284521,0.0,0.0,1.1434006992258065e-05,3.353756124126441e-05,0.0,0.0001430804,False,OR2L13; olfactory receptor family 2 subfamily L member
hsa:4905,0.0,0.0,6.434920689806452e-05,0.00011237728392221234,0.0,0.00042575673,False,NSF; N-ethylmaleimide sensitive factor
hsa:3084,8.3428665e-07,0.0005897630569560467,5.095412853225807e-06,9.984211581933907e-06,0.0,3.656204e-05,False,NRG1; neuregulin
hsa:4194,0.0,0.0,1.80026203e-05,7.496036380125166e-05,0.0,0.00041644377,False,MDM4; MDM4 regulator of
hsa:64798,2.2768519e-07,0.0001609522502583714,1.1961716493548387e-06,2.2227172236416163e-06,0.0,1.0622936e-05,False,DEPTOR; DEP domain containing MTOR interacting
hsa:55568,0.00019688648,0.13918042715667997,0.00042298560090322585,0.000739099267907576,0.0,0.0031845788,False,GALNT10; polypeptide N-acetylgalactosaminyltransferase
hsa:7711,0.0,0.0,1.3243621334193546e-07,3.881598999785792e-07,0.0,1.7694978e-06,False,ZNF155; zinc finger protein
hsa:1577,0.0,0.0,0.00017622770322580646,0.000515691960907358,0.0,0.0022605376,False,CYP3A5; cytochrome P450 family 3 subfamily A member
hsa:9619,0.00018380617,0.12993386470535373,0.0005112715231612903,0.0009085444572340916,0.0,0.004419343,False,ABCG1; ATP binding cassette subfamily G member
hsa:1020,0.0,0.0,4.2237945161290327e-07,1.1446573401637995e-06,0.0,4.4517506e-06,False,CDK5; cyclin dependent kinase
hsa:2068,0.0,0.0,4.688310448387097e-07,1.2164201083268054e-06,0.0,5.5804253e-06,False,ERCC2; ERCC excision repair 2
hsa:4848,0.0,0.0,2.453152532816128e-05,8.485298688838954e-05,0.0,0.00038256703,False,CNOT2; CCR4-NOT transcription complex subunit
hsa:26735,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1L3; olfactory receptor family 1 subfamily L member
hsa:54965,0.0,0.0,1.075005698903226e-05,2.5188460424314712e-05,0.0,0.00010671478,False,PIGX; phosphatidylinositol glycan anchor biosynthesis class
hsa:3301,0.0,0.0,3.870578063161291e-06,7.621133734862839e-06,0.0,3.270472e-05,False,DNAJA1; DnaJ heat shock protein family (Hsp40) member
hsa:9314,0.0,0.0,5.292570843645161e-05,0.00013729363506018885,0.0,0.0005972046,False,KLF4; KLF transcription factor
hsa:8892,0.0,0.0,3.5384647335483875e-08,8.650371683018134e-08,0.0,3.5719083e-07,False,EIF2B2; eukaryotic translation initiation factor 2B subunit
hsa:6530,0.0,0.0,1.683444391967742e-07,3.491804464562619e-07,0.0,1.4002582e-06,False,SLC6A2; solute carrier family 6 member
hsa:142827,-0.0,0.0,7.559655130548386e-07,2.1136238900626707e-06,0.0,1.0030612e-05,False,ACSM6; acyl-CoA synthetase medium chain family member
hsa:51083,2.979621e-06,0.0021063148853339955,8.82537867551613e-06,1.4497071629641548e-05,0.0,6.779162e-05,False,GAL; galanin and GMAP
hsa:1903,1.1579213e-05,0.008185426503019313,6.715757514419355e-05,8.436219359425715e-05,0.0,0.0003049143,False,S1PR3; sphingosine-1-phosphate receptor
hsa:57101,3.6932477e-05,0.02610782581320088,0.00023815909666174192,0.00042760580723818115,0.0,0.001596505,False,ANO2; anoctamin
hsa:113130,1.6470208e-08,1.1642905012062625e-05,1.7366078912258064e-06,3.094322673084464e-06,0.0,1.134904e-05,False,CDCA5; cell division cycle associated
hsa:4352,6.7797384e-10,4.792644403630691e-07,1.5835169285851617e-06,4.9549083295919174e-06,0.0,2.0823092e-05,False,MPL; MPL proto-oncogene
hsa:4247,6.766525e-07,0.00047833037589292774,9.184050834258062e-05,0.0001830134154191867,0.0,0.00072875887,False,MGAT2; alpha-1
hsa:23094,0.0,0.0,1.6891611296451614e-07,4.5573101423450996e-07,0.0,1.9963645e-06,False,SIPA1L3; signal induced proliferation associated 1 like
hsa:2595,8.786657e-06,0.006211349172067235,6.484790935483871e-05,0.00013116511762394624,0.0,0.0007000353,False,GANC; glucosidase alpha
hsa:442891,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135B; microRNA
hsa:8863,0.0,0.0,0.00036985109669129026,0.000872743355359947,0.0,0.0034064518,False,PER3; period circadian regulator
hsa:9241,0.0,0.0,4.7462971616129026e-08,1.3812874827490993e-07,0.0,6.446536e-07,False,NOG;
hsa:1036,0.0,0.0,4.919263906451612e-05,8.68558468631637e-05,0.0,0.0003406647,False,CDO1; cysteine dioxygenase type
hsa:390059,0.0,0.0,1.96113e-09,1.0919109724876842e-08,0.0,6.079503e-08,False,OR51M1; olfactory receptor family 51 subfamily M member
hsa:153201,0.0,0.0,2.7018532477419356e-07,1.3499754281135293e-06,0.0,7.5334774e-06,False,SLC36A2; solute carrier family 36 member
hsa:3065,0.0,0.0,0.00015957524858064518,0.0004306756980383185,0.0,0.0021330025,False,HDAC1; histone deacetylase
hsa:3799,0.0,0.0,7.63364471483871e-06,1.5503294010451538e-05,0.0,7.460018e-05,False,KIF5B; kinesin family member
hsa:55502,0.0,0.0,9.9875932e-08,1.9721345733330092e-07,0.0,7.4375134e-07,False,HES6; hes family bHLH transcription factor
hsa:5293,0.0,0.0,6.241646569032257e-05,0.00013675755730653216,0.0,0.0005239354,False,PIK3CD; phosphatidylinositol-4
hsa:57104,0.0,0.0,0.0003227667203870968,0.0007101922124165005,0.0,0.0031175858,False,PNPLA2; patatin like phospholipase domain containing
hsa:9821,6.3627255e-07,0.0004497855073495652,2.021694804193549e-06,2.8591575970173365e-06,0.0,1.18208945e-05,False,RB1CC1; RB1 inducible coiled-coil
hsa:54807,0.0,0.0,2.547360218064516e-08,6.041788228473186e-08,0.0,2.5575483e-07,False,ZNF586; zinc finger protein
hsa:132789,0.0,0.0,1.5610471463548385e-05,4.9941197262241625e-05,0.0,0.00026550575,False,GNPDA2; glucosamine-6-phosphate deaminase
hsa:23385,0.0,0.0,2.4548987306451614e-05,6.78655284660951e-05,0.0,0.00026432364,False,NCSTN;
hsa:338755,0.0,0.0,5.825211015483873e-07,1.9215762354758833e-06,-0.0,9.2273e-06,False,OR2AG2; olfactory receptor family 2 subfamily AG member
hsa:6136,0.0,0.0,1.7352434801290324e-06,4.98084408051437e-06,0.0,2.1440068e-05,False,RPL12; ribosomal protein
hsa:6096,0.0,0.0,6.410226638709678e-07,1.8215469247951907e-06,0.0,7.5844578e-06,False,RORB; RAR related orphan receptor
hsa:9087,0.0,0.0,2.6584626574193547e-09,6.13874849189236e-09,0.0,2.3995316e-08,False,TMSB4Y; thymosin beta 4
hsa:391194,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2M2; olfactory receptor family 2 subfamily M member
hsa:338440,0.0,0.0,1.5451478525806451e-07,4.1873603654013017e-07,0.0,1.6214179e-06,False,ANO9; anoctamin
hsa:80055,0.0,0.0,3.191240484516129e-05,8.97605058092685e-05,0.0,0.00042087823,False,PGAP1; post-GPI attachment to proteins inositol deacylase
hsa:2524,0.0,0.0,1.976273193548387e-06,3.563276055500946e-06,0.0,1.266511e-05,False,FUT2; fucosyltransferase
hsa:11040,1.9120894e-07,0.00013516693449634526,1.6841969387741932e-06,3.819041569713036e-06,0.0,1.854736e-05,False,PIM2; Pim-2 proto-oncogene
hsa:4931,0.0,0.0,7.742680106774192e-07,1.7470556580541636e-06,0.0,6.762591e-06,False,NVL; nuclear VCP
hsa:51251,5.4167604e-08,3.829145740618597e-05,1.2666041502312905e-05,3.3430903736558906e-05,0.0,0.00017169598,False,NT5C3A; 5'-nucleotidase
hsa:4724,3.5788498e-06,0.002529913907209874,6.485430245806452e-06,7.76803532781597e-06,0.0,2.970107e-05,False,NDUFS4; NADH:ubiquinone oxidoreductase subunit
hsa:2792,0.0,0.0,2.5534490612903225e-07,1.0863971001754508e-06,0.0,5.7760376e-06,False,GNGT1; G protein subunit gamma transducin
hsa:57600,4.4649607e-08,3.1563118882707887e-05,5.510897888387097e-07,9.134999717444873e-07,0.0,4.387444e-06,False,FNIP2; folliculin interacting protein
hsa:6013,0.0,0.0,2.4135781622580646e-08,7.913732403059394e-08,0.0,3.9711878e-07,False,RLN1; relaxin
hsa:3691,0.0005086208,0.35954759415055976,0.0008601615115709679,0.001049711337768651,3.3031147e-06,0.004612729,False,ITGB4; integrin subunit beta
hsa:353288,0.0,0.0,0.0,0.0,0.0,0.0,False,KRT26; keratin
hsa:22800,0.0,0.0,2.3839503774193553e-06,8.0248631667104e-06,0.0,3.388613e-05,False,RRAS2; RAS related
hsa:6222,1.6113532e-07,0.00011390768257743405,5.852447418709677e-07,7.523376434838482e-07,0.0,2.3707757e-06,False,RPS18; ribosomal protein
hsa:5828,0.0,0.0,6.65752160967742e-08,1.2028852921207244e-07,0.0,4.5561538e-07,False,PEX2; peroxisomal biogenesis factor
hsa:8639,0.0005855567,0.4139341189423261,0.0011062451015129032,0.0014289347720468823,0.0,0.0048332615,True,AOC3; amine oxidase copper containing
hsa:7388,5.854989e-06,0.004138932597188301,0.00011164275997741937,0.0003875149619499536,0.0,0.001772612,False,UQCRH; ubiquinol-cytochrome c reductase hinge
hsa:5243,0.00019476666,0.13768191160043014,0.0005946184504193549,0.0007298232677229273,0.0,0.0023641568,False,ABCB1; ATP binding cassette subfamily B member
hsa:1628,0.0,0.0,6.7146077267741935e-06,1.3414569503236877e-05,0.0,4.9193935e-05,False,DBP; D-box binding PAR bZIP transcription
hsa:53905,0.0,0.0,2.311400250954774e-05,6.446928614399719e-05,0.0,0.00028991615,False,DUOX1; dual oxidase
hsa:64321,6.428433e-08,4.5443041639430895e-05,3.001417629174194e-05,9.456221877243541e-05,0.0,0.0004175519,False,SOX17; SRY-box transcription factor
hsa:151636,2.2527194e-05,0.01592463069867163,0.00035303100784677424,0.0006851543704804798,0.0,0.002937869,False,DTX3L; deltex E3 ubiquitin ligase
hsa:868,0.0,0.0,3.368199608064516e-05,8.33199390116553e-05,0.0,0.00031587222,False,CBLB; Cbl proto-oncogene
hsa:100134444,0.0,0.0,1.9464320790322577e-08,9.669727132796302e-08,0.0,5.390449e-07,False,KCNJ18; potassium inwardly rectifying channel subfamily J member
hsa:406977,0.0,0.0,9.770384516129032e-09,5.439919872004947e-08,-0.0,3.0288192e-07,False,MIR199A2; microRNA
hsa:5143,0.0,0.0,1.454953820483871e-05,3.2602678416828354e-05,0.0,0.00014848467,False,PDE4C; phosphodiesterase
hsa:9294,1.2103275e-05,0.008555889589243333,2.019030972516129e-05,2.6674573849300488e-05,0.0,0.00010199378,False,S1PR2; sphingosine-1-phosphate receptor
hsa:3476,0.0,0.0,4.218472189148387e-06,1.1560053161009882e-05,0.0,5.657258e-05,False,IGBP1; immunoglobulin binding protein
hsa:83549,3.816768e-06,0.0026980999436728575,0.00011745147593870965,0.0002858752669619657,0.0,0.0011666989,False,UCK1; uridine-cytidine kinase
hsa:29934,1.2664847e-07,8.952868756320886e-05,5.624283994883872e-07,1.1630571744593305e-06,0.0,5.481289e-06,False,SNX12; sorting nexin
hsa:56171,0.0,0.0,6.896417380967742e-08,2.54062831313874e-07,0.0,1.2216287e-06,False,DNAH7; dynein axonemal heavy chain
hsa:6635,1.2547892e-07,8.870192450369814e-05,7.127536691096775e-07,1.0084797086744555e-06,0.0,3.3181816e-06,False,SNRPE; small nuclear ribonucleoprotein polypeptide
hsa:2811,0.0,0.0,2.3082304193548387e-06,1.1223033110254356e-05,0.0,6.2081475e-05,False,GP1BA; glycoprotein Ib platelet subunit
hsa:55301,8.8466413e-07,0.000625375249248159,9.953539828387096e-06,3.5992193295787136e-05,0.0,0.00019827497,False,OLAH; oleoyl-ACP
hsa:23527,0.0,0.0,9.098278326129032e-09,2.1262726271208857e-08,0.0,9.4298954e-08,False,ACAP2; ArfGAP with coiled-coil
hsa:835,0.0,0.0,5.280967461048388e-07,1.0739820475814276e-06,0.0,3.3099686e-06,False,CASP2; caspase
hsa:7448,0.0,0.0,1.2226e-08,6.807148709995985e-08,0.0,3.79006e-07,False,VTN;
hsa:3308,0.0,0.0,2.117944514387096e-06,5.4336570381428745e-06,0.0,2.8572069e-05,False,HSPA4; heat shock protein family A (Hsp70) member
hsa:10864,0.0,0.0,2.1594342419354836e-08,8.69878725785652e-08,0.0,4.78067e-07,False,SLC22A7; solute carrier family 22 member
hsa:2017,3.512204e-06,0.0024828015259422587,4.9982568365483886e-05,0.00010815054647774184,0.0,0.00043368211,False,CTTN;
hsa:112714,0.0,0.0,5.502153337806452e-07,2.9219389806164302e-06,0.0,1.6290898e-05,False,TUBA3E; tubulin alpha
hsa:2592,0.0,0.0,8.375596077419356e-05,0.0002900659360138944,0.0,0.001554452,False,GALT; galactose-1-phosphate
hsa:2050,0.0,0.0,5.1804894409032256e-06,2.0033432974672052e-05,0.0,0.00010865886,False,EPHB4; EPH receptor
hsa:7029,0.0,0.0,8.30564803067742e-08,2.2675649677343324e-07,0.0,1.1424002e-06,False,TFDP2; transcription factor
hsa:29072,4.8720253e-08,3.444068695687748e-05,2.155449615312903e-05,4.2054464139506194e-05,0.0,0.00013368751,False,SETD2; SET domain containing 2
hsa:100506742,0.0,0.0,3.7471901128387094e-07,9.770966035216853e-07,0.0,4.8894735e-06,False,CASP12; caspase 12
hsa:9131,0.0,0.0,3.8428672992058056e-05,0.000157291146373173,0.0,0.0008620031,False,AIFM1; apoptosis inducing factor mitochondria associated
hsa:25833,0.0,0.0,2.2195174929032262e-08,6.10096151165416e-08,0.0,3.2066976e-07,False,POU2F3; POU class 2 homeobox
hsa:55556,0.0,0.0,2.138297719258065e-05,6.098185673978927e-05,0.0,0.0002267084,False,ENOSF1; enolase superfamily member
hsa:4048,0.0,0.0,1.7921749677419353e-06,5.7233128249172256e-06,0.0,2.8561282e-05,False,LTA4H; leukotriene A4
hsa:55970,0.000101557,0.07179135225918483,0.0005685528337419357,0.0010844492301178847,0.0,0.004231091,False,GNG12; G protein subunit gamma
hsa:1555,0.0,0.0,0.0,0.0,0.0,0.0,False,CYP2B6; cytochrome P450 family 2 subfamily B member
hsa:257397,0.0,0.0,1.2162006711290325e-05,3.625797129054675e-05,0.0,0.00015054778,False,TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:6048,1.4528571e-08,1.0270348262390353e-05,8.143887672903223e-07,1.5123193879284453e-06,0.0,6.1220017e-06,False,RNF5; ring finger protein
hsa:8790,7.5412718e-06,0.00533097768027863,3.932591240741935e-05,7.923323788753112e-05,0.0,0.00033872222,False,FPGT; fucose-1-phosphate
hsa:126328,8.410382e-06,0.005945357747829371,1.2469617677419353e-05,1.8456549312280857e-05,0.0,8.722757e-05,False,NDUFA11; NADH:ubiquinone oxidoreductase subunit
hsa:8326,2.3100054e-06,0.0016329589431749573,4.839760141935484e-06,6.462305019156361e-06,0.0,2.194253e-05,False,FZD9; frizzled class receptor
hsa:5592,0.00049895863,0.3527173387269244,0.0008639354059354839,0.0007865099329263015,6.2549414e-05,0.0029845138,False,PRKG1; protein kinase cGMP-dependent
hsa:80146,3.3169614e-05,0.023447831690333397,4.118606886612902e-05,5.915865267855776e-05,0.0,0.00029164858,False,UXS1; UDP-glucuronate decarboxylase
hsa:8115,0.0,0.0,6.55231335483871e-09,2.0132722847562746e-08,0.0,8.1472045e-08,False,TCL1A; TCL1 family AKT coactivator
hsa:6507,0.0,0.0,0.00015955095292580643,0.00042198218645689696,0.0,0.0018116618,False,SLC1A3; solute carrier family 1 member
hsa:5079,0.0,0.0,3.0412705082937096e-08,6.914077005730434e-08,0.0,2.925342e-07,False,PAX5; paired box
hsa:80228,1.55344e-07,0.00010981375804081262,4.166801677419355e-06,1.0572170818822262e-05,0.0,4.837396e-05,False,ORAI2; ORAI calcium release-activated calcium modulator
hsa:26683,-0.0,0.0,3.493908709677419e-08,1.945326040072338e-07,-0.0,1.0831117e-06,False,OR4F3; olfactory receptor family 4 subfamily F member
hsa:6614,0.0,0.0,4.386441085161289e-06,1.348895305087293e-05,0.0,7.026701e-05,False,SIGLEC1; sialic acid binding Ig like lectin
hsa:56998,3.3927398e-07,0.00023983514489947147,2.1266506510258062e-05,7.286482683743404e-05,0.0,0.00035776972,False,CTNNBIP1; catenin beta interacting protein
hsa:4688,2.6827786e-06,0.0018964749205471084,1.8610852012903226e-05,3.163870668963631e-05,0.0,0.00012270173,False,NCF2; neutrophil cytosolic factor
hsa:5226,0.0,0.0,7.863135597999998e-05,0.00034618123564805823,0.0,0.0019151852,False,PGD; phosphogluconate
hsa:3948,0.0,0.0,2.0413003070967746e-06,8.206795082239332e-06,0.0,4.4729848e-05,False,LDHC; lactate dehydrogenase
hsa:442898,0.0,0.0,4.882041306032258e-08,2.717527476580313e-07,-0.0,1.5130674e-06,False,MIR324; microRNA
hsa:2771,0.0017794629,1.2579147462612188,0.002593272094838709,0.00284990176423006,0.0,0.00957625,True,GNAI2; G protein subunit alpha
hsa:51085,2.2012434e-06,0.0015560743261183937,1.7833092600264516e-05,3.470831127384962e-05,0.0,0.00012420904,False,MLXIPL; MLX interacting protein
hsa:406951,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-2; microRNA
hsa:79646,0.0,0.0,2.9889809427419352e-05,7.063191287637369e-05,0.0,0.00027104767,False,PANK3; pantothenate kinase
hsa:7799,0.0,0.0,1.041349470967742e-07,2.3664707383076593e-07,0.0,1.0264346e-06,False,PRDM2; PR/SET domain
hsa:5899,1.04032715e-05,0.00735414524754018,6.467879974838711e-05,0.00010302082048383409,0.0,0.00041030836,False,RALB; RAS like proto-oncogene
hsa:79611,6.6332103e-07,0.0004689062666842788,0.00020084026801580647,0.0007566396500111383,0.0,0.0034782097,False,ACSS3; acyl-CoA synthetase short chain family member
hsa:7341,0.0,0.0,6.733446814516128e-07,1.4452742394212517e-06,0.0,5.371845e-06,False,SUMO1; small ubiquitin like modifier
hsa:898,0.0,0.0,4.327840201935483e-05,8.583577422094927e-05,0.0,0.0003491222,False,CCNE1; cyclin
hsa:64399,0.0,0.0,1.0585454625806452e-05,3.463215855480562e-05,0.0,0.00019069648,False,HHIP; hedgehog interacting
hsa:594855,0.0,0.0,3.103343990322581e-07,9.116229850382675e-07,0.0,4.715498e-06,False,CPLX3; complexin
hsa:653361,4.2656484e-06,0.003015416632021703,1.6547871958064518e-05,2.7481755775199483e-05,0.0,0.00011795266,False,NCF1; neutrophil cytosolic factor
hsa:80022,1.5521248e-09,1.0972078563468475e-06,1.647395934483871e-07,3.7868744909562327e-07,0.0,1.6948039e-06,False,MYO15B; myosin
hsa:55423,0.0,0.0,2.6472951212903223e-07,6.257221125972145e-07,0.0,2.7128408e-06,False,SIRPG; signal regulatory protein
hsa:64581,1.823072e-06,0.001288742323481952,2.0268341546129032e-05,4.05870133279106e-05,0.0,0.00016071474,False,CLEC7A; C-type lectin domain containing
hsa:6616,0.0,0.0,5.889467526032258e-05,0.0001424328948197195,0.0,0.00062362873,False,SNAP25; synaptosome associated protein
hsa:56655,7.941406e-06,0.0056138353395551645,6.447198368064519e-05,0.00011439601871767955,0.0,0.00039105272,False,POLE4; DNA polymerase epsilon 4
hsa:1982,0.0,0.0,2.7432813603225808e-05,9.058229808685543e-05,0.0,0.00041141003,False,EIF4G2; eukaryotic translation initiation factor 4 gamma
hsa:85417,0.0,0.0,5.009766220774194e-07,1.1627396985845246e-06,0.0,4.67577e-06,False,CCNB3; cyclin
hsa:22808,0.0,0.0,1.8900177022580644e-05,4.831092970687746e-05,0.0,0.00021404892,False,MRAS; muscle RAS oncogene
hsa:6799,4.0383336e-05,0.028547262130399875,9.014867481612903e-05,0.00014831370079156677,0.0,0.00063467363,False,SULT1A2; sulfotransferase family 1A member
hsa:64374,1.482324e-08,1.0478651835544954e-05,5.438105589603225e-06,1.4602198372696006e-05,0.0,6.0756935e-05,False,SIL1; SIL1 nucleotide exchange
hsa:5906,0.00017936077,0.12679138041246424,0.0006263268089999999,0.0011891935687663223,0.0,0.0060121524,False,RAP1A; RAP1A
hsa:101954278,0.0,0.0,1.9376293548387096e-10,1.0788263670244293e-09,0.0,6.006651e-09,False,RNU6-8; RNA
hsa:25973,0.0,0.0,1.2114066040129033e-06,2.8530039219585425e-06,0.0,1.1508048e-05,False,PARS2; prolyl-tRNA synthetase 2
hsa:2395,4.8447702e-05,0.03424801875232641,0.00013023216536225808,0.00020165123982576465,0.0,0.0009886314,False,FXN;
hsa:2852,1.3095375e-05,0.009257212004993477,4.9660476275161286e-05,7.717288649991769e-05,0.0,0.0002757577,False,GPER1; G protein-coupled estrogen receptor
hsa:7480,0.0,0.0,7.391253296774194e-06,1.2763082358950719e-05,0.0,5.5496927e-05,False,WNT10B; Wnt family member
hsa:10400,0.0,0.0,1.0752998035483872e-05,4.0823343081196114e-05,0.0,0.0002275179,False,PEMT; phosphatidylethanolamine
hsa:5536,7.321139e-08,5.175364267233732e-05,8.433600972580647e-07,1.4745260700709877e-06,0.0,7.333278e-06,False,PPP5C; protein phosphatase 5 catalytic
hsa:9060,0.00081367395,0.5751917954308648,0.0014947645581290321,0.0016190022552337307,0.0,0.005793664,True,PAPSS2; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:4322,0.0,0.0,1.4505307474193545e-07,5.075930547786046e-07,0.0,2.6948383e-06,False,MMP13; matrix metallopeptidase
hsa:54948,1.0132506e-07,7.162739225403505e-05,3.052375677741936e-07,3.656626655340736e-07,0.0,1.2448992e-06,False,MRPL16; mitochondrial ribosomal protein
hsa:3770,1.7891438e-07,0.00012647582420526063,1.8846820660064515e-06,4.538990568386269e-06,0.0,1.9889163e-05,False,KCNJ14; potassium inwardly rectifying channel subfamily J member
hsa:116983,1.5665159e-09,1.1073810253996666e-06,2.819328497387097e-07,5.417987361771932e-07,0.0,2.0151838e-06,False,ACAP3; ArfGAP with coiled-coil
hsa:4722,3.0425513e-06,0.002150800753714079,7.176270103225806e-06,1.3525543491569827e-05,0.0,5.8999005e-05,False,NDUFS3; NADH:ubiquinone oxidoreductase core subunit
hsa:23221,2.1585075e-08,1.5258640200733813e-05,5.56564859283871e-07,9.06251935807485e-07,0.0,3.4385284e-06,False,RHOBTB2; Rho related BTB domain containing
hsa:54880,6.378239e-08,4.5088216749438316e-05,5.728830232225807e-06,2.1293167771546724e-05,0.0,9.258746e-05,False,BCOR; BCL6
hsa:8622,1.0119932e-05,0.007153850577025679,8.016744557741937e-05,0.00015185466945320756,0.0,0.00076023507,False,PDE8B; phosphodiesterase
hsa:3421,0.0,0.0,2.726172687451613e-05,9.563346459207302e-05,0.0,0.00046470235,False,IDH3G; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:51187,0.0,0.0,5.563999559290322e-07,1.422339674919642e-06,0.0,5.983143e-06,False,RSL24D1; ribosomal L24 domain containing
hsa:55585,0.0,0.0,3.321533533870968e-07,6.454773919378e-07,0.0,2.5070894e-06,False,UBE2Q1; ubiquitin conjugating enzyme E2
hsa:1757,0.0,0.0,1.737851303870968e-05,3.396235840917587e-05,0.0,0.00016276997,False,SARDH; sarcosine
hsa:10509,0.0,0.0,7.551570612903227e-08,1.780368493688713e-07,0.0,6.411034e-07,False,SEMA4B; semaphorin
hsa:390261,0.0,0.0,1.7566037583870965e-06,7.400560633578919e-06,0.0,3.8784518e-05,False,OR6M1; olfactory receptor family 6 subfamily M member
hsa:920,0.00022950812,0.16224089220106208,0.001365806514548387,0.00251768790156263,0.0,0.009304682,False,CD4; CD4
hsa:839,2.4944733e-08,1.7633605894367815e-05,1.446189273e-06,3.321195940560717e-06,0.0,1.5566968e-05,False,CASP6; caspase
hsa:10788,5.742586e-10,4.0594741318142836e-07,2.6315768727441933e-06,8.429061989557764e-06,0.0,3.2619322e-05,False,IQGAP2; IQ motif containing GTPase activating protein
hsa:57693,2.863572e-10,2.0242790371076185e-07,5.1756586612903226e-08,9.788162222129858e-08,0.0,3.4141317e-07,False,ZNF317; zinc finger protein
hsa:1969,0.0,0.0,2.9785490709677418e-06,1.099001480231461e-05,0.0,5.8484748e-05,False,EPHA2; EPH receptor
hsa:91584,0.0,0.0,6.573416820196774e-08,1.8036666825811312e-07,0.0,8.1110954e-07,False,PLXNA4; plexin
hsa:8802,0.0,0.0,2.973284100548387e-05,0.00011256599712479006,0.0,0.0006230427,False,SUCLG1; succinate-CoA ligase GDP/ADP-forming subunit
hsa:55274,0.0,0.0,1.1898710665645164e-05,2.3644479693153122e-05,0.0,9.261656e-05,False,PHF10; PHD finger protein
hsa:5152,8.314131e-09,5.877317244010837e-06,1.6562760329352452e-05,5.3869654612788484e-05,0.0,0.00026081502,False,PDE9A; phosphodiesterase
hsa:7364,0.0,0.0,1.5554613741935485e-05,5.430256351506485e-05,0.0,0.00028788106,False,UGT2B7; UDP glucuronosyltransferase family 2 member
hsa:50855,0.0,0.0,5.065182683870967e-07,1.4622377487757918e-06,0.0,6.172413e-06,False,PARD6A; par-6 family cell polarity regulator
hsa:64802,1.1535649e-05,0.008154630807303418,4.525840591935483e-05,7.03306495114334e-05,0.0,0.00027344783,False,NMNAT1; nicotinamide nucleotide adenylyltransferase
hsa:51071,1.0341773e-06,0.0007310671528575349,5.383443442903227e-06,7.900998064646423e-06,0.0,3.1690837e-05,False,DERA; deoxyribose-phosphate
hsa:7050,9.855646e-07,0.000696702495867174,0.0004063516338267741,0.0008410981407967799,0.0,0.0034169946,False,TGIF1; TGFB induced factor homeobox
hsa:818,0.0,0.0,9.871680322580646e-05,0.00020823240180957442,0.0,0.00065619196,False,CAMK2G; calcium/calmodulin dependent protein kinase II
hsa:4056,4.1057276e-05,0.029023675021107108,5.6955123409677415e-05,6.94615559196358e-05,0.0,0.00023422106,False,LTC4S; leukotriene C4
hsa:8193,0.0,0.0,9.702807546774195e-06,1.862440764787522e-05,0.0,7.6683806e-05,False,DPF1; double PHD fingers
hsa:163223,4.648275e-11,3.2858980466394476e-08,7.135692159645161e-09,2.082657149257698e-08,0.0,1.049749e-07,False,ZNF676; zinc finger protein
hsa:391107,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10K2; olfactory receptor family 10 subfamily K member
hsa:9575,0.0,0.0,1.613666100967742e-05,4.9920824384024305e-05,0.0,0.00021524844,False,CLOCK; clock circadian
hsa:9476,0.0,0.0,3.092081025806452e-08,6.726838264125885e-08,0.0,2.8422846e-07,False,NAPSA; napsin A aspartic
hsa:4300,0.0,0.0,4.017358575806452e-06,8.047581317761814e-06,0.0,3.079455e-05,False,MLLT3; MLLT3 super elongation complex
hsa:55578,0.0,0.0,3.485317006229032e-07,8.3214897756402e-07,0.0,3.7494613e-06,False,SUPT20H; SPT20 homolog
hsa:6183,1.0558595e-07,7.463944513987884e-05,3.583344774064516e-07,6.520879065832527e-07,0.0,2.872937e-06,False,MRPS12; mitochondrial ribosomal protein
hsa:3417,0.0,0.0,9.600218831612903e-05,0.00031356060979084927,0.0,0.0016042927,False,IDH1; isocitrate dehydrogenase (NADP(+))
hsa:10376,1.9103341e-05,0.0135042851113988,0.00019810190249354843,0.0005340668237087314,0.0,0.0024545852,False,TUBA1B; tubulin alpha
hsa:5411,0.0,0.0,4.0816955548387097e-07,6.468392878995052e-07,0.0,2.4699411e-06,False,PNN; pinin
hsa:10120,2.8766609e-08,2.0335316718899104e-05,7.485412752129033e-07,1.519704365159173e-06,0.0,6.81614e-06,False,ACTR1B; actin related protein
hsa:3270,5.0870216e-07,0.00035960510810252567,5.7394910313612894e-05,0.00011082418018836386,0.0,0.00034016898,False,HRC; histidine rich calcium binding
hsa:134,1.7011535e-05,0.012025572847311872,7.510709430096775e-05,0.00017307124166718844,0.0,0.0009293779,False,ADORA1; adenosine A1
hsa:51084,0.00027724076,0.19598342863381268,0.00037938408529032263,0.0004569630711714919,0.0,0.001861565,False,CRYL1; crystallin lambda
hsa:57406,1.4527822e-09,1.026981878906166e-06,6.802720072677418e-07,1.264019577835175e-06,0.0,5.721422e-06,False,ABHD6; abhydrolase domain containing 6
hsa:25956,0.0,0.0,4.6084884886870974e-07,8.70575228978841e-07,0.0,3.0929727e-06,False,SEC31B; SEC31 homolog B
hsa:5932,1.207499e-05,0.008535894725288599,4.280471742309678e-05,9.289733693690923e-05,0.0,0.0004046849,False,RBBP8; RB binding protein 8
hsa:1441,3.067852e-05,0.02168685995165717,0.00024782806916829025,0.00038981084330474606,0.0,0.0016295923,False,CSF3R; colony stimulating factor 3
hsa:4771,0.0,0.0,1.4483649838709677e-05,2.976210216369692e-05,0.0,8.835062e-05,False,NF2; NF2
hsa:8797,4.4174412e-05,0.031227200219919465,0.0002386623722335484,0.00038537112192416355,0.0,0.0013043528,False,TNFRSF10A; TNF receptor superfamily member
hsa:64221,0.0,0.0,2.2519494322580646e-08,6.708211160209134e-08,0.0,3.4615127e-07,False,ROBO3; roundabout guidance receptor
hsa:6846,0.0,0.0,2.2169320172258064e-05,7.718607401718792e-05,0.0,0.00042683134,False,XCL2; X-C motif chemokine ligand
hsa:100289635,0.0,0.0,7.254061570967741e-09,1.7411454411464447e-08,0.0,9.068398e-08,False,ZNF605; zinc finger protein
hsa:5050,0.0,0.0,3.902049664429031e-05,8.777915412969395e-05,0.0,0.0003254199,False,PAFAH1B3; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4208,3.668299e-05,0.02593146171125727,0.00021569067834741938,0.0004219255796419405,0.0,0.0018354274,False,MEF2C; myocyte enhancer factor
hsa:57053,3.4749913e-08,2.4564956085341496e-05,5.345995842903226e-07,9.002487899739362e-07,0.0,3.6017893e-06,False,CHRNA10; cholinergic receptor nicotinic alpha 10
hsa:1535,1.7857032e-05,0.012623260578941241,7.917115932258066e-05,0.0001191423306449223,0.0,0.00040850253,False,CYBA; cytochrome b-245 alpha
hsa:1491,5.7975572e-05,0.04098333656842692,0.00016337064625806454,0.0002564778471267931,0.0,0.0009782283,False,CTH; cystathionine
hsa:84890,0.0,0.0,5.317967919354839e-05,0.0001275512344180667,0.0,0.0005830894,False,ADO; 2-aminoethanethiol
hsa:4825,0.0,0.0,9.175443027096775e-06,5.039983202023374e-05,0.0,0.00028072958,False,NKX6-1; NK6 homeobox
hsa:3676,0.00013117702,0.09272995117156015,0.0002510630870322581,0.00024703539311074604,0.0,0.0007167293,False,ITGA4; integrin subunit alpha
hsa:26047,0.0,0.0,6.166037777096773e-07,2.653239050824584e-06,0.0,1.4786059e-05,False,CNTNAP2; contactin associated protein
hsa:7567,1.21266925e-08,8.572443583468541e-06,2.995613225806451e-08,4.256462294820502e-08,0.0,1.5559863e-07,False,ZNF19; zinc finger protein
hsa:4994,9.384559e-08,6.634010269760856e-05,1.6322576456129034e-05,3.0730924476503284e-05,0.0,0.00010178226,False,OR3A1; olfactory receptor family 3 subfamily A member
hsa:4717,0.0,0.0,4.345859222580645e-06,9.121775192387145e-06,0.0,3.5233337e-05,False,NDUFC1; NADH:ubiquinone oxidoreductase subunit
hsa:199777,0.0,0.0,6.05058830483871e-08,1.2689607210573388e-07,0.0,4.162142e-07,False,ZNF626; zinc finger protein
hsa:63982,0.0,0.0,4.111103560580644e-08,1.2014808384402564e-07,0.0,6.306793e-07,False,ANO3; anoctamin
hsa:406996,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR214; microRNA
hsa:721,7.5355633e-06,0.005326942301778167,0.00014323874987225808,0.0002021513902171122,0.0,0.00073763856,False,C4B; complement C4B (Chido blood
hsa:267,6.8628956e-09,4.851428808822726e-06,1.7439414848270968e-06,3.7675391428728855e-06,0.0,1.6955944e-05,False,AMFR; autocrine motility factor
hsa:406881,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A1; microRNA
hsa:57551,0.0,0.0,4.2444513841935485e-07,9.771366991566776e-07,0.0,4.8835127e-06,False,TAOK1; TAO kinase
hsa:958,0.00061534555,0.43499206496028664,0.0011456182706774194,0.0014300611503633256,0.0,0.0061642863,True,CD40; CD40
hsa:925,0.0,0.0,5.342635225806451e-07,2.5099526946669426e-06,0.0,1.3789792e-05,False,CD8A; CD8 subunit
hsa:57396,0.0,0.0,1.5748053324193548e-06,4.9608089186593935e-06,0.0,2.189912e-05,False,CLK4; CDC like kinase
hsa:624,5.632947e-05,0.039819695573354706,0.00022887340758064517,0.0004008530737036287,0.0,0.0018636183,False,BDKRB2; bradykinin receptor
hsa:7514,1.23098835e-05,0.008701942580206457,4.483971146774194e-05,9.995851691424475e-05,0.0,0.0005090218,False,XPO1; exportin
hsa:2014,2.1196749e-07,0.00014984129840469134,0.0004198472653769677,0.0012295084756458975,0.0,0.0047254963,False,EMP3; epithelial membrane protein
hsa:4685,2.596862e-05,0.0183573987623198,0.0013856617479677416,0.0029111599635474293,0.0,0.011761711,False,NCAM2; neural cell adhesion molecule
hsa:8021,0.0,0.0,7.943775051612904e-08,1.5324831012575407e-07,0.0,6.2368247e-07,False,NUP214; nucleoporin
hsa:5630,2.926876e-08,2.0690290766264642e-05,8.509250779258063e-08,1.2112108598871271e-07,0.0,4.9317896e-07,False,PRPH;
hsa:213,0.0,0.0,4.591743506451612e-06,1.3081128493785638e-05,0.0,5.306891e-05,False,ALB;
hsa:94,1.4445432e-06,0.001021157672290537,9.973214429354838e-06,2.539407863781934e-05,0.0,0.00012672196,False,ACVRL1; activin A receptor like type
hsa:862,0.0,0.0,7.399998648064515e-07,1.6103239180720664e-06,0.0,6.2947815e-06,False,RUNX1T1; RUNX1 partner transcriptional co-repressor
hsa:59348,2.2292001e-08,1.5758371125112996e-05,6.434724832258063e-08,8.868731032724402e-08,0.0,3.0310332e-07,False,ZNF350; zinc finger protein
hsa:4696,0.0,0.0,3.0017102129032253e-06,6.319423355155329e-06,0.0,2.206312e-05,False,NDUFA3; NADH:ubiquinone oxidoreductase subunit
hsa:2054,0.0,0.0,4.865936839064516e-05,0.00012510372949873843,0.0,0.0005564236,False,STX2; syntaxin
hsa:9500,0.0,0.0,1.1011359842903228e-05,2.6224996667522508e-05,0.0,0.000110761044,False,MAGED1; MAGE family member
hsa:7187,0.0,0.0,2.684396548387097e-05,6.12493973372672e-05,0.0,0.00032537532,False,TRAF3; TNF receptor associated factor
hsa:1656,4.2948193e-07,0.0003036037744870818,8.185108026451613e-06,2.58301270297759e-05,0.0,0.00011771445,False,DDX6; DEAD-box helicase
hsa:375189,0.0,0.0,1.1847509298709679e-07,3.47112065895784e-07,0.0,1.629263e-06,False,PFN4; profilin family member
hsa:2052,0.00034546587,0.24421223516543172,0.000782420329032258,0.0010212989979999044,0.0,0.0044932915,False,EPHX1; epoxide hydrolase
hsa:55845,3.421571e-08,2.4187324255424175e-05,1.4676723563870964e-06,2.33832782516753e-06,0.0,7.441968e-06,False,BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating
hsa:7761,2.9033285e-09,2.0523831844937398e-06,3.485320493451614e-08,6.705256471770566e-08,0.0,2.8519378e-07,False,ZNF214; zinc finger protein
hsa:123688,8.519879e-07,0.0006022761941516895,1.997026727403226e-05,4.693360914267552e-05,0.0,0.0002012929,False,HYKK; hydroxylysine
hsa:55183,0.0,0.0,8.27392908263226e-06,2.220237487218001e-05,0.0,9.191339e-05,False,RIF1; replication timing regulatory factor
hsa:29982,1.0467946e-08,7.399864103076349e-06,4.071952192903226e-07,1.0155591865392566e-06,0.0,4.349891e-06,False,NRBF2; nuclear receptor binding factor
hsa:23471,0.0,0.0,6.220639950612903e-07,1.4502155520638078e-06,0.0,6.404524e-06,False,TRAM1; translocation associated membrane protein
hsa:328,5.083815e-07,0.00035937843131003054,8.299072158638708e-05,0.00021363187083637322,0.0,0.0008794018,False,APEX1; apurinic/apyrimidinic endodeoxyribonuclease
hsa:8992,9.1365175e-05,0.06458668001858137,0.0002765704840967742,0.00034488637472793816,0.0,0.001071287,False,ATP6V0E1; ATPase H+ transporting V0 subunit
hsa:8645,0.00042469084,0.30021691951996515,0.0007080807645032258,0.0010820624654914984,0.0,0.0052700466,False,KCNK5; potassium two pore domain channel subfamily K member
hsa:55624,0.0,0.0,2.7692340219354837e-05,9.462002668403279e-05,0.0,0.00045792942,False,POMGNT1; protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta
hsa:5197,1.3585595e-06,0.0009603751945169906,0.00011091797932825805,0.0002615856276343448,0.0,0.0011962446,False,PF4V1; platelet factor 4 variant
hsa:949,0.0,0.0,0.00026022668822580643,0.0008488085387303112,0.0,0.003813668,False,SCARB1; scavenger receptor class B member
hsa:162605,-0.0,0.0,2.4709619354838712e-09,1.3757733806296602e-08,0.0,7.659982e-08,False,KRT28; keratin
hsa:56603,2.306511e-05,0.01630488727420903,0.00016629308740967743,0.0003847861065357704,0.0,0.0017407199,False,CYP26B1; cytochrome P450 family 26 subfamily B member
hsa:3055,7.1415414e-08,5.048405470040982e-05,8.329163399064517e-06,1.8614840511677123e-05,0.0,7.202899e-05,False,HCK; HCK proto-oncogene
hsa:63923,1.430775e-07,0.00010114248355961202,9.239121868903226e-06,1.748484451440589e-05,0.0,6.041183e-05,False,TNN; tenascin
hsa:4277,3.087195e-06,0.0021823596968972504,2.0046022049064517e-05,3.840044006062961e-05,0.0,0.00017126216,False,MICB; MHC class I polypeptide-related sequence
hsa:9722,0.0,0.0,1.0239228318064517e-05,2.4266051737796286e-05,0.0,0.000100566336,False,NOS1AP; nitric oxide synthase 1 adaptor
hsa:51555,3.984778e-09,2.81686738553374e-06,1.5286228699032261e-07,5.04908513863577e-07,0.0,2.6305813e-06,False,PEX5L; peroxisomal biogenesis factor 5
hsa:26229,7.664966e-06,0.0054184179737553784,0.0005644132788709678,0.001343643789450797,0.0,0.005796388,False,B3GAT3; beta-1
hsa:3834,0.0,0.0,1.063247607483871e-08,2.828571547816532e-08,0.0,1.3163213e-07,False,KIF25; kinesin family member
hsa:1585,0.0,0.0,4.2389962903225804e-07,1.7982988808175282e-06,0.0,9.8016535e-06,False,CYP11B2; cytochrome P450 family 11 subfamily B member
hsa:390201,0.0,0.0,7.478744193548388e-09,4.163988539956068e-08,-0.0,2.3184107e-07,False,OR10V1; olfactory receptor family 10 subfamily V member
hsa:7415,1.4345736e-06,0.001014110092453764,2.4303648830645164e-05,4.8571203632471636e-05,0.0,0.00019264693,False,VCP; valosin containing
hsa:148198,0.0,0.0,4.5152890039999995e-09,1.347157615341934e-08,0.0,7.039857e-08,False,ZNF98; zinc finger protein
hsa:241,4.5957813e-07,0.0003248789883656216,2.3753099238709676e-06,3.6969852924332115e-06,0.0,1.1479176e-05,False,ALOX5AP; arachidonate 5-lipoxygenase activating
hsa:22914,0.0,0.0,2.895895219354838e-06,6.252734250202353e-06,0.0,2.7356222e-05,False,KLRK1; killer cell lectin like receptor
hsa:1643,0.0,0.0,7.569811758064518e-05,0.00015972155969856864,0.0,0.0006486285,False,DDB2; damage specific DNA binding protein
hsa:406980,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B1; microRNA
hsa:100169756,0.0,0.0,2.5569175580645164e-06,9.893117260734746e-06,0.0,5.3228963e-05,False,RNA5S5; RNA
hsa:84987,3.313805e-08,2.342551887838829e-05,7.514600839999999e-07,1.5826637809943212e-06,0.0,6.8566965e-06,False,COX14; cytochrome c oxidase assembly factor
hsa:83737,1.4400324e-05,0.010179689562810968,9.955147123870967e-05,0.00014439632602691687,0.0,0.00048041463,False,ITCH; itchy E3 ubiquitin protein
hsa:7852,0.0,0.0,0.0005613090012903226,0.0017458595266260633,0.0,0.009328618,False,CXCR4; C-X-C motif chemokine receptor
hsa:1455,0.0,0.0,0.0001027102978064516,0.0002402783857989244,0.0,0.0011980018,False,CSNK1G2; casein kinase 1 gamma
hsa:3093,0.0,0.0,6.648388649032259e-07,1.2997509155858833e-06,0.0,4.8248035e-06,False,UBE2K; ubiquitin conjugating enzyme E2
hsa:6355,4.13165e-05,0.029206922276323738,0.00013527425884193552,0.00019120101839921962,0.0,0.0006818932,False,CCL8; C-C motif chemokine ligand
hsa:8862,3.6560855e-06,0.002584512362714514,1.1271952908064514e-05,2.3333957037919943e-05,0.0,0.00010629643,False,APLN;
hsa:7023,0.0,0.0,1.3696022753870968e-07,2.679681615981022e-07,0.0,9.469616e-07,False,TFAP4; transcription factor
hsa:471,2.0860225e-06,0.0014746238675628993,8.436966252580644e-05,0.00012153399600821368,0.0,0.0003995359,False,ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
hsa:3687,1.3480525e-07,9.529477228686822e-05,5.197369165290323e-06,1.2632892962090573e-05,0.0,6.132972e-05,False,ITGAX; integrin subunit alpha
hsa:1519,0.0,0.0,3.283958916129032e-07,5.761526591079757e-07,0.0,1.9835027e-06,False,CTSO; cathepsin
hsa:51706,0.0,0.0,5.502695553870968e-06,1.5184192354888191e-05,0.0,7.6032804e-05,False,CYB5R1; cytochrome b5 reductase
hsa:64754,6.919116e-06,0.004891171402051675,3.167645390314193e-05,8.349962755302694e-05,0.0,0.00045290365,False,SMYD3; SET and MYND domain containing
hsa:100529063,5.7175638e-09,4.041785763956826e-06,4.411508474654838e-06,2.1345349359624112e-05,0.0,0.000119157674,False,BCL2L2-PABPN1; BCL2L2-PABPN1
hsa:6011,0.0,0.0,9.205845161290322e-07,5.125597661876345e-06,0.0,2.853812e-05,False,GRK1; G protein-coupled receptor kinase
hsa:171568,0.0,0.0,7.121536148387097e-05,0.00012999588023915573,0.0,0.0005475084,False,POLR3H; RNA polymerase III subunit
hsa:2934,0.0,0.0,3.468635532580646e-05,9.68190955547123e-05,0.0,0.00040037232,False,GSN;
hsa:340252,0.0,0.0,8.521557267741936e-09,1.7958087110938627e-08,0.0,8.1982996e-08,False,ZNF680; zinc finger protein
hsa:5922,0.0,0.0,3.96009434516129e-07,7.390555773802409e-07,0.0,2.9516157e-06,False,RASA2; RAS p21 protein activator
hsa:406991,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR21; microRNA
hsa:5585,4.832534e-07,0.00034161520200329617,3.839903004838709e-06,6.6391353964232215e-06,0.0,2.1111724e-05,False,PKN1; protein kinase
hsa:390323,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C75; olfactory receptor family 6 subfamily C member
hsa:4316,0.0,0.0,2.0211413071290322e-07,8.376051962140867e-07,0.0,4.6194896e-06,False,MMP7; matrix metallopeptidase
hsa:25961,0.0,0.0,3.7635217096774196e-06,9.895021649874096e-06,0.0,3.9467322e-05,False,NUDT13; nudix hydrolase
hsa:4036,0.0,0.0,2.778757451612903e-08,1.3630634314135495e-07,0.0,7.584731e-07,False,LRP2; LDL receptor related protein
hsa:1767,1.1453534e-09,8.096583140566877e-07,1.0080970732258064e-08,2.31624838349037e-08,0.0,1.2036622e-07,False,DNAH5; dynein axonemal heavy chain
hsa:6311,7.836765e-09,5.539863886166888e-06,8.383539758064517e-08,1.560435104579502e-07,0.0,6.694269e-07,False,ATXN2; ataxin
hsa:23237,1.7229747e-06,0.0012179828433427858,2.761847049226451e-05,5.8937737583923715e-05,0.0,0.00025130904,False,ARC; activity regulated cytoskeleton associated
hsa:3356,7.4479317e-06,0.005264994911990796,2.4230045222580655e-05,3.4649234958261336e-05,0.0,0.0001348951,False,HTR2A; 5-hydroxytryptamine receptor
hsa:7143,0.0,0.0,5.074874870967742e-09,2.075932730797282e-08,0.0,1.1160995e-07,False,TNR; tenascin
hsa:23214,1.3772651e-08,9.735983137388995e-06,1.4180267438709675e-07,2.3726009741709335e-07,0.0,1.0241846e-06,False,XPO6; exportin
hsa:85363,0.0,0.0,2.0587517387096776e-05,4.933876332954258e-05,0.0,0.00017728098,False,TRIM5; tripartite motif containing
hsa:8706,0.0,0.0,1.2173199096774193e-05,2.13667591499281e-05,0.0,7.7443605e-05,False,B3GALNT1; beta-1
hsa:6697,4.5224556e-06,0.0031969554344468925,2.305526329354839e-05,4.647507763862164e-05,0.0,0.00019253691,False,SPR; sepiapterin
hsa:91373,0.0,0.0,2.3609048596774195e-05,5.7580043402602504e-05,0.0,0.00028741694,False,UAP1L1; UDP-N-acetylglucosamine pyrophosphorylase 1 like
hsa:7569,1.6416635e-08,1.160503388437491e-05,5.5222009272944194e-08,8.609862381817365e-08,0.0,2.8479377e-07,False,ZNF182; zinc finger protein
hsa:54107,0.0,0.0,1.2431628088064514e-05,2.5918376749835934e-05,0.0,0.000118020864,False,POLE3; DNA polymerase epsilon 3
hsa:26508,5.7978854e-05,0.04098565663713823,0.00022473704822451615,0.000299781850265252,0.0,0.00092354446,False,HEYL; hes related family bHLH transcription factor with YRPW motif
hsa:7879,2.5384662e-07,0.0001794459477556784,0.00010782054376580645,0.0002277070064080712,0.0,0.0010297518,False,RAB7A; RAB7A
hsa:10105,0.0,0.0,8.883186979032258e-06,3.450769868334073e-05,0.0,0.00018940947,False,PPIF; peptidylprolyl isomerase
hsa:100528030,0.0,0.0,8.886712469354841e-06,2.1901568493572427e-05,0.0,0.00010565004,False,POC1B-GALNT4; POC1B-GALNT4
hsa:2867,1.1813097e-09,8.350760735339953e-07,2.765967150225806e-08,7.64440069583546e-08,0.0,3.9263128e-07,False,FFAR2; free fatty acid receptor
hsa:122970,8.9162095e-05,0.06302930738710184,0.00019707547755741932,0.00033314375331923907,0.0,0.0015971084,False,ACOT4; acyl-CoA thioesterase
hsa:4257,0.00085780444,0.6063879468823692,0.0011794602542580645,0.0012906768519719393,0.0,0.004621798,True,MGST1; microsomal glutathione S-transferase
hsa:8605,9.698772e-05,0.0685612963295015,0.000561766560967742,0.0012423360331642666,0.0,0.0062920507,False,PLA2G4C; phospholipase A2 group
hsa:10941,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2A1; UDP glucuronosyltransferase family 2 member A1 complex
hsa:5030,0.0,0.0,7.950548093548386e-06,3.367139716622122e-05,0.0,0.00018726023,False,P2RY4; pyrimidinergic receptor
hsa:8029,1.9473184e-06,0.001376572970993552,7.967165266203226e-05,0.00015520688028972094,0.0,0.0005848244,False,CUBN;
hsa:4170,0.0,0.0,2.50497518983871e-06,8.741625488331624e-06,0.0,4.3669417e-05,False,MCL1; MCL1 apoptosis regulator
hsa:5595,0.0,0.0,0.0010850422785806454,0.0016891013658030746,0.0,0.0053896643,False,MAPK3; mitogen-activated protein kinase
hsa:5158,0.0,0.0,9.327059567741936e-06,2.1361032231401055e-05,0.0,8.469701e-05,False,PDE6B; phosphodiesterase
hsa:3798,5.3707477e-06,0.0037966190417785747,3.650648029677421e-05,9.570670348340446e-05,0.0,0.00050454657,False,KIF5A; kinesin family member
hsa:51691,0.0,0.0,1.0013218388709678e-06,1.6721027872660502e-06,0.0,6.042346e-06,False,LSM8; LSM8 homolog
hsa:54881,0.0,0.0,7.448984485774193e-06,2.512378302521346e-05,0.0,0.00010762693,False,TEX10; testis expressed
hsa:60559,2.4152098e-06,0.0017073286679562742,0.00011315727072096775,0.00022970362594433984,0.0,0.00091481186,False,SPCS3; signal peptidase complex subunit
hsa:163702,0.0,0.0,2.2568396612903227e-07,7.715534028001007e-07,0.0,3.5435764e-06,False,IFNLR1; interferon lambda receptor
hsa:57804,0.0006235844,0.4408161655398684,0.0012037589747741933,0.0015783874286865699,0.0,0.0065975375,True,POLD4; DNA polymerase delta 4
hsa:388333,0.0,0.0,1.7975474822580646e-07,8.485834251559867e-07,0.0,4.7177364e-06,False,SPDYE4; speedy/RINGO cell cycle regulator family member
hsa:91750,0.0,0.0,4.419889001387098e-07,8.070756485461542e-07,0.0,2.9855594e-06,False,LIN52; lin-52 DREAM MuvB core complex
hsa:6241,0.0,0.0,4.5677609096774194e-05,0.0001257980672859954,0.0,0.00065835234,False,RRM2; ribonucleotide reductase regulatory subunit
hsa:3030,0.0,0.0,0.0006162228940322581,0.0016212253187144646,0.0,0.007414072,False,HADHA; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:54460,0.0,0.0,6.179944941935484e-08,1.107958332780699e-07,0.0,4.3761415e-07,False,MRPS21; mitochondrial ribosomal protein
hsa:7335,0.0,0.0,5.736097862903225e-08,1.2209496777313787e-07,0.0,4.2685676e-07,False,UBE2V1; ubiquitin conjugating enzyme E2
hsa:4882,5.0144236e-06,0.003544731048025933,5.157054557161292e-05,0.00015899127729754065,0.0,0.00088137377,False,NPR2; natriuretic peptide receptor
hsa:7473,0.0,0.0,1.9381119048387094e-05,3.735502782956974e-05,0.0,0.00017217943,False,WNT3; Wnt family member
hsa:55616,0.0,0.0,8.022984097258065e-06,2.310593927230274e-05,0.0,9.603247e-05,False,ASAP3; ArfGAP with SH3 domain
hsa:79490,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10G6; olfactory receptor family 10 subfamily G member
hsa:6171,7.1099876e-08,5.026099868547082e-05,1.2925856888064517e-06,2.7243252715634664e-06,0.0,1.1745754e-05,False,RPL41; ribosomal protein
hsa:154807,0.0,0.0,2.574543442096774e-05,4.539941174834254e-05,0.0,0.00015679616,False,VKORC1L1; vitamin K epoxide reductase complex subunit 1 like
hsa:6427,0.0,0.0,2.65231755516129e-07,6.083759739062943e-07,0.0,2.3847329e-06,False,SRSF2; serine and arginine rich splicing factor
hsa:81797,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR12D3; olfactory receptor family 12 subfamily D member
hsa:1978,0.0,0.0,3.9596307000000005e-05,0.0001117459357319099,0.0,0.0004552884,False,EIF4EBP1; eukaryotic translation initiation factor 4E binding protein
hsa:284390,7.726659e-09,5.462029186127995e-06,6.119428366451612e-08,1.1343253249648184e-07,0.0,4.1762837e-07,False,ZNF763; zinc finger protein
hsa:55349,2.382891e-07,0.00016844822826219874,2.2587903980645164e-06,4.83354056469197e-06,0.0,2.0149862e-05,False,CHDH; choline
hsa:5210,0.0,0.0,5.816804733548387e-06,1.1857882256613854e-05,0.0,4.2802683e-05,False,PFKFB4; 6-phosphofructo-2-kinase/fructose-2
hsa:6594,5.761552e-08,4.072881329614018e-05,1.2462500024070967e-05,2.4928329406705003e-05,0.0,8.458025e-05,False,SMARCA1; SWI/SNF related
hsa:2944,0.0,0.0,8.783049217870967e-05,0.00033584822824873147,0.0,0.0018358366,False,GSTM1; glutathione S-transferase mu
hsa:22901,0.0,0.0,6.001929487096775e-08,1.1882950316819804e-07,0.0,4.6102343e-07,False,ARSG; arylsulfatase
hsa:7048,0.00036904495,0.26088045142061356,0.0007267250840967741,0.0009144452439493059,0.0,0.0028743646,False,TGFBR2; transforming growth factor beta receptor
hsa:6223,6.5118975e-08,4.6033058016503546e-05,2.1568845745483867e-06,6.108185261025356e-06,0.0,2.640859e-05,False,RPS19; ribosomal protein
hsa:10484,0.0,0.0,4.026328751435484e-07,1.0357415424691385e-06,0.0,4.2764555e-06,False,SEC23A; SEC23 homolog A
hsa:81567,1.32779245e-08,9.386257520903144e-06,1.1229530681903227e-06,3.270995781149695e-06,0.0,1.337366e-05,False,TXNDC5; thioredoxin domain containing
hsa:1736,0.0,0.0,9.825601488064518e-07,3.192762631466445e-06,0.0,1.274744e-05,False,DKC1; dyskerin pseudouridine synthase
hsa:6794,8.36503e-06,0.005913298102431628,3.519579400322581e-05,7.449638972456223e-05,0.0,0.0003364372,False,STK11; serine/threonine kinase
hsa:2916,0.0,0.0,1.4129705e-05,5.09523886831492e-05,0.0,0.00021017267,False,GRM6; glutamate metabotropic receptor
hsa:10767,1.3906053e-06,0.0009830285942454915,5.875106880193549e-05,0.00015564224078999292,0.0,0.0006685144,False,HBS1L; HBS1 like translational
hsa:2155,0.0,0.0,5.092389360967742e-08,1.4413375875053197e-07,0.0,7.589063e-07,False,F7; coagulation factor
hsa:8688,0.0,0.0,2.543585806451613e-08,1.3167233944509625e-07,0.0,7.3286276e-07,False,KRT37; keratin
hsa:637,1.0230478e-05,0.007231996316136166,0.00037661202519354844,0.0007384623836722905,0.0,0.0031808289,False,BID; BH3 interacting domain death
hsa:6996,0.0,0.0,6.285454033983871e-05,0.00020098253942621953,0.0,0.00082706625,False,TDG; thymine DNA
hsa:153090,0.0,0.0,1.1202007781870968e-05,3.581297351232817e-05,0.0,0.0001447538,False,DAB2IP; DAB2 interacting
hsa:8607,0.0,0.0,2.1720704401096773e-05,4.734889716673254e-05,0.0,0.00020650281,False,RUVBL1; RuvB like AAA ATPase
hsa:116228,2.3702978e-07,0.00016755800616301272,8.896203532903228e-07,1.340005841060629e-06,0.0,5.1268885e-06,False,COX20; cytochrome c oxidase assembly factor
hsa:7066,1.1901205e-06,0.0008413044895613024,3.077368522580645e-05,9.570131883006887e-05,0.0,0.00039603404,False,THPO;
hsa:57786,1.663275e-08,1.1757807086551951e-05,4.715693026774194e-08,5.544651239126818e-08,0.0,1.6907086e-07,False,RBAK; RB associated KRAB zinc
hsa:7381,4.135115e-06,0.0029231416603211894,1.1621604803225808e-05,2.0078542342566134e-05,0.0,8.353216e-05,False,UQCRB; ubiquinol-cytochrome c reductase binding
hsa:10775,0.0,0.0,3.807092105451613e-06,1.1997095065900544e-05,0.0,5.7098132e-05,False,POP4; POP4 homolog
hsa:1645,0.0,0.0,0.00042360271151612903,0.001287848457020029,0.0,0.0052223187,False,AKR1C1; aldo-keto reductase family 1 member
hsa:51128,1.4057617e-06,0.000993742759210793,3.783480687212904e-05,7.381781590021847e-05,0.0,0.00027697164,False,SAR1B; secretion associated Ras related GTPase
hsa:125,7.201069e-05,0.0509048594603716,0.000434535211967742,0.0008935640744776737,0.0,0.0036779435,False,ADH1B; alcohol dehydrogenase 1B (class I)
hsa:101954273,0.0,0.0,1.208184193548387e-09,6.726884896573238e-09,0.0,3.745371e-08,False,RNVU1-1; RNA
hsa:4090,2.0703679e-08,1.4635575215397142e-05,0.00022436564129029032,0.0004200393841091431,0.0,0.0012719211,False,SMAD5; SMAD family member
hsa:3815,0.0,0.0,0.0,0.0,0.0,0.0,False,KIT; KIT proto-oncogene
hsa:6646,5.0127004e-05,0.035435129059164475,0.00017803606828709675,0.00020973025872982122,0.0,0.0005980802,False,SOAT1; sterol O-acyltransferase
hsa:7779,1.3087244e-06,0.0009251464144331785,6.756698788387096e-05,0.00010421797191794582,0.0,0.00035971418,False,SLC30A1; solute carrier family 30 member
hsa:2316,1.6248053e-06,0.0011485862091720953,2.405819054516129e-06,3.1854610273405572e-06,0.0,1.2685553e-05,False,FLNA; filamin
hsa:1263,6.876093e-06,0.004860758143012446,2.4803514971290325e-05,4.059098947552364e-05,0.0,0.00013687772,False,PLK3; polo like kinase
hsa:3428,2.6944392e-07,0.00019047178800885823,9.207627764451613e-07,1.4609472271288811e-06,0.0,6.1136916e-06,False,IFI16; interferon gamma inducible protein
hsa:81168,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8J3; olfactory receptor family 8 subfamily J member
hsa:91012,1.2395926e-06,0.0008762766624110479,2.7209278891483868e-05,4.166633165178418e-05,0.0,0.00012853715,False,CERS5; ceramide synthase
hsa:4620,0.0,0.0,1.0617494225806452e-11,3.6901346039707414e-11,0.0,1.7471094e-10,False,MYH2; myosin heavy chain
hsa:11226,2.4595147e-07,0.0001738648111054317,5.956803422064516e-05,0.00015803639070572707,0.0,0.00071073277,False,GALNT6; polypeptide N-acetylgalactosaminyltransferase
hsa:340665,2.1726272e-07,0.00015358453345715845,2.0750093983870966e-06,4.26229409276803e-06,0.0,2.0279778e-05,False,CYP26C1; cytochrome P450 family 26 subfamily C member
hsa:3455,5.228379e-05,0.03695977613887024,0.00012515195554838713,0.00020656878898637056,0.0,0.0007900541,False,IFNAR2; interferon alpha and beta receptor subunit
hsa:2634,2.7373204e-07,0.0001935030899717919,1.0487090549354838e-06,1.993325856622401e-06,0.0,8.069738e-06,False,GBP2; guanylate binding protein
hsa:3809,0.0,0.0,1.5117834419354839e-09,7.412755498800623e-09,0.0,4.1055653e-08,False,KIR2DS4; killer cell immunoglobulin like receptor
hsa:9436,0.0,0.0,3.3642051451612904e-09,1.6326803991756568e-08,0.0,9.088578e-08,False,NCR2; natural cytotoxicity triggering receptor
hsa:6636,2.537052e-08,1.7934597697043962e-05,3.1070743157419353e-07,5.586313876477253e-07,0.0,2.0613074e-06,False,SNRPF; small nuclear ribonucleoprotein polypeptide
hsa:7770,0.0,0.0,4.8063548016129044e-08,7.025464502950946e-08,0.0,2.466676e-07,False,ZNF227; zinc finger protein
hsa:23547,0.0,0.0,1.675663871806452e-06,3.856367524085061e-06,0.0,1.84329e-05,False,LILRA4; leukocyte immunoglobulin like receptor
hsa:7414,1.7268547e-05,0.01220725642428675,0.0001262792604290323,0.00018849594246431867,0.0,0.0006988179,False,VCL;
hsa:5540,1.4556469e-09,1.0290069553343482e-06,3.1921756560967746e-07,8.836043685586845e-07,0.0,4.242142e-06,False,NPY4R; neuropeptide Y receptor
hsa:55341,0.0,0.0,2.280422818580645e-06,6.059817439915373e-06,0.0,2.9045386e-05,False,LSG1; large 60S subunit nuclear export GTPase
hsa:4547,0.0,0.0,1.0928217525806452e-07,3.4414395145993963e-07,0.0,1.6118332e-06,False,MTTP; microsomal triglyceride transfer
hsa:84647,0.0,0.0,2.228440306451613e-07,7.777377669682504e-07,0.0,3.4787445e-06,False,PLA2G12B; phospholipase A2 group
hsa:2173,2.1174606e-07,0.00014968476799191081,0.00011486829730880645,0.00042953818632582595,0.0,0.0022142446,False,FABP7; fatty acid binding protein
hsa:96459,0.0,0.0,1.9402309322580647e-06,5.70178029052737e-06,0.0,2.4588946e-05,False,FNIP1; folliculin interacting protein
hsa:5144,1.8870555e-06,0.001333972706294319,0.00012811197048290325,0.0003050879902111185,0.0,0.0013696811,False,PDE4D; phosphodiesterase
hsa:11264,0.0,0.0,2.2960511945161285e-07,4.810462450908231e-07,0.0,1.7576775e-06,False,PXMP4; peroxisomal membrane protein
hsa:840,0.00011522953,0.08145655916273921,0.0007187961340258065,0.0009923455611293658,0.0,0.003264699,False,CASP7; caspase
hsa:6185,0.0,0.0,7.177166922935484e-05,0.00019843528112728403,0.0,0.0008407208,False,RPN2; ribophorin
hsa:9442,0.0,0.0,3.563452167516129e-06,9.490903207009549e-06,0.0,4.7646576e-05,False,MED27; mediator complex subunit
hsa:23382,4.9310387e-07,0.0003485785680114348,3.4762994249677424e-05,7.37482715286064e-05,0.0,0.00035471263,False,AHCYL2; adenosylhomocysteinase like
hsa:8642,0.0,0.0,1.7454008032258065e-05,3.7874384334667184e-05,0.0,0.00013874662,False,DCHS1; dachsous cadherin-related
hsa:94033,0.0,0.0,0.0,0.0,0.0,0.0,False,FTMT; ferritin
hsa:8399,0.0,0.0,0.0,0.0,0.0,0.0,False,PLA2G10; phospholipase A2 group
hsa:406884,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7B; microRNA
hsa:56953,0.0,0.0,1.0321401290322581e-05,2.236132526187229e-05,0.0,9.539169e-05,False,NT5M; 5'
hsa:3670,0.0,0.0,4.852845723e-07,1.1509497710951475e-06,0.0,5.364011e-06,False,ISL1; ISL LIM homeobox
hsa:11091,0.0,0.0,4.836645214516128e-06,1.9418638350807506e-05,0.0,0.00010696612,False,WDR5; WD repeat domain
hsa:7185,1.4253558e-06,0.0010075939652852309,4.1482017741935485e-05,0.00011384450245262115,0.0,0.0005369886,False,TRAF1; TNF receptor associated factor
hsa:5252,0.0,0.0,0.0001317036656620645,0.0003883086504507642,0.0,0.001395863,False,PHF1; PHD finger protein
hsa:56670,4.1558925e-09,2.9378294201168237e-06,1.5440744795893546e-05,6.24387040109468e-05,0.0,0.00033399148,False,SUCNR1; succinate receptor
hsa:10911,5.3543545e-08,3.785030574259297e-05,3.2538283401129034e-05,0.0001354559835310766,0.0,0.0007444398,False,UTS2; urotensin
hsa:390321,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C1; olfactory receptor family 6 subfamily C member
hsa:2049,0.0,0.0,3.2102598366935484e-06,1.3337437493585799e-05,0.0,7.3182804e-05,False,EPHB3; EPH receptor
hsa:1296,3.2799196e-06,0.0023185980620282656,5.723971648870968e-05,0.00016623121110601735,0.0,0.00084836397,False,COL8A2; collagen type VIII alpha 2
hsa:23025,7.5127865e-08,5.31084122285562e-05,1.3984208376774196e-06,3.0148221204174645e-06,0.0,1.100787e-05,False,UNC13A; unc-13 homolog
hsa:1852,0.0,0.0,8.966773348387096e-08,2.8953257696192995e-07,0.0,1.290455e-06,False,DUSP9; dual specificity phosphatase
hsa:4337,2.2427396e-06,0.0015854082795791846,7.879146247741934e-06,1.7659393809326774e-05,0.0,6.346627e-05,False,MOCS1; molybdenum cofactor synthesis
hsa:7476,0.0,0.0,0.0,0.0,0.0,0.0,False,WNT7A; Wnt family member
hsa:10427,0.0,0.0,3.489437903870968e-07,8.610835838131547e-07,0.0,2.836292e-06,False,SEC24B; SEC24 homolog B
hsa:219473,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8K3; olfactory receptor family 8 subfamily K member 3
hsa:60412,0.0,0.0,5.686330729032258e-07,1.4587073113827906e-06,0.0,6.477635e-06,False,EXOC4; exocyst complex component
hsa:25,0.0,0.0,4.491071007322582e-05,0.00010250203985418332,0.0,0.0004090733,False,ABL1; ABL proto-oncogene 1
hsa:4860,7.1241426e-05,0.050361061368617115,0.00019828812534838713,0.0004294191199206278,0.0,0.0023575043,False,PNP; purine nucleoside
hsa:292,8.539387e-06,0.006036552282900278,0.00014741879507096774,0.0004445226934614939,0.0,0.0024436093,False,SLC25A5; solute carrier family 25 member
hsa:1356,5.0872973e-06,0.003596245975279891,7.618181354838709e-05,0.00016555169189443755,0.0,0.0007825657,False,CP;
hsa:3680,3.651431e-05,0.02581222064171918,0.00019985049150438714,0.00032990806240951957,0.0,0.0010727196,False,ITGA9; integrin subunit alpha
hsa:81,0.0,0.0,0.00013067983071451614,0.00030177477789291603,0.0,0.001062779,False,ACTN4; actinin alpha
hsa:9489,0.0,0.0,7.100548870887096e-06,3.2205386328719016e-05,0.0,0.0001795601,False,PGS1; phosphatidylglycerophosphate synthase
hsa:406894,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR101-2; microRNA
hsa:219986,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4D11; olfactory receptor family 4 subfamily D member
hsa:1135,1.5261384e-09,1.0788378887784073e-06,1.214454264e-07,2.4254288509434114e-07,0.0,1.146407e-06,False,CHRNA2; cholinergic receptor nicotinic alpha 2
hsa:220441,0.0,0.0,4.323221145683871e-07,9.499451185596925e-07,0.0,3.2400494e-06,False,RNF152; ring finger protein
hsa:1654,2.1234162e-06,0.0015010577351345518,4.8219691672580654e-05,0.00015440563216147137,0.0,0.00065895286,False,DDX3X; DEAD-box helicase 3
hsa:7456,0.0,0.0,2.3630652570967742e-07,5.024158514684019e-07,0.0,1.8893788e-06,False,WIPF1; WAS/WASL interacting protein family member
hsa:8801,1.7278993e-05,0.012214640774609221,0.000496460696,0.0017976478497469827,0.0,0.008921726,False,SUCLG2; succinate-CoA ligase GDP-forming subunit
hsa:5373,2.7610445e-06,0.0019518016316234707,2.0152224183870967e-05,4.189409027099302e-05,0.0,0.00017089641,False,PMM2; phosphomannomutase
hsa:6344,0.0,0.0,1.002307793548387e-06,4.297435420583903e-06,0.0,2.3504515e-05,False,SCTR; secretin
hsa:219429,0.0,0.0,5.299535483870968e-07,2.950656480664996e-06,0.0,1.642856e-05,False,OR4C11; olfactory receptor family 4 subfamily C member
hsa:390916,1.6354482e-08,1.156109749479108e-05,6.243855090741935e-06,1.6419517287188246e-05,0.0,6.7249886e-05,False,NUDT19; nudix hydrolase
hsa:3880,0.0,0.0,2.755612838483871e-06,5.701032872344888e-06,0.0,2.409902e-05,False,KRT19; keratin
hsa:3667,5.123515e-05,0.036218485202420055,0.00034310321151612903,0.0006179187890540498,0.0,0.0029332587,False,IRS1; insulin receptor substrate
hsa:1742,0.0,0.0,7.464402558064516e-05,0.0001971624007234841,0.0,0.0009033963,False,DLG4; discs large MAGUK scaffold protein
hsa:487,0.0,0.0,1.5777479999999998e-07,8.784529087926343e-07,0.0,4.8910188e-06,False,ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84671,0.0,0.0,2.128725983548387e-08,4.6305106563707366e-08,0.0,1.6417951e-07,False,ZNF347; zinc finger protein
hsa:100169763,0.0,0.0,1.8725654838709677e-06,9.112079062110757e-06,0.0,5.0410825e-05,False,RNA5S12; RNA
hsa:7374,0.0,0.0,3.977521935483871e-06,1.0088751266382158e-05,0.0,4.1764793e-05,False,UNG; uracil DNA
hsa:10573,0.0,0.0,3.3576536783870965e-07,7.918886523103895e-07,0.0,3.0042982e-06,False,MRPL28; mitochondrial ribosomal protein
hsa:137970,0.0,0.0,3.6472466225806456e-09,1.2980235243932327e-08,0.0,7.108644e-08,False,UNC5D; unc-5 netrin receptor
hsa:3772,5.7008856e-07,0.0004029995827947992,2.6795124909135488e-05,8.012796964982208e-05,0.0,0.00041880825,False,KCNJ15; potassium inwardly rectifying channel subfamily J member
hsa:10841,0.0,0.0,5.8493667141806455e-06,1.3296251607128276e-05,0.0,5.2081712e-05,False,FTCD; formimidoyltransferase
hsa:6456,0.0,0.0,1.313533479483871e-07,3.562465467315237e-07,0.0,1.5468041e-06,False,SH3GL2; SH3 domain containing GRB2 like 2
hsa:1589,1.9572492e-05,0.013835931228394665,4.925997412580644e-05,8.688034317813482e-05,0.0,0.00044048458,False,CYP21A2; cytochrome P450 family 21 subfamily A member
hsa:765,0.0,0.0,4.6011773387096767e-07,1.1449757151442312e-06,0.0,4.5147817e-06,False,CA6; carbonic anhydrase
hsa:97,1.0528989e-06,0.0007443015825911381,6.723371107483871e-06,1.2917568713073014e-05,0.0,4.0991406e-05,False,ACYP1; acylphosphatase
hsa:5705,1.1345953e-07,8.020533380654754e-05,6.133259339354838e-06,1.07587585104863e-05,0.0,3.8296464e-05,False,PSMC5; proteasome 26S subunit
hsa:4889,4.561191e-08,3.224337759114818e-05,3.7899416172516125e-07,5.638186931354039e-07,0.0,1.8036852e-06,False,NPY5R; neuropeptide Y receptor
hsa:57452,0.0,0.0,0.00018902628958064512,0.0004332425885457033,0.0,0.0018577304,False,GALNT16; polypeptide N-acetylgalactosaminyltransferase
hsa:1807,0.0,0.0,2.4018888870967746e-05,4.52683627464573e-05,0.0,0.00017098957,False,DPYS;
hsa:138716,0.0,0.0,1.9655688677741933e-06,6.246284169766752e-06,0.0,3.24483e-05,False,RPP25L; ribonuclease P/MRP subunit p25
hsa:6875,1.8733724e-08,1.3243000273839765e-05,1.1173159420645165e-06,2.54303351552379e-06,0.0,8.815598e-06,False,TAF4B; TATA-box binding protein associated factor
hsa:390883,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR7G3; olfactory receptor family 7 subfamily G member
hsa:204851,6.295779e-07,0.000445053012529888,1.4289241858064515e-06,1.7301229130115853e-06,0.0,5.9472854e-06,False,HIPK1; homeodomain interacting protein kinase
hsa:28227,5.3112306e-08,3.7545459883056956e-05,6.826304347612903e-06,1.4171087193081567e-05,0.0,6.9535556e-05,False,PPP2R3B; protein phosphatase 2 regulatory subunit
hsa:4635,0.0,0.0,8.659020568258065e-05,0.0003206344139469736,0.0,0.0017604016,False,MYL4; myosin light chain
hsa:9020,0.0,0.0,4.218361093548387e-05,6.588591557446501e-05,0.0,0.0002702001,False,MAP3K14; mitogen-activated protein kinase kinase kinase
hsa:341276,0.0,0.0,1.5490123612903226e-07,6.464444514478333e-07,0.0,3.5309008e-06,False,OR10A2; olfactory receptor family 10 subfamily A member
hsa:3817,0.0,0.0,1.890174058064516e-06,6.185083250777901e-06,0.0,3.1050982e-05,False,KLK2; kallikrein related peptidase
hsa:2149,8.186644e-06,0.005787195793736934,0.00033467138810645163,0.0011818278019130113,0.0,0.0062985155,False,F2R; coagulation factor II thrombin
hsa:51143,0.0,0.0,0.00013149076104612903,0.00035938235037289774,0.0,0.0014465039,False,DYNC1LI1; dynein cytoplasmic 1 light intermediate chain
hsa:8717,5.3277574e-05,0.03766228898597622,0.00012620714232258065,0.00017911453398492653,0.0,0.00066603784,False,TRADD; TNFRSF1A associated via death
hsa:63934,0.0,0.0,6.623627153225808e-08,1.1051811163810841e-07,0.0,3.6191645e-07,False,ZNF667; zinc finger protein
hsa:285203,3.6834618e-07,0.0002603864860295706,1.575852587354839e-05,2.761284141254567e-05,0.0,9.6063166e-05,False,EOGT; EGF domain specific O-linked N-acetylglucosamine
hsa:5980,2.0714098e-05,0.01464294047923113,9.808334695161291e-05,0.0001617672739983066,0.0,0.0007208735,False,REV3L; REV3 like
hsa:55788,0.0,0.0,0.00016819412843225806,0.0005126263223109023,0.0,0.0021399711,False,LMBRD1; LMBR1 domain containing
hsa:1357,0.0,0.0,3.05803935483871e-08,1.192112002232347e-07,0.0,5.2869837e-07,False,CPA1; carboxypeptidase
hsa:3674,0.0,0.0,0.0,0.0,0.0,0.0,False,ITGA2B; integrin subunit alpha
hsa:23533,3.9779883e-05,0.028120676992055282,0.00011764713145870969,0.00016866567951135273,0.0,0.0005575096,False,PIK3R5; phosphoinositide-3-kinase regulatory subunit
hsa:951,1.236432e-05,0.008740424122072177,0.00012644045293354838,0.00028287868943970376,0.0,0.0012298055,False,CD37; CD37
hsa:26831,0.0,0.0,9.097008835161291e-08,2.6308114107433117e-07,0.0,1.2367591e-06,False,RNU5A-1; RNA
hsa:403273,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5H14; olfactory receptor family 5 subfamily H member
hsa:5644,0.0,0.0,0.0,0.0,0.0,0.0,False,PRSS1; serine protease
hsa:8315,0.0,0.0,2.2155533432258065e-08,5.098848725576529e-08,0.0,1.9781102e-07,False,BRAP; BRCA1 associated
hsa:2259,9.5963e-09,6.7836914608034445e-06,1.2829502311612904e-07,3.1600403361451165e-07,0.0,1.5316227e-06,False,FGF14; fibroblast growth factor
hsa:84823,7.819648e-08,5.5277637593748346e-05,1.8993260515651613e-06,4.315623067007041e-06,0.0,1.6438722e-05,False,LMNB2; lamin
hsa:58538,0.0,0.0,8.786811155806453e-08,2.8544286107551807e-07,0.0,1.323528e-06,False,MPP4; MAGUK p55 scaffold protein
hsa:3460,1.0098596e-05,0.007138768009681212,0.00016304432612903222,0.00026509437142287505,0.0,0.0012065793,False,IFNGR2; interferon gamma receptor
hsa:9037,0.0,0.0,9.805885806451614e-11,5.4596861539142e-10,0.0,3.0398246e-09,False,SEMA5A; semaphorin
hsa:1610,0.0,0.0,5.117232888387097e-06,1.57054045608321e-05,0.0,7.469832e-05,False,DAO; D-amino acid
hsa:5208,8.146174e-06,0.005758587268219943,6.507628269741935e-05,0.00014341449960607577,0.0,0.00066721364,False,PFKFB2; 6-phosphofructo-2-kinase/fructose-2
hsa:122481,3.751799e-07,0.0002652172904030814,6.708314647419355e-06,1.1575549645904524e-05,0.0,3.7336686e-05,False,AK7; adenylate kinase
hsa:5551,0.0,0.0,2.6483079866774192e-05,6.882724175308593e-05,0.0,0.00033650277,False,PRF1; perforin
hsa:6403,2.2838869e-05,0.016144955931943403,0.00015874661945225807,0.00029157699377962867,0.0,0.0010623963,False,SELP; selectin
hsa:4142,0.0,0.0,9.86285527419355e-07,2.7835278321551174e-06,0.0,1.3143551e-05,False,MAS1; MAS1 proto-oncogene
hsa:54995,0.0,0.0,1.3552657741935483e-05,7.035725938520193e-05,0.0,0.00039201122,False,OXSM; 3-oxoacyl-ACP synthase
hsa:253314,0.0,0.0,6.452468754838709e-07,1.2286929720960833e-06,0.0,5.4302914e-06,False,EIF4E1B; eukaryotic translation initiation factor 4E family member
hsa:284406,0.0,0.0,5.0512962229999996e-08,1.0197635965746997e-07,0.0,4.4056296e-07,False,ZFP82; ZFP82 zinc finger
hsa:8807,3.5200569e-07,0.0002488352795772563,4.479190113774193e-05,9.049408924499713e-05,0.0,0.00036695556,False,IL18RAP; interleukin 18 receptor accessory
hsa:7425,1.0804278e-06,0.0007637619541776155,1.1795593840751614e-05,2.2822860861129475e-05,0.0,8.5816406e-05,False,VGF; VGF nerve growth factor
hsa:79290,0.0,0.0,2.748971219354839e-07,1.3471163184800757e-06,0.0,7.4740024e-06,False,OR13A1; olfactory receptor family 13 subfamily A member
hsa:139735,2.2214341e-10,1.5703472728976358e-07,1.1286068120322583e-08,2.514241375329977e-08,0.0,1.2499181e-07,False,ZFP92; ZFP92 zinc finger
hsa:728358,0.0,0.0,5.508613112903226e-06,2.0967780156751505e-05,0.0,0.00011240121,False,DEFA1B; defensin alpha
hsa:2290,0.0,0.0,5.506902045225805e-08,1.7906387550350152e-07,0.0,7.118342e-07,False,FOXG1; forkhead box
hsa:4710,0.0,0.0,3.763107251612903e-06,8.320569705344477e-06,0.0,3.5151294e-05,False,NDUFB4; NADH:ubiquinone oxidoreductase subunit
hsa:390649,0.0,0.0,1.0539486923870968e-06,5.474320600890868e-06,0.0,3.0482775e-05,False,OR4F15; olfactory receptor family 4 subfamily F member
hsa:57704,0.0,0.0,8.965578312903225e-05,0.00023689260075370402,0.0,0.0009335654,False,GBA2; glucosylceramidase beta
hsa:5696,1.0124754e-06,0.0007157259282487574,6.859470984516129e-06,1.2787678958406754e-05,0.0,5.427909e-05,False,PSMB8; proteasome 20S subunit beta
hsa:440153,-0.0,0.0,8.031729677419355e-07,4.471877826981971e-06,-0.0,2.4898362e-05,False,OR11H12; olfactory receptor family 11 subfamily H member
hsa:8646,7.656777e-08,5.412629112488794e-05,0.0001309395885945161,0.00032474195685229025,0.0,0.001197415,False,CHRD;
hsa:4490,-0.0,0.0,3.728245806451613e-07,2.0757994137031767e-06,-0.0,1.1557562e-05,False,MT1B; metallothionein
hsa:8654,7.362276e-07,0.0005204444299706984,1.5136299249677418e-05,4.293460945672128e-05,0.0,0.00016696329,False,PDE5A; phosphodiesterase
hsa:547,5.8511135e-10,4.136192979183826e-07,1.4492501682741933e-07,2.6927929406463864e-07,0.0,9.998932e-07,False,KIF1A; kinesin family member
hsa:144811,0.0,0.0,1.1462115558709677e-05,3.149418080513138e-05,0.0,0.00016427298,False,LACC1; laccase domain containing
hsa:2717,0.0,0.0,0.00025879148412903224,0.0006734804826681284,0.0,0.00327067,False,GLA; galactosidase
hsa:59344,7.616037e-08,5.3838297220869575e-05,2.3581436240000005e-05,6.202807704794414e-05,-0.0,0.00025968108,False,ALOXE3; arachidonate lipoxygenase
hsa:1544,0.0,0.0,2.1350589032258065e-06,1.1323355941118637e-05,0.0,6.307271e-05,False,CYP1A2; cytochrome P450 family 1 subfamily A member
hsa:2766,0.0,0.0,7.483811983721289e-06,2.5648320835869617e-05,0.0,0.00012506916,False,GMPR; guanosine monophosphate
hsa:9212,0.0,0.0,2.1055087324893546e-05,7.589164086625024e-05,0.0,0.00039585918,False,AURKB; aurora kinase
hsa:282770,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10AG1; olfactory receptor family 10 subfamily AG member
hsa:5133,0.0,0.0,3.1806428650967744e-06,8.266287921360073e-06,0.0,3.5234087e-05,False,PDCD1; programmed cell death
hsa:119678,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52E2; olfactory receptor family 52 subfamily E member
hsa:79744,3.747294e-10,2.648988288081863e-07,8.40923591183871e-08,1.5143210833947362e-07,0.0,5.550229e-07,False,ZNF419; zinc finger protein
hsa:3598,0.0,0.0,8.586076771935483e-07,2.400289742374904e-06,0.0,1.1999187e-05,False,IL13RA2; interleukin 13 receptor subunit alpha
hsa:1073,0.0,0.0,2.3906248225806447e-05,6.740040647807764e-05,0.0,0.00028749657,False,CFL2; cofilin
hsa:29956,7.2341237e-07,0.0005113852544218689,2.4872432263548386e-05,5.5083374304149735e-05,0.0,0.00022434797,False,CERS2; ceramide synthase
hsa:54766,0.0,0.0,4.488594800816129e-07,2.0809804698488497e-06,0.0,1.1492782e-05,False,BTG4; BTG anti-proliferation factor
hsa:50838,-0.0,0.0,1.5692908064516128e-08,6.437741350820713e-08,0.0,3.2581235e-07,False,TAS2R13; taste 2 receptor member
hsa:10220,0.0,0.0,2.2356211983870964e-06,8.135119620614564e-06,0.0,4.3989425e-05,False,GDF11; growth differentiation factor
hsa:55705,0.0,0.0,3.03540901483871e-08,7.727101464090217e-08,0.0,3.4334144e-07,False,IPO9; importin
hsa:219493,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5AR1; olfactory receptor family 5 subfamily AR member
hsa:23262,3.5506994e-07,0.0002510014192934768,8.747393670774194e-06,2.2662586212704312e-05,0.0,0.0001146347,False,PPIP5K2; diphosphoinositol pentakisphosphate kinase
hsa:11277,0.0,0.0,2.2493002301064517e-06,5.608095781660111e-06,0.0,2.1283222e-05,False,TREX1; three prime repair exonuclease
hsa:9759,0.0,0.0,2.0995293306451614e-05,4.558560149505631e-05,0.0,0.00022354265,False,HDAC4; histone deacetylase
hsa:27345,2.5669792e-06,0.0018146155163031642,7.83196266064516e-05,0.00020958215632570915,0.0,0.0010936691,False,KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:51393,0.0,0.0,6.216401086990323e-05,0.00014556144327111792,0.0,0.0006520959,False,TRPV2; transient receptor potential cation channel subfamily V member
hsa:30844,0.0,0.0,5.8867194303225794e-08,1.9824850365286207e-07,0.0,1.0900704e-06,False,EHD4; EH domain containing
hsa:8932,0.0,0.0,1.417967268548387e-05,2.875557612342714e-05,0.0,0.00010469361,False,MBD2; methyl-CpG binding domain protein
hsa:5223,6.089434e-05,0.04304663404325225,0.0003891141622580645,0.0011575324205363145,0.0,0.005319656,False,PGAM1; phosphoglycerate mutase
hsa:1843,0.0,0.0,0.00027314298027661285,0.000588911980933231,0.0,0.0020695182,False,DUSP1; dual specificity phosphatase
hsa:27248,0.0,0.0,2.899188842225806e-06,8.641874303953795e-06,0.0,3.838143e-05,False,ERLEC1; endoplasmic reticulum lectin
hsa:27094,0.0,0.0,1.0377977274193552e-06,1.8584580801683955e-06,0.0,7.148109e-06,False,KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:29088,1.604971e-08,1.1345652040408455e-05,2.3047759709677415e-07,3.210052748445827e-07,0.0,9.892362e-07,False,MRPL15; mitochondrial ribosomal protein
hsa:163255,0.0,0.0,3.3839531741935485e-08,7.003915844449256e-08,0.0,2.831659e-07,False,ZNF540; zinc finger protein
hsa:85407,2.3040663e-08,1.6287605519246985e-05,6.091688752580645e-07,1.535640094073038e-06,0.0,8.015405e-06,False,NKD1; NKD inhibitor of WNT signaling pathway
hsa:6165,2.4261277e-07,0.0001715046607683034,1.6809606461290324e-06,3.306602003994317e-06,0.0,1.3725905e-05,False,RPL35A; ribosomal protein
hsa:26147,0.0,0.0,2.9876609296774195e-06,1.0922683940405805e-05,0.0,5.4041364e-05,False,PHF19; PHD finger protein
hsa:219482,0.0,0.0,1.1869972258064516e-07,6.608920852623261e-07,0.0,3.6796914e-06,False,OR5M3; olfactory receptor family 5 subfamily M member
hsa:8809,2.1305594e-05,0.01506107313080511,5.1889537564516126e-05,8.0889178044088e-05,0.0,0.00037803393,False,IL18R1; interleukin 18 receptor
hsa:147923,0.0,0.0,6.240424283225807e-08,1.8437883775384636e-07,0.0,7.159091e-07,False,ZNF420; zinc finger protein
hsa:79334,0.0,0.0,0.0,0.0,0.0,0.0,False,OR11H2; olfactory receptor family 11 subfamily H member
hsa:79623,1.1262983e-06,0.0007961881308449543,3.844750079032258e-05,6.596883610250218e-05,0.0,0.00029340826,False,GALNT14; polypeptide N-acetylgalactosaminyltransferase
hsa:2189,6.5827376e-06,0.004653383162867955,6.373985264193548e-05,0.00023158590327409368,0.0,0.0012816471,False,FANCG; FA complementation group
hsa:1595,0.0,0.0,2.843750837096774e-05,6.409773759537484e-05,0.0,0.00030374478,False,CYP51A1; cytochrome P450 family 51 subfamily A member
hsa:23039,0.0,0.0,2.3684833056774197e-07,6.558509892186114e-07,0.0,2.277004e-06,False,XPO7; exportin
hsa:124583,0.0,0.0,2.7536353304290326e-05,7.187556187999916e-05,0.0,0.00027652193,False,CANT1; calcium activated nucleotidase
hsa:6541,0.0,0.0,3.8902564285806455e-07,7.232465216897244e-07,0.0,2.7599908e-06,False,SLC7A1; solute carrier family 7 member
hsa:401993,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T5; olfactory receptor family 2 subfamily T member
hsa:4049,0.0,0.0,0.0,0.0,0.0,0.0,False,LTA; lymphotoxin
hsa:79748,0.0,0.0,9.949757730129032e-09,2.014069999492387e-08,0.0,7.219814e-08,False,LMAN1L; lectin
hsa:9831,9.982947e-09,7.057014924247195e-06,5.887659797419355e-08,1.2840038085879573e-07,0.0,4.9618467e-07,False,ZNF623; zinc finger protein
hsa:4632,0.0,0.0,3.837332672903226e-08,1.5759027920131303e-07,-0.0,8.403415e-07,False,MYL1; myosin light chain
hsa:54468,0.0,0.0,1.9415142174516127e-06,4.871436846895739e-06,0.0,1.9723348e-05,False,MIOS; meiosis regulator for oocyte
hsa:6095,0.0,0.0,6.862680276774195e-05,0.00015621215606766853,0.0,0.00063503673,False,RORA; RAR related orphan receptor
hsa:10772,7.755139e-09,5.482161896944006e-06,6.336145228064516e-07,1.17322953000965e-06,0.0,4.3682912e-06,False,SRSF10; serine and arginine rich splicing factor
hsa:54457,0.0,0.0,3.4131148637096775e-08,6.939424079275971e-08,0.0,2.3601532e-07,False,TAF7L; TATA-box binding protein associated factor 7
hsa:1176,0.0,0.0,1.8564174108709677e-07,3.413561939074434e-07,0.0,1.2238751e-06,False,AP3S1; adaptor related protein complex 3 subunit sigma
hsa:525,7.946509e-06,0.005617442685878694,7.452670904193549e-05,0.00020420496953648906,0.0,0.0009907663,False,ATP6V1B1; ATPase H+ transporting V1 subunit
hsa:51729,0.0,0.0,1.6623365333870967e-07,2.932772129427018e-07,0.0,9.424409e-07,False,WBP11; WW domain binding protein
hsa:9248,0.0,0.0,5.711238323635484e-07,2.3853028813861263e-06,0.0,1.3068529e-05,False,GPR50; G protein-coupled receptor
hsa:169200,0.0,0.0,1.5224559767741936e-07,4.755651650324928e-07,0.0,2.0844057e-06,False,TMEM64; transmembrane protein
hsa:1828,0.0,0.0,3.5245025806451613e-11,1.9623599865218581e-10,0.0,1.0925958e-09,False,DSG1; desmoglein
hsa:59272,0.0,0.0,5.6035569080645164e-05,0.00010535280524913974,0.0,0.00042566634,False,ACE2; angiotensin converting enzyme
hsa:26539,0.0,0.0,1.7023631290322583e-08,8.848989110719564e-08,0.0,4.926095e-07,False,OR10H1; olfactory receptor family 10 subfamily H member
hsa:23049,0.0,0.0,9.986947051612903e-08,2.4063421156214165e-07,0.0,9.110007e-07,False,SMG1; SMG1 nonsense mediated mRNA decay associated PI3K related
hsa:1901,4.3240714e-05,0.030567162585667797,9.700395876258066e-05,0.00012777567669245557,0.0,0.00040072537,False,S1PR1; sphingosine-1-phosphate receptor
hsa:29904,0.0,0.0,1.454481312903226e-06,2.6910975852860748e-06,0.0,1.1509439e-05,False,EEF2K; eukaryotic elongation factor 2
hsa:4609,0.0007268417,0.5138094717386762,0.0015244877616129033,0.0017772474072494226,3.689512e-05,0.007575838,True,MYC; MYC proto-oncogene
hsa:9133,2.047222e-06,0.001447195523250518,4.858469159558065e-05,0.000208505460554628,0.0,0.0011667267,False,CCNB2; cyclin
hsa:6788,9.6774675e-05,0.06841069333175584,0.0003728404739032259,0.0006988364932616586,0.0,0.003042993,False,STK3; serine/threonine kinase
hsa:24,0.0,0.0,1.7786076451612902e-05,3.847570509898918e-05,0.0,0.00013767135,False,ABCA4; ATP binding cassette subfamily A member
hsa:2959,5.1772656e-07,0.00036598451946095285,5.617780955387097e-06,9.609845886631059e-06,0.0,3.6398596e-05,False,GTF2B; general transcription factor
hsa:3107,4.4003467e-05,0.031106358006069645,0.0004853476731935484,0.0008682794441872742,0.0,0.0033773521,False,HLA-C; major histocompatibility complex
hsa:100529097,0.0,0.0,2.0429290619354836e-08,4.0673171883678e-08,0.0,1.5739674e-07,False,RPL36A-HNRNPH2; RPL36A-HNRNPH2
hsa:6041,0.0,0.0,3.313155006451613e-07,5.689301601565556e-07,0.0,2.5733261e-06,False,RNASEL; ribonuclease
hsa:4891,0.0,0.0,3.9805136480645154e-05,0.00012490180550101882,0.0,0.0006152444,False,SLC11A2; solute carrier family 11 member
hsa:9351,0.0,0.0,0.0005371936019354838,0.001281641633921583,0.0,0.0055087116,False,NHERF2; NHERF family PDZ scaffold protein
hsa:10885,0.0,0.0,4.7668112554838714e-07,1.170053721015818e-06,0.0,4.8868424e-06,False,WDR3; WD repeat domain
hsa:5281,2.635209e-06,0.0018628476382285234,1.9436963816387098e-05,3.385924377875294e-05,0.0,0.00014709466,False,PIGF; phosphatidylinositol glycan anchor biosynthesis class
hsa:50613,0.0,0.0,0.0,0.0,0.0,0.0,False,UBQLN3; ubiquilin
hsa:342892,0.0,0.0,3.1080434970967733e-09,8.27755941068726e-09,0.0,3.7282973e-08,False,ZNF850; zinc finger protein
hsa:54464,0.0,0.0,3.75079195483871e-07,7.174913063440034e-07,0.0,2.4263547e-06,False,XRN1; 5'-3' exoribonuclease
hsa:135,0.0,0.0,0.00010449586741161291,0.0003575023725531845,0.0,0.0017233443,False,ADORA2A; adenosine A2a
hsa:10671,3.6173979e-06,0.002557163828200276,6.773753648709678e-05,0.00017057730510311195,0.0,0.00070112594,False,DCTN6; dynactin subunit
hsa:50,1.2985168e-06,0.0009179305907349514,4.1747668790322586e-05,9.568321805802507e-05,0.0,0.00045026685,False,ACO2; aconitase
hsa:1749,0.0,0.0,3.347068664516129e-07,9.2422582072263e-07,0.0,4.909622e-06,False,DLX5; distal-less homeobox
hsa:5880,0.0,0.0,3.539133227096773e-05,6.932025884414789e-05,0.0,0.000251551,False,RAC2; Rac family small GTPase
hsa:84274,0.0,0.0,3.166907461290323e-05,6.388737409897078e-05,0.0,0.00021545935,False,COQ5; coenzyme Q5
hsa:3777,0.0,0.0,1.6004331064516128e-06,3.5336186000739143e-06,0.0,1.5023539e-05,False,KCNK3; potassium two pore domain channel subfamily K member
hsa:463,7.01635e-09,4.959906795432431e-06,1.9902446580645161e-07,4.4975694236119946e-07,0.0,2.075067e-06,False,ZFHX3; zinc finger homeobox
hsa:5569,3.9858044e-08,2.8175929548589343e-05,5.271495886580645e-06,1.2845787944026181e-05,0.0,6.652878e-05,False,PKIA; cAMP-dependent protein kinase inhibitor
hsa:713,0.0,0.0,6.787980387096775e-05,0.00012973459977526114,0.0,0.00048786777,False,C1QB; complement C1q B
hsa:2046,0.0,0.0,4.056410322580645e-09,1.3652285375109396e-08,0.0,7.367869e-08,False,EPHA8; EPH receptor
hsa:79153,2.985557e-06,0.002110511085172613,1.74769022032258e-05,3.469173776027873e-05,0.0,0.0001443947,False,GDPD3; glycerophosphodiester phosphodiesterase domain containing
hsa:23236,0.00026542292,0.18762931503866234,0.0006562124548709678,0.0009095035793756444,0.0,0.003626975,False,PLCB1; phospholipase C beta
hsa:1946,0.0,0.0,6.206113266387097e-07,1.418777055718563e-06,0.0,6.8964446e-06,False,EFNA5; ephrin
hsa:5890,3.5486557e-06,0.002508569487137904,3.683371858529032e-05,6.0139175221331376e-05,0.0,0.00024989035,False,RAD51B; RAD51 paralog
hsa:93589,0.00051767536,0.3659483258235308,0.0008802133701612906,0.0009687671465666211,0.0,0.003708483,False,CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:189,0.0,0.0,3.3808710967741938e-09,1.4431652715357865e-08,0.0,7.596473e-08,False,AGXT; alanine--glyoxylate
hsa:129607,0.0,0.0,5.679629811315484e-05,0.00015529278345447365,0.0,0.00072461896,False,CMPK2; cytidine/uridine monophosphate kinase
hsa:1295,3.0083871e-05,0.02126649842237241,0.00014902058199774192,0.0003324495428891507,0.0,0.001583122,False,COL8A1; collagen type VIII alpha 1
hsa:2925,1.7793576e-07,0.00012578403089561299,1.1930021950387097e-06,2.300046872454232e-06,0.0,1.0003899e-05,False,GRPR; gastrin releasing peptide
hsa:153,0.0,0.0,1.9521098868064514e-05,4.465120219613686e-05,0.0,0.0002016366,False,ADRB1; adrenoceptor beta
hsa:5976,8.703794e-08,6.15277273890898e-05,5.380336617741934e-07,9.64937373516942e-07,0.0,3.5727815e-06,False,UPF1; UPF1 RNA helicase and
hsa:55512,9.534597e-09,6.740073179361017e-06,2.8432075069129032e-05,9.37870575374085e-05,0.0,0.00041709442,False,SMPD3; sphingomyelin phosphodiesterase
hsa:285268,0.0,0.0,6.441911706451615e-08,1.0852599084939617e-07,0.0,3.751281e-07,False,ZNF621; zinc finger protein
hsa:121364,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10A7; olfactory receptor family 10 subfamily A member
hsa:441272,0.0,0.0,6.4338498409677424e-06,2.0350562804734572e-05,0.0,0.00010069148,False,SPDYE3; speedy/RINGO cell cycle regulator family member
hsa:4209,0.0,0.0,0.00014914152684741936,0.00032805189447351007,0.0,0.001716215,False,MEF2D; myocyte enhancer factor
hsa:284383,0.0,0.0,0.0,0.0,0.0,0.0,False,OR2Z1; olfactory receptor family 2 subfamily Z member
hsa:133686,0.0,0.0,2.6855488577193554e-05,8.867731828916e-05,0.0,0.00043729052,False,NADK2; NAD kinase 2
hsa:3064,0.0,0.0,3.625608295483871e-08,9.001262743218125e-08,0.0,4.2313332e-07,False,HTT;
hsa:3081,0.0,0.0,1.0152832887096774e-07,3.660519213594862e-07,0.0,1.5604553e-06,False,HGD; homogentisate
hsa:2028,0.00015393073,0.10881470761191714,0.0003751383108258064,0.0004468626778710502,0.0,0.0014898197,False,ENPEP; glutamyl
hsa:587,0.0,0.0,1.8581353096774195e-05,5.418255681980802e-05,0.0,0.00019594574,False,BCAT2; branched chain amino acid transaminase
hsa:255743,5.4066146e-07,0.000382197360377179,7.454174501935485e-05,0.00014593969413625847,0.0,0.00053116767,False,NPNT;
hsa:11149,5.884469e-07,0.00041597722149852107,7.96532403451613e-06,2.0127208947060214e-05,0.0,9.150392e-05,False,BVES; blood vessel epicardial
hsa:1118,0.0,0.0,4.043740600967742e-07,9.443962758271823e-07,0.0,4.705725e-06,False,CHIT1; chitinase
hsa:2695,0.0,0.0,5.829638935483871e-07,3.0927776520625992e-06,0.0,1.7236076e-05,False,GIP; gastric inhibitory
hsa:5153,0.0008809869,0.6227757896907868,0.0028543204556129033,0.005150887691452526,0.0,0.01998825,True,PDE1B; phosphodiesterase
hsa:54556,3.0480185e-09,2.1546655555600514e-06,3.1920986203829033e-06,8.35525228275581e-06,0.0,3.52536e-05,False,ING3; inhibitor of growth family member
hsa:23439,0.0,0.0,2.126104812903226e-05,0.0001061646900803907,0.0,0.0005923453,False,ATP1B4; ATPase Na+/K+ transporting family member beta
hsa:2530,8.190367e-07,0.0005789827608426823,6.058952608709678e-05,0.00012624147165374048,0.0,0.00059914216,False,FUT8; fucosyltransferase
hsa:10455,0.0,0.0,2.9656150377419355e-06,9.000698539737825e-06,0.0,3.536763e-05,False,ECI2; enoyl-CoA delta isomerase
hsa:51330,8.88057e-06,0.0062777369273644265,0.00011613920780954839,0.00024235245521280247,8.499668e-08,0.001202919,False,TNFRSF12A; TNF receptor superfamily member
hsa:150,4.1910253e-06,0.002962665041695361,0.00010466802153206448,0.00035986798763974585,0.0,0.0019968834,False,ADRA2A; adrenoceptor alpha
hsa:57634,0.0,0.0,5.608550104354838e-07,1.397048859651042e-06,0.0,5.5616074e-06,False,EP400; E1A binding protein
hsa:255738,1.1888799e-08,8.404275007607986e-06,2.474842060709677e-06,7.421219630659046e-06,0.0,3.9678445e-05,False,PCSK9; proprotein convertase subtilisin/kexin type
hsa:7786,2.4996336e-07,0.00017670084415303161,4.2582523193548384e-07,5.292832620038319e-07,0.0,1.7602773e-06,False,MAP3K12; mitogen-activated protein kinase kinase kinase
hsa:771,1.2885087e-06,0.0009108557949794136,0.00010990576884935484,0.00024536298614571896,0.0,0.0011046989,False,CA12; carbonic anhydrase
hsa:26037,0.0,0.0,3.16284157483871e-07,8.111939067227449e-07,0.0,3.5605538e-06,False,SIPA1L1; signal induced proliferation associated 1 like
hsa:117283,0.0,0.0,1.3253007822903226e-06,4.291104797382547e-06,0.0,2.092339e-05,False,IP6K3; inositol hexakisphosphate kinase
hsa:1487,3.4615816e-05,0.024470161979923848,0.00023156363616129032,0.0004251351481863997,0.0,0.0014780747,False,CTBP1; C-terminal binding protein
hsa:735,0.0,0.0,6.695180225806451e-09,1.6971855588873883e-08,0.0,6.880913e-08,False,C9; complement
hsa:10577,0.0,0.0,5.760354035180645e-05,0.00014752982662757878,0.0,0.0005560036,False,NPC2; NPC intracellular cholesterol transporter
hsa:23542,1.2627592e-07,8.926532936747484e-05,6.800268238709677e-07,1.0466624007508882e-06,0.0,3.910001e-06,False,MAPK8IP2; mitogen-activated protein kinase 8 interacting protein
hsa:200315,0.0,0.0,1.4649105424387096e-06,3.85211204003477e-06,0.0,1.8340572e-05,False,APOBEC3A; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:4654,0.0,0.0,3.412085822580645e-10,1.525388041890166e-09,0.0,8.460339e-09,False,MYOD1; myogenic differentiation
hsa:27091,0.0,0.0,1.1048101741935484e-06,4.553143733738858e-06,0.0,2.3989944e-05,False,CACNG5; calcium voltage-gated channel auxiliary subunit gamma
hsa:152138,-0.0,0.0,0.0,0.0,0.0,0.0,False,PYDC2; pyrin domain containing
hsa:391190,0.0,0.0,6.194267096774194e-08,3.448821959526992e-07,0.0,1.9202228e-06,False,OR2L8; olfactory receptor family 2 subfamily L member
hsa:5649,0.0,0.0,0.0,0.0,0.0,0.0,False,RELN;
hsa:25836,0.0,0.0,2.0501931544838713e-07,4.343492177954804e-07,0.0,1.6301777e-06,False,NIPBL; NIPBL cohesin loading
hsa:254786,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C3; olfactory receptor family 6 subfamily C member
hsa:931,0.0,0.0,1.459494421419355e-06,6.512578756543887e-06,0.0,3.5847777e-05,False,MS4A1; membrane spanning 4-domains
hsa:5887,0.0,0.0,3.090240754193548e-06,5.763803061289023e-06,0.0,2.3185848e-05,False,RAD23B; RAD23 homolog B
hsa:6529,8.967263e-06,0.006339020814259524,4.542791720225807e-05,7.829068770166026e-05,0.0,0.0002763956,False,SLC6A1; solute carrier family 6 member
hsa:7568,0.0,0.0,1.2783119096774192e-08,2.682521722851145e-08,0.0,1.1344052e-07,False,ZNF20; zinc finger protein
hsa:729020,0.0,0.0,1.325483422580645e-08,6.08641856606105e-08,0.0,3.3510923e-07,False,RPEL1; ribulose-5-phosphate-3-epimerase like
hsa:4159,0.0,0.0,9.900765777419355e-08,4.3936729374451917e-07,0.0,2.392902e-06,False,MC3R; melanocortin 3
hsa:113189,1.8858215e-07,0.00013331003830798895,0.0005028290215787096,0.0013525183921664916,0.0,0.0052832095,False,CHST14; carbohydrate sulfotransferase
hsa:7040,0.0009984084,0.7057818677484478,0.0011795815058064515,0.001245433122330221,0.0,0.004526003,True,TGFB1; transforming growth factor beta
hsa:6129,7.586145e-09,5.362698858613919e-06,3.278186459677419e-07,6.414129717150887e-07,0.0,2.4992785e-06,False,RPL7; ribosomal protein
hsa:407011,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23B; microRNA
hsa:4174,6.608186e-07,0.0004671372814480671,1.2276725024193549e-05,4.065008131149964e-05,0.0,0.00017362932,False,MCM5; minichromosome maintenance complex component
hsa:5571,0.0,0.0,0.0005625549341612903,0.001295097150020652,0.0,0.006124805,False,PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma
hsa:25996,0.0,0.0,7.3790173200967745e-06,2.3812833208325694e-05,0.0,0.00010833095,False,REXO2; RNA exonuclease
hsa:28958,0.0,0.0,1.342548671516129e-07,3.5321661592587984e-07,0.0,1.5338882e-06,False,COA3; cytochrome c oxidase assembly factor
hsa:2677,5.898949e-05,0.04170008228068632,0.00015260433574193548,0.00045278020251965606,0.0,0.0025494078,False,GGCX; gamma-glutamyl
hsa:440738,0.0,0.0,5.692988526493549e-06,2.35210744786867e-05,0.0,0.00013065692,False,MAP1LC3C; microtubule associated protein 1 light chain 3
hsa:7096,0.0,0.0,1.910096631806452e-05,5.877259871555335e-05,0.0,0.00023877977,False,TLR1; toll like receptor
hsa:2057,0.0,0.0,5.200285056032259e-05,9.690348063151614e-05,0.0,0.00040143364,False,EPOR; erythropoietin
hsa:6015,1.5920781e-07,0.00011254511230268095,6.542445453709677e-06,3.191398640668753e-05,0.0,0.00017836309,False,RING1; ring finger protein
hsa:8945,0.0,0.0,0.00015067938748096775,0.00038053014389234294,0.0,0.0015925777,False,BTRC; beta-transducin repeat containing E3 ubiquitin protein
hsa:1949,0.0,0.0,4.5678829290322584e-08,1.2666076724562105e-07,0.0,6.715628e-07,False,EFNB3; ephrin
hsa:341152,0.0,0.0,1.8312271161290325e-07,9.475012498957799e-07,0.0,5.273485e-06,False,OR2AT4; olfactory receptor family 2 subfamily AT member
hsa:84458,0.0,0.0,4.14501853063871e-06,1.559743487764214e-05,0.0,6.765805e-05,False,LCOR; ligand dependent nuclear receptor
hsa:9568,0.0,0.0,7.628495178322581e-06,1.5837055374512607e-05,0.0,5.2846073e-05,False,GABBR2; gamma-aminobutyric acid type B receptor subunit
hsa:10333,1.2149089e-06,0.0008588275825666252,1.4771589752387096e-05,4.381544265589157e-05,0.0,0.00022289394,False,TLR6; toll like receptor
hsa:2326,0.00065637275,0.4639944790470363,0.0008903411646129032,0.0009922641532787125,0.0,0.0040041385,True,FMO1; flavin containing dimethylaniline monoxygenase
hsa:627,0.0,0.0,4.494228363548387e-05,0.00010920134110313182,0.0,0.00045777473,False,BDNF; brain derived neurotrophic
hsa:122740,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K14; olfactory receptor family 4 subfamily K member
hsa:2570,3.1540765e-08,2.2296386961402636e-05,3.796919594080644e-05,6.691148033624835e-05,0.0,0.00025022926,False,GABRR2; gamma-aminobutyric acid type A receptor subunit
hsa:113675,0.00014414662,0.10189825195103101,0.00023109133493548386,0.00040070002500222407,0.0,0.0021824557,False,SDSL; serine dehydratase
hsa:51604,5.724119e-06,0.004046419680598017,6.266917220967742e-05,0.0001221985691208722,0.0,0.0005515589,False,PIGT; phosphatidylinositol glycan anchor biosynthesis class
hsa:22955,0.0,0.0,5.170345993677419e-06,1.9567756761180695e-05,0.0,8.1434475e-05,False,SCMH1; Scm polycomb group protein homolog
hsa:2152,1.8037845e-06,0.0012751078550878579,0.00014656558792774192,0.00034054831595002773,0.0,0.0017106069,False,F3; coagulation factor III
hsa:11021,6.828331e-08,4.826994851790737e-05,4.1778220958064515e-07,5.604177121811941e-07,0.0,1.9835788e-06,False,RAB35; RAB35
hsa:3993,5.1003803e-07,0.00036054944393109956,1.3670138919464514e-05,3.4957269915312355e-05,0.0,0.00013837537,False,LLGL2; LLGL scribble cell polarity complex component
hsa:406970,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR194-2; microRNA
hsa:186,0.0,0.0,2.3713287806451616e-06,9.535890114618578e-06,0.0,5.1104296e-05,False,AGTR2; angiotensin II receptor type
hsa:6387,2.2485694e-06,0.0015895294058964312,0.00035448644459354844,0.0007283714662541284,0.0,0.0031883128,False,CXCL12; C-X-C motif chemokine ligand
hsa:10312,3.891359e-05,0.027508288422851128,0.0007616355068709678,0.0017975990661507337,0.0,0.006658678,False,TCIRG1; T cell immune regulator 1
hsa:54539,0.0,0.0,9.618631125806452e-07,1.5931036296075246e-06,0.0,5.3748104e-06,False,NDUFB11; NADH:ubiquinone oxidoreductase subunit
hsa:5593,0.0,0.0,0.0,0.0,0.0,0.0,False,PRKG2; protein kinase cGMP-dependent
hsa:7571,1.7831729e-08,1.2605373711603549e-05,7.770608958064515e-08,1.2311501425581777e-07,0.0,4.25036e-07,False,ZNF23; zinc finger protein
hsa:2582,0.0,0.0,3.312238463870968e-05,0.00012093535849660296,0.0,0.00066153525,False,GALE;
hsa:2914,0.0,0.0,1.2174256838709678e-06,6.6246576552324475e-06,0.0,3.6902948e-05,False,GRM4; glutamate metabotropic receptor
hsa:56924,0.0,0.0,8.736380206451613e-07,1.5249035400597081e-06,0.0,6.9353105e-06,False,PAK6; p21 (RAC1) activated kinase
hsa:6729,0.0,0.0,1.6138296726903225e-05,4.5377838288880344e-05,0.0,0.00020686141,False,SRP54; signal recognition particle
hsa:8723,5.867392e-09,4.147700364472395e-06,2.1296491351612902e-07,4.093405649475573e-07,0.0,1.4793964e-06,False,SNX4; sorting nexin
hsa:84674,4.756973e-08,3.3627374216492336e-05,4.6594182254838707e-07,7.677868519046778e-07,0.0,3.0965887e-06,False,CARD6; caspase recruitment domain family member
hsa:10747,9.594979e-08,6.782757636681677e-05,2.2048110654838704e-06,4.392395350400664e-06,0.0,2.2435714e-05,False,MASP2; MBL associated serine protease
hsa:25814,0.0,0.0,2.45013888483871e-07,4.5362390956394464e-07,0.0,1.8717445e-06,False,ATXN10; ataxin
hsa:286410,0.0,0.0,1.4107315371935483e-06,4.410333744496767e-06,0.0,1.773762e-05,False,ATP11C; ATPase phospholipid transporting
hsa:406953,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR18A; microRNA
hsa:6196,8.841104e-06,0.006249838136456257,6.873227802064515e-05,0.00010853410214690883,0.0,0.00034413562,False,RPS6KA2; ribosomal protein S6 kinase
hsa:138881,0.0,0.0,1.682135344516129e-05,5.7308212634520655e-05,0.0,0.00030213795,False,OR1L8; olfactory receptor family 1 subfamily L member
hsa:4619,0.0,0.0,9.44633e-12,5.259493953353212e-11,0.0,2.9283623e-10,False,MYH1; myosin heavy chain
hsa:55615,0.0,0.0,5.460701466129032e-07,1.1764176737348194e-06,0.0,4.947105e-06,False,PRR5; proline rich
hsa:3753,6.838454e-08,4.8341508711583786e-05,7.136143095483871e-07,1.3274284895962192e-06,0.0,5.037425e-06,False,KCNE1; potassium voltage-gated channel subfamily E regulatory subunit
hsa:4627,0.0,0.0,1.130420058064516e-05,4.15149482859488e-05,0.0,0.00023070248,False,MYH9; myosin heavy chain
hsa:1950,7.249641e-06,0.0051248218319133974,3.41987224667742e-05,6.382502376406827e-05,0.0,0.00026480772,False,EGF; epidermal growth
hsa:22888,1.4228398e-07,0.00010058153873212885,5.49013321516129e-07,8.469675377792113e-07,0.0,3.083902e-06,False,UBOX5; U-box domain containing
hsa:27101,0.0,0.0,8.513512913548388e-06,2.6990401642832543e-05,0.0,0.00012743531,False,CACYBP; calcyclin binding
hsa:114769,2.3304697e-08,1.6474252997041738e-05,6.000403341612903e-07,1.2142155275439068e-06,0.0,4.698914e-06,False,CARD16; caspase recruitment domain family member
hsa:10468,0.0,0.0,0.0003144569738593549,0.0006497563720914745,0.0,0.0025224024,False,FST;
hsa:57697,4.70991e-07,0.00033294682584071724,4.407353419225806e-05,0.00010459543621979374,0.0,0.00042114093,False,FANCM; FA complementation group
hsa:695,4.3441938e-05,0.03070940923599227,9.865156307419356e-05,0.0001476604278076725,0.0,0.0005655129,False,BTK; Bruton tyrosine
hsa:128866,0.0,0.0,2.1330336089354837e-05,4.517112453780934e-05,0.0,0.0001817557,False,CHMP4B; charged multivesicular body protein
hsa:965,8.289262e-08,5.859737174302854e-05,9.287208462580647e-06,1.9079506606085456e-05,0.0,7.738738e-05,False,CD58; CD58
hsa:26253,0.0,0.0,5.898344922548389e-06,1.3502484906640913e-05,0.0,4.8838516e-05,False,CLEC4E; C-type lectin domain family 4 member
hsa:4060,0.0,0.0,3.823035888183871e-06,1.2022977482183296e-05,0.0,4.9817503e-05,False,LUM;
hsa:56000,0.0,0.0,4.774349819483871e-07,1.4559376762634878e-06,0.0,6.0185193e-06,False,NXF3; nuclear RNA export factor
hsa:8574,0.0,0.0,6.589624956258065e-05,0.00034053983308592804,0.0,0.0018975599,False,AKR7A2; aldo-keto reductase family 7 member
hsa:8503,0.0,0.0,0.00011102732064516128,0.0002403267093740211,0.0,0.0008131917,False,PIK3R3; phosphoinositide-3-kinase regulatory subunit
hsa:23279,0.0,0.0,4.0132222429032256e-08,7.723804858999869e-08,0.0,3.3386831e-07,False,NUP160; nucleoporin
hsa:2932,0.0,0.0,5.294388496774193e-05,0.00012672861287470625,0.0,0.00060527504,False,GSK3B; glycogen synthase kinase 3
hsa:83988,0.0,0.0,0.00022160841344838714,0.0004644690744822908,0.0,0.0016199894,False,NCALD; neurocalcin
hsa:239,1.2836518e-06,0.000907422418463884,2.7665340919999994e-05,7.075822766722764e-05,0.0,0.00031175662,False,ALOX12; arachidonate 12-lipoxygenase
hsa:7321,6.7654855e-07,0.00047825689291226326,3.340045051419355e-05,9.037379647082806e-05,0.0,0.0003290066,False,UBE2D1; ubiquitin conjugating enzyme E2
hsa:219960,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10Q1; olfactory receptor family 10 subfamily Q member
hsa:8795,0.0,0.0,0.00024000284856048388,0.0003505355038686854,0.0,0.0012468847,False,TNFRSF10B; TNF receptor superfamily member
hsa:5141,1.07632e-06,0.0007608581216814776,0.0003500514411022581,0.0011265639878252505,0.0,0.0061642607,False,PDE4A; phosphodiesterase
hsa:9466,0.0,0.0,0.00012375950738387098,0.00032754004913461724,0.0,0.0012464329,False,IL27RA; interleukin 27 receptor subunit
hsa:29954,0.0,0.0,9.228992220967742e-05,0.0002636647362794699,0.0,0.0012332542,False,POMT2; protein O-mannosyltransferase
hsa:2898,0.0,0.0,2.7806122300000003e-05,5.800614206987156e-05,0.0,0.00022359123,False,GRIK2; glutamate ionotropic receptor kainate type subunit
hsa:25902,0.0,0.0,3.3610500945161294e-05,0.00010703253676795491,0.0,0.00055309467,False,MTHFD1L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1
hsa:9410,0.0,0.0,2.3642924791935485e-07,3.737220714718772e-07,0.0,1.369204e-06,False,SNRNP40; small nuclear ribonucleoprotein U5 subunit
hsa:22894,5.13507e-08,3.630016830406296e-05,1.8092948751612905e-06,5.903959310268069e-06,0.0,3.2269756e-05,False,DIS3; DIS3 homolog
hsa:143,4.931719e-07,0.00034862665889334537,8.371797633870969e-06,1.7573688882725328e-05,0.0,5.8074715e-05,False,PARP4; poly(ADP-ribose) polymerase family member
hsa:4172,1.9757921e-07,0.00013967012282955832,3.0829194167741943e-06,4.88787885572856e-06,0.0,1.9488349e-05,False,MCM3; minichromosome maintenance complex component
hsa:55818,1.6046913e-07,0.00011343674821582879,1.4600115142580645e-06,2.9365096955000305e-06,0.0,1.1346733e-05,False,KDM3A; lysine demethylase
hsa:9547,6.89716e-05,0.0487565055237905,0.00032627790710161293,0.00046784550008811045,0.0,0.0014170344,False,CXCL14; C-X-C motif chemokine ligand
hsa:7922,1.5668968e-08,1.1076502862686913e-05,5.035778602516127e-07,1.3891399670561788e-06,0.0,6.48361e-06,False,SLC39A7; solute carrier family 39 member
hsa:8689,0.0,0.0,4.962518349354838e-08,2.0319321875228954e-07,0.0,1.1224904e-06,False,KRT36; keratin
hsa:83440,0.0,0.0,1.6457734032258066e-07,4.045417821200122e-07,0.0,2.0138311e-06,False,ADPGK; ADP dependent
hsa:442590,0.0,0.0,2.386591574193548e-07,5.112065165025287e-07,0.0,2.1587932e-06,False,SPDYE5; speedy/RINGO cell cycle regulator family member
hsa:219870,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10G9; olfactory receptor family 10 subfamily G member
hsa:23048,0.0,0.0,5.59006106451613e-08,1.3346599627375567e-07,0.0,5.3534933e-07,False,FNBP1; formin binding protein
hsa:5232,0.0,0.0,0.0,0.0,0.0,0.0,False,PGK2; phosphoglycerate kinase
hsa:3985,9.1131176e-07,0.0006442126449195791,2.353021327258065e-05,5.7357175155731004e-05,0.0,0.00027025992,False,LIMK2; LIM domain kinase
hsa:1994,0.0,0.0,1.0803212193548387e-05,2.022087398071433e-05,0.0,8.693397e-05,False,ELAVL1; ELAV like RNA binding protein
hsa:2247,1.4961426e-05,0.010576336483607498,7.2206063216129e-05,0.0001047150745073768,0.0,0.00045263304,False,FGF2; fibroblast growth factor
hsa:823,2.1851561e-07,0.0001544702101444573,1.239932798096774e-05,3.74040998068693e-05,0.0,0.00020793981,False,CAPN1; calpain
hsa:1525,0.0,0.0,9.781387893548388e-05,0.0001998654642639257,0.0,0.00065023644,False,CXADR; CXADR Ig-like cell adhesion
hsa:5142,9.948988e-06,0.007033009070082837,6.71960226483871e-05,0.0001437560878169114,0.0,0.0006883227,False,PDE4B; phosphodiesterase
hsa:10061,0.0,0.0,9.321860645161291e-08,3.039050116229795e-07,0.0,1.2951075e-06,False,ABCF2; ATP binding cassette subfamily F member
hsa:114798,0.0,0.0,2.9079959850709677e-07,1.1876149556416906e-06,0.0,6.4534897e-06,False,SLITRK1; SLIT and NTRK like family member
hsa:574457,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181D; microRNA
hsa:54617,2.4245833e-07,0.00017139548605417333,3.724688249224516e-06,9.294553994371703e-06,0.0,3.4639386e-05,False,INO80; INO80 complex ATPase
hsa:142678,0.0,0.0,8.739446023548386e-07,1.8127640678682245e-06,0.0,5.8362657e-06,False,MIB2; MIB E3 ubiquitin protein ligase
hsa:10606,0.0,0.0,1.790338652548387e-07,5.315627188432895e-07,0.0,1.8613532e-06,False,PAICS; phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide
hsa:6634,2.3920268e-07,0.00016909404434180869,6.159460076935484e-06,2.049778556928172e-05,0.0,0.00011190546,False,SNRPD3; small nuclear ribonucleoprotein D3
hsa:26664,0.0,0.0,3.3697170967741935e-07,1.8761790764238397e-06,-0.0,1.0446123e-05,False,OR7C1; olfactory receptor family 7 subfamily C member
hsa:10136,0.0,0.0,8.163718458064517e-07,3.507052837678039e-06,0.0,1.86877e-05,False,CELA3A; chymotrypsin like elastase
hsa:9437,0.0,0.0,2.5405397597806455e-07,7.385363492650424e-07,0.0,3.0856334e-06,False,NCR1; natural cytotoxicity triggering receptor
hsa:120776,-0.0,0.0,2.378339193548387e-09,1.3242032204560598e-08,0.0,7.3728515e-08,False,OR2D2; olfactory receptor family 2 subfamily D member
hsa:23659,0.0,0.0,2.069625896774194e-06,4.86985291247277e-06,0.0,2.5986723e-05,False,PLA2G15; phospholipase A2 group
hsa:494335,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR423; microRNA
hsa:3177,0.0,0.0,2.2888511516129035e-06,7.236730606611401e-06,0.0,3.8961316e-05,False,SLC29A2; solute carrier family 29 member
hsa:5582,0.0,0.0,1.1927901967741935e-05,3.913518588671417e-05,0.0,0.00018880633,False,PRKCG; protein kinase C
hsa:127066,0.0,0.0,8.37204293548387e-08,4.4104671295716293e-07,0.0,2.456345e-06,False,OR14C36; olfactory receptor family 14 subfamily C member
hsa:5161,0.0,0.0,0.0,0.0,0.0,0.0,False,PDHA2; pyruvate dehydrogenase E1 subunit alpha
hsa:10451,0.0,0.0,1.399281541935484e-07,4.717751301832149e-07,0.0,2.436764e-06,False,VAV3; vav guanine nucleotide exchange factor
hsa:54187,2.3268172e-05,0.016448433219564393,2.5069015424516133e-05,2.910656809612177e-05,0.0,0.00010942919,False,NANS; N-acetylneuraminate
hsa:9287,0.0,0.0,3.44417935483871e-09,1.9176379071065877e-08,-0.0,1.0676956e-07,False,TAAR2; trace amine associated receptor
hsa:51477,0.0,0.0,5.600887827096775e-06,1.671298699718796e-05,0.0,5.772937e-05,False,ISYNA1; inositol-3-phosphate synthase
hsa:483,0.0014462703,1.0223785713372482,0.0017146414906451613,0.0017064160321188895,0.0,0.007284937,True,ATP1B3; ATPase Na+/K+ transporting subunit beta
hsa:406933,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR141; microRNA
hsa:7678,0.0,0.0,3.674225338709678e-08,8.218668026577547e-08,0.0,3.0383958e-07,False,ZNF124; zinc finger protein
hsa:1479,0.0,0.0,3.8504121287096784e-07,9.131126350192831e-07,0.0,3.6875597e-06,False,CSTF3; cleavage stimulation factor subunit
hsa:26974,0.0,0.0,2.8871518199999997e-08,7.998420600382671e-08,0.0,3.2580115e-07,False,ZNF285; zinc finger protein
hsa:9320,1.7860734e-07,0.00012625877548584532,5.969306062903227e-07,1.0258724862801404e-06,0.0,4.1734907e-06,False,TRIP12; thyroid hormone receptor interactor
hsa:31,0.0,0.0,0.0001885006523709677,0.0005470647787789643,0.0,0.0024563088,False,ACACA; acetyl-CoA carboxylase
hsa:7012,0.0,0.0,2.7250092051935485e-07,8.85971783506724e-07,0.0,3.6583644e-06,False,TERC; telomerase RNA
hsa:5981,2.0515101e-05,0.01450226811075312,0.00028221549022580645,0.0004407699857414276,0.0,0.0015874264,False,RFC1; replication factor C subunit
hsa:101060200,0.0,0.0,5.9906761670967734e-09,1.364563324827494e-08,0.0,5.1371607e-08,False,ZNF891; zinc finger protein
hsa:51318,1.509435e-08,1.0670301387136547e-05,1.7692183459677416e-07,4.312839317776737e-07,0.0,1.7544756e-06,False,MRPL35; mitochondrial ribosomal protein
hsa:51660,1.3836815e-07,9.781341116911414e-05,5.059162136451613e-07,9.992640748230473e-07,0.0,5.1788766e-06,False,MPC1; mitochondrial pyruvate carrier
hsa:23265,8.635699e-07,0.0006104635908044646,8.030567569032259e-06,1.9431820511229738e-05,0.0,0.00010226373,False,EXOC7; exocyst complex component
hsa:1306,2.3955695e-06,0.0016934448027793186,0.0002153934343180645,0.00043746239226634235,0.0,0.0015066899,False,COL15A1; collagen type XV alpha 1
hsa:1511,0.00014594126,0.10316689549523204,0.0003083394468290322,0.00035035509764739766,0.0,0.0013671779,False,CTSG; cathepsin
hsa:1470,2.8103793e-06,0.001986676746144739,0.0002206696925567742,0.0004287018656633502,0.0,0.0018203367,False,CST2; cystatin
hsa:27159,0.0,0.0,0.0,0.0,0.0,0.0,False,CHIA; chitinase
hsa:6235,4.9507003e-09,3.499684602409996e-06,3.2249663904193546e-07,5.200579179459145e-07,0.0,1.9680363e-06,False,RPS29; ribosomal protein
hsa:1409,0.0,0.0,2.7452063432258062e-08,1.1543300655907647e-07,0.0,6.2090766e-07,False,CRYAA; crystallin alpha
hsa:200576,1.4964257e-07,0.00010578337737270421,5.427209628064516e-06,1.39642035297444e-05,0.0,6.901585e-05,False,PIKFYVE; phosphoinositide kinase
hsa:26052,0.0,0.0,8.75317922889355e-05,0.00020696575055123158,0.0,0.00092703255,False,DNM3; dynamin
hsa:25874,1.6362101e-07,0.0001156648341907855,5.766904121612903e-07,7.488677911344458e-07,0.0,2.5028328e-06,False,MPC2; mitochondrial pyruvate carrier
hsa:79899,0.0,0.0,1.6272874767741936e-06,4.7151239769560695e-06,0.0,1.9619194e-05,False,PRR5L; proline rich 5
hsa:53615,0.0,0.0,2.2356196590322576e-06,5.8498909101405464e-06,0.0,2.0208145e-05,False,MBD3; methyl-CpG binding domain protein
hsa:5119,0.0,0.0,7.093965998870969e-05,0.00026120682636900723,0.0,0.0013716125,False,CHMP1A; charged multivesicular body protein
hsa:7539,5.8967036e-09,4.168420939133721e-06,5.556258539806451e-08,1.1620875792733282e-07,0.0,4.7686746e-07,False,ZFP37; ZFP37 zinc finger
hsa:3206,4.0168658e-08,2.839550475355438e-05,1.8872499528547976e-05,7.705063194021176e-05,0.0,0.00039669272,False,HOXA10; homeobox
hsa:87,0.0,0.0,2.7468119999999997e-05,0.00012396109150033605,0.0,0.00067257957,False,ACTN1; actinin alpha
hsa:340385,0.0,0.0,4.0176804566741937e-08,7.652861110341284e-08,0.0,3.041016e-07,False,ZNF517; zinc finger protein
hsa:2161,0.0,0.0,2.3435502790322585e-06,7.875952874291746e-06,0.0,4.1086336e-05,False,F12; coagulation factor
hsa:375,0.0,0.0,6.158624160967742e-05,0.00011748292001151632,0.0,0.00037879954,False,ARF1; ADP ribosylation factor
hsa:9765,0.0,0.0,2.746843484516129e-06,6.7711150273576044e-06,0.0,2.6817917e-05,False,ZFYVE16; zinc finger FYVE-type containing
hsa:9820,3.1009584e-08,2.1920891404381594e-05,2.034447006129032e-07,3.6679493170332053e-07,0.0,1.7799464e-06,False,CUL7; cullin
hsa:4846,0.00037348416,0.26401855995929135,0.0005651925783870967,0.0007723700028917362,0.0,0.004109495,False,NOS3; nitric oxide synthase
hsa:5156,0.00033703394,0.23825164498597795,0.0006835489059677419,0.0010352004678382937,0.0,0.0044851415,False,PDGFRA; platelet derived growth factor receptor
hsa:4544,0.0,0.0,1.5961887658709676e-06,4.713530838283436e-06,0.0,1.869222e-05,False,MTNR1B; melatonin receptor
hsa:60481,1.2186639e-05,0.008614820182799018,0.00043452796706451607,0.0009547115657104675,0.0,0.0033450287,False,ELOVL5; ELOVL fatty acid elongase
hsa:64064,2.0863905e-05,0.014748840093318703,9.30539719548387e-05,0.00021145353945535087,0.0,0.0009386049,False,OXCT2; 3-oxoacid CoA-transferase
hsa:55697,0.0,0.0,5.125251775483873e-07,1.2842857166671433e-06,0.0,6.300418e-06,False,VAC14; VAC14 component of PIKFYVE
hsa:4660,0.0,0.0,3.0011752487096774e-05,0.0001342471296765526,0.0,0.0007436395,False,PPP1R12B; protein phosphatase 1 regulatory subunit
hsa:8566,0.0,0.0,0.00032708093329032257,0.0005272175010246683,0.0,0.0018859124,False,PDXK; pyridoxal
hsa:55004,1.2077836e-06,0.0008537906582556237,5.851789660322581e-06,1.6155973169798046e-05,0.0,8.1084836e-05,False,LAMTOR1; late endosomal/lysosomal adaptor
hsa:64137,0.0,0.0,1.1261790322580645e-06,3.969624028468384e-06,0.0,1.8681014e-05,False,ABCG4; ATP binding cassette subfamily G member
hsa:9218,0.0,0.0,3.377925786774194e-05,9.951225826905381e-05,0.0,0.0003966021,False,VAPA; VAMP associated protein
hsa:9265,4.068193e-08,2.8758340313454498e-05,1.580791956903226e-05,3.4273274207215225e-05,0.0,0.00011931216,False,CYTH3; cytohesin
hsa:7134,0.00020668727,0.14610867402600752,0.00046184128567741944,0.0006403184527955658,0.0,0.0025655488,False,TNNC1; troponin C1
hsa:3113,0.00047770137,0.33769043323813414,0.0005736937162096773,0.0006147919381178082,0.0,0.0017380213,False,HLA-DPA1; major histocompatibility complex
hsa:55799,0.0,0.0,8.230412903225805e-06,3.181779083706486e-05,0.0,0.00016329158,False,CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:491,0.0,0.0,7.552221870967742e-07,3.830995766462312e-06,0.0,2.129549e-05,False,ATP2B2; ATPase plasma membrane Ca2+ transporting
hsa:283,7.65476e-12,5.4112032811083205e-09,1.8804473467419355e-08,3.3389987684756485e-08,0.0,1.13690994e-07,False,ANG;
hsa:1340,0.0,0.0,1.7083392887096777e-05,4.308599466544985e-05,0.0,0.00022095472,False,COX6B1; cytochrome c oxidase subunit
hsa:2319,0.0,0.0,1.0022337349741937e-06,2.4797542403335743e-06,0.0,9.156074e-06,False,FLOT2; flotillin
hsa:6742,0.0,0.0,0.00041827760316129033,0.000957534067536072,0.0,0.0038034732,False,SSBP1; single stranded DNA binding protein
hsa:1524,8.258217e-05,0.05837791247080837,0.0002718898287444194,0.00034190217886409155,0.0,0.0011951042,False,CX3CR1; C-X3-C motif chemokine receptor
hsa:3646,0.0,0.0,2.3383751293548387e-07,4.677952546246824e-07,0.0,1.5668182e-06,False,EIF3E; eukaryotic translation initiation factor 3 subunit
hsa:10201,0.0,0.0,4.264880762903226e-05,9.873294493864887e-05,0.0,0.00037192614,False,NME6; NME/NM23 nucleoside diphosphate kinase
hsa:7791,0.0,0.0,1.7969915306451614e-08,5.672658058939565e-08,0.0,2.3869177e-07,False,ZYX;
hsa:406916,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR128-2; microRNA
hsa:6367,3.7882593e-08,2.6779469446264948e-05,1.4071724107032257e-05,4.436946124042507e-05,0.0,0.0002462749,False,CCL22; C-C motif chemokine ligand
hsa:92126,0.0,0.0,5.129301309677419e-07,1.8259624772783658e-06,0.0,8.059164e-06,False,DSEL; dermatan sulfate epimerase
hsa:7128,0.0,0.0,6.558001518387097e-05,0.00017697423213748801,0.0,0.000954119,False,TNFAIP3; TNF alpha induced protein
hsa:3939,3.3631677e-05,0.023774467250648645,0.0006352648437741934,0.0016327405636535005,0.0,0.00802277,False,LDHA; lactate dehydrogenase
hsa:26530,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR12D1; olfactory receptor family 12 subfamily D member 1
hsa:57335,0.0,0.0,2.3440567870967745e-08,5.5993204722867614e-08,0.0,2.2305406e-07,False,ZNF286A; zinc finger protein
hsa:3838,0.0,0.0,7.076715317419355e-07,1.480849629574839e-06,0.0,4.8222123e-06,False,KPNA2; karyopherin subunit alpha
hsa:130013,0.0,0.0,9.8995026483871e-08,4.558990528901316e-07,0.0,2.539474e-06,False,ACMSD; aminocarboxymuconate semialdehyde
hsa:51301,5.1503186e-08,3.6407961721952365e-05,2.5185703103838704e-05,6.43389690468848e-05,0.0,0.0002552085,False,GCNT4; glucosaminyl (N-acetyl) transferase
hsa:84126,8.931817e-07,0.0006313963789414569,8.422311566548387e-05,0.00021695273559332634,0.0,0.00086648035,False,ATRIP; ATR interacting
hsa:8891,8.321405e-09,5.882459285389898e-06,1.5821205961290326e-07,3.011404464502645e-07,0.0,1.0881396e-06,False,EIF2B3; eukaryotic translation initiation factor 2B subunit
hsa:7471,0.0,0.0,2.885609204516129e-06,8.072566711803703e-06,0.0,3.4532462e-05,False,WNT1; Wnt family member
hsa:23190,0.0,0.0,4.94321784935484e-07,1.2561184190534596e-06,0.0,4.6076934e-06,False,UBXN4; UBX domain protein
hsa:147694,4.1781888e-08,2.9535908302350475e-05,1.0444875151612901e-07,1.2388496942465173e-07,0.0,4.1762436e-07,False,ZNF548; zinc finger protein
hsa:23746,0.0,0.0,4.564961113835484e-08,2.3014301349016793e-07,0.0,1.2833946e-06,False,AIPL1; aryl hydrocarbon receptor interacting protein like
hsa:81494,0.0,0.0,8.186582903225806e-10,3.2564675060185612e-09,-0.0,1.778894e-08,False,CFHR5; complement factor H related
hsa:2355,0.0,0.0,4.823319003225807e-07,1.328950853153156e-06,0.0,7.0278807e-06,False,FOSL2; FOS like 2
hsa:57818,0.0,0.0,3.586006750451613e-06,8.700204084331638e-06,0.0,4.0832503e-05,False,G6PC2; glucose-6-phosphatase catalytic subunit
hsa:5921,4.351044e-07,0.00030757833777997833,1.113149766116129e-05,3.962765400549709e-05,0.0,0.00021583035,False,RASA1; RAS p21 protein activator
hsa:11185,0.00014116602,0.09979124500376271,0.00030743132317354846,0.00036632882250632197,0.0,0.0012833865,False,INMT; indolethylamine
hsa:26019,6.3767686e-08,4.5077822389191186e-05,1.0814960815709678e-06,2.0964696807235176e-06,0.0,1.023516e-05,False,UPF2; UPF2 regulator of nonsense mediated mRNA
hsa:90993,0.0014959752,1.057515312132147,0.0017402709615483875,0.001362071709020401,2.3491388e-05,0.0054961005,True,CREB3L1; cAMP responsive element binding protein 3 like
hsa:91252,3.723747e-09,2.6323427494026284e-06,3.5926326015000003e-07,7.984898337745146e-07,0.0,3.8454627e-06,False,SLC39A13; solute carrier family 39 member
hsa:1312,4.5043485e-06,0.003184155399053052,0.00035460413640322575,0.000722233974686269,0.0,0.0029128722,False,COMT;
hsa:164284,1.2231031e-08,8.646201197495098e-06,1.256791719032258e-06,3.6613950091735886e-06,0.0,1.2742135e-05,False,APCDD1L; APC down-regulated 1
hsa:1174,4.3310231e-07,0.00030616304638258975,1.4563238484193548e-06,2.3067794626612684e-06,0.0,8.758716e-06,False,AP1S1; adaptor related protein complex 1 subunit sigma
hsa:148,2.3024115e-06,0.0016275907622527064,4.867368144858065e-05,0.00014729714679605823,0.0,0.0008088322,False,ADRA1A; adrenoceptor alpha
hsa:699,1.4475228e-07,0.00010232639723308246,5.268697695806451e-06,1.8207269092026297e-05,0.0,8.184552e-05,False,BUB1; BUB1 mitotic checkpoint serine/threonine
hsa:2519,0.0,0.0,3.87756620516129e-05,6.1010961674769176e-05,0.0,0.0002084151,False,FUCA2; alpha-L-fucosidase
hsa:54815,5.327099e-07,0.00037657634710413975,4.2642929299064515e-06,7.831648179204005e-06,0.0,2.6478681e-05,False,GATAD2A; GATA zinc finger domain containing
hsa:342372,0.0,0.0,1.7545824413548386e-05,3.917121682661958e-05,0.0,0.00019517903,False,PKD1L3; polycystin 1 like 3
hsa:51616,4.2066944e-07,0.0002973741637869769,8.956550244193547e-06,2.056419499070574e-05,0.0,9.3887174e-05,False,TAF9B; TATA-box binding protein associated factor
hsa:390327,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C70; olfactory receptor family 6 subfamily C member
hsa:56920,0.0,0.0,1.783341164087742e-05,7.287066866471295e-05,0.0,0.00039357858,False,SEMA3G; semaphorin
hsa:23404,1.15522255e-07,8.166348850872294e-05,6.685346556451611e-07,1.9171597489658087e-06,0.0,1.0414621e-05,False,EXOSC2; exosome component
hsa:9249,0.00021987682,0.15543245899592717,0.00035346307789999997,0.00041994081127212353,0.0,0.0018162162,False,DHRS3; dehydrogenase/reductase
hsa:5618,7.855427e-06,0.005553056184244429,6.802763796387094e-05,0.00016168858290638757,0.0,0.00064551516,False,PRLR; prolactin
hsa:146433,0.000510393,0.3608003747021094,0.0007068021082212903,0.0007289133606048653,9.3771666e-07,0.0023003872,False,IL34; interleukin
hsa:6900,0.0,0.0,2.988496876516129e-06,9.684135341896664e-06,0.0,5.3280437e-05,False,CNTN2; contactin
hsa:7481,2.231606e-05,0.015775378600166447,0.00010025210587741934,0.00023626429396535122,0.0,0.001128421,False,WNT11; Wnt family member
hsa:26333,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR7A17; olfactory receptor family 7 subfamily A member
hsa:199704,0.0,0.0,1.135299319032258e-07,3.025776460142133e-07,0.0,1.4609569e-06,False,ZNF585A; zinc finger protein
hsa:2357,9.761563e-05,0.06900517029187796,0.0002597547572258065,0.00044787238524362485,0.0,0.0018202156,False,FPR1; formyl peptide receptor
hsa:51081,2.861515e-08,2.0228249294479086e-05,3.175150296774193e-07,8.309751666967654e-07,0.0,3.6889935e-06,False,MRPS7; mitochondrial ribosomal protein
hsa:5530,0.0,0.0,1.549664984516129e-05,5.1952875974135276e-05,0.0,0.00027372534,False,PPP3CA; protein phosphatase 3 catalytic subunit
hsa:55968,0.0,0.0,7.311174813045161e-07,1.9316421893944915e-06,0.0,7.1974705e-06,False,NSFL1C; NSFL1
hsa:5894,0.0,0.0,0.0002932321638709677,0.0006277157693223031,0.0,0.0022921683,False,RAF1; Raf-1 proto-oncogene
hsa:2810,0.0,0.0,9.986133306774195e-05,0.0002646569686891914,0.0,0.0010911053,False,SFN;
hsa:56901,2.2888205e-06,0.0016179831894753047,3.248278870967742e-06,3.291198289894788e-06,0.0,8.789506e-06,False,NDUFA4L2; NDUFA4 mitochondrial complex associated like
hsa:10527,0.0,0.0,1.7886505212903225e-07,3.5381002475178594e-07,0.0,1.2673219e-06,False,IPO7; importin
hsa:406942,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR150; microRNA
hsa:116379,0.0,0.0,2.9560774193548385e-09,9.859833684373849e-09,0.0,4.6581075e-08,False,IL22RA2; interleukin 22 receptor subunit alpha
hsa:63917,0.0,0.0,7.223952898129033e-05,0.0001631910771399533,0.0,0.00070005294,False,GALNT11; polypeptide N-acetylgalactosaminyltransferase
hsa:2770,9.7887154e-05,0.06919711250295965,0.00038570074980645157,0.0005063521697772511,0.0,0.001600854,False,GNAI1; G protein subunit alpha
hsa:2317,9.80479e-08,6.931074497251128e-05,4.6808847324193555e-06,1.1561795907866235e-05,0.0,4.930205e-05,False,FLNB; filamin
hsa:5269,0.0,0.0,9.402758269483869e-06,2.5377998123332206e-05,0.0,0.00011150528,False,SERPINB6; serpin family B member
hsa:5972,0.0,0.0,3.7071325807322584e-06,1.3990883636896343e-05,0.0,7.5514385e-05,False,REN;
hsa:6167,0.0,0.0,6.986464883870969e-07,1.3430775432263192e-06,0.0,4.659837e-06,False,RPL37; ribosomal protein
hsa:1184,0.0,0.0,6.193289743225807e-07,1.737314765366128e-06,0.0,7.4589184e-06,False,CLCN5; chloride voltage-gated channel
hsa:55768,1.9791496e-08,1.3990746684839525e-05,7.268909224470968e-07,1.088237890790368e-06,0.0,3.0718231e-06,False,NGLY1; N-glycanase
hsa:2268,0.0,0.0,2.786689161290323e-08,5.223527932140751e-08,0.0,1.7547214e-07,False,FGR; FGR proto-oncogene
hsa:1647,5.985686e-05,0.042313232188708895,0.0003093844842483871,0.0005614849208901263,0.0,0.0022003686,False,GADD45A; growth arrest and DNA damage inducible
hsa:9033,0.0,0.0,2.385180594516129e-06,8.221959248376833e-06,0.0,4.3571134e-05,False,PKD2L1; polycystin 2 like 1
hsa:6128,0.0,0.0,1.658369168064516e-06,5.161574580487617e-06,0.0,2.1894888e-05,False,RPL6; ribosomal protein
hsa:10059,0.0,0.0,1.775802902967742e-05,5.048277536682107e-05,0.0,0.00019301356,False,DNM1L; dynamin 1
hsa:2805,0.0,0.0,7.661215554838708e-05,0.00014211087067121298,0.0,0.00049972435,False,GOT1; glutamic-oxaloacetic transaminase
hsa:72,0.0,0.0,1.328904365387097e-07,3.602353637270164e-07,0.0,1.8525785e-06,False,ACTG2; actin gamma 2
hsa:641371,0.0,0.0,6.946853156774195e-05,0.00016732751523958428,0.0,0.0006103354,False,ACOT1; acyl-CoA thioesterase
hsa:10319,4.494043e-06,0.003176870369161394,7.022824961935486e-05,0.00012299429092395056,0.0,0.00048522063,False,LAMC3; laminin subunit gamma
hsa:10006,0.0,0.0,2.0359769109677421e-07,3.7852758703595424e-07,0.0,1.3062062e-06,False,ABI1; abl interactor
hsa:441282,0.0,0.0,0.0,0.0,0.0,0.0,False,AKR1B15; aldo-keto reductase family 1 member
hsa:126295,0.0,0.0,3.735101487096774e-09,8.902667042401957e-09,0.0,4.151265e-08,False,ZNF57; zinc finger protein
hsa:7846,1.8180915e-06,0.0012852215732635833,0.0002422132576322581,0.0008791528162670182,0.0,0.003653417,False,TUBA1A; tubulin alpha
hsa:553,0.0,0.0,7.340973714193552e-08,2.1699642649753585e-07,0.0,9.690584e-07,False,AVPR1B; arginine vasopressin receptor
hsa:64682,0.0,0.0,1.7434909824193548e-06,5.163187497172458e-06,0.0,2.3589891e-05,False,ANAPC1; anaphase promoting complex subunit
hsa:9775,0.0,0.0,1.524908274193548e-06,3.1239259093913696e-06,0.0,1.3874757e-05,False,EIF4A3; eukaryotic translation initiation factor
hsa:56259,8.270385e-09,5.846392891224418e-06,2.617148937096775e-07,4.97663219611994e-07,0.0,1.8873931e-06,False,CTNNBL1; catenin beta like
hsa:6272,0.0,0.0,9.26718776364516e-06,2.4833756329554024e-05,0.0,0.00011204373,False,SORT1; sortilin
hsa:2242,2.7889484e-07,0.00019715270933277858,2.983338799935484e-05,0.0001068766326832329,0.0,0.00056013465,False,FES; FES proto-oncogene
hsa:5516,0.0002618758,0.18512183114857503,0.0009791894501774197,0.0016439099841050189,0.0,0.0061468696,False,PPP2CB; protein phosphatase 2 catalytic subunit
hsa:18,0.0,0.0,9.530656451612903e-07,5.30644493456664e-06,0.0,2.9545035e-05,False,ABAT; 4-aminobutyrate
hsa:1325,0.0,0.0,3.918192290967742e-07,8.039008727268414e-07,0.0,4.0003074e-06,False,CORT;
hsa:199713,0.0,0.0,2.470232049032258e-09,5.264478034814434e-09,0.0,2.07563e-08,False,NLRP7; NLR family pyrin domain containing
hsa:30012,0.0,0.0,1.3665558024677421e-08,3.217292460307833e-08,0.0,1.2619415e-07,False,TLX3; T cell leukemia homeobox
hsa:124602,0.0,0.0,5.041724333064516e-07,1.9348654952196905e-06,0.0,1.044915e-05,False,KIF19; kinesin family member
hsa:4772,0.00022347637,0.15797700601902304,0.0006061600292258064,0.0008935384170021036,0.0,0.004319898,False,NFATC1; nuclear factor of activated T cells
hsa:390157,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8K1; olfactory receptor family 8 subfamily K member
hsa:55081,4.7898374e-09,3.3859694954322988e-06,1.1129016220838712e-07,2.331172715040786e-07,0.0,1.0178115e-06,False,IFT57; intraflagellar transport
hsa:81608,5.75015e-08,4.064821176217805e-05,9.493640091806454e-07,2.2631771593047426e-06,0.0,9.0297235e-06,False,FIP1L1; factor interacting with PAPOLA and
hsa:255967,2.0136413e-07,0.0001423457091997035,9.329506108387097e-07,2.1765717112439853e-06,0.0,9.856555e-06,False,PAN3; poly(A) specific ribonuclease subunit
hsa:84333,2.852955e-06,0.002016773805691411,0.00011855756854428066,0.00023063268569098328,0.0,0.00080413034,False,PCGF5; polycomb group ring finger
hsa:2212,8.593399e-05,0.06074733742752607,0.00039500376920483866,0.0008598282816362413,0.0,0.003120038,False,FCGR2A; Fc gamma receptor
hsa:23646,7.0514825e-06,0.004984742204938874,1.6692043138709675e-05,2.5620513983477634e-05,0.0,9.160686e-05,False,PLD3; phospholipase D family member
hsa:3577,0.0,0.0,3.427111611967742e-06,1.2178580912135179e-05,0.0,6.5211374e-05,False,CXCR1; C-X-C motif chemokine receptor
hsa:25805,0.0,0.0,0.00011062284701193546,0.0003519605195288236,0.0,0.0018376114,False,BAMBI; BMP and activin membrane bound
hsa:79823,0.0,0.0,9.252108450983871e-06,2.5004313042122416e-05,0.0,0.0001045509,False,CAMKMT; calmodulin-lysine
hsa:389668,0.0,0.0,5.1617838953225806e-08,1.498401240739268e-07,0.0,6.596244e-07,False,XKR9; XK related
hsa:3312,7.802e-06,0.005515288264975924,7.607944328645161e-05,0.0001332772174906447,0.0,0.00044179818,False,HSPA8; heat shock protein family A (Hsp70) member
hsa:10542,0.0,0.0,1.2040512303225803e-07,1.8230949509896332e-07,0.0,6.695496e-07,False,LAMTOR5; late endosomal/lysosomal adaptor
hsa:10286,0.0,0.0,1.4128206826129033e-07,2.6268170689306793e-07,0.0,1.096587e-06,False,BCAS2; BCAS2 pre-mRNA processing
hsa:256987,0.0,0.0,1.1500585663225807e-05,2.4602727700145557e-05,0.0,9.308155e-05,False,SERINC5; serine incorporator
hsa:2822,2.8507444e-07,0.0002015211117119435,9.198254329354839e-06,3.105939196558006e-05,0.0,0.00016746273,False,GPLD1; glycosylphosphatidylinositol specific phospholipase
hsa:100507027,0.0,0.0,1.953575535483871e-08,7.568681253909419e-08,0.0,4.0305466e-07,False,MRLN;
hsa:8031,5.3926988e-06,0.003812136427606992,2.398475840419355e-05,3.58797000693083e-05,0.0,0.0001295439,False,NCOA4; nuclear receptor coactivator
hsa:816,0.0,0.0,3.74659850967742e-06,1.4034348440945171e-05,0.0,6.7402274e-05,False,CAMK2B; calcium/calmodulin dependent protein kinase II
hsa:23654,3.64252e-07,0.00025749228160651253,3.380435022580646e-06,1.1818184329535628e-05,0.0,6.438675e-05,False,PLXNB2; plexin
hsa:91,0.0,0.0,6.972220709677419e-07,1.384256184359798e-06,0.0,5.2901237e-06,False,ACVR1B; activin A receptor type
hsa:6331,0.0,0.0,4.312383483870968e-07,9.142429641710481e-07,0.0,3.198159e-06,False,SCN5A; sodium voltage-gated channel alpha subunit
hsa:5523,0.0,0.0,2.861695587096774e-06,7.945309793955408e-06,0.0,3.7549755e-05,False,PPP2R3A; protein phosphatase 2 regulatory subunit
hsa:7368,0.0,0.0,2.377542200622581e-06,6.87325516728203e-06,0.0,3.5729463e-05,False,UGT8; UDP glycosyltransferase
hsa:140564,4.9043647e-06,0.0034669296433058414,1.1237052401935485e-05,1.616910788526362e-05,0.0,7.252599e-05,False,APOBEC3D; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:140679,0.0,0.0,2.4829737620322578e-05,9.522503016941593e-05,0.0,0.0005131808,False,SLC32A1; solute carrier family 32 member
hsa:5625,8.275924e-08,5.85030844899162e-05,2.5383424487290323e-05,6.520607189579368e-05,0.0,0.00027709946,False,PRODH; proline dehydrogenase
hsa:55699,0.0,0.0,1.0964768220967741e-06,2.3293047780193882e-06,0.0,1.1596419e-05,False,IARS2; isoleucyl-tRNA synthetase 2
hsa:5957,3.1069252e-05,0.02196307113011789,0.00032365035952258063,0.0005920543027519814,0.0,0.0024333154,False,RCVRN;
hsa:7099,2.006384e-05,0.014183268559645548,0.00020344813554838706,0.00044391071302722553,0.0,0.0018240563,False,TLR4; toll like receptor
hsa:51377,7.316195e-08,5.171869319120166e-05,3.139857148845161e-06,5.834028556161658e-06,0.0,1.9012887e-05,False,UCHL5; ubiquitin C-terminal hydrolase
hsa:3265,0.0,0.0,0.00032872197238709676,0.0008282261427031818,0.0,0.0040783333,False,HRAS; HRas proto-oncogene
hsa:2569,7.631568e-06,0.005394808694407305,0.00012958494221229034,0.00041905948851946723,0.0,0.001743996,False,GABRR1; gamma-aminobutyric acid type A receptor subunit
hsa:55191,3.383474e-08,2.3918013902910992e-05,5.8342189356129035e-05,0.00010774096177596338,0.0,0.0004512931,False,NADSYN1; NAD synthetase
hsa:3364,0.0,0.0,5.717283284838708e-07,1.2307580181698476e-06,0.0,4.025e-06,False,HUS1; HUS1 checkpoint clamp
hsa:26035,1.1659813e-05,0.008242403205679791,0.00015583526864225807,0.00024412495793477715,0.0,0.0007428336,False,GLCE; glucuronic acid
hsa:407020,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR28; microRNA
hsa:55930,9.495954e-10,6.71275617289813e-07,1.1525450573225806e-07,4.3786275556633255e-07,0.0,2.4099998e-06,False,MYO5C; myosin
hsa:353514,2.101457e-07,0.0001485534623359589,7.020373139999999e-06,1.3814199424056264e-05,0.0,5.657569e-05,False,LILRA5; leukocyte immunoglobulin like receptor
hsa:6610,1.2822555e-06,0.0009064353642464543,1.990292692677419e-05,4.135375564614064e-05,0.0,0.00016236314,False,SMPD2; sphingomyelin phosphodiesterase
hsa:91120,0.0,0.0,2.102403294516129e-08,3.3258415215669414e-08,0.0,1.0449284e-07,False,ZNF682; zinc finger protein
hsa:9296,2.7486207e-05,0.01943019160674175,0.00016387697877419353,0.00028738803401903625,0.0,0.0009894395,False,ATP6V1F; ATPase H+ transporting V1 subunit
hsa:1366,1.5375359e-06,0.0010868948610932066,1.3355826210354837e-05,2.4001608467824655e-05,0.0,0.00010904131,False,CLDN7; claudin
hsa:116988,3.2997814e-08,2.3326385071014907e-05,6.738779170000001e-07,1.3399340099071067e-06,0.0,5.0798008e-06,False,AGAP3; ArfGAP with GTPase domain
hsa:81617,2.8559268e-07,0.00020188745918572475,4.997366629580645e-06,9.696418780260686e-06,0.0,3.706464e-05,False,CAB39L; calcium binding protein 39
hsa:8911,0.0,0.0,1.266551635483871e-06,2.993023002579017e-06,0.0,1.2681164e-05,False,CACNA1I; calcium voltage-gated channel subunit alpha1
hsa:80032,0.0,0.0,4.857504316774193e-09,1.5531908819695098e-08,0.0,7.6395644e-08,False,ZNF556; zinc finger protein
hsa:55753,1.1570404e-05,0.00817919935942457,2.2103163631612907e-05,3.526954978306852e-05,0.0,0.00012517162,False,OGDHL; oxoglutarate dehydrogenase
hsa:4488,1.7731175e-08,1.2534291387046205e-05,2.956832752606452e-07,7.075919271504147e-07,0.0,2.6640307e-06,False,MSX2; msh homeobox
hsa:1737,0.0,0.0,1.1758634425806452e-05,2.453575695250418e-05,0.0,7.555869e-05,False,DLAT; dihydrolipoamide
hsa:196294,0.0,0.0,1.0707878305483873e-05,2.7873964061755637e-05,0.0,0.00012735918,False,IMMP1L; inner mitochondrial membrane peptidase subunit
hsa:7466,1.4882764e-08,1.0520729766676e-05,3.346038223654839e-06,8.479166442753117e-06,0.0,3.8330763e-05,False,WFS1; wolframin ER transmembrane
hsa:56994,0.00015626803,0.11046696129837295,0.00037715654298709677,0.0006631356093492288,0.0,0.0029739605,False,CHPT1; choline phosphotransferase
hsa:10054,6.85207e-07,0.00048437761166103034,8.829977736451613e-07,1.2250480061554877e-06,0.0,5.6940275e-06,False,UBA2; ubiquitin like modifier activating enzyme
hsa:10396,0.0,0.0,1.7887242815806453e-07,5.540950222876078e-07,0.0,2.2260806e-06,False,ATP8A1; ATPase phospholipid transporting
hsa:53919,2.1035194e-07,0.00014869925483169955,2.791578152787097e-06,6.783102059839755e-06,0.0,3.090524e-05,False,SLCO1C1; solute carrier organic anion transporter family member
hsa:10331,3.266884e-06,0.0023093831053880554,3.420392602032258e-05,0.00012651397339679521,0.0,0.0007028186,False,B3GNT3; UDP-GlcNAc:betaGal beta-1
hsa:56979,-0.0,0.0,5.154793225806452e-09,2.8700674020402772e-08,0.0,1.5979859e-07,False,PRDM9; PR/SET domain
hsa:353500,0.0,0.0,7.481853757935484e-05,0.00022043367444133817,0.0,0.001166034,False,BMP8A; bone morphogenetic protein
hsa:27235,5.280291e-05,0.03732674569079466,0.00019895768229677421,0.0003074494269006768,0.0,0.001310937,False,COQ2; coenzyme Q2
hsa:100528021,7.0317054e-07,0.0004970761634886932,1.390508852835484e-05,2.3635346064087844e-05,0.0,0.00010123966,False,ST20-MTHFS; ST20-MTHFS
hsa:8001,2.6158045e-08,1.849130461717664e-05,6.179075080812902e-07,2.106931825560889e-06,0.0,1.1702006e-05,False,GLRA3; glycine receptor alpha
hsa:402569,0.0,0.0,3.197298653516129e-07,1.0762249471035103e-06,0.0,4.958978e-06,False,KPNA7; karyopherin subunit alpha
hsa:3953,4.7855967e-05,0.03382971714998399,0.0003069210682258065,0.0006291956427627168,0.0,0.0024813893,False,LEPR; leptin
hsa:3728,0.0,0.0,3.161493526129033e-05,6.531998157507333e-05,0.0,0.00024504116,False,JUP; junction
hsa:64284,0.0,0.0,1.6716290322580645e-08,5.4310107424696337e-08,0.0,2.324195e-07,False,RAB17; RAB17
hsa:1445,3.6325005e-07,0.0002567839961570005,3.255175059483871e-05,9.485073816608934e-05,0.0,0.00035687452,False,CSK; C-terminal Src
hsa:3930,0.0,0.0,9.064638857096775e-06,2.0795190529813003e-05,0.0,9.83608e-05,False,LBR; lamin B
hsa:79792,0.0,0.0,2.070586593548387e-05,4.45633789862591e-05,0.0,0.00017641224,False,GSDMD; gasdermin
hsa:5230,1.2859078e-06,0.0009090172006127928,7.903109441870968e-05,0.00016212782918771787,0.0,0.00066557695,False,PGK1; phosphoglycerate kinase
hsa:3568,0.0,0.0,9.260284924774191e-07,2.702056975694485e-06,0.0,1.4231931e-05,False,IL5RA; interleukin 5 receptor subunit
hsa:4775,0.0,0.0,5.306297081290322e-05,0.00015075726005466165,0.0,0.0007723683,False,NFATC3; nuclear factor of activated T cells
hsa:407044,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-2; microRNA
hsa:1739,0.0,0.0,7.256784458064516e-06,1.3142717033970533e-05,0.0,4.1796906e-05,False,DLG1; discs large MAGUK scaffold protein
hsa:23046,0.0,0.0,2.803086578064516e-08,5.709107325980783e-08,0.0,2.5818613e-07,False,KIF21B; kinesin family member
hsa:27244,0.0,0.0,3.320283687741935e-05,8.626740564455628e-05,0.0,0.00047184384,False,SESN1; sestrin
hsa:622,0.0,0.0,2.852866451612903e-07,1.2279745438002986e-06,0.0,6.5020304e-06,False,BDH1; 3-hydroxybutyrate dehydrogenase
hsa:406999,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR217; microRNA
hsa:132014,1.811583e-05,0.012806206691784006,7.171413074516129e-05,0.00011440545138289004,0.0,0.00045766946,False,IL17RE; interleukin 17 receptor
hsa:8513,0.0,0.0,3.0096429032258067e-08,1.6756982501424933e-07,0.0,9.329893e-07,False,LIPF; lipase F
hsa:390265,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10G7; olfactory receptor family 10 subfamily G member
hsa:2686,0.0,0.0,1.9267817870967742e-05,5.13862410171464e-05,0.0,0.00021157517,False,GGT7; gamma-glutamyltransferase
hsa:5055,3.894023e-08,2.752712042482228e-05,7.509484296129031e-07,1.7060522253634812e-06,0.0,7.649019e-06,False,SERPINB2; serpin family B member
hsa:26496,0.0,0.0,4.600527032258065e-08,2.0190604042528221e-07,0.0,1.0816068e-06,False,OR10A3; olfactory receptor family 10 subfamily A member
hsa:9411,2.8506508e-07,0.00020151449506260232,3.1181814428709683e-06,8.57278005030672e-06,0.0,3.8965012e-05,False,ARHGAP29; Rho GTPase activating protein
hsa:1522,0.0,0.0,5.844469959032259e-07,1.091518702140495e-06,0.0,4.045619e-06,False,CTSZ; cathepsin
hsa:5256,6.7827744e-07,0.00047947905732247017,5.465775622580645e-06,1.6334919389773646e-05,0.0,8.246648e-05,False,PHKA2; phosphorylase kinase regulatory subunit alpha
hsa:1551,0.0,0.0,6.298862258064516e-07,2.5342921203116224e-06,0.0,1.244064e-05,False,CYP3A7; cytochrome P450 family 3 subfamily A member
hsa:643,0.0,0.0,4.341509793419354e-06,1.1937124644201579e-05,0.0,4.488183e-05,False,CXCR5; C-X-C motif chemokine receptor
hsa:4166,4.2373043e-09,2.995379989864397e-06,4.2276261082548386e-06,8.17566567640208e-06,0.0,3.268176e-05,False,CHST6; carbohydrate sulfotransferase
hsa:124044,3.117609e-09,2.2038595658143205e-06,7.826791150032257e-07,1.5081859856134072e-06,0.0,6.4693654e-06,False,SPATA2L; spermatogenesis associated 2
hsa:56242,0.0,0.0,2.446461533612903e-08,6.037356161073282e-08,0.0,2.5847774e-07,False,ZNF253; zinc finger protein
hsa:10056,0.0,0.0,1.308253126032258e-06,3.667498639448005e-06,0.0,1.9320398e-05,False,FARSB; phenylalanyl-tRNA synthetase subunit
hsa:112817,0.0,0.0,3.120640727096774e-06,1.1471373071095867e-05,0.0,6.197148e-05,False,HOGA1; 4-hydroxy-2-oxoglutarate aldolase
hsa:51107,0.0,0.0,0.0004093559628234194,0.0009549077585506841,0.0,0.0037319767,False,APH1A; aph-1 homolog A
hsa:1811,0.0,0.0,1.3568773512903227e-07,7.271502149439668e-07,0.0,4.052526e-06,False,SLC26A3; solute carrier family 26 member
hsa:63924,0.0,0.0,8.024811838709679e-08,2.1789334219324607e-07,0.0,9.3875434e-07,False,CIDEC; cell death inducing DFFA like effector
hsa:1363,0.0,0.0,0.00026271549793548387,0.0005520344400017733,0.0,0.002419371,False,CPE; carboxypeptidase
hsa:51497,0.0,0.0,1.2604828225806453e-06,2.7403966189370995e-06,0.0,9.140496e-06,False,NELFCD; negative elongation factor complex member
hsa:653689,0.0,0.0,4.664909806451613e-05,0.00016520682540086315,0.0,0.0007285718,False,GSTT2B; glutathione S-transferase theta
hsa:2348,0.0,0.0,9.10708376032258e-06,2.0313632854505962e-05,0.0,7.123979e-05,False,FOLR1; folate receptor
hsa:7222,0.0,0.0,1.647829062903226e-08,3.801636603615759e-08,0.0,1.9071173e-07,False,TRPC3; transient receptor potential cation channel subfamily C member
hsa:56985,2.1784097e-06,0.0015399330241886344,8.722348836129032e-06,2.9516355632596173e-05,0.0,0.00016574204,False,ADPRM; ADP-ribose/CDP-alcohol diphosphatase
hsa:55770,0.0,0.0,7.968241759354838e-07,2.0304395110144474e-06,0.0,8.9779605e-06,False,EXOC2; exocyst complex component
hsa:116285,6.559459e-07,0.0004636927358022394,6.718894193548386e-06,2.0984980818889175e-05,0.0,0.00011049021,False,ACSM1; acyl-CoA synthetase medium chain family member
hsa:285362,0.0,0.0,1.03220293536129e-06,3.178173542810939e-06,0.0,1.40444645e-05,False,SUMF1; sulfatase modifying factor
hsa:51495,0.0,0.0,1.9402408687096773e-05,4.735008659650379e-05,0.0,0.00022171797,False,HACD3; 3-hydroxyacyl-CoA dehydratase
hsa:7328,0.0,0.0,1.5629516278709679e-06,3.6137184675503766e-06,0.0,1.582434e-05,False,UBE2H; ubiquitin conjugating enzyme E2
hsa:4023,0.00018340856,0.1296527914206784,0.0003599031693935483,0.0004382751215880958,0.0,0.001813257,False,LPL; lipoprotein
hsa:5105,0.0,0.0,7.937447991290324e-06,2.5573274902563425e-05,0.0,0.00013698191,False,PCK1; phosphoenolpyruvate carboxykinase
hsa:9534,2.062317e-09,1.4578662841271923e-06,1.6470508628064516e-08,4.087931772405366e-08,0.0,1.9548537e-07,False,ZNF254; zinc finger protein
hsa:7512,3.1778782e-06,0.0022464642840275334,5.5501435959806446e-05,0.0001378177214705586,0.0,0.0006987484,False,XPNPEP2; X-prolyl aminopeptidase
hsa:79993,0.0,0.0,0.00023179836157741934,0.0006608344663485103,0.0,0.0026193918,False,ELOVL7; ELOVL fatty acid elongase
hsa:63931,5.3134258e-08,3.756097790510166e-05,2.786420894322581e-07,5.096320654370823e-07,0.0,1.9577412e-06,False,MRPS14; mitochondrial ribosomal protein
hsa:9167,0.0,0.0,0.0003372077360741936,0.0008548202027382624,0.0,0.0032803018,False,COX7A2L; cytochrome c oxidase subunit 7A2
hsa:7297,1.6130887e-05,0.011403036628396911,0.0001885664437419355,0.0005897424983158316,0.0,0.0031108088,False,TYK2; tyrosine kinase
hsa:11006,7.4632567e-06,0.005275828261473077,1.6650858835483865e-05,2.069368197347791e-05,0.0,8.097261e-05,False,LILRB4; leukocyte immunoglobulin like receptor
hsa:10109,0.0,0.0,4.118886788387096e-06,7.500195832787713e-06,0.0,3.09014e-05,False,ARPC2; actin related protein 2/3 complex subunit
hsa:442909,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR342; microRNA
hsa:5337,0.00026983532,0.19074847140118217,0.00042872327380645163,0.0006246300169290946,0.0,0.00287627,False,PLD1; phospholipase
hsa:2033,0.0,0.0,0.0003434601660929033,0.0008841690897868244,0.0,0.003905187,False,EP300; E1A binding protein
hsa:730291,0.0,0.0,9.542012258064517e-12,5.3127675800138815e-11,0.0,2.9580238e-10,False,ZNF735; zinc finger protein
hsa:9088,0.0,0.0,2.5303591677419354e-06,5.665149704242818e-06,0.0,2.5568988e-05,False,PKMYT1; protein kinase
hsa:23269,0.0,0.0,5.136561250129032e-06,1.8015396173502908e-05,0.0,8.983759e-05,False,MGA; MAX dimerization protein
hsa:5701,0.0,0.0,2.191326235483871e-06,3.78412774976841e-06,0.0,1.4422893e-05,False,PSMC2; proteasome 26S subunit
hsa:4999,1.1476837e-09,8.11305619394277e-07,4.404052232161289e-07,1.087931157459774e-06,0.0,4.184616e-06,False,ORC2; origin recognition complex subunit
hsa:375387,4.1628041e-07,0.00029427152784060074,4.654542399741935e-05,0.00010275036724679587,0.0,0.00038592453,False,NRROS; negative regulator of reactive oxygen
hsa:51733,0.0,0.0,8.768423193548387e-06,2.656552336858911e-05,0.0,0.00011584787,False,UPB1; beta-ureidopropionase
hsa:10886,3.7603336e-08,2.6582060723499966e-05,4.280427302967742e-07,1.2025401698875855e-06,0.0,6.5477157e-06,False,NPFFR2; neuropeptide FF receptor
hsa:127550,0.0,0.0,7.103999982967741e-06,1.4159901367758796e-05,0.0,4.9141665e-05,False,A3GALT2; alpha 1
hsa:8771,0.0,0.0,1.0539159174193548e-06,2.3763535094951056e-06,0.0,1.1138659e-05,False,TNFRSF6B; TNF receptor superfamily member
hsa:94005,0.0,0.0,8.27519606451613e-06,1.6979053406077132e-05,0.0,7.8487836e-05,False,PIGS; phosphatidylinositol glycan anchor biosynthesis class
hsa:50848,0.0,0.0,3.5259986844258074e-05,9.601227429694009e-05,0.0,0.00036818814,False,F11R; F11
hsa:5714,2.4631248e-07,0.00017412001159460615,7.087806196129032e-06,1.658862230766011e-05,0.0,7.2831885e-05,False,PSMD8; proteasome 26S subunit
hsa:8841,0.0,0.0,1.2238093008709679e-05,3.196874816668347e-05,0.0,0.00014480586,False,HDAC3; histone deacetylase
hsa:100169760,0.0,0.0,6.861808587096775e-07,2.6327783741315634e-06,0.0,1.3870191e-05,False,RNA5S9; RNA
hsa:389114,0.0,0.0,6.394556299999999e-09,1.2994843670896914e-08,0.0,5.5160008e-08,False,ZNF662; zinc finger protein
hsa:79717,2.3829175e-06,0.0016845010156569815,2.7566688896774193e-05,4.0387053037966785e-05,0.0,0.00013528457,False,PPCS; phosphopantothenoylcysteine
hsa:23244,1.4273009e-07,0.0001008968970053778,1.4576367252206444e-06,2.698791684654369e-06,0.0,1.1747979e-05,False,PDS5A; PDS5 cohesin associated factor
hsa:103910,6.397551e-06,0.004522473462558958,7.590469329354838e-05,0.00012640116758215009,0.0,0.00044488892,False,MYL12B; myosin light chain
hsa:4864,2.782353e-06,0.0019668647590259623,3.967863774935484e-05,8.33421022120646e-05,0.0,0.00034228197,False,NPC1; NPC intracellular cholesterol transporter
hsa:84876,0.00034017372,0.24047117738646576,0.0006690308372258066,0.0008396928647857938,0.0,0.0029143414,False,ORAI1; ORAI calcium release-activated calcium modulator
hsa:10892,0.0,0.0,1.9769930906451613e-06,3.542494894157967e-06,0.0,1.5567555e-05,False,MALT1; MALT1
hsa:2897,0.0,0.0,9.74493501451613e-07,2.6408628281633726e-06,0.0,1.3047456e-05,False,GRIK1; glutamate ionotropic receptor kainate type subunit
hsa:7704,0.0,0.0,8.476574435935484e-06,2.6736598460673544e-05,0.0,0.00014305976,False,ZBTB16; zinc finger and BTB domain containing
hsa:7398,0.0,0.0,5.3314939003548384e-05,0.0001270510316320477,0.0,0.0006352758,False,USP1; ubiquitin specific peptidase
hsa:100287226,0.0,0.0,7.88537804516129e-10,3.574978801547119e-09,0.0,1.9572857e-08,False,ZNF729; zinc finger protein
hsa:353497,0.0,0.0,1.3412367575999999e-05,2.7351834549207792e-05,0.0,0.0001047139,False,POLN; DNA polymerase
hsa:64816,0.0,0.0,5.840532732258064e-06,1.8197373436512974e-05,0.0,7.9615056e-05,False,CYP3A43; cytochrome P450 family 3 subfamily A member
hsa:51227,0.0,0.0,3.8512674529032266e-05,0.0001235607551422621,0.0,0.0005938934,False,PIGP; phosphatidylinositol glycan anchor biosynthesis class
hsa:3673,0.00032287888,0.22824533425693025,0.0004891371679032258,0.0004275112468414256,0.0,0.001623331,False,ITGA2; integrin subunit alpha
hsa:80778,1.6131048e-08,1.1403150440420835e-05,7.0767157e-08,1.1949313234178063e-07,0.0,5.2640627e-07,False,ZNF34; zinc finger protein
hsa:6347,6.487847e-05,0.04586304335306237,0.00022313922290322587,0.00031945291968867723,0.0,0.0011323611,False,CCL2; C-C motif chemokine ligand
hsa:93474,0.0,0.0,1.5156040587096773e-08,2.7904632624872344e-08,0.0,8.686843e-08,False,ZNF670; zinc finger protein
hsa:6770,5.072432e-06,0.003585737590936729,0.00018213992310322583,0.00036432506938441,0.0,0.001731926,False,STAR; steroidogenic acute regulatory
hsa:7070,0.0,0.0,6.27845744516129e-08,1.755197251794656e-07,0.0,7.8102096e-07,False,THY1; Thy-1 cell surface
hsa:685,1.7594009e-06,0.001243732778410418,5.305136310051613e-05,0.00012991398066253666,0.0,0.00052674196,False,BTC;
hsa:56548,2.260625e-05,0.015980515936953602,0.0006960175320003224,0.0012151345866086747,0.0,0.0037047383,False,CHST7; carbohydrate sulfotransferase
hsa:2752,4.3702108e-05,0.030893325225212827,0.0009607378819677419,0.002215926355348022,0.0,0.009421927,False,GLUL; glutamate-ammonia
hsa:9435,1.2372205e-07,8.745998083616568e-05,0.00010466549871903226,0.00029560776866904587,0.0,0.0013285277,False,CHST2; carbohydrate sulfotransferase
hsa:219869,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10G8; olfactory receptor family 10 subfamily G member
hsa:6558,0.0,0.0,0.00013697500717419357,0.00021468926755364897,0.0,0.0008469034,False,SLC12A2; solute carrier family 12 member
hsa:126068,6.385263e-09,4.513786989577669e-06,3.1461800516129034e-08,4.7733084435737195e-08,0.0,1.4531341e-07,False,ZNF441; zinc finger protein
hsa:58517,1.0010082e-07,7.076196845173896e-05,6.537163943870969e-07,1.2968734005402386e-06,0.0,4.7431813e-06,False,RBM25; RNA binding motif protein
hsa:7298,0.0,0.0,7.948465248387097e-05,0.00022374658853846954,0.0,0.0011145697,False,TYMS; thymidylate
hsa:9601,5.9095555e-06,0.00417750603696154,0.0001676944613967742,0.0003244135381342304,0.0,0.0011867862,False,PDIA4; protein disulfide isomerase family A member
hsa:59341,3.4437946e-08,2.4344424435231304e-05,1.2627868390193546e-05,3.3852154475408404e-05,0.0,0.00015097561,False,TRPV4; transient receptor potential cation channel subfamily V member
hsa:493753,2.588156e-08,1.8295855440562713e-05,5.934341089032258e-07,1.1584971928278946e-06,0.0,4.7508624e-06,False,COA5; cytochrome c oxidase assembly factor
hsa:79728,0.0,0.0,2.6376009716129034e-05,9.4122310549336e-05,0.0,0.00051463186,False,PALB2; partner and localizer of
hsa:2206,8.410268e-06,0.005945277160433549,3.543612838645161e-05,7.237597407208865e-05,0.0,0.00031558127,False,MS4A2; membrane spanning 4-domains
hsa:347148,1.17262964e-07,8.289400785253708e-05,5.032976415516129e-07,8.84583118814287e-07,0.0,3.6835934e-06,False,QRFP; pyroglutamylated RFamide
hsa:6369,0.0,0.0,1.5486393548387096e-08,8.622459010747038e-08,0.0,4.800782e-07,False,CCL24; C-C motif chemokine ligand
hsa:80326,0.0,0.0,3.2853468064516137e-06,8.194835220398284e-06,0.0,3.513553e-05,False,WNT10A; Wnt family member
hsa:6295,0.0,0.0,1.0662819053870971e-05,3.159941558303222e-05,0.0,0.00012951712,False,SAG; S-antigen visual
hsa:3557,2.5274921e-06,0.0017867018096576978,1.9286668969806458e-05,3.904396542643238e-05,0.0,0.0001453434,False,IL1RN; interleukin 1 receptor
hsa:79799,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2A3; UDP glucuronosyltransferase family 2 member
hsa:23162,0.0,0.0,3.5983549464516126e-07,8.749935641754875e-07,0.0,4.291696e-06,False,MAPK8IP3; mitogen-activated protein kinase 8 interacting protein
hsa:4715,7.053468e-06,0.00498614576874945,1.0940276133870969e-05,1.2711615635699751e-05,0.0,4.9666483e-05,False,NDUFB9; NADH:ubiquinone oxidoreductase subunit
hsa:5300,0.0,0.0,4.874929991935483e-05,0.00015495695987393713,0.0,0.00065621437,False,PIN1; peptidylprolyl cis/trans isomerase
hsa:3062,8.2478224e-10,5.830443231777181e-07,4.6489764626903235e-07,1.0191661844870188e-06,0.0,4.353053e-06,False,HCRTR2; hypocretin receptor
hsa:113220,0.0,0.0,1.7321263454193548e-09,5.25615553580553e-09,0.0,2.5799741e-08,False,KIF12; kinesin family member
hsa:10565,3.4426142e-09,2.4336080105228763e-06,4.1650143161935484e-07,8.373586809170189e-07,0.0,3.1391423e-06,False,ARFGEF1; ADP ribosylation factor guanine nucleotide exchange factor
hsa:4130,0.0,0.0,1.0155991336516127e-05,2.3367576179281456e-05,0.0,7.89896e-05,False,MAP1A; microtubule associated protein
hsa:9049,0.0,0.0,6.696230140967741e-07,1.2020157135127046e-06,0.0,4.4974768e-06,False,AIP; aryl hydrocarbon receptor interacting
hsa:288,0.0,0.0,1.4964777940177418e-07,2.9567785458561005e-07,0.0,1.1716918e-06,False,ANK3; ankyrin
hsa:23460,0.00012376806,0.08749250562635685,0.0009445041979322582,0.0012363166862771877,0.0,0.0040424736,False,ABCA6; ATP binding cassette subfamily A member
hsa:57107,4.2070262e-08,2.9739761896060318e-05,9.124982444238709e-05,0.00022218031471447572,0.0,0.0009850193,False,PDSS2; decaprenyl diphosphate synthase subunit
hsa:391109,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10K1; olfactory receptor family 10 subfamily K member
hsa:55224,4.848043e-07,0.00034271154403997284,8.92158193483871e-06,1.859765351831013e-05,0.0,9.485916e-05,False,ETNK2; ethanolamine kinase
hsa:1270,1.642427e-07,0.00011610431119174074,1.0509242109193547e-05,3.036402284667972e-05,0.0,0.00014138327,False,CNTF; ciliary neurotrophic
hsa:54922,4.9386284e-08,3.491150892027279e-05,1.986948069058064e-05,6.171326078325514e-05,0.0,0.00033286362,False,RASIP1; Ras interacting protein
hsa:5365,9.773869e-08,6.909216226494743e-05,1.3419814059580645e-05,4.176787674890929e-05,0.0,0.00018325917,False,PLXNB3; plexin
hsa:197322,0.0,0.0,2.376112942258065e-05,7.044595886608364e-05,0.0,0.0003835287,False,ACSF3; acyl-CoA synthetase family member
hsa:586,5.9935883e-06,0.00423690940990605,7.616158052580645e-05,0.00014294418982254716,0.0,0.0006953411,False,BCAT1; branched chain amino acid transaminase
hsa:23020,0.0,0.0,3.2076946941935485e-07,6.096671380544194e-07,0.0,2.2671384e-06,False,SNRNP200; small nuclear ribonucleoprotein U5 subunit
hsa:10717,5.148399e-10,3.6394391935547023e-07,2.6789380279774196e-07,5.99916074102633e-07,0.0,2.1033447e-06,False,AP4B1; adaptor related protein complex 4 subunit beta
hsa:7018,4.749e-07,0.00033571012522905236,7.195080385161289e-05,0.00012961690798220945,0.0,0.00053963484,False,TF;
hsa:5431,0.0,0.0,5.743005042258064e-06,1.3413640587973557e-05,0.0,5.3039363e-05,False,POLR2B; RNA polymerase II subunit
hsa:2354,0.00047556908,0.3361831025518325,0.0005953058658806453,0.0006227868289307573,0.0,0.0023856414,False,FOSB; FosB proto-oncogene
hsa:7136,0.0,0.0,3.826816864516129e-09,1.65666991007681e-08,0.0,9.065641e-08,False,TNNI2; troponin I2
hsa:84128,0.0,0.0,9.747087851903225e-07,3.4675672186991807e-06,0.0,1.7932474e-05,False,WDR75; WD repeat domain
hsa:8027,0.0,0.0,2.354736670322581e-06,7.88744618975122e-06,0.0,3.9166513e-05,False,STAM; signal transducing adaptor
hsa:10791,0.0,0.0,0.00010377100153419354,0.0003340389406748135,0.0,0.0016318365,False,VAMP5; vesicle associated membrane protein
hsa:3725,0.00041061887,0.2902693456919604,0.0010435016451612901,0.0016279925849228187,0.0,0.0077016084,False,JUN; Jun proto-oncogene
hsa:8890,1.1334549e-08,8.012471813444578e-06,5.894019897419355e-08,9.2064699848809e-08,0.0,3.3792884e-07,False,EIF2B4; eukaryotic translation initiation factor 2B subunit
hsa:51380,0.00027961755,0.19766359807694422,0.0003035706930645162,0.0003310078864405211,0.0,0.001397742,False,CSAD; cysteine sulfinic acid
hsa:57555,0.0,0.0,4.0277266225806454e-07,7.719413433118978e-07,0.0,2.7022793e-06,False,NLGN2; neuroligin
hsa:902,6.874698e-07,0.0004859772007774092,1.0936930117741937e-05,2.9935789859474423e-05,0.0,0.00014528619,False,CCNH; cyclin
hsa:777,0.0,0.0,2.5146265709677416e-06,5.67384351890963e-06,0.0,2.2644184e-05,False,CACNA1E; calcium voltage-gated channel subunit alpha1
hsa:2776,0.0,0.0,3.5620124193548384e-05,0.00011662544765298922,0.0,0.0005958787,False,GNAQ; G protein subunit alpha
hsa:121278,0.0,0.0,8.089163027419355e-06,2.7771741470757865e-05,0.0,0.00014755462,False,TPH2; tryptophan hydroxylase
hsa:3748,1.0405161e-09,7.355480948280589e-07,1.7039390210967743e-08,3.025519116352051e-08,0.0,1.3716239e-07,False,KCNC3; potassium voltage-gated channel subfamily C member
hsa:2159,0.0,0.0,8.141933268387097e-07,2.0534850229943523e-06,0.0,8.85899e-06,False,F10; coagulation factor
hsa:51773,0.0,0.0,1.0235193549354838e-07,2.84808513865184e-07,0.0,1.2632463e-06,False,RSF1; remodeling and spacing factor
hsa:2963,0.0,0.0,1.3450320980645162e-06,2.2146839454335172e-06,0.0,7.843811e-06,False,GTF2F2; general transcription factor IIF subunit
hsa:54714,0.0,0.0,1.2782361819354842e-07,6.957336189793466e-07,0.0,3.875948e-06,False,CNGB3; cyclic nucleotide gated channel subunit beta
hsa:25888,0.0,0.0,3.434159483870968e-08,1.0879783049539962e-07,0.0,4.370753e-07,False,ZNF473; zinc finger protein
hsa:51503,0.0,0.0,8.70016506451613e-08,1.2875342974116766e-07,0.0,4.5079517e-07,False,CWC15; CWC15 spliceosome associated protein
hsa:81328,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4A15; olfactory receptor family 4 subfamily A member
hsa:9641,1.3253576e-05,0.009369045396278718,7.170548667290324e-05,0.00015887319749904703,0.0,0.0006735568,False,IKBKE; inhibitor of nuclear factor kappa B kinase subunit
hsa:50616,0.0,0.0,5.2618919354838705e-08,2.371742727646017e-07,0.0,1.2862288e-06,False,IL22; interleukin
hsa:192134,0.0,0.0,6.79428143548387e-08,2.606192236388493e-07,0.0,1.3408786e-06,False,B3GNT6; UDP-GlcNAc:betaGal beta-1
hsa:3082,1.3914931e-05,0.00983656186263134,8.147385736774194e-05,0.00017302360632198238,0.0,0.000733799,False,HGF; hepatocyte growth
hsa:84265,0.0,0.0,6.193653988387098e-05,0.0001107813217181208,0.0,0.0003384368,False,POLR3GL; RNA polymerase III subunit
hsa:27074,0.0,0.0,2.655892301612903e-08,6.188939687955682e-08,0.0,2.9425368e-07,False,LAMP3; lysosomal associated membrane protein
hsa:9969,4.6756337e-08,3.305238102657775e-05,3.1257927440645165e-06,8.915286942263123e-06,0.0,4.1465417e-05,False,MED13; mediator complex subunit
hsa:2044,3.1410593e-07,0.0002220436746588502,2.440924324652904e-06,6.918022713130311e-06,0.0,3.0871113e-05,False,EPHA5; EPH receptor
hsa:2135,0.0,0.0,0.00022067294009677423,0.0005124783739374404,0.0,0.0024126114,False,EXTL2; exostosin like glycosyltransferase
hsa:5788,0.0,0.0,6.271096458774193e-05,0.0002009721858757157,0.0,0.0009569779,False,PTPRC; protein tyrosine phosphatase receptor type
hsa:8527,1.8341545e-05,0.012965766200977679,8.05897652148387e-05,0.00014363503875295812,0.0,0.0005348315,False,DGKD; diacylglycerol kinase
hsa:122618,9.751906e-06,0.006893690428473253,2.9959035006451607e-05,4.378243852814225e-05,0.0,0.00017063478,False,PLD4; phospholipase D family member
hsa:9021,0.00077779836,0.5498310904159857,0.0015358083166129037,0.0019097808880680052,0.0,0.0073312647,True,SOCS3; suppressor of cytokine signaling
hsa:23450,4.0920085e-08,2.8926693745490566e-05,2.8633082574193545e-07,5.319708129106067e-07,0.0,1.9385654e-06,False,SF3B3; splicing factor 3b subunit
hsa:51264,8.31819e-08,5.8801865794463075e-05,6.658035680838708e-07,1.1864321708290686e-06,0.0,3.9490446e-06,False,MRPL27; mitochondrial ribosomal protein
hsa:9337,4.2434405e-07,0.0002999717712480591,9.854271175032256e-06,3.111613824989599e-05,0.0,0.00013721065,False,CNOT8; CCR4-NOT transcription complex subunit
hsa:2877,0.0,0.0,0.0,0.0,0.0,0.0,False,GPX2; glutathione peroxidase
hsa:27334,9.8340365e-08,6.951749052267998e-05,4.3412361383870953e-07,7.675090781312978e-07,0.0,3.100447e-06,False,P2RY10; P2Y receptor family member
hsa:1832,0.0,0.0,8.482939139354841e-06,2.429184706298104e-05,0.0,0.000105259605,False,DSP;
hsa:6748,0.0,0.0,3.4434195275935483e-06,8.861059583518514e-06,0.0,3.6882924e-05,False,SSR4; signal sequence receptor subunit
hsa:70,1.0341512e-05,0.007310487025853333,6.211679505806451e-05,0.00012742812899775268,0.0,0.0006272204,False,ACTC1; actin alpha cardiac muscle
hsa:23166,5.1911755e-09,3.669678200023139e-06,7.606769637837097e-05,0.00016936388134813367,0.0,0.00055117125,False,STAB1; stabilin
hsa:5564,0.0,0.0,8.331550850709678e-05,0.00018328764359304927,0.0,0.00061461236,False,PRKAB1; protein kinase AMP-activated non-catalytic subunit beta
hsa:7332,3.1989015e-07,0.00022613258015590724,7.123646963677419e-07,1.0209615204702907e-06,0.0,3.954879e-06,False,UBE2L3; ubiquitin conjugating enzyme E2
hsa:51735,0.0,0.0,6.373601637806452e-07,1.4116309451564934e-06,0.0,4.811409e-06,False,RAPGEF6; Rap guanine nucleotide exchange factor
hsa:6469,3.333161e-05,0.02356234779361115,0.0001292733756019355,0.0002093902573390234,0.0,0.0008969101,False,SHH; sonic hedgehog signaling
hsa:5699,0.0,0.0,2.9154993603225807e-06,7.170229989624185e-06,0.0,3.2671993e-05,False,PSMB10; proteasome 20S subunit beta
hsa:389015,0.0,0.0,2.0687156838709675e-09,9.933687533884035e-09,0.0,5.5081873e-08,False,SLC9A4; solute carrier family 9 member
hsa:7067,0.0,0.0,5.248914261612904e-06,1.0019025815136058e-05,0.0,4.0664785e-05,False,THRA; thyroid hormone receptor
hsa:2012,9.3838864e-08,6.633534804125503e-05,1.8807710646774194e-06,2.9956129183963447e-06,0.0,9.938814e-06,False,EMP1; epithelial membrane protein
hsa:3381,0.0,0.0,4.925836451612903e-06,2.0640794584923082e-05,0.0,0.00010696635,False,IBSP; integrin binding
hsa:100271849,0.0,0.0,4.243523945806452e-06,1.0238020056452265e-05,0.0,3.579623e-05,False,MEF2B; myocyte enhancer factor
hsa:22827,9.197483e-08,6.501764939402149e-05,5.10946281504516e-07,6.629301308075995e-07,0.0,2.0193852e-06,False,PUF60; poly(U) binding splicing factor
hsa:8908,0.0,0.0,1.2026408440645161e-05,3.987212647455896e-05,0.0,0.00016930871,False,GYG2; glycogenin
hsa:27131,1.00391304e-07,7.09673136191785e-05,5.836966207096775e-07,9.027262897039509e-07,0.0,3.0173449e-06,False,SNX5; sorting nexin
hsa:5706,0.0,0.0,4.156286194193548e-06,9.710732884129493e-06,0.0,4.327529e-05,False,PSMC6; proteasome 26S subunit
hsa:56649,0.0,0.0,6.218994376345163e-07,3.1756611644361395e-06,0.0,1.771441e-05,False,TMPRSS4; transmembrane serine protease
hsa:256076,0.0,0.0,1.2256795612903225e-07,3.179846099097594e-07,0.0,1.4586686e-06,False,COL6A5; collagen type VI alpha 5
hsa:23118,1.18181215e-05,0.00835431258946548,4.829240103548387e-05,8.211626185576721e-05,0.0,0.0003764522,False,TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:10369,0.0,0.0,1.0892452709677419e-05,4.017986022358561e-05,0.0,0.00019841587,False,CACNG2; calcium voltage-gated channel auxiliary subunit gamma
hsa:5792,0.0,0.0,4.5173016129032254e-07,9.165622026323795e-07,0.0,3.366747e-06,False,PTPRF; protein tyrosine phosphatase receptor type
hsa:84570,2.4477297e-06,0.0017303172122844195,9.271373529032257e-06,1.6040720247435527e-05,0.0,5.891001e-05,False,COL25A1; collagen type XXV alpha 1
hsa:231,0.0,0.0,9.460762258064516e-05,0.0002885478163362901,0.0,0.0014237734,False,AKR1B1; aldo-keto reductase family 1 member
hsa:29074,0.0,0.0,1.6969635765483867e-07,4.57156142827729e-07,0.0,1.943731e-06,False,MRPL18; mitochondrial ribosomal protein
hsa:390264,0.0,0.0,5.8745593548387094e-09,2.2739480926669374e-08,0.0,9.124748e-08,False,OR10G4; olfactory receptor family 10 subfamily G member
hsa:91522,2.4647218e-07,0.00017423290463945573,4.395433403225807e-06,1.0148906904177173e-05,0.0,4.6518773e-05,False,COL23A1; collagen type XXIII alpha 1
hsa:51365,0.0,0.0,1.8635033632258065e-06,3.258410148664246e-06,0.0,1.4374771e-05,False,PLA1A; phospholipase A1 member
hsa:10350,0.00023775673,0.16807189219277743,0.0010245992830064518,0.0016750836043775133,0.0,0.006268,False,ABCA9; ATP binding cassette subfamily A member
hsa:5091,6.355859e-07,0.00044930010967113065,5.799509192258063e-06,1.4443637040322417e-05,0.0,6.441998e-05,False,PC; pyruvate
hsa:5604,4.0671857e-05,0.02875121963943591,0.0005541566408709678,0.0011533298086953132,0.0,0.0058517815,False,MAP2K1; mitogen-activated protein kinase kinase
hsa:64772,1.7279503e-06,0.001221500129716948,6.151621816774194e-05,0.0001369757931124357,0.0,0.0005618748,False,ENGASE;
hsa:389541,0.0,0.0,4.8936530193548375e-06,1.5745915905349054e-05,0.0,7.658984e-05,False,LAMTOR4; late endosomal/lysosomal adaptor
hsa:1303,5.695054e-05,0.040258734291981804,0.00026199019098387095,0.0003911401930326627,0.0,0.0012878164,False,COL12A1; collagen type XII alpha 1
hsa:162239,0.0,0.0,9.009984249096775e-08,2.310332215795872e-07,0.0,8.199847e-07,False,ZFP1; ZFP1 zinc finger
hsa:9972,0.0,0.0,2.018068845741936e-05,5.6184342133585774e-05,0.0,0.00021973021,False,NUP153; nucleoporin
hsa:11325,0.0,0.0,6.102891832258066e-08,1.1640054155958967e-07,0.0,4.385294e-07,False,DDX42; DEAD-box helicase
hsa:2353,0.0005711739,0.40376681721744845,0.0009318417258064518,0.001246569581774494,0.0,0.0049749566,True,FOS; Fos proto-oncogene
hsa:55698,0.0,0.0,2.9463424945161287e-07,6.641987413470828e-07,0.0,2.6422792e-06,False,RADIL; Rap associating with DIL
hsa:55742,0.0,0.0,7.229818821290323e-07,1.46402303365529e-06,0.0,5.4706534e-06,False,PARVA; parvin
hsa:4922,0.0,0.0,1.9482808664516125e-07,5.543627185683812e-07,0.0,2.3072284e-06,False,NTS;
hsa:120793,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR56A4; olfactory receptor family 56 subfamily A member
hsa:124872,0.0,0.0,2.3487161290322576e-08,9.88522107584135e-08,0.0,5.143633e-07,False,B4GALNT2; beta-1
hsa:7389,8.755e-06,0.006188970617772908,0.0001235365336032258,0.00027854997387831844,0.0,0.0012654045,False,UROD; uroporphyrinogen
hsa:55540,0.0,0.0,3.61331945483871e-07,1.184517724624758e-06,0.0,5.755994e-06,False,IL17RB; interleukin 17 receptor
hsa:57007,0.00021539579,0.15226478760730822,0.0005043101656580644,0.0006495795750385284,0.0,0.0027222403,False,ACKR3; atypical chemokine receptor
hsa:5611,0.0,0.0,1.3491773904903227e-05,3.9377360466201714e-05,0.0,0.00016464583,False,DNAJC3; DnaJ heat shock protein family (Hsp40) member
hsa:3732,1.2150888e-07,8.58954755132489e-05,0.00024149662126232257,0.0005921845723839672,0.0,0.0024078141,False,CD82; CD82
hsa:5607,1.4586238e-06,0.001031111346725787,9.181822114483874e-05,0.00022928316192735121,0.0,0.0009323716,False,MAP2K5; mitogen-activated protein kinase kinase
hsa:7408,7.10906e-06,0.005025444141631601,3.3721391483870974e-05,5.434710619509236e-05,0.0,0.0001760648,False,VASP; vasodilator stimulated
hsa:220992,1.1626952e-08,8.219173535380463e-06,5.1017552683870966e-08,1.0930851244169112e-07,0.0,4.3863614e-07,False,ZNF485; zinc finger protein
hsa:9934,1.2900337e-06,0.000911933828125285,5.332616216709677e-06,1.274095882204594e-05,0.0,5.5870863e-05,False,P2RY14; purinergic receptor
hsa:7757,5.3507354e-09,3.7824722072047248e-06,2.6748609012903225e-08,4.6359397939950386e-08,0.0,1.832847e-07,False,ZNF208; zinc finger protein
hsa:1281,1.6848075e-05,0.01191002183221408,0.00018884964961290323,0.00024481901207093053,0.0,0.00077440473,False,COL3A1; collagen type III alpha 1
hsa:168391,0.0,0.0,2.5377899999999998e-09,1.41298167223464e-08,-0.0,7.867149e-08,False,GALNTL5; polypeptide N-acetylgalactosaminyltransferase like
hsa:166824,0.0,0.0,0.0,0.0,0.0,0.0,False,RASSF6; Ras association domain family member
hsa:406976,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR199A1; microRNA
hsa:9894,5.8018045e-06,0.004101336102862665,0.00022196150239193552,0.0004414258204585559,0.0,0.0016553176,False,TELO2; telomere maintenance
hsa:19,0.0010264007,0.7255698200298737,0.0018696331799999998,0.0021398263703914207,0.0,0.008646533,True,ABCA1; ATP binding cassette subfamily A member
hsa:54518,1.0236795e-08,7.236461847534508e-06,8.899823004838711e-07,1.3580667486937933e-06,0.0,5.0072026e-06,False,APBB1IP; amyloid beta precursor protein binding family B member 1 interacting
hsa:55422,0.0,0.0,1.9581851396774191e-07,6.263242960241622e-07,0.0,3.037556e-06,False,ZNF331; zinc finger protein
hsa:10092,1.0582545e-06,0.0007480874936180422,3.6277888394516126e-05,9.679906623683703e-05,0.0,0.00044405015,False,ARPC5; actin related protein 2/3 complex subunit
hsa:23457,3.9117833e-05,0.02765266922535093,0.00019582354022258067,0.000420203885499252,0.0,0.0022999195,False,ABCB9; ATP binding cassette subfamily B member
hsa:7432,8.865059e-07,0.0006266772093183698,0.0001345473506004839,0.00035337643960637834,0.0,0.0017754337,False,VIP; vasoactive intestinal
hsa:51426,0.0,0.0,0.0002052206235967742,0.00034442882653596416,0.0,0.0013597298,False,POLK; DNA polymerase
hsa:11157,0.0,0.0,3.990335917419355e-07,8.545562354221671e-07,0.0,3.1281033e-06,False,LSM6; LSM6 homolog
hsa:219931,0.0,0.0,1.7297300320967742e-06,3.743190946094756e-06,0.0,1.732296e-05,False,TPCN2; two pore segment channel
hsa:494143,0.0,0.0,1.646140223548387e-07,4.289335381070887e-07,0.0,1.9869203e-06,False,CHAC2; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:959,0.0,0.0,0.0,0.0,0.0,0.0,False,CD40LG; CD40
hsa:10242,9.10573e-11,6.436904103183699e-08,1.086826158049355e-05,4.807178688931927e-05,0.0,0.00026798956,False,KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:7561,1.47921515e-08,1.0456675157869268e-05,6.89257022967742e-08,1.0760596354501512e-07,0.0,3.8788917e-07,False,ZNF14; zinc finger protein
hsa:3306,0.0,0.0,2.6032915972903227e-06,5.278954173903511e-06,0.0,1.8825684e-05,False,HSPA2; heat shock protein family A (Hsp70) member
hsa:27316,0.0,0.0,1.3770616496774196e-07,3.2777304283216064e-07,0.0,1.5972986e-06,False,RBMX; RNA binding motif protein
hsa:112724,0.0,0.0,0.00019420586574193547,0.0006199615988889348,0.0,0.0033345905,False,RDH13; retinol dehydrogenase
hsa:4899,0.0,0.0,3.092436227064515e-06,6.587548216498838e-06,0.0,2.6926798e-05,False,NRF1; nuclear respiratory factor
hsa:1437,0.0,0.0,2.1145138601612902e-05,8.950043545469684e-05,0.0,0.0004908594,False,CSF2; colony stimulating factor
hsa:388753,0.0,0.0,1.6708291634341935e-06,5.1736135955814925e-06,0.0,2.0379191e-05,False,COA6; cytochrome c oxidase assembly factor
hsa:117,0.0,0.0,7.899129464516129e-06,1.8493981399781493e-05,0.0,8.9908106e-05,False,ADCYAP1R1; ADCYAP receptor type
hsa:55102,1.1713637e-08,8.280451767019712e-06,1.2838684694290324e-05,2.876897334116108e-05,0.0,9.90501e-05,False,ATG2B; autophagy related
hsa:138429,0.0,0.0,4.2375185330870975e-07,1.5225921793860034e-06,0.0,6.973546e-06,False,PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase like
hsa:6556,6.0715564e-08,4.2920256040835014e-05,1.6319055293890323e-06,3.718118901106958e-06,0.0,1.4450179e-05,False,SLC11A1; solute carrier family 11 member
hsa:2687,0.00042779202,0.3024091653109903,0.0012312916302483874,0.0018029421975925273,6.6979337e-06,0.005974463,False,GGT5; gamma-glutamyltransferase
hsa:3479,0.0010237689,0.7237093822375431,0.001127953949967742,0.0011323582028735218,0.0,0.0038836808,True,IGF1; insulin like growth factor
hsa:5662,7.7976566e-08,5.512217885195087e-05,5.836629268451611e-07,8.165886019190708e-07,0.0,2.7949288e-06,False,PSD; pleckstrin and Sec7 domain
hsa:124975,0.0,0.0,5.028789009677419e-06,1.3203324101432707e-05,0.0,5.0202565e-05,False,GGT6; gamma-glutamyltransferase
hsa:8463,0.000357218,0.2525198979028672,0.0006089691403225807,0.0007012789607402049,0.0,0.0025069632,False,TEAD2; TEA domain transcription factor
hsa:81888,0.0,0.0,8.85885922580645e-06,1.8418251466690745e-05,0.0,7.492816e-05,False,HYI; hydroxypyruvate isomerase
hsa:93432,0.0,0.0,4.3850769677419355e-07,2.2019963649938197e-06,0.0,1.2229628e-05,False,MGAM2; maltase-glucoamylase 2
hsa:2821,0.0,0.0,3.660012712903226e-05,9.40689794383198e-05,0.0,0.0004003017,False,GPI; glucose-6-phosphate
hsa:27178,-0.0,0.0,5.963641993548388e-08,3.0115554270641437e-07,0.0,1.6751377e-06,False,IL37; interleukin
hsa:6352,2.4326468e-05,0.01719655004982214,0.0001301357423548387,0.00026191187745021636,0.0,0.0011471926,False,CCL5; C-C motif chemokine ligand
hsa:1910,5.976051e-05,0.04224512170109926,0.00027874232291935484,0.0005949227985219557,0.0,0.0028188971,False,EDNRB; endothelin receptor type
hsa:55454,0.0,0.0,8.347359398580647e-05,0.0003197804042260481,0.0,0.0016748755,False,CSGALNACT2; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:2241,2.7877242e-08,1.9706616978017684e-05,1.2282423729677418e-06,3.2461876409097515e-06,0.0,1.3494483e-05,False,FER; FER tyrosine
hsa:55746,5.4553113e-09,3.8563976409485456e-06,1.2756888266967742e-07,2.4148898674501185e-07,0.0,8.8413447e-07,False,NUP133; nucleoporin
hsa:4698,4.5441075e-06,0.0032122613137066246,7.546527838709677e-06,1.0618824132432928e-05,0.0,4.134626e-05,False,NDUFA5; NADH:ubiquinone oxidoreductase subunit
hsa:219438,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5D18; olfactory receptor family 5 subfamily D member
hsa:148327,0.0,0.0,0.0,0.0,0.0,0.0,False,CREB3L4; cAMP responsive element binding protein 3 like
hsa:23480,0.0,0.0,3.4641694393548395e-05,8.25704559015722e-05,0.0,0.00030747938,False,SEC61G; SEC61 translocon subunit
hsa:493,5.5475895e-05,0.03921629744713363,0.000377730893,0.0007206404882840833,0.0,0.002765591,False,ATP2B4; ATPase plasma membrane Ca2+ transporting
hsa:9071,0.0,0.0,8.335655645161291e-08,2.498594464123722e-07,0.0,1.1913569e-06,False,CLDN10; claudin
hsa:1183,5.3193577e-07,0.0003760291092030162,2.4687133179032265e-06,5.604026961860063e-06,0.0,2.9396859e-05,False,CLCN4; chloride voltage-gated channel
hsa:7056,1.2005625e-05,0.008486860122558523,0.00016437381396451612,0.00039657021103087247,0.0,0.0020729806,False,THBD;
hsa:81578,9.8382925e-06,0.006954757648378705,4.207529766290323e-05,6.653536528926749e-05,0.0,0.00022764801,False,COL21A1; collagen type XXI alpha 1
hsa:554235,0.0,0.0,2.2799496183870968e-05,5.156783088937694e-05,0.0,0.0002674525,False,ASPDH; aspartate dehydrogenase domain
hsa:54480,0.0,0.0,1.8354343516129031e-06,5.853501860804554e-06,0.0,2.551598e-05,False,CHPF2; chondroitin polymerizing factor
hsa:115019,0.0,0.0,5.036621942903226e-07,1.6979135123693152e-06,0.0,7.86015e-06,False,SLC26A9; solute carrier family 26 member
hsa:406957,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181C; microRNA
hsa:64841,0.0,0.0,1.2292812239032257e-05,2.9235335752607707e-05,0.0,0.00013599347,False,GNPNAT1; glucosamine-phosphate N-acetyltransferase
hsa:29949,0.0,0.0,3.724376129032258e-09,2.073644868500063e-08,0.0,1.1545566e-07,False,IL19; interleukin
hsa:10368,0.0,0.0,2.9045426196774193e-05,5.412033197370059e-05,0.0,0.00023204858,False,CACNG3; calcium voltage-gated channel auxiliary subunit gamma
hsa:84892,3.684877e-06,0.0026048652750550747,3.645600796774193e-05,9.42595074642099e-05,0.0,0.0004225671,False,POMGNT2; protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta
hsa:7508,1.4361554e-07,0.00010152282779161505,5.39497651935484e-07,6.802460381869782e-07,0.0,2.2637907e-06,False,XPC; XPC complex subunit
hsa:64132,1.08211725e-05,0.007649562381764958,0.00048788808171935477,0.00126540035694236,0.0,0.0060839127,False,XYLT2; xylosyltransferase
hsa:94274,0.0,0.0,1.3684279713129034e-05,7.021360184606848e-05,0.0,0.00039148927,False,PPP1R14A; protein phosphatase 1 regulatory inhibitor subunit
hsa:1948,0.0,0.0,1.274229172585484e-05,5.449050316588168e-05,0.0,0.000299876,False,EFNB2; ephrin
hsa:10950,0.0,0.0,4.1941265183870974e-07,1.0357569333360369e-06,0.0,5.588576e-06,False,BTG3; BTG anti-proliferation factor
hsa:4294,0.0,0.0,5.684222928709678e-07,1.776198506281158e-06,0.0,9.373434e-06,False,MAP3K10; mitogen-activated protein kinase kinase kinase
hsa:10248,0.0,0.0,2.0683751225806451e-07,4.0919616445097923e-07,0.0,1.9817976e-06,False,POP7; POP7 homolog
hsa:1387,0.0,0.0,0.00013484502399999999,0.00023455355846559433,0.0,0.00081606477,False,CREBBP; CREB binding
hsa:220988,3.972795e-08,2.808396519181624e-05,3.4073283467741933e-07,5.715726417794952e-07,0.0,1.9857878e-06,False,HNRNPA3; heterogeneous nuclear ribonucleoprotein
hsa:258010,0.0,0.0,1.5161865200019353e-06,4.9311949956563074e-06,0.0,2.3260021e-05,False,SVIP; small VCP interacting
hsa:10291,2.0686342e-07,0.0001462331956906929,7.707963378709676e-07,1.362969942737842e-06,0.0,4.757628e-06,False,SF3A1; splicing factor 3a subunit
hsa:167227,0.0,0.0,5.536726804193549e-06,1.7765981423327365e-05,0.0,7.6094904e-05,False,DCP2; decapping mRNA
hsa:259295,0.0,0.0,2.8584654193548385e-06,1.159689506883786e-05,0.0,6.2846266e-05,False,TAS2R20; taste 2 receptor member
hsa:137075,0.0,0.0,2.4247050312903226e-06,7.863433859714755e-06,0.0,4.351725e-05,False,CLDN23; claudin
hsa:5704,2.8116353e-06,0.0019875646213127485,5.817704948387097e-06,9.03733070257523e-06,0.0,3.334917e-05,False,PSMC4; proteasome 26S subunit
hsa:9127,9.920733e-07,0.0007013035413337528,6.0660381064516125e-06,1.0765055846155756e-05,0.0,5.2984815e-05,False,P2RX6; purinergic receptor P2X
hsa:65110,0.0,0.0,5.981985850645162e-07,2.156164976475674e-06,0.0,1.0289809e-05,False,UPF3A; UPF3A regulator of nonsense mediated mRNA
hsa:3572,0.0,0.0,0.0003562652033548388,0.0006954470065596036,0.0,0.0023145298,False,IL6ST; interleukin 6 cytokine family signal
hsa:4837,0.00016370752,0.1157259887137031,0.0004158903690967742,0.001035690263168503,0.0,0.005822614,False,NNMT; nicotinamide
hsa:51434,0.0,0.0,2.9396998362580653e-06,8.642868065683845e-06,0.0,4.5375746e-05,False,ANAPC7; anaphase promoting complex subunit
hsa:5576,0.0,0.0,1.3977743707048385e-06,2.6819645181324524e-06,0.0,1.0379323e-05,False,PRKAR2A; protein kinase cAMP-dependent type II regulatory subunit
hsa:406890,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7G; microRNA
hsa:657,0.0,0.0,2.5029163362580645e-05,6.351247168535532e-05,0.0,0.0002655252,False,BMPR1A; bone morphogenetic protein receptor type
hsa:5287,2.5244668e-07,0.0001784563203968383,8.503992370645162e-06,2.387048802263677e-05,0.0,0.00012868708,False,PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:3822,3.1486346e-07,0.0002225791779040908,1.836055639635484e-06,2.9763290591972526e-06,0.0,1.2045609e-05,False,KLRC2; killer cell lectin like receptor
hsa:27250,0.0,0.0,2.6690031679419357e-06,7.96031084396868e-06,0.0,3.27646e-05,False,PDCD4; programmed cell death
hsa:92960,0.0,0.0,2.2854464415096775e-06,5.596168793302365e-06,0.0,2.2843817e-05,False,PEX11G; peroxisomal biogenesis factor 11
hsa:783,0.0,0.0,3.707192841935484e-05,7.521009880270956e-05,0.0,0.0003026796,False,CACNB2; calcium voltage-gated channel auxiliary subunit beta
hsa:64109,4.1725876e-10,2.949631302853635e-07,7.847657121250322e-06,1.7717970599152946e-05,0.0,8.353955e-05,False,CRLF2; cytokine receptor like factor
hsa:3292,1.0922759e-06,0.0007721374587780078,5.1209511525806444e-05,9.261551815487582e-05,0.0,0.0003226803,False,HSD17B1; hydroxysteroid 17-beta dehydrogenase
hsa:376497,1.9625044e-05,0.01387308060405488,0.0003337553291290322,0.0007202460413870331,0.0,0.0026634533,False,SLC27A1; solute carrier family 27 member
hsa:4638,2.6076992e-05,0.018434007685653817,0.00019441062372580644,0.0005034428634951551,0.0,0.0026395102,False,MYLK; myosin light chain
hsa:29926,0.0,0.0,8.755607792903225e-05,0.00039537829458083677,0.0,0.002206051,False,GMPPA; GDP-mannose pyrophosphorylase
hsa:5878,0.00011391965,0.0805305958465989,0.00046760228540322575,0.000850723622562991,0.0,0.0030435033,False,RAB5C; RAB5C
hsa:5982,0.0,0.0,5.5467443259032265e-05,0.00013118435959182781,0.0,0.0005989631,False,RFC2; replication factor C subunit
hsa:10298,0.0,0.0,1.1853340570967742e-06,2.294993733187054e-06,0.0,9.660984e-06,False,PAK4; p21 (RAC1) activated kinase
hsa:23461,0.0,0.0,0.00044584248045677414,0.00103809917961278,0.0,0.004384401,False,ABCA5; ATP binding cassette subfamily A member
hsa:9801,0.0,0.0,6.818620826774194e-08,1.3677331147600236e-07,0.0,5.046946e-07,False,MRPL19; mitochondrial ribosomal protein
hsa:406913,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR126; microRNA
hsa:2862,4.982264e-08,3.521997202283006e-05,5.070721827741935e-07,1.1744150052900798e-06,0.0,5.40203e-06,False,MLNR; motilin
hsa:57498,0.0,0.0,2.3356276022580648e-07,4.552680650732915e-07,0.0,1.4023072e-06,False,KIDINS220; kinase D interacting substrate
hsa:22929,0.0,0.0,6.743580361290323e-05,0.00015951255948001936,0.0,0.0006391713,False,SEPHS1; selenophosphate synthetase
hsa:364,2.25616e-06,0.001594895254025645,9.039106069483872e-05,0.00020530467639365155,0.0,0.00084432634,False,AQP7; aquaporin
hsa:6647,0.0,0.0,5.01465741967742e-05,0.00015301353903968503,0.0,0.0006138767,False,SOD1; superoxide dismutase
hsa:8625,4.8356037e-07,0.00034183220123922285,0.00013630711090225806,0.00035871903303571573,0.0,0.0016324462,False,RFXANK; regulatory factor X associated ankyrin containing
hsa:23705,3.379217e-08,2.3887920872734106e-05,6.190090085483871e-06,1.4850230005113488e-05,0.0,6.674568e-05,False,CADM1; cell adhesion molecule
hsa:284532,0.0,0.0,0.0,0.0,0.0,0.0,False,OR14A16; olfactory receptor family 14 subfamily A member
hsa:11227,4.5151123e-06,0.0031917644044140553,6.178159588548387e-05,0.00014426715464460656,0.0,0.0007216279,False,GALNT5; polypeptide N-acetylgalactosaminyltransferase
hsa:6198,0.0,0.0,0.0002528233487741935,0.0004946988776176872,0.0,0.0017091633,False,RPS6KB1; ribosomal protein S6 kinase
hsa:64601,0.0,0.0,1.1918916237419354e-06,3.2167329197750497e-06,0.0,1.4280922e-05,False,VPS16; VPS16 core subunit of CORVET and HOPS
hsa:1869,0.0,0.0,4.332166225806452e-06,1.6019613159175076e-05,0.0,7.4562326e-05,False,E2F1; E2F transcription factor
hsa:1392,8.178512e-06,0.005781447226168262,0.00013283157222741934,0.00021138887713073755,0.0,0.00072235096,False,CRH; corticotropin releasing
hsa:715,2.3021059e-05,0.01627374731479344,0.0001845478850645161,0.00029395597471422636,0.0,0.0008642591,False,C1R; complement
hsa:548644,4.123099e-06,0.0029146474660387044,2.862455213387097e-05,4.719819364214973e-05,0.0,0.00015551587,False,POLR2J3; RNA polymerase II subunit
hsa:8312,4.851898e-05,0.034298405668110946,0.00011425611425806452,0.0001738781116903857,0.0,0.0007096995,False,AXIN1; axin
hsa:84733,0.0,0.0,4.523483517929031e-06,1.687914668881151e-05,0.0,7.0668146e-05,False,CBX2; chromobox
hsa:793,0.0,0.0,6.010689084096776e-07,2.690901423466643e-06,0.0,1.4962994e-05,False,CALB1; calbindin
hsa:2253,0.0,0.0,3.3412439487096775e-07,1.245891522221685e-06,0.0,6.5267773e-06,False,FGF8; fibroblast growth factor
hsa:286,0.0,0.0,7.690091483870968e-08,1.623033373433395e-07,0.0,6.953769e-07,False,ANK1; ankyrin
hsa:407017,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26B; microRNA
hsa:81458,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T7; olfactory receptor family 2 subfamily T member
hsa:8549,0.0,0.0,4.820708091096774e-07,9.354310664692316e-07,0.0,3.552195e-06,False,LGR5; leucine rich repeat containing G protein-coupled receptor
hsa:6712,0.0,0.0,2.2182153193548387e-08,5.401185741922606e-08,0.0,2.1974405e-07,False,SPTBN2; spectrin beta
hsa:4897,0.0,0.0,3.980038318709677e-06,7.628607643482551e-06,0.0,2.868062e-05,False,NRCAM; neuronal cell adhesion
hsa:10381,0.0,0.0,0.0001405725572645161,0.00046121304519800954,0.0,0.0018528897,False,TUBB3; tubulin beta 3 class
hsa:101954269,-0.0,0.0,0.0,0.0,0.0,0.0,False,RNVU1-17; RNA
hsa:8559,1.748535e-09,1.2360515978466647e-06,3.5408492899354835e-07,5.280694768975923e-07,0.0,1.400842e-06,False,PRPF18; pre-mRNA processing factor
hsa:8411,4.7671588e-08,3.369937834775277e-05,3.671605992903226e-07,5.854935019693827e-07,0.0,1.9560878e-06,False,EEA1; early endosome antigen
hsa:122748,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR11H6; olfactory receptor family 11 subfamily H member
hsa:5172,8.6341765e-07,0.0006103559642166227,1.5493784641129033e-05,2.761749390118566e-05,0.0,0.0001043249,False,SLC26A4; solute carrier family 26 member
hsa:2071,0.0,0.0,3.3992678967741936e-07,5.2709437947249e-07,0.0,1.3561538e-06,False,ERCC3; ERCC excision repair 3
hsa:4047,1.006209e-06,0.0007112961663436504,9.334902322096775e-05,0.00016883197369906418,0.0,0.00070073875,False,LSS; lanosterol
hsa:116443,0.0,0.0,1.0036333937741934e-05,3.6722611749862e-05,0.0,0.0001839006,False,GRIN3A; glutamate ionotropic receptor NMDA type subunit
hsa:11214,3.385341e-08,2.3931211856244375e-05,3.406773643419355e-05,0.00011250801985157006,0.0,0.00056433346,False,AKAP13; A-kinase anchoring protein
hsa:23624,0.0,0.0,1.4210625806451612e-10,7.912141593867398e-10,0.0,4.405294e-09,False,CBLC; Cbl proto-oncogene
hsa:23303,0.0,0.0,6.157357371612903e-07,1.9857877868323895e-06,0.0,8.527278e-06,False,KIF13B; kinesin family member
hsa:900,1.1292157e-06,0.0007982504612710298,7.48009298967742e-05,0.00022559883410002955,0.0,0.001094411,False,CCNG1; cyclin
hsa:5789,3.0688277e-08,2.1693757243069804e-05,8.686134853870968e-07,1.5922351251800487e-06,0.0,6.567757e-06,False,PTPRD; protein tyrosine phosphatase receptor type
hsa:10195,0.0,0.0,1.1690934965483867e-05,5.519148536607063e-05,0.0,0.00030825517,False,ALG3; ALG3 alpha-1
hsa:55176,3.5462247e-07,0.0002506850996267338,5.9556348260854844e-05,0.00016125270574388295,0.0,0.00079576,False,SEC61A2; SEC61 translocon subunit alpha
hsa:100132463,0.0,0.0,1.7148401935483871e-09,6.803221428412169e-09,0.0,3.235412e-08,False,CLDN24; claudin
hsa:6567,2.912242e-07,0.0002058684199867985,1.8128374125806451e-06,4.732963266631725e-06,0.0,2.327404e-05,False,SLC16A2; solute carrier family 16 member
hsa:51024,2.2128884e-07,0.00015643062579109653,5.785728298806452e-06,1.2671491689452834e-05,0.0,4.2854375e-05,False,FIS1; fission
hsa:406915,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR128-1; microRNA
hsa:7755,6.881671e-08,4.864701270151901e-05,1.9244423009677416e-07,2.691227278686e-07,0.0,8.7127296e-07,False,ZNF205; zinc finger protein
hsa:4832,0.0,0.0,0.00010674681533225805,0.00032609112082494877,0.0,0.0015068342,False,NME3; NME/NM23 nucleoside diphosphate kinase
hsa:9056,8.935314e-07,0.0006316435843126773,2.624987182483871e-05,6.338346671883114e-05,0.0,0.00026400684,False,SLC7A7; solute carrier family 7 member
hsa:445329,0.0,0.0,3.772727559032258e-05,0.00010653143556435592,0.0,0.0005642124,False,SULT1A4; sulfotransferase family 1A member
hsa:10929,0.0,0.0,5.575678424516129e-07,1.1127766287729473e-06,0.0,3.6716121e-06,False,SRSF8; serine and arginine rich splicing factor
hsa:27304,0.0,0.0,9.319958735806452e-05,0.0002800488848647982,0.0,0.0012925413,False,MOCS3; molybdenum cofactor synthesis
hsa:4701,1.9738538e-06,0.001395331030494506,4.4513023274193556e-06,5.28813894019356e-06,0.0,1.7629702e-05,False,NDUFA7; NADH:ubiquinone oxidoreductase subunit
hsa:1380,0.0,0.0,0.0,0.0,0.0,0.0,False,CR2; complement C3d receptor
hsa:349075,7.599185e-09,5.371916925644844e-06,8.381629884677419e-08,1.500313232072761e-07,0.0,5.8587216e-07,False,ZNF713; zinc finger protein
hsa:55283,0.0,0.0,7.507855666258065e-07,1.911104901474006e-06,0.0,7.983629e-06,False,MCOLN3; mucolipin TRP cation channel
hsa:3516,7.805134e-07,0.0005517503711454062,8.082872525516129e-05,0.00020590359421848899,0.0,0.0007710837,False,RBPJ; recombination signal binding protein for immunoglobulin kappa J
hsa:23405,5.2498343e-08,3.711144515234311e-05,8.110485908258062e-07,1.8554183247785692e-06,0.0,8.092866e-06,False,DICER1; dicer 1
hsa:6779,0.0,0.0,0.0,0.0,0.0,0.0,False,STATH;
hsa:146850,4.1028716e-06,0.0029003485757732625,4.08246464667742e-05,7.737596073284805e-05,0.0,0.00036819195,False,PIK3R6; phosphoinositide-3-kinase regulatory subunit
hsa:23207,3.7548674e-08,2.6543419774110057e-05,6.569885037258065e-07,1.2068574691565669e-06,0.0,4.801829e-06,False,PLEKHM2; pleckstrin homology and RUN domain containing
hsa:4351,0.0,0.0,2.7189010116129034e-05,0.0001000147706921282,0.0,0.0005550651,False,MPI; mannose phosphate
hsa:30000,1.5853056e-08,1.1206635954986693e-05,8.564355967741935e-08,1.3979986466199434e-07,0.0,4.842702e-07,False,TNPO2; transportin
hsa:2006,0.0,0.0,1.72083699e-05,4.9546025195746405e-05,0.0,0.00023721613,False,ELN;
hsa:90,6.642913e-05,0.046959215732063596,0.000430073019816129,0.0008080241080889331,0.0,0.003708594,False,ACVR1; activin A receptor type
hsa:79818,3.1055531e-09,2.1953371659432974e-06,5.420256369354838e-08,1.4503160262376402e-07,0.0,6.101415e-07,False,ZNF552; zinc finger protein
hsa:169044,0.0,0.0,6.636677787096776e-07,1.6178862166289878e-06,0.0,7.221402e-06,False,COL22A1; collagen type XXII alpha 1
hsa:2591,0.0,0.0,9.99368413548387e-06,2.2711203972615724e-05,0.0,9.5209645e-05,False,GALNT3; polypeptide N-acetylgalactosaminyltransferase
hsa:3105,0.0,0.0,0.00013812474519354838,0.00023374939094260059,0.0,0.0007254877,False,HLA-A; major histocompatibility complex
hsa:147660,8.43848e-10,5.965220420178678e-07,4.66860828016129e-09,1.1398938785553701e-08,0.0,6.047623e-08,False,ZNF578; zinc finger protein
hsa:91664,2.1923956e-09,1.5498197545327929e-06,1.7239566193548386e-08,2.761584986163611e-08,0.0,1.1057316e-07,False,ZNF845; zinc finger protein
hsa:10403,0.0,0.0,3.9759496299906446e-07,1.1831949475689263e-06,0.0,5.565647e-06,False,NDC80; NDC80 kinetochore complex
hsa:54822,0.0,0.0,1.8900104914516133e-05,7.1469740588573e-05,0.0,0.00037711594,False,TRPM7; transient receptor potential cation channel subfamily M member
hsa:53842,0.0,0.0,5.4972798019354836e-08,1.7125491524289473e-07,0.0,6.676848e-07,False,CLDN22; claudin
hsa:5164,0.0,0.0,3.1829450562580643e-07,6.524407363496474e-07,0.0,2.4092442e-06,False,PDK2; pyruvate dehydrogenase kinase
hsa:5192,1.1255221e-07,7.956394296463802e-05,1.3583418340129031e-05,3.234162879084553e-05,0.0,0.00013550297,False,PEX10; peroxisomal biogenesis factor
hsa:32,5.64073e-05,0.039874714143678096,0.0005077368602903225,0.0009568197017446812,0.0,0.003735842,False,ACACB; acetyl-CoA carboxylase
hsa:374291,5.783003e-07,0.0004088045191261287,4.457172566225806e-06,6.1276006829240385e-06,0.0,2.1025047e-05,False,NDUFS7; NADH:ubiquinone oxidoreductase core subunit
hsa:160428,0.0,0.0,4.543275731354838e-06,1.0766247602855497e-05,0.0,4.3954908e-05,False,ALDH1L2; aldehyde dehydrogenase 1 family member
hsa:4534,1.0974048e-06,0.0007757631139923419,1.5506727276135484e-05,3.6626576891196656e-05,0.0,0.00017473903,False,MTM1; myotubularin
hsa:4719,7.189784e-07,0.0005082508500757712,7.4910260503225825e-06,1.2522182829636218e-05,0.0,4.8228285e-05,False,NDUFS1; NADH:ubiquinone oxidoreductase core subunit
hsa:4641,3.1647783e-08,2.237203873268451e-05,8.339811560967742e-07,1.430437634334114e-06,0.0,5.125529e-06,False,MYO1C; myosin
hsa:10540,3.7313328e-06,0.002637705204378334,0.0003141101202967742,0.0007577496709511097,0.0,0.0028849312,False,DCTN2; dynactin subunit
hsa:2874,9.5563564e-08,6.755455051121197e-05,8.399588364032258e-07,2.173856251332634e-06,0.0,8.314178e-06,False,GPS2; G protein pathway suppressor
hsa:1557,0.0,0.0,0.0,0.0,0.0,0.0,False,CYP2C19; cytochrome P450 family 2 subfamily C member
hsa:4919,7.457386e-08,5.271678222660312e-05,1.355668005935484e-05,4.9985056334699685e-05,0.0,0.00026983526,False,ROR1; receptor tyrosine kinase like orphan receptor
hsa:51241,0.0,0.0,2.5737682294193555e-06,6.630215688417722e-06,0.0,2.5886713e-05,False,COX16; cytochrome c oxidase assembly factor
hsa:5684,4.036277e-06,0.0028532723881430698,7.115650412903226e-06,9.019938199873232e-06,0.0,3.285844e-05,False,PSMA3; proteasome 20S subunit alpha
hsa:10991,3.9778215e-06,0.0028119497871211137,4.005328488387097e-05,5.966879322184078e-05,0.0,0.00017080067,False,SLC38A3; solute carrier family 38 member
hsa:147687,0.0,0.0,3.010611336451613e-08,6.716241809670495e-08,0.0,3.166288e-07,False,ZNF417; zinc finger protein
hsa:4666,0.0,0.0,1.1648010958451612e-05,2.59781616870002e-05,0.0,0.00012523966,False,NACA; nascent polypeptide associated complex subunit
hsa:6376,3.959771e-05,0.02799189762662392,0.00014047162408709676,0.00019492636912243246,0.0,0.0006540865,False,CX3CL1; C-X3-C motif chemokine ligand
hsa:84924,0.0,0.0,1.6458310044193554e-08,3.6518806148772e-08,0.0,1.3215403e-07,False,ZNF566; zinc finger protein
hsa:57530,0.0,0.0,9.980892327096773e-08,3.183339305870598e-07,0.0,1.3252917e-06,False,CGN;
hsa:538,0.0,0.0,3.509884558709677e-05,9.51499570359277e-05,0.0,0.00037634518,False,ATP7A; ATPase copper transporting
hsa:3459,1.302442e-05,0.009207053420163772,0.0001729374911774194,0.0002681290082041149,0.0,0.0011296598,False,IFNGR1; interferon gamma receptor
hsa:9414,8.7114273e-07,0.0006158168771966279,1.372210932516129e-05,2.4128144531833462e-05,0.0,9.202707e-05,False,TJP2; tight junction protein
hsa:1958,3.2972373e-05,0.023308400650513848,0.00025131575667741935,0.0004065432881249833,0.0,0.001429404,False,EGR1; early growth response
hsa:27330,0.0,0.0,2.485933032258065e-07,1.2190169957075228e-06,0.0,6.780537e-06,False,RPS6KA6; ribosomal protein S6 kinase
hsa:10477,0.0,0.0,2.551341884516129e-07,4.819645616161924e-07,0.0,1.5846634e-06,False,UBE2E3; ubiquitin conjugating enzyme E2
hsa:207,0.0,0.0,0.0003679741448387096,0.00065168310644009,0.0,0.0026493631,False,AKT1; AKT serine/threonine kinase
hsa:8789,0.0,0.0,9.468267096774194e-07,5.271708011917541e-06,0.0,2.9351628e-05,False,FBP2; fructose-bisphosphatase
hsa:345462,0.0,0.0,2.3764467422580648e-08,3.613950679254353e-08,0.0,1.4452422e-07,False,ZNF879; zinc finger protein
hsa:8318,0.0,0.0,9.12359833844e-07,2.939119365032926e-06,0.0,1.3942915e-05,False,CDC45; cell division cycle
hsa:390792,0.0,0.0,1.8451934759999998e-06,5.260486888633308e-06,0.0,2.473552e-05,False,KRT39; keratin
hsa:9402,3.4690085e-08,2.452266325448825e-05,2.3338019218387095e-07,3.8604779351620547e-07,0.0,1.6290792e-06,False,GRAP2; GRB2 related adaptor protein
hsa:441925,0.0,0.0,7.422502145483871e-08,4.121488107607284e-07,0.0,2.2949441e-06,False,BECN2; beclin
hsa:7078,2.1686606e-07,0.00015330413173411496,4.79735238483871e-07,6.626906237264553e-07,0.0,2.2278623e-06,False,TIMP3; TIMP metallopeptidase inhibitor
hsa:8761,8.3169385e-07,0.0005879301885359713,8.120775550967744e-06,2.2482373270216967e-05,0.0,9.651327e-05,False,PABPC4; poly(A) binding protein cytoplasmic
hsa:117247,6.684911e-08,4.725610252590165e-05,8.775631368064517e-06,2.156024872263394e-05,0.0,0.000115304916,False,SLC16A10; solute carrier family 16 member
hsa:10135,5.228979e-05,0.03696401758075563,0.00010850306970967743,0.00017553225570862439,0.0,0.00082313915,False,NAMPT; nicotinamide
hsa:80319,0.0,0.0,1.0045807212903227e-07,1.975614310476562e-07,0.0,7.515717e-07,False,CXXC4; CXXC finger protein
hsa:162417,1.4551466e-05,0.010286532897718042,4.306966189354839e-05,7.863639946673544e-05,0.0,0.000410448,False,NAGS; N-acetylglutamate
hsa:219957,0.0,0.0,0.0,0.0,0.0,0.0,False,OR9Q2; olfactory receptor family 9 subfamily Q member
hsa:9839,1.2313401e-07,8.70442912551177e-05,5.196285663806451e-07,1.078428919379658e-06,0.0,4.573433e-06,False,ZEB2; zinc finger E-box binding homeobox
hsa:1103,0.0,0.0,4.0165238141935485e-07,7.412658068930773e-07,0.0,2.9818511e-06,False,CHAT; choline
hsa:119765,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4B1; olfactory receptor family 4 subfamily B member
hsa:4077,2.0669706e-09,1.4611559464535052e-06,1.0872887676225804e-06,1.7508665317951584e-06,0.0,7.346032e-06,False,NBR1; NBR1 autophagy cargo
hsa:7357,1.306013e-07,9.232297068451682e-05,1.4520764730967742e-05,2.738351037178853e-05,0.0,0.00011219544,False,UGCG; UDP-glucose ceramide
hsa:147948,4.151539e-09,2.934751900575479e-06,3.2214217438709677e-08,5.78257886424228e-08,0.0,2.497174e-07,False,ZNF582; zinc finger protein
hsa:3767,0.0,0.0,2.1588050903225802e-06,4.957706481053623e-06,0.0,1.905031e-05,False,KCNJ11; potassium inwardly rectifying channel subfamily J member
hsa:246721,3.8466547e-07,0.00027192270605388985,3.169558629067742e-05,6.66563849368298e-05,0.0,0.00028641577,False,POLR2J2; RNA polymerase II subunit
hsa:3679,0.0,0.0,0.00034722354693548385,0.0006762866490214482,0.0,0.0022323418,False,ITGA7; integrin subunit alpha
hsa:26211,0.0,0.0,6.391660322580646e-08,3.558725856337915e-07,0.0,1.9814147e-06,False,OR2F1; olfactory receptor family 2 subfamily F member
hsa:54331,0.0,0.0,7.529500440000001e-05,0.00021867763842063577,0.0,0.0011111174,False,GNG2; G protein subunit gamma
hsa:6945,0.0,0.0,1.4126985577419354e-05,3.1738384218029476e-05,0.0,0.00014086437,False,MLX; MAX dimerization protein
hsa:4292,2.7910522e-05,0.01973014284234201,7.547001935483872e-05,9.435408898870689e-05,0.0,0.00039158904,False,MLH1; mutL homolog
hsa:22875,0.0,0.0,1.7023742910387097e-07,4.3599582305500137e-07,0.0,1.844461e-06,False,ENPP4; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:51129,7.602553e-05,0.053742977883565135,0.0007025114418096776,0.0011470140273065613,0.0,0.0039738365,False,ANGPTL4; angiopoietin like
hsa:5464,2.6352933e-07,0.00018629072304870135,2.0925583835483873e-06,3.882658261451591e-06,0.0,1.6725173e-05,False,PPA1; inorganic pyrophosphatase
hsa:9045,0.0,0.0,2.860338185483871e-07,6.124202208935635e-07,0.0,2.2291513e-06,False,RPL14; ribosomal protein
hsa:2475,0.0,0.0,3.4566424419354845e-05,0.0001079263229207771,0.0,0.0005465248,False,MTOR; mechanistic target of rapamycin
hsa:1937,0.0,0.0,0.00019614972983935487,0.0005495487309764927,0.0,0.002185341,False,EEF1G; eukaryotic translation elongation factor 1
hsa:8976,0.0,0.0,1.9658539526451612e-05,3.628705863742297e-05,0.0,0.00013528517,False,WASL; WASP like actin nucleation promoting
hsa:406935,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR143; microRNA
hsa:54472,3.1963802e-07,0.00022595434769881313,9.310566056451614e-06,3.245501972354538e-05,0.0,0.00013342685,False,TOLLIP; toll interacting
hsa:8655,2.8454642e-06,0.002011478506878891,0.00040035716120322585,0.0008041572073755739,0.0,0.0030434486,False,DYNLL1; dynein light chain LC8-type
hsa:283375,4.6113326e-09,3.259783206188275e-06,2.1771947683774197e-08,5.115687540063828e-08,0.0,2.421699e-07,False,SLC39A5; solute carrier family 39 member
hsa:341418,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C4; olfactory receptor family 6 subfamily C member
hsa:397,2.989786e-06,0.002113500594794836,0.00014624415048387096,0.0002852454182379443,0.0,0.0012820377,False,ARHGDIB; Rho GDP dissociation inhibitor
hsa:79175,1.8503822e-08,1.3080480945117069e-05,3.776351903548387e-08,6.077690725320985e-08,0.0,2.2302467e-07,False,ZNF343; zinc finger protein
hsa:5364,0.0,0.0,1.3864752643716127e-05,6.017395867604746e-05,0.0,0.0003319922,False,PLXNB1; plexin
hsa:57026,0.0,0.0,0.00018439326129032253,0.000717957414121836,0.0,0.003995004,False,PDXP; pyridoxal
hsa:89846,7.6031315e-09,5.374706734044963e-06,2.318009824629033e-08,4.4483090940357334e-08,0.0,2.1100125e-07,False,FGD3; FYVE
hsa:2525,0.0,0.0,1.414948658387097e-06,3.90600740950718e-06,0.0,2.1390439e-05,False,FUT3; fucosyltransferase 3 (Lewis blood
hsa:4248,3.042921e-08,2.1510620972249176e-05,1.5694870695580643e-05,6.158314020270967e-05,0.0,0.00033721363,False,MGAT3; beta-1
hsa:10720,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2B11; UDP glucuronosyltransferase family 2 member
hsa:2252,5.1917006e-05,0.03670049396878809,0.00022793753087096776,0.0005790844301421799,0.0,0.0030095815,False,FGF7; fibroblast growth factor
hsa:1841,0.0,0.0,8.309666217516128e-06,2.8123344498248096e-05,0.0,0.00014245084,False,DTYMK; deoxythymidylate
hsa:3656,0.0,0.0,3.927470060967742e-07,6.510689629437536e-07,0.0,2.0644138e-06,False,IRAK2; interleukin 1 receptor associated kinase
hsa:91942,3.147509e-09,2.224996084543208e-06,1.645189835719355e-06,4.9408573772782294e-06,0.0,1.9228437e-05,False,NDUFAF2; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:339327,0.0,0.0,5.192083725806451e-08,8.870281001553093e-08,0.0,3.371914e-07,False,ZNF546; zinc finger protein
hsa:1385,0.0,0.0,6.0468012774193546e-05,0.0001434720640520491,0.0,0.00054884015,False,CREB1; cAMP responsive element binding protein
hsa:10563,0.0,0.0,3.233785315354838e-05,6.587066487640121e-05,0.0,0.000299091,False,CXCL13; C-X-C motif chemokine ligand
hsa:22900,5.5570786e-07,0.0003928337655745814,1.2253676291935485e-06,1.8295237533663656e-06,0.0,7.6037477e-06,False,CARD8; caspase recruitment domain family member
hsa:1452,0.0,0.0,0.00012719949503451619,0.000374446779025216,0.0,0.0019883686,False,CSNK1A1; casein kinase 1 alpha
hsa:494551,0.0,0.0,4.9591191431290325e-08,1.2627488308916058e-07,0.0,5.5656017e-07,False,WEE2; WEE2 oocyte meiosis inhibiting
hsa:1337,1.718242e-05,0.01214637264674284,5.093955929032257e-05,0.00010883127919733805,0.0,0.00048058317,False,COX6A1; cytochrome c oxidase subunit
hsa:10488,0.00035643697,0.2519677823435755,0.0009012936245161291,0.0010954973926260378,0.0,0.0036217133,False,CREB3; cAMP responsive element binding protein
hsa:3115,0.00021369892,0.15106525835862972,0.0010044413551612901,0.0015280033112179013,0.0,0.006423019,False,HLA-DPB1; major histocompatibility complex
hsa:7046,0.0,0.0,1.0742362225806453e-05,3.271889014735552e-05,0.0,0.00012570026,False,TGFBR1; transforming growth factor beta receptor
hsa:5602,0.0,0.0,1.2765970354838711e-05,6.833286724608005e-05,0.0,0.00038066533,False,MAPK10; mitogen-activated protein kinase
hsa:2967,1.5127513e-06,0.0010693744543344111,1.1178122389354838e-05,2.858694572993458e-05,0.0,0.00012972826,False,GTF2H3; general transcription factor IIH subunit
hsa:36,0.0,0.0,2.0091685635161288e-05,5.080878971504699e-05,0.0,0.00022513699,False,ACADSB; acyl-CoA dehydrogenase short/branched
hsa:5049,5.642056e-06,0.003988408773024482,4.844078642903225e-05,9.125867667972923e-05,0.0,0.0003419145,False,PAFAH1B2; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4171,5.083571e-07,0.0003593611827796966,1.077738634419355e-05,2.9942051384975358e-05,0.0,0.00011115648,False,MCM2; minichromosome maintenance complex component
hsa:6123,0.0,0.0,4.484799693548387e-09,1.50245317414482e-08,0.0,7.342643e-08,False,RPL3L; ribosomal protein L3
hsa:65251,0.0,0.0,1.1700136878387097e-07,3.3728708928766684e-07,0.0,1.3128862e-06,False,ZNF649; zinc finger protein
hsa:390061,0.0,0.0,6.711868932258065e-07,2.69357043372786e-06,0.0,1.336822e-05,False,OR51Q1; olfactory receptor family 51 subfamily Q member
hsa:9700,3.6690858e-07,0.00025937023655382983,2.021561455829032e-06,3.4599792281386126e-06,0.0,1.2474166e-05,False,ESPL1; extra spindle pole bodies like 1
hsa:7434,0.0,0.0,5.984947620967742e-08,1.849165931489061e-07,0.0,7.983166e-07,False,VIPR2; vasoactive intestinal peptide receptor
hsa:6916,0.0,0.0,7.415286931290324e-05,0.00020693119562753396,0.0,0.0008639887,False,TBXAS1; thromboxane A synthase
hsa:2969,0.0,0.0,1.8583174577419356e-06,5.166430730056321e-06,0.0,2.1664264e-05,False,GTF2I; general transcription factor
hsa:5998,5.7438182e-08,4.060345182596147e-05,2.2949833014258064e-05,9.101008302567601e-05,0.0,0.0004922326,False,RGS3; regulator of G protein signaling
hsa:406904,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR1-1; microRNA
hsa:26084,3.0117388e-07,0.0002129019182365121,1.928618110826452e-05,3.6743100550476295e-05,0.0,0.0001594997,False,ARHGEF26; Rho guanine nucleotide exchange factor
hsa:51809,0.0,0.0,1.4652034950322582e-05,3.124505418159444e-05,0.0,0.00012033326,False,GALNT7; polypeptide N-acetylgalactosaminyltransferase
hsa:132864,4.1528815e-06,0.002935700923197336,4.358814969354839e-05,0.0001011173476491401,0.0,0.00047043353,False,CPEB2; cytoplasmic polyadenylation element binding protein
hsa:3028,0.0,0.0,3.4077889935483866e-07,6.472098562232188e-07,0.0,2.3922987e-06,False,HSD17B10; hydroxysteroid 17-beta dehydrogenase
hsa:7159,1.2674495e-06,0.0008959688994872601,3.0314073396774188e-06,4.674991390972885e-06,0.0,2.0008878e-05,False,TP53BP2; tumor protein p53 binding protein
hsa:9732,5.116589e-08,3.6169524824922974e-05,1.2204840629032258e-07,1.8971046118489488e-07,0.0,6.469601e-07,False,DOCK4; dedicator of cytokinesis
hsa:857,1.0970943e-05,0.007755436193747727,0.0001556801182,0.00024124151252505533,0.0,0.0008987214,False,CAV1; caveolin
hsa:5090,9.7820405e-11,6.91499271688916e-08,3.783622164340323e-07,5.659211694410619e-07,0.0,1.6708124e-06,False,PBX3; PBX homeobox
hsa:1133,0.0,0.0,5.7553790077419345e-06,2.058877087941291e-05,0.0,0.000109821885,False,CHRM5; cholinergic receptor muscarinic
hsa:27242,1.0901293e-06,0.0007706200122528094,3.093750002e-05,8.17797391310455e-05,0.0,0.00039606055,False,TNFRSF21; TNF receptor superfamily member
hsa:836,0.0,0.0,5.416483425806452e-05,0.00018908821410038934,0.0,0.0009777112,False,CASP3; caspase
hsa:51726,0.0,0.0,1.36560589516129e-07,3.4211955186812725e-07,0.0,1.7498143e-06,False,DNAJB11; DnaJ heat shock protein family (Hsp40) member
hsa:39,0.0,0.0,9.82690184186129e-05,0.0002335036211751326,0.0,0.00091043673,False,ACAT2; acetyl-CoA acetyltransferase
hsa:9530,0.0,0.0,1.7300348580645162e-07,4.550433281612709e-07,0.0,2.2223674e-06,False,BAG4; BAG cochaperone
hsa:401994,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR14I1; olfactory receptor family 14 subfamily I member
hsa:3087,0.00064138666,0.4534007074096518,0.0013536426372903225,0.0019761025986064396,0.0,0.008307779,True,HHEX; hematopoietically expressed
hsa:8913,0.0,0.0,7.894730783870967e-06,2.0363049555945113e-05,0.0,9.308838e-05,False,CACNA1G; calcium voltage-gated channel subunit alpha1
hsa:8743,2.7927765e-05,0.01974233203941366,0.0002145487384664516,0.00034791705866074016,0.0,0.0013685599,False,TNFSF10; TNF superfamily member
hsa:10557,0.0,0.0,1.0542387185741935e-06,3.1866230440842504e-06,0.0,1.561544e-05,False,RPP38; ribonuclease P/MRP subunit
hsa:6929,0.0,0.0,2.8961167387768386e-05,5.422558082419597e-05,0.0,0.00016992724,False,TCF3; transcription factor
hsa:112936,9.4241926e-08,6.662027538279026e-05,6.799775856451614e-07,9.822779764363114e-07,0.0,3.4087823e-06,False,VPS26B; VPS26 retromer complex component
hsa:23759,3.377367e-08,2.3874843093587476e-05,1.1471056320806453e-06,2.1284486999431513e-06,0.0,8.240954e-06,False,PPIL2; peptidylprolyl isomerase like
hsa:22926,0.0,0.0,1.556784271419355e-06,4.331942850602996e-06,0.0,1.9259754e-05,False,ATF6; activating transcription factor
hsa:3108,0.0,0.0,0.0002711783468548387,0.0004825467727870001,0.0,0.0014180199,False,HLA-DMA; major histocompatibility complex
hsa:30846,2.7631886e-08,1.953317310881217e-05,3.523342793548387e-07,6.684127899936735e-07,0.0,2.791784e-06,False,EHD2; EH domain containing
hsa:26270,0.0,0.0,8.853710054722581e-07,2.0957497756597946e-06,0.0,9.254582e-06,False,FBXO6; F-box protein
hsa:83439,0.00019421139,0.1372893873611462,0.00041375516961290323,0.0005343861434081625,2.8337909e-05,0.0023473813,False,TCF7L1; transcription factor 7 like
hsa:10919,6.363186e-06,0.004498180604160356,2.2996162883870964e-05,5.129972553392295e-05,0.0,0.00023013543,False,EHMT2; euchromatic histone lysine methyltransferase
hsa:55958,0.0,0.0,4.428411223548387e-08,1.328168272631528e-07,0.0,6.296856e-07,False,KLHL9; kelch like family member
hsa:147,2.1786425e-05,0.015400975921337878,0.0002847573335580645,0.0007637373640240112,0.0,0.0041356613,False,ADRA1B; adrenoceptor alpha
hsa:5893,1.234439e-06,0.0008726335465942855,9.547571598258065e-06,1.817284887153971e-05,0.0,6.872927e-05,False,RAD52; RAD52 homolog
hsa:55504,1.7886282e-06,0.0012643937608132546,6.9177350017741924e-06,1.1554926373141311e-05,0.0,4.9819242e-05,False,TNFRSF19; TNF receptor superfamily member
hsa:48,1.2086435e-05,0.008543985275684991,2.782998932548387e-05,4.0864832120807826e-05,0.0,0.00017147795,False,ACO1; aconitase
hsa:283209,0.0,0.0,9.747856967419356e-05,0.00023163123480724946,0.0,0.0009406891,False,PGM2L1; phosphoglucomutase 2 like
hsa:8631,6.4236927e-09,4.540953212781532e-06,6.797068267741937e-08,1.229237979924373e-07,0.0,6.1226115e-07,False,SKAP1; src kinase associated phosphoprotein
hsa:3397,9.736474e-08,6.882781439944015e-05,0.0004776658757658064,0.000993864759147769,0.0,0.0043283897,False,ID1; inhibitor of DNA binding
hsa:57510,0.0,0.0,1.3119846351612902e-08,2.7131971557106746e-08,0.0,1.2263305e-07,False,XPO5; exportin
hsa:51067,0.0,0.0,1.7890092839677422e-06,6.078974933570874e-06,0.0,3.287415e-05,False,YARS2; tyrosyl-tRNA synthetase
hsa:57617,0.0,0.0,2.422322097983871e-05,5.3112939596369394e-05,0.0,0.0001817131,False,VPS18; VPS18 core subunit of CORVET and HOPS
hsa:830,3.1362575e-08,2.2170423206476204e-05,5.209419260645162e-07,8.415693007934443e-07,0.0,2.7831343e-06,False,CAPZA2; capping actin protein of muscle Z-line subunit alpha
hsa:7691,2.2113245e-09,1.563200726083537e-06,2.3221964547677418e-08,3.932924473192287e-08,0.0,1.3077569e-07,False,ZNF132; zinc finger protein
hsa:181,6.282847e-08,4.441388404221891e-05,4.1116058770761286e-06,8.46799955163617e-06,0.0,3.24154e-05,False,AGRP; agouti related
hsa:8493,9.161261e-09,6.476159354740017e-06,4.857850563145161e-06,9.992521346335559e-06,0.0,3.8234077e-05,False,PPM1D; protein phosphatase
hsa:5695,1.3235009e-06,0.0009355920254364362,5.08765002516129e-06,8.304894507888888e-06,0.0,2.8719563e-05,False,PSMB7; proteasome 20S subunit beta
hsa:57122,0.0,0.0,3.148379838064516e-08,6.384522467033378e-08,0.0,2.0145099e-07,False,NUP107; nucleoporin
hsa:27445,0.0,0.0,5.235341948387096e-07,1.4125595349120055e-06,0.0,7.101504e-06,False,PCLO; piccolo presynaptic cytomatrix
hsa:84769,0.0,0.0,6.415278940870968e-07,1.6345447365426413e-06,0.0,7.761174e-06,False,MPV17L2; MPV17 mitochondrial inner membrane protein like
hsa:81470,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2G2; olfactory receptor family 2 subfamily G member
hsa:29844,0.0,0.0,2.4970409327419354e-06,8.299693887814164e-06,0.0,3.9844614e-05,False,TFPT; TCF3 fusion
hsa:23658,3.7381196e-07,0.00026425028406763004,1.0287154741935483e-06,1.922800303165332e-06,0.0,8.674876e-06,False,LSM5; LSM5 homolog
hsa:1954,0.0,0.0,5.305551217741936e-05,0.00015531337903244225,0.0,0.00061202695,False,MEGF8; multiple EGF like domains
hsa:1786,0.0,0.0,4.811080770967742e-06,1.5158813462389894e-05,0.0,7.9350175e-05,False,DNMT1; DNA methyltransferase
hsa:2350,4.5207162e-07,0.00031957258404443164,2.1164890439354835e-05,3.1485118315163616e-05,0.0,8.7060616e-05,False,FOLR2; folate receptor
hsa:4035,3.4193556e-05,0.02417166343816933,0.0002721677783225807,0.0006475240906171759,0.0,0.0026315986,False,LRP1; LDL receptor related protein
hsa:6573,0.0,0.0,5.296543774193548e-05,0.00020613279530772933,0.0,0.00090379734,False,SLC19A1; solute carrier family 19 member
hsa:5900,0.0,0.0,1.7132920225806452e-05,5.180670899609909e-05,0.0,0.000224336,False,RALGDS; ral guanine nucleotide dissociation
hsa:342574,0.0,0.0,3.724225516129032e-09,1.5366843887702262e-08,0.0,7.8337344e-08,False,KRT27; keratin
hsa:128239,1.3744709e-08,9.716230742528708e-06,2.1001168355103226e-07,5.590044005111789e-07,0.0,2.708699e-06,False,IQGAP3; IQ motif containing GTPase activating protein
hsa:5724,2.5490563e-06,0.0018019456931752053,3.397991678709677e-05,6.997586481500621e-05,0.0,0.0003312944,False,PTAFR; platelet activating factor
hsa:1160,1.0655021e-06,0.0007532108726528076,6.313913233187097e-05,0.00010208472974441687,0.0,0.00035184046,False,CKMT2; creatine kinase
hsa:766,6.3897836e-08,4.516982633275521e-05,8.722263748258065e-06,2.1830968215378057e-05,0.0,9.4830684e-05,False,CA7; carbonic anhydrase
hsa:338324,-0.0,0.0,3.23584564516129e-09,1.263159404439668e-08,0.0,5.6485565e-08,False,S100A7A; S100 calcium binding protein
hsa:160287,0.0,0.0,0.0,0.0,0.0,0.0,False,LDHAL6A; lactate dehydrogenase A like
hsa:57680,0.0,0.0,1.5768628561290322e-07,4.074029603954811e-07,0.0,1.9028406e-06,False,CHD8; chromodomain helicase DNA binding protein
hsa:57381,3.0822058e-08,2.1788327965881485e-05,2.5459989435483873e-07,5.898127633220289e-07,0.0,2.556245e-06,False,RHOJ; ras homolog family member
hsa:125061,2.8495085e-06,0.0020143374507817415,2.2291086958064512e-05,4.378785258557262e-05,0.0,0.00019171041,False,AFMID;
hsa:79444,0.0,0.0,1.16272450016129e-05,2.737889148965532e-05,0.0,0.00011287759,False,BIRC7; baculoviral IAP repeat containing
hsa:2645,0.0,0.0,2.762167258064516e-05,9.946356081732347e-05,0.0,0.0005019174,False,GCK;
hsa:3843,0.0,0.0,1.5675131748387097e-07,3.892303422304115e-07,0.0,1.5645494e-06,False,IPO5; importin
hsa:7124,0.0,0.0,1.3802256687096774e-05,3.0621827985635624e-05,0.0,0.00011674967,False,TNF; tumor necrosis
hsa:9374,2.7294104e-07,0.00019294392654990063,2.2339261181935482e-05,4.0556755088483584e-05,0.0,0.000120609824,False,PPT2; palmitoyl-protein thioesterase
hsa:10413,0.00014853502,0.10500044254600925,0.0011908922078064518,0.0025291011237791408,0.0,0.011023348,False,YAP1; Yes1 associated transcriptional
hsa:5191,0.0,0.0,8.028101530870969e-06,2.3343602260442702e-05,0.0,9.386432e-05,False,PEX7; peroxisomal biogenesis factor
hsa:126375,2.2058013e-09,1.5592963374466341e-06,2.766160421290323e-08,5.775287825209871e-08,0.0,2.956032e-07,False,ZNF792; zinc finger protein
hsa:10921,0.0,0.0,2.4240166190322584e-07,6.837201864334836e-07,0.0,3.4462703e-06,False,RNPS1; RNA binding protein with serine rich domain
hsa:65980,0.0,0.0,4.690686742951613e-06,1.583933965797155e-05,0.0,7.2776355e-05,False,BRD9; bromodomain containing
hsa:1268,0.0,0.0,6.980654612903227e-07,1.48607652812698e-06,0.0,7.0050037e-06,False,CNR1; cannabinoid receptor
hsa:390190,0.0,0.0,2.475549045806452e-07,1.375194391800539e-06,0.0,7.657303e-06,False,OR5B2; olfactory receptor family 5 subfamily B member
hsa:10490,0.0,0.0,2.1836277148064517e-05,5.8158394185575987e-05,0.0,0.00024430573,False,VTI1B; vesicle transport through interaction with t-SNAREs
hsa:367,6.671698e-08,4.716269890651544e-05,6.265615043193549e-06,1.9342869631009255e-05,0.0,9.5769065e-05,False,AR; androgen
hsa:163688,0.0,0.0,1.840374977419355e-06,5.672743621296387e-06,0.0,2.3306186e-05,False,CALML6; calmodulin like
hsa:4074,0.0,0.0,1.627332476870968e-06,3.3431315003790067e-06,0.0,1.1738768e-05,False,M6PR; mannose-6-phosphate receptor
hsa:3384,0.0,0.0,1.2217877109677422e-05,3.462565557720466e-05,0.0,0.0001571577,False,ICAM2; intercellular adhesion molecule
hsa:3451,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA17; interferon alpha
hsa:182,0.00036343405,0.25691406704148595,0.0006696796996967743,0.0010514611313897902,0.0,0.0043014064,False,JAG1; jagged canonical Notch ligand
hsa:390082,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR52E5; olfactory receptor family 52 subfamily E member
hsa:56916,5.741861e-08,4.0589616242531315e-05,8.081055803109677e-07,1.9213627142615896e-06,0.0,9.067045e-06,False,SMARCAD1; SWI/SNF-related
hsa:23478,3.1789666e-06,0.002247233681585544,0.0002414995321974839,0.0005873874314800863,0.0,0.0026353628,False,SEC11A; SEC11 homolog A
hsa:10351,0.0005404122,0.38202115674312004,0.002310206858667742,0.003900471713075652,0.0,0.0143918,True,ABCA8; ATP binding cassette subfamily A member
hsa:80143,4.4593494e-07,0.00031523452211288684,3.260191571935484e-05,0.00011370552792947253,0.0,0.00047516372,False,SIKE1; suppressor of IKBKE
hsa:4852,0.0,0.0,7.35412836451613e-05,0.00023113544146302438,0.0,0.0009559579,False,NPY; neuropeptide
hsa:1496,0.0,0.0,1.1974348820967742e-05,3.595573840951387e-05,0.0,0.00014856177,False,CTNNA2; catenin alpha
hsa:7305,8.038684e-07,0.0005682601836843082,6.436151636451613e-05,0.00017129961605842975,0.0,0.0007255191,False,TYROBP; transmembrane immune signaling adaptor
hsa:10014,0.0,0.0,2.5819529046129037e-05,4.559164890005368e-05,0.0,0.00017154742,False,HDAC5; histone deacetylase
hsa:414325,0.0,0.0,2.5355980990322583e-06,9.56899400544643e-06,0.0,4.043877e-05,False,DEFB103A; defensin beta
hsa:864,2.478828e-07,0.00017523008176485188,4.422429651216129e-06,8.287664540383017e-06,0.0,3.0488332e-05,False,RUNX3; RUNX family transcription factor
hsa:4094,0.0,0.0,9.463437701951613e-05,0.000271378886210507,0.0,0.0013447916,False,MAF; MAF bZIP transcription
hsa:406886,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7D; microRNA
hsa:5216,0.0,0.0,3.871331876129032e-07,1.4201373660591769e-06,0.0,7.658329e-06,False,PFN1; profilin
hsa:64111,-0.0,0.0,9.99548064516129e-10,5.56524809254862e-09,0.0,3.098599e-08,False,NPVF; neuropeptide VF
hsa:406926,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135A2; microRNA
hsa:6613,1.03544e-07,7.319597643023164e-05,9.627786363225806e-07,2.314529280568619e-06,0.0,1.2650478e-05,False,SUMO2; small ubiquitin like modifier
hsa:4973,1.8497676e-07,0.0001307613629481246,0.00012874240864225807,0.0004069866076154115,0.0,0.0019631032,False,OLR1; oxidized low density lipoprotein receptor
hsa:2041,5.4149663e-08,3.827877478804166e-05,3.7550454259354844e-07,7.386966943856387e-07,0.0,2.9228217e-06,False,EPHA1; EPH receptor
hsa:4643,0.0,0.0,7.51406161935484e-07,1.5434858071627658e-06,0.0,6.2216977e-06,False,MYO1E; myosin
hsa:6338,9.493638e-06,0.006711118976330367,0.00015147110073096776,0.0003666106893871086,0.0,0.0018782285,False,SCNN1B; sodium channel epithelial 1 subunit
hsa:3709,0.00041787472,0.29539855670931814,0.0006695848659032257,0.0006399725739238732,0.0,0.002142349,False,ITPR2; inositol 1
hsa:127059,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2M5; olfactory receptor family 2 subfamily M member
hsa:55567,0.0,0.0,2.4455145058064513e-09,4.732327942199057e-09,0.0,1.8047308e-08,False,DNAH3; dynein axonemal heavy chain
hsa:57232,4.106538e-09,2.902940379528032e-06,1.699897176451613e-08,2.944825719619531e-08,0.0,1.06343975e-07,False,ZNF630; zinc finger protein
hsa:4681,4.6591867e-06,0.0032936116035429254,0.0002462442670612903,0.0005282195758155832,0.0,0.0019600657,False,NBL1; NBL1
hsa:10637,0.0,0.0,1.9023506193548385e-08,6.298196163149982e-08,0.0,3.1828012e-07,False,LEFTY1; left-right determination factor
hsa:51433,0.0,0.0,1.41065018483871e-05,4.0455795343057064e-05,0.0,0.0001801421,False,ANAPC5; anaphase promoting complex subunit
hsa:10318,0.0,0.0,5.097141634774193e-06,1.6004569682389913e-05,0.0,6.960504e-05,False,TNIP1; TNFAIP3 interacting protein
hsa:143496,0.0,0.0,0.0,0.0,0.0,0.0,False,OR52B4; olfactory receptor family 52 subfamily B member
hsa:51454,1.3475414e-08,9.525864227107446e-06,0.00011261465810192903,0.00019061194883362897,0.0,0.0008481947,False,GULP1; GULP PTB domain containing engulfment adaptor
hsa:641339,1.0131196e-08,7.161813177258528e-06,5.620004772903226e-08,1.0455893096507992e-07,0.0,3.7613984e-07,False,ZNF674; zinc finger protein
hsa:9698,0.0,0.0,3.735292096774194e-09,1.2039518142680846e-08,0.0,4.7251774e-08,False,PUM1; pumilio RNA binding family member
hsa:132430,7.5713224e-08,5.352220659198841e-05,4.9720260097580655e-06,1.7815397674118134e-05,0.0,7.710453e-05,False,PABPC4L; poly(A) binding protein cytoplasmic 4
hsa:3236,0.0,0.0,4.0738361990322573e-07,2.0519734222541916e-06,0.0,1.1440865e-05,False,HOXD10; homeobox
hsa:4993,0.0,0.0,7.991829001290324e-07,2.534677423427052e-06,0.0,1.2771391e-05,False,OR2C1; olfactory receptor family 2 subfamily C member
hsa:10961,3.6506897e-08,2.5806980340269778e-05,7.118687861090324e-07,1.4131279933487477e-06,0.0,5.632082e-06,False,ERP29; endoplasmic reticulum protein
hsa:6714,0.0,0.0,0.00011253909032258065,0.0002444716449681098,0.0,0.0011630014,False,SRC; SRC proto-oncogene
hsa:131,0.0,0.0,2.8202309677419355e-07,1.5702381477143164e-06,0.0,8.742716e-06,False,ADH7; alcohol dehydrogenase 7 (class IV)
hsa:59340,2.0575772e-10,1.454515686419126e-07,2.846135505548387e-08,4.5259302391457195e-08,0.0,1.6382093e-07,False,HRH4; histamine receptor
hsa:6518,2.3823934e-05,0.016841305257082922,0.0003437493084267742,0.0007074335831198053,0.0,0.0030494898,False,SLC2A5; solute carrier family 2 member
hsa:593,0.0,0.0,8.679273860322581e-05,0.0003605606057957571,0.0,0.0019635553,False,BCKDHA; branched chain keto acid dehydrogenase E1 subunit
hsa:374879,0.0,0.0,1.978593346451613e-08,3.448827531943239e-08,0.0,1.1746673e-07,False,ZNF699; zinc finger protein
hsa:119391,0.0,0.0,4.510335303225807e-05,0.00012549439194010407,0.0,0.00050104165,False,GSTO2; glutathione S-transferase omega
hsa:59352,0.0,0.0,7.483475508032259e-07,2.725899400542054e-06,0.0,1.4194704e-05,False,LGR6; leucine rich repeat containing G protein-coupled receptor
hsa:284217,0.0,0.0,5.960419290322581e-06,1.5723477568344837e-05,0.0,5.9451922e-05,False,LAMA1; laminin subunit alpha
hsa:528,0.0,0.0,2.601692923870968e-05,7.042403133556307e-05,0.0,0.0003122542,False,ATP6V1C1; ATPase H+ transporting V1 subunit
hsa:6366,0.0,0.0,0.0001435620311870968,0.0002738889032646499,0.0,0.0011233874,False,CCL21; C-C motif chemokine ligand
hsa:5028,0.00032124997,0.22709384640667366,0.0012208185594838712,0.0023670386073633603,0.0,0.010231108,False,P2RY1; purinergic receptor
hsa:355,0.00012534307,0.08860589119034297,0.0005358594965161291,0.0008557259850468676,0.0,0.0030122513,False,FAS; Fas cell surface death
hsa:7316,0.0,0.0,3.0327836387096774e-05,0.00013509114404766344,0.0,0.0007518784,False,UBC; ubiquitin
hsa:5534,0.0,0.0,0.000157710488516129,0.00030728199209612765,0.0,0.0012299285,False,PPP3R1; protein phosphatase 3 regulatory subunit B
hsa:208,1.6801398e-05,0.011877025535066647,0.0007729140918483872,0.0013650698596139887,0.0,0.0062527163,False,AKT2; AKT serine/threonine kinase
hsa:406923,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A2; microRNA
hsa:2846,0.0,0.0,6.90175826283871e-06,1.2909416624704775e-05,0.0,4.404015e-05,False,LPAR4; lysophosphatidic acid receptor
hsa:1734,4.198289e-07,0.00029677998019325187,7.420151142903225e-06,1.72053276096316e-05,0.0,6.332694e-05,False,DIO2; iodothyronine deiodinase
hsa:114131,0.0,0.0,8.624364669096774e-07,3.312245060603224e-06,0.0,1.8244591e-05,False,UCN3; urocortin
hsa:84249,0.0,0.0,2.1438264258096777e-08,5.997870722188431e-08,0.0,2.517266e-07,False,PSD2; pleckstrin and Sec7 domain containing
hsa:6777,0.0,0.0,2.468193161290322e-05,7.119151607124877e-05,0.0,0.00032547794,False,STAT5B; signal transducer and activator of transcription
hsa:9762,1.1443526e-07,8.089508415502036e-05,3.1375442494741935e-05,6.716078190681524e-05,0.0,0.0002831654,False,LZTS3; leucine zipper tumor suppressor family member
hsa:2168,0.0,0.0,5.04183811935484e-06,1.1059444174969619e-05,0.0,4.3319207e-05,False,FABP1; fatty acid binding protein
hsa:23283,0.0,0.0,1.651033440967742e-07,3.569342949868073e-07,0.0,1.4815288e-06,False,CSTF2T; cleavage stimulation factor subunit 2 tau
hsa:5605,0.00026651076,0.1883983167287638,0.0005047347149999999,0.0006152979751823966,0.0,0.001970039,False,MAP2K2; mitogen-activated protein kinase kinase
hsa:11213,3.4910056e-07,0.00024678162289983643,3.3170115888387094e-06,9.13836975545628e-06,0.0,4.4010703e-05,False,IRAK3; interleukin 1 receptor associated kinase
hsa:81327,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4A16; olfactory receptor family 4 subfamily A member
hsa:79875,9.589804e-08,6.779099393055522e-05,5.137059990580644e-06,1.2330738897634586e-05,0.0,5.8694193e-05,False,THSD4; thrombospondin type 1 domain containing
hsa:79053,1.9533289e-07,0.00013808218354022472,7.10198792119355e-05,0.0002191211481655565,0.0,0.0011250692,False,ALG8; ALG8
hsa:5931,0.0,0.0,0.00010384585710645164,0.0002660113724139843,0.0,0.0009422277,False,RBBP7; RB binding protein 7
hsa:2826,0.0,0.0,6.170028064516129e-07,2.2895666433712146e-06,0.0,1.0622479e-05,False,CCR10; C-C motif chemokine receptor
hsa:90592,0.0,0.0,1.4078411903870968e-07,3.794614833087487e-07,0.0,1.7208591e-06,False,ZNF700; zinc finger protein
hsa:8722,4.129625e-07,0.0002919260740996053,4.815167860751613e-06,8.753134802163536e-06,0.0,2.9069464e-05,False,CTSF; cathepsin
hsa:51246,5.787948e-07,0.0004091540846281835,0.00022725858957461936,0.0007013394788010317,0.0,0.0029703858,False,SHISA5; shisa family member
hsa:347344,9.608851e-09,6.792563850320711e-06,5.863759381935485e-08,9.627503974888577e-08,0.0,3.8075305e-07,False,ZNF81; zinc finger protein
hsa:22849,0.0,0.0,3.05618504516129e-07,1.1516380975333694e-06,0.0,6.1409814e-06,False,CPEB3; cytoplasmic polyadenylation element binding protein
hsa:23495,0.0,0.0,1.1915427823225809e-05,3.866480924687075e-05,0.0,0.00018562368,False,TNFRSF13B; TNF receptor superfamily member
hsa:10094,3.0947817e-07,0.00021877227880892392,1.4816370086129031e-05,2.6420787299007744e-05,0.0,0.00010715067,False,ARPC3; actin related protein 2/3 complex subunit
hsa:5429,5.9351974e-06,0.00419563247507506,1.2304177254838707e-05,2.493547705383012e-05,0.0,0.00010748962,False,POLH; DNA polymerase
hsa:10111,0.0,0.0,9.409477587741936e-05,0.0001821229974832787,0.0,0.0006727492,False,RAD50; RAD50 double strand break repair
hsa:278,0.0,0.0,0.0,0.0,0.0,0.0,False,AMY1C; amylase alpha
hsa:6323,1.4644863e-07,0.00010352555889013088,8.077127094517096e-07,1.3412074660731728e-06,0.0,4.922306e-06,False,SCN1A; sodium voltage-gated channel alpha subunit
hsa:8467,0.0,0.0,3.666678253096774e-06,1.2619818041907024e-05,0.0,5.458056e-05,False,SMARCA5; SWI/SNF related
hsa:57209,0.0,0.0,4.245984496774194e-09,7.1670222680773435e-09,0.0,2.2989491e-08,False,ZNF248; zinc finger protein
hsa:57835,0.0,0.0,1.4722067741935484e-09,8.19690041207178e-09,0.0,4.563841e-08,False,SLC4A5; solute carrier family 4 member
hsa:197259,1.5880199e-06,0.0011225823531169242,0.00011079568825161287,0.0002298984572010849,0.0,0.0009214375,False,MLKL; mixed lineage kinase domain like
hsa:8985,3.743693e-05,0.02646442716043645,0.0002233127717419355,0.00037010118013772647,0.0,0.0012748761,False,PLOD3; procollagen-lysine
hsa:7038,0.0,0.0,1.089739493548387e-06,4.388347176638665e-06,0.0,2.4229501e-05,False,TG;
hsa:9108,0.0,0.0,6.490806278967741e-07,1.5361351331019075e-06,0.0,8.159956e-06,False,MTMR7; myotubularin related protein
hsa:9446,0.00016283705,0.11511064739403971,0.0005688769645806452,0.0007674495747331727,0.0,0.0030213895,False,GSTO1; glutathione S-transferase omega
hsa:79465,6.8079555e-09,4.8125912686014234e-06,1.600492648354839e-07,3.1020719225151145e-07,0.0,1.4013854e-06,False,ULBP3; UL16 binding protein
hsa:5238,0.0,0.0,2.8725615909677415e-06,7.386867196101965e-06,0.0,3.1234882e-05,False,PGM3; phosphoglucomutase
hsa:6709,0.0,0.0,5.091424419558064e-06,1.2483106201478517e-05,0.0,5.147027e-05,False,SPTAN1; spectrin alpha
hsa:10053,0.0,0.0,6.933686203935484e-08,3.00664074804478e-07,0.0,1.6721035e-06,False,AP1M2; adaptor related protein complex 1 subunit mu
hsa:6543,0.0,0.0,3.915919506451614e-05,0.00011527202537072789,0.0,0.0005839558,False,SLC8A2; solute carrier family 8 member
hsa:8989,0.0,0.0,5.629487823354839e-06,1.5302100707768896e-05,0.0,7.24147e-05,False,TRPA1; transient receptor potential cation channel subfamily A member
hsa:57552,0.00014931236,0.10554994961854149,0.0003446523474516129,0.0004115900904965712,0.0,0.0014679293,False,NCEH1; neutral cholesterol ester hydrolase
hsa:196,7.918302e-05,0.0559750296066847,8.320710353225806e-05,8.067483834543616e-05,0.0,0.0002624667,False,AHR; aryl hydrocarbon
hsa:1129,0.0,0.0,5.1784895497096775e-05,0.0001981390656076793,0.0,0.0010123432,False,CHRM2; cholinergic receptor muscarinic
hsa:130075,0.0,0.0,2.109487219483871e-06,8.954257611149771e-06,0.0,4.8043064e-05,False,OR9A4; olfactory receptor family 9 subfamily A member
hsa:442904,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR335; microRNA
hsa:84135,9.286397e-08,6.564618866701825e-05,2.288665335712258e-06,6.500483544233208e-06,0.0,3.133918e-05,False,UTP15; UTP15 small subunit processome
hsa:388585,0.0,0.0,7.368110580645161e-09,2.6978408701185305e-08,0.0,1.3894895e-07,False,HES5; hes family bHLH transcription factor
hsa:5159,0.000119011434,0.08413001350143,0.0006047609065806451,0.0016356174784284128,0.0,0.008004753,False,PDGFRB; platelet derived growth factor receptor
hsa:133522,2.4933846e-07,0.00017625909798066767,3.97795715732258e-06,7.62911221848272e-06,0.0,2.7289345e-05,False,PPARGC1B; PPARG coactivator 1
hsa:9945,5.5471966e-05,0.03921352000960568,9.573130587580645e-05,0.00015052041297905177,0.0,0.0007972157,False,GFPT2; glutamine-fructose-6-phosphate transaminase
hsa:2922,5.3471577e-10,3.7799431060991616e-07,2.536395231179678e-06,9.115005490453197e-06,0.0,4.954694e-05,False,GRP; gastrin releasing
hsa:4684,0.0,0.0,0.00018252242459032255,0.0005383332855904743,0.0,0.002352324,False,NCAM1; neural cell adhesion molecule
hsa:55929,0.0,0.0,2.2646604406451613e-07,3.869029844048784e-07,0.0,1.6047862e-06,False,DMAP1; DNA methyltransferase 1 associated protein
hsa:57642,0.0,0.0,1.421977559032258e-07,3.630482881169817e-07,0.0,1.6804859e-06,False,COL20A1; collagen type XX alpha 1
hsa:3117,2.6996506e-05,0.019084018551288405,0.0002011009458064516,0.0003718846000656361,0.0,0.0015266195,False,HLA-DQA1; major histocompatibility complex
hsa:1173,0.0,0.0,0.00015348120195483872,0.00044186053235668546,0.0,0.0023322345,False,AP2M1; adaptor related protein complex 2 subunit mu
hsa:10199,0.0,0.0,6.11365924516129e-07,1.7772536086058987e-06,0.0,7.901866e-06,False,MPHOSPH10; M-phase phosphoprotein
hsa:9232,0.0,0.0,3.5927641258064525e-07,7.495172001004971e-07,0.0,3.2541889e-06,False,PTTG1; PTTG1 regulator of sister chromatid separation
hsa:6874,0.0,0.0,1.673573682903226e-08,3.7736819053839136e-08,0.0,1.2711435e-07,False,TAF4; TATA-box binding protein associated factor
hsa:100169757,0.0,0.0,1.025429264516129e-06,3.290055980288683e-06,0.0,1.7333668e-05,False,RNA5S6; RNA
hsa:1349,0.0,0.0,4.230707205580646e-05,0.00014233621359488463,0.0,0.0005863636,False,COX7B; cytochrome c oxidase subunit
hsa:146227,0.0,0.0,4.928180554193549e-08,1.1459241454834531e-07,0.0,4.6000287e-07,False,BEAN1; brain expressed associated with NEDD4
hsa:5781,0.0,0.0,3.261482625806452e-05,9.811572810726649e-05,0.0,0.00041642366,False,PTPN11; protein tyrosine phosphatase non-receptor type
hsa:356,0.0,0.0,5.832361461806451e-06,2.0202988257331435e-05,0.0,0.00011005263,False,FASLG; Fas
hsa:3309,0.000350922,0.24806921155112555,0.0005465112003225807,0.0007365940898949356,0.0,0.00287407,False,HSPA5; heat shock protein family A (Hsp70) member
hsa:9560,0.0,0.0,3.971599376774194e-05,0.00010971178205345534,0.0,0.00051054277,False,CCL4L2; C-C motif chemokine ligand 4 like
hsa:558,3.6645322e-06,0.0025904833939100758,0.0001515604255,0.00020802050964990423,0.0,0.0005707624,False,AXL; AXL receptor tyrosine
hsa:222545,0.0,0.0,4.236884759354839e-10,2.3198901261418562e-09,0.0,1.2922706e-08,False,GPRC6A; G protein-coupled receptor class C group 6 member
hsa:5610,1.8376399e-07,0.0001299040473688994,6.694893475161288e-06,2.7516798399957765e-05,0.0,0.00015273044,False,EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase
hsa:6747,0.0,0.0,8.056014942258065e-07,2.2136727211220495e-06,0.0,9.523059e-06,False,SSR3; signal sequence receptor subunit
hsa:5868,0.0,0.0,0.00014653964450967743,0.0002462107238246029,0.0,0.0009181524,False,RAB5A; RAB5A
hsa:6948,0.0004114849,0.29088154834462854,0.000870597597716129,0.0010326413436943732,0.0,0.0043115416,False,TCN2; transcobalamin
hsa:170589,0.0,0.0,2.916624929032258e-08,1.1770521673744927e-07,0.0,6.460822e-07,False,GPHA2; glycoprotein hormone subunit alpha
hsa:6715,3.0917613e-07,0.00021855876462441312,3.5947499665161304e-05,7.391999110344875e-05,0.0,0.00025620277,False,SRD5A1; steroid 5 alpha-reductase
hsa:57505,7.718286e-07,0.0005456110253976925,2.556929467967742e-06,6.0833590680791055e-06,0.0,3.3263157e-05,False,AARS2; alanyl-tRNA synthetase 2
hsa:1565,2.9876637e-06,0.0021120003261092734,0.00010827519060967744,0.0002924422949487212,0.0,0.0011103596,False,CYP2D6; cytochrome P450 family 2 subfamily D member
hsa:25898,1.47116225e-05,0.010399748645604433,0.00011158264743064514,0.0001903053294942719,0.0,0.0006271093,False,RCHY1; ring finger and CHY zinc finger domain containing
hsa:5332,0.0,0.0,0.00015990779354838706,0.0004271484578603268,0.0,0.0013999272,False,PLCB4; phospholipase C beta
hsa:84309,0.0,0.0,2.5877989354838713e-08,1.0127534177349825e-07,0.0,5.4295657e-07,False,NUDT16L1; nudix hydrolase 16 like
hsa:5327,4.0003742e-06,0.0028278924481892407,0.00011147766804096775,0.0004180414794478793,0.0,0.0022107556,False,PLAT; plasminogen activator
hsa:407046,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-1; microRNA
hsa:112399,0.0,0.0,2.4512382580645164e-06,5.3598519922332615e-06,0.0,2.2192708e-05,False,EGLN3; egl-9 family hypoxia inducible factor
hsa:10975,0.0,0.0,8.050254077822582e-05,0.00028667355077567587,0.0,0.001338123,False,UQCR11; ubiquinol-cytochrome c reductase
hsa:9254,0.0,0.0,2.3807048903225807e-06,1.0069514988441953e-05,0.0,5.5713743e-05,False,CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:3816,0.0,0.0,2.7265539096774195e-06,7.266011204569483e-06,0.0,3.329398e-05,False,KLK1; kallikrein
hsa:56949,2.94349e-09,2.0807736292071245e-06,3.6516448564516126e-07,6.428700810699189e-07,0.0,2.3145449e-06,False,XAB2; XPA binding protein
hsa:51065,1.6265744e-07,0.00011498367983120043,8.408786316129031e-07,1.242330380811405e-06,0.0,4.191253e-06,False,RPS27L; ribosomal protein S27
hsa:219927,2.6653032e-08,1.884121438293102e-05,1.4873569163870967e-07,2.251771808989821e-07,0.0,7.6801194e-07,False,MRPL21; mitochondrial ribosomal protein
hsa:57580,0.0,0.0,1.6404591819354838e-07,3.2290204361755696e-07,0.0,1.0383967e-06,False,PREX1; phosphatidylinositol-3
hsa:50807,0.0,0.0,2.293524209677419e-07,4.931036001816652e-07,0.0,1.8261527e-06,False,ASAP1; ArfGAP with SH3 domain
hsa:1501,0.0,0.0,9.258428599677418e-07,1.801063831335057e-06,0.0,6.5587e-06,False,CTNND2; catenin delta
hsa:154810,5.137962e-08,3.632061205395056e-05,4.755951820258063e-06,1.0228698647809021e-05,0.0,4.2034448e-05,False,AMOTL1; angiomotin like
hsa:4670,0.0,0.0,2.9852884439677416e-07,4.951413325965505e-07,0.0,2.086154e-06,False,HNRNPM; heterogeneous nuclear ribonucleoprotein
hsa:28998,0.0,0.0,5.333944980366129e-08,8.55816571624291e-08,0.0,2.7138148e-07,False,MRPL13; mitochondrial ribosomal protein
hsa:4507,5.2115734e-06,0.0036840976179288243,2.767754961935484e-05,8.462677740018046e-05,0.0,0.00047367226,False,MTAP; methylthioadenosine
hsa:3916,1.5235378e-07,0.00010769995064838808,2.8202496268064515e-06,5.878668666333867e-06,0.0,2.5422629e-05,False,LAMP1; lysosomal associated membrane protein
hsa:8431,0.0,0.0,0.0,0.0,-0.0,-0.0,False,NR0B2; nuclear receptor subfamily 0 group B member
hsa:54207,0.0,0.0,5.9938250348483874e-06,1.8848246179933785e-05,0.0,8.040061e-05,False,KCNK10; potassium two pore domain channel subfamily K member
hsa:2880,0.0,0.0,0.0,0.0,0.0,0.0,False,GPX5; glutathione peroxidase
hsa:9217,0.0,0.0,8.153966083774193e-06,1.759606984470416e-05,0.0,8.06951e-05,False,VAPB; VAMP associated protein B and
hsa:406947,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR155; microRNA
hsa:730,0.0,0.0,4.544099160774194e-06,1.0049288062022257e-05,0.0,4.0126626e-05,False,C7; complement
hsa:2182,9.420555e-07,0.0006659456093445306,0.00011188774969354836,0.00019258441310567446,0.0,0.0007234136,False,ACSL4; acyl-CoA synthetase long chain family member
hsa:725,1.0874005e-08,7.686910044833317e-06,1.1050795396e-06,3.565973676613475e-06,0.0,1.843843e-05,False,C4BPB; complement component 4 binding protein
hsa:7507,0.0,0.0,2.4945962296129033e-06,5.922024281680312e-06,0.0,2.4858458e-05,False,XPA; XPA
hsa:79228,8.1265705e-09,5.7447294172198835e-06,1.770861845064516e-07,3.814343057711546e-07,0.0,1.4079703e-06,False,THOC6; THO complex subunit
hsa:3355,5.3366684e-06,0.0037725281467044145,3.494366020358064e-05,9.361140595438515e-05,0.0,0.00050578173,False,HTR1F; 5-hydroxytryptamine receptor
hsa:3073,0.0001194978,0.08447382902210203,0.0006253698430322581,0.00133724777848931,0.0,0.0052490137,False,HEXA; hexosaminidase subunit
hsa:4145,0.0,0.0,7.252724811870967e-06,2.6593362057961504e-05,0.0,0.00014400354,False,MATK; megakaryocyte-associated tyrosine
hsa:1621,0.0,0.0,1.9613276449354836e-05,4.349310714695837e-05,0.0,0.00016983073,False,DBH; dopamine
hsa:60489,5.8885958e-06,0.004162689478713986,1.830387889677419e-05,2.868271382334388e-05,0.0,0.00012995911,False,APOBEC3G; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5663,0.0,0.0,7.701558442580645e-05,0.00019296693728553216,0.0,0.00073286134,False,PSEN1; presenilin
hsa:7976,0.0,0.0,1.2766463819354837e-05,2.3776832790873602e-05,0.0,8.018355e-05,False,FZD3; frizzled class receptor
hsa:23786,4.990666e-07,0.0003527936634736521,5.684270235193548e-05,0.0001032530572856628,0.0,0.00036621522,False,BCL2L13; BCL2 like
hsa:219958,0.0,0.0,1.883724741935484e-07,1.048813548752957e-06,-0.0,5.8395467e-06,False,OR1S2; olfactory receptor family 1 subfamily S member
hsa:10990,1.1982931e-07,8.470817575533994e-05,9.256584135741938e-06,1.8796704768835425e-05,0.0,6.577e-05,False,LILRB5; leukocyte immunoglobulin like receptor
hsa:58476,0.0,0.0,2.6487834884677425e-07,8.393987901166066e-07,0.0,4.1413227e-06,False,TP53INP2; tumor protein p53 inducible nuclear protein
hsa:126070,0.0,0.0,1.641426380096774e-08,3.004780520106904e-08,0.0,9.7063044e-08,False,ZNF440; zinc finger protein
hsa:11168,9.909269e-08,7.004931431708501e-05,3.111189492645162e-05,6.53285365634382e-05,0.0,0.00025730848,False,PSIP1; PC4 and SRSF1 interacting protein
hsa:8148,3.8068836e-06,0.0026911125923108565,4.600858394580646e-05,0.00016129232879209874,0.0,0.00088495505,False,TAF15; TATA-box binding protein associated factor
hsa:8323,3.0214544e-05,0.02135887207828746,0.00017805811237096774,0.00031140299295367735,0.0,0.0011293752,False,FZD6; frizzled class receptor
hsa:51466,0.0,0.0,4.0507930096774195e-07,9.321013448909916e-07,0.0,3.7067855e-06,False,EVL;
hsa:400916,1.8491408e-10,1.3071705401856183e-07,6.460539530645161e-09,1.0194884535514992e-08,0.0,3.4210505e-08,False,CHCHD10; coiled-coil-helix-coiled-coil-helix domain containing
hsa:55741,0.0,0.0,2.7618737867741933e-08,8.370343604088963e-08,0.0,3.4414052e-07,False,EDEM2; ER degradation enhancing alpha-mannosidase like protein
hsa:23765,2.9967567e-05,0.021184282312865906,6.046693552903224e-05,0.0001115823503628998,0.0,0.00045788466,False,IL17RA; interleukin 17 receptor
hsa:9377,0.0,0.0,3.5099441401290326e-05,0.00011902004492406109,0.0,0.00051852455,False,COX5A; cytochrome c oxidase subunit
hsa:10636,0.0,0.0,1.600579964516129e-07,2.4403798753991146e-07,0.0,7.138974e-07,False,RGS14; regulator of G protein signaling
hsa:80781,3.6609586e-06,0.002587957191123134,0.00014930554162774195,0.0002984070250614299,0.0,0.0011946358,False,COL18A1; collagen type XVIII alpha 1
hsa:7478,0.0,0.0,0.0,0.0,0.0,0.0,False,WNT8A; Wnt family member
hsa:5052,2.3545634e-07,0.0001664457304429866,5.715164580193548e-05,0.0001355726087662753,0.0,0.00057170633,False,PRDX1; peroxiredoxin
hsa:51021,5.8829766e-08,4.1587172270069175e-05,4.4214772172258064e-07,8.506917308851138e-07,0.0,3.3910135e-06,False,MRPS16; mitochondrial ribosomal protein
hsa:5864,0.0,0.0,4.932110098387096e-06,1.702327189648637e-05,0.0,9.282252e-05,False,RAB3A; RAB3A
hsa:10713,0.0,0.0,4.4742315516129034e-08,9.322978725073854e-08,0.0,3.4960647e-07,False,USP39; ubiquitin specific peptidase
hsa:54344,2.6624575e-08,1.882109793097557e-05,7.437009392225808e-05,0.000162487638209332,0.0,0.0006792426,False,DPM3; dolichyl-phosphate mannosyltransferase subunit 3
hsa:3175,0.0,0.0,2.395725032258065e-07,7.91815751418769e-07,0.0,4.0223217e-06,False,ONECUT1; one cut homeobox
hsa:2861,0.0,0.0,2.4038733918451614e-08,7.443943629455826e-08,0.0,3.353187e-07,False,GPR37; G protein-coupled receptor
hsa:5729,1.0827488e-07,7.654026852802826e-05,2.004910117770968e-06,4.386314878890688e-06,0.0,1.9434234e-05,False,PTGDR; prostaglandin D2
hsa:2948,0.0,0.0,0.0003983057959677419,0.0006550959604676991,0.0,0.0022316794,False,GSTM4; glutathione S-transferase mu
hsa:64421,0.0,0.0,4.144675438709677e-05,8.145909729038749e-05,0.0,0.00029692048,False,DCLRE1C; DNA cross-link repair
hsa:10162,0.0,0.0,5.6074911999999995e-06,1.683879314990553e-05,0.0,6.749731e-05,False,LPCAT3; lysophosphatidylcholine acyltransferase
hsa:407015,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A1; microRNA
hsa:5460,0.0,0.0,6.428585601442387e-06,1.8670096062400384e-05,0.0,8.9946836e-05,False,POU5F1; POU class 5 homeobox
hsa:255061,0.0,0.0,3.9489245081419354e-07,1.3932603884176768e-06,0.0,6.5328304e-06,False,TAC4; tachykinin precursor
hsa:22802,0.0,0.0,2.940032521935484e-08,9.007135797548775e-08,0.0,4.0730146e-07,False,CLCA4; chloride channel accessory
hsa:26686,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4E2; olfactory receptor family 4 subfamily E member
hsa:6205,1.6312967e-07,0.00011531750251479046,7.871257102580645e-07,1.773718815449513e-06,0.0,7.650907e-06,False,RPS11; ribosomal protein
hsa:51606,0.0,0.0,4.424446624838709e-05,0.0001347011037058428,0.0,0.0005808353,False,ATP6V1H; ATPase H+ transporting V1 subunit
hsa:1788,0.0,0.0,1.0601195151612903e-06,2.542794946138041e-06,0.0,1.0297269e-05,False,DNMT3A; DNA methyltransferase 3
hsa:10874,0.0,0.0,2.943240097283871e-07,6.993450274336596e-07,0.0,2.9048856e-06,False,NMU; neuromedin
hsa:27294,0.0,0.0,9.76344206451613e-07,3.2016712624666414e-06,0.0,1.7194807e-05,False,DHDH; dihydrodiol
hsa:51324,6.785673e-08,4.796839613799536e-05,3.0490952561290316e-07,6.021333114363046e-07,0.0,2.4891804e-06,False,SPG21; SPG21 abhydrolase domain containing
hsa:399,1.6460933e-07,0.00011636348449814784,2.5762371674193544e-06,6.665506023617412e-06,0.0,3.5049514e-05,False,RHOH; ras homolog family member
hsa:54511,0.0,0.0,4.9348966774193555e-06,1.670935412785005e-05,0.0,7.614224e-05,False,HMGCLL1; 3-hydroxy-3-methylglutaryl-CoA lyase like
hsa:80271,0.0,0.0,3.33840304316129e-05,8.574332830144652e-05,0.0,0.00033599083,False,ITPKC; inositol-trisphosphate 3-kinase
hsa:3543,0.0,0.0,1.1348292438387096e-07,3.176035258238923e-07,0.0,1.6749618e-06,False,IGLL1; immunoglobulin lambda like polypeptide
hsa:27189,0.0,0.0,3.264136525806452e-08,1.2611212918883925e-07,0.0,5.3856036e-07,False,IL17C; interleukin
hsa:53833,0.0,0.0,1.7175131806451615e-07,5.831964370366968e-07,0.0,2.724129e-06,False,IL20RB; interleukin 20 receptor subunit
hsa:8974,3.6714084e-06,0.002595344227692135,0.00016246326689887093,0.00027633110810576386,0.0,0.0011426018,False,P4HA2; prolyl 4-hydroxylase subunit alpha
hsa:51164,0.0,0.0,3.3210491100000005e-06,6.192211579962812e-06,0.0,2.0675223e-05,False,DCTN4; dynactin subunit
hsa:80153,0.0,0.0,9.427112713580646e-06,3.08664634675388e-05,0.0,0.0001451259,False,EDC3; enhancer of mRNA decapping
hsa:144124,0.0,0.0,3.730006129032258e-08,2.0767795198363366e-07,0.0,1.1563019e-06,False,OR10A5; olfactory receptor family 10 subfamily A member
hsa:282617,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNL3; interferon lambda
hsa:5603,3.9405662e-05,0.02785613755475618,0.0001337578147967742,0.00018367640342257155,0.0,0.0006590644,False,MAPK13; mitogen-activated protein kinase
hsa:253152,5.834921e-09,4.124746387895616e-06,1.877134699580645e-07,4.7236051361295003e-07,0.0,2.2847348e-06,False,EPHX4; epoxide hydrolase
hsa:51,8.0075595e-05,0.056605997105160843,0.0007598955882903225,0.0013578500340510474,0.0,0.0047966526,False,ACOX1; acyl-CoA oxidase
hsa:8704,3.3956097e-05,0.024003802013391976,0.0005293114859354839,0.0013674987975337881,0.0,0.0059164,False,B4GALT2; beta-1
hsa:55750,1.7942441e-06,0.0012683636797272866,4.926133437741936e-05,0.0001029162529501824,0.0,0.00037778285,False,AGK; acylglycerol
hsa:84612,0.0,0.0,1.4263985726774195e-07,2.2369927452253599e-07,0.0,9.1946913e-07,False,PARD6B; par-6 family cell polarity regulator
hsa:22885,0.0,0.0,1.3180869072258067e-07,3.5689893966741955e-07,0.0,1.6291383e-06,False,ABLIM3; actin binding LIM protein family member
hsa:51548,0.0,0.0,6.760876629354838e-05,0.00029505795577745104,0.0,0.0016498,False,SIRT6; sirtuin
hsa:10269,0.0,0.0,0.0001607649276080645,0.000524146361877718,0.0,0.0025194192,False,ZMPSTE24; zinc metallopeptidase
hsa:55014,0.0,0.0,9.54377921335484e-06,2.8986423550029305e-05,0.0,0.00012154077,False,STX17; syntaxin
hsa:29102,0.0,0.0,2.972358029032258e-06,8.38065473269225e-06,0.0,3.453419e-05,False,DROSHA; drosha ribonuclease
hsa:406948,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15A; microRNA
hsa:2521,0.0,0.0,1.1099811595806451e-05,2.9156705487928012e-05,0.0,0.00011527429,False,FUS; FUS RNA binding
hsa:57689,0.0,0.0,3.364213712903226e-07,8.599758991387233e-07,0.0,3.8044539e-06,False,LRRC4C; leucine rich repeat containing
hsa:6624,8.053526e-08,5.693093750253589e-05,7.890113138064516e-07,1.5895039035407283e-06,0.0,6.801225e-06,False,FSCN1; fascin actin-bundling protein
hsa:6890,0.00017622851,0.12457716395247276,0.001139340735258065,0.0018982528799268527,0.0,0.007708139,False,TAP1; transporter 1
hsa:30849,0.0,0.0,3.798139158064516e-05,7.081703730194098e-05,0.0,0.00025246185,False,PIK3R4; phosphoinositide-3-kinase regulatory subunit
hsa:1311,3.9077048e-07,0.0002762383802413496,5.084173349635483e-05,0.00012190364834695841,0.0,0.0004820144,False,COMP; cartilage oligomeric matrix
hsa:55718,0.0,0.0,1.1122183050000001e-05,2.95582513577731e-05,0.0,0.0001246203,False,POLR3E; RNA polymerase III subunit
hsa:3778,0.0,0.0,0.00020707649376225804,0.0003906796408963805,0.0,0.001332489,False,KCNMA1; potassium calcium-activated channel subfamily M alpha
hsa:6100,1.6585189e-07,0.00011724185883633401,4.0176780974193545e-07,5.237921062181867e-07,0.0,1.5589799e-06,False,RP9; RP9 pre-mRNA splicing
hsa:51547,0.0,0.0,1.321394706451613e-05,2.857634886471563e-05,0.0,0.00013237307,False,SIRT7; sirtuin
hsa:10274,0.0,0.0,2.4557065338587096e-06,4.839715828723157e-06,0.0,2.1166652e-05,False,STAG1; STAG1 cohesin complex
hsa:53373,1.3682346e-07,9.672145902478888e-05,1.3587605222580644e-06,2.8423715303103897e-06,0.0,1.0902414e-05,False,TPCN1; two pore segment channel
hsa:55054,0.0,0.0,5.839959975290323e-05,0.00014998832323955452,0.0,0.00057637243,False,ATG16L1; autophagy related 16 like
hsa:5265,9.540446e-07,0.0006744207878292298,4.602520219677419e-06,1.092934458035487e-05,0.0,4.613228e-05,False,SERPINA1; serpin family A member
hsa:9170,0.0,0.0,4.4475436451612905e-07,1.5349733443093716e-06,0.0,7.5230446e-06,False,LPAR2; lysophosphatidic acid receptor
hsa:55120,0.0,0.0,3.281039538709678e-05,7.505522718097235e-05,0.0,0.00029373224,False,FANCL; FA complementation group
hsa:2837,0.0,0.0,6.522414387419355e-08,2.742039560175937e-07,0.0,1.4796886e-06,False,UTS2R; urotensin 2
hsa:128368,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10Z1; olfactory receptor family 10 subfamily Z member
hsa:219952,0.0,0.0,4.6446137322580646e-07,2.4345896662967287e-06,0.0,1.3557166e-05,False,OR6Q1; olfactory receptor family 6 subfamily Q member
hsa:8648,0.0,0.0,5.759494264516129e-07,2.069670952897356e-06,0.0,9.045514e-06,False,NCOA1; nuclear receptor coactivator
hsa:2250,1.0533246e-06,0.000744602512892907,8.971428850322581e-06,1.9083187525239555e-05,0.0,8.9107794e-05,False,FGF5; fibroblast growth factor
hsa:79966,0.0,0.0,3.0816297645161296e-05,6.284334056327275e-05,0.0,0.0002536679,False,SCD5; stearoyl-CoA desaturase
hsa:406893,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR101-1; microRNA
hsa:4628,0.0,0.0,1.0595831716129031e-06,2.91231420643887e-06,0.0,1.1899534e-05,False,MYH10; myosin heavy chain
hsa:366,9.364919e-06,0.006620126616655994,0.00011727813674548388,0.000265634556823657,0.0,0.0013524495,False,AQP9; aquaporin
hsa:1234,2.8066179e-05,0.019840177862267848,0.00030065804618064517,0.0007570264459517995,0.0,0.0037601604,False,CCR5; C-C motif chemokine receptor
hsa:3350,0.0,0.0,5.423285096774194e-06,2.797538475485728e-05,0.0,0.00015567782,False,HTR1A; 5-hydroxytryptamine receptor
hsa:6362,0.0,0.0,1.4255427580645164e-07,7.613079565492265e-07,0.0,4.24098e-06,False,CCL18; C-C motif chemokine ligand
hsa:50846,4.0225314e-05,0.02843555527546421,0.00016753344997741935,0.000254107414003637,0.0,0.0009937505,False,DHH; desert hedgehog signaling
hsa:10159,0.0,0.0,0.00011645660204516128,0.0002400686229644416,0.0,0.00096770807,False,ATP6AP2; ATPase H+ transporting accessory protein
hsa:85464,0.0,0.0,1.1508010589419355e-05,4.567798384801997e-05,0.0,0.0002469451,False,SSH2; slingshot protein phosphatase
hsa:1586,8.538116e-06,0.006035653804127555,8.181010325129035e-05,0.0001740973204686333,0.0,0.00068244553,False,CYP17A1; cytochrome P450 family 17 subfamily A member
hsa:64131,0.0,0.0,8.366401551612903e-06,2.232992060310361e-05,0.0,7.500936e-05,False,XYLT1; xylosyltransferase
hsa:84735,0.0,0.0,1.4390865645161292e-06,3.49416763278815e-06,0.0,1.4932869e-05,False,CNDP1; carnosine dipeptidase
hsa:127068,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T34; olfactory receptor family 2 subfamily T member
hsa:6431,6.929829e-08,4.898744496538048e-05,4.088082425806452e-07,6.203864352496175e-07,0.0,2.3808864e-06,False,SRSF6; serine and arginine rich splicing factor
hsa:23095,0.0,0.0,1.0451805248709678e-07,1.9895653153913723e-07,0.0,7.760867e-07,False,KIF1B; kinesin family member
hsa:5478,0.0,0.0,6.611242659677419e-05,0.00016724253779583424,0.0,0.00070363475,False,PPIA; peptidylprolyl isomerase
hsa:23673,0.0,0.0,1.3637503982258065e-07,3.201447283567647e-07,0.0,1.0289691e-06,False,STX12; syntaxin
hsa:54552,0.0,0.0,2.9536009632258064e-07,8.985403659056566e-07,0.0,3.5583876e-06,False,GNL3L; G protein nucleolar 3
hsa:214,0.0,0.0,2.4207562258064517e-07,8.805971472938496e-07,0.0,3.8275084e-06,False,ALCAM; activated leukocyte cell adhesion
hsa:1549,0.0,0.0,1.3447589032258062e-06,5.290803255501975e-06,0.0,2.4512055e-05,False,CYP2A7; cytochrome P450 family 2 subfamily A member
hsa:4211,0.0,0.0,1.6792016419354838e-07,4.271140737717503e-07,0.0,1.6648298e-06,False,MEIS1; Meis homeobox
hsa:10642,4.0461092e-09,2.8602228389606677e-06,9.499295949677418e-08,2.3325800074247383e-07,0.0,1.2109961e-06,False,IGF2BP1; insulin like growth factor 2 mRNA binding protein
hsa:51094,0.0,0.0,5.803793881290324e-05,0.0001238850103870524,0.0,0.00047626658,False,ADIPOR1; adiponectin receptor
hsa:3293,0.0,0.0,4.21989687433871e-06,1.2208136716727927e-05,0.0,5.4781958e-05,False,HSD17B3; hydroxysteroid 17-beta dehydrogenase
hsa:84105,0.0,0.0,7.130468957774193e-06,1.758200674428841e-05,0.0,8.371774e-05,False,PCBD2; pterin-4 alpha-carbinolamine dehydratase
hsa:3034,0.0,0.0,1.1013978040322582e-06,2.9312798014288673e-06,0.0,1.4336486e-05,False,HAL; histidine
hsa:5933,0.0,0.0,2.9994861754838707e-07,5.677520045201113e-07,0.0,2.5682418e-06,False,RBL1; RB transcriptional corepressor like
hsa:54925,1.0016883e-08,7.081004519550992e-06,1.5971861158064516e-07,3.406344933184465e-07,0.0,1.4253678e-06,False,ZSCAN32; zinc finger and SCAN domain containing
hsa:2261,9.784676e-06,0.006916855770237321,6.523289614161289e-05,0.00017054756096533541,0.0,0.0008921085,False,FGFR3; fibroblast growth factor receptor
hsa:23019,0.0,0.0,1.1197795983870968e-06,2.8842556313447616e-06,0.0,1.33456615e-05,False,CNOT1; CCR4-NOT transcription complex subunit
hsa:1613,3.891419e-05,0.02750871256703967,0.00011901982708387098,0.000165577046481047,0.0,0.00054742343,False,DAPK3; death associated protein kinase
hsa:8091,9.7910394e-08,6.921354102119574e-05,1.2796584497745162e-05,4.819222957023906e-05,0.0,0.00023933317,False,HMGA2; high mobility group AT-hook
hsa:6181,1.3465883e-09,9.519126696672495e-07,9.25173948816129e-07,1.7985303952991187e-06,0.0,6.431017e-06,False,RPLP2; ribosomal protein lateral stalk subunit
hsa:3651,0.0,0.0,0.0,0.0,0.0,0.0,False,PDX1; pancreatic and duodenal homeobox
hsa:6192,0.0,0.0,1.602391895387097e-08,5.503832157239978e-08,0.0,2.6856094e-07,False,RPS4Y1; ribosomal protein S4 Y-linked
hsa:9311,0.0,0.0,2.2351736616129028e-05,5.2051470651534076e-05,0.0,0.00019631503,False,ASIC3; acid sensing ion channel subunit
hsa:83447,0.0,0.0,2.4549469451612905e-08,8.648884218146881e-08,0.0,4.0583433e-07,False,SLC25A31; solute carrier family 25 member
hsa:144125,0.0,0.0,1.4619059483870968e-07,7.081740429252359e-07,-0.0,3.9150054e-06,False,OR2AG1; olfactory receptor family 2 subfamily AG member
hsa:51311,0.0,0.0,3.963384773083871e-06,1.0503646395030859e-05,0.0,3.8391325e-05,False,TLR8; toll like receptor
hsa:65109,3.8596157e-09,2.728389281918334e-06,8.450263397967744e-07,1.4273397299436499e-06,0.0,5.423174e-06,False,UPF3B; UPF3B regulator of nonsense mediated mRNA
hsa:570,0.0,0.0,0.0,0.0,0.0,0.0,False,BAAT; bile acid-CoA:amino acid
hsa:29915,8.45203e-08,5.974799009769863e-05,4.4114403924838704e-05,0.00013331059475400463,0.0,0.0005318301,False,HCFC2; host cell factor
hsa:4622,0.0,0.0,0.0,0.0,0.0,0.0,False,MYH4; myosin heavy chain
hsa:2796,0.0,0.0,3.5757786758064516e-05,0.00011725651572266004,0.0,0.00061197317,False,GNRH1; gonadotropin releasing hormone
hsa:4190,0.0,0.0,2.2846500483870968e-05,9.565623824712986e-05,0.0,0.00053279765,False,MDH1; malate dehydrogenase
hsa:26088,0.0,0.0,1.6166743887741937e-07,3.5573024227450453e-07,0.0,1.569791e-06,False,GGA1; golgi associated
hsa:2950,0.00012765366,0.09023926339133896,0.000948592003032258,0.0018930525212958213,0.0,0.0063108723,False,GSTP1; glutathione S-transferase pi
hsa:10555,0.00017567517,0.12418600404366195,0.0003817365496774194,0.00047156077317343185,0.0,0.0014187566,False,AGPAT2; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:58498,0.0,0.0,3.432448740645161e-07,8.492638520255946e-07,0.0,3.1797128e-06,False,MYL7; myosin light chain
hsa:729092,4.3655316e-08,3.086024763376259e-05,3.0887106990322575e-07,7.400583881618836e-07,0.0,3.2572711e-06,False,AGAP5; ArfGAP with GTPase domain
hsa:126,5.8348076e-05,0.04124666224643981,0.00037345508348387093,0.0007331211278727283,0.0,0.00349309,False,ADH1C; alcohol dehydrogenase 1C (class I)
hsa:27306,0.00024761,0.17503723754046255,0.000420705302548387,0.00044099832827024335,0.0,0.0016315193,False,HPGDS; hematopoietic prostaglandin D
hsa:401667,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51A2; olfactory receptor family 51 subfamily A member
hsa:57863,0.0,0.0,4.8577239677419356e-08,1.802288981605727e-07,0.0,7.951102e-07,False,CADM3; cell adhesion molecule
hsa:80835,1.8653429e-05,0.01318623917780846,0.0001461303255225806,0.00043990967175298255,0.0,0.0024154624,False,TAS1R1; taste 1 receptor member
hsa:3881,0.0,0.0,3.3787843387096774e-08,1.3575117539660474e-07,0.0,7.369077e-07,False,KRT31; keratin
hsa:3077,0.0,0.0,8.986604014806453e-05,0.0002669710444629498,0.0,0.0012010083,False,HFE; homeostatic iron
hsa:162998,-0.0,0.0,4.553819911612904e-07,1.3910463353096161e-06,0.0,7.2716816e-06,False,OR7D2; olfactory receptor family 7 subfamily D member
hsa:7472,3.2563617e-05,0.023019448180629395,6.28475105096774e-05,9.507819065473157e-05,0.0,0.00047750215,False,WNT2; Wnt family member
hsa:7015,0.0,0.0,7.40775345516129e-08,1.8984171303776568e-07,0.0,8.6596356e-07,False,TERT; telomerase reverse
hsa:5539,0.0,0.0,4.474746516129032e-07,1.3117095758386185e-06,0.0,5.394202e-06,False,PPY; pancreatic
hsa:4792,0.0002103767,0.1487167578485466,0.0010220799975483872,0.0019359606205195529,0.0,0.009790538,False,NFKBIA; NFKB inhibitor
hsa:5291,2.4442978e-05,0.01727891178216671,0.0006817466761193548,0.0008345620239609277,0.0,0.0029320023,False,PIK3CB; phosphatidylinositol-4
hsa:5318,0.0,0.0,9.438986896774192e-06,2.1804721224293202e-05,0.0,8.412762e-05,False,PKP2; plakophilin
hsa:9855,3.3235498e-08,2.349440554986296e-05,1.4489688173225807e-06,2.421264807250742e-06,0.0,9.148181e-06,False,FARP2; FERM
hsa:283111,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51V1; olfactory receptor family 51 subfamily V member
hsa:3362,0.0,0.0,2.543505380645161e-06,1.0246893141625385e-05,0.0,5.3871292e-05,False,HTR6; 5-hydroxytryptamine receptor
hsa:4760,0.0,0.0,3.0015362903225808e-09,1.6711846790999102e-08,0.0,9.3047625e-08,False,NEUROD1; neuronal differentiation
hsa:29906,1.077568e-07,7.617403415936398e-05,3.967387252903225e-05,0.00012754650134058127,0.0,0.000685575,False,ST8SIA5; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:5434,2.0086956e-05,0.014199609421416013,0.00014387216117741936,0.00022862886377912473,0.0,0.00095592753,False,POLR2E; RNA polymerase II
hsa:407055,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR99A; microRNA
hsa:64900,1.7771063e-05,0.012562488492700313,0.00023655306463225804,0.0004907154579950125,0.0,0.0022942084,False,LPIN3; lipin
hsa:4286,2.7003846e-06,0.0019089207248528207,8.245820868709677e-05,0.00020067788152597645,0.0,0.000833928,False,MITF; melanocyte inducing transcription
hsa:406905,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR1-2; microRNA
hsa:6730,0.0,0.0,3.5043226483870967e-06,6.073926146350685e-06,0.0,2.3286175e-05,False,SRP68; signal recognition particle
hsa:55339,0.0,0.0,4.786911486774193e-07,1.15041271662104e-06,0.0,4.627664e-06,False,WDR33; WD repeat domain
hsa:915,0.0,0.0,1.4091990322580646e-05,3.681728992062737e-05,0.0,0.00015108935,False,CD3D; CD3 delta subunit of T-cell receptor
hsa:5441,2.2431745e-05,0.01585715713425178,0.00012821670049354837,0.0002134937017898181,0.0,0.000799149,False,POLR2L; RNA polymerase II
hsa:1302,0.0,0.0,1.246385272903226e-06,4.114862305099493e-06,0.0,2.0808659e-05,False,COL11A2; collagen type XI alpha 2
hsa:57153,0.0,0.0,9.787127649032259e-06,2.278782159292274e-05,0.0,9.2775204e-05,False,SLC44A2; solute carrier family 44 member
hsa:2632,6.914534e-05,0.04887932354265194,0.00020608995941612905,0.0002548260044283475,0.0,0.0006901301,False,GBE1; 1
hsa:123,9.739072e-07,0.0006884617984280391,4.850473323032258e-05,0.0001048703736158492,0.0,0.00045510067,False,PLIN2; perilipin
hsa:406955,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181B1; microRNA
hsa:1056,0.0,0.0,1.2428932903225806e-06,5.385372433215611e-06,0.0,2.8637327e-05,False,CEL; carboxyl ester
hsa:2026,0.0,0.0,1.9420328534580644e-05,5.412991886871982e-05,0.0,0.00023746755,False,ENO2; enolase
hsa:8386,-0.0,0.0,1.4448114193548388e-09,8.044369531693734e-09,0.0,4.4789154e-08,False,OR1D5; olfactory receptor family 1 subfamily D member
hsa:4982,3.043467e-07,0.00021514480684364884,5.757503279677418e-06,1.6578940833646927e-05,0.0,8.1767685e-05,False,TNFRSF11B; TNF receptor superfamily member
hsa:206358,0.0,0.0,8.692428693548385e-06,2.7767012342532446e-05,0.0,0.0001342611,False,SLC36A1; solute carrier family 36 member
hsa:5600,0.0,0.0,1.2098510880645161e-05,6.622871573681078e-05,0.0,0.00036889972,False,MAPK11; mitogen-activated protein kinase
hsa:55957,0.0,0.0,5.011840725806452e-07,9.494212836938816e-07,0.0,3.9629094e-06,False,LIN37; lin-37 DREAM MuvB core complex
hsa:5361,0.0,0.0,2.6066722741935486e-07,4.640152504099895e-07,0.0,1.6123824e-06,False,PLXNA1; plexin
hsa:4005,0.0,0.0,1.2140669855483872e-05,4.421172528282981e-05,0.0,0.00024276722,False,LMO2; LIM domain only
hsa:2120,5.851392e-07,0.00041363898527780067,2.976220141338516e-05,0.00012783679277365915,0.0,0.0007088094,False,ETV6; ETS variant transcription factor
hsa:85320,0.0,0.0,4.399210019354838e-06,1.3592197416182512e-05,0.0,6.25063e-05,False,ABCC11; ATP binding cassette subfamily C member
hsa:3552,2.174365e-05,0.01537073797522991,5.673307861483872e-05,8.376578662608634e-05,0.0,0.00033260375,False,IL1A; interleukin 1
hsa:388523,0.0,0.0,1.4058169999999999e-09,5.313287209428296e-09,0.0,2.8876123e-08,False,ZNF728; zinc finger protein
hsa:246,0.0,0.0,1.1663290451612903e-06,4.703508097084393e-06,0.0,2.5546715e-05,False,ALOX15; arachidonate
hsa:79711,2.4072346e-08,1.7016909434022065e-05,1.283734256451613e-07,1.9918102363274965e-07,0.0,7.0121257e-07,False,IPO4; importin
hsa:2815,0.0,0.0,7.05755213967742e-06,2.174015326187535e-05,0.0,0.00011770396,False,GP9; glycoprotein IX
hsa:7482,2.7797498e-06,0.0019650245387732856,1.0347758219354838e-05,1.7891275430387657e-05,0.0,7.175144e-05,False,WNT2B; Wnt family member
hsa:6202,2.4222105e-08,1.7122775116574556e-05,4.196548455161291e-07,7.287922506626172e-07,0.0,3.0458714e-06,False,RPS8; ribosomal protein
hsa:51035,0.0,0.0,1.2168807161096773e-06,2.370446343522865e-06,0.0,8.868544e-06,False,UBXN1; UBX domain protein
hsa:5168,6.402459e-06,0.004525942962021212,4.478030043225806e-05,8.975809119304692e-05,0.0,0.0004176332,False,ENPP2; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:9776,0.0,0.0,9.97660470967742e-07,2.727242410964658e-06,0.0,1.3675834e-05,False,ATG13; autophagy related
hsa:9533,0.0,0.0,3.0761534838709678e-06,9.73876752265471e-06,0.0,3.9113896e-05,False,POLR1C; RNA polymerase I and III subunit
hsa:7454,0.0,0.0,4.9374780080645166e-05,0.00010946065324758146,0.0,0.0004016035,False,WAS; WASP actin nucleation promoting
hsa:3812,0.0,0.0,3.4157289203225805e-07,1.465570262465303e-06,0.0,8.09518e-06,False,KIR3DL2; killer cell immunoglobulin like receptor
hsa:22989,2.1816302e-10,1.5422096181206203e-07,1.0205698527419354e-08,2.1882880821624602e-08,0.0,9.485081e-08,False,MYH15; myosin heavy chain
hsa:23430,0.0,0.0,1.4556681006451614e-07,5.361515523308636e-07,0.0,2.9345222e-06,False,TPSD1; tryptase delta
hsa:4704,0.0,0.0,3.759585967096774e-06,6.975364101897438e-06,0.0,2.2003103e-05,False,NDUFA9; NADH:ubiquinone oxidoreductase subunit
hsa:64411,0.0,0.0,4.638877838709678e-07,9.55050340820417e-07,0.0,3.3428262e-06,False,ARAP3; ArfGAP with RhoGAP domain
hsa:381,2.2515025e-09,1.591602834762107e-06,2.6664804894193556e-07,8.096496114993385e-07,0.0,3.4659984e-06,False,ARF5; ADP ribosylation factor
hsa:9177,0.0,0.0,0.0,0.0,0.0,0.0,False,HTR3B; 5-hydroxytryptamine receptor
hsa:5468,2.0801255e-05,0.014704552370965365,0.0001635311422580645,0.0003499086398748649,0.0,0.0014791571,False,PPARG; peroxisome proliferator activated receptor
hsa:3112,0.0,0.0,1.3659559580645161e-05,4.4552503077475894e-05,0.0,0.00020539304,False,HLA-DOB; major histocompatibility complex
hsa:112398,3.8040043e-06,0.0026890771950407533,7.746287672258065e-05,0.0001725179647595407,0.0,0.00066164,False,EGLN2; egl-9 family hypoxia inducible factor
hsa:57474,0.0,0.0,9.017880858064517e-09,1.541402960577891e-08,0.0,6.805642e-08,False,ZNF490; zinc finger protein
hsa:4720,0.0,0.0,4.164890796774193e-06,7.197071483313984e-06,0.0,2.3560428e-05,False,NDUFS2; NADH:ubiquinone oxidoreductase core subunit
hsa:51305,8.691847e-09,6.144327321208178e-06,1.8840185171290322e-06,3.151397171539718e-06,0.0,1.0867312e-05,False,KCNK9; potassium two pore domain channel subfamily K member
hsa:1676,0.0,0.0,1.6667704678048388e-06,3.022341360218921e-06,0.0,9.960356e-06,False,DFFA; DNA fragmentation factor subunit
hsa:8540,2.4791239e-06,0.0017525099914241667,1.1947183848387097e-05,2.300091839128419e-05,0.0,8.8835695e-05,False,AGPS; alkylglycerone phosphate
hsa:999,4.763699e-05,0.033674920780027616,0.00016746194234838714,0.0002770833609015355,0.0,0.0010386986,False,CDH1; cadherin
hsa:2526,0.0,0.0,3.5424318406451614e-05,5.387908875830992e-05,0.0,0.00016853267,False,FUT4; fucosyltransferase
hsa:55669,1.2870362e-06,0.0009098148744500393,6.277057431935484e-06,1.6068271308845157e-05,0.0,6.692656e-05,False,MFN1; mitofusin
hsa:2812,0.0,0.0,5.526561e-07,2.0534961291077423e-06,0.0,9.859339e-06,False,GP1BB; glycoprotein Ib platelet subunit
hsa:79869,5.89801e-07,0.00041693444424135674,1.7172118907741937e-05,2.739247335874654e-05,0.0,9.006524e-05,False,CPSF7; cleavage and polyadenylation specific factor
hsa:2890,0.0,0.0,9.483942527741935e-05,0.00041076696229923733,0.0,0.0022350613,False,GRIA1; glutamate ionotropic receptor AMPA type subunit
hsa:7139,4.2185593e-06,0.002982129018507441,0.00018106447735806452,0.0004492865731263621,0.0,0.0019275481,False,TNNT2; troponin T2
hsa:2100,1.4851781e-05,0.0104988276676868,2.4398024287741935e-05,2.8790975767979587e-05,0.0,0.000120554476,False,ESR2; estrogen receptor
hsa:64135,0.0,0.0,5.12059448548387e-05,0.00012803434790798979,0.0,0.00057501957,False,IFIH1; interferon induced with helicase C domain
hsa:79602,1.0209777e-05,0.007217362634724572,4.089074544193549e-05,6.281371319437579e-05,0.0,0.00022253652,False,ADIPOR2; adiponectin receptor
hsa:2909,0.0,0.0,4.3841393548387095e-06,1.5303589621966634e-05,0.0,6.578873e-05,False,ARHGAP35; Rho GTPase activating protein
hsa:1634,0.0,0.0,0.0004553743101177419,0.0011349686882888216,0.0,0.0040828087,False,DCN;
hsa:3558,0.0,0.0,9.055491046774193e-06,2.8454205188145065e-05,0.0,0.0001561014,False,IL2; interleukin
hsa:29935,2.742069e-06,0.0019383877182074173,2.082321305264516e-05,3.469293797533246e-05,0.0,0.00012906194,False,RPA4; replication protein
hsa:3726,5.6575946e-06,0.003999393117837882,3.498115600645161e-05,5.886123943407795e-05,0.0,0.00020963553,False,JUNB; JunB proto-oncogene
hsa:9380,4.1374748e-05,0.029248098194147157,0.00019658503225806448,0.00032619455576395637,0.0,0.0012722049,False,GRHPR; glyoxylate and hydroxypyruvate
hsa:9525,3.8173284e-06,0.002698496094344953,6.91942016451613e-06,9.417755040845062e-06,0.0,3.4229088e-05,False,VPS4B; vacuolar protein sorting 4 homolog
hsa:343637,2.2500291e-08,1.59056127801645e-05,2.9332669438709683e-07,8.158063275980938e-07,0.0,3.807302e-06,False,RSPO4; R-spondin
hsa:138882,0.0,0.0,5.283867300483871e-07,2.1169046020478366e-06,0.0,1.0316573e-05,False,OR1N2; olfactory receptor family 1 subfamily N member
hsa:3911,0.0,0.0,0.000147626424,0.000314271113546404,0.0,0.00107004,False,LAMA5; laminin subunit alpha
hsa:3938,0.0,0.0,8.770924791290322e-07,2.9626439267449923e-06,-0.0,1.3031105e-05,False,LCT;
hsa:26330,-0.0,0.0,2.1037521141935484e-08,1.0607435328321446e-07,0.0,5.9052536e-07,False,GAPDHS; glyceraldehyde-3-phosphate dehydrogenase
hsa:55582,2.5946953e-08,1.834208220876466e-05,1.1811823644383871e-07,1.870949315281674e-07,0.0,6.864445e-07,False,KIF27; kinesin family member
hsa:80150,0.0,0.0,7.154068174193549e-07,1.6268291567127112e-06,0.0,5.7245143e-06,False,ASRGL1; asparaginase and isoaspartyl peptidase
hsa:9939,0.0,0.0,2.2150128424193547e-07,5.971462309494392e-07,0.0,2.7055457e-06,False,RBM8A; RNA binding motif protein
hsa:2864,0.0,0.0,4.496664261612903e-07,1.8106435689551018e-06,0.0,9.817108e-06,False,FFAR1; free fatty acid receptor
hsa:3614,8.7981863e-07,0.0006219499314722117,0.00013058010125258063,0.00026542475683078294,0.0,0.00096090726,False,IMPDH1; inosine monophosphate dehydrogenase
hsa:9984,9.334877e-09,6.59888971713582e-06,1.5682805648387098e-07,3.718035695857262e-07,0.0,1.5629175e-06,False,THOC1; THO complex subunit
hsa:10640,7.5443054e-08,5.333122153295887e-05,1.663667383064516e-07,2.486498563037807e-07,0.0,1.0628953e-06,False,EXOC5; exocyst complex component
hsa:1733,0.0,0.0,6.814107060967742e-08,1.7754800274986046e-07,0.0,7.1472573e-07,False,DIO1; iodothyronine deiodinase
hsa:5406,0.0,0.0,3.339527891451614e-05,0.00014345997604977556,0.0,0.0007983355,False,PNLIP; pancreatic
hsa:80208,0.0,0.0,2.602671645501613e-08,5.99622734863451e-08,0.0,2.4287297e-07,False,SPG11; SPG11 vesicle trafficking associated
hsa:344787,7.2602363e-10,5.13231172344812e-07,1.1803650217096773e-08,2.4348250233169328e-08,0.0,1.1613222e-07,False,ZNF860; zinc finger protein
hsa:7709,0.0,0.0,1.4106807429032258e-05,3.7411756772469294e-05,0.0,0.00018724691,False,ZBTB17; zinc finger and BTB domain containing
hsa:51465,0.0,0.0,1.298429105903226e-06,2.4939829203585262e-06,0.0,8.459406e-06,False,UBE2J1; ubiquitin conjugating enzyme E2
hsa:22941,0.0,0.0,4.471010437741935e-06,8.33911548797372e-06,0.0,2.806894e-05,False,SHANK2; SH3 and multiple ankyrin repeat domains
hsa:83860,0.0,0.0,1.9394974370967743e-07,3.4367224509502846e-07,0.0,1.3031193e-06,False,TAF3; TATA-box binding protein associated factor
hsa:22933,5.5707446e-08,3.937998246546783e-05,9.725817935632256e-05,0.00021801410192824573,0.0,0.0011059565,False,SIRT2; sirtuin
hsa:7528,0.0,0.0,3.8407799564709675e-06,1.585060108421905e-05,0.0,8.7682325e-05,False,YY1; YY1 transcription
hsa:3358,1.6622329e-07,0.00011750440408904,6.710918644838709e-06,1.5253439710443306e-05,0.0,5.8588746e-05,False,HTR2C; 5-hydroxytryptamine receptor
hsa:9886,0.0,0.0,1.2780445967741936e-07,2.6076550394178244e-07,0.0,1.1375295e-06,False,RHOBTB1; Rho related BTB domain containing
hsa:6604,0.0,0.0,7.346046797096774e-06,1.8969437866899478e-05,0.0,8.8093715e-05,False,SMARCD3; SWI/SNF related
hsa:10021,0.0,0.0,1.1640463290322582e-06,2.8724479853505197e-06,0.0,1.236807e-05,False,HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:81341,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10W1; olfactory receptor family 10 subfamily W member
hsa:6296,5.223922e-07,0.00036928269294731565,1.7244454675483874e-05,3.122577450030926e-05,0.0,0.00011884059,False,ACSM3; acyl-CoA synthetase medium chain family member
hsa:79685,0.0,0.0,1.0368089443387096e-07,1.8663328101538843e-07,0.0,7.2585203e-07,False,SAP30L; SAP30
hsa:2529,0.0,0.0,1.2807981225806452e-06,5.4389623398774234e-06,0.0,3.0294439e-05,False,FUT7; fucosyltransferase
hsa:55012,0.0,0.0,3.0382170225806454e-06,6.3635485979111255e-06,0.0,2.3060407e-05,False,PPP2R3C; protein phosphatase 2 regulatory subunit
hsa:220,0.00012548888,0.0887089652972279,0.000282264842716129,0.00043587286985561225,0.0,0.0020228762,False,ALDH1A3; aldehyde dehydrogenase 1 family member
hsa:442918,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR373; microRNA
hsa:722,0.0,0.0,4.903739149354839e-08,1.3828587369123573e-07,0.0,6.941655e-07,False,C4BPA; complement component 4 binding protein
hsa:6812,4.5823825e-08,3.239318178400544e-05,5.5743665021225796e-05,0.0001561674222789174,0.0,0.0007912973,False,STXBP1; syntaxin binding protein
hsa:219965,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5B17; olfactory receptor family 5 subfamily B member
hsa:1489,8.657227e-06,0.006119854201529445,0.0003049023395993549,0.000733729187272288,0.0,0.0024937,False,CTF1; cardiotrophin
hsa:4144,1.0940719e-06,0.0007734070637157028,4.6680279222580645e-05,0.00014769695439421416,0.0,0.0008025008,False,MAT2A; methionine adenosyltransferase
hsa:10585,0.0,0.0,0.00019639522814193544,0.0005327839606039756,0.0,0.0026019905,False,POMT1; protein O-mannosyltransferase
hsa:5872,2.5200912e-08,1.7814700617827604e-05,2.7622277818741937e-05,7.530746914651562e-05,0.0,0.00028200992,False,RAB13; RAB13
hsa:3181,7.0711907e-09,4.998674069099833e-06,5.806771282322581e-08,1.208942844318321e-07,0.0,4.965734e-07,False,HNRNPA2B1; heterogeneous nuclear ribonucleoprotein
hsa:2209,0.00018955056,0.13399461409736158,0.0004179455711612904,0.0004932731807627933,0.0,0.0014907444,False,FCGR1A; Fc gamma receptor
hsa:4116,0.0,0.0,1.1010656913548385e-06,1.9727785233337154e-06,0.0,6.651551e-06,False,MAGOH; mago homolog
hsa:5051,0.0,0.0,7.1531709169032255e-06,1.8115540790451403e-05,0.0,8.248589e-05,False,PAFAH2; platelet activating factor acetylhydrolase
hsa:1942,0.0,0.0,1.1348844018709678e-05,3.981199594828674e-05,0.0,0.00021632807,False,EFNA1; ephrin
hsa:11017,6.114121e-08,4.322114816962685e-05,1.435988795806452e-07,2.0179849762995203e-07,0.0,6.44852e-07,False,SNRNP27; small nuclear ribonucleoprotein U4/U6.U5 subunit
hsa:246243,4.1812186e-07,0.00029557326170057764,1.099231924267742e-05,3.333573682432863e-05,0.0,0.00015208524,False,RNASEH1; ribonuclease
hsa:407018,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27A; microRNA
hsa:1639,1.9073476e-06,0.0013483173334414246,7.645298154774194e-05,0.00020874805821183932,0.0,0.0008409198,False,DCTN1; dynactin subunit
hsa:1163,0.0,0.0,4.893159696912903e-05,0.00013855111224323128,0.0,0.00055537146,False,CKS1B; CDC28 protein kinase regulatory subunit
hsa:5439,1.8678049e-05,0.0132036432276782,5.171244496612904e-05,8.360068048563858e-05,0.0,0.00032501252,False,POLR2J; RNA polymerase II subunit
hsa:3659,1.1267623e-05,0.007965161356840916,7.48947304193548e-05,0.00012111609586402947,0.0,0.0004562346,False,IRF1; interferon regulatory factor
hsa:27443,0.0,0.0,9.389506615282581e-07,3.0052079628956343e-06,0.0,1.4137535e-05,False,CECR2; CECR2 histone acetyl-lysine
hsa:407008,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR223; microRNA
hsa:5542,0.0,0.0,3.6175649027419355e-06,2.0115083038051522e-05,0.0,0.000112000766,False,PRB1; proline rich protein BstNI subfamily
hsa:2799,4.1683597e-06,0.0029466425708290908,0.00010224353291290322,0.00028190836049486674,0.0,0.0012435224,False,GNS; glucosamine
hsa:51100,2.1595534e-08,1.526603374084704e-05,1.2233009680419355e-06,2.569522063379703e-06,0.0,9.838109e-06,False,SH3GLB1; SH3 domain containing GRB2 like
hsa:9247,0.0,0.0,6.79275461832258e-08,3.7006874965589985e-07,0.0,2.0614757e-06,False,GCM2; glial cells missing transcription factor
hsa:4694,2.8082557e-06,0.0019851755584801016,4.529570119354838e-06,7.280742638292794e-06,0.0,2.9862258e-05,False,NDUFA1; NADH:ubiquinone oxidoreductase subunit
hsa:3762,2.873667e-05,0.020314152630797964,0.00017613216761041937,0.0004010628543650746,0.0,0.0018903952,False,KCNJ5; potassium inwardly rectifying channel subfamily J member
hsa:93129,0.0,0.0,2.337627186996774e-06,7.436977008273267e-06,0.0,3.2956814e-05,False,ORAI3; ORAI calcium release-activated calcium modulator
hsa:6554,0.0,0.0,4.497896250870968e-08,2.503502198161035e-07,0.0,1.3939057e-06,False,SLC10A1; solute carrier family 10 member
hsa:10945,7.598584e-07,0.0005371492074549324,8.376850398129032e-05,0.0002661932082786024,0.0,0.0011857974,False,KDELR1; KDEL endoplasmic reticulum protein retention receptor
hsa:6432,1.4555766e-07,0.00010289572597735908,4.0094157619354823e-07,5.860777999104162e-07,0.0,1.8102165e-06,False,SRSF7; serine and arginine rich splicing factor
hsa:10170,8.3717623e-07,0.0005918057212299136,7.716270865096773e-05,0.00011661187992091612,0.0,0.0004128867,False,DHRS9; dehydrogenase/reductase
hsa:5368,9.478877e-08,6.700684322385312e-05,3.822884477909677e-06,1.3611246882037443e-05,0.0,7.499238e-05,False,PNOC;
hsa:55786,7.6182805e-10,5.385415667898606e-07,8.197423239516129e-08,1.9774580533212502e-07,0.0,8.764837e-07,False,ZNF415; zinc finger protein
hsa:29110,0.0,0.0,2.7071714287096775e-05,6.206524641119793e-05,0.0,0.00032585076,False,TBK1; TANK binding kinase
hsa:6844,0.0,0.0,0.00019120529796774193,0.00035748555414242124,0.0,0.0014522799,False,VAMP2; vesicle associated membrane protein
hsa:6159,8.0608785e-08,5.698291283830651e-05,7.617382211935483e-07,1.424921560998949e-06,0.0,6.002119e-06,False,RPL29; ribosomal protein
hsa:9420,0.00021849861,0.154458192725782,0.0004451485020367742,0.000631710740104739,0.0,0.002698963,False,CYP7B1; cytochrome P450 family 7 subfamily B member
hsa:338442,1.2689548e-10,8.970330065656078e-08,8.578061496567096e-06,3.955252101219704e-05,0.0,0.00021791115,False,HCAR2; hydroxycarboxylic acid receptor
hsa:83539,0.0,0.0,3.439445328080645e-06,1.3527770591655316e-05,0.0,6.8510635e-05,False,CHST9; carbohydrate sulfotransferase
hsa:80347,0.0,0.0,6.06782395e-05,0.00012341242517933558,0.0,0.00046124004,False,COASY; Coenzyme A
hsa:26737,0.0,0.0,1.3229270967741935e-07,7.365746344041546e-07,0.0,4.101074e-06,False,OR1L1; olfactory receptor family 1 subfamily L member
hsa:8439,0.0,0.0,1.1756265369677418e-05,2.3709508648381315e-05,0.0,7.9624275e-05,False,NSMAF; neutral sphingomyelinase activation associated
hsa:91442,1.4782049e-07,0.00010449533630094733,4.029016677516129e-05,9.998203747056591e-05,0.0,0.00054283,False,FAAP24; FA core complex associated protein
hsa:80144,2.165643e-07,0.0001530908154835588,7.313544466451612e-06,1.80980310160716e-05,0.0,7.180352e-05,False,FRAS1; Fraser extracellular matrix complex subunit
hsa:26835,0.0,0.0,1.9207805753225806e-07,4.320382255891304e-07,0.0,1.9034718e-06,False,RNU4-1; RNA
hsa:89853,0.0,0.0,3.7667089732258065e-08,9.32853778785911e-08,0.0,3.6728588e-07,False,MVB12B; multivesicular body subunit
hsa:919,0.0,0.0,1.9176759238709677e-05,4.399443845591323e-05,0.0,0.00017372688,False,CD247; CD247
hsa:8289,0.0,0.0,2.6666972161290322e-06,4.776617711323337e-06,0.0,1.6264205e-05,False,ARID1A; AT-rich interaction domain
hsa:656,1.1060829e-05,0.007818977234632839,0.0004181353976758065,0.0008764361129594388,0.0,0.0032990212,False,BMP8B; bone morphogenetic protein
hsa:3170,0.0,0.0,0.0,0.0,0.0,0.0,False,FOXA2; forkhead box
hsa:57666,7.598293e-07,0.0005371286364617882,4.5097879843838715e-05,0.00012698444882207037,0.0,0.000551585,False,FBRSL1; fibrosin like
hsa:127069,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T10; olfactory receptor family 2 subfamily T member
hsa:50839,0.0,0.0,1.91757014516129e-05,3.5914839331561456e-05,0.0,0.000118476826,False,TAS2R10; taste 2 receptor member
hsa:2581,3.004563e-07,0.00021239465592515843,1.3280674501080645e-05,2.9998315131374425e-05,0.0,0.00015175017,False,GALC;
hsa:218,3.4499404e-05,0.024387869524463406,9.108255783645161e-05,0.00016886264495865087,0.0,0.0008806697,False,ALDH3A1; aldehyde dehydrogenase 3 family member
hsa:29109,0.0,0.0,8.207566572258064e-07,1.7201138971231458e-06,0.0,6.758634e-06,False,FHOD1; formin homology 2 domain containing
hsa:2954,5.884818e-08,4.160018925521545e-05,6.0837418541290324e-05,0.00019814545395266725,0.0,0.001079999,False,GSTZ1; glutathione S-transferase zeta
hsa:1361,0.0,0.0,0.0,0.0,0.0,0.0,False,CPB2; carboxypeptidase
hsa:10023,0.0,0.0,8.1527654e-07,1.6382139214171254e-06,0.0,5.7834905e-06,False,FRAT1; FRAT regulator of WNT signaling pathway
hsa:440503,0.0,0.0,3.4238224254300006e-06,1.176110857670112e-05,0.0,4.8855003e-05,False,PLIN5; perilipin
hsa:4953,0.0,0.0,1.1095381645161291e-05,4.1041852166724917e-05,0.0,0.00022710109,False,ODC1; ornithine decarboxylase
hsa:8651,0.000116212614,0.08215150810514957,0.0003101117399354839,0.0004904491285684496,0.0,0.0017886164,False,SOCS1; suppressor of cytokine signaling
hsa:84790,1.779296e-06,0.0012577967634861066,0.00030508756081548384,0.0010466212628963208,0.0,0.0048860125,False,TUBA1C; tubulin alpha
hsa:56270,0.0,0.0,4.635887855806452e-07,9.189407508754729e-07,0.0,3.2223113e-06,False,WDR45B; WD repeat domain
hsa:8061,4.49576e-05,0.03178084128447598,0.00013365806618263867,0.0002196969293202482,0.0,0.0009461493,False,FOSL1; FOS like 1
hsa:361,0.0,0.0,5.543083436812903e-06,1.8144644524558915e-05,0.0,7.8793026e-05,False,AQP4; aquaporin
hsa:716,1.7128845e-05,0.012108500105241162,0.00023791268064516128,0.00044922992901269174,0.0,0.0015598272,False,C1S; complement
hsa:6152,0.0,0.0,5.758371096774194e-08,1.9471294230699955e-07,0.0,8.878881e-07,False,RPL24; ribosomal protein
hsa:26707,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2J2; olfactory receptor family 2 subfamily J member
hsa:6633,2.866982e-08,2.026689589912485e-05,2.9482958509677423e-07,4.178656494471805e-07,0.0,1.3205281e-06,False,SNRPD2; small nuclear ribonucleoprotein D2
hsa:126374,0.00019800417,0.13997053002016124,0.0008609214199354839,0.00157937655452949,0.0,0.006332427,False,WTIP; WT1 interacting
hsa:9627,0.0,0.0,1.304493111564516e-08,2.8624468474447952e-08,0.0,1.1404173e-07,False,SNCAIP; synuclein alpha interacting
hsa:158131,0.0,0.0,5.033594533870969e-07,1.972966162127933e-06,0.0,9.014619e-06,False,OR1Q1; olfactory receptor family 1 subfamily Q member
hsa:1856,0.0,0.0,4.561036341935484e-05,9.179636145054163e-05,0.0,0.00039399523,False,DVL2; dishevelled segment polarity protein
hsa:5562,0.00014912554,0.10541788525636989,0.0007019377512000001,0.0011610190148188576,0.0,0.004257279,False,PRKAA1; protein kinase AMP-activated catalytic subunit alpha
hsa:282763,-0.0,0.0,3.6191568387096773e-07,1.1619949397480608e-06,0.0,5.0580716e-06,False,OR51B5; olfactory receptor family 51 subfamily B member
hsa:1457,0.0,0.0,8.289860516129032e-06,1.67022847267285e-05,0.0,8.369039e-05,False,CSNK2A1; casein kinase 2 alpha
hsa:2328,0.00044730003,0.31619951376344263,0.0005264649486451613,0.00046481812933737613,0.0,0.0016782318,False,FMO3; flavin containing dimethylaniline monoxygenase
hsa:7319,5.5354427e-08,3.9130430869977765e-05,1.1430036569290323e-06,2.1855782602661426e-06,0.0,8.6351365e-06,False,UBE2A; ubiquitin conjugating enzyme E2
hsa:7158,5.23373e-07,0.0003699760273141816,8.691382286129029e-07,1.1096448032361802e-06,0.0,3.9587853e-06,False,TP53BP1; tumor protein p53 binding protein
hsa:127064,0.0,0.0,9.642385161290323e-08,5.368652847371327e-07,0.0,2.9891394e-06,False,OR2T12; olfactory receptor family 2 subfamily T member
hsa:3661,0.0,0.0,2.557540470967742e-05,5.3699583515044066e-05,0.0,0.00022059945,False,IRF3; interferon regulatory factor
hsa:57620,0.0,0.0,4.411531515483871e-07,1.5255300357937894e-06,0.0,7.648944e-06,False,STIM2; stromal interaction molecule
hsa:11255,0.0,0.0,4.253077667806451e-07,1.236173023756198e-06,0.0,5.770611e-06,False,HRH3; histamine receptor
hsa:100534599,5.8465478e-08,4.1329654539811345e-05,1.6217289006451615e-07,1.9027246009383836e-07,0.0,5.8780296e-07,False,ISY1-RAB43; ISY1-RAB43
hsa:22949,2.5779775e-05,0.01822390291351188,0.0001220491525490323,0.0002466445121374577,0.0,0.0011638587,False,PTGR1; prostaglandin reductase
hsa:9882,7.426472e-06,0.005249824900252793,1.206973315483871e-05,1.863397594315955e-05,0.0,7.620607e-05,False,TBC1D4; TBC1 domain family member
hsa:3955,9.022681e-06,0.0063781961853269994,0.0001007614242135484,0.00016122039092877056,0.0,0.00062570773,False,LFNG; LFNG O-fucosylpeptide
hsa:140775,0.0,0.0,3.3171587475806455e-07,5.881462090116154e-07,0.0,2.1007058e-06,False,SMCR8; SMCR8-C9orf72 complex
hsa:10238,1.6118072e-08,1.1393977615436687e-05,4.0337310855967745e-06,2.0707766075765402e-05,0.0,0.00011556671,False,DCAF7; DDB1 and CUL4 associated factor
hsa:2690,3.742127e-05,0.02645335699711556,4.9696024506451616e-05,5.765956362774144e-05,0.0,0.00020575785,False,GHR; growth hormone
hsa:219982,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5A1; olfactory receptor family 5 subfamily A member
hsa:5137,0.00014660928,0.10363912349661236,0.0005793449535774194,0.0008265919157183652,0.0,0.0028254834,False,PDE1C; phosphodiesterase
hsa:727897,2.1645698e-07,0.00015301495022636868,8.887771084967742e-06,2.2364012814883308e-05,0.0,0.00010804111,False,MUC5B; mucin 5B
hsa:1111,0.0,0.0,4.629412827838709e-06,1.0481084984391423e-05,0.0,4.0374507e-05,False,CHEK1; checkpoint kinase
hsa:2323,0.0,0.0,7.644727338532257e-05,0.0002418136330203157,0.0,0.0011080869,False,FLT3LG; fms related receptor tyrosine kinase 3
hsa:2151,1.8658508e-06,0.0013189829558364447,2.1172024306774197e-05,4.2125779953331745e-05,0.0,0.00017319329,False,F2RL2; coagulation factor II thrombin receptor like
hsa:10723,3.8007656e-06,0.002686787735401715,0.00017966681480645162,0.00045797527443783276,0.0,0.0018105948,False,SLC12A7; solute carrier family 12 member
hsa:23355,0.0,0.0,2.266938687935484e-05,5.588782937578491e-05,0.0,0.00019076756,False,VPS8; VPS8 subunit of CORVET
hsa:26232,0.0,0.0,7.29402535483871e-07,1.786844065667145e-06,0.0,8.098258e-06,False,FBXO2; F-box protein
hsa:3310,8.274727e-07,0.0005849462281335483,0.00020507932380870963,0.0003816923744582088,0.0,0.0016376748,False,HSPA6; heat shock protein family A (Hsp70) member
hsa:7403,7.314812e-08,5.1708916667655824e-05,5.0550980920645155e-06,1.7697841362547216e-05,0.0,9.7211436e-05,False,KDM6A; lysine demethylase
hsa:8726,0.0,0.0,1.1398111658193547e-05,3.6246372374763726e-05,0.0,0.00017249238,False,EED; embryonic ectoderm
hsa:26532,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR10H3; olfactory receptor family 10 subfamily H member
hsa:1028,3.4808298e-10,2.46062288494213e-07,1.1567593033219354e-06,1.835373397440635e-06,0.0,6.3628613e-06,False,CDKN1C; cyclin dependent kinase inhibitor
hsa:7484,9.183132e-06,0.006491620117319264,4.678285357741935e-05,0.00012022171897806837,0.0,0.0005296048,False,WNT9B; Wnt family member
hsa:6429,0.0,0.0,1.1338679445161289e-07,1.8089137675863703e-07,0.0,7.362507e-07,False,SRSF4; serine and arginine rich splicing factor
hsa:196335,0.0,0.0,9.322679290322582e-08,5.169333553880805e-07,-0.0,2.8785237e-06,False,OR56B4; olfactory receptor family 56 subfamily B member
hsa:26863,5.036985e-08,3.5606798591847935e-05,2.7276989874193546e-07,6.343507900687205e-07,0.0,3.0491103e-06,False,RNVU1-18; RNA
hsa:9755,0.0,0.0,4.902849582258064e-07,1.0676281709359315e-06,0.0,4.159316e-06,False,TBKBP1; TBK1 binding protein
hsa:1780,0.0,0.0,0.00031580417704787087,0.0006909172487377745,0.0,0.0030530442,False,DYNC1I1; dynein cytoplasmic 1 intermediate chain
hsa:163049,0.0,0.0,1.379170141935484e-08,2.6673447860004592e-08,0.0,1.05466505e-07,False,ZNF791; zinc finger protein
hsa:4763,1.0546868e-06,0.0007455654615822879,5.443856537419354e-06,1.1683218489237204e-05,0.0,5.5766308e-05,False,NF1; neurofibromin
hsa:5394,1.971918e-07,0.00013939625999608813,2.100312772258065e-06,4.514180946879928e-06,0.0,2.1520087e-05,False,EXOSC10; exosome component
hsa:1289,4.509072e-06,0.003187494474177329,6.455298102225806e-05,0.00011692219873194139,0.0,0.0005149903,False,COL5A1; collagen type V alpha 1
hsa:15,5.511241e-07,0.00038959347363181463,5.534659445806452e-06,9.182097459927111e-06,0.0,4.324059e-05,False,AANAT; aralkylamine
hsa:79957,3.9666898e-07,0.0002804080710681838,2.0142015071516127e-06,4.038763902334615e-06,0.0,2.0624318e-05,False,PAQR6; progestin and adipoQ receptor family member
hsa:217,0.0002770529,0.19585062908838097,0.0007583274353225807,0.001167616063233305,0.0,0.0045619356,False,ALDH2; aldehyde dehydrogenase 2 family
hsa:1351,0.0,0.0,2.4090024412258064e-05,8.496583754588608e-05,0.0,0.00042618773,False,COX8A; cytochrome c oxidase subunit
hsa:130,0.0,0.0,0.0,0.0,0.0,0.0,False,ADH6; alcohol dehydrogenase 6 (class
hsa:916,0.0,0.0,7.718387311935483e-05,0.00018694253750996964,0.0,0.00067330484,False,CD3E; CD3 epsilon subunit of T-cell receptor
hsa:6146,6.7784063e-09,4.791702732841436e-06,1.0794038964935487e-06,2.3579588503392817e-06,0.0,9.927486e-06,False,RPL22; ribosomal protein
hsa:27072,0.0,0.0,1.1075979721935483e-06,3.028111824957692e-06,0.0,1.2951908e-05,False,VPS41; VPS41 subunit of HOPS
hsa:7252,0.0,0.0,0.0,0.0,0.0,0.0,False,TSHB; thyroid stimulating hormone subunit
hsa:10971,0.0,0.0,1.6120922401612903e-05,3.608767283812045e-05,0.0,0.00013648612,False,YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:284,0.0,0.0,1.1984209970967744e-05,3.631835150838472e-05,0.0,0.00013567955,False,ANGPT1; angiopoietin
hsa:6891,0.0007011949,0.4956795697809494,0.0018103345048064523,0.0026431766072889822,0.0,0.010095178,True,TAP2; transporter 2
hsa:5440,0.0,0.0,7.913477432258066e-06,2.5001774418878257e-05,0.0,0.00011022358,False,POLR2K; RNA polymerase II
hsa:123263,0.0,0.0,9.341785477419355e-06,1.8144758750216273e-05,0.0,6.353685e-05,False,MTFMT; mitochondrial methionyl-tRNA
hsa:80315,1.6904102e-06,0.0011949627709632923,2.361602767419355e-05,6.838447505666466e-05,0.0,0.00033037516,False,CPEB4; cytoplasmic polyadenylation element binding protein
hsa:407025,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B2; microRNA
hsa:5702,0.0,0.0,1.2112301077419356e-06,2.0381119334243144e-06,0.0,8.316195e-06,False,PSMC3; proteasome 26S subunit
hsa:1778,0.0,0.0,0.00010418889021580644,0.0002984479302421168,0.0,0.0011723978,False,DYNC1H1; dynein cytoplasmic 1 heavy chain
hsa:54677,0.0,0.0,4.0952729447741934e-07,1.1968580860005594e-06,0.0,4.797756e-06,False,CROT; carnitine
hsa:124944,0.0,0.0,1.1815316594516126e-05,2.7817759908610732e-05,0.0,0.00012857479,False,C17orf49; chromosome 17 open reading frame
hsa:190,1.7776154e-07,0.00012566087356140072,8.273870411896772e-06,1.8549764835129883e-05,0.0,8.829715e-05,False,NR0B1; nuclear receptor subfamily 0 group B member
hsa:55552,1.7487707e-09,1.2362182158220629e-06,1.6795839332258066e-08,4.2313010960874976e-08,0.0,2.2243404e-07,False,ZNF823; zinc finger protein
hsa:283899,0.0,0.0,1.2938561041935483e-06,2.46343635815122e-06,0.0,9.24235e-06,False,INO80E; INO80 complex subunit
hsa:9635,1.377002e-09,9.734123265122249e-07,9.728110774322581e-07,2.4822321738698205e-06,0.0,1.1536914e-05,False,CLCA2; chloride channel accessory
hsa:10273,0.0,0.0,5.464017572903225e-07,1.0283020402002078e-06,0.0,3.799196e-06,False,STUB1; STIP1 homology and U-box containing protein
hsa:27165,0.0,0.0,2.849786785387097e-05,7.884909618477406e-05,0.0,0.0004065011,False,GLS2; glutaminase
hsa:30832,0.0,0.0,3.775501425161291e-08,1.026882711338952e-07,0.0,4.1095944e-07,False,ZNF354C; zinc finger protein
hsa:51701,0.0,0.0,1.516460723548387e-06,3.4271694563631236e-06,0.0,1.6653928e-05,False,NLK; nemo like
hsa:3801,0.0,0.0,1.6273098545806451e-06,5.236885707002429e-06,0.0,2.3535125e-05,False,KIFC3; kinesin family member
hsa:6597,1.1281952e-06,0.000797529062697022,1.4523890662903227e-05,2.5777729662159677e-05,0.0,8.39726e-05,False,SMARCA4; SWI/SNF related
hsa:125115,0.0,0.0,5.363193258709677e-07,1.3474240519096125e-06,0.0,6.4482956e-06,False,KRT40; keratin
hsa:9631,1.3069306e-08,9.238783646908414e-06,9.471025880645161e-08,1.5344398327186835e-07,0.0,5.4418973e-07,False,NUP155; nucleoporin
hsa:2875,1.4509413e-06,0.0010256805338450287,9.86257766612903e-06,1.911750906428246e-05,0.0,8.293388e-05,False,GPT; glutamic--pyruvic
hsa:133022,7.144966e-09,5.05082634368777e-06,6.045383342645163e-07,1.2930522991524266e-06,0.0,5.527729e-06,False,TRAM1L1; translocation associated membrane protein 1 like
hsa:5546,0.0,0.0,1.4343920693548387e-06,3.0627165820494194e-06,0.0,1.18071075e-05,False,PRCC; proline rich mitotic checkpoint control
hsa:284098,0.0,0.0,1.871030176451613e-05,5.7747495915809165e-05,0.0,0.0002715417,False,PIGW; phosphatidylinositol glycan anchor biosynthesis class
hsa:5294,0.0,0.0,4.139288681806452e-05,0.00010302728149958654,0.0,0.00043085494,False,PIK3CG; phosphatidylinositol-4
hsa:3446,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA10; interferon alpha
hsa:26263,1.2425407e-08,8.783606948814369e-06,1.8719134403225806e-07,2.736139341410348e-07,0.0,9.619796e-07,False,FBXO22; F-box protein
hsa:8842,0.0,0.0,4.4946725939016127e-08,9.519048862360009e-08,0.0,4.5379377e-07,False,PROM1; prominin
hsa:338707,3.728044e-07,0.00026353803286995525,4.960669248387098e-06,1.3706144746084172e-05,0.0,5.958635e-05,False,B4GALNT4; beta-1
hsa:641,0.0,0.0,3.0934078950967745e-05,7.310408131864677e-05,0.0,0.00026879055,False,BLM; BLM RecQ like
hsa:6434,1.4996152e-07,0.00010600884535426205,8.432626266129032e-06,1.9088657257754133e-05,0.0,9.55924e-05,False,TRA2B; transformer 2 beta
hsa:90987,0.0,0.0,1.3282904441935483e-08,4.703340506274051e-08,0.0,2.5883287e-07,False,ZNF251; zinc finger protein
hsa:79094,0.0,0.0,1.3245797612903228e-06,2.873176612387008e-06,0.0,1.27226285e-05,False,CHAC1; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:27128,0.0,0.0,6.320829132258064e-06,1.962570175099019e-05,0.0,9.083969e-05,False,CYTH4; cytohesin
hsa:7311,0.0,0.0,9.36139505483871e-06,2.3105564109202302e-05,0.0,0.00010123845,False,UBA52; ubiquitin A-52 residue ribosomal protein fusion product
hsa:100526842,3.9855186e-09,2.8173909208437935e-06,3.8562881040645164e-07,7.728167026980588e-07,0.0,3.1016655e-06,False,RPL17-C18orf32; RPL17-C18orf32
hsa:826,0.0,0.0,4.22139809032258e-08,9.938403137571342e-08,0.0,4.3853763e-07,False,CAPNS1; calpain small subunit
hsa:6227,6.472039e-07,0.00045751295497521813,1.6255867394516126e-06,2.4196327495978466e-06,0.0,8.697683e-06,False,RPS21; ribosomal protein
hsa:51367,5.9310366e-08,4.1926911765089344e-05,3.3024704765304842e-06,7.179043690156186e-06,0.0,2.8798557e-05,False,POP5; POP5 homolog
hsa:4913,5.9288762e-08,4.1911639746674e-05,4.410181876509677e-05,0.00012508701244394718,0.0,0.00046101608,False,NTHL1; nth like DNA glycosylase
hsa:7617,0.0,0.0,2.223130570322581e-08,5.77252791909006e-08,0.0,2.9860655e-07,False,ZNF66; zinc finger protein
hsa:160065,0.0,0.0,6.055360887096775e-09,1.950294783026417e-08,0.0,8.895334e-08,False,PATE1; prostate and testis expressed
hsa:10818,1.64057e-07,0.00011597303856538775,4.127590511709677e-06,8.726741079536842e-06,0.0,3.494762e-05,False,FRS2; fibroblast growth factor receptor substrate
hsa:51690,1.1079571e-06,0.0007832226085268851,9.009200922258064e-06,2.1586775667683173e-05,0.0,9.5886004e-05,False,LSM7; LSM7 homolog
hsa:1282,8.875108e-05,0.06273875801434753,0.0003796412540645162,0.0006285607309446809,0.0,0.0024683122,False,COL4A1; collagen type IV alpha 1
hsa:29994,3.074586e-08,2.1734463067750922e-05,3.4273927231290327e-06,7.595954764302702e-06,0.0,2.8377059e-05,False,BAZ2B; bromodomain adjacent to zinc finger domain
hsa:119694,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR51F2; olfactory receptor family 51 subfamily F member
hsa:1673,0.0,0.0,0.0,0.0,0.0,0.0,False,DEFB4A; defensin beta
hsa:6726,0.0,0.0,1.521055672903226e-05,3.16110548283027e-05,0.0,0.00013055957,False,SRP9; signal recognition particle
hsa:646625,-0.0,0.0,2.0052427419354837e-11,1.1164719077371944e-10,0.0,6.2162525e-10,False,URAD; ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-)
hsa:406892,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR100; microRNA
hsa:64098,0.0,0.0,4.6051947251290316e-07,9.844524527367488e-07,0.0,3.6245315e-06,False,PARVG; parvin
hsa:1981,0.0,0.0,1.9227120061290324e-05,4.2432698090157474e-05,0.0,0.0001719515,False,EIF4G1; eukaryotic translation initiation factor 4 gamma
hsa:54579,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT1A5; UDP glucuronosyltransferase family 1 member
hsa:6234,1.6443973e-07,0.00011624359307418734,7.801409045483871e-07,1.0992930546866723e-06,0.0,3.5446974e-06,False,RPS28; ribosomal protein
hsa:10888,2.286003e-08,1.6159914790566213e-05,1.002835006287484e-05,3.468901204856548e-05,0.0,0.00019131646,False,GPR83; G protein-coupled receptor
hsa:2798,2.3757211e-08,1.679413830259638e-05,1.837346846741936e-07,3.6872044365018154e-07,0.0,1.8054044e-06,False,GNRHR; gonadotropin releasing hormone
hsa:3781,0.0,0.0,1.2391307354838709e-06,4.087054561669807e-06,0.0,2.2153916e-05,False,KCNN2; potassium calcium-activated channel subfamily N member
hsa:6357,2.392964e-05,0.01691602956640586,0.00012498026965877422,0.0002202853397382952,0.0,0.0008514056,False,CCL13; C-C motif chemokine ligand
hsa:7172,1.6251683e-07,0.00011488428164061616,4.2882354610483874e-05,0.00012387415339415445,0.0,0.0005539029,False,TPMT; thiopurine
hsa:8776,0.0,0.0,1.2440335203225805e-06,2.2370561039047932e-06,0.0,8.452878e-06,False,MTMR1; myotubularin related protein
hsa:5682,2.3969867e-06,0.001694446631352649,6.167306104193547e-06,1.0386991204541034e-05,0.0,4.8903927e-05,False,PSMA1; proteasome 20S subunit alpha
hsa:50832,0.0,0.0,1.1441477925806453e-05,2.9145916854461598e-05,0.0,0.00013649918,False,TAS2R4; taste 2 receptor member
hsa:83452,1.516639e-08,1.072122696604053e-05,1.703160847903226e-07,2.55614490643543e-07,0.0,8.03302e-07,False,RAB33B; RAB33B
hsa:8943,1.2050432e-07,8.518534503651675e-05,1.7391467919516127e-06,4.483601995450053e-06,0.0,2.0490612e-05,False,AP3D1; adaptor related protein complex 3 subunit delta
hsa:8874,1.0388498e-07,7.343701757257865e-05,1.7121558208387097e-06,4.5764374948768025e-06,0.0,1.9410332e-05,False,ARHGEF7; Rho guanine nucleotide exchange factor
hsa:8451,0.0,0.0,1.5500169354838709e-06,3.2401923838137614e-06,0.0,1.4645427e-05,False,CUL4A; cullin
hsa:6534,0.0,0.0,4.910716917741936e-09,9.468593733539024e-09,0.0,3.7804632e-08,False,SLC6A7; solute carrier family 6 member
hsa:65018,7.498716e-07,0.0005300894688180877,5.589285219967744e-06,1.4114884321686842e-05,0.0,5.5291606e-05,False,PINK1; PTEN induced kinase
hsa:3920,0.0,0.0,3.0101446209677416e-07,5.966819929281244e-07,0.0,2.533072e-06,False,LAMP2; lysosomal associated membrane protein
hsa:3779,2.6673895e-05,0.01885596258327352,0.00013246129367258064,0.0002332898433152832,7.1365315e-07,0.0008903937,False,KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:23286,2.9433473e-05,0.020806727535809505,0.00020229242606451615,0.0003276957301267099,0.0,0.0013510777,False,WWC1; WW and C2 domain containing
hsa:8608,0.0,0.0,5.520738239354839e-06,2.1141529714490445e-05,0.0,9.545136e-05,False,RDH16; retinol dehydrogenase
hsa:27434,0.0,0.0,6.798988663548388e-05,0.0001317092973141212,0.0,0.00047791252,False,POLM; DNA polymerase
hsa:1408,1.07317555e-05,0.007586352880253888,0.0006601932876693548,0.0015350331739865735,0.0,0.006063734,False,CRY2; cryptochrome circadian regulator
hsa:5993,0.0,0.0,2.2768049651612902e-05,9.920473677564223e-05,0.0,0.00054743036,False,RFX5; regulatory factor
hsa:100529239,2.8506467e-08,2.0151420523074015e-05,2.1683378864516133e-07,4.5405243413380035e-07,0.0,1.702247e-06,False,RPS10-NUDT3; RPS10-NUDT3
hsa:1374,0.0,0.0,6.092846653225806e-05,0.00013702607857922006,0.0,0.0007034293,False,CPT1A; carnitine palmitoyltransferase
hsa:51268,0.0,0.0,7.688699787096774e-06,1.837793072185904e-05,0.0,7.697094e-05,False,PIPOX; pipecolic acid and sarcosine
hsa:406938,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR146A; microRNA
hsa:9901,0.0,0.0,5.169355982903226e-07,1.0616519341825437e-06,0.0,3.665744e-06,False,SRGAP3; SLIT-ROBO Rho GTPase activating protein
hsa:2997,4.991955e-06,0.0035288478378349003,9.619325038709678e-05,0.00016486449450124128,0.0,0.00058343436,False,GYS1; glycogen synthase
hsa:57522,5.917163e-08,4.182883831818731e-05,1.0780536414000003e-06,3.2787712182783205e-06,0.0,1.7707784e-05,False,SRGAP1; SLIT-ROBO Rho GTPase activating protein
hsa:2272,0.0,0.0,1.0168778077419355e-05,2.3590559380200268e-05,0.0,9.379205e-05,False,FHIT; fragile histidine triad diadenosine
hsa:79898,0.0,0.0,4.9734119967741934e-08,8.249711008765754e-08,0.0,3.327922e-07,False,ZNF613; zinc finger protein
hsa:6231,0.0,0.0,1.8958529812903224e-07,3.461028021554805e-07,0.0,1.5890215e-06,False,RPS26; ribosomal protein
hsa:219956,0.0,0.0,3.9082691451612903e-07,2.151968019964865e-06,0.0,1.19852875e-05,False,OR9Q1; olfactory receptor family 9 subfamily Q member
hsa:6652,0.0,0.0,4.1613099122580637e-05,0.00017317513218697824,0.0,0.00096124894,False,SORD; sorbitol
hsa:64080,8.643568e-07,0.0006110198559077342,9.253477225806452e-06,2.0461007985413213e-05,0.0,9.3911076e-05,False,RBKS;
hsa:51373,2.3311606e-09,1.647913701737277e-06,3.965655581290322e-08,6.035281327612433e-08,0.0,2.2187962e-07,False,MRPS17; mitochondrial ribosomal protein
hsa:66008,2.9958252e-07,0.00021177697474338827,1.1370798818709677e-05,3.073821049663422e-05,0.0,0.00010996321,False,TRAK2; trafficking kinesin protein
hsa:3486,7.3535953e-06,0.0051983078522778925,0.00029302185395483867,0.0007129499349980633,0.0,0.0031782938,False,IGFBP3; insulin like growth factor binding protein
hsa:120103,0.0,0.0,1.4539736958064515e-06,3.204171134303502e-06,0.0,1.4760072e-05,False,SLC36A4; solute carrier family 36 member
hsa:55808,4.4990924e-07,0.00031804398252707473,6.895367220725807e-05,0.00016753021293728013,0.0,0.00082696084,False,ST6GALNAC1; ST6 N-acetylgalactosaminide alpha-2
hsa:686,0.0010529797,0.7443587006751948,0.0012574625280645166,0.0012102641372112712,0.0,0.0038996493,True,BTD;
hsa:10734,0.0,0.0,1.0205331773225808e-07,2.2838399285393874e-07,0.0,1.1070758e-06,False,STAG3; STAG3 cohesin complex
hsa:7365,0.0,0.0,0.0,0.0,0.0,0.0,False,UGT2B10; UDP glucuronosyltransferase family 2 member
hsa:5623,9.586753e-09,6.776942619856799e-06,3.283469361290322e-08,5.33474485276429e-08,0.0,2.0236394e-07,False,PSPN;
hsa:6419,0.0,0.0,2.685754073387097e-06,6.3994313529967065e-06,0.0,2.5462085e-05,False,SETMAR; SET domain and mariner transposase fusion
hsa:4879,0.0,0.0,6.322709851612904e-06,1.7897087677051686e-05,0.0,7.5890785e-05,False,NPPB; natriuretic peptide
hsa:1669,0.0,0.0,4.262805322580646e-08,1.8514721765232522e-07,0.0,1.0161976e-06,False,DEFA4; defensin alpha
hsa:64121,0.0,0.0,5.228504930322582e-07,1.0008256477423212e-06,0.0,3.584851e-06,False,RRAGC; Ras related GTP binding
hsa:443,0.00018939993,0.1338881326988287,0.0006593961138709678,0.0011877013202303212,0.0,0.005087214,False,ASPA;
hsa:3363,0.0,0.0,1.6708352331290323e-05,4.81755832960682e-05,0.0,0.00019216302,False,HTR7; 5-hydroxytryptamine receptor
hsa:5261,9.173127e-08,6.484547512975368e-05,4.406214241935484e-06,9.739358731875334e-06,0.0,3.7566693e-05,False,PHKG2; phosphorylase kinase catalytic subunit gamma
hsa:9623,0.0,0.0,8.191479838709678e-10,4.502745166536937e-09,0.0,2.5078744e-08,False,TCL1B; TCL1 family AKT coactivator
hsa:1208,0.0,0.0,0.0,0.0,0.0,0.0,False,CLPS;
hsa:59283,0.0,0.0,4.541854716129031e-06,1.65513894066512e-05,0.0,9.157282e-05,False,CACNG8; calcium voltage-gated channel auxiliary subunit gamma
hsa:55201,0.0,0.0,2.5090014223870968e-05,8.015375611627308e-05,0.0,0.00035340435,False,MAP1S; microtubule associated protein
hsa:1493,8.677321e-07,0.0006134058790403635,2.796929823348387e-05,7.824559681352993e-05,0.0,0.00030605297,False,CTLA4; cytotoxic T-lymphocyte associated protein
hsa:5020,1.1285908e-07,7.978087150986659e-05,6.496844663870968e-06,1.8709459265914903e-05,0.0,0.000100514706,False,OXT; oxytocin/neurophysin I
hsa:26341,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5H1; olfactory receptor family 5 subfamily H member
hsa:353355,6.0100454e-09,4.248543048781408e-06,1.472804448387097e-08,2.0143847827575468e-08,0.0,8.090272e-08,False,ZNF233; zinc finger protein
hsa:406907,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR124-1; microRNA
hsa:3710,0.003923217,2.773349484882601,0.004074873567419355,0.003174937036581986,0.00037056513,0.010697976,True,ITPR3; inositol 1
hsa:23632,6.208079e-07,0.00043885343830740167,4.119435904645162e-05,0.00012470812752706973,0.0,0.00060963084,False,CA14; carbonic anhydrase
hsa:6199,0.0,0.0,0.0001511021829354839,0.0002568183704051548,0.0,0.0010775614,False,RPS6KB2; ribosomal protein S6 kinase
hsa:7430,0.0,0.0,4.216274677419355e-05,0.00013825575452899725,0.0,0.00074745936,False,EZR;
hsa:6608,7.8998666e-05,0.055844708477128,0.00018036640557419356,0.00020341180899132396,0.0,0.0006908609,False,SMO; smoothened
hsa:5179,2.1578267e-06,0.0015253827578007853,1.6658939458387093e-05,3.7171019667050954e-05,0.0,0.00017755078,False,PENK;
hsa:57826,4.3385433e-09,3.066946545703656e-06,4.507210275525807e-06,1.1984074184016427e-05,0.0,4.715275e-05,False,RAP2C; RAP2C
hsa:51295,9.1133494e-08,6.442290310233964e-05,6.140251888387096e-07,1.110254286984323e-06,0.0,4.9296254e-06,False,ECSIT; ECSIT signaling
hsa:3654,0.0,0.0,1.123848812903226e-05,2.943628018853866e-05,0.0,0.00013897427,False,IRAK1; interleukin 1 receptor associated kinase
hsa:81061,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR11H1; olfactory receptor family 11 subfamily H member
hsa:1612,0.0,0.0,7.088676796935485e-06,1.5738690954285186e-05,0.0,5.810411e-05,False,DAPK1; death associated protein kinase
hsa:22845,0.0,0.0,5.706700135129032e-05,0.00011707178783357991,0.0,0.00046234392,False,DOLK; dolichol
hsa:343173,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR2T3; olfactory receptor family 2 subfamily T member
hsa:3797,0.0,0.0,2.2824354487096777e-07,3.9346312291585684e-07,0.0,1.3271455e-06,False,KIF3C; kinesin family member
hsa:3663,0.0,0.0,2.2642605903225805e-07,4.602237216261466e-07,0.0,2.0103473e-06,False,IRF5; interferon regulatory factor
hsa:80310,1.0044825e-05,0.007100756914411278,7.946793315161291e-05,0.0001834676991616879,0.0,0.0009054029,False,PDGFD; platelet derived growth factor
hsa:4176,1.6761757e-07,0.00011849003035436819,1.0236942018387095e-05,2.4869965934176142e-05,0.0,9.0926784e-05,False,MCM7; minichromosome maintenance complex component
hsa:54583,4.03493e-06,0.0028523201844397983,1.5415737548387097e-05,2.6934757686837496e-05,0.0,0.00010301907,False,EGLN1; egl-9 family hypoxia inducible factor
hsa:55193,0.0,0.0,7.16790161e-07,1.6572593921878601e-06,0.0,6.5097674e-06,False,PBRM1; polybromo
hsa:165679,0.0,0.0,2.5141940377419353e-07,5.785986500933638e-07,0.0,2.6312593e-06,False,SPTSSB; serine palmitoyltransferase small subunit
hsa:4542,4.0646082e-08,2.8732999112003222e-05,8.56676314464516e-07,2.704459783408785e-06,0.0,1.4155616e-05,False,MYO1F; myosin
hsa:155066,0.0,0.0,6.748347302258064e-05,9.887000939864296e-05,0.0,0.00032423812,False,ATP6V0E2; ATPase H+ transporting V0 subunit
hsa:54852,0.0,0.0,4.062340072525806e-08,1.1721684858902958e-07,0.0,5.820302e-07,False,PAQR5; progestin and adipoQ receptor family member
hsa:1572,2.3770137e-07,0.00016803275782231484,6.7257973923225805e-06,1.4455946149723977e-05,0.0,6.0034654e-05,False,CYP2F1; cytochrome P450 family 2 subfamily F member
hsa:27297,5.0792956e-08,3.590589517690829e-05,4.548596494064516e-06,7.912175563895552e-06,0.0,2.8148454e-05,False,CRCP; CGRP receptor
hsa:390152,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8H3; olfactory receptor family 8 subfamily H member
hsa:33,0.0,0.0,6.12733398483871e-08,1.5770773698942071e-07,0.0,6.5683514e-07,False,ACADL; acyl-CoA dehydrogenase long
hsa:8491,1.5957794e-07,0.00011280675978352116,6.654528966451613e-07,9.074228714345692e-07,0.0,3.318009e-06,False,MAP4K3; mitogen-activated protein kinase kinase kinase kinase
hsa:25851,3.932536e-08,2.779937151037601e-05,5.486194290096775e-06,1.7486442377569694e-05,0.0,7.6512995e-05,False,TECPR1; tectonin beta-propeller repeat containing
hsa:391195,4.255283e-07,0.00030080892584018903,1.9505517927741934e-05,6.094457098069838e-05,0.0,0.00033118573,False,OR2T33; olfactory receptor family 2 subfamily T member
hsa:26224,0.0,0.0,0.00012071881808096775,0.0003343090332770751,0.0,0.0016587924,False,FBXL3; F-box and leucine rich repeat protein
hsa:1460,2.2276705e-05,0.01574755827593316,0.00010660519536774195,0.00024949969358238925,0.0,0.0010852247,False,CSNK2B; casein kinase 2
hsa:4671,0.0,0.0,3.603670084193548e-05,0.00011282020242358628,0.0,0.00047264853,False,NAIP; NLR family apoptosis inhibitory
hsa:10097,1.5492601e-06,0.0010951827799186653,1.917921087451613e-05,4.8246714019458046e-05,0.0,0.00022275666,False,ACTR2; actin related protein
hsa:1182,0.0,0.0,9.808771232258066e-06,2.882441610901271e-05,0.0,0.00014608107,False,CLCN3; chloride voltage-gated channel
hsa:406985,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR200C; microRNA
hsa:9538,1.2499629e-09,8.836074998750674e-07,0.00018705035519295805,0.0004124879814445089,0.0,0.0015881234,False,EI24; EI24 autophagy associated transmembrane
hsa:5986,0.0,0.0,0.0001256043479096774,0.0003506952267415254,0.0,0.0015659125,False,RFNG; RFNG O-fucosylpeptide
hsa:84914,7.931647e-09,5.606936634328569e-06,2.4719487890322575e-08,3.9219080316771556e-08,0.0,1.7101458e-07,False,ZNF587; zinc finger protein
hsa:79731,0.0,0.0,2.337651657290322e-06,5.022384007977252e-06,0.0,2.1166568e-05,False,NARS2; asparaginyl-tRNA synthetase 2
hsa:63036,0.0,0.0,2.183889937096774e-06,6.305610233381563e-06,0.0,2.3234186e-05,False,CELA2A; chymotrypsin like elastase
hsa:55680,9.696738e-09,6.854691784151003e-06,3.218084377580645e-07,5.163965484265097e-07,0.0,1.8868034e-06,False,RUFY2; RUN and FYVE domain containing
hsa:3313,0.0,0.0,1.1803834221935482e-05,3.892811242584957e-05,0.0,0.00018044033,False,HSPA9; heat shock protein family A (Hsp70) member
hsa:23389,4.8237954e-08,3.409974642689675e-05,6.342986563516129e-06,2.7227126290028736e-05,0.0,0.00015055868,False,MED13L; mediator complex subunit
hsa:147837,1.1139342e-08,7.87447862242418e-06,3.821920216451612e-08,5.9562259307250244e-08,0.0,2.0522116e-07,False,ZNF563; zinc finger protein
hsa:150572,0.0,0.0,1.75100370846129e-07,4.3064686775938433e-07,0.0,1.789925e-06,False,SMYD1; SET and MYND domain containing
hsa:1606,2.1261712e-06,0.0015030052638669291,5.674413309354839e-05,9.067266303409563e-05,0.0,0.00027898306,False,DGKA; diacylglycerol kinase
hsa:55769,0.0,0.0,5.281264522580645e-08,1.411277181486144e-07,0.0,6.2465864e-07,False,ZNF83; zinc finger protein
hsa:23438,0.0,0.0,3.0375232509677423e-06,1.0555141363964827e-05,0.0,5.603018e-05,False,HARS2; histidyl-tRNA synthetase 2
hsa:55114,8.624678e-08,6.096845086208155e-05,1.4902788392483871e-05,4.140797619074312e-05,0.0,0.0001640679,False,ARHGAP17; Rho GTPase activating protein
hsa:10599,0.0,0.0,0.0,0.0,-0.0,-0.0,False,SLCO1B1; solute carrier organic anion transporter family member
hsa:9184,2.3081817e-08,1.6316697569138914e-05,8.602840627419355e-07,2.170486005518646e-06,0.0,7.880952e-06,False,BUB3; BUB3 mitotic checkpoint
hsa:9896,0.0,0.0,1.5126656376774196e-06,4.380454369620455e-06,0.0,2.3082039e-05,False,FIG4; FIG4 phosphoinositide
hsa:2626,0.0,0.0,3.9958704501612896e-07,1.48472616103101e-06,0.0,8.014936e-06,False,GATA4; GATA binding protein
hsa:6627,7.34225e-08,5.190287780507496e-05,4.6385350516774203e-07,7.033600337578797e-07,0.0,2.6711339e-06,False,SNRPA1; small nuclear ribonucleoprotein polypeptide
hsa:27087,4.887194e-06,0.003454791555608914,3.896087783548386e-05,9.183563033925554e-05,0.0,0.0003673418,False,B3GAT1; beta-1
hsa:56955,0.0,0.0,4.689115327419355e-08,1.3320993755140256e-07,0.0,4.8562305e-07,False,MEPE; matrix extracellular
hsa:2947,3.92924e-05,0.02777607185628557,0.0003284483735806452,0.0005845262744974667,0.0,0.00286161,False,GSTM3; glutathione S-transferase mu
hsa:22977,0.0,0.0,8.193204831032257e-05,0.00023488993013447287,0.0,0.0008820333,False,AKR7A3; aldo-keto reductase family 7 member
hsa:29093,1.942635e-07,0.00013732622428392087,6.833632165161289e-07,1.117007163184392e-06,0.0,4.192075e-06,False,MRPL22; mitochondrial ribosomal protein
hsa:3118,5.0706858e-05,0.03584503189966683,0.00025498207500967746,0.0003980362664791364,0.0,0.0016603118,False,HLA-DQA2; major histocompatibility complex
hsa:6472,3.15437e-05,0.02229846173339158,0.0001670714443548387,0.00028044217340685116,0.0,0.0012791904,False,SHMT2; serine hydroxymethyltransferase
hsa:5726,-0.0,0.0,2.3326819354838708e-08,1.2987823350204463e-07,0.0,7.231314e-07,False,TAS2R38; taste 2 receptor member
hsa:26271,1.9061409e-06,0.0013474643087875735,3.109132729032258e-06,4.20790390116278e-06,0.0,1.8947816e-05,False,FBXO5; F-box protein
hsa:7122,0.0,0.0,1.0120431951129033e-05,3.5896250903751805e-05,0.0,0.00019662104,False,CLDN5; claudin
hsa:6359,0.0,0.0,4.73773564516129e-10,2.637859568563853e-09,0.0,1.46869805e-08,False,CCL15; C-C motif chemokine ligand
hsa:5567,0.0,0.0,5.2321789032258065e-05,0.000193314363639535,0.0,0.001034573,False,PRKACB; protein kinase cAMP-activated catalytic subunit
hsa:2693,0.0,0.0,4.441901516129032e-07,2.3930265470106434e-06,0.0,1.3331215e-05,False,GHSR; growth hormone secretagogue
hsa:145482,6.494043e-07,0.00045906843309598884,4.9218702677419366e-06,6.691401807419244e-06,0.0,2.0221954e-05,False,PTGR2; prostaglandin reductase
hsa:480,0.0,0.0,8.59847935483871e-09,4.7874306926400617e-08,0.0,2.6655286e-07,False,ATP1A4; ATPase Na+/K+ transporting subunit alpha
hsa:891,0.0,0.0,4.437440847096773e-06,8.361007881766859e-06,0.0,3.5443925e-05,False,CCNB1; cyclin
hsa:26659,-0.0,0.0,2.5568842967741943e-06,8.93331692379281e-06,0.0,4.8381135e-05,False,OR7A5; olfactory receptor family 7 subfamily A member
hsa:79852,0.0,0.0,4.1075819016129025e-08,7.286352702880119e-08,0.0,2.6726542e-07,False,EPHX3; epoxide hydrolase
hsa:9076,8.277077e-06,0.005851123512740596,6.220411676152259e-05,0.00010763840981545714,0.0,0.00034322718,False,CLDN1; claudin
hsa:55589,0.0,0.0,2.4250289136774195e-05,0.00010479082113743762,0.0,0.00057760713,False,BMP2K; BMP2 inducible
hsa:27349,1.1430471e-06,0.0008080279744866397,6.27224213148387e-05,0.00012408689617035885,0.0,0.0006150207,False,MCAT; malonyl-CoA-acyl carrier protein
hsa:122809,0.0,0.0,2.5567938225806455e-05,5.033297739410738e-05,0.0,0.00018877628,False,SOCS4; suppressor of cytokine signaling
hsa:64806,-0.0,0.0,0.0,0.0,0.0,0.0,False,IL25; interleukin
hsa:8867,4.5362899e-07,0.00032067349976927474,4.437823943548387e-06,8.776934551506713e-06,0.0,3.1498093e-05,False,SYNJ1; synaptojanin
hsa:8744,4.207539e-06,0.002974338691505837,2.2311972910645165e-05,3.6490118488227643e-05,0.0,0.00013709332,False,TNFSF9; TNF superfamily member
hsa:940,0.0,0.0,1.3904893877419357e-05,5.839953998669114e-05,0.0,0.00032556202,False,CD28; CD28
hsa:993,4.9525227e-08,3.500972869691987e-05,2.785935035387096e-06,6.798815365590154e-06,0.0,2.9695895e-05,False,CDC25A; cell division cycle
hsa:93134,1.5961932e-09,1.128360115943908e-06,5.369293021612904e-08,1.0420753901877106e-07,0.0,3.8301744e-07,False,ZNF561; zinc finger protein
hsa:2005,9.1284114e-08,6.452937743180268e-05,4.543862810903226e-06,1.0633382314857301e-05,0.0,4.1374155e-05,False,ELK4; ETS transcription factor
hsa:8877,7.360304e-05,0.0520305027914065,0.00021759136012903228,0.00031273604020290105,0.0,0.001067229,False,SPHK1; sphingosine kinase
hsa:6318,0.0,0.0,7.676196027419355e-07,3.233030302786282e-06,0.0,1.772966e-05,False,SERPINB4; serpin family B member
hsa:10317,0.0,0.0,6.596534990322581e-07,2.28241251536722e-06,0.0,1.2354334e-05,False,B3GALT5; beta-1
hsa:80270,1.6888838e-05,0.011938837481476477,0.0002016848417290323,0.0004055999161464165,0.0,0.0015009589,False,HSD3B7; hydroxy-delta-5-steroid dehydrogenase
hsa:440193,0.0,0.0,1.627942064516129e-08,6.539265484543561e-08,0.0,3.200056e-07,False,CCDC88C; coiled-coil domain containing
hsa:6372,3.9864273e-05,0.02818033287217337,0.0001824091858064516,0.00021540084174265136,0.0,0.0008721534,False,CXCL6; C-X-C motif chemokine ligand
hsa:10161,0.0,0.0,1.4378088445161292e-05,3.148276244850023e-05,0.0,0.00010600604,False,LPAR6; lysophosphatidic acid receptor
hsa:6147,0.0,0.0,3.47889231e-07,5.878228455109765e-07,0.0,1.8404204e-06,False,RPL23A; ribosomal protein
hsa:440138,4.1422763e-07,0.0002928204033283504,1.2008061426290321e-05,2.4534909194026275e-05,0.0,0.00011629605,False,ALG11; ALG11
hsa:26693,0.0,0.0,2.5091912903225807e-08,1.134696738778026e-07,0.0,6.1614037e-07,False,OR2V1; olfactory receptor family 2 subfamily V member
hsa:478,0.0,0.0,0.00013334801432258065,0.00044779534020289365,0.0,0.0021626812,False,ATP1A3; ATPase Na+/K+ transporting subunit alpha
hsa:138802,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR13C8; olfactory receptor family 13 subfamily C member
hsa:5154,8.2957136e-05,0.058642978553808234,0.00013879832090322582,0.000162568089399066,0.0,0.00055545784,False,PDGFA; platelet derived growth factor subunit
hsa:8898,4.2199807e-07,0.0002983133816090091,1.460706049351613e-05,3.519928536569094e-05,0.0,0.00015866868,False,MTMR2; myotubularin related protein
hsa:1671,0.0,0.0,0.0,0.0,0.0,0.0,False,DEFA6; defensin alpha
hsa:406900,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR106B; microRNA
hsa:55255,1.3675185e-07,9.667083741588668e-05,4.5910192658387095e-07,7.754778433630114e-07,0.0,2.9698506e-06,False,WDR41; WD repeat domain
hsa:9227,0.00015008464,0.10609587974175036,0.000309302756232258,0.00048467877159173814,0.0,0.0022783312,False,LRAT; lecithin retinol
hsa:4338,0.0,0.0,9.251273277419355e-05,0.0002715777916758399,0.0,0.0012847196,False,MOCS2; molybdenum cofactor synthesis
hsa:3783,0.00011801692,0.08342698461222796,0.0002221743564645161,0.0003082666593789517,0.0,0.0011082749,False,KCNN4; potassium calcium-activated channel subfamily N member
hsa:5167,0.00018229689,0.12886694413722213,0.0003155845858709677,0.0005960215309108918,0.0,0.0033809897,False,ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:196513,2.6283723e-07,0.00018580147272722098,4.156888700000001e-07,5.727885791415512e-07,0.0,2.1198405e-06,False,DCP1B; decapping mRNA
hsa:4783,0.0,0.0,0.0008539498295129033,0.0025498352604742436,0.0,0.0100041265,False,NFIL3; nuclear factor
hsa:29927,0.0,0.0,3.788499148387096e-05,7.60858815646031e-05,0.0,0.00031988203,False,SEC61A1; SEC61 translocon subunit alpha
hsa:81448,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6K2; olfactory receptor family 6 subfamily K member
hsa:6279,1.4654399e-06,0.0010359296953982944,1.0573404018387099e-05,2.2710352223721714e-05,0.0,8.1825616e-05,False,S100A8; S100 calcium binding protein
hsa:9794,0.0,0.0,7.90219144516129e-06,2.1852189187761923e-05,0.0,9.938617e-05,False,MAML1; mastermind like transcriptional coactivator
hsa:9114,3.6649606e-05,0.02590786232860693,0.00014660680134096776,0.0003158553018373298,0.0,0.0014736578,False,ATP6V0D1; ATPase H+ transporting V0 subunit
hsa:55757,4.208826e-08,2.9752484807902542e-05,1.074553248593548e-06,2.5696731591665685e-06,0.0,1.2490002e-05,False,UGGT2; UDP-glucose glycoprotein glucosyltransferase
hsa:22821,4.0680808e-07,0.00028757547163821935,5.729331170967743e-07,9.520345885559224e-07,0.0,4.462935e-06,False,RASA3; RAS p21 protein activator
hsa:63875,0.0,0.0,2.5466417829032258e-08,5.394621359945077e-08,0.0,1.9519707e-07,False,MRPL17; mitochondrial ribosomal protein
hsa:10766,1.6569841e-07,0.0001171333627529056,1.3584233598709679e-05,4.6363460483847434e-05,0.0,0.00019249336,False,TOB2; transducer of ERBB2
hsa:93034,0.0,0.0,8.467199641935484e-07,3.6190893840890776e-06,0.0,1.9835827e-05,False,NT5C1B; 5'-nucleotidase
hsa:3039,0.0,0.0,0.0002892072028580645,0.0009188672588067333,0.0,0.004980088,False,HBA1; hemoglobin subunit alpha
hsa:3190,8.2395366e-07,0.0005824585941914846,3.7062853396774195e-06,7.814225221011173e-06,0.0,3.786981e-05,False,HNRNPK; heterogeneous nuclear ribonucleoprotein
hsa:5586,2.2144138e-07,0.0001565384573819629,2.0165317023870967e-06,3.7030994485616636e-06,0.0,1.34565935e-05,False,PKN2; protein kinase
hsa:3172,0.0,0.0,3.8083100677419357e-07,1.4298349231660521e-06,0.0,7.768946e-06,False,HNF4A; hepatocyte nuclear factor 4
hsa:6204,0.0,0.0,7.864971145161291e-07,1.5909514983334664e-06,0.0,6.3309003e-06,False,RPS10; ribosomal protein
hsa:55869,0.0,0.0,5.4290666096774186e-06,8.972165650810236e-06,0.0,3.1269767e-05,False,HDAC8; histone deacetylase
hsa:442185,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2J1; olfactory receptor family 2 subfamily J member
hsa:91782,0.0,0.0,1.5935096554838706e-06,3.0515365859928933e-06,0.0,1.1040013e-05,False,CHMP7; charged multivesicular body protein
hsa:4831,6.084406e-05,0.04301109076025264,0.00022385673389032257,0.00034114447598952014,0.0,0.0014651429,False,NME2; NME/NM23 nucleoside diphosphate kinase
hsa:5978,0.0,0.0,1.1861065172903226e-05,3.226246054370719e-05,0.0,0.000116810355,False,REST; RE1 silencing transcription
hsa:152687,0.0,0.0,1.5336800193548388e-08,2.731190127790483e-08,0.0,8.6943245e-08,False,ZNF595; zinc finger protein
hsa:53,0.0,0.0,2.8133134290322585e-05,6.796700527846348e-05,0.0,0.00024994163,False,ACP2; acid phosphatase 2
hsa:406928,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR137; microRNA
hsa:23511,0.0,0.0,1.0320501487096774e-07,2.606862495138502e-07,0.0,9.2324933e-07,False,NUP188; nucleoporin
hsa:4729,5.0413687e-06,0.0035637787273169615,7.187687818064515e-06,7.117291966401517e-06,0.0,2.362463e-05,False,NDUFV2; NADH:ubiquinone oxidoreductase core subunit
hsa:1509,6.05164e-07,0.00042779465618891197,8.120509305290321e-05,0.00015501314991127075,0.0,0.00079208886,False,CTSD; cathepsin
hsa:10140,7.279211e-08,5.145725071338589e-05,1.662561723324194e-05,5.6208290646404874e-05,0.0,0.0002425566,False,TOB1; transducer of ERBB2
hsa:4689,0.0,0.0,1.7332882758064515e-05,3.4162065469473615e-05,0.0,0.00014265675,False,NCF4; neutrophil cytosolic factor
hsa:55272,8.454041e-09,5.976220599708451e-06,1.7876436929225806e-06,4.196357268133163e-06,0.0,1.7856255e-05,False,IMP3; IMP U3 small nucleolar ribonucleoprotein
hsa:3040,0.0,0.0,8.547703589032257e-05,0.00017992363664856705,0.0,0.000797495,False,HBA2; hemoglobin subunit alpha
hsa:3764,0.0,0.0,4.247350485806452e-07,7.905531990599238e-07,0.0,2.863481e-06,False,KCNJ8; potassium inwardly rectifying channel subfamily J member
hsa:5744,4.1219323e-07,0.00029138227176640893,5.3062044760258055e-05,0.000126514604713187,0.0,0.0005128738,False,PTHLH; parathyroid hormone like
hsa:662,0.0,0.0,4.318659356012903e-06,1.2119771261187449e-05,0.0,5.1475236e-05,False,BNIP1; BCL2 interacting protein
hsa:23288,0.0,0.0,3.4747131378387096e-05,9.923622423979661e-05,0.0,0.00039327473,False,IQCE; IQ motif containing
hsa:8449,0.0,0.0,4.6675390119354844e-07,1.0196200232474861e-06,0.0,3.62094e-06,False,DHX16; DEAH-box helicase
hsa:26219,0.0,0.0,8.886702451612902e-08,4.368929325118678e-07,0.0,2.4327885e-06,False,OR1J4; olfactory receptor family 1 subfamily J member
hsa:3795,0.0,0.0,4.4787826464516124e-05,0.0002031369749164176,0.0,0.0011201507,False,KHK;
hsa:23594,0.0,0.0,5.555637595580644e-07,1.203112278887289e-06,0.0,4.5595275e-06,False,ORC6; origin recognition complex subunit
hsa:8851,0.0,0.0,7.534776130727096e-05,0.0001850209981461813,0.0,0.00090923527,False,CDK5R1; cyclin dependent kinase 5 regulatory subunit
hsa:5096,0.0,0.0,7.167567054838709e-06,1.3232790172284622e-05,0.0,4.6834837e-05,False,PCCB; propionyl-CoA carboxylase subunit
hsa:259292,0.0,0.0,4.5778984887096775e-06,1.3795510780014892e-05,0.0,7.299873e-05,False,TAS2R46; taste 2 receptor member
hsa:9587,4.2834993e-09,3.028035557847038e-06,2.2210657393161293e-06,4.8523799585160445e-06,0.0,1.8985518e-05,False,MAD2L1BP; MAD2L1 binding
hsa:415117,0.0,0.0,3.496839381503226e-08,8.242343551759974e-08,0.0,3.0876512e-07,False,STX19; syntaxin
hsa:2260,5.001551e-06,0.0035356313172236094,5.942036246451613e-05,9.498219143229911e-05,0.0,0.00027671186,False,FGFR1; fibroblast growth factor receptor
hsa:3426,2.5737563e-05,0.018194062956034165,0.0003675055688096774,0.0009288120952055275,0.0,0.00331599,False,CFI; complement factor
hsa:2030,1.2135835e-06,0.0008578906480541413,2.18161831375e-05,6.906900512147883e-05,0.0,0.00037861406,False,SLC29A1; solute carrier family 29 member 1 (Augustine blood
hsa:2819,2.2042161e-07,0.00015581757485005126,1.3249421428387096e-06,3.854459612686699e-06,0.0,2.1188314e-05,False,GPD1; glycerol-3-phosphate dehydrogenase
hsa:10380,0.0,0.0,1.0388333809516129e-05,3.6153612832541466e-05,0.0,0.00019418578,False,BPNT1; 3'(2')
hsa:285521,0.0,0.0,8.174569067741936e-08,1.3667326306165412e-07,0.0,4.622353e-07,False,COX18; cytochrome c oxidase assembly factor
hsa:4714,0.0,0.0,4.601518156129032e-06,7.488111347905721e-06,0.0,2.5706559e-05,False,NDUFB8; NADH:ubiquinone oxidoreductase subunit
hsa:3913,0.0,0.0,0.00015101367908387095,0.00027970833641960174,0.0,0.0009402595,False,LAMB2; laminin subunit beta
hsa:2670,4.894479e-07,0.00034599413729647656,0.00015289815633810644,0.0003981080370200356,0.0,0.001526295,False,GFAP; glial fibrillary acidic
hsa:2978,0.0,0.0,3.587592952903226e-05,0.00013573609571439208,0.0,0.00064587186,False,GUCA1A; guanylate cyclase activator
hsa:2720,0.00011583659,0.08188569411456391,0.00042832676038709685,0.0007281031772630941,0.0,0.0028729923,False,GLB1; galactosidase beta
hsa:4052,0.0,0.0,0.00016734162659096775,0.0004172679975116273,0.0,0.0014478472,False,LTBP1; latent transforming growth factor beta binding protein
hsa:6632,1.3322048e-06,0.0009417448731074852,1.3177445511516126e-05,3.41703747834224e-05,0.0,0.00016185566,False,SNRPD1; small nuclear ribonucleoprotein D1
hsa:2557,0.0,0.0,0.0,0.0,0.0,0.0,False,GABRA4; gamma-aminobutyric acid type A receptor subunit
hsa:10912,1.5309119e-05,0.010822123092517299,0.000246716246483871,0.0003821969520928357,0.0,0.0013582105,False,GADD45G; growth arrest and DNA damage inducible
hsa:2254,0.0,0.0,3.787677091612903e-06,9.945891254607373e-06,0.0,4.5248726e-05,False,FGF9; fibroblast growth factor
hsa:5515,8.62568e-06,0.006097553407003016,0.00040168787825806455,0.0009621715086389048,0.0,0.0043946863,False,PPP2CA; protein phosphatase 2 catalytic subunit
hsa:2892,0.0003190488,0.22553782396752767,0.0005076725637080644,0.0006086693317894183,8.2916745e-07,0.0024443155,False,GRIA3; glutamate ionotropic receptor AMPA type subunit
hsa:957,3.8134954e-10,2.6957865198871666e-07,5.6670969813217415e-05,0.00017068598972405213,0.0,0.00068758574,False,ENTPD5; ectonucleoside triphosphate diphosphohydrolase 5
hsa:57152,0.0,0.0,2.579125889032258e-07,1.401492028015588e-06,0.0,7.808679e-06,False,SLURP1; secreted LY6/PLAUR domain containing
hsa:58500,0.0,0.0,1.2074410327419355e-07,3.166981349236165e-07,0.0,1.2808091e-06,False,ZNF250; zinc finger protein
hsa:1149,0.0,0.0,4.1144604712612914e-07,1.2858158418464945e-06,0.0,5.7037378e-06,False,CIDEA; cell death inducing DFFA like effector
hsa:5308,5.9209944e-09,4.185592275225348e-06,3.121699394416129e-06,9.81458377961348e-06,0.0,5.0760445e-05,False,PITX2; paired like homeodomain
hsa:810,0.0,0.0,5.36891006451613e-07,2.1364863542139284e-06,0.0,1.0241181e-05,False,CALML3; calmodulin like
hsa:760,0.0,0.0,9.67434866451613e-05,0.00019255191635077012,0.0,0.00076936604,False,CA2; carbonic anhydrase
hsa:113451,1.0471493e-05,0.007402371502137599,9.044035783212905e-05,0.0001539434217023542,0.0,0.00059850834,False,AZIN2; antizyme inhibitor
hsa:3280,0.0016888406,1.1938532097660728,0.0024115554667419356,0.001962116653456733,0.0,0.006258311,True,HES1; hes family bHLH transcription factor
hsa:240,0.00034969542,0.24720213358649418,0.00035732772992903226,0.0003397915387142563,0.0,0.0010129191,False,ALOX5; arachidonate
hsa:7363,0.0,0.0,4.889903387096775e-08,2.2966148120317415e-07,0.0,1.2616837e-06,False,UGT2B4; UDP glucuronosyltransferase family 2 member
hsa:441024,0.0,0.0,2.244723400290323e-05,4.8313590281782644e-05,0.0,0.00020713452,False,MTHFD2L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:1593,0.00040757493,0.28811756325652194,0.0007800013145161293,0.0009140626979223459,0.0,0.0025740364,False,CYP27A1; cytochrome P450 family 27 subfamily A member
hsa:128178,0.0,0.0,1.5543979193548384e-07,4.254331144380638e-07,0.0,1.7796683e-06,False,EDARADD; EDAR associated via death
hsa:6667,6.0596627e-05,0.042836178645247795,0.000136134415,0.00018859099460497537,0.0,0.00067955157,False,SP1; Sp1 transcription
hsa:6206,0.0,0.0,1.444882428367742e-06,3.166032286670473e-06,0.0,1.26523655e-05,False,RPS12; ribosomal protein
hsa:2137,8.7198356e-07,0.0006164112657933774,0.0005004263509325161,0.0011973090470077912,0.0,0.0050184326,False,EXTL3; exostosin like glycosyltransferase
hsa:2895,0.0,0.0,3.0507317285483866e-07,8.050488281640448e-07,0.0,3.1881204e-06,False,GRID2; glutamate ionotropic receptor delta type subunit
hsa:11009,5.4631905e-06,0.003861967502432448,3.945388179677419e-05,0.00010051904102926023,0.0,0.00047018926,False,IL24; interleukin
hsa:1636,0.0,0.0,5.165061021290322e-05,0.00012754807466609734,0.0,0.00056003546,False,ACE; angiotensin I converting
hsa:50837,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,TAS2R7; taste 2 receptor member
hsa:90338,8.02351e-09,5.6718752303149175e-06,4.661641284032257e-08,8.096713124050348e-08,0.0,2.5940088e-07,False,ZNF160; zinc finger protein
hsa:147111,0.0,0.0,3.1486654516129035e-07,1.00792930765469e-06,0.0,5.1449733e-06,False,NOTUM; notum
hsa:84706,1.0358232e-06,0.0007322306510573969,3.131339147483871e-05,4.8309738483504e-05,0.0,0.00018438016,False,GPT2; glutamic--pyruvic transaminase
hsa:3840,0.0,0.0,7.009782947096774e-07,1.9444762769362222e-06,0.0,8.496766e-06,False,KPNA4; karyopherin subunit alpha
hsa:2516,0.0,0.0,1.1379828698967741e-05,4.3838634945169775e-05,0.0,0.00022857146,False,NR5A1; nuclear receptor subfamily 5 group A member
hsa:28984,0.0,0.0,1.1684112480645162e-07,3.171263044543538e-07,0.0,1.4890974e-06,False,RGCC; regulator of cell
hsa:1203,0.0,0.0,3.8883383363870975e-07,9.044503905977339e-07,0.0,3.9747392e-06,False,CLN5; CLN5 intracellular trafficking
hsa:974,0.0,0.0,6.752096280000001e-07,2.012298244697945e-06,0.0,1.0036811e-05,False,CD79B; CD79b
hsa:51166,0.0,0.0,3.2354974174193545e-05,8.458898587194919e-05,0.0,0.00033625026,False,AADAT; aminoadipate
hsa:3174,0.0,0.0,1.5542439351612903e-05,4.088647436647935e-05,0.0,0.00021143023,False,HNF4G; hepatocyte nuclear factor 4
hsa:84076,0.0,0.0,2.895742333870968e-07,7.315684984114076e-07,0.0,3.0682781e-06,False,TKTL2; transketolase like
hsa:405753,0.0,0.0,1.456955509677419e-06,3.909848678943015e-06,0.0,1.7856155e-05,False,DUOXA2; dual oxidase maturation factor
hsa:338675,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AP2; olfactory receptor family 5 subfamily AP member
hsa:6280,2.3293094e-06,0.0016466050755342364,9.58070029483871e-06,1.2837436785668534e-05,0.0,4.4400058e-05,False,S100A9; S100 calcium binding protein
hsa:1965,4.2602474e-06,0.003011598627417867,2.1861116822580645e-05,3.5866163861549755e-05,0.0,0.00013335531,False,EIF2S1; eukaryotic translation initiation factor 2 subunit
hsa:29116,3.932783e-07,0.00027801117570618836,5.4216871918709675e-05,0.00015491696865612805,0.0,0.00066285644,False,MYLIP; myosin regulatory light chain interacting
hsa:27127,0.0,0.0,4.1743647419354825e-08,1.0669837961995291e-07,0.0,4.3749557e-07,False,SMC1B; structural maintenance of chromosomes
hsa:201163,0.0,0.0,9.182328483870969e-07,2.3107742883174593e-06,0.0,9.19782e-06,False,FLCN;
hsa:23645,0.0,0.0,3.943721582193549e-06,1.2842160386764848e-05,0.0,6.058606e-05,False,PPP1R15A; protein phosphatase 1 regulatory subunit
hsa:1352,8.217847e-06,0.005809253412261934,7.802967061741935e-05,0.00012500180775682195,0.0,0.00048226435,False,COX10; cytochrome c oxidase assembly factor heme A:farnesyltransferase
hsa:27102,0.0,0.0,2.6780231158064513e-06,7.061215843511638e-06,0.0,2.8108678e-05,False,EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase
hsa:1031,3.0239676e-06,0.002137663806453142,2.787884868354839e-05,4.9661334159296145e-05,0.0,0.00024112758,False,CDKN2C; cyclin dependent kinase inhibitor
hsa:57192,9.869344e-07,0.0006976708170496098,2.391073564516129e-06,4.122038466320511e-06,0.0,1.8453831e-05,False,MCOLN1; mucolipin TRP cation channel
hsa:51347,0.0,0.0,2.1085052467741932e-07,5.260369013762446e-07,0.0,2.6567377e-06,False,TAOK3; TAO kinase
hsa:9040,1.569565e-07,0.00011095364554751266,7.717858051612904e-07,1.1384171644276034e-06,0.0,4.0816576e-06,False,UBE2M; ubiquitin conjugating enzyme E2
hsa:6505,0.0,0.0,2.941588261419355e-05,7.378100380786328e-05,0.0,0.00035676113,False,SLC1A1; solute carrier family 1 member
hsa:3303,7.018365e-06,0.004961331212998943,0.00014255560343870967,0.00023887466959388162,0.0,0.00071572687,False,HSPA1A; heat shock protein family A (Hsp70) member
hsa:8535,2.8858588e-07,0.00020400337316095235,5.354059375935483e-06,1.886643722355256e-05,0.0,8.416343e-05,False,CBX4; chromobox
hsa:1515,0.0,0.0,7.17503567983871e-08,2.1616684645980467e-07,0.0,9.21457e-07,False,CTSV; cathepsin
hsa:2171,0.0,0.0,5.999674289322581e-06,1.5853958820191706e-05,0.0,5.718004e-05,False,FABP5; fatty acid binding protein
hsa:1290,0.000105054845,0.07426400330778836,0.0003154808993232258,0.0005139185752279328,3.2744816e-07,0.002013504,False,COL5A2; collagen type V alpha 2
hsa:200186,0.0,0.0,9.52853754516129e-06,1.5985384769028508e-05,0.0,6.8233676e-05,False,CRTC2; CREB regulated transcription coactivator
hsa:81889,0.0,0.0,3.173903180774194e-05,9.2834570370829e-05,0.0,0.00048012976,False,FAHD1; fumarylacetoacetate hydrolase domain containing
hsa:79369,0.0,0.0,9.100143567741936e-06,1.9048016810448674e-05,0.0,7.799407e-05,False,B3GNT4; UDP-GlcNAc:betaGal beta-1
hsa:2559,0.0,0.0,0.0,0.0,0.0,0.0,False,GABRA6; gamma-aminobutyric acid type A receptor subunit
hsa:6324,0.0,0.0,1.243038680580645e-06,2.5655374572064013e-06,0.0,9.986297e-06,False,SCN1B; sodium voltage-gated channel beta subunit
hsa:286365,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR13D1; olfactory receptor family 13 subfamily D member
hsa:1588,0.00019770171,0.13975671893471847,0.00026605312779516137,0.000274707684800932,0.0,0.00093004847,False,CYP19A1; cytochrome P450 family 19 subfamily A member
hsa:92,0.0,0.0,0.0,0.0,0.0,0.0,False,ACVR2A; activin A receptor type
hsa:6883,0.0,0.0,1.1484344251935483e-05,3.566306753002346e-05,0.0,0.00016653757,False,TAF12; TATA-box binding protein associated factor
hsa:26864,0.0,0.0,1.2029012419354838e-07,2.7522771144872086e-07,0.0,1.2796373e-06,False,RNVU1-7; RNA
hsa:253260,0.0,0.0,1.257898593870968e-06,3.332641576308035e-06,0.0,1.3277741e-05,False,RICTOR; RPTOR independent companion of MTOR complex
hsa:58985,0.0,0.0,1.958084904516129e-06,7.008887680346686e-06,0.0,3.3306365e-05,False,IL22RA1; interleukin 22 receptor subunit alpha
hsa:22856,6.9008616e-05,0.048782672392595476,0.000273998352630871,0.0004442468624711015,0.0,0.0017833622,False,CHSY1; chondroitin sulfate synthase
hsa:3445,0.0,0.0,2.3168951612903226e-07,1.2899926311445574e-06,0.0,7.182375e-06,False,IFNA8; interferon alpha
hsa:5737,0.0,0.0,5.016743130322581e-06,1.199815100464198e-05,0.0,5.0972583e-05,False,PTGFR; prostaglandin F
hsa:9699,0.0,0.0,1.7792827501935485e-06,5.908314873536241e-06,0.0,2.9809014e-05,False,RIMS2; regulating synaptic membrane exocytosis
hsa:1137,0.0,0.0,1.0948499e-06,4.859269571717734e-06,0.0,2.7033831e-05,False,CHRNA4; cholinergic receptor nicotinic alpha 4
hsa:6531,0.0,0.0,1.3816342345161289e-06,4.9354534293590445e-06,0.0,2.3705823e-05,False,SLC6A3; solute carrier family 6 member
hsa:9586,6.1405844e-05,0.043408219791610136,0.00016830456706451615,0.0002582672932552734,0.0,0.0010184246,False,CREB5; cAMP responsive element binding protein
hsa:10379,2.4373845e-05,0.017230041181856205,0.0004722989145483871,0.0010280807915169854,0.0,0.0038369508,False,IRF9; interferon regulatory factor
hsa:146540,6.0216365e-10,4.2567368782877087e-07,3.077034696935484e-08,6.496222926869319e-08,0.0,2.5167827e-07,False,ZNF785; zinc finger protein
hsa:114609,6.287671e-06,0.004444798523497748,2.1947390080645162e-05,3.548754889270666e-05,0.0,0.00013521689,False,TIRAP; TIR domain containing adaptor
hsa:7516,0.0,0.0,1.7449886189354838e-06,8.00391315778351e-06,0.0,4.4435743e-05,False,XRCC2; X-ray repair cross complementing
hsa:26985,0.0,0.0,2.372219694064516e-07,7.324963767875155e-07,0.0,3.5840503e-06,False,AP3M1; adaptor related protein complex 3 subunit mu
hsa:4624,0.0,0.0,2.5866932438709683e-06,1.263442213295858e-05,0.0,7.012122e-05,False,MYH6; myosin heavy chain
hsa:29889,0.0,0.0,2.150401711483871e-06,6.623245002356591e-06,0.0,3.3095625e-05,False,GNL2; G protein nucleolar
hsa:353,2.2360544e-08,1.5806824650304773e-05,3.3921706171612907e-06,1.0297751491587727e-05,0.0,4.8430058e-05,False,APRT; adenine
hsa:904,0.0,0.0,9.460053945161292e-06,2.144203687223997e-05,0.0,0.00011160523,False,CCNT1; cyclin
hsa:163071,0.0,0.0,3.379219144193549e-09,1.1566112025968662e-08,0.0,6.242517e-08,False,ZNF114; zinc finger protein
hsa:5908,0.0,0.0,0.00014292703739032258,0.00036797403033219696,0.0,0.0013071811,False,RAP1B; RAP1B
hsa:54894,0.0,0.0,3.551169396774194e-08,9.751409729415727e-08,0.0,5.333282e-07,False,RNF43; ring finger protein
hsa:10262,0.0,0.0,8.738999087096775e-08,1.467280694740524e-07,0.0,5.5320965e-07,False,SF3B4; splicing factor 3b subunit
hsa:56919,0.0,0.0,9.617584393548386e-08,1.9892516737318462e-07,0.0,7.438229e-07,False,DHX33; DEAH-box helicase
hsa:2204,2.2063732e-06,0.0015597006175490104,6.202087077741935e-05,0.00019808955080824275,0.0,0.00097049616,False,FCAR; Fc alpha
hsa:2356,0.0,0.0,0.0001583548433548387,0.0002877299041050636,0.0,0.001008012,False,FPGS; folylpolyglutamate
hsa:2308,0.00016185499,0.1144164223243778,0.00031295013400000005,0.0004709359796507011,0.0,0.002353744,False,FOXO1; forkhead box
hsa:4830,0.0,0.0,0.00012343708299258064,0.00036377353413355034,0.0,0.001540636,False,NME1; NME/NM23 nucleoside diphosphate kinase
hsa:7005,0.00015808317,0.1117500964356824,0.0002476193893870968,0.0003305989452575112,0.0,0.0013119485,False,TEAD3; TEA domain transcription factor
hsa:8392,0.0,0.0,1.1162097695806453e-06,5.260870972425417e-06,0.0,2.9223982e-05,False,OR3A3; olfactory receptor family 3 subfamily A member
hsa:6906,0.0,0.0,2.8037016024322574e-07,1.4913286313130003e-06,0.0,8.308812e-06,False,SERPINA7; serpin family A member
hsa:23562,2.6649384e-06,0.00188386355862647,1.2804082551612903e-05,2.195879301753913e-05,0.0,9.2718874e-05,False,CLDN14; claudin
hsa:80198,4.9912975e-05,0.03528383046494959,0.0002844443380322581,0.0007574621613540527,0.0,0.003009086,False,MUS81; MUS81 structure-specific endonuclease
hsa:120892,0.0,0.0,8.389350634193548e-09,2.7953708790617462e-08,0.0,1.18644735e-07,False,LRRK2; leucine rich repeat kinase
hsa:84447,4.9259125e-07,0.0003482161933548862,3.9565116887096774e-06,1.0271009369178909e-05,0.0,4.5780165e-05,False,SYVN1; synoviolin
hsa:285641,0.0,0.0,4.8338449409677424e-08,2.629948643202609e-07,0.0,1.4651242e-06,False,SLC36A3; solute carrier family 36 member
hsa:51802,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,ASIC5; acid sensing ion channel subunit family member
hsa:8536,0.0,0.0,8.763101041935483e-07,1.977690511750622e-06,0.0,7.6033252e-06,False,CAMK1; calcium/calmodulin dependent protein kinase
hsa:10956,1.3539899e-09,9.571449123770734e-07,3.1414399619032256e-07,6.571448854964416e-07,0.0,2.6483185e-06,False,OS9; OS9 endoplasmic reticulum
hsa:23096,0.0,0.0,4.6510268377419356e-07,7.912052039330671e-07,0.0,2.4556316e-06,False,IQSEC2; IQ motif and Sec7 domain ArfGEF
hsa:30845,3.8597317e-10,2.7284712831281183e-07,1.7750472703129034e-07,3.885806458436501e-07,0.0,1.5429345e-06,False,EHD3; EH domain containing
hsa:51289,0.0,0.0,9.033546921290322e-08,3.30347821226609e-07,0.0,1.5827102e-06,False,RXFP3; relaxin family peptide receptor
hsa:340273,2.1606827e-05,0.015274016841382333,0.00032215017235806456,0.0006544284808980001,0.0,0.0029256714,False,ABCB5; ATP binding cassette subfamily B member
hsa:2213,4.3682514e-05,0.03087947408982909,0.00018662365728822582,0.0004061674801195331,0.0,0.0017401339,False,FCGR2B; Fc gamma receptor
hsa:115650,0.0,0.0,9.858110322580644e-07,4.001604414034038e-06,0.0,2.1003507e-05,False,TNFRSF13C; TNF receptor superfamily member
hsa:1459,1.8359962e-05,0.0129787853068449,7.691844464987094e-05,0.00012136441129019806,0.0,0.0005077585,False,CSNK2A2; casein kinase 2 alpha
hsa:26687,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4E1; olfactory receptor family 4 subfamily E member
hsa:51449,8.4959663e-07,0.0006005857886954746,4.999680625167742e-05,0.00010782660367633527,0.0,0.0003836067,False,PCYOX1; prenylcysteine oxidase
hsa:63893,8.248589e-09,5.830985146668738e-06,5.647723086451612e-07,1.0906793267542396e-06,0.0,3.8961734e-06,False,UBE2O; ubiquitin conjugating enzyme E2
hsa:65260,0.0,0.0,3.137884251935484e-07,8.633731582198495e-07,0.0,3.3318668e-06,False,COA7; cytochrome c oxidase assembly factor
hsa:3416,0.0,0.0,0.00021927660193548387,0.0003678006218387511,0.0,0.0012996247,False,IDE; insulin degrading
hsa:6487,0.0,0.0,0.00013870174067741935,0.00043849135525867876,0.0,0.0022995695,False,ST3GAL3; ST3 beta-galactoside alpha-2
hsa:22835,8.541102e-09,6.03776462837252e-06,3.391877459354839e-08,4.445266556161818e-08,0.0,1.2766483e-07,False,ZFP30; ZFP30 zinc finger
hsa:6882,5.525827e-07,0.00039062456815415437,2.4607533012903228e-06,4.799980378290833e-06,0.0,2.15739e-05,False,TAF11; TATA-box binding protein associated factor
hsa:5532,0.0,0.0,3.0001526483870964e-05,8.909164927461284e-05,0.0,0.00042225528,False,PPP3CB; protein phosphatase 3 catalytic subunit
hsa:7296,0.0,0.0,0.0001057432282903226,0.0001685476938262656,0.0,0.00069604226,False,TXNRD1; thioredoxin reductase
hsa:359,0.0,0.0,2.0132081273225806e-07,9.507573070941217e-07,0.0,5.310084e-06,False,AQP2; aquaporin
hsa:9367,6.9760226e-08,4.931399074850915e-05,4.7114855869032265e-06,1.2146264758715833e-05,0.0,6.0951676e-05,False,RAB9A; RAB9A
hsa:55894,0.0,0.0,5.428569593548387e-07,2.5963853873550778e-06,0.0,1.4416375e-05,False,DEFB103B; defensin beta
hsa:10963,1.1697174e-09,8.268813957393169e-07,6.479796138387095e-08,1.2130390286890416e-07,0.0,4.0207001e-07,False,STIP1; stress induced phosphoprotein
hsa:1280,0.0,0.0,1.700063435483871e-07,3.8014260335143713e-07,0.0,1.3199981e-06,False,COL2A1; collagen type II alpha 1
hsa:10075,6.493503e-08,4.590302601190202e-05,6.077259279677419e-07,1.0684119937503742e-06,0.0,3.57292e-06,False,HUWE1; HECT
hsa:2648,0.0,0.0,2.7498473522580647e-05,5.0235587215896415e-05,0.0,0.00019012531,False,KAT2A; lysine acetyltransferase
hsa:9487,0.0,0.0,2.3991124237096774e-05,7.346100931300013e-05,0.0,0.0003307371,False,PIGL; phosphatidylinositol glycan anchor biosynthesis class
hsa:8940,0.0,0.0,0.00013040557191935483,0.0003828378052192746,0.0,0.0014642355,False,TOP3B; DNA topoisomerase III
hsa:2072,1.9722695e-06,0.0013942110777646673,2.833405297225807e-05,7.395120585157721e-05,0.0,0.00035365624,False,ERCC4; ERCC excision repair 4
hsa:6879,0.0,0.0,2.011181712903226e-07,4.2015894094397755e-07,0.0,1.4500807e-06,False,TAF7; TATA-box binding protein associated factor
hsa:10933,0.0,0.0,4.0549030896322577e-07,6.467112963261679e-07,0.0,2.542501e-06,False,MORF4L1; mortality factor 4 like
hsa:90353,0.0,0.0,5.1777650284806454e-05,0.00014669172974911715,0.0,0.00061021216,False,CTU1; cytosolic thiouridylase subunit
hsa:51478,0.0,0.0,8.504331332258064e-06,1.4903309309092048e-05,0.0,4.8870494e-05,False,HSD17B7; hydroxysteroid 17-beta dehydrogenase
hsa:28965,0.0,0.0,1.2674190050322582e-05,5.021737192323004e-05,0.0,0.00028005292,False,SLC27A6; solute carrier family 27 member
hsa:5195,4.2067575e-07,0.00029737862437002644,3.3203595420612905e-06,5.494633090751396e-06,0.0,1.994072e-05,False,PEX14; peroxisomal biogenesis factor
hsa:1650,0.0,0.0,5.84976490116129e-05,0.0002295200495184873,0.0,0.0012382896,False,DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic
hsa:2330,0.0,0.0,6.9701550709677416e-06,1.9533422009302968e-05,0.0,9.984698e-05,False,FMO5; flavin containing dimethylaniline monoxygenase
hsa:406952,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR17; microRNA
hsa:8525,0.0,0.0,2.122472724193549e-05,5.336484688707147e-05,0.0,0.00027479,False,DGKZ; diacylglycerol kinase
hsa:3910,0.00015910895,0.11247522747854924,0.000478210908483871,0.0006793678330993529,0.0,0.0023745275,False,LAMA4; laminin subunit alpha
hsa:85015,0.0,0.0,3.040072408806452e-06,1.1648066877777063e-05,0.0,5.0354985e-05,False,USP45; ubiquitin specific peptidase
hsa:1845,6.578948e-08,4.650704268173139e-05,5.593294436451612e-07,9.603782895028516e-07,0.0,4.113223e-06,False,DUSP3; dual specificity phosphatase
hsa:5889,0.0,0.0,0.00015629535035483868,0.0003782419888159971,0.0,0.0014466649,False,RAD51C; RAD51 paralog
hsa:3773,0.0,0.0,2.1025176825806452e-07,5.321730222235839e-07,0.0,2.47925e-06,False,KCNJ16; potassium inwardly rectifying channel subfamily J member
hsa:22863,5.8574933e-08,4.140702904340567e-05,3.937282673612903e-06,1.2029930169251808e-05,0.0,5.2786374e-05,False,ATG14; autophagy related
hsa:29920,0.0,0.0,8.28597929032258e-07,1.6112000249541845e-06,0.0,5.783146e-06,False,PYCR2; pyrroline-5-carboxylate reductase
hsa:7188,0.0,0.0,7.0871299225806455e-06,1.8615668532581403e-05,0.0,9.8048506e-05,False,TRAF5; TNF receptor associated factor
hsa:10512,5.803838e-10,4.1027735982083236e-07,1.9675019170544198e-05,6.176016594554851e-05,0.0,0.00024754356,False,SEMA3C; semaphorin
hsa:101447996,0.0,0.0,0.0,0.0,0.0,0.0,False,RNVU1-8; RNA
hsa:2833,1.775712e-05,0.012552632088665638,9.523439144051611e-05,0.0001784724231350638,0.0,0.0007575851,False,CXCR3; C-X-C motif chemokine receptor
hsa:57403,0.0,0.0,1.89653571e-07,3.4737208324296384e-07,0.0,1.3314794e-06,False,RAB22A; RAB22A
hsa:50511,9.322396e-08,6.590066811107217e-05,1.0914394165161288e-06,2.4129156293078245e-06,0.0,1.1324042e-05,False,SYCP3; synaptonemal complex protein
hsa:128371,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6K6; olfactory receptor family 6 subfamily K member
hsa:347733,0.0,0.0,6.419601008064517e-07,1.2759438961490017e-06,0.0,5.437144e-06,False,TUBB2B; tubulin beta 2B class
hsa:838,8.6847045e-09,6.1392782380971046e-06,2.8073856874193543e-08,4.6024797502911865e-08,0.0,2.0168184e-07,False,CASP5; caspase
hsa:10326,1.5026105e-10,1.0622058520225081e-07,1.650553099380806e-05,4.5947224957547e-05,0.0,0.00023753969,False,SIRPB1; signal regulatory protein beta
hsa:441608,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5B3; olfactory receptor family 5 subfamily B member
hsa:4586,0.0,0.0,1.0662769996774193e-07,5.797351625245639e-07,0.0,3.2300268e-06,False,MUC5AC; mucin 5AC
hsa:8564,0.0,0.0,3.4484856638387094e-06,1.0382081854539406e-05,0.0,5.2181724e-05,False,KMO; kynurenine
hsa:7140,2.9259658e-08,2.06838564989245e-05,3.214346430587678e-07,8.405969608995421e-07,0.0,3.9906295e-06,False,TNNT3; troponin T3
hsa:29941,0.0,0.0,1.3251606090322583e-07,3.261536689519207e-07,0.0,1.7231085e-06,False,PKN3; protein kinase
hsa:1576,0.0,0.0,3.7411534509677417e-06,1.1456864074411387e-05,0.0,5.489966e-05,False,CYP3A4; cytochrome P450 family 3 subfamily A member
hsa:4589,0.0,0.0,6.329283998064516e-07,3.0784148469430203e-06,0.0,1.7126695e-05,False,MUC7; mucin 7
hsa:27231,0.0,0.0,5.773495593548387e-07,2.236724267494569e-06,0.0,1.21503535e-05,False,NMRK2; nicotinamide riboside kinase
hsa:728957,0.0,0.0,1.1983591612903225e-12,6.672181432103132e-12,0.0,3.7149134e-11,False,ZNF705D; zinc finger protein
hsa:10526,2.5507147e-08,1.8031180277123285e-05,2.2636299032258068e-07,6.357670901301565e-07,0.0,2.8544518e-06,False,IPO8; importin
hsa:8175,0.0,0.0,2.048612475483871e-07,3.8295481310717065e-07,0.0,1.4478072e-06,False,SF3A2; splicing factor 3a subunit
hsa:10130,0.0,0.0,3.725171129422581e-06,1.0612484351246428e-05,0.0,4.7296748e-05,False,PDIA6; protein disulfide isomerase family A member
hsa:2730,3.8148855e-06,0.0026967691912813145,0.00016039617218064514,0.0004900907372100847,0.0,0.0024492873,False,GCLM; glutamate-cysteine ligase modifier
hsa:2653,0.0,0.0,8.321797890322581e-06,1.8417169196362856e-05,0.0,6.539786e-05,False,GCSH; glycine cleavage system protein
hsa:80381,0.0,0.0,5.890724686129032e-06,1.1701031757358033e-05,0.0,4.3880736e-05,False,CD276; CD276
hsa:8837,0.0,0.0,6.411201473548387e-05,0.0002063966786188876,0.0,0.0010535805,False,CFLAR; CASP8 and FADD like apoptosis
hsa:4436,5.5284063e-06,0.003908069006717377,2.0345089041935482e-05,3.377462118215386e-05,0.0,0.00012163483,False,MSH2; mutS homolog
hsa:85365,1.067679e-07,7.547497384595271e-05,6.556436116270968e-05,0.0001611661090512658,0.0,0.00060197734,False,ALG2; ALG2
hsa:1545,0.0030184435,2.1337587815999566,0.002525246155161291,0.001986500048404605,0.0,0.0061970116,True,CYP1B1; cytochrome P450 family 1 subfamily B member
hsa:10554,0.0,0.0,9.797111451612903e-05,0.00023256028783438432,0.0,0.00091412786,False,AGPAT1; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:51808,0.0,0.0,1.4204567677419356e-07,2.3656043506284774e-07,0.0,7.994591e-07,False,PHAX; phosphorylated adaptor for RNA
hsa:23064,1.3500798e-10,9.543808353910592e-08,3.0382246417419355e-09,4.5651844545100426e-09,0.0,1.9356253e-08,False,SETX;
hsa:9887,2.1165324e-08,1.4961915288594372e-05,5.739639330161291e-07,9.485072558401441e-07,0.0,2.838206e-06,False,SMG7; SMG7 nonsense mediated mRNA decay
hsa:546,0.0,0.0,3.488291659064516e-07,6.985704133921713e-07,0.0,2.7847827e-06,False,ATRX; ATRX chromatin
hsa:3858,0.0,0.0,9.272289961290324e-06,3.466840751521628e-05,0.0,0.000186864,False,KRT10; keratin
hsa:219874,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6T1; olfactory receptor family 6 subfamily T member
hsa:629,8.1687895e-06,0.005774574323046469,5.58452703816129e-05,0.0001030851573090837,0.0,0.00033351296,False,CFB; complement factor
hsa:406978,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR199B; microRNA
hsa:101954266,0.0,0.0,1.3976260754838712e-08,5.471421121206981e-08,0.0,2.7104258e-07,False,RNVU1-14; RNA
hsa:9128,0.0,0.0,3.5491271841935485e-07,8.913001290110015e-07,0.0,3.3333897e-06,False,PRPF4; pre-mRNA processing factor
hsa:7360,0.0,0.0,0.0002327676795612903,0.0005223906831002793,0.0,0.0019300656,False,UGP2; UDP-glucose pyrophosphorylase
hsa:118672,0.0,0.0,1.1699655006451612e-05,2.80041945996362e-05,0.0,9.6383286e-05,False,PSTK; phosphoseryl-tRNA
hsa:7562,5.842781e-09,4.130302676765483e-06,2.5720788599999995e-08,3.871737906335636e-08,0.0,1.469213e-07,False,ZNF708; zinc finger protein
hsa:23186,0.0,0.0,2.4513028687096773e-08,5.7050229580137585e-08,0.0,2.091595e-07,False,RCOR1; REST corepressor
hsa:331,0.0,0.0,2.914017451612903e-05,6.921470092992027e-05,0.0,0.00021391195,False,XIAP; X-linked inhibitor of
hsa:1143,0.0,0.0,3.341365783870968e-06,6.642744572186992e-06,0.0,2.5493582e-05,False,CHRNB4; cholinergic receptor nicotinic beta 4
hsa:5583,2.2962943e-06,0.0016232664708691498,6.023423796903226e-05,0.000139922049457196,0.0,0.0006211462,False,PRKCH; protein kinase C
hsa:343702,0.0,0.0,5.456706316129032e-08,1.7651403432996108e-07,0.0,8.297858e-07,False,XKR7; XK related
hsa:7743,0.0,0.0,1.1518452601290321e-07,3.3247972923319367e-07,0.0,1.3507092e-06,False,ZNF189; zinc finger protein
hsa:6066,0.0,0.0,6.162909572580645e-09,3.1237202695975714e-08,0.0,1.7427132e-07,False,RNU2-1; RNA
hsa:7019,0.0,0.0,4.103231810451613e-06,7.21626917031475e-06,0.0,2.461027e-05,False,TFAM; transcription factor A
hsa:846,0.0,0.0,2.5569759e-08,9.28662052562158e-08,0.0,5.1638267e-07,False,CASR; calcium sensing
hsa:81282,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR51G2; olfactory receptor family 51 subfamily G member
hsa:27300,0.0,0.0,1.4748226612903227e-07,3.0202153586124257e-07,0.0,1.3089884e-06,False,ZNF544; zinc finger protein
hsa:55660,0.0,0.0,5.150029208064516e-07,1.3251256124752153e-06,0.0,4.704108e-06,False,PRPF40A; pre-mRNA processing factor 40 homolog
hsa:6118,3.3026616e-05,0.023346745405878763,0.00032701371187870976,0.0006917274681483647,0.0,0.002677365,False,RPA2; replication protein
hsa:407042,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34C; microRNA
hsa:2274,5.9848145e-07,0.00042307071494370363,1.2701801882064514e-05,3.331329339877848e-05,0.0,0.00014698575,False,FHL2; four and a half LIM domains
hsa:55630,2.6649257e-05,0.018838545809078126,8.46467847e-05,0.00010955191667748612,0.0,0.00041697576,False,SLC39A4; solute carrier family 39 member
hsa:113835,2.624105e-10,1.8549981431126182e-07,5.2240343022580644e-09,1.0187221623307888e-08,0.0,3.608848e-08,False,ZNF257; zinc finger protein
hsa:5608,0.0,0.0,1.089657298387097e-05,2.1521182343023313e-05,0.0,7.403005e-05,False,MAP2K6; mitogen-activated protein kinase kinase
hsa:4125,3.2862234e-05,0.023230542622544585,0.00011894868492580646,0.0001682554283800449,0.0,0.00066387997,False,MAN2B1; mannosidase alpha class 2B member
hsa:64969,1.2006713e-08,8.487629237353742e-06,2.7773662184516134e-07,8.261234569925945e-07,0.0,3.7134348e-06,False,MRPS5; mitochondrial ribosomal protein
hsa:7337,5.604081e-07,0.00039615639804248335,1.1737782962e-06,1.6316784388686773e-06,0.0,6.0554044e-06,False,UBE3A; ubiquitin protein ligase
hsa:5506,0.0,0.0,4.827093548387097e-10,2.6876119434756396e-09,0.0,1.496399e-08,False,PPP1R3A; protein phosphatase 1 regulatory subunit
hsa:51429,3.450314e-08,2.4390510528944043e-05,9.447991220322581e-07,2.172709312303372e-06,0.0,9.335622e-06,False,SNX9; sorting nexin
hsa:26762,0.0,0.0,8.295452902903228e-06,2.3379085894262146e-05,0.0,0.00011231031,False,HAVCR1; hepatitis A virus cellular receptor
hsa:6628,0.0,0.0,4.629721449354838e-06,1.2393824465492052e-05,0.0,5.3675663e-05,False,SNRPB; small nuclear ribonucleoprotein polypeptides B and
hsa:348,6.1891747e-06,0.004375170801435003,0.00011162042624645162,0.00021992955620754522,0.0,0.00086677156,False,APOE; apolipoprotein
hsa:10627,2.9234969e-05,0.020666403672473077,8.728465112258063e-05,0.00014375023971552423,0.0,0.0005968415,False,MYL12A; myosin light chain
hsa:195814,0.0,0.0,1.3643485949551615e-05,3.805910449448146e-05,0.0,0.00016285376,False,SDR16C5; short chain dehydrogenase/reductase family 16C member
hsa:219873,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10S1; olfactory receptor family 10 subfamily S member
hsa:51684,0.0,0.0,5.496629608064516e-05,9.914767424008066e-05,0.0,0.000326959,False,SUFU; SUFU negative regulator of hedgehog
hsa:11051,0.0,0.0,2.8804109735483866e-07,6.874314944404881e-07,0.0,3.402848e-06,False,NUDT21; nudix hydrolase
hsa:2027,1.3280297e-07,9.387934657715327e-05,3.0608229568709682e-06,4.996459154947829e-06,0.0,1.6744802e-05,False,ENO3; enolase
hsa:8529,0.0,0.0,1.998144076935484e-07,6.350007362686832e-07,-0.0,3.2332005e-06,False,CYP4F2; cytochrome P450 family 4 subfamily F member
hsa:1373,0.0,0.0,2.2498138206451614e-05,5.4505791169292157e-05,0.0,0.00026474555,False,CPS1; carbamoyl-phosphate synthase
hsa:83943,7.1595605e-07,0.0005061143297620503,1.8133585771935488e-05,5.670755678953811e-05,0.0,0.00028875997,False,IMMP2L; inner mitochondrial membrane peptidase subunit
hsa:5689,9.000347e-07,0.0006362408124815595,7.647669264838708e-06,1.128400082805581e-05,0.0,3.8311016e-05,False,PSMB1; proteasome 20S subunit beta
hsa:4762,0.0,0.0,7.66961935483871e-12,4.2702633320342365e-11,0.0,2.377582e-10,False,NEUROG1; neurogenin
hsa:1672,0.0,0.0,2.6359432258064516e-07,1.4676310755088378e-06,0.0,8.171424e-06,False,DEFB1; defensin beta
hsa:10383,0.0,0.0,8.569533251612904e-06,1.898912040449762e-05,0.0,6.8402784e-05,False,TUBB4B; tubulin beta 4B class
hsa:5971,3.899791e-06,0.002756789481948055,2.6523930877419357e-05,4.2418896060825325e-05,0.0,0.00015464844,False,RELB; RELB proto-oncogene
hsa:22934,0.0,0.0,1.4743962664516126e-06,4.318751951654661e-06,0.0,1.994017e-05,False,RPIA; ribose 5-phosphate isomerase
hsa:3906,0.0,0.0,2.993454909677419e-08,1.5695654013595132e-07,-0.0,8.740306e-07,False,LALBA; lactalbumin
hsa:688,0.0,0.0,2.0392363802096775e-07,6.367723728169888e-07,0.0,3.3036504e-06,False,KLF5; KLF transcription factor
hsa:727936,0.0,0.0,0.00013711543915741938,0.00041089306630097275,0.0,0.001611364,False,GXYLT2; glucoside xylosyltransferase
hsa:64834,2.6075053e-05,0.01843263699301785,0.00038278002540741943,0.0009689671346626561,0.0,0.004332439,False,ELOVL1; ELOVL fatty acid elongase
hsa:345611,1.9177613e-09,1.355678850668415e-06,4.1842369519354844e-08,8.789280849729247e-08,0.0,3.566596e-07,False,IRGM; immunity related GTPase
hsa:113612,0.0,0.0,0.00011005324221612904,0.0002411068516093373,0.0,0.0008166831,False,CYP2U1; cytochrome P450 family 2 subfamily U member
hsa:7380,0.0,0.0,4.345916468387097e-06,1.015580950028593e-05,0.0,5.0028986e-05,False,UPK3A; uroplakin
hsa:762,0.0,0.0,1.6585614867741938e-05,3.437698143929084e-05,0.0,0.00013986145,False,CA4; carbonic anhydrase
hsa:53981,8.760322e-09,6.192732776725254e-06,1.416313925483871e-07,2.0204585733633687e-07,0.0,7.23082e-07,False,CPSF2; cleavage and polyadenylation specific factor
hsa:9415,1.2989807e-05,0.009182585248833905,0.0004912936098387098,0.0012727941996723761,0.0,0.0055145454,False,FADS2; fatty acid desaturase
hsa:10288,3.145334e-06,0.002223458561859752,1.6196324548387096e-05,2.233862390492582e-05,0.0,9.148787e-05,False,LILRB2; leukocyte immunoglobulin like receptor
hsa:2788,0.000111928915,0.07912333137797845,0.00045184153538709677,0.0006394187669476212,0.0,0.001963459,False,GNG7; G protein subunit gamma
hsa:406922,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A1; microRNA
hsa:23200,0.0,0.0,1.6442103671451618e-05,5.093905289611405e-05,0.0,0.00017852506,False,ATP11B; ATPase phospholipid transporting 11B
hsa:2065,9.011012e-06,0.006369947287766886,5.68398622032258e-05,8.959396498701447e-05,0.0,0.00031868825,False,ERBB3; erb-b2 receptor tyrosine kinase
hsa:83706,3.6786753e-07,0.0002600481250031632,4.0043449225806456e-07,3.898392602600961e-07,0.0,1.252757e-06,False,FERMT3; FERM domain containing kindlin
hsa:25796,0.0,0.0,2.0522628354838707e-06,3.863783210269192e-06,0.0,1.5586673e-05,False,PGLS;
hsa:90827,-0.0,0.0,2.6924268935483876e-10,1.4399028499866965e-09,0.0,8.0212885e-09,False,ZNF479; zinc finger protein
hsa:5831,0.0,0.0,4.076571253325806e-06,1.1679077390924889e-05,0.0,5.6884044e-05,False,PYCR1; pyrroline-5-carboxylate reductase
hsa:10093,1.8127083e-07,0.00012814161516040064,6.371317093596775e-05,0.00012712438145892296,0.0,0.0004681725,False,ARPC4; actin related protein 2/3 complex subunit
hsa:6513,0.00017735931,0.1253765343664736,0.0004105573035483871,0.0005723244602293338,0.0,0.002616272,False,SLC2A1; solute carrier family 2 member
hsa:143471,1.454814e-08,1.0284181725099572e-05,1.684833151e-07,3.7819185620394217e-07,0.0,1.8171875e-06,False,PSMA8; proteasome 20S subunit alpha
hsa:2532,9.963941e-07,0.0007043579450168225,2.9298631892e-05,6.746902841448391e-05,0.0,0.00027740374,False,ACKR1; atypical chemokine receptor 1 (Duffy blood
hsa:5861,3.4135664e-07,0.00024130739179231112,3.0025621698290323e-05,5.239302897199468e-05,0.0,0.0001608109,False,RAB1A; RAB1A
hsa:284309,0.0,0.0,1.1570872180645163e-07,2.6196059616394735e-07,0.0,9.607387e-07,False,ZNF776; zinc finger protein
hsa:3061,1.1558515e-08,8.17079494232866e-06,3.2541452029354846e-07,5.208096697430391e-07,0.0,1.8420261e-06,False,HCRTR1; hypocretin receptor
hsa:814,0.0,0.0,3.175616364516129e-06,8.241692192757454e-06,0.0,3.9711398e-05,False,CAMK4; calcium/calmodulin dependent protein kinase
hsa:79837,0.0,0.0,4.6450569903225805e-06,1.0065091498062739e-05,0.0,3.7104208e-05,False,PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:27090,0.0,0.0,0.0005065156722580646,0.001124788799153291,0.0,0.00494344,False,ST6GALNAC4; ST6 N-acetylgalactosaminide alpha-2
hsa:28973,0.0,0.0,1.944477747741935e-07,4.4699553796324246e-07,0.0,1.7144184e-06,False,MRPS18B; mitochondrial ribosomal protein
hsa:79784,8.804841e-07,0.0006224203568607907,3.549341801898387e-05,6.669618680220081e-05,0.0,0.0002690475,False,MYH14; myosin heavy chain
hsa:26692,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2W1; olfactory receptor family 2 subfamily W member
hsa:390155,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5T1; olfactory receptor family 5 subfamily T member
hsa:11197,0.0,0.0,2.0366986891290323e-07,9.321844986878426e-07,0.0,5.1696297e-06,False,WIF1; WNT inhibitory factor
hsa:4731,2.2538193e-06,0.0015932405968554543,2.747504841935484e-06,3.367926840743462e-06,0.0,1.526505e-05,False,NDUFV3; NADH:ubiquinone oxidoreductase subunit
hsa:10686,0.0,0.0,8.21419945932258e-07,3.2537220954665666e-06,0.0,1.7749859e-05,False,CLDN16; claudin
hsa:468,2.6497893e-05,0.01873154554082129,0.0006980939575161291,0.0009412093861604065,0.0,0.0030794083,False,ATF4; activating transcription factor
hsa:123041,5.7559355e-06,0.004068910986555797,0.00014817630933935486,0.00038322043194956166,0.0,0.0020103368,False,SLC24A4; solute carrier family 24 member
hsa:55334,0.0,0.0,1.599302674866452e-07,4.0744817117437464e-07,0.0,1.7948832e-06,False,SLC39A9; solute carrier family 39 member
hsa:644672,0.0,0.0,2.8334035483870967e-09,1.577572330222581e-08,0.0,8.783551e-08,False,CLDN25; claudin
hsa:406983,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200A; microRNA
hsa:7915,0.0,0.0,1.3670464677419353e-06,3.865761662603298e-06,0.0,1.8039676e-05,False,ALDH5A1; aldehyde dehydrogenase 5 family member
hsa:9668,3.804325e-09,2.6893039001095277e-06,3.197602900967742e-08,4.794589047999472e-08,0.0,2.021733e-07,False,ZNF432; zinc finger protein
hsa:4485,4.592767e-08,3.246659053943692e-05,9.170437248387097e-07,1.3855679393869363e-06,0.0,4.7726267e-06,False,MST1; macrophage stimulating
hsa:3448,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA14; interferon alpha
hsa:5826,1.9073299e-05,0.013483048211878625,0.0008822959273225808,0.0020119684402457295,0.0,0.008697783,False,ABCD4; ATP binding cassette subfamily D member
hsa:1438,0.00010702191,0.07565453528817093,0.00031230532873680636,0.0004842978132941686,0.0,0.0021079343,False,CSF2RA; colony stimulating factor 2 receptor subunit
hsa:3714,0.0,0.0,3.2130851958064506e-05,8.646406398406652e-05,0.0,0.00036096157,False,JAG2; jagged canonical Notch ligand
hsa:1947,3.174852e-07,0.0002244325042121936,6.527411288612902e-06,2.217096362569679e-05,0.0,0.00011794205,False,EFNB1; ephrin
hsa:7652,1.6683363e-11,1.1793585769576204e-08,2.186561531935484e-10,3.7618222480472807e-10,0.0,1.59308e-09,False,ZNF99; zinc finger protein
hsa:442902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR330; microRNA
hsa:55278,4.8481184e-07,0.0003427168741186088,4.232807038709677e-06,1.168919788273615e-05,0.0,5.4227097e-05,False,QRSL1; glutaminyl-tRNA amidotransferase subunit
hsa:23152,0.0,0.0,1.5170379039032257e-07,2.861053908377642e-07,0.0,9.754554e-07,False,CIC; capicua transcriptional
hsa:346171,0.0,0.0,3.1856617525806456e-09,1.5223353560996423e-08,0.0,8.4925716e-08,False,ZFP57; ZFP57 zinc finger
hsa:100289462,0.0,0.0,6.891705806451613e-09,3.8371393988270036e-08,0.0,2.1364288e-07,False,DEFB4B; defensin beta
hsa:9734,0.0,0.0,1.331307364516129e-05,5.3847851098856025e-05,0.0,0.00029799753,False,HDAC9; histone deacetylase
hsa:7307,1.1033178e-07,7.799430549703992e-05,3.13471212516129e-07,4.439824087219786e-07,0.0,1.6795143e-06,False,U2AF1; U2 small nuclear RNA auxiliary factor
